data_2kpu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kpu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 . . . . . 0 C--O 1.233 0.232 0 CA-C-O 121.341 0.591 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.72 152.97 59.37 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.603 2.202 . . . . 0.0 112.051 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.6 m -107.39 113.13 26.3 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.707 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.479 HD21 HD22 ' A' ' 41' ' ' ASN . 93.1 mt -90.23 127.84 36.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.087 0.47 . . . . 0.0 110.511 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -103.64 102.93 12.8 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.305 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -102.89 144.14 31.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.286 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.2 m -76.86 143.96 39.33 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.798 HD13 HG12 ' A' ' 53' ' ' VAL . 52.7 tp -88.32 127.32 35.48 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.8 pt -122.77 171.17 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.933 0.396 . . . . 0.0 110.842 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.485 ' HB3' ' OG1' ' A' ' 20' ' ' THR . . . -107.11 122.21 46.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.158 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -114.95 139.89 49.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.594 0.235 . . . . 0.0 110.679 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.8 t30 56.13 32.04 19.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.392 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.485 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 89.6 m -90.02 114.74 61.96 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.311 -176.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.7 163.87 37.54 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.758 2.306 . . . . 0.0 111.561 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.92 -13.29 59.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.855 0.36 . . . . 0.0 110.598 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -67.19 -35.02 78.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.885 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.8 p -95.24 102.67 14.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.602 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 52.6 ttp -102.79 111.98 24.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.061 0.458 . . . . 0.0 110.56 -174.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.6 mt -75.44 113.46 14.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.414 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 84.9 mtp -99.78 10.86 40.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.426 0.631 . . . . 0.0 110.103 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.3 m -105.39 119.19 38.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.827 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -60.78 136.07 57.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.713 0.292 . . . . 0.0 110.335 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.7 mt -81.86 122.9 80.47 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.419 -171.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.502 ' HD2' HD22 ' A' ' 15' ' ' LEU . 87.4 Cg_endo -83.55 -164.88 0.28 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.207 2.605 . . . . 0.0 112.803 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.2 t -125.35 144.91 50.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.074 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.21 144.42 14.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.808 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 35.6 mtm-85 -118.08 99.21 6.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 80' ' ' ILE . 21.2 m -98.85 128.76 50.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.328 0.585 . . . . 0.0 111.497 -174.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.467 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 85.4 tttt -80.6 124.26 28.83 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.453 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 13.1 p -126.11 138.91 53.72 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -173.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.845 ' HB2' ' HB2' ' A' ' 76' ' ' LYS . 40.1 mt-10 -93.95 89.62 6.15 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 172.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.7 136.56 2.02 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -104.39 135.8 45.16 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.101 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.597 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 6.1 p30 -135.07 102.49 10.97 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 121.329 0.585 . . . . 0.0 111.158 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -88.01 -10.05 5.13 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.341 2.027 . . . . 0.0 111.693 174.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.9 p -113.19 -45.08 3.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.508 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.597 ' HB ' ' HB2' ' A' ' 41' ' ' ASN . 57.1 mt -57.85 136.5 21.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 120.96 0.41 . . . . 0.0 110.666 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.418 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 14.3 m120 -101.67 147.38 26.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.816 -176.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.9 m -80.85 -5.88 9.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.293 0.568 . . . . 0.0 110.042 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -93.01 -19.27 21.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.996 169.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 76.9 tt0 -80.78 -32.61 35.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.219 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.6 mt -94.37 138.52 32.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.234 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -133.3 152.65 51.94 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.388 0.613 . . . . 0.0 111.552 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . . . -110.78 125.08 53.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.505 171.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -121.24 159.41 26.01 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.309 0.576 . . . . 0.0 111.718 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.798 HG12 HD13 ' A' ' 15' ' ' LEU . 11.4 m -112.5 123.52 68.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.048 171.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.0 110.47 12.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.441 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.421 HD22 HD11 ' A' ' 89' ' ' LEU . 55.4 mt -106.87 29.31 7.14 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.693 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m -57.85 -43.78 86.12 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.758 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.81 84.76 1.3 Allowed Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.6 p -71.09 91.09 0.89 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.045 0.45 . . . . 0.0 111.995 -173.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -101.33 107.73 52.0 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.01 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.32 152.18 75.83 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.904 2.402 . . . . 0.0 112.292 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.05 -179.38 20.52 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 88' ' ' GLN . 32.2 tt0 -80.14 102.98 9.7 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 176.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -129.12 143.34 50.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.593 -172.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.487 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 26.8 m-20 -81.74 124.98 30.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.226 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.474 ' HH ' HD13 ' A' ' 89' ' ' LEU . 75.2 m-85 -120.92 151.18 40.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.463 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.13 134.52 34.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.124 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.468 HG12 HD11 ' A' ' 15' ' ' LEU . 68.7 t -79.13 106.4 10.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 174.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -99.67 106.08 17.97 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.517 -177.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 42.4 t -87.12 134.9 26.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.088 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -63.73 135.33 96.24 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.323 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.54 132.3 44.76 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.083 2.522 . . . . 0.0 112.61 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.7 mp -97.53 121.05 59.36 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.052 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.56 119.32 6.47 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.979 2.453 . . . . 0.0 113.0 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.3 m120 69.17 15.08 8.68 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.207 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.499 HD12 ' HB3' ' A' ' 41' ' ' ASN . 57.4 mt -129.53 130.12 67.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.845 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 97.1 mttt -80.89 137.42 36.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.855 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.8 tt -93.41 116.88 35.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.408 0.623 . . . . 0.0 109.659 172.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.7 t -95.63 -50.29 11.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.253 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.467 ' HB2' ' H ' ' A' ' 36' ' ' LYS . 50.1 mt-10 -118.76 157.74 26.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.087 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.545 ' HA ' HG12 ' A' ' 35' ' ' VAL . 18.9 tt -144.55 25.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 122.163 0.982 . . . . 0.0 108.985 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.516 ' HA ' ' N ' ' A' ' 83' ' ' ARG . 16.1 m -85.79 142.86 37.19 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.377 -175.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 81' ' ' SER . 17.4 Cg_exo -67.15 124.39 5.97 Favored 'Cis proline' 0 C--N 1.346 0.425 0 C-N-CA 123.633 -1.403 . . . . 0.0 111.921 -1.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.516 ' N ' ' HA ' ' A' ' 81' ' ' SER . 70.3 mtm180 -69.72 -31.14 68.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.712 -173.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.487 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 43.9 t -127.58 134.98 64.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.699 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 m -120.73 133.26 67.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.195 0.521 . . . . 0.0 110.453 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.43 HG23 ' HG2' ' A' ' 62' ' ' GLU . 4.2 m -87.26 101.38 13.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.983 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.3 mt -107.05 134.52 50.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.226 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 62.4 tt0 -95.34 103.12 14.97 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.013 0.435 . . . . 0.0 110.443 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.474 HD13 ' HH ' ' A' ' 65' ' ' TYR . 49.4 mt -82.46 120.05 24.97 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.474 175.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.62 149.88 23.3 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.1 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -71.0 124.53 24.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.504 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 . . . . . 0 C--N 1.321 -0.672 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.792 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.433 ' HB3' ' HA ' ' A' ' 38' ' ' GLU . 10.2 m-20 . . . . . 0 N--CA 1.467 0.39 0 CA-C-O 121.145 0.498 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.18 147.88 23.82 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.647 2.231 . . . . 0.0 113.567 -173.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 67.9 m -90.72 109.18 20.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.522 171.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.6 mt -83.12 138.51 33.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.217 0.532 . . . . 0.0 110.876 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.3 m -109.96 102.05 10.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.926 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.412 ' HB2' ' CG1' ' A' ' 33' ' ' VAL . 44.3 mt -101.78 155.3 18.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.106 -176.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 m -88.53 143.48 26.94 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.805 HD12 HG11 ' A' ' 53' ' ' VAL . 52.6 tp -94.91 127.04 40.65 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.7 pt -124.05 160.61 27.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.036 0.446 . . . . 0.0 111.392 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.33 115.73 26.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.308 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 18.3 tptm -114.29 141.12 47.99 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 63.34 20.95 12.56 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.67 0.606 . . . . 0.0 110.579 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 43.1 m -83.17 118.77 72.66 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.845 -173.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 2.9 Cg_exo -76.12 154.58 37.44 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.298 2.665 . . . . 0.0 112.194 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.9 -1.93 21.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.224 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -80.92 -29.12 35.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.071 0.463 . . . . 0.0 110.553 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.8 p -107.16 128.71 54.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.152 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.765 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 58.0 ttp -119.11 126.78 52.44 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.033 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.453 HG12 ' CD2' ' A' ' 89' ' ' LEU . 13.9 mt -84.83 115.14 26.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.558 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 94.1 mmm -80.63 -7.98 59.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.306 0.574 . . . . 0.0 110.189 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.2 m -99.23 118.39 35.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.579 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -66.31 132.89 49.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.781 0.324 . . . . 0.0 110.677 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.4 mt -75.45 122.26 86.85 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.415 -173.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.479 ' HD2' HD21 ' A' ' 15' ' ' LEU . 95.2 Cg_endo -89.49 -157.71 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.183 2.588 . . . . 0.0 112.628 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.5 p -113.71 160.63 18.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.412 ' CG1' ' HB2' ' A' ' 13' ' ' LEU . 11.3 p -112.91 139.4 38.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.83 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -111.31 109.59 19.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.061 0.458 . . . . 0.0 110.8 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.519 HG11 ' HA ' ' A' ' 80' ' ' ILE . 25.2 m -117.24 111.69 35.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.085 -177.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 6.5 ttpm? -74.77 125.95 29.86 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 174.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.506 HG22 ' HA ' ' A' ' 77' ' ' ILE . 25.3 p -124.66 138.07 54.32 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.056 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.433 ' HA ' ' HB3' ' A' ' 8' ' ' ASP . 48.9 mt-10 -94.64 135.46 36.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.366 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.35 -168.4 12.89 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.832 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -132.9 140.2 47.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.914 0.388 . . . . 0.0 110.673 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.568 ' N ' HD21 ' A' ' 41' ' ' ASN . 0.0 OUTLIER -160.92 80.47 2.19 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.996 178.519 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.66 -24.28 11.96 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.881 2.387 . . . . 0.0 112.53 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.9 p -84.35 -12.98 53.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.695 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.4 mt -103.21 111.08 31.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -95.47 151.72 19.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.096 0.474 . . . . 0.0 111.745 -174.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.5 m -69.4 -13.47 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.358 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -85.5 -9.63 57.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.24 0.543 . . . . 0.0 109.707 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -105.22 -26.33 12.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.754 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.41 ' HB2' HD21 ' A' ' 13' ' ' LEU . 91.2 mt -88.64 132.32 34.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.831 175.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -125.19 154.06 42.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.613 0.72 . . . . 0.0 111.791 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -120.85 134.98 55.28 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.494 171.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.544 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 18.9 p90 -129.12 161.02 31.01 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.321 0.581 . . . . 0.0 111.411 -174.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.805 HG11 HD12 ' A' ' 15' ' ' LEU . 5.7 m -112.29 118.38 57.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -78.06 105.08 9.03 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.526 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.61 ' HB3' ' HB2' ' A' ' 58' ' ' SER . 64.0 mt -104.73 35.57 2.72 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.755 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.0 m -60.28 -38.63 84.18 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.56 53.33 0.78 Allowed Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.276 173.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.61 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 23.1 t -74.18 107.08 6.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.049 0.452 . . . . 0.0 110.865 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -104.69 126.2 31.91 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.26 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.3 141.23 81.57 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.961 2.441 . . . . 0.0 111.932 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.44 175.29 19.17 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.45 107.77 13.52 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -134.0 156.78 47.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.982 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -95.7 125.84 40.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.194 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.548 ' HH ' HD12 ' A' ' 89' ' ' LEU . 96.5 m-85 -121.7 161.68 22.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.823 0.344 . . . . 0.0 110.664 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -93.86 138.13 32.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.987 -175.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.1 t -88.35 121.29 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.985 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -105.06 127.12 52.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.002 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.14 138.64 35.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.14 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -68.59 139.48 91.55 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.62 150.5 86.4 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.113 2.542 . . . . 0.0 112.577 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.474 ' HB ' ' HB ' ' A' ' 75' ' ' ILE . 11.5 mt -122.26 118.58 28.89 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.9 114.81 2.09 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 123.277 2.651 . . . . 0.0 113.479 -175.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.3 m120 70.85 11.37 7.11 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.321 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.474 ' HB ' ' HB ' ' A' ' 72' ' ' ILE . 41.3 mm -107.81 121.79 61.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.12 0.486 . . . . 0.0 110.472 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -80.66 114.81 19.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.425 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.506 ' HA ' HG22 ' A' ' 37' ' ' THR . 16.0 tt -87.94 115.7 28.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.466 0.651 . . . . 0.0 109.918 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.98 -53.02 9.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.64 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' A' ' 36' ' ' LYS . 66.8 mm-40 -106.64 146.76 30.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.509 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.558 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 26.8 mt -133.71 81.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 165.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 17.7 m -118.58 116.34 35.01 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.719 -175.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 72.8 Cg_endo -94.33 158.33 17.42 Favored 'Cis proline' 0 C--N 1.346 0.41 0 C-N-CA 124.131 -1.195 . . . . 0.0 113.302 -0.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 80' ' ' ILE . 61.2 mtm180 -96.43 -31.99 12.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.592 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.0 t -119.84 122.17 67.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.019 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.1 m -121.55 138.86 50.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.6 m -88.81 102.73 15.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.067 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.6 mt -101.22 128.44 47.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.016 0.436 . . . . 0.0 110.933 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -91.36 103.6 16.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.183 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.548 HD12 ' HH ' ' A' ' 65' ' ' TYR . 96.0 mt -97.05 128.68 44.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.064 0.459 . . . . 0.0 110.728 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -119.33 178.76 4.41 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.482 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -80.55 114.79 19.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.281 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.765 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 74.5 t60 . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 121.245 0.545 . . . . 0.0 109.66 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.474 ' HB3' ' HG2' ' A' ' 38' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.24 151.59 12.22 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.676 2.917 . . . . 0.0 113.509 -170.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 37.9 m -95.25 109.88 21.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.632 174.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.8 mt -87.43 137.99 31.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.027 0.441 . . . . 0.0 110.603 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 m -102.63 95.77 6.44 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.071 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.1 mt -101.74 120.11 39.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.192 -175.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 48.6 m -63.35 140.81 58.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.879 0.371 . . . . 0.0 111.406 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.81 HD13 HG11 ' A' ' 53' ' ' VAL . 40.3 tp -84.01 123.58 30.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.788 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.4 pt -109.83 146.17 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.04 0.448 . . . . 0.0 111.58 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.6 94.16 5.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.126 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -96.31 131.51 42.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.026 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.1 t30 58.62 39.18 24.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.755 0.788 . . . . 0.0 109.933 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 63.8 m -88.59 124.81 65.04 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.638 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.853 ' HG2' ' HB3' ' A' ' 58' ' ' SER . 17.0 Cg_exo -67.51 175.76 5.69 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.0 2.466 . . . . 0.0 112.756 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 92' ' ' HIS . . . -94.2 -6.59 44.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.88 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -88.65 -23.64 22.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.018 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.9 p -114.74 112.45 22.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.834 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.0 ttp -105.69 132.7 51.51 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.7 mt -81.31 118.77 29.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 120.759 0.314 . . . . 0.0 110.718 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 83.6 mtp -74.18 -52.5 12.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.106 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 m -70.27 110.14 5.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.4 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -63.26 133.96 55.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.089 0.471 . . . . 0.0 110.63 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.432 HD23 HD22 ' A' ' 15' ' ' LEU . 50.3 mt -71.54 129.41 88.69 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.454 -173.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -92.32 -170.89 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.37 2.713 . . . . 0.0 111.933 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 24.8 m -105.39 135.6 46.47 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.525 HG12 HG13 ' A' ' 67' ' ' VAL . 10.9 m -86.26 145.22 8.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.789 0.328 . . . . 0.0 110.201 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.5 mtp85 -111.51 101.59 10.0 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.123 0.487 . . . . 0.0 109.937 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 80' ' ' ILE . 26.8 m -110.7 137.04 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.757 -177.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 61.1 tttp -85.9 129.66 34.77 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.2 p -126.36 175.22 8.0 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.174 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.474 ' HG2' ' HB3' ' A' ' 8' ' ' ASP . 35.8 mt-10 -139.07 137.63 36.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.704 0.288 . . . . 0.0 110.651 176.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.5 -175.28 17.46 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.552 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -118.15 126.64 52.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.648 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 4.2 p30 -130.48 62.69 66.2 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.166 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.52 -29.83 36.55 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.139 1.893 . . . . 0.0 111.954 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.8 p -91.15 -1.25 57.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.57 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.648 ' HB ' ' HB2' ' A' ' 41' ' ' ASN . 61.2 mt -109.95 126.64 67.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.777 0.322 . . . . 0.0 110.47 -178.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.416 ' ND2' ' HG3' ' A' ' 48' ' ' GLU . 39.8 t30 -85.58 110.92 19.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.405 0.621 . . . . 0.0 110.912 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.6 t -59.93 -27.35 38.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.336 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -71.02 -28.03 64.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.862 0.363 . . . . 0.0 111.174 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.416 ' HG3' ' ND2' ' A' ' 45' ' ' ASN . 40.9 mt-10 -91.3 -12.17 35.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.096 0.474 . . . . 0.0 110.652 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 93.6 mt -77.06 129.7 36.42 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 167.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -131.92 162.38 30.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.86 0.838 . . . . 0.0 112.564 -174.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -109.74 127.86 54.9 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.907 169.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -123.66 144.03 49.89 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.355 0.598 . . . . 0.0 112.036 -172.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.81 HG11 HD13 ' A' ' 15' ' ' LEU . 7.0 m -112.47 131.48 63.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.159 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.53 115.73 28.39 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.679 -0.408 . . . . 0.0 109.982 -175.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 66.1 mt -105.6 51.97 0.74 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.44 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.1 m -57.32 -47.33 81.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.307 0.575 . . . . 0.0 109.661 173.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.11 100.14 2.47 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.501 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.853 ' HB3' ' HG2' ' A' ' 21' ' ' PRO . 1.5 p -73.18 87.8 1.45 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.969 0.414 . . . . 0.0 110.5 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -102.82 110.21 62.86 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.08 -174.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.95 141.32 57.95 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.59 2.194 . . . . 0.0 112.294 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.22 -172.24 17.64 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.67 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.496 ' HG3' ' HG2' ' A' ' 88' ' ' GLN . 1.9 mp0 -87.46 89.15 7.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.789 0.328 . . . . 0.0 110.253 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 38.1 m-70 -104.97 148.35 26.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.442 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -92.19 122.76 34.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.998 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -118.87 147.66 43.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.694 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.501 ' HG2' HG21 ' A' ' 84' ' ' VAL . 36.2 mt-10 -93.79 132.19 38.42 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.888 0.375 . . . . 0.0 110.513 -172.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.525 HG13 HG12 ' A' ' 33' ' ' VAL . 59.8 t -73.22 106.83 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.647 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -86.97 109.48 19.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.804 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.76 123.26 39.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.52 119.53 51.21 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.57 110.01 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.108 2.539 . . . . 0.0 112.704 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.3 mt -82.73 114.48 52.4 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.873 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.31 140.78 54.25 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.427 2.085 . . . . 0.0 112.141 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.4 t30 76.31 -2.78 2.66 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.86 0.725 . . . . 0.0 111.015 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.4 mm -116.62 144.85 23.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.982 0.42 . . . . 0.0 110.543 -177.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -98.91 137.39 37.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.211 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.6 tt -104.64 133.77 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.7 t -102.54 -63.36 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.916 0.389 . . . . 0.0 111.222 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -135.46 143.18 45.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.574 -170.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.54 ' HA ' HG12 ' A' ' 35' ' ' VAL . 57.9 mt -112.32 127.07 69.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.335 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 51.2 m -146.39 114.31 4.47 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.636 0.255 . . . . 0.0 110.957 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 2.8 Cg_endo -83.13 172.33 48.43 Favored 'Cis proline' 0 C--N 1.343 0.254 0 C-N-CA 123.803 -1.332 . . . . 0.0 111.964 -2.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -99.56 -45.25 5.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.369 0.604 . . . . 0.0 109.893 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.501 HG21 ' HG2' ' A' ' 66' ' ' GLU . 59.9 t -128.11 125.6 64.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.344 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 m -113.26 139.34 39.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.173 0.511 . . . . 0.0 111.006 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.4 m -86.61 106.54 17.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.068 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.7 mt -101.34 127.86 47.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.213 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.496 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 48.2 mt-30 -90.21 105.39 17.78 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.654 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.4 mt -95.24 126.42 40.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.217 0.532 . . . . 0.0 110.799 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -108.73 153.51 23.35 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.144 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -76.68 113.43 14.32 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.168 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.466 ' HB3' ' O ' ' A' ' 22' ' ' ALA . 79.4 t60 . . . . . 0 C--N 1.324 -0.517 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.473 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 8.0 p-10 . . . . . 0 C--O 1.234 0.284 0 CA-C-O 121.522 0.677 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 66.6 Cg_endo -99.42 173.53 0.41 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.693 2.928 . . . . 0.0 113.948 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 3.7 m -107.38 130.97 54.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.404 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.7 tp -102.87 135.38 44.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.894 0.378 . . . . 0.0 110.012 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.4 m -100.68 106.33 17.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.096 0.474 . . . . 0.0 110.754 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.482 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 92.0 mt -102.8 158.32 16.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.068 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.4 t -97.86 138.61 34.95 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.478 HD11 HG12 ' A' ' 53' ' ' VAL . 46.9 tp -79.93 124.59 28.81 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.422 HG13 ' HB3' ' A' ' 52' ' ' TYR . 43.8 pt -116.61 156.95 17.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.146 0.498 . . . . 0.0 111.249 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.465 ' HB3' ' OG1' ' A' ' 20' ' ' THR . . . -87.84 118.68 27.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.668 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -115.78 132.1 56.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.542 -176.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.718 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 95.3 m-20 60.34 26.31 15.83 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.104 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 50.7 m -79.58 119.51 77.12 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.937 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 27.9 Cg_exo -62.56 158.74 39.81 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 123.14 2.56 . . . . 0.0 112.356 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.77 -8.03 59.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.026 0.441 . . . . 0.0 110.635 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -88.19 -5.86 58.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.611 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.0 p -114.55 131.2 56.75 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.863 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.53 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 49.7 ttp -124.93 120.58 32.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.96 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.444 HG12 ' CD2' ' A' ' 89' ' ' LEU . 8.1 mt -82.08 123.5 38.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 45.6 ttp -74.81 -57.47 3.89 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.091 0.472 . . . . 0.0 110.011 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -70.58 154.14 42.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.57 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -94.15 141.16 28.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.889 0.376 . . . . 0.0 110.6 -178.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 65.4 mt -67.4 114.32 18.51 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.229 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 2.8 Cg_exo -73.76 172.95 14.78 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.695 2.263 . . . . 0.0 112.906 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.2 m -82.48 134.35 35.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.364 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' HB2' ' A' ' 13' ' ' LEU . 33.7 m -95.32 138.12 21.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.149 0.499 . . . . 0.0 110.038 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.416 ' HG3' ' CG2' ' A' ' 10' ' ' THR . 9.7 ttp180 -104.84 103.66 13.29 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.958 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.518 HG12 ' HA ' ' A' ' 80' ' ' ILE . 25.9 m -117.38 126.11 74.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.096 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 42.3 tttt -93.08 141.92 27.88 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.9 p -118.33 144.56 45.77 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 123.357 0.41 . . . . 0.0 110.996 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 31.6 tt0 -96.37 107.36 19.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 146.0 -138.71 7.69 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -148.81 126.77 11.94 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -104.78 109.16 62.65 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.318 0.58 . . . . 0.0 111.77 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.39 -47.98 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.749 2.299 . . . . 0.0 111.691 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.1 m -131.64 -68.7 0.64 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.753 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.7 mm 64.91 117.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.398 0.618 . . . . 0.0 111.504 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.434 ' ND2' ' HG2' ' A' ' 48' ' ' GLU . 59.4 t30 -84.5 90.65 7.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.642 0.734 . . . . 0.0 110.681 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.413 ' O ' HG12 ' A' ' 46' ' ' VAL . 11.2 t -78.34 7.11 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.333 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -82.63 -20.24 36.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.814 174.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.434 ' HG2' ' ND2' ' A' ' 45' ' ' ASN . 12.6 mm-40 -107.0 -35.15 6.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.304 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.3 mt -83.01 124.63 30.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.301 -177.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -147.36 175.62 10.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.777 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -123.59 137.36 54.76 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 170.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.422 ' HB3' HG13 ' A' ' 16' ' ' ILE . 20.1 p90 -136.41 160.87 37.44 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.642 0.734 . . . . 0.0 112.917 -173.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.478 HG12 HD11 ' A' ' 15' ' ' LEU . 14.6 m -113.12 125.95 70.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.313 167.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -91.67 102.35 14.98 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -175.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 71.4 mt -92.84 15.13 15.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.572 -173.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.718 ' HB2' ' HB3' ' A' ' 19' ' ' ASN . 8.0 t -73.74 106.19 5.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 175.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.08 35.32 6.76 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.266 -175.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.1 m -120.16 145.84 46.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.725 0.297 . . . . 0.0 110.663 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.91 154.25 37.87 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.978 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.504 ' HA ' ' HB2' ' A' ' 89' ' ' LEU . 26.1 Cg_exo -64.93 169.86 11.17 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.936 2.424 . . . . 0.0 112.159 175.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.37 -177.73 27.41 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -175.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -86.56 111.39 20.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.004 0.431 . . . . 0.0 110.396 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 65' ' ' TYR . 35.5 m80 -129.03 151.79 49.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.953 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.455 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 19.2 m-20 -90.11 103.22 15.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.847 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.553 ' HH ' HD12 ' A' ' 89' ' ' LEU . 72.5 m-85 -97.39 147.33 24.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.766 -176.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -87.9 125.26 34.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.807 -172.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 64.6 t -74.74 110.63 9.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.134 0.493 . . . . 0.0 110.094 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -101.82 106.14 17.08 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.111 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.2 t -91.91 136.36 24.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.491 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -75.1 122.05 86.58 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 171.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.42 142.35 88.97 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.705 2.27 . . . . 0.0 112.063 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.7 mm -82.18 120.1 76.44 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.571 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 22.0 Cg_exo -66.08 146.04 80.9 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.23 1.953 . . . . 0.0 111.307 175.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 73' ' ' PRO . 84.5 m-20 76.8 -41.19 0.39 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.491 0.716 . . . . 0.0 112.079 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.7 mt -103.08 157.4 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 58.4 tttm -92.88 146.07 23.91 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 tt -95.18 144.51 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 122.094 -0.379 . . . . 0.0 109.979 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.4 t -114.62 -70.89 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.951 0.405 . . . . 0.0 111.349 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -116.51 148.76 40.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.226 -169.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.518 ' HA ' HG12 ' A' ' 35' ' ' VAL . 73.8 mt -132.08 107.04 12.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.025 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.4 t -137.66 126.66 14.86 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.092 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HD2' HG12 ' A' ' 33' ' ' VAL . 97.3 Cg_endo -81.51 177.52 34.53 Favored 'Cis proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.065 -1.639 . . . . 0.0 112.637 -0.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -112.6 -47.32 3.08 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.627 -173.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.455 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 61.4 t -125.45 121.49 60.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 m -111.69 135.6 50.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.021 0.439 . . . . 0.0 111.575 -175.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.7 m -83.12 110.25 17.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.687 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.6 mt -110.66 129.11 55.9 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.406 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -93.46 107.24 19.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.91 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.553 HD12 ' HH ' ' A' ' 65' ' ' TYR . 80.7 mt -93.29 123.66 36.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.993 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.64 162.04 13.19 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.192 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.459 ' CE1' ' HG2' ' A' ' 60' ' ' PRO . 55.6 m-70 -82.55 117.93 22.9 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.907 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.53 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 5.5 t60 . . . . . 0 C--N 1.323 -0.55 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 175.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 121.466 0.651 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -79.05 169.87 18.63 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.66 2.24 . . . . 0.0 112.631 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 m -105.21 103.7 13.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.998 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.513 ' HB2' HG21 ' A' ' 35' ' ' VAL . 83.4 mt -83.24 134.7 34.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.067 0.46 . . . . 0.0 110.156 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.3 m -110.63 104.57 13.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.233 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 60.1 mt -104.68 157.91 16.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.242 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 m -91.01 143.78 26.35 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.566 HD13 HG12 ' A' ' 53' ' ' VAL . 49.9 tp -92.56 133.23 36.15 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.0 pt -132.26 162.61 39.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.012 0.434 . . . . 0.0 110.893 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.411 ' HB3' ' OG1' ' A' ' 20' ' ' THR . . . -97.26 126.28 42.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.224 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -124.27 139.82 53.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 64.45 19.06 11.66 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.61 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 49.2 m -83.9 120.5 75.06 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.821 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.97 177.44 8.73 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.578 2.185 . . . . 0.0 112.72 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.23 -14.38 53.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.336 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -77.9 -16.18 58.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.314 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 p -110.38 113.39 26.0 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.363 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 56.1 ttp -102.98 123.9 47.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.569 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.506 HG12 ' CD2' ' A' ' 89' ' ' LEU . 26.3 mt -86.8 119.56 34.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.052 -173.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 89.4 mmm -92.57 -30.8 15.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.402 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -72.33 105.45 4.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.31 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.42 129.51 39.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.388 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 84.4 mt -72.19 127.77 89.91 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.832 -170.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 95.2 Cg_endo -96.5 -162.49 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.684 2.923 . . . . 0.0 112.4 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.6 p -104.24 158.64 16.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.086 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.3 m -111.55 152.78 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -112.95 97.42 6.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.943 0.401 . . . . 0.0 110.149 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 80' ' ' ILE . 17.8 m -96.98 107.97 20.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.917 0.865 . . . . 0.0 110.205 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.52 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 1.2 mmmp? -75.02 130.98 40.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.745 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.447 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 26.3 p -135.21 128.43 31.95 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.974 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.541 ' HG3' ' CG2' ' A' ' 78' ' ' VAL . 40.2 mt-10 -86.45 94.23 9.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.46 ' HA3' HG22 ' A' ' 75' ' ' ILE . . . 160.06 157.1 8.45 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.899 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -98.65 118.51 35.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -126.99 82.42 68.09 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -89.63 -15.8 2.14 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.542 2.161 . . . . 0.0 112.281 171.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.3 t -98.1 15.55 23.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.013 0.435 . . . . 0.0 110.823 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.4 mt -124.58 137.92 55.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.235 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -94.79 114.58 26.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.312 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.444 HG11 HD23 ' A' ' 11' ' ' LEU . 35.1 m -76.23 -24.34 16.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -75.19 -24.58 57.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.142 0.496 . . . . 0.0 109.929 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -83.6 -34.0 25.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.843 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.69 126.12 28.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.533 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -115.98 147.78 40.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.268 0.556 . . . . 0.0 111.378 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -109.71 124.44 51.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -121.53 160.29 24.58 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.381 0.61 . . . . 0.0 111.865 -174.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.566 HG12 HD13 ' A' ' 15' ' ' LEU . 6.0 m -112.29 123.35 67.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.111 172.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -86.48 108.77 18.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.18 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.8 34.97 2.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.368 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.3 m -64.91 107.57 1.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.896 0.379 . . . . 0.0 110.337 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.92 48.31 5.51 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.908 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.3 p -101.29 113.8 27.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.815 0.34 . . . . 0.0 111.336 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -79.31 128.27 76.13 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 173.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -49.84 100.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.681 2.921 . . . . 0.0 113.265 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.76 175.36 47.5 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -80.28 114.48 19.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.02 0.41 . . . . 0.0 109.979 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 65' ' ' TYR . 31.6 m170 -134.15 160.12 38.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.0 t70 -97.0 108.19 20.88 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 63' ' ' HIS . 78.1 m-85 -109.72 152.58 25.46 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 111.291 -171.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.84 139.4 37.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.098 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 97.4 t -92.14 120.53 41.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -117.36 108.88 16.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.422 -175.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.1 t -89.2 148.96 4.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.914 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -61.81 118.61 40.16 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 171.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.55 128.99 30.12 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.979 2.453 . . . . 0.0 112.53 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.28 114.71 63.98 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.906 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.8 151.09 18.86 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.066 2.511 . . . . 0.0 111.657 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 74.37 -39.73 0.43 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.653 0.781 . . . . 0.0 111.712 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.46 HG22 ' HA3' ' A' ' 39' ' ' GLY . 40.0 mm -92.39 136.02 25.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -87.6 118.49 27.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.616 0.246 . . . . 0.0 110.448 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.3 tt -81.31 123.84 38.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.346 0.594 . . . . 0.0 110.907 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.541 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 31.6 t -86.19 -60.9 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.441 0.639 . . . . 0.0 109.916 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -121.01 153.31 37.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.585 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.63 HG22 ' HG2' ' A' ' 83' ' ' ARG . 14.8 tt -127.39 18.41 3.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 173.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.5 m -64.18 134.65 96.03 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.695 -175.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.59 133.14 30.02 Favored 'Cis proline' 0 C--N 1.343 0.267 0 C-N-CA 123.382 -1.507 . . . . 0.0 111.988 -0.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.63 ' HG2' HG22 ' A' ' 80' ' ' ILE . 58.8 mtm180 -72.05 -38.14 69.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.208 0.528 . . . . 0.0 110.517 -176.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -134.59 136.45 52.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.068 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.5 m -129.04 141.79 45.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.141 0.495 . . . . 0.0 111.144 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 15.8 m -89.72 109.41 20.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.138 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.6 mt -100.29 124.9 46.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.631 -176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -85.67 99.03 11.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.01 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.506 ' CD2' HG12 ' A' ' 26' ' ' ILE . 89.8 mt -95.57 139.8 31.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.901 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.755 ' HG2' ' H ' ' A' ' 91' ' ' HIS . 22.4 tt0 -117.67 176.84 4.99 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.755 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 25.9 m-70 -82.46 151.65 26.45 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.909 -176.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.5 p80 . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 121.644 0.735 . . . . 0.0 109.958 178.33 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.484 ' CG ' ' HZ1' ' A' ' 36' ' ' LYS . 30.1 t70 . . . . . 0 C--O 1.235 0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 110.735 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 37' ' ' THR . 6.2 Cg_exo -80.22 130.37 8.17 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.925 2.417 . . . . 0.0 112.29 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 m -105.88 110.32 22.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.925 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 40.1 tp -93.63 135.52 34.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.745 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 16.3 m -117.02 109.6 17.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.896 0.379 . . . . 0.0 110.631 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.7 mt -111.64 144.16 41.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.192 -174.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -75.98 147.26 38.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.924 0.392 . . . . 0.0 110.771 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.739 HD11 HG13 ' A' ' 53' ' ' VAL . 41.4 tp -90.49 133.51 35.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.114 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.488 ' CG1' ' HB3' ' A' ' 52' ' ' TYR . 48.0 pt -112.63 153.55 14.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.979 0.419 . . . . 0.0 110.725 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.38 105.66 17.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.547 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 62.0 tttm -93.82 106.65 18.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.012 0.434 . . . . 0.0 111.204 -175.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 56.26 77.75 0.23 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.89 174.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.9 t -106.86 140.22 21.16 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 172.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.426 ' HD2' ' OG ' ' A' ' 24' ' ' SER . 36.2 Cg_exo -62.75 169.16 9.06 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.017 2.478 . . . . 0.0 112.91 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.1 6.87 27.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.534 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -107.5 -6.16 17.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.314 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.426 ' OG ' ' HD2' ' A' ' 21' ' ' PRO . 5.0 p -118.42 128.9 55.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.814 -176.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.0 ttp -115.66 131.86 56.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.652 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.5 mt -90.34 103.73 14.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.799 0.333 . . . . 0.0 110.665 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 81.3 mtp -75.58 -38.82 58.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.303 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.5 m -71.52 120.02 16.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.241 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.57 120.09 16.66 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.6 mt -54.71 117.76 14.78 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.513 -174.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.67 -163.2 0.2 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.976 2.45 . . . . 0.0 112.227 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 m -123.31 134.9 54.01 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 120.914 0.388 . . . . 0.0 110.363 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.808 HG12 HG11 ' A' ' 67' ' ' VAL . 33.2 m -85.94 133.04 30.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.979 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 34' ' ' ARG . 25.7 ttt180 -110.01 97.34 6.86 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.512 HG13 ' HA ' ' A' ' 80' ' ' ILE . 33.5 m -102.89 157.58 4.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.58 -171.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.484 ' HZ1' ' CG ' ' A' ' 8' ' ' ASP . 10.3 mmmt -98.37 128.25 44.68 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.472 ' O ' ' HD2' ' A' ' 9' ' ' PRO . 10.0 p -116.07 145.91 42.63 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.962 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.46 ' HB2' ' CG2' ' A' ' 78' ' ' VAL . 41.7 tt0 -110.39 107.0 16.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.598 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.36 -153.79 25.26 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.739 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.575 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 96.6 m-85 -121.8 135.82 54.92 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -105.57 96.33 11.88 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 6.1 Cg_exo -79.62 -71.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.801 2.334 . . . . 0.0 111.505 177.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.5 t -162.45 95.47 0.92 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.415 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.564 ' HB ' HG11 ' A' ' 46' ' ' VAL . 32.7 mt -132.67 160.78 42.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -76.9 46.16 0.46 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.329 0.585 . . . . 0.0 110.633 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.564 HG11 ' HB ' ' A' ' 44' ' ' ILE . 20.2 m -67.24 -32.29 56.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.273 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -81.94 -9.5 59.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.151 0.5 . . . . 0.0 110.252 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -95.13 -12.5 26.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.005 176.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.6 mt -78.6 136.36 37.49 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 166.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -130.24 171.24 13.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.221 0.534 . . . . 0.0 111.703 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.37 139.53 42.96 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.38 175.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.488 ' HB3' ' CG1' ' A' ' 16' ' ' ILE . 2.0 p90 -127.55 145.13 50.96 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.217 0.532 . . . . 0.0 111.99 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.739 HG13 HD11 ' A' ' 15' ' ' LEU . 17.0 m -119.56 129.05 75.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.049 174.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -76.45 119.42 20.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.975 0.416 . . . . 0.0 110.148 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.413 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 76.7 mt -112.16 26.88 10.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.301 -176.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.7 m -70.25 -33.74 71.99 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -169.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.89 86.61 0.14 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.231 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.4 m -143.43 155.95 44.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.554 0.216 . . . . 0.0 110.521 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.473 ' HB2' ' NE2' ' A' ' 63' ' ' HIS . 1.6 mp0 -64.97 145.42 99.07 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.392 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 59' ' ' GLU . 10.2 Cg_exo -71.27 91.19 0.66 Allowed 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.806 2.337 . . . . 0.0 112.045 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.28 -166.8 39.66 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.594 ' HG2' ' HB2' ' A' ' 88' ' ' GLN . 42.5 mt-10 -77.34 113.38 15.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.238 0.519 . . . . 0.0 110.336 177.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.473 ' NE2' ' HB2' ' A' ' 59' ' ' GLU . 94.3 m-70 -139.67 173.67 11.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.819 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -94.02 133.34 37.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.11 -173.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.416 ' CE2' ' HB2' ' A' ' 87' ' ' LEU . 74.0 m-85 -131.34 135.63 47.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.103 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -78.83 125.94 30.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.235 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.808 HG11 HG12 ' A' ' 33' ' ' VAL . 93.2 t -85.25 108.77 17.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.237 0.541 . . . . 0.0 110.566 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -99.75 115.86 30.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.782 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.8 t -101.49 148.71 7.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.89 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.28 144.23 97.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.056 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -83.41 149.64 13.16 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.908 2.405 . . . . 0.0 112.704 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 75' ' ' ILE . 23.4 mt -117.94 119.0 34.15 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.63 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -85.13 21.07 1.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.69 2.26 . . . . 0.0 112.911 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -131.17 -56.25 1.03 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.157 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.539 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 53.1 mt -105.61 137.84 33.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.182 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -89.71 133.25 34.77 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.707 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.5 tt -83.88 123.38 38.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.547 0.689 . . . . 0.0 109.635 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 38' ' ' GLU . 47.0 t -94.29 -60.84 2.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.943 -174.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 36' ' ' LYS . 27.3 tt0 -118.76 134.48 55.11 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.216 -172.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.707 ' HB ' ' HG3' ' A' ' 83' ' ' ARG . 59.0 mt -109.26 109.59 28.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.8 m -133.34 124.52 18.26 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.626 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.505 ' HD2' HG11 ' A' ' 33' ' ' VAL . 4.5 Cg_exo -81.48 142.72 55.77 Favored 'Cis proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.29 -1.546 . . . . 0.0 111.641 -5.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.707 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 5.5 mtm180 -78.71 -37.8 40.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.221 0.534 . . . . 0.0 110.3 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.6 t -124.06 117.5 51.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.49 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.6 m -107.36 152.52 8.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.773 0.321 . . . . 0.0 111.034 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 14.5 m -109.05 99.31 8.64 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.966 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 89.8 mt -102.79 142.62 33.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.317 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.594 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 53.6 tt0 -98.03 106.45 18.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.0 0.429 . . . . 0.0 110.802 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.2 mt -88.79 151.19 22.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.014 174.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -131.7 167.57 19.26 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.511 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -73.36 113.34 10.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.957 0.408 . . . . 0.0 110.761 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 21.6 t60 . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.121 -179.213 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 . . . . . 0 CA--C 1.532 0.277 0 CA-C-O 121.417 0.627 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -90.54 174.96 2.8 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.979 2.452 . . . . 0.0 112.873 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.0 m -107.38 122.22 46.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.76 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.683 HD21 HG11 ' A' ' 46' ' ' VAL . 67.4 mt -104.15 127.4 51.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.138 0.494 . . . . 0.0 110.907 -176.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.0 m -101.34 107.18 18.46 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.132 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.3 mt -108.02 149.17 28.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.36 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.6 p -82.78 141.24 32.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.646 0.26 . . . . 0.0 110.515 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.793 HD13 HG11 ' A' ' 53' ' ' VAL . 43.0 tp -90.09 133.04 35.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.516 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.3 pt -116.67 155.68 18.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.968 0.413 . . . . 0.0 111.006 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.457 ' HB3' ' OG1' ' A' ' 20' ' ' THR . . . -85.12 110.47 19.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.24 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -106.21 137.16 44.64 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.534 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 63.0 16.4 9.23 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.548 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.458 ' OG1' HD12 ' A' ' 55' ' ' LEU . 18.7 m -74.36 117.24 60.29 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.28 -176.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 5.7 Cg_exo -74.51 173.1 14.87 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.064 2.51 . . . . 0.0 112.449 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.69 -5.96 59.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.603 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -78.07 -9.2 59.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.562 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.503 ' HB2' HD22 ' A' ' 89' ' ' LEU . 11.9 p -129.78 128.73 42.98 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.992 -176.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.584 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 58.5 ttp -114.54 139.03 49.91 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.5 mt -110.19 99.13 8.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.523 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 78.2 mtp -82.14 -15.35 53.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.982 0.42 . . . . 0.0 110.362 176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.4 m -81.05 106.28 12.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -63.44 123.0 17.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.011 -175.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.4 mt -62.02 119.26 47.03 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.504 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.75 -164.05 0.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.802 2.335 . . . . 0.0 112.655 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.1 p -106.43 142.03 36.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.757 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.0 p -99.0 139.4 20.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -110.74 101.67 10.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.303 0.573 . . . . 0.0 110.381 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 80' ' ' ILE . 33.4 m -105.09 130.83 55.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.388 -177.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.49 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 58.2 tttm -94.0 132.64 38.27 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.507 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 26.2 p -126.81 152.19 47.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.465 -174.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 76' ' ' LYS . 50.4 mt-10 -108.94 96.0 6.02 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.57 156.47 7.72 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -108.64 129.36 55.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 41.2 m-80 -70.89 114.06 23.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.96 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 41' ' ' ASN . 3.5 Cg_exo -80.14 -71.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.804 2.336 . . . . 0.0 111.833 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 p -113.04 10.16 18.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.482 0.658 . . . . 0.0 110.048 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.0 mt -92.94 133.37 34.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.111 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.535 ' HB2' ' HG3' ' A' ' 48' ' ' GLU . 53.6 m-80 -113.18 126.51 55.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.073 0.463 . . . . 0.0 110.061 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.683 HG11 HD21 ' A' ' 11' ' ' LEU . 34.4 m -77.41 -8.41 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.51 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -89.39 -4.14 58.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.27 0.557 . . . . 0.0 110.127 173.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.535 ' HG3' ' HB2' ' A' ' 45' ' ' ASN . 42.3 mt-10 -99.57 -34.56 10.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.571 174.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.7 mt -81.24 138.57 35.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.921 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -127.23 168.43 14.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.505 0.669 . . . . 0.0 111.299 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.6 147.59 29.31 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 171.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -140.46 146.88 38.82 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.19 0.519 . . . . 0.0 111.29 -174.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.793 HG11 HD13 ' A' ' 15' ' ' LEU . 4.3 m -112.25 130.64 65.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.405 175.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -79.47 91.56 5.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.043 -176.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.458 HD12 ' OG1' ' A' ' 20' ' ' THR . 52.0 mt -93.84 59.14 2.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.835 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 p -77.58 -4.72 47.25 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.332 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.66 -178.31 39.56 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.799 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.1 m -144.95 21.19 1.61 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.198 0.523 . . . . 0.0 109.786 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.11 115.84 52.28 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.342 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.13 158.51 56.24 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.955 2.436 . . . . 0.0 112.496 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.43 -163.29 22.82 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.47 ' HB3' HG23 ' A' ' 86' ' ' THR . 40.7 mt-10 -86.45 108.82 18.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.153 0.501 . . . . 0.0 110.293 177.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -117.68 143.03 46.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.652 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 10.0 m-20 -81.51 138.08 35.51 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -138.95 150.89 46.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.993 0.425 . . . . 0.0 111.18 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -90.33 123.03 33.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.69 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.9 t -81.24 134.74 26.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.556 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -125.45 153.44 43.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.095 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.7 t -127.28 146.44 33.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 43.6 mt-10 -63.04 125.49 86.92 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 32.2 Cg_exo -59.13 124.16 15.02 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.086 2.524 . . . . 0.0 112.857 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.0 mp -95.18 125.94 48.34 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.725 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.95 146.57 42.1 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.254 1.969 . . . . 0.0 111.98 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 72.78 -45.85 0.63 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.722 0.809 . . . . 0.0 112.197 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.507 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 51.2 mt -84.05 133.09 29.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.014 0.435 . . . . 0.0 110.514 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 94.7 mttt -87.07 142.04 28.22 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.206 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 tt -99.58 119.28 47.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.22 0.533 . . . . 0.0 110.316 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.5 t -94.17 -48.02 13.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.807 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.49 ' HB2' ' H ' ' A' ' 36' ' ' LYS . 20.3 mm-40 -118.7 148.66 42.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.173 -176.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.823 HG21 ' HG2' ' A' ' 83' ' ' ARG . 16.1 tt -138.96 27.54 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 122.361 1.077 . . . . 0.0 108.419 174.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.6 m -83.1 141.04 42.9 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.131 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.51 131.43 23.23 Favored 'Cis proline' 0 C--N 1.346 0.418 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.215 0.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.823 ' HG2' HG21 ' A' ' 80' ' ' ILE . 73.7 mtm180 -78.24 -49.55 13.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.306 -175.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.8 119.5 60.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.788 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.29 145.59 27.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.732 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.47 HG23 ' HB3' ' A' ' 62' ' ' GLU . 8.6 m -99.86 101.74 12.96 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.3 mt -94.08 145.74 24.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 -175.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -97.56 125.85 42.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.124 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.503 HD22 ' HB2' ' A' ' 24' ' ' SER . 90.0 mt -116.47 131.96 56.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.853 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -100.38 151.52 21.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.529 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -66.75 104.69 1.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.214 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.584 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 74.7 t60 . . . . . 0 C--N 1.321 -0.644 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 120.483 0.182 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.589 ' HG2' ' OG1' ' A' ' 37' ' ' THR . 29.6 Cg_endo -65.45 115.66 3.48 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.955 1.77 . . . . 0.0 112.816 -172.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.7 m -87.56 99.34 11.97 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 171.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.42 125.27 31.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.555 -175.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.2 m -95.26 89.85 5.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.88 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.42 HD22 HG12 ' A' ' 46' ' ' VAL . 60.2 mt -91.0 131.62 36.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.437 -174.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.4 m -74.41 139.8 44.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.839 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.876 HD11 HG11 ' A' ' 53' ' ' VAL . 30.0 tp -84.71 127.34 34.05 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.403 HD13 ' CE2' ' A' ' 52' ' ' TYR . 29.0 pt -120.68 142.51 36.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.445 0.641 . . . . 0.0 112.23 -176.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.552 ' HB3' ' OG1' ' A' ' 20' ' ' THR . . . -72.76 111.93 8.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.288 175.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -79.21 -78.24 0.16 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.094 0.473 . . . . 0.0 110.645 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -110.61 75.83 0.95 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.405 0.621 . . . . 0.0 109.571 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.623 ' HG1' ' HB2' ' A' ' 55' ' ' LEU . 94.6 m -99.62 113.04 64.74 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.225 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.11 155.2 52.15 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.13 2.553 . . . . 0.0 112.767 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.3 -1.82 11.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.947 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -104.6 -2.03 25.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.879 0.371 . . . . 0.0 110.567 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.4 m -107.3 115.49 30.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.468 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 55.7 ttp -107.55 117.39 33.97 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.014 0.435 . . . . 0.0 110.657 -177.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.5 mt -92.08 102.59 13.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.892 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 80.5 mtp -86.23 -33.33 20.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.747 0.308 . . . . 0.0 110.807 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.4 m -81.08 117.78 21.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.047 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -59.84 124.55 20.52 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 84.1 mt -59.66 121.16 55.42 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.289 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 12.4 Cg_exo -69.33 -179.36 2.67 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.865 2.377 . . . . 0.0 112.502 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 p -109.07 146.22 34.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.124 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.652 HG12 HG13 ' A' ' 67' ' ' VAL . 20.3 m -97.08 140.07 18.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.067 0.461 . . . . 0.0 109.993 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -109.56 98.28 7.68 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.661 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 80' ' ' ILE . 32.8 m -103.09 142.32 17.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.074 -176.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -92.53 129.84 38.35 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.589 ' OG1' ' HG2' ' A' ' 9' ' ' PRO . 27.3 p -121.46 161.46 22.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.592 0.234 . . . . 0.0 110.585 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.46 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 22.6 tt0 -123.79 143.1 50.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.056 -175.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.09 -118.93 1.91 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.336 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -144.48 131.74 20.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.445 ' HB3' ' HG3' ' A' ' 9' ' ' PRO . 2.5 p-10 -120.88 91.64 47.74 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 121.354 0.597 . . . . 0.0 112.154 -174.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -89.48 -51.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.731 2.287 . . . . 0.0 112.671 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -159.28 96.63 1.32 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.256 0.551 . . . . 0.0 110.243 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mp -117.21 126.38 74.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.597 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' A' ' 48' ' ' GLU . 58.0 t30 -80.01 94.47 5.93 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.762 0.791 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.42 HG12 HD22 ' A' ' 13' ' ' LEU . 19.1 t -68.59 -17.79 22.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.536 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -82.8 5.49 21.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.719 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.513 ' HB2' ' ND2' ' A' ' 45' ' ' ASN . 40.7 tt0 -119.17 -33.35 4.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.199 176.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.7 mt -79.51 127.84 32.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -136.81 166.87 22.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.628 0.727 . . . . 0.0 112.14 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.439 ' HB3' HG11 ' A' ' 67' ' ' VAL . . . -109.35 128.76 55.36 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.046 172.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.645 ' HE1' ' HB2' ' A' ' 70' ' ' GLU . 48.5 m-85 -103.42 138.51 40.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.934 0.397 . . . . 0.0 111.391 -173.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.876 HG11 HD11 ' A' ' 15' ' ' LEU . 3.0 m -125.86 129.76 72.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.815 169.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -88.49 91.61 8.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.303 0.573 . . . . 0.0 109.566 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.623 ' HB2' ' HG1' ' A' ' 20' ' ' THR . 52.4 mt -87.79 38.82 0.86 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.691 -174.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.9 p -68.77 -24.55 64.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.974 0.416 . . . . 0.0 109.982 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.2 111.93 3.8 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 m -96.97 26.22 4.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.996 0.427 . . . . 0.0 110.727 -173.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -87.27 115.38 62.54 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.671 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.06 140.88 55.75 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.446 2.098 . . . . 0.0 111.248 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.64 -150.66 19.05 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -116.5 105.79 12.87 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.997 0.427 . . . . 0.0 109.969 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -122.25 148.91 44.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.093 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -81.76 132.83 35.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.908 0.385 . . . . 0.0 110.703 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -127.91 137.15 52.19 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.499 ' HG2' HG22 ' A' ' 84' ' ' VAL . 40.3 mt-10 -88.71 134.85 33.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.036 0.446 . . . . 0.0 110.885 -173.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.652 HG13 HG12 ' A' ' 33' ' ' VAL . 65.2 t -71.81 102.2 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.732 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -92.67 101.69 14.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.554 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.2 t -87.27 143.64 10.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.146 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.645 ' HB2' ' HE1' ' A' ' 52' ' ' TYR . 32.2 tt0 -77.95 114.76 44.73 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -56.41 130.84 42.25 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.051 2.5 . . . . 0.0 112.738 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.7 mt -94.32 125.09 53.54 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.51 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.57 141.87 42.99 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.578 2.186 . . . . 0.0 111.504 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.3 t30 74.16 -44.03 0.55 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.368 0.667 . . . . 0.0 111.801 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.8 mm -83.86 119.22 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.125 0.488 . . . . 0.0 110.37 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.46 ' HD3' ' HB3' ' A' ' 38' ' ' GLU . 80.0 tttt -80.73 124.82 29.36 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.598 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.527 ' HA ' HG23 ' A' ' 37' ' ' THR . 17.0 tt -88.96 131.61 35.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.148 0.499 . . . . 0.0 110.233 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.7 t -100.78 -58.87 3.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.319 -175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -138.14 147.24 43.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.881 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.545 ' HA ' HG12 ' A' ' 35' ' ' VAL . 58.9 mt -115.57 121.78 67.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.203 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 70.1 m -138.16 115.85 9.39 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.921 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.5 ' HD2' HG11 ' A' ' 33' ' ' VAL . 2.1 Cg_endo -86.31 170.94 40.95 Favored 'Cis proline' 0 N--CA 1.462 -0.347 0 C-N-CA 124.063 -1.224 . . . . 0.0 112.308 -1.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -98.83 -32.43 11.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.346 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.499 HG22 ' HG2' ' A' ' 66' ' ' GLU . 45.4 t -129.79 132.13 66.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.384 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 m -123.85 128.77 74.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.164 0.507 . . . . 0.0 111.139 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.4 m -82.54 103.89 12.41 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.449 HD13 HD22 ' A' ' 55' ' ' LEU . 90.1 mt -94.83 146.27 24.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.16 0.505 . . . . 0.0 111.237 -173.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.2 tm0? -98.23 119.43 36.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.282 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.8 mt -123.63 146.33 48.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.813 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -139.45 173.17 11.81 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 169.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -69.73 127.88 34.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.828 0.347 . . . . 0.0 110.632 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 11.9 t-80 . . . . . 0 C--N 1.323 -0.582 0 CA-C-O 122.426 1.108 . . . . 0.0 108.131 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.412 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 28.2 m-20 . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.417 0.151 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.82 101.82 0.19 Allowed 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.464 2.109 . . . . 0.0 112.153 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 m -98.2 109.0 21.83 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.283 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.1 mt -104.8 145.91 29.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.177 0.513 . . . . 0.0 111.042 -173.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 20.6 m -122.83 102.49 8.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.527 174.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.7 mt -96.17 140.05 31.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.334 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -73.21 135.95 44.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.325 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.709 HD11 HG11 ' A' ' 53' ' ' VAL . 42.4 tp -85.88 119.59 26.36 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.5 pt -112.58 155.65 13.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.166 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.86 114.73 24.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.048 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -117.37 143.28 46.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.8 t30 61.01 26.26 16.23 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.879 0.847 . . . . 0.0 109.698 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.469 HG21 HD13 ' A' ' 55' ' ' LEU . 85.1 m -85.86 117.41 68.67 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.736 -177.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.38 162.69 40.88 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.016 2.477 . . . . 0.0 112.575 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.39 -8.64 58.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.415 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -92.31 3.74 54.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.887 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 p -127.88 139.71 52.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.759 0.314 . . . . 0.0 111.212 -175.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.447 ' HB2' ' NE2' ' A' ' 92' ' ' HIS . 14.1 ttm -127.13 129.95 48.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.741 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.473 HG12 ' CD2' ' A' ' 89' ' ' LEU . 12.9 mt -88.17 97.47 6.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 86.9 mtp -62.85 -33.24 74.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.237 0.541 . . . . 0.0 110.05 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 m -74.49 104.71 5.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.624 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -64.33 121.0 13.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.092 0.472 . . . . 0.0 110.664 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.21 122.69 65.37 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.224 -171.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -87.05 -155.8 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.523 2.815 . . . . 0.0 112.093 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.5 m -120.19 150.51 40.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.85 0.357 . . . . 0.0 110.657 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 12' ' ' THR . 12.7 p -103.45 138.71 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.835 -177.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -98.38 119.91 37.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.073 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.429 HG13 ' HA ' ' A' ' 80' ' ' ILE . 25.1 m -128.59 123.77 60.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.651 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.412 ' HE3' ' HB3' ' A' ' 8' ' ' ASP . 87.8 tttt -95.84 138.83 32.93 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.519 HG22 ' HA ' ' A' ' 77' ' ' ILE . 35.5 p -126.73 155.2 43.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.993 0.425 . . . . 0.0 111.869 -175.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.521 ' HG3' ' CG2' ' A' ' 78' ' ' VAL . 42.8 mt-10 -105.81 120.59 42.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.797 174.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.2 -171.53 26.28 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -135.03 101.07 4.76 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.76 112.36 6.0 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.228 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.11 -62.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.767 2.311 . . . . 0.0 111.143 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.5 t -145.7 79.09 1.56 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.131 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -121.85 130.73 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.795 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.43 ' ND2' ' HG3' ' A' ' 48' ' ' GLU . 59.0 t30 -94.59 103.93 15.87 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.729 0.776 . . . . 0.0 110.895 -175.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.4 t -62.91 -23.88 34.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.294 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -66.18 -20.78 66.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.951 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.43 ' HG3' ' ND2' ' A' ' 45' ' ' ASN . 48.3 mt-10 -105.28 -11.17 16.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.939 0.399 . . . . 0.0 110.831 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.9 128.68 33.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 170.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -136.67 173.3 11.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.31 0.576 . . . . 0.0 111.697 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -131.45 140.89 49.69 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -129.07 156.75 43.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.472 0.653 . . . . 0.0 112.102 -173.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.709 HG11 HD11 ' A' ' 15' ' ' LEU . 4.6 m -112.17 118.18 57.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.363 172.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.78 106.3 16.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.246 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 20' ' ' THR . 63.4 mt -95.05 45.29 1.1 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.537 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 p -57.37 -44.64 84.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.806 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.88 67.19 0.49 Allowed Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.106 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 p -68.9 101.14 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.054 0.454 . . . . 0.0 111.126 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.5 129.99 23.54 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.527 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.413 ' HB3' ' HB2' ' A' ' 91' ' ' HIS . 33.7 Cg_endo -65.45 138.97 57.17 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.552 2.168 . . . . 0.0 112.22 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.46 178.16 19.81 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.02 99.13 4.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.862 0.363 . . . . 0.0 110.534 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -119.93 141.23 49.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.454 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -84.97 133.29 34.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.029 0.443 . . . . 0.0 109.994 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -126.11 157.75 37.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.809 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -84.73 128.05 34.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.619 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.1 t -78.25 99.37 2.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.114 0.483 . . . . 0.0 109.731 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -87.77 118.51 27.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.906 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.1 t -95.32 143.78 11.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.729 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.435 ' OE1' ' HD2' ' A' ' 71' ' ' PRO . 8.5 tp10 -70.32 113.89 21.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 174.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.435 ' HD2' ' OE1' ' A' ' 70' ' ' GLU . 11.7 Cg_endo -55.33 124.03 15.27 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.995 2.463 . . . . 0.0 112.646 -176.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -94.45 119.98 65.7 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.889 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.61 135.38 48.82 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.494 2.13 . . . . 0.0 112.537 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 t30 73.52 -33.96 0.27 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.771 0.828 . . . . 0.0 112.96 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.424 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 49.9 mm -84.16 136.4 22.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.048 0.451 . . . . 0.0 111.031 -177.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -97.6 121.12 39.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.446 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.519 ' HA ' HG22 ' A' ' 37' ' ' THR . 16.0 tt -90.75 125.38 43.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.408 0.623 . . . . 0.0 111.012 -176.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.521 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 38.3 t -100.62 -56.52 5.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.384 -175.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 71.7 mm-40 -109.65 139.35 44.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.092 -173.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.429 ' HA ' HG13 ' A' ' 35' ' ' VAL . 50.7 mt -129.13 97.57 3.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 5.7 m -127.21 112.74 21.53 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.211 -176.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 2.0 Cg_endo -85.14 171.6 43.39 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.763 -1.349 . . . . 0.0 112.37 0.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -110.85 -34.26 6.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.98 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.39 117.17 49.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.588 176.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.5 m -108.29 146.46 14.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.931 0.396 . . . . 0.0 110.871 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.5 m -97.97 109.01 21.84 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 84.9 mt -102.97 122.64 45.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.385 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -85.58 95.55 9.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.473 ' CD2' HG12 ' A' ' 26' ' ' ILE . 76.5 mt -90.43 128.68 36.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.517 -175.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -102.88 120.83 41.3 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.422 173.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 60' ' ' PRO . 27.5 t60 -72.42 110.41 6.81 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 173.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.447 ' NE2' ' HB2' ' A' ' 25' ' ' MET . 13.5 m-70 . . . . . 0 CA--C 1.514 -0.404 0 O-C-N 123.886 0.741 . . . . 0.0 110.867 -176.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.834 0.826 . . . . 0.0 109.116 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.76 162.66 32.37 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.547 2.831 . . . . 0.0 113.498 -170.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 14.6 m -118.62 123.57 45.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.972 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.492 ' HB2' HG23 ' A' ' 35' ' ' VAL . 98.1 mt -101.34 148.8 24.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.019 0.438 . . . . 0.0 110.631 -177.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.2 m -125.5 100.17 6.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.889 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.4 mt -101.16 156.43 17.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.357 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 t -88.53 137.35 32.4 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.858 HD12 HG12 ' A' ' 53' ' ' VAL . 42.6 tp -83.39 126.48 32.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.0 pt -108.32 143.0 19.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.113 0.482 . . . . 0.0 111.182 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.403 ' HB2' ' OG1' ' A' ' 20' ' ' THR . . . -77.07 105.21 8.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.838 176.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -99.06 127.73 45.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.13 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 61.87 23.75 14.02 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.404 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.527 ' OG1' HD13 ' A' ' 55' ' ' LEU . 25.7 m -74.51 124.04 89.51 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.452 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -81.2 171.45 13.88 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.711 2.274 . . . . 0.0 112.562 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.72 6.37 38.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.061 -177.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -92.85 -18.03 23.35 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.42 0.628 . . . . 0.0 110.107 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.2 p -119.2 121.37 39.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.716 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 52.8 ttp -102.79 131.0 49.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.337 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.5 mt -90.21 107.71 18.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 49.1 ttp -75.41 -33.27 60.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.055 0.455 . . . . 0.0 110.739 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.9 m -84.71 132.68 34.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.513 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -66.85 143.14 57.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 3.7 mm? -67.1 115.64 27.72 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.534 -178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 3.0 Cg_exo -74.15 167.38 27.33 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.899 2.399 . . . . 0.0 112.666 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.4 m -94.7 129.12 41.74 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.784 175.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.0 m -86.28 143.54 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.121 0.486 . . . . 0.0 111.12 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.0 ttp85 -104.28 108.39 19.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.537 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.53 HG11 ' HA ' ' A' ' 80' ' ' ILE . 13.4 m -119.56 112.97 39.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.185 0.517 . . . . 0.0 110.227 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 78.0 tttt -87.73 142.02 28.15 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.465 ' HB ' HG22 ' A' ' 75' ' ' ILE . 47.9 p -130.62 179.61 5.85 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.817 -172.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.62 ' HB2' ' HB2' ' A' ' 76' ' ' LYS . 55.7 mt-10 -132.74 130.3 39.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 175.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.54 -144.05 14.96 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -136.13 158.6 44.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.781 0.324 . . . . 0.0 110.704 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -112.31 93.0 20.57 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.653 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.558 ' HD2' HG12 ' A' ' 44' ' ' ILE . 57.8 Cg_endo -79.76 -76.7 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.181 1.921 . . . . 0.0 112.846 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.1 p -107.76 24.22 13.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.402 0.62 . . . . 0.0 110.154 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.74 HG13 HD13 ' A' ' 75' ' ' ILE . 46.4 mm -79.79 112.08 17.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.396 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -91.64 108.62 20.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.28 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.58 -21.85 29.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.583 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -78.2 -13.24 59.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.642 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -105.9 -24.73 12.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.81 -175.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.2 mt -92.58 139.45 30.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.072 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -136.04 176.68 8.46 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.76 0.79 . . . . 0.0 112.145 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -122.6 133.97 54.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.375 172.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -121.75 141.41 51.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.13 0.491 . . . . 0.0 111.903 -173.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.858 HG12 HD12 ' A' ' 15' ' ' LEU . 6.8 m -114.38 119.7 62.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.19 174.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -74.55 100.69 3.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.479 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.527 HD13 ' OG1' ' A' ' 20' ' ' THR . 38.2 mt -89.96 36.18 0.86 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.935 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 p -61.49 -38.93 89.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.542 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.63 69.15 2.64 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 172.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 m -73.28 84.13 1.4 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.076 0.465 . . . . 0.0 111.847 -173.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -108.52 117.71 53.75 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.497 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.74 100.85 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.895 2.396 . . . . 0.0 112.166 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.02 177.33 32.0 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.859 ' HG2' ' HG2' ' A' ' 88' ' ' GLN . 41.2 mt-10 -74.66 99.64 3.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.104 0.452 . . . . 0.0 110.35 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -125.01 144.35 50.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.562 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.512 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 9.4 m-20 -89.23 115.06 26.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.713 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.443 ' HH ' HD13 ' A' ' 89' ' ' LEU . 92.5 m-85 -111.49 164.81 12.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.883 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -89.92 131.51 35.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.296 -176.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.0 t -90.0 123.14 42.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.101 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -111.72 110.66 21.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.068 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.418 HG21 HG12 ' A' ' 35' ' ' VAL . 42.1 t -90.44 142.3 13.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.013 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 46.5 mt-10 -68.75 117.24 49.02 Favored Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.627 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 11.4 Cg_exo -70.93 136.0 28.93 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.874 2.382 . . . . 0.0 111.862 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.451 ' C ' ' H ' ' A' ' 74' ' ' ASN . 4.3 mp -100.44 117.55 62.73 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.12 25.29 0.46 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.576 2.184 . . . . 0.0 112.396 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.451 ' H ' ' C ' ' A' ' 72' ' ' ILE . 88.1 m-20 -133.95 -8.91 2.71 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.503 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.74 HD13 HG13 ' A' ' 44' ' ' ILE . 26.5 mt -141.01 143.56 28.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.171 -172.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.62 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 43.5 mtpt -81.16 167.38 19.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.8 tt -129.6 135.84 60.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.079 0.466 . . . . 0.0 110.701 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.3 t -115.63 -53.97 4.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.412 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.06 142.55 50.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.216 -174.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.58 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 57.6 mt -123.67 94.22 2.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 169.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 36.6 m -115.49 112.04 43.71 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.53 -174.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.477 ' HG2' HG12 ' A' ' 85' ' ' VAL . 7.1 Cg_endo -93.24 165.03 22.8 Favored 'Cis proline' 0 CA--C 1.531 0.335 0 C-N-CA 124.831 -0.904 . . . . 0.0 112.393 -5.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.58 ' HG3' ' O ' ' A' ' 80' ' ' ILE . 39.6 mtm180 -92.25 -36.85 13.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.378 0.609 . . . . 0.0 109.833 176.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.512 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 62.1 t -117.52 121.44 67.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.626 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.477 HG12 ' HG2' ' A' ' 82' ' ' PRO . 13.9 m -116.1 133.2 63.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.181 0.515 . . . . 0.0 111.817 -177.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.7 m -83.54 95.9 8.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.682 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 90.4 mt -90.41 124.08 34.66 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.884 0.373 . . . . 0.0 110.385 -178.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.859 ' HG2' ' HG2' ' A' ' 62' ' ' GLU . 94.5 mt-30 -85.6 92.99 8.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.55 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.443 HD13 ' HH ' ' A' ' 65' ' ' TYR . 85.5 mt -92.37 157.63 16.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.497 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.69 163.63 32.3 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 178.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -67.4 132.17 47.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.348 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 79.1 t60 . . . . . 0 C--N 1.323 -0.548 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 172.593 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--O 1.234 0.265 0 CA-C-O 120.419 0.152 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -75.84 118.31 5.01 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.795 2.33 . . . . 0.0 111.689 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.7 m -87.94 92.31 9.08 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.692 HD13 ' HB ' ' A' ' 46' ' ' VAL . 41.1 tp -84.06 123.06 29.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.312 -171.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.1 m -103.32 118.1 35.99 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.935 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.2 mt -120.18 141.54 49.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.237 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.0 t -74.89 135.25 41.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.26 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.601 HD12 HG12 ' A' ' 53' ' ' VAL . 50.0 tp -79.75 131.82 36.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.5 pt -128.08 148.35 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.261 0.553 . . . . 0.0 111.264 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.517 ' HB3' ' OG1' ' A' ' 20' ' ' THR . . . -85.83 108.69 18.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.443 175.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 22.9 tptm -97.41 -66.81 0.88 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.189 0.518 . . . . 0.0 110.712 -174.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.832 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 6.3 m-20 -84.0 57.42 4.16 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.887 -177.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 34.5 m -114.66 124.22 30.89 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.699 -174.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 16.5 Cg_exo -68.21 146.76 70.88 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.963 2.442 . . . . 0.0 111.516 174.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.63 -13.87 60.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.775 0.321 . . . . 0.0 111.821 -175.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -89.35 2.47 54.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.101 0.477 . . . . 0.0 110.662 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 p -125.97 122.9 37.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.158 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 42.4 ttp -113.87 126.86 55.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.653 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.8 mt -77.65 132.12 33.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.389 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.433 ' SD ' ' HB2' ' A' ' 90' ' ' GLU . 74.6 mtm -93.68 -26.11 17.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.149 0.5 . . . . 0.0 110.496 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.8 p -83.78 118.44 23.92 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.78 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.29 142.97 56.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.907 0.385 . . . . 0.0 110.244 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 85.4 mt -86.32 119.1 71.34 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.151 -171.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 3.0 Cg_exo -74.35 175.72 10.6 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.846 2.364 . . . . 0.0 112.484 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.2 m -98.23 128.4 44.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.76 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -85.83 129.53 37.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -112.41 108.84 18.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.074 0.464 . . . . 0.0 109.861 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.526 HG13 ' HA ' ' A' ' 80' ' ' ILE . 34.7 m -109.79 143.84 19.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.091 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -99.46 121.45 41.16 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.9 p -106.0 159.15 16.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.779 0.323 . . . . 0.0 111.589 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.669 ' HB3' ' HB2' ' A' ' 76' ' ' LYS . 32.6 tt0 -112.69 109.6 19.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.493 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.42 -144.25 14.98 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.898 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.423 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 40.9 t80 -155.13 116.05 3.93 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.89 105.54 15.35 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.929 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 5.3 Cg_exo -77.85 -66.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.15 2.567 . . . . 0.0 112.986 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 t -125.63 39.36 3.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.322 0.582 . . . . 0.0 110.457 -175.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.8 mt -91.83 130.3 41.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.704 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.529 ' HB3' ' HG2' ' A' ' 48' ' ' GLU . 17.5 m120 -75.26 89.41 2.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.315 0.578 . . . . 0.0 111.096 -176.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.692 ' HB ' HD13 ' A' ' 11' ' ' LEU . 33.6 m -70.65 -13.94 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.178 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -87.6 -18.28 30.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.911 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.529 ' HG2' ' HB3' ' A' ' 45' ' ' ASN . 16.1 mm-40 -96.2 -20.83 18.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.387 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 99.0 mt -82.01 132.4 35.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.697 174.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -129.31 168.5 16.15 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.358 0.599 . . . . 0.0 111.506 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.461 ' O ' HD11 ' A' ' 15' ' ' LEU . . . -108.89 117.3 33.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.376 170.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 25.5 p90 -114.84 152.21 32.58 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.138 0.494 . . . . 0.0 111.666 -173.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.601 HG12 HD12 ' A' ' 15' ' ' LEU . 21.2 m -115.64 144.69 22.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.128 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.832 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 4.5 t70 -98.21 109.07 21.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.061 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.455 HD12 HG21 ' A' ' 20' ' ' THR . 53.0 mt -101.57 68.7 1.19 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.348 0.594 . . . . 0.0 109.946 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.1 p -82.64 -1.2 50.36 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.74 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.22 112.8 4.34 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.7 p -84.45 16.15 3.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.869 0.366 . . . . 0.0 111.768 -177.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -85.86 119.55 72.0 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.529 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.532 ' HA ' ' HB2' ' A' ' 89' ' ' LEU . 11.6 Cg_exo -70.91 -174.56 1.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.906 2.404 . . . . 0.0 112.329 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 88' ' ' GLN . . . 97.89 -137.6 13.39 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.691 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -125.96 113.86 17.72 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.781 0.324 . . . . 0.0 110.133 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -130.45 155.07 47.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.824 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -100.12 130.21 46.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.441 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -128.44 158.03 39.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.93 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.86 141.49 28.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.041 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.425 HG11 HD13 ' A' ' 15' ' ' LEU . 59.0 t -86.37 107.8 17.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.631 174.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.444 ' HD3' ' CE2' ' A' ' 52' ' ' TYR . 57.9 tttm -99.1 103.17 15.06 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.09 0.472 . . . . 0.0 110.264 -178.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.95 130.38 36.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.632 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.419 ' HG3' ' HD2' ' A' ' 71' ' ' PRO . 27.5 tt0 -68.57 128.33 93.02 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.419 ' HD2' ' HG3' ' A' ' 70' ' ' GLU . 12.1 Cg_endo -55.19 131.64 47.53 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.185 2.59 . . . . 0.0 113.158 -175.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.498 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.2 mp -81.5 125.9 77.47 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.062 177.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.85 109.86 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.291 2.66 . . . . 0.0 113.671 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.6 t30 71.9 2.82 4.45 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.721 173.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.469 ' HB ' ' HB ' ' A' ' 72' ' ' ILE . 48.9 mm -102.29 135.31 39.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 O-C-N 121.928 -0.482 . . . . 0.0 110.387 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.669 ' HB2' ' HB3' ' A' ' 38' ' ' GLU . 72.8 mttt -87.39 148.76 24.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.62 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.473 HD11 HG12 ' A' ' 80' ' ' ILE . 21.4 tt -110.21 128.19 66.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.293 0.568 . . . . 0.0 110.105 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.606 HG11 ' HG3' ' A' ' 79' ' ' GLU . 42.6 t -95.42 -63.84 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.988 -175.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.606 ' HG3' HG11 ' A' ' 78' ' ' VAL . 43.0 mt-10 -123.81 127.36 47.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.743 -175.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.526 ' HA ' HG13 ' A' ' 35' ' ' VAL . 26.3 mt -105.78 127.75 60.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 15.6 m -150.5 115.12 3.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.842 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 88.6 Cg_endo -85.87 177.21 26.36 Favored 'Cis proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.502 -1.458 . . . . 0.0 112.682 -0.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.445 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 84.8 mtm180 -119.97 -28.96 5.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.838 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.98 117.16 48.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.5 m -110.75 135.86 48.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.251 0.548 . . . . 0.0 111.254 -178.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.9 m -88.93 112.24 23.07 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.604 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 90.0 mt -111.55 145.67 38.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 -174.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 93.0 mt-30 -113.09 129.71 56.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.12 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 60' ' ' PRO . 82.8 mt -113.86 136.78 52.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.036 0.446 . . . . 0.0 111.616 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.433 ' HB2' ' SD ' ' A' ' 27' ' ' MET . 43.2 tt0 -119.21 162.96 17.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.163 176.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -80.35 151.3 29.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.538 0.685 . . . . 0.0 112.198 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 43.0 t60 . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.661 172.09 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.59 ' HB3' ' HE2' ' A' ' 36' ' ' LYS . 11.9 m-20 . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 120.523 0.201 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.71 124.47 10.26 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.13 1.887 . . . . 0.0 112.623 -178.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.0 m -101.37 103.69 14.65 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.2 mt -83.1 122.46 28.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.268 0.556 . . . . 0.0 110.715 -173.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.4 m -99.22 106.45 18.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.138 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.8 mt -107.94 -174.67 2.58 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.628 -177.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -114.79 145.37 42.19 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.535 HD12 HG13 ' A' ' 53' ' ' VAL . 45.6 tp -87.44 130.15 34.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.8 pt -128.0 144.8 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.22 0.534 . . . . 0.0 111.763 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.482 ' HB2' ' OG1' ' A' ' 20' ' ' THR . . . -81.29 102.82 10.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.233 173.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.418 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 59.6 tttm -91.65 -71.57 0.63 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.937 0.399 . . . . 0.0 110.874 -173.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.418 ' OD1' ' HG2' ' A' ' 18' ' ' LYS . 5.2 m-20 -94.27 67.09 3.5 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.623 0.725 . . . . 0.0 109.86 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.549 ' HG1' HD12 ' A' ' 55' ' ' LEU . 88.1 m -105.79 116.71 59.4 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.287 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 16.9 Cg_exo -67.87 156.39 66.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.168 2.578 . . . . 0.0 112.599 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.96 151.69 45.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.38 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 73.29 9.35 5.19 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.793 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.2 p -103.63 137.48 41.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 171.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.753 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 52.1 ttp -128.87 119.25 24.1 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.811 0.338 . . . . 0.0 110.405 -174.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.5 mt -85.31 124.75 40.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.448 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.537 ' HB2' ' HB2' ' A' ' 88' ' ' GLN . 86.1 mtp -85.36 -31.9 22.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.388 178.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 p -78.27 118.32 20.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.794 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.68 141.01 53.65 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.84 118.44 70.33 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.415 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -89.8 176.96 2.72 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.893 2.395 . . . . 0.0 112.741 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -83.06 135.28 34.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.147 176.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.528 HG11 ' HB1' ' A' ' 51' ' ' ALA . 9.5 p -104.03 152.99 6.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -128.54 134.27 48.61 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.957 0.408 . . . . 0.0 110.838 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 16.3 m -124.33 129.1 74.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.352 175.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.59 ' HE2' ' HB3' ' A' ' 8' ' ' ASP . 13.1 tmtt? -86.16 127.36 34.7 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.526 HG23 ' HA ' ' A' ' 77' ' ' ILE . 33.0 p -128.68 168.15 16.2 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -171.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 76' ' ' LYS . 40.3 mm-40 -114.21 127.32 55.84 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.38 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.97 -161.89 15.94 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.578 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -128.35 128.53 44.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.725 0.298 . . . . 0.0 110.27 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.418 ' HB3' HD13 ' A' ' 44' ' ' ILE . 3.0 p30 -122.41 77.34 44.92 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.261 0.553 . . . . 0.0 111.267 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.12 -47.04 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.649 2.233 . . . . 0.0 111.796 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 m -129.33 80.21 1.95 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.195 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.418 HD13 ' HB3' ' A' ' 41' ' ' ASN . 44.7 mt -134.64 157.5 41.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -73.85 55.59 0.54 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.457 0.646 . . . . 0.0 111.504 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.8 t -66.39 -26.27 37.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.76 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -89.9 5.08 47.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.152 0.501 . . . . 0.0 110.906 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -107.12 -24.29 12.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.506 0.669 . . . . 0.0 109.22 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.604 HD11 HG12 ' A' ' 72' ' ' ILE . 63.5 mt -88.11 132.67 34.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.66 177.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -143.51 178.03 8.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.934 0.397 . . . . 0.0 110.812 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.528 ' HB1' HG11 ' A' ' 33' ' ' VAL . . . -105.85 119.88 40.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.956 172.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -115.18 148.91 38.47 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.087 0.47 . . . . 0.0 110.946 -174.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.535 HG13 HD12 ' A' ' 15' ' ' LEU . 18.3 m -112.85 133.42 58.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.951 174.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -104.8 105.53 15.63 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.822 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.549 HD12 ' HG1' ' A' ' 20' ' ' THR . 61.6 mt -92.41 90.09 7.07 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.043 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.5 p -75.05 1.91 11.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.541 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.06 132.62 2.87 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.707 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 m -80.44 76.75 7.26 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 89' ' ' LEU . 30.9 mt-10 -91.36 108.91 32.3 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.53 -176.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 11.8 Cg_exo -69.07 131.29 21.88 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.761 2.307 . . . . 0.0 112.204 -176.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.91 174.15 17.59 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 1.008 ' HG2' ' HG2' ' A' ' 88' ' ' GLN . 33.2 mt-10 -76.78 106.42 8.43 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -118.62 156.03 29.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.149 0.5 . . . . 0.0 111.269 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -90.47 116.05 28.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.161 -176.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -127.15 157.42 39.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.052 0.453 . . . . 0.0 111.727 -176.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -89.33 144.5 26.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.692 -173.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.07 114.05 35.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.658 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -108.01 125.32 51.4 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.8 t -102.41 136.29 35.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.557 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -54.83 122.35 40.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.187 174.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.17 116.49 2.98 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.699 2.266 . . . . 0.0 111.973 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.604 HG12 HD11 ' A' ' 49' ' ' LEU . 55.8 mt -81.47 121.71 80.21 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.982 -175.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.59 143.09 37.43 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.463 2.108 . . . . 0.0 111.747 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 t30 75.17 -44.47 0.54 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.362 0.665 . . . . 0.0 111.901 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.52 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 48.9 mm -91.58 136.93 23.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.0 -176.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.6 ' HB3' ' HB2' ' A' ' 38' ' ' GLU . 74.7 tttt -85.17 135.13 34.09 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.526 ' HA ' HG23 ' A' ' 37' ' ' THR . 15.1 tt -96.03 133.69 36.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.953 0.406 . . . . 0.0 109.996 176.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -110.86 -57.97 3.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.339 0.59 . . . . 0.0 111.386 -176.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 38.6 tt0 -126.07 124.81 41.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.403 -170.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.55 ' HB ' ' HG2' ' A' ' 83' ' ' ARG . 61.0 mt -99.22 113.5 34.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 25.2 p -127.22 110.49 21.44 Favored Pre-proline 0 C--N 1.318 -0.782 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.035 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 98.1 Cg_endo -88.43 162.76 42.52 Favored 'Cis proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.77 -1.346 . . . . 0.0 112.716 -1.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.55 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 63.2 mtm180 -87.56 -25.47 23.61 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.947 0.404 . . . . 0.0 110.345 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.7 t -136.2 135.66 49.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.505 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 m -122.52 151.27 26.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.071 0.462 . . . . 0.0 110.963 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.8 m -101.28 107.28 18.61 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.579 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.4 mt -101.62 137.42 39.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.167 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 1.008 ' HG2' ' HG2' ' A' ' 62' ' ' GLU . 79.9 mt-30 -99.71 109.0 21.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.576 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 70.8 mt -104.62 142.85 33.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.088 0.47 . . . . 0.0 111.673 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.539 ' HG2' ' H ' ' A' ' 91' ' ' HIS . 27.0 tt0 -136.04 176.1 9.0 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 172.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.539 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 86.3 m-70 -99.72 118.83 37.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.753 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 63.8 t60 . . . . . 0 C--N 1.324 -0.512 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -85.52 166.18 10.55 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.436 2.757 . . . . 0.0 113.34 -173.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 20.1 m -100.84 137.33 39.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.502 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.1 mt -107.45 137.89 44.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.072 0.463 . . . . 0.0 110.597 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -107.79 114.12 27.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.866 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.86 165.58 14.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.128 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.3 m -100.8 142.97 31.52 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.589 HD12 HG13 ' A' ' 53' ' ' VAL . 30.7 tp -91.44 128.22 37.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.159 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.7 pt -115.09 160.75 14.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.969 0.414 . . . . 0.0 111.43 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.538 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -92.64 100.08 12.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.445 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -101.61 135.41 43.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.149 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 66.5 t30 62.28 16.51 8.53 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.536 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.538 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 91.7 m -60.74 119.68 46.34 Favored Pre-proline 0 N--CA 1.447 -0.595 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.777 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.647 ' HG2' ' HA ' ' A' ' 58' ' ' SER . 51.7 Cg_exo -55.02 162.49 5.24 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.869 3.046 . . . . 0.0 113.456 -173.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.76 149.08 32.75 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.156 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 65.13 37.32 6.71 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.617 0.573 . . . . 0.0 111.297 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.0 p -123.36 160.04 27.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.796 0.332 . . . . 0.0 110.559 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.0 ttp -144.86 129.12 17.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.401 HG12 ' CD2' ' A' ' 89' ' ' LEU . 19.1 mt -95.44 109.88 23.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 83.9 mtp -71.63 -27.96 63.46 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 110.527 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.8 m -77.95 123.99 27.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.719 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -71.79 130.54 41.35 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.531 -176.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.07 113.57 17.38 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.093 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.425 ' HD2' HD22 ' A' ' 15' ' ' LEU . 92.2 Cg_endo -85.15 -175.93 2.19 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.84 2.36 . . . . 0.0 112.79 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.4 m -105.76 126.31 52.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.356 174.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.509 HG13 ' HD2' ' A' ' 82' ' ' PRO . 13.4 m -85.91 148.24 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.474 -175.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -127.57 97.52 4.89 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' A' ' 80' ' ' ILE . 30.7 m -105.32 132.64 51.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.381 -176.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 71.2 tttt -81.46 136.13 35.64 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.526 HG23 ' HA ' ' A' ' 77' ' ' ILE . 22.4 p -125.9 162.69 24.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.316 -177.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.24 112.93 18.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.87 178.91 24.33 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.61 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -118.41 144.18 46.13 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -128.96 92.51 39.57 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 121.328 0.585 . . . . 0.0 111.756 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.09 -45.46 15.88 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.788 2.325 . . . . 0.0 111.096 174.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.7 m -117.63 -115.58 0.33 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.552 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.1 mt 56.52 99.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 111.795 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -73.21 100.96 3.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.698 0.761 . . . . 0.0 111.289 -177.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.0 t -64.2 -22.41 31.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.756 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -80.3 -11.61 59.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.87 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -98.13 -21.66 16.63 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 90.8 mt -70.03 132.35 45.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.887 174.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -130.47 152.97 49.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.281 0.562 . . . . 0.0 111.848 -177.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -115.45 141.28 48.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 170.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.435 ' CE1' ' HB2' ' A' ' 68' ' ' LYS . 47.0 p90 -133.24 161.31 34.82 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.028 -175.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.589 HG13 HD12 ' A' ' 15' ' ' LEU . 6.7 m -112.35 117.98 56.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -86.38 102.59 14.16 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 20' ' ' THR . 43.5 mt -88.45 76.41 8.26 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.151 -175.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.8 m -84.09 9.69 11.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.565 0.698 . . . . 0.0 109.754 173.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.39 107.06 1.88 Allowed Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.162 175.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.647 ' HA ' ' HG2' ' A' ' 21' ' ' PRO . 16.1 m -85.7 9.5 16.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.223 0.535 . . . . 0.0 110.69 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.88 121.13 83.06 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.54 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.71 175.84 10.78 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.663 2.242 . . . . 0.0 112.304 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.81 -158.99 19.11 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -176.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -100.12 107.76 19.73 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -132.74 144.41 50.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.138 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 4.4 p30 -94.15 141.29 28.72 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.197 0.523 . . . . 0.0 110.787 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -133.69 164.23 27.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.06 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -93.3 140.27 29.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.246 -172.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 98.6 t -79.88 108.71 13.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 172.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.435 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 40.6 mtpt -108.77 114.06 27.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.711 -176.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.6 139.97 17.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.24 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.26 132.44 94.43 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.48 113.66 1.56 Allowed 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.966 2.444 . . . . 0.0 112.574 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.471 HD11 ' H ' ' A' ' 72' ' ' ILE . 4.4 mp -83.29 122.31 77.23 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.018 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 75' ' ' ILE . 54.0 Cg_endo -70.79 143.62 46.38 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.361 2.041 . . . . 0.0 111.716 176.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.4 t30 73.79 -23.38 0.22 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.097 0.559 . . . . 0.0 112.203 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.427 ' H ' ' C ' ' A' ' 73' ' ' PRO . 48.2 mm -108.38 125.66 65.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.758 0.313 . . . . 0.0 110.877 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -88.16 125.97 34.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.115 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.526 ' HA ' HG23 ' A' ' 37' ' ' THR . 16.6 tt -80.06 135.88 24.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.5 t -104.49 -64.91 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.263 0.554 . . . . 0.0 110.907 -178.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -122.5 137.71 54.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.434 -172.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.478 ' HA ' HG13 ' A' ' 35' ' ' VAL . 61.0 mt -103.06 109.44 26.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.675 176.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.447 ' HA ' ' C ' ' A' ' 82' ' ' PRO . 18.2 p -141.87 124.46 9.34 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.457 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.509 ' HD2' HG13 ' A' ' 33' ' ' VAL . 43.0 Cg_endo -67.72 160.36 81.16 Favored 'Cis proline' 0 C--N 1.344 0.315 0 C-N-CA 123.386 -1.506 . . . . 0.0 113.204 0.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -86.36 -70.21 0.62 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.538 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.441 HG11 ' HB2' ' A' ' 64' ' ' ASP . 62.6 t -121.48 129.34 75.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.374 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.3 m -110.21 134.93 50.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.972 0.415 . . . . 0.0 110.879 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 24.0 m -92.92 111.39 22.99 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.079 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.2 mt -106.12 138.88 41.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.155 0.502 . . . . 0.0 111.365 -173.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -94.77 109.83 21.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.066 174.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.401 ' CD2' HG12 ' A' ' 26' ' ' ILE . 80.0 mt -100.79 130.0 46.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.239 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -119.14 178.5 4.49 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.414 171.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -97.96 151.86 19.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.48 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 14.4 t60 . . . . . 0 C--N 1.323 -0.558 0 CA-C-O 120.989 0.423 . . . . 0.0 110.147 -178.909 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.574 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 9.1 m-20 . . . . . 0 C--O 1.233 0.225 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -75.26 129.69 12.34 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.673 2.249 . . . . 0.0 112.553 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 43.1 m -102.33 109.68 21.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.672 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.538 HD23 ' ND2' ' A' ' 41' ' ' ASN . 83.7 mt -92.48 147.11 23.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.258 0.551 . . . . 0.0 111.528 -172.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.9 m -121.62 97.59 5.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.427 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 56.2 mt -99.17 162.9 12.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.319 -175.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.6 p -100.68 148.67 24.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.705 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.783 HD13 HG13 ' A' ' 53' ' ' VAL . 34.1 tp -94.34 125.03 38.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.189 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.6 pt -112.04 151.9 13.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.318 0.58 . . . . 0.0 111.768 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.62 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -83.69 102.19 12.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.116 176.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 86.4 tttt -83.34 115.24 21.92 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.312 -178.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 73.89 -68.27 0.23 Allowed 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.198 0.999 . . . . 0.0 109.668 -177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.62 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 47.7 m 48.13 97.76 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.404 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.96 -172.16 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.776 2.984 . . . . 0.0 115.151 -169.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.74 105.82 0.16 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.422 -1.263 . . . . 0.0 113.598 -172.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.48 22.13 13.08 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.003 168.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.0 p -84.64 102.72 13.15 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 170.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.9 ttp -103.08 126.5 50.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.633 -172.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.446 HG12 ' CD2' ' A' ' 89' ' ' LEU . 5.8 mt -84.81 110.59 19.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.957 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 58.1 ttp -73.18 -32.11 64.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.9 m -69.3 131.68 45.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.169 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -75.65 119.84 20.23 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -56.96 114.35 7.86 Favored Pre-proline 0 C--N 1.328 -0.35 0 O-C-N 123.488 0.493 . . . . 0.0 110.064 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.27 -172.56 1.4 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.89 2.394 . . . . 0.0 112.792 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.8 p -99.1 149.54 22.93 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.821 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 13' ' ' LEU . 35.6 m -108.17 129.29 62.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.149 0.5 . . . . 0.0 109.804 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -106.88 110.35 22.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.218 0.533 . . . . 0.0 109.88 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.519 HG11 ' HA ' ' A' ' 80' ' ' ILE . 27.2 m -120.45 137.46 54.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.527 -176.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.574 ' HE3' ' HB3' ' A' ' 8' ' ' ASP . 83.3 tttt -93.19 136.24 33.64 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.502 HG23 ' HA ' ' A' ' 77' ' ' ILE . 22.5 p -124.56 168.42 13.13 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.278 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.443 ' HG3' ' CG2' ' A' ' 78' ' ' VAL . 42.1 mt-10 -122.5 123.13 40.55 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 176.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.0 -148.63 20.44 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.778 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.498 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 73.1 m-85 -129.57 129.07 43.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.804 0.335 . . . . 0.0 110.384 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.538 ' ND2' HD23 ' A' ' 11' ' ' LEU . 1.6 m-20 -116.71 77.98 8.67 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.629 -176.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 3.0 Cg_endo -86.63 -62.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.635 2.223 . . . . 0.0 112.2 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.0 p -91.5 -8.99 46.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.597 -177.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.21 116.11 33.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -111.63 150.34 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.58 -171.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.409 ' HB ' HD21 ' A' ' 13' ' ' LEU . 31.4 m -76.12 -5.34 7.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.964 178.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -85.31 -8.45 58.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.935 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -114.58 -29.15 6.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.737 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.411 ' HB2' HD22 ' A' ' 13' ' ' LEU . 79.0 mt -84.54 134.34 34.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -130.61 160.63 33.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.468 0.652 . . . . 0.0 111.828 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -117.42 133.95 55.39 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 170.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.408 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 48.7 p90 -122.04 152.01 40.24 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.018 -174.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.783 HG13 HD13 ' A' ' 15' ' ' LEU . 6.4 m -112.24 125.9 69.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.785 172.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -86.61 99.98 12.1 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.473 HD12 ' OG1' ' A' ' 20' ' ' THR . 64.6 mt -92.16 21.11 5.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.602 -173.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.5 p -60.37 115.9 3.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.153 0.501 . . . . 0.0 110.093 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.452 ' C ' ' HG ' ' A' ' 58' ' ' SER . . . 145.8 -28.5 1.74 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.594 -175.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.452 ' HG ' ' C ' ' A' ' 57' ' ' GLY . 51.9 p 49.98 38.29 16.04 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.438 0.695 . . . . 0.0 111.897 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -84.84 115.02 59.06 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.953 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.3 150.21 28.63 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.825 2.35 . . . . 0.0 112.092 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.82 -174.43 21.64 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.745 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -80.26 105.75 11.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.753 0.311 . . . . 0.0 110.27 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -125.18 151.68 45.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.523 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -91.98 123.11 35.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.519 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.495 ' HH ' HD13 ' A' ' 89' ' ' LEU . 98.1 m-85 -121.62 139.33 53.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.231 178.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.49 136.82 51.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.237 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 64.2 t -83.26 106.08 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -103.6 104.99 15.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.118 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.9 t -90.91 140.18 16.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.334 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 36.3 mt-10 -66.64 128.14 93.72 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.33 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 25.3 Cg_exo -62.58 115.88 3.18 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.829 2.352 . . . . 0.0 111.92 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.3 mp -81.33 122.62 81.33 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.073 -173.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.86 135.94 34.04 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.791 2.327 . . . . 0.0 112.221 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.4 m120 71.5 6.79 5.84 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.387 176.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.1 mt -135.9 131.23 49.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.823 0.344 . . . . 0.0 110.612 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -84.79 129.56 34.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.396 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.502 ' HA ' HG23 ' A' ' 37' ' ' THR . 17.7 tt -92.72 134.35 30.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.443 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 35.4 t -108.18 -60.46 2.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.904 0.383 . . . . 0.0 111.459 -174.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.408 ' HG3' HG13 ' A' ' 78' ' ' VAL . 41.8 mt-10 -118.58 128.44 54.56 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 -171.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.519 ' HA ' HG11 ' A' ' 35' ' ' VAL . 62.4 mt -111.92 109.47 28.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.273 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.8 p -139.75 126.96 12.7 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.601 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -80.63 159.78 84.8 Favored 'Cis proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.452 -1.479 . . . . 0.0 112.535 -0.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -80.34 -50.32 10.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.291 0.567 . . . . 0.0 110.527 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.1 t -131.11 137.1 56.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.377 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.5 m -117.77 134.11 62.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.159 0.504 . . . . 0.0 111.172 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.3 m -85.04 105.82 16.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.598 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.8 mt -104.89 130.49 53.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.271 -177.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -94.23 106.12 18.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.076 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.495 HD13 ' HH ' ' A' ' 65' ' ' TYR . 90.1 mt -91.96 126.82 37.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.59 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -118.55 150.33 39.82 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.377 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -77.43 137.93 38.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.954 0.407 . . . . 0.0 111.257 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.012 177.244 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 . . . . . 0 CA--C 1.528 0.108 0 CA-C-O 121.437 0.637 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.19 161.97 11.45 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.627 2.218 . . . . 0.0 113.01 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.1 m -93.96 105.65 17.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.784 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.523 HD13 ' HB ' ' A' ' 46' ' ' VAL . 54.3 tp -83.2 139.02 33.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.632 -176.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.7 m -116.77 115.36 25.44 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.787 0.327 . . . . 0.0 110.561 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.6 mt -114.52 141.73 47.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.164 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.6 m -75.05 142.31 43.76 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.711 0.291 . . . . 0.0 110.472 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.79 HD11 HG11 ' A' ' 53' ' ' VAL . 38.6 tp -89.1 122.03 32.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.234 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.6 pt -104.42 148.38 9.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.149 0.499 . . . . 0.0 111.114 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.33 113.44 18.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.855 176.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -111.64 133.17 54.08 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 68.13 3.68 3.75 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.608 0.568 . . . . 0.0 112.067 174.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 27.1 m -62.3 113.66 9.44 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.995 -177.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 24.0 Cg_exo -65.16 166.88 17.59 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.373 2.716 . . . . 0.0 113.51 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.34 -23.02 60.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.123 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -85.46 3.61 39.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.84 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.2 m -117.01 124.55 49.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.612 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.5 ttp -117.18 113.03 21.65 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.8 mt -75.95 115.9 18.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.254 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 22.1 ttt -77.9 -35.58 50.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.073 0.463 . . . . 0.0 110.049 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.7 m -78.6 121.65 24.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.775 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -69.48 128.26 35.9 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.8 mt -67.95 126.4 92.58 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.196 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -90.99 -161.25 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.119 2.546 . . . . 0.0 112.397 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.8 m -117.83 141.96 47.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.405 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 p -97.75 145.22 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.965 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.6 mtp180 -114.93 118.43 33.44 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.551 HG13 ' HA ' ' A' ' 80' ' ' ILE . 17.3 m -117.3 134.45 60.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.057 -177.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 11.9 mmtt -79.09 122.21 25.95 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 173.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.3 p -120.95 129.83 53.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.773 0.321 . . . . 0.0 111.509 -176.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 28.3 tt0 -96.04 106.15 18.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.601 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 135.17 -178.41 18.59 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.029 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -113.23 161.06 17.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.101 0.476 . . . . 0.0 111.043 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.603 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 3.2 p30 -128.74 74.57 80.54 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.687 176.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.66 -45.46 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.585 2.19 . . . . 0.0 111.767 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 p -102.9 3.93 37.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.054 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.627 HD11 ' HB2' ' A' ' 74' ' ' ASN . 56.9 mt -106.69 121.51 59.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.629 -175.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.401 ' ND2' ' HG3' ' A' ' 48' ' ' GLU . 47.7 t30 -91.72 106.23 18.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.541 0.686 . . . . 0.0 110.665 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.523 ' HB ' HD13 ' A' ' 11' ' ' LEU . 33.2 m -69.66 -10.88 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.68 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -82.87 -11.01 58.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.978 0.418 . . . . 0.0 110.497 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HG3' ' ND2' ' A' ' 45' ' ' ASN . 40.2 mt-10 -106.26 -16.46 14.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.213 174.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.8 mt -70.32 128.56 36.63 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 168.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -124.3 157.86 33.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.361 0.6 . . . . 0.0 112.044 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.88 129.54 56.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 169.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -129.57 143.78 50.98 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.466 0.651 . . . . 0.0 111.622 -173.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.79 HG11 HD11 ' A' ' 15' ' ' LEU . 3.2 m -112.52 119.52 60.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.94 172.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -84.84 100.3 11.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.571 -173.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.452 HD21 HD12 ' A' ' 89' ' ' LEU . 10.5 mp -90.6 76.26 6.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.0 m -57.3 -42.63 82.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.919 -174.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -112.21 172.56 14.82 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.041 -174.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.9 m -91.4 31.07 1.19 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.975 0.417 . . . . 0.0 110.168 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -59.73 112.28 5.08 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.521 -175.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.41 151.88 20.27 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.633 2.222 . . . . 0.0 112.055 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.82 179.3 19.13 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.351 176.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 88' ' ' GLN . 41.8 tt0 -87.08 107.99 18.68 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 65' ' ' TYR . 76.6 m-70 -117.33 161.76 19.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.818 -175.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -95.53 127.24 41.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 63' ' ' HIS . 95.3 m-85 -116.88 134.24 55.02 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.322 0.582 . . . . 0.0 111.165 -177.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -77.09 120.64 22.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.146 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.5 t -73.44 106.25 3.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.27 0.557 . . . . 0.0 110.044 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -100.5 126.02 46.88 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.554 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.9 146.73 10.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -58.94 115.38 11.69 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 173.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.19 108.0 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.713 2.276 . . . . 0.0 112.486 -176.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.496 HD12 ' H ' ' A' ' 72' ' ' ILE . 3.8 mp -81.06 111.11 21.09 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.9 24.51 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.829 2.353 . . . . 0.0 113.15 -172.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.627 ' HB2' HD11 ' A' ' 44' ' ' ILE . 21.8 m120 -144.38 -1.42 0.92 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.721 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.518 HD12 ' HB3' ' A' ' 41' ' ' ASN . 70.1 mt -129.96 134.23 63.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.874 0.368 . . . . 0.0 110.407 -176.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 52.2 tttm -83.18 112.83 20.2 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.802 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.9 tt -80.66 125.46 39.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.203 0.525 . . . . 0.0 110.163 -176.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 22.7 t -93.59 -54.18 7.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.35 -173.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -153.28 156.82 39.15 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.722 -174.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.557 ' HB ' ' HG2' ' A' ' 83' ' ' ARG . 60.9 mt -122.78 132.08 72.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.2 t -139.21 110.5 7.7 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.464 0.173 . . . . 0.0 110.642 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -87.35 153.38 42.07 Favored 'Cis proline' 0 N--CA 1.462 -0.379 0 C-N-CA 124.215 -1.161 . . . . 0.0 112.152 -2.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.557 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 85.1 mtm180 -76.33 -34.68 59.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.878 0.371 . . . . 0.0 111.392 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.8 t -129.23 129.62 67.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.913 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.3 m -116.11 133.44 62.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.971 0.415 . . . . 0.0 110.859 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.3 m -90.78 115.4 27.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.144 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 65' ' ' TYR . 70.8 mt -118.82 138.86 52.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.178 -177.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 53.1 tt0 -93.83 115.78 28.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.951 0.405 . . . . 0.0 110.581 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.452 HD12 HD21 ' A' ' 55' ' ' LEU . 23.7 mt -100.42 135.68 41.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.282 0.563 . . . . 0.0 111.118 177.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -118.86 170.51 8.95 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 169.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -83.43 166.15 18.61 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.885 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.2 t60 . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.201 -178.735 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.814 ' HB3' ' HG3' ' A' ' 38' ' ' GLU . 6.1 p-10 . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 121.737 0.779 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.32 141.1 25.36 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.097 2.532 . . . . 0.0 113.36 -173.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 40.9 m -87.77 110.35 20.4 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.9 tp -108.92 144.69 36.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.538 -171.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 12.4 t -116.64 123.47 47.37 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.353 0.597 . . . . 0.0 109.796 174.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt -109.5 166.29 11.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.011 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.2 t -86.07 126.65 34.34 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.634 HD13 HG11 ' A' ' 53' ' ' VAL . 60.3 tp -80.82 104.24 11.2 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 174.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 36.2 pt -107.08 147.45 12.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.257 0.551 . . . . 0.0 111.599 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.557 ' HB3' ' OG1' ' A' ' 20' ' ' THR . . . -86.91 105.03 16.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.54 175.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -90.42 -77.84 0.39 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.859 -174.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -80.71 64.82 5.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.906 0.86 . . . . 0.0 109.253 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.557 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 46.5 m -112.0 111.48 53.47 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.564 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -71.25 -178.93 3.18 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.035 2.49 . . . . 0.0 111.979 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.56 ' O ' ' HB3' ' A' ' 23' ' ' ASN . . . -77.87 160.96 27.96 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.571 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.56 ' HB3' ' O ' ' A' ' 22' ' ' ALA . 18.1 t30 80.1 -38.09 0.16 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.847 0.717 . . . . 0.0 111.274 174.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 p -78.72 94.58 5.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.14 0.495 . . . . 0.0 110.123 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.4 ttp -102.94 133.0 48.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.244 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.9 mt -85.9 110.43 19.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.3 ttt -70.4 -32.5 70.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.088 0.47 . . . . 0.0 110.088 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.5 m -78.01 106.62 10.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.477 174.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.58 129.57 40.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.051 0.453 . . . . 0.0 111.175 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.441 ' HB3' ' O ' ' A' ' 15' ' ' LEU . 73.1 mt -55.94 122.72 48.98 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.856 -174.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -95.25 176.19 0.94 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.343 2.695 . . . . 0.0 112.82 176.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 m -87.0 140.08 29.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.925 173.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 12' ' ' THR . 14.4 p -101.83 148.09 7.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.044 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 34' ' ' ARG . 37.2 mtm-85 -103.17 120.45 40.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.904 0.383 . . . . 0.0 110.638 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 80' ' ' ILE . 6.9 m -133.77 116.67 24.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.236 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 16.7 ttpp -87.55 129.07 35.23 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.1 p -105.03 -178.05 3.54 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.814 ' HG3' ' HB3' ' A' ' 8' ' ' ASP . 3.4 tt0 -154.66 110.31 3.15 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.41 165.66 10.85 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.927 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -88.02 113.13 23.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.594 0.235 . . . . 0.0 110.529 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.515 ' HB3' HG13 ' A' ' 75' ' ' ILE . 5.1 p30 -135.5 82.01 40.89 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.537 0.684 . . . . 0.0 111.626 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -91.13 -6.18 3.98 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.096 2.531 . . . . 0.0 111.948 175.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.1 p -97.74 -52.16 3.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.238 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.31 126.35 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.243 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -86.24 128.78 34.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.926 -177.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.63 -13.08 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.451 -174.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -97.06 -9.53 27.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.688 0.28 . . . . 0.0 110.844 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.82 -25.13 22.37 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 172.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.6 128.51 34.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.743 172.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -130.85 157.61 42.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.987 0.422 . . . . 0.0 111.11 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -123.0 114.0 19.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.556 ' CZ ' ' HD2' ' A' ' 68' ' ' LYS . 53.1 p90 -118.55 159.53 23.39 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.121 0.486 . . . . 0.0 111.839 -171.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.634 HG11 HD13 ' A' ' 15' ' ' LEU . 17.0 m -112.43 139.46 37.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.695 172.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -103.68 106.69 17.27 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.458 HD12 HG21 ' A' ' 20' ' ' THR . 78.8 mt -98.49 44.18 1.04 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.947 0.403 . . . . 0.0 111.0 -174.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 t -56.56 -44.04 80.55 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.454 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.99 69.97 3.22 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 173.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 p -69.54 91.58 0.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.488 0.661 . . . . 0.0 110.779 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 42.5 tt0 -117.87 125.48 27.98 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.958 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 59' ' ' GLU . 25.3 Cg_exo -62.89 150.9 87.0 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.194 2.596 . . . . 0.0 112.818 -177.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.38 -177.27 27.15 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.862 ' HG2' ' HB2' ' A' ' 88' ' ' GLN . 42.6 mt-10 -87.68 107.49 18.65 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -124.15 148.76 46.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.414 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 39.4 m-20 -81.89 109.64 16.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.71 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -111.61 146.54 37.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.283 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -80.52 134.06 35.89 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.523 -174.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.461 HG12 HD11 ' A' ' 15' ' ' LEU . 60.1 t -81.75 112.36 19.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.556 ' HD2' ' CZ ' ' A' ' 52' ' ' TYR . 7.8 tmtt? -103.1 111.57 24.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.093 0.473 . . . . 0.0 109.885 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 34.9 t -92.4 143.13 12.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.421 -178.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -58.3 139.16 84.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.908 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.27 136.38 47.14 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.499 2.133 . . . . 0.0 111.702 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.444 ' CG2' ' HB ' ' A' ' 75' ' ' ILE . 41.2 mt -116.24 110.41 43.32 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.312 -177.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.52 137.31 50.1 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.763 2.308 . . . . 0.0 111.938 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 73.41 -45.3 0.61 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.524 0.729 . . . . 0.0 112.447 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.515 HG13 ' HB3' ' A' ' 41' ' ' ASN . 26.3 mm -84.33 129.36 37.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.031 0.443 . . . . 0.0 110.362 -175.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -81.8 141.48 33.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.562 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.2 tt -98.69 112.42 30.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.548 0.69 . . . . 0.0 109.144 174.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.6 t -86.42 -53.22 10.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.633 -170.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -133.86 147.71 51.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.099 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.688 ' HB ' ' HG2' ' A' ' 83' ' ' ARG . 55.0 mt -127.8 111.8 25.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 21.0 m -128.78 108.45 18.57 Favored Pre-proline 0 C--N 1.318 -0.771 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.145 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.479 ' HG2' HG13 ' A' ' 85' ' ' VAL . 4.1 Cg_endo -89.33 166.81 36.09 Favored 'Cis proline' 0 C--N 1.344 0.316 0 C-N-CA 124.459 -1.059 . . . . 0.0 112.344 -3.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.688 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 80.5 mtm180 -93.49 -28.62 15.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.081 0.467 . . . . 0.0 109.888 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.414 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 53.9 t -130.22 120.18 48.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.526 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.479 HG13 ' HG2' ' A' ' 82' ' ' PRO . 16.2 m -112.72 135.45 52.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.157 0.504 . . . . 0.0 111.219 -177.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.8 m -83.09 104.1 13.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.766 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.1 mt -101.51 133.02 46.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.61 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.862 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 42.8 tt0 -92.02 108.73 20.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.86 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 72.2 mt -94.31 120.65 34.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.532 177.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -109.12 152.33 25.24 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.592 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -84.13 100.44 11.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.647 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 83.4 t60 . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.804 -176.373 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 . . . . . 0 CA--C 1.517 -0.308 0 CA-C-O 120.425 0.155 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.14 130.38 18.78 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.398 2.065 . . . . 0.0 111.445 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.7 m -95.75 92.6 6.64 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 175.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.49 HD23 HD12 ' A' ' 49' ' ' LEU . 14.6 tp -82.85 114.98 21.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.953 -170.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.5 m -93.81 101.57 13.67 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.253 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.8 mt -100.83 177.91 4.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.482 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.9 m -105.35 137.63 42.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.521 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.805 HD13 HG11 ' A' ' 53' ' ' VAL . 50.7 tp -86.99 123.46 32.11 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.7 pt -119.79 146.7 24.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.133 0.492 . . . . 0.0 111.034 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.27 115.79 23.24 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -71.05 -76.46 0.1 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.063 -175.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.408 ' HB3' ' HG ' ' A' ' 56' ' ' SER . 31.5 t30 -126.19 81.11 1.97 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.893 0.378 . . . . 0.0 110.317 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.9 t -90.67 127.17 53.46 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 170.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.89 157.33 13.2 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.323 2.682 . . . . 0.0 113.158 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.97 -19.82 64.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.679 -177.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -86.03 -5.8 59.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.26 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 p -118.59 144.61 46.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.106 0.479 . . . . 0.0 111.218 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.9 ttp -132.62 130.7 40.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.738 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.7 mt -82.84 116.92 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.652 0.263 . . . . 0.0 111.134 -176.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.493 ' HG2' ' HB2' ' A' ' 90' ' ' GLU . 95.9 mmm -82.94 -39.24 21.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.175 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.6 m -66.85 112.9 4.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.297 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -58.07 120.63 8.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.164 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.25 109.22 2.27 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.422 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -85.01 -170.87 0.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.879 2.386 . . . . 0.0 113.015 -173.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.2 m -97.2 134.31 40.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.147 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.489 HG11 HG11 ' A' ' 67' ' ' VAL . 17.8 m -96.85 142.39 14.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -120.94 119.26 32.08 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.352 -178.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.505 HG11 ' HA ' ' A' ' 80' ' ' ILE . 30.1 m -112.54 137.29 45.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.066 0.46 . . . . 0.0 111.527 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -87.53 122.2 30.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 173.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.427 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 24.1 p -126.34 159.15 33.99 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 123.368 0.417 . . . . 0.0 110.925 -177.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -114.86 112.04 22.14 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.87 -159.0 26.88 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.841 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -137.78 157.14 47.06 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.417 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 6.3 p30 -128.78 85.66 59.62 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 121.204 0.526 . . . . 0.0 111.768 -174.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.59 -67.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.018 2.478 . . . . 0.0 112.422 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.3 p -84.4 -11.41 56.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.153 0.501 . . . . 0.0 111.045 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 41' ' ' ASN . 70.1 mt -76.46 113.2 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.273 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.417 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 35.2 m-80 -84.77 121.6 27.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.747 -176.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.456 HG22 HD13 ' A' ' 11' ' ' LEU . 37.7 t -62.62 -36.53 75.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.455 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -71.15 -22.13 62.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.635 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -88.56 -17.31 30.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.449 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.49 HD12 HD23 ' A' ' 11' ' ' LEU . 91.3 mt -85.03 131.09 34.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.61 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -128.14 152.66 47.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.073 0.463 . . . . 0.0 111.447 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . . . -115.42 115.99 27.48 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 171.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -107.69 145.94 32.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.346 0.593 . . . . 0.0 112.023 -173.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.805 HG11 HD13 ' A' ' 15' ' ' LEU . 4.4 m -112.6 121.07 64.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.218 169.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 56' ' ' SER . 18.9 p-10 -87.35 86.28 7.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.218 1.009 . . . . 0.0 110.528 -177.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 mp -78.96 29.89 0.21 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.214 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 54' ' ' ASP . 20.1 m -65.52 95.65 0.23 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.208 0.527 . . . . 0.0 110.064 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.83 -74.1 0.44 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -173.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m 58.37 98.41 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 173.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -85.1 119.59 72.64 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.81 114.65 1.95 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.695 2.264 . . . . 0.0 112.183 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.08 -158.48 27.7 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -100.36 104.71 16.16 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -130.89 152.68 49.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.822 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.465 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 18.8 m-20 -91.69 130.29 37.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.765 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -123.99 151.78 43.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.209 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 53' ' ' VAL . 24.8 mt-10 -87.2 134.72 33.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.306 -175.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.489 HG11 HG11 ' A' ' 33' ' ' VAL . 90.6 t -79.86 109.51 14.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.932 173.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -108.92 109.67 20.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.023 0.44 . . . . 0.0 110.431 -177.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 31.8 t -87.27 149.83 3.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.293 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -53.03 128.97 48.44 Favored Pre-proline 0 C--O 1.232 0.138 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.67 124.91 15.99 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.373 2.049 . . . . 0.0 111.683 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.6 mt -113.79 95.47 37.46 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.544 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.02 24.43 0.71 Allowed 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 123.072 2.514 . . . . 0.0 111.751 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -118.28 -30.51 5.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.171 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.427 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 61.9 mt -130.95 142.11 44.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.201 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -80.73 128.13 33.29 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.149 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.9 tt -97.41 122.16 48.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.396 0.617 . . . . 0.0 109.889 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.816 HG13 ' HG3' ' A' ' 79' ' ' GLU . 41.4 t -94.87 -60.47 2.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.115 -175.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.816 ' HG3' HG13 ' A' ' 78' ' ' VAL . 43.8 mt-10 -141.87 139.37 32.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.28 -172.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.505 ' HA ' HG11 ' A' ' 35' ' ' VAL . 46.3 mt -107.31 120.27 58.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.496 175.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 15.1 m -118.18 108.01 42.74 Favored Pre-proline 0 C--N 1.323 -0.586 0 O-C-N 122.423 -0.173 . . . . 0.0 110.93 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 83.9 Cg_endo -91.74 174.54 18.92 Favored 'Cis proline' 0 C--N 1.346 0.439 0 C-N-CA 124.186 -1.172 . . . . 0.0 112.53 -2.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 83' ' ' ARG . 27.3 mtm105 -94.97 -50.66 5.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.46 0.648 . . . . 0.0 110.085 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.465 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 41.1 t -115.53 118.66 59.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.138 -177.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.7 m -107.44 134.69 48.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.024 0.44 . . . . 0.0 111.18 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.2 m -85.21 103.97 14.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.82 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.5 mt -97.92 124.64 42.45 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.102 0.477 . . . . 0.0 110.572 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -87.93 104.66 16.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.965 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.5 mt -94.31 134.33 36.91 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.941 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.493 ' HB2' ' HG2' ' A' ' 27' ' ' MET . 0.0 OUTLIER -110.72 170.99 7.73 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.656 179.242 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -84.98 110.74 19.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.358 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 177.514 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.464 0.65 . . . . 0.0 109.83 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.95 154.82 33.79 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.874 2.383 . . . . 0.0 113.453 -174.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 35.3 m -100.23 123.28 44.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.826 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.2 mt -101.33 159.01 15.63 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.051 0.453 . . . . 0.0 110.496 -176.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 31.0 m -126.4 99.55 5.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.02 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.436 HD23 ' HB2' ' A' ' 49' ' ' LEU . 79.5 mt -95.8 141.84 28.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.244 -173.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 m -74.01 140.78 45.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.92 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.834 HD13 HG13 ' A' ' 53' ' ' VAL . 45.0 tp -96.32 125.19 40.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.035 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.499 HD12 ' CE2' ' A' ' 52' ' ' TYR . 39.7 pt -122.77 151.85 27.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.035 0.445 . . . . 0.0 111.507 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.428 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -78.99 132.91 36.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.537 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.541 ' HD2' ' CD2' ' A' ' 52' ' ' TYR . 60.6 tttm -129.73 140.15 51.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.213 178.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.549 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 65.0 m-20 60.91 20.17 10.47 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.719 0.637 . . . . 0.0 110.798 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.428 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 72.7 m -79.76 116.44 61.01 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.196 -174.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.1 178.0 3.93 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.911 2.407 . . . . 0.0 112.647 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.0 -28.44 27.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.114 -175.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -73.92 -10.15 59.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.674 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.6 p -100.93 110.12 22.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.128 0.489 . . . . 0.0 109.972 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.595 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 25.6 ttt -102.9 108.83 20.17 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.032 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.0 mt -78.35 108.19 11.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.665 -175.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.469 ' SD ' ' HB2' ' A' ' 90' ' ' GLU . 85.4 mtp -86.19 -32.9 20.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.553 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.9 m -71.87 111.39 7.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.985 176.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -65.9 117.88 8.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.5 114.53 13.41 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.507 -173.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -85.06 -161.99 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.903 2.402 . . . . 0.0 111.74 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.8 m -113.31 150.79 32.02 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.743 0.306 . . . . 0.0 110.911 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.603 HG12 HG13 ' A' ' 67' ' ' VAL . 35.7 m -94.38 152.48 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.777 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -110.53 102.02 10.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.988 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.523 HG13 ' HA ' ' A' ' 80' ' ' ILE . 23.7 m -120.12 132.79 68.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.786 -176.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 81.8 tttt -97.17 136.06 38.23 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.519 HG21 ' HA ' ' A' ' 77' ' ' ILE . 37.0 p -127.98 138.35 52.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.289 -175.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.46 ' HG3' HG22 ' A' ' 78' ' ' VAL . 53.6 mt-10 -97.37 100.27 11.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.183 0.516 . . . . 0.0 109.64 175.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.24 151.65 5.78 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.19 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -89.93 147.58 23.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.677 0.275 . . . . 0.0 110.385 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.445 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 4.6 p30 -109.46 111.49 59.53 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.562 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 41' ' ' ASN . 5.1 Cg_exo -79.87 -73.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.814 2.342 . . . . 0.0 112.072 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 p -105.11 6.13 32.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.787 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.2 126.22 40.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.47 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -114.95 153.38 30.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.83 0.348 . . . . 0.0 111.322 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.0 m -83.56 -9.71 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.695 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -93.58 -4.81 50.21 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -98.78 -37.4 9.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.668 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.446 HD11 HG12 ' A' ' 72' ' ' ILE . 20.0 mt -88.3 144.57 26.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.657 177.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -135.89 157.9 45.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.684 0.754 . . . . 0.0 112.419 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.18 135.61 48.43 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.981 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.541 ' CD2' ' HD2' ' A' ' 18' ' ' LYS . 29.6 m-85 -112.25 150.16 31.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.956 0.408 . . . . 0.0 111.022 -173.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.834 HG13 HD13 ' A' ' 15' ' ' LEU . 3.1 m -122.08 118.28 55.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.814 168.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -83.63 105.65 14.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.224 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.4 mt -101.87 15.58 28.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.605 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.549 ' HB2' ' HB3' ' A' ' 19' ' ' ASN . 12.7 t -72.26 96.81 1.89 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 173.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.52 51.34 1.44 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 -172.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.2 p -106.01 162.36 13.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.717 0.294 . . . . 0.0 110.833 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 63' ' ' HIS . 1.2 mp0 -120.38 132.89 23.98 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.4 147.74 66.25 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.775 2.316 . . . . 0.0 112.13 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.34 -171.02 17.05 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.491 -177.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -84.76 111.98 20.09 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . 0.45 ' CE1' ' HB2' ' A' ' 59' ' ' GLU . 25.6 m80 -137.1 145.19 43.59 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.025 0.44 . . . . 0.0 110.932 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.529 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 11.5 m-20 -85.25 125.72 33.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.364 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -121.79 151.79 40.2 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.086 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -90.16 142.8 27.36 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.797 -170.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.603 HG13 HG12 ' A' ' 33' ' ' VAL . 67.5 t -83.15 121.77 36.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.946 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 50.4 tttm -95.4 112.66 24.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.331 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.5 t -92.53 127.09 44.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.695 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 37.5 tt0 -72.21 122.87 88.54 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.979 177.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 50.0 Cg_exo -55.99 125.66 19.82 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.134 2.556 . . . . 0.0 113.062 -176.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.446 HG12 HD11 ' A' ' 49' ' ' LEU . 52.1 mt -88.54 117.1 67.98 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.948 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.86 137.27 37.69 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.318 2.012 . . . . 0.0 112.551 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 71.15 4.38 5.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.264 173.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 58.3 mt -132.06 136.14 57.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -90.41 123.33 34.04 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.43 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.519 ' HA ' HG21 ' A' ' 37' ' ' THR . 16.6 tt -80.28 139.49 18.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.46 HG22 ' HG3' ' A' ' 38' ' ' GLU . 39.4 t -108.05 -69.13 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.069 0.462 . . . . 0.0 110.902 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -107.79 141.66 39.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.864 -171.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.523 ' HA ' HG13 ' A' ' 35' ' ' VAL . 66.3 mt -120.1 110.43 28.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.362 177.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 47.0 m -144.78 123.84 6.92 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.92 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 93.2 Cg_endo -85.32 158.68 63.04 Favored 'Cis proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.123 -3.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -81.58 -35.64 29.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.984 0.421 . . . . 0.0 110.453 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 71.3 t -130.54 130.61 65.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.445 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.7 m -116.92 141.2 36.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.098 0.475 . . . . 0.0 111.168 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.1 m -80.44 117.51 21.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.229 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.2 mt -113.92 123.44 49.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.854 0.359 . . . . 0.0 110.681 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -88.79 104.37 16.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.078 176.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.9 mt -94.77 127.44 40.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.403 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 25' ' ' MET . 10.4 tp10 -100.41 154.61 18.38 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.686 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -80.62 90.46 5.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.611 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.595 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 22.4 t60 . . . . . 0 C--N 1.326 -0.452 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 120.62 0.248 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.83 125.97 13.95 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.412 2.075 . . . . 0.0 111.983 -178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.4 m -90.74 116.39 28.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.648 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.523 HD12 HD22 ' A' ' 41' ' ' ASN . 88.8 mt -108.85 131.84 54.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.18 0.514 . . . . 0.0 111.316 -173.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 m -103.86 99.14 8.91 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.823 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.5 mt -106.25 134.35 49.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.043 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -73.45 142.49 46.87 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.787 0.327 . . . . 0.0 110.75 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.731 HD12 HG13 ' A' ' 53' ' ' VAL . 55.4 tp -87.02 122.25 30.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.028 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.4 pt -108.93 153.78 10.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.141 0.496 . . . . 0.0 111.398 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.03 111.22 17.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.968 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -109.37 134.76 51.43 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.981 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.1 t30 62.28 18.15 9.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.707 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.473 HG21 HD11 ' A' ' 55' ' ' LEU . 31.0 m -72.09 118.95 71.61 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.922 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 7.0 Cg_exo -72.89 -179.95 4.74 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.905 2.403 . . . . 0.0 112.365 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 23' ' ' ASN . . . -80.82 161.43 24.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.276 175.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 22' ' ' ALA . 95.3 m-20 75.28 -34.47 0.26 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.532 0.733 . . . . 0.0 111.639 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.4 p -76.91 98.49 4.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.369 0.604 . . . . 0.0 109.695 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' MET . . . . . 0.678 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 51.1 ttp -103.0 124.56 48.74 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.639 -174.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.402 HG12 ' CD2' ' A' ' 89' ' ' LEU . 17.4 mt -84.65 97.62 5.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 44.1 ttp -79.05 -20.23 49.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.027 0.441 . . . . 0.0 109.953 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.0 m -75.75 105.97 7.07 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -54.61 132.25 44.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.012 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.51 114.64 29.88 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.438 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -89.2 -161.24 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.936 2.424 . . . . 0.0 112.222 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.3 p -120.81 141.95 50.06 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.793 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.593 HG12 HG11 ' A' ' 67' ' ' VAL . 25.1 m -93.9 142.86 12.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.923 0.392 . . . . 0.0 109.964 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -112.05 93.25 4.36 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.456 0.646 . . . . 0.0 109.444 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 80' ' ' ILE . 30.2 m -99.22 162.55 2.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.676 -175.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 36.0 tttm -123.17 122.99 39.8 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.422 HG22 ' HA ' ' A' ' 77' ' ' ILE . 30.5 p -112.77 175.04 5.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.78 -175.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 28.2 tt0 -123.84 117.51 25.02 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.74 -137.35 9.33 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.196 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.517 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 79.2 m-85 -145.02 157.66 44.05 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.523 HD22 HD12 ' A' ' 11' ' ' LEU . 8.2 m120 -114.44 82.03 7.29 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 1.2 Cg_endo -84.84 -68.53 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.781 2.321 . . . . 0.0 112.766 -176.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.6 p -93.72 -14.69 26.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.116 -178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.4 mt -86.58 117.63 31.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.619 -176.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -84.79 128.16 34.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.931 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.6 m -71.7 -17.11 19.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.198 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -91.2 -0.04 57.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.143 0.497 . . . . 0.0 110.158 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -102.88 -28.22 12.18 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.2 mt -81.99 135.8 35.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.791 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -128.05 156.88 42.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.522 0.677 . . . . 0.0 111.755 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.21 138.45 44.47 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 170.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -136.42 151.68 49.77 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.472 0.653 . . . . 0.0 112.294 -171.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.731 HG13 HD12 ' A' ' 15' ' ' LEU . 4.9 m -112.54 118.11 56.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.433 169.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -88.68 98.5 11.72 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.79 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.473 HD11 HG21 ' A' ' 20' ' ' THR . 60.1 mt -84.97 67.62 10.26 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.35 0.595 . . . . 0.0 110.248 -177.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.44 -20.73 59.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.18 176.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -99.36 142.51 16.05 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.248 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 m -92.94 38.12 1.03 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.636 ' HB2' ' OH ' ' A' ' 65' ' ' TYR . 11.1 mm-40 -66.16 110.22 4.38 Favored Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.765 -177.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -87.58 141.64 5.67 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.996 2.464 . . . . 0.0 111.994 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.21 -168.77 13.9 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.06 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 88' ' ' GLN . 36.3 mt-10 -82.51 97.73 8.58 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -122.77 143.13 50.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.956 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 28.5 m-20 -81.29 119.91 24.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.759 0.314 . . . . 0.0 110.297 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.636 ' OH ' ' HB2' ' A' ' 59' ' ' GLU . 53.6 m-85 -111.03 167.17 10.46 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.15 0.5 . . . . 0.0 111.04 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -106.77 122.63 46.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.626 -173.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.593 HG11 HG12 ' A' ' 33' ' ' VAL . 67.8 t -79.74 113.82 19.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.293 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -100.83 151.4 21.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.708 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.5 t -118.44 141.38 38.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.26 123.21 81.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.65 113.67 1.34 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.002 2.468 . . . . 0.0 112.382 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.7 mt -90.94 119.59 68.85 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.757 -176.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.94 149.57 53.52 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.733 2.289 . . . . 0.0 111.647 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 72.27 -51.22 0.7 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.589 0.756 . . . . 0.0 111.936 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.7 mt -83.89 134.25 27.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.348 0.594 . . . . 0.0 110.811 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 76.8 tttt -88.87 124.35 34.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.891 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.422 ' HA ' HG22 ' A' ' 37' ' ' THR . 18.0 tt -87.98 133.49 30.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.7 HG11 ' HG3' ' A' ' 79' ' ' GLU . 43.5 t -112.26 -59.89 3.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.106 0.479 . . . . 0.0 111.849 -171.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.7 ' HG3' HG11 ' A' ' 78' ' ' VAL . 46.2 mt-10 -125.23 102.79 7.62 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.084 -172.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.492 ' HA ' HG12 ' A' ' 35' ' ' VAL . 53.0 mt -80.18 118.79 28.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 171.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 36.5 m -141.58 116.48 7.0 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-O 120.548 0.213 . . . . 0.0 110.915 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 94.6 Cg_endo -87.68 -177.24 12.92 Favored 'Cis proline' 0 C--N 1.343 0.252 0 C-N-CA 123.701 -1.374 . . . . 0.0 112.358 -2.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 83' ' ' ARG . 52.0 mtm180 -122.7 -35.94 2.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.837 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.13 117.74 55.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.042 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.1 m -128.39 135.38 62.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.031 0.443 . . . . 0.0 110.846 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 3.9 m -80.09 99.53 7.76 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.097 177.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.55 ' HB2' ' HD2' ' A' ' 65' ' ' TYR . 80.2 mt -96.0 120.98 37.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.035 0.445 . . . . 0.0 109.892 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 59.3 tt0 -86.75 97.7 10.75 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.093 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.623 HD11 ' HH ' ' A' ' 65' ' ' TYR . 28.0 mt -82.04 109.57 16.49 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.626 0.727 . . . . 0.0 109.698 175.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -101.28 175.29 5.63 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.674 -175.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -91.55 110.44 21.75 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.603 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.678 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 36.7 t-80 . . . . . 0 C--N 1.328 -0.357 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.009 0.433 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -89.21 144.76 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.884 2.39 . . . . 0.0 113.85 -175.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 21.2 m -88.11 109.19 19.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.291 171.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.3 tp -86.64 136.2 33.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.981 -174.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.1 m -101.15 119.26 38.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.432 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.2 mt -129.45 152.92 48.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.218 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 p -88.55 151.5 22.46 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.98 0.419 . . . . 0.0 111.091 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.634 HD13 HG13 ' A' ' 53' ' ' VAL . 38.6 tp -92.63 139.31 30.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.293 178.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.0 pt -127.78 160.33 37.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.441 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -109.11 129.12 55.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.365 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -120.29 131.87 55.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.092 0.472 . . . . 0.0 111.248 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.6 t30 61.72 46.27 7.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.53 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.53 ' HB ' HD11 ' A' ' 55' ' ' LEU . 12.1 t -79.36 138.18 55.73 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -52.51 146.82 32.08 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.811 2.341 . . . . 0.0 112.74 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.54 -35.56 79.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.825 -176.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -100.74 20.31 15.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.796 0.331 . . . . 0.0 111.861 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.4 p -110.61 127.39 55.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 43.1 ttp -112.6 126.5 55.42 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.228 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.1 mt -84.95 111.7 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.396 -175.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 95.5 mmm -83.57 -42.52 16.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.993 0.425 . . . . 0.0 110.439 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.2 m -74.26 127.25 32.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.734 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -71.96 139.91 48.88 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.697 173.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.2 mt -71.78 115.73 40.83 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.79 -173.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.32 172.56 7.49 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.312 2.675 . . . . 0.0 113.627 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.8 t -102.9 125.21 49.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.218 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.532 HG12 HG13 ' A' ' 67' ' ' VAL . 13.2 m -90.59 153.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.976 0.417 . . . . 0.0 110.615 -176.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -130.04 101.62 5.91 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.67 HG12 HG21 ' A' ' 69' ' ' VAL . 34.9 m -104.41 135.05 44.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.859 -175.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 62.9 tttp -83.62 121.35 27.13 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 77' ' ' ILE . 20.9 p -121.95 155.35 35.7 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.497 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.498 ' HG3' ' HB3' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -121.1 119.44 32.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.978 0.418 . . . . 0.0 110.13 176.033 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.9 169.24 12.75 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.032 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -96.0 136.92 35.81 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.469 ' HB3' ' CD1' ' A' ' 75' ' ' ILE . 19.6 p30 -128.96 55.35 17.71 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.18 -56.71 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.689 1.593 . . . . 0.0 111.987 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.8 m -114.64 38.39 3.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.088 0.471 . . . . 0.0 111.06 -176.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.3 mt -114.66 142.71 26.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.798 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -80.63 41.28 0.55 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 111.008 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.433 HG21 ' OD1' ' A' ' 47' ' ' ASN . 11.9 m -61.27 -36.19 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.126 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.433 ' OD1' HG21 ' A' ' 46' ' ' VAL . 2.9 m-20 -79.4 -5.43 54.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.099 0.475 . . . . 0.0 110.604 -178.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -106.9 -10.84 15.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.736 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.2 mt -82.25 125.22 30.7 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 171.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -109.5 170.76 7.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.66 0.743 . . . . 0.0 112.353 -171.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.446 ' HB2' HG23 ' A' ' 69' ' ' VAL . . . -106.73 137.96 43.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.891 174.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.559 ' CZ ' ' HD3' ' A' ' 68' ' ' LYS . 27.2 p90 -135.29 158.08 45.28 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.615 -178.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.634 HG13 HD13 ' A' ' 15' ' ' LEU . 23.1 m -112.47 141.96 26.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.583 174.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -89.48 118.04 28.83 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.53 HD11 ' HB ' ' A' ' 20' ' ' THR . 85.6 mt -109.16 25.76 11.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.591 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.2 m -73.49 95.32 2.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.309 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.82 23.03 14.25 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.601 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.6 p -88.57 122.96 32.6 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.782 -0.246 . . . . 0.0 110.566 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -75.32 155.08 86.08 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.085 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.54 90.99 0.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.59 2.193 . . . . 0.0 112.029 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.05 172.87 42.86 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 88' ' ' GLN . 40.0 tt0 -82.24 105.47 13.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -130.61 167.9 17.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.347 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.411 ' HB3' HG12 ' A' ' 84' ' ' VAL . 13.6 m-20 -98.59 121.84 41.04 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.351 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.486 ' HH ' HD11 ' A' ' 89' ' ' LEU . 71.7 m-85 -116.89 128.09 54.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.104 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.42 ' HG2' HG23 ' A' ' 84' ' ' VAL . 46.8 mt-10 -69.95 134.61 48.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.204 -175.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.532 HG13 HG12 ' A' ' 33' ' ' VAL . 59.4 t -78.92 112.18 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.546 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.559 ' HD3' ' CZ ' ' A' ' 52' ' ' TYR . 53.6 tttm -102.88 102.63 12.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.388 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.67 HG21 HG12 ' A' ' 35' ' ' VAL . 39.4 t -86.86 125.5 40.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -63.86 127.67 91.93 Favored Pre-proline 0 C--N 1.323 -0.58 0 O-C-N 123.198 0.311 . . . . 0.0 110.958 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.35 137.52 47.28 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.617 2.878 . . . . 0.0 112.92 -175.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.461 ' CG2' ' HB ' ' A' ' 75' ' ' ILE . 30.5 mm -89.17 126.89 57.37 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.262 -177.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.1 131.04 29.1 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.286 1.991 . . . . 0.0 111.725 176.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.3 t30 73.79 -44.42 0.57 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.538 0.735 . . . . 0.0 111.998 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.469 ' CD1' ' HB3' ' A' ' 41' ' ' ASN . 71.5 mt -83.94 140.84 15.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.946 0.403 . . . . 0.0 110.682 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.498 ' HB3' ' HG3' ' A' ' 38' ' ' GLU . 57.3 tttp -94.84 125.71 39.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.387 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.468 ' HA ' HG22 ' A' ' 37' ' ' THR . 14.0 tt -88.36 122.21 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.498 0.666 . . . . 0.0 109.94 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.3 t -85.31 -64.57 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.069 -175.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -130.51 136.8 49.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.113 -170.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.561 ' HA ' HG11 ' A' ' 35' ' ' VAL . 67.5 mt -104.41 108.26 24.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.203 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.445 ' HA ' ' C ' ' A' ' 82' ' ' PRO . 11.6 p -136.13 126.93 16.74 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.735 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.445 ' C ' ' HA ' ' A' ' 81' ' ' SER . 15.3 Cg_exo -68.51 156.85 88.81 Favored 'Cis proline' 0 C--N 1.344 0.32 0 C-N-CA 123.55 -1.438 . . . . 0.0 112.508 0.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -85.23 -38.1 19.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.746 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.42 HG23 ' HG2' ' A' ' 66' ' ' GLU . 59.3 t -137.86 143.58 33.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.375 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 m -118.26 140.03 43.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.957 0.408 . . . . 0.0 111.011 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 m -92.36 105.2 17.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.04 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.9 mt -105.37 124.91 50.34 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.761 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 47.0 tt0 -85.8 99.88 11.66 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.012 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.486 HD11 ' HH ' ' A' ' 65' ' ' TYR . 84.2 mt -88.22 139.52 30.41 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.14 174.0 7.22 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.74 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -83.89 137.57 33.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.36 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 68.6 t60 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.686 0.755 . . . . 0.0 109.296 173.788 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 120.541 0.21 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 p -114.15 152.99 30.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.523 0.201 . . . . 0.0 110.671 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -66.28 -49.6 66.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.095 0.474 . . . . 0.0 109.971 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.5 m -107.91 111.09 23.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.612 173.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.04 153.16 44.24 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -65.68 -28.76 69.31 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.509 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 37.5 ttt180 62.14 34.67 16.14 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.227 175.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -112.82 85.96 8.27 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.799 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 7' ' ' ARG . 8.1 Cg_exo -71.72 152.97 59.37 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.603 2.202 . . . . 0.0 112.051 -178.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.6 m -107.39 113.13 26.3 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.707 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.479 HD21 HD22 ' A' ' 41' ' ' ASN . 93.1 mt -90.23 127.84 36.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.087 0.47 . . . . 0.0 110.511 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -103.64 102.93 12.8 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.305 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -102.89 144.14 31.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.286 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.2 m -76.86 143.96 39.33 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.798 HD13 HG12 ' A' ' 53' ' ' VAL . 52.7 tp -88.32 127.32 35.48 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.8 pt -122.77 171.17 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.933 0.396 . . . . 0.0 110.842 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.485 ' HB3' ' OG1' ' A' ' 20' ' ' THR . . . -107.11 122.21 46.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.158 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -114.95 139.89 49.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.594 0.235 . . . . 0.0 110.679 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.8 t30 56.13 32.04 19.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.392 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.485 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 89.6 m -90.02 114.74 61.96 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.311 -176.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.7 163.87 37.54 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.758 2.306 . . . . 0.0 111.561 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.92 -13.29 59.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.855 0.36 . . . . 0.0 110.598 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -67.19 -35.02 78.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.885 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.8 p -95.24 102.67 14.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.602 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 52.6 ttp -102.79 111.98 24.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.061 0.458 . . . . 0.0 110.56 -174.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.6 mt -75.44 113.46 14.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.414 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 84.9 mtp -99.78 10.86 40.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.426 0.631 . . . . 0.0 110.103 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.3 m -105.39 119.19 38.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.827 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -60.78 136.07 57.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.713 0.292 . . . . 0.0 110.335 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.7 mt -81.86 122.9 80.47 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.419 -171.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.502 ' HD2' HD22 ' A' ' 15' ' ' LEU . 87.4 Cg_endo -83.55 -164.88 0.28 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.207 2.605 . . . . 0.0 112.803 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.2 t -125.35 144.91 50.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.074 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.21 144.42 14.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.808 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 35.6 mtm-85 -118.08 99.21 6.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 80' ' ' ILE . 21.2 m -98.85 128.76 50.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.328 0.585 . . . . 0.0 111.497 -174.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.467 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 85.4 tttt -80.6 124.26 28.83 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.453 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 13.1 p -126.11 138.91 53.72 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -173.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.845 ' HB2' ' HB2' ' A' ' 76' ' ' LYS . 40.1 mt-10 -93.95 89.62 6.15 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 172.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.7 136.56 2.02 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -104.39 135.8 45.16 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.101 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.597 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 6.1 p30 -135.07 102.49 10.97 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 121.329 0.585 . . . . 0.0 111.158 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -88.01 -10.05 5.13 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.341 2.027 . . . . 0.0 111.693 174.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.9 p -113.19 -45.08 3.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.508 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.597 ' HB ' ' HB2' ' A' ' 41' ' ' ASN . 57.1 mt -57.85 136.5 21.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 120.96 0.41 . . . . 0.0 110.666 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.418 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 14.3 m120 -101.67 147.38 26.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.816 -176.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.9 m -80.85 -5.88 9.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.293 0.568 . . . . 0.0 110.042 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -93.01 -19.27 21.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.996 169.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.418 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 76.9 tt0 -80.78 -32.61 35.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.219 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.6 mt -94.37 138.52 32.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.234 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -133.3 152.65 51.94 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.388 0.613 . . . . 0.0 111.552 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . . . -110.78 125.08 53.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.505 171.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -121.24 159.41 26.01 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.309 0.576 . . . . 0.0 111.718 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.798 HG12 HD13 ' A' ' 15' ' ' LEU . 11.4 m -112.5 123.52 68.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.048 171.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.0 110.47 12.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.441 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.421 HD22 HD11 ' A' ' 89' ' ' LEU . 55.4 mt -106.87 29.31 7.14 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.693 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m -57.85 -43.78 86.12 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.758 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.81 84.76 1.3 Allowed Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.6 p -71.09 91.09 0.89 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.045 0.45 . . . . 0.0 111.995 -173.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -101.33 107.73 52.0 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.01 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.32 152.18 75.83 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.904 2.402 . . . . 0.0 112.292 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.05 -179.38 20.52 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 88' ' ' GLN . 32.2 tt0 -80.14 102.98 9.7 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 176.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -129.12 143.34 50.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.593 -172.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.487 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 26.8 m-20 -81.74 124.98 30.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.226 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.474 ' HH ' HD13 ' A' ' 89' ' ' LEU . 75.2 m-85 -120.92 151.18 40.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.463 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.13 134.52 34.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.124 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.468 HG12 HD11 ' A' ' 15' ' ' LEU . 68.7 t -79.13 106.4 10.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 174.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -99.67 106.08 17.97 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.517 -177.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 42.4 t -87.12 134.9 26.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.088 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -63.73 135.33 96.24 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.323 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.54 132.3 44.76 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.083 2.522 . . . . 0.0 112.61 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.7 mp -97.53 121.05 59.36 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.052 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.56 119.32 6.47 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.979 2.453 . . . . 0.0 113.0 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.3 m120 69.17 15.08 8.68 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.207 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.499 HD12 ' HB3' ' A' ' 41' ' ' ASN . 57.4 mt -129.53 130.12 67.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.845 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 97.1 mttt -80.89 137.42 36.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.855 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.8 tt -93.41 116.88 35.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.408 0.623 . . . . 0.0 109.659 172.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.7 t -95.63 -50.29 11.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.253 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.467 ' HB2' ' H ' ' A' ' 36' ' ' LYS . 50.1 mt-10 -118.76 157.74 26.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.087 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.545 ' HA ' HG12 ' A' ' 35' ' ' VAL . 18.9 tt -144.55 25.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 122.163 0.982 . . . . 0.0 108.985 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.516 ' HA ' ' N ' ' A' ' 83' ' ' ARG . 16.1 m -85.79 142.86 37.19 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.377 -175.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.479 ' C ' ' HA ' ' A' ' 81' ' ' SER . 17.4 Cg_exo -67.15 124.39 5.97 Favored 'Cis proline' 0 C--N 1.346 0.425 0 C-N-CA 123.633 -1.403 . . . . 0.0 111.921 -1.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.516 ' N ' ' HA ' ' A' ' 81' ' ' SER . 70.3 mtm180 -69.72 -31.14 68.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.712 -173.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.487 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 43.9 t -127.58 134.98 64.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.699 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 m -120.73 133.26 67.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.195 0.521 . . . . 0.0 110.453 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.43 HG23 ' HG2' ' A' ' 62' ' ' GLU . 4.2 m -87.26 101.38 13.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.983 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.3 mt -107.05 134.52 50.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.226 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 62.4 tt0 -95.34 103.12 14.97 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.013 0.435 . . . . 0.0 110.443 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.474 HD13 ' HH ' ' A' ' 65' ' ' TYR . 49.4 mt -82.46 120.05 24.97 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.474 175.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.62 149.88 23.3 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.1 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -71.0 124.53 24.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.504 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -85.35 -8.96 58.19 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -114.18 120.55 40.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.874 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -124.91 173.24 8.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.788 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . 0.477 ' O ' ' HB2' ' A' ' 96' ' ' HIS . 68.0 m-70 -91.98 -65.97 0.96 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 172.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 95' ' ' HIS . 36.2 t-80 . . . . . 0 C--O 1.242 0.704 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.624 169.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.8 m . . . . . 0 N--CA 1.475 0.782 0 CA-C-O 120.607 0.242 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m -70.76 132.74 45.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.375 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -74.9 -45.82 40.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.074 0.464 . . . . 0.0 110.936 -174.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.1 p -75.96 -0.42 21.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.628 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.0 tp -85.66 -18.02 34.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.21 0.529 . . . . 0.0 109.69 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.75 -14.96 59.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.55 0.691 . . . . 0.0 109.936 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -108.34 133.1 53.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.519 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.433 ' HB3' ' HA ' ' A' ' 38' ' ' GLU . 10.2 m-20 52.32 85.46 0.19 Allowed Pre-proline 0 N--CA 1.467 0.39 0 O-C-N 123.909 0.756 . . . . 0.0 111.245 172.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.18 147.88 23.82 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.647 2.231 . . . . 0.0 113.567 -173.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 67.9 m -90.72 109.18 20.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.522 171.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.6 mt -83.12 138.51 33.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.217 0.532 . . . . 0.0 110.876 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.3 m -109.96 102.05 10.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.926 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.412 ' HB2' ' CG1' ' A' ' 33' ' ' VAL . 44.3 mt -101.78 155.3 18.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.106 -176.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 m -88.53 143.48 26.94 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.805 HD12 HG11 ' A' ' 53' ' ' VAL . 52.6 tp -94.91 127.04 40.65 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.7 pt -124.05 160.61 27.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.036 0.446 . . . . 0.0 111.392 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.33 115.73 26.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.308 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.544 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 18.3 tptm -114.29 141.12 47.99 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 63.34 20.95 12.56 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.67 0.606 . . . . 0.0 110.579 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 43.1 m -83.17 118.77 72.66 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.845 -173.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 2.9 Cg_exo -76.12 154.58 37.44 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.298 2.665 . . . . 0.0 112.194 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.9 -1.93 21.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.224 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -80.92 -29.12 35.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.071 0.463 . . . . 0.0 110.553 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.8 p -107.16 128.71 54.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.152 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.765 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 58.0 ttp -119.11 126.78 52.44 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.033 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.453 HG12 ' CD2' ' A' ' 89' ' ' LEU . 13.9 mt -84.83 115.14 26.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.558 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 94.1 mmm -80.63 -7.98 59.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.306 0.574 . . . . 0.0 110.189 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.2 m -99.23 118.39 35.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.579 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -66.31 132.89 49.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.781 0.324 . . . . 0.0 110.677 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.4 mt -75.45 122.26 86.85 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.415 -173.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.479 ' HD2' HD21 ' A' ' 15' ' ' LEU . 95.2 Cg_endo -89.49 -157.71 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.183 2.588 . . . . 0.0 112.628 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.5 p -113.71 160.63 18.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.412 ' CG1' ' HB2' ' A' ' 13' ' ' LEU . 11.3 p -112.91 139.4 38.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.83 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -111.31 109.59 19.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.061 0.458 . . . . 0.0 110.8 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.519 HG11 ' HA ' ' A' ' 80' ' ' ILE . 25.2 m -117.24 111.69 35.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.085 -177.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 6.5 ttpm? -74.77 125.95 29.86 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 174.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.506 HG22 ' HA ' ' A' ' 77' ' ' ILE . 25.3 p -124.66 138.07 54.32 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.056 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.433 ' HA ' ' HB3' ' A' ' 8' ' ' ASP . 48.9 mt-10 -94.64 135.46 36.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.366 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.35 -168.4 12.89 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.832 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -132.9 140.2 47.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.914 0.388 . . . . 0.0 110.673 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.568 ' N ' HD21 ' A' ' 41' ' ' ASN . 0.0 OUTLIER -160.92 80.47 2.19 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.996 178.519 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.66 -24.28 11.96 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.881 2.387 . . . . 0.0 112.53 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.9 p -84.35 -12.98 53.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.695 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.4 mt -103.21 111.08 31.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -95.47 151.72 19.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.096 0.474 . . . . 0.0 111.745 -174.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.5 m -69.4 -13.47 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.358 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -85.5 -9.63 57.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.24 0.543 . . . . 0.0 109.707 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -105.22 -26.33 12.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.754 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.41 ' HB2' HD21 ' A' ' 13' ' ' LEU . 91.2 mt -88.64 132.32 34.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.831 175.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -125.19 154.06 42.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.613 0.72 . . . . 0.0 111.791 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -120.85 134.98 55.28 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.494 171.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.544 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 18.9 p90 -129.12 161.02 31.01 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.321 0.581 . . . . 0.0 111.411 -174.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.805 HG11 HD12 ' A' ' 15' ' ' LEU . 5.7 m -112.29 118.38 57.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -78.06 105.08 9.03 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.526 -175.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.61 ' HB3' ' HB2' ' A' ' 58' ' ' SER . 64.0 mt -104.73 35.57 2.72 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.755 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.0 m -60.28 -38.63 84.18 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.56 53.33 0.78 Allowed Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.276 173.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.61 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 23.1 t -74.18 107.08 6.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.049 0.452 . . . . 0.0 110.865 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -104.69 126.2 31.91 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.26 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.3 141.23 81.57 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.961 2.441 . . . . 0.0 111.932 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.44 175.29 19.17 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.45 107.77 13.52 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -134.0 156.78 47.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.982 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -95.7 125.84 40.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.194 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.548 ' HH ' HD12 ' A' ' 89' ' ' LEU . 96.5 m-85 -121.7 161.68 22.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.823 0.344 . . . . 0.0 110.664 -178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -93.86 138.13 32.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.987 -175.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.1 t -88.35 121.29 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.985 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -105.06 127.12 52.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.002 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.14 138.64 35.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.14 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -68.59 139.48 91.55 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.62 150.5 86.4 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.113 2.542 . . . . 0.0 112.577 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.474 ' HB ' ' HB ' ' A' ' 75' ' ' ILE . 11.5 mt -122.26 118.58 28.89 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.9 114.81 2.09 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 123.277 2.651 . . . . 0.0 113.479 -175.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.3 m120 70.85 11.37 7.11 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.321 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.474 ' HB ' ' HB ' ' A' ' 72' ' ' ILE . 41.3 mm -107.81 121.79 61.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.12 0.486 . . . . 0.0 110.472 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -80.66 114.81 19.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.425 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.506 ' HA ' HG22 ' A' ' 37' ' ' THR . 16.0 tt -87.94 115.7 28.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.466 0.651 . . . . 0.0 109.918 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.98 -53.02 9.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.64 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' A' ' 36' ' ' LYS . 66.8 mm-40 -106.64 146.76 30.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.509 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.558 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 26.8 mt -133.71 81.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 165.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 17.7 m -118.58 116.34 35.01 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.719 -175.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 72.8 Cg_endo -94.33 158.33 17.42 Favored 'Cis proline' 0 C--N 1.346 0.41 0 C-N-CA 124.131 -1.195 . . . . 0.0 113.302 -0.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 80' ' ' ILE . 61.2 mtm180 -96.43 -31.99 12.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.592 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.0 t -119.84 122.17 67.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.019 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.1 m -121.55 138.86 50.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.6 m -88.81 102.73 15.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.067 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.6 mt -101.22 128.44 47.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.016 0.436 . . . . 0.0 110.933 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -91.36 103.6 16.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.183 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.548 HD12 ' HH ' ' A' ' 65' ' ' TYR . 96.0 mt -97.05 128.68 44.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.064 0.459 . . . . 0.0 110.728 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -119.33 178.76 4.41 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.482 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -80.55 114.79 19.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.281 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.765 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 74.5 t60 -83.55 -16.57 44.92 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.245 0.545 . . . . 0.0 109.66 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -122.78 101.94 7.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.572 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 68.25 110.13 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 O-C-N 124.075 0.859 . . . . 0.0 111.11 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -110.19 -62.22 1.55 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.175 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 78.7 t60 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.03 -179.811 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.7 p . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.677 0.275 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.1 p -148.13 -30.6 0.29 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.414 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 66.27 15.46 10.1 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.537 -173.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.3 m -86.44 90.29 8.16 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.601 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.8 mt -67.32 -56.08 11.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.344 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -85.03 122.45 29.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.528 174.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.476 ' HG2' ' OH ' ' A' ' 40' ' ' TYR . 7.1 mtt180 -91.65 -3.82 55.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.615 0.721 . . . . 0.0 110.568 -170.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.474 ' HB3' ' HG2' ' A' ' 38' ' ' GLU . 0.9 OUTLIER -127.29 75.35 77.14 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.848 168.395 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.24 151.59 12.22 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.676 2.917 . . . . 0.0 113.509 -170.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 37.9 m -95.25 109.88 21.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.632 174.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.8 mt -87.43 137.99 31.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.027 0.441 . . . . 0.0 110.603 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 m -102.63 95.77 6.44 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.071 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.1 mt -101.74 120.11 39.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.192 -175.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 48.6 m -63.35 140.81 58.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.879 0.371 . . . . 0.0 111.406 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.81 HD13 HG11 ' A' ' 53' ' ' VAL . 40.3 tp -84.01 123.58 30.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.788 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.4 pt -109.83 146.17 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.04 0.448 . . . . 0.0 111.58 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.6 94.16 5.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.126 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -96.31 131.51 42.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.026 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.1 t30 58.62 39.18 24.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.755 0.788 . . . . 0.0 109.933 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 63.8 m -88.59 124.81 65.04 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.638 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.853 ' HG2' ' HB3' ' A' ' 58' ' ' SER . 17.0 Cg_exo -67.51 175.76 5.69 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.0 2.466 . . . . 0.0 112.756 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 92' ' ' HIS . . . -94.2 -6.59 44.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.88 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -88.65 -23.64 22.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.018 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.9 p -114.74 112.45 22.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.834 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.0 ttp -105.69 132.7 51.51 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.7 mt -81.31 118.77 29.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 120.759 0.314 . . . . 0.0 110.718 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 83.6 mtp -74.18 -52.5 12.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.106 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 m -70.27 110.14 5.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.4 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -63.26 133.96 55.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.089 0.471 . . . . 0.0 110.63 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.432 HD23 HD22 ' A' ' 15' ' ' LEU . 50.3 mt -71.54 129.41 88.69 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.454 -173.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -92.32 -170.89 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.37 2.713 . . . . 0.0 111.933 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.592 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 24.8 m -105.39 135.6 46.47 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.525 HG12 HG13 ' A' ' 67' ' ' VAL . 10.9 m -86.26 145.22 8.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.789 0.328 . . . . 0.0 110.201 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.5 mtp85 -111.51 101.59 10.0 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.123 0.487 . . . . 0.0 109.937 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 80' ' ' ILE . 26.8 m -110.7 137.04 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.757 -177.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 61.1 tttp -85.9 129.66 34.77 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.2 p -126.36 175.22 8.0 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.174 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.474 ' HG2' ' HB3' ' A' ' 8' ' ' ASP . 35.8 mt-10 -139.07 137.63 36.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.704 0.288 . . . . 0.0 110.651 176.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.5 -175.28 17.46 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.552 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.476 ' OH ' ' HG2' ' A' ' 7' ' ' ARG . 82.0 m-85 -118.15 126.64 52.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.648 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 4.2 p30 -130.48 62.69 66.2 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.166 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.52 -29.83 36.55 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.139 1.893 . . . . 0.0 111.954 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.8 p -91.15 -1.25 57.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.57 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.648 ' HB ' ' HB2' ' A' ' 41' ' ' ASN . 61.2 mt -109.95 126.64 67.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.777 0.322 . . . . 0.0 110.47 -178.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.416 ' ND2' ' HG3' ' A' ' 48' ' ' GLU . 39.8 t30 -85.58 110.92 19.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.405 0.621 . . . . 0.0 110.912 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.6 t -59.93 -27.35 38.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.336 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -71.02 -28.03 64.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.862 0.363 . . . . 0.0 111.174 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.416 ' HG3' ' ND2' ' A' ' 45' ' ' ASN . 40.9 mt-10 -91.3 -12.17 35.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.096 0.474 . . . . 0.0 110.652 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 93.6 mt -77.06 129.7 36.42 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 167.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -131.92 162.38 30.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.86 0.838 . . . . 0.0 112.564 -174.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -109.74 127.86 54.9 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.907 169.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -123.66 144.03 49.89 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.355 0.598 . . . . 0.0 112.036 -172.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.81 HG11 HD13 ' A' ' 15' ' ' LEU . 7.0 m -112.47 131.48 63.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.159 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.53 115.73 28.39 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.679 -0.408 . . . . 0.0 109.982 -175.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 66.1 mt -105.6 51.97 0.74 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.44 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.1 m -57.32 -47.33 81.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.307 0.575 . . . . 0.0 109.661 173.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.11 100.14 2.47 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.501 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.853 ' HB3' ' HG2' ' A' ' 21' ' ' PRO . 1.5 p -73.18 87.8 1.45 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.969 0.414 . . . . 0.0 110.5 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -102.82 110.21 62.86 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.08 -174.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -66.95 141.32 57.95 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.59 2.194 . . . . 0.0 112.294 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.22 -172.24 17.64 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.67 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.496 ' HG3' ' HG2' ' A' ' 88' ' ' GLN . 1.9 mp0 -87.46 89.15 7.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.789 0.328 . . . . 0.0 110.253 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 38.1 m-70 -104.97 148.35 26.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.442 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -92.19 122.76 34.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.998 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -118.87 147.66 43.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.694 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.501 ' HG2' HG21 ' A' ' 84' ' ' VAL . 36.2 mt-10 -93.79 132.19 38.42 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.888 0.375 . . . . 0.0 110.513 -172.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.525 HG13 HG12 ' A' ' 33' ' ' VAL . 59.8 t -73.22 106.83 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.647 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -86.97 109.48 19.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.804 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.76 123.26 39.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.52 119.53 51.21 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.57 110.01 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.108 2.539 . . . . 0.0 112.704 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.3 mt -82.73 114.48 52.4 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.873 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.31 140.78 54.25 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.427 2.085 . . . . 0.0 112.141 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.4 t30 76.31 -2.78 2.66 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.86 0.725 . . . . 0.0 111.015 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.4 mm -116.62 144.85 23.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.982 0.42 . . . . 0.0 110.543 -177.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -98.91 137.39 37.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.211 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.6 tt -104.64 133.77 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.7 t -102.54 -63.36 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.916 0.389 . . . . 0.0 111.222 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -135.46 143.18 45.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.574 -170.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.54 ' HA ' HG12 ' A' ' 35' ' ' VAL . 57.9 mt -112.32 127.07 69.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.335 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 51.2 m -146.39 114.31 4.47 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.636 0.255 . . . . 0.0 110.957 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.45 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 2.8 Cg_endo -83.13 172.33 48.43 Favored 'Cis proline' 0 C--N 1.343 0.254 0 C-N-CA 123.803 -1.332 . . . . 0.0 111.964 -2.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -99.56 -45.25 5.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.369 0.604 . . . . 0.0 109.893 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.501 HG21 ' HG2' ' A' ' 66' ' ' GLU . 59.9 t -128.11 125.6 64.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.344 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 m -113.26 139.34 39.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.173 0.511 . . . . 0.0 111.006 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.4 m -86.61 106.54 17.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.068 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.7 mt -101.34 127.86 47.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.213 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.496 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 48.2 mt-30 -90.21 105.39 17.78 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.654 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.4 mt -95.24 126.42 40.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.217 0.532 . . . . 0.0 110.799 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -108.73 153.51 23.35 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.144 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -76.68 113.43 14.32 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.168 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.466 ' HB3' ' O ' ' A' ' 22' ' ' ALA . 79.4 t60 -72.71 -25.27 61.17 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -138.31 124.67 20.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.163 -1.381 . . . . 0.0 107.904 165.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -67.99 -76.71 0.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.941 0.401 . . . . 0.0 110.051 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -178.28 -36.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 25.8 t60 . . . . . 0 C--O 1.244 0.765 0 CA-C-O 118.489 -0.767 . . . . 0.0 108.969 175.455 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.475 0.812 0 CA-C-O 121.151 0.501 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.0 t -92.46 173.58 7.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.368 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -85.78 -1.37 57.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.246 0.546 . . . . 0.0 110.297 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.0 p -83.51 16.68 2.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.005 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 5' ' ' LEU . 38.5 tp -112.17 16.07 20.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.193 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -114.03 99.13 7.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.815 -177.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 63.71 -78.95 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.473 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 8.0 p-10 -63.46 112.11 6.46 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-O 121.522 0.677 . . . . 0.0 111.135 -171.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 66.6 Cg_endo -99.42 173.53 0.41 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.693 2.928 . . . . 0.0 113.948 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.541 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 3.7 m -107.38 130.97 54.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.404 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.7 tp -102.87 135.38 44.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.894 0.378 . . . . 0.0 110.012 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.4 m -100.68 106.33 17.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.096 0.474 . . . . 0.0 110.754 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.482 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 92.0 mt -102.8 158.32 16.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.068 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.4 t -97.86 138.61 34.95 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.478 HD11 HG12 ' A' ' 53' ' ' VAL . 46.9 tp -79.93 124.59 28.81 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.422 HG13 ' HB3' ' A' ' 52' ' ' TYR . 43.8 pt -116.61 156.95 17.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.146 0.498 . . . . 0.0 111.249 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.465 ' HB3' ' OG1' ' A' ' 20' ' ' THR . . . -87.84 118.68 27.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.668 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -115.78 132.1 56.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.542 -176.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.718 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 95.3 m-20 60.34 26.31 15.83 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.104 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 50.7 m -79.58 119.51 77.12 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.937 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 27.9 Cg_exo -62.56 158.74 39.81 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 123.14 2.56 . . . . 0.0 112.356 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.77 -8.03 59.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.026 0.441 . . . . 0.0 110.635 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -88.19 -5.86 58.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.611 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.0 p -114.55 131.2 56.75 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.863 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.53 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 49.7 ttp -124.93 120.58 32.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.96 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.444 HG12 ' CD2' ' A' ' 89' ' ' LEU . 8.1 mt -82.08 123.5 38.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 45.6 ttp -74.81 -57.47 3.89 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.091 0.472 . . . . 0.0 110.011 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -70.58 154.14 42.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.57 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -94.15 141.16 28.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.889 0.376 . . . . 0.0 110.6 -178.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 65.4 mt -67.4 114.32 18.51 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.229 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 2.8 Cg_exo -73.76 172.95 14.78 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.695 2.263 . . . . 0.0 112.906 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.2 m -82.48 134.35 35.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.364 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.482 ' CG2' ' HB2' ' A' ' 13' ' ' LEU . 33.7 m -95.32 138.12 21.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.149 0.499 . . . . 0.0 110.038 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.416 ' HG3' ' CG2' ' A' ' 10' ' ' THR . 9.7 ttp180 -104.84 103.66 13.29 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.958 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.518 HG12 ' HA ' ' A' ' 80' ' ' ILE . 25.9 m -117.38 126.11 74.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.096 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 42.3 tttt -93.08 141.92 27.88 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 32.9 p -118.33 144.56 45.77 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 123.357 0.41 . . . . 0.0 110.996 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 31.6 tt0 -96.37 107.36 19.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 146.0 -138.71 7.69 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -148.81 126.77 11.94 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -104.78 109.16 62.65 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.318 0.58 . . . . 0.0 111.77 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.39 -47.98 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.749 2.299 . . . . 0.0 111.691 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.1 m -131.64 -68.7 0.64 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.753 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.7 mm 64.91 117.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.398 0.618 . . . . 0.0 111.504 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.434 ' ND2' ' HG2' ' A' ' 48' ' ' GLU . 59.4 t30 -84.5 90.65 7.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.642 0.734 . . . . 0.0 110.681 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.413 ' O ' HG12 ' A' ' 46' ' ' VAL . 11.2 t -78.34 7.11 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.333 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -82.63 -20.24 36.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.814 174.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.434 ' HG2' ' ND2' ' A' ' 45' ' ' ASN . 12.6 mm-40 -107.0 -35.15 6.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.304 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.3 mt -83.01 124.63 30.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.301 -177.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -147.36 175.62 10.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.777 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -123.59 137.36 54.76 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 170.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.422 ' HB3' HG13 ' A' ' 16' ' ' ILE . 20.1 p90 -136.41 160.87 37.44 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.642 0.734 . . . . 0.0 112.917 -173.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.478 HG12 HD11 ' A' ' 15' ' ' LEU . 14.6 m -113.12 125.95 70.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.313 167.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -91.67 102.35 14.98 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -175.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 71.4 mt -92.84 15.13 15.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.572 -173.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.718 ' HB2' ' HB3' ' A' ' 19' ' ' ASN . 8.0 t -73.74 106.19 5.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 175.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.08 35.32 6.76 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.266 -175.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.1 m -120.16 145.84 46.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.725 0.297 . . . . 0.0 110.663 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.91 154.25 37.87 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.978 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.504 ' HA ' ' HB2' ' A' ' 89' ' ' LEU . 26.1 Cg_exo -64.93 169.86 11.17 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.936 2.424 . . . . 0.0 112.159 175.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.37 -177.73 27.41 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -175.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -86.56 111.39 20.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.004 0.431 . . . . 0.0 110.396 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 65' ' ' TYR . 35.5 m80 -129.03 151.79 49.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.953 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.455 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 19.2 m-20 -90.11 103.22 15.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.847 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.553 ' HH ' HD12 ' A' ' 89' ' ' LEU . 72.5 m-85 -97.39 147.33 24.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.766 -176.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -87.9 125.26 34.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.807 -172.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 64.6 t -74.74 110.63 9.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.134 0.493 . . . . 0.0 110.094 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -101.82 106.14 17.08 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.111 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.2 t -91.91 136.36 24.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.491 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -75.1 122.05 86.58 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 171.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.42 142.35 88.97 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.705 2.27 . . . . 0.0 112.063 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 32.7 mm -82.18 120.1 76.44 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.571 -177.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 22.0 Cg_exo -66.08 146.04 80.9 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.23 1.953 . . . . 0.0 111.307 175.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 73' ' ' PRO . 84.5 m-20 76.8 -41.19 0.39 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.491 0.716 . . . . 0.0 112.079 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.7 mt -103.08 157.4 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.596 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 58.4 tttm -92.88 146.07 23.91 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 tt -95.18 144.51 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 122.094 -0.379 . . . . 0.0 109.979 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 45.4 t -114.62 -70.89 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.951 0.405 . . . . 0.0 111.349 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -116.51 148.76 40.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.226 -169.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.518 ' HA ' HG12 ' A' ' 35' ' ' VAL . 73.8 mt -132.08 107.04 12.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.025 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.4 t -137.66 126.66 14.86 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.092 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.412 ' HD2' HG12 ' A' ' 33' ' ' VAL . 97.3 Cg_endo -81.51 177.52 34.53 Favored 'Cis proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.065 -1.639 . . . . 0.0 112.637 -0.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -112.6 -47.32 3.08 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.627 -173.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.455 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 61.4 t -125.45 121.49 60.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 m -111.69 135.6 50.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.021 0.439 . . . . 0.0 111.575 -175.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.7 m -83.12 110.25 17.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.687 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 93.6 mt -110.66 129.11 55.9 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.406 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -93.46 107.24 19.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.91 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.553 HD12 ' HH ' ' A' ' 65' ' ' TYR . 80.7 mt -93.29 123.66 36.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.993 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.64 162.04 13.19 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.192 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.459 ' CE1' ' HG2' ' A' ' 60' ' ' PRO . 55.6 m-70 -82.55 117.93 22.9 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.907 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.53 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 5.5 t60 -89.03 91.89 9.0 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 175.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -98.1 124.11 42.47 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.103 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -104.52 121.91 44.46 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 170.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -56.47 -64.69 0.78 Allowed 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.437 0.461 . . . . 0.0 110.386 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.101 178.859 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.478 0.932 0 CA-C-O 120.926 0.394 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.4 t -126.41 151.22 47.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.659 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -109.81 118.58 36.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.91 0.386 . . . . 0.0 110.885 -177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 p -83.34 6.46 19.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.771 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.8 mt -103.61 3.23 34.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.506 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -116.88 144.13 44.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.674 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.1 ttm105 -64.63 -29.24 70.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.615 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -147.83 93.05 4.58 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.466 0.651 . . . . 0.0 111.214 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -79.05 169.87 18.63 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.66 2.24 . . . . 0.0 112.631 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 m -105.21 103.7 13.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.998 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.513 ' HB2' HG21 ' A' ' 35' ' ' VAL . 83.4 mt -83.24 134.7 34.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.067 0.46 . . . . 0.0 110.156 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.3 m -110.63 104.57 13.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.233 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 60.1 mt -104.68 157.91 16.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.242 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 m -91.01 143.78 26.35 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.566 HD13 HG12 ' A' ' 53' ' ' VAL . 49.9 tp -92.56 133.23 36.15 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.0 pt -132.26 162.61 39.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.012 0.434 . . . . 0.0 110.893 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.411 ' HB3' ' OG1' ' A' ' 20' ' ' THR . . . -97.26 126.28 42.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.224 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -124.27 139.82 53.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 64.45 19.06 11.66 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.61 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.411 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 49.2 m -83.9 120.5 75.06 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.821 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.97 177.44 8.73 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.578 2.185 . . . . 0.0 112.72 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.23 -14.38 53.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.336 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -77.9 -16.18 58.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.314 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 p -110.38 113.39 26.0 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.363 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 56.1 ttp -102.98 123.9 47.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.569 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.506 HG12 ' CD2' ' A' ' 89' ' ' LEU . 26.3 mt -86.8 119.56 34.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.052 -173.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 89.4 mmm -92.57 -30.8 15.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.402 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -72.33 105.45 4.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.31 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.42 129.51 39.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.388 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 84.4 mt -72.19 127.77 89.91 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.832 -170.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 95.2 Cg_endo -96.5 -162.49 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.684 2.923 . . . . 0.0 112.4 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.6 p -104.24 158.64 16.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.086 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.3 m -111.55 152.78 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -112.95 97.42 6.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.943 0.401 . . . . 0.0 110.149 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 80' ' ' ILE . 17.8 m -96.98 107.97 20.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.917 0.865 . . . . 0.0 110.205 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.52 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 1.2 mmmp? -75.02 130.98 40.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.745 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.447 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 26.3 p -135.21 128.43 31.95 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.974 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.541 ' HG3' ' CG2' ' A' ' 78' ' ' VAL . 40.2 mt-10 -86.45 94.23 9.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.46 ' HA3' HG22 ' A' ' 75' ' ' ILE . . . 160.06 157.1 8.45 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.899 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -98.65 118.51 35.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -126.99 82.42 68.09 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -89.63 -15.8 2.14 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.542 2.161 . . . . 0.0 112.281 171.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.3 t -98.1 15.55 23.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.013 0.435 . . . . 0.0 110.823 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.4 mt -124.58 137.92 55.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.235 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -94.79 114.58 26.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.312 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.444 HG11 HD23 ' A' ' 11' ' ' LEU . 35.1 m -76.23 -24.34 16.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -75.19 -24.58 57.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.142 0.496 . . . . 0.0 109.929 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -83.6 -34.0 25.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.843 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.69 126.12 28.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.533 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -115.98 147.78 40.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.268 0.556 . . . . 0.0 111.378 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -109.71 124.44 51.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -121.53 160.29 24.58 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.381 0.61 . . . . 0.0 111.865 -174.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.566 HG12 HD13 ' A' ' 15' ' ' LEU . 6.0 m -112.29 123.35 67.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.111 172.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -86.48 108.77 18.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.18 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.8 34.97 2.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.368 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.3 m -64.91 107.57 1.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.896 0.379 . . . . 0.0 110.337 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.92 48.31 5.51 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.908 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.3 p -101.29 113.8 27.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.815 0.34 . . . . 0.0 111.336 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -79.31 128.27 76.13 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 173.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -49.84 100.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.681 2.921 . . . . 0.0 113.265 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -177.76 175.36 47.5 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -80.28 114.48 19.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.02 0.41 . . . . 0.0 109.979 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.502 ' HB2' ' CZ ' ' A' ' 65' ' ' TYR . 31.6 m170 -134.15 160.12 38.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.0 t70 -97.0 108.19 20.88 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.502 ' CZ ' ' HB2' ' A' ' 63' ' ' HIS . 78.1 m-85 -109.72 152.58 25.46 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 111.291 -171.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.84 139.4 37.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.098 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 97.4 t -92.14 120.53 41.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -117.36 108.88 16.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.422 -175.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.1 t -89.2 148.96 4.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.914 178.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -61.81 118.61 40.16 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 171.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.55 128.99 30.12 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.979 2.453 . . . . 0.0 112.53 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.28 114.71 63.98 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.906 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.8 151.09 18.86 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.066 2.511 . . . . 0.0 111.657 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 74.37 -39.73 0.43 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.653 0.781 . . . . 0.0 111.712 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.46 HG22 ' HA3' ' A' ' 39' ' ' GLY . 40.0 mm -92.39 136.02 25.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -87.6 118.49 27.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.616 0.246 . . . . 0.0 110.448 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.3 tt -81.31 123.84 38.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.346 0.594 . . . . 0.0 110.907 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.541 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 31.6 t -86.19 -60.9 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.441 0.639 . . . . 0.0 109.916 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -121.01 153.31 37.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.585 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.63 HG22 ' HG2' ' A' ' 83' ' ' ARG . 14.8 tt -127.39 18.41 3.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 173.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.5 m -64.18 134.65 96.03 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.695 -175.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.59 133.14 30.02 Favored 'Cis proline' 0 C--N 1.343 0.267 0 C-N-CA 123.382 -1.507 . . . . 0.0 111.988 -0.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.63 ' HG2' HG22 ' A' ' 80' ' ' ILE . 58.8 mtm180 -72.05 -38.14 69.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.208 0.528 . . . . 0.0 110.517 -176.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -134.59 136.45 52.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.068 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.5 m -129.04 141.79 45.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.141 0.495 . . . . 0.0 111.144 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 15.8 m -89.72 109.41 20.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.138 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.6 mt -100.29 124.9 46.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.631 -176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -85.67 99.03 11.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.01 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.506 ' CD2' HG12 ' A' ' 26' ' ' ILE . 89.8 mt -95.57 139.8 31.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.901 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.755 ' HG2' ' H ' ' A' ' 91' ' ' HIS . 22.4 tt0 -117.67 176.84 4.99 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.755 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 25.9 m-70 -82.46 151.65 26.45 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.909 -176.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -79.5 19.19 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.644 0.735 . . . . 0.0 109.958 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.477 ' H ' ' C ' ' A' ' 91' ' ' HIS . 6.2 t60 -87.18 -21.69 25.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.532 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -132.41 -170.64 2.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.155 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -164.85 107.97 0.87 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 66.9 t60 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.627 -176.748 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.2 m . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 121.226 0.536 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.1 p -95.29 -67.49 0.85 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.711 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -85.11 -175.77 5.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.924 0.392 . . . . 0.0 111.338 -173.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.4 m -72.51 -32.82 66.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 69.0 mt -66.15 -18.29 65.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.019 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.04 -28.87 62.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.216 0.532 . . . . 0.0 109.941 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 7' ' ' ARG . 15.6 ttm-85 -102.33 -12.3 18.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.941 -177.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.484 ' CG ' ' HZ1' ' A' ' 36' ' ' LYS . 30.1 t70 -140.95 92.88 8.46 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.735 -176.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 37' ' ' THR . 6.2 Cg_exo -80.22 130.37 8.17 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.925 2.417 . . . . 0.0 112.29 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 m -105.88 110.32 22.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.925 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 40.1 tp -93.63 135.52 34.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.745 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 16.3 m -117.02 109.6 17.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.896 0.379 . . . . 0.0 110.631 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.7 mt -111.64 144.16 41.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.192 -174.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -75.98 147.26 38.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.924 0.392 . . . . 0.0 110.771 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.739 HD11 HG13 ' A' ' 53' ' ' VAL . 41.4 tp -90.49 133.51 35.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.114 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.488 ' CG1' ' HB3' ' A' ' 52' ' ' TYR . 48.0 pt -112.63 153.55 14.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.979 0.419 . . . . 0.0 110.725 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.38 105.66 17.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.547 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 62.0 tttm -93.82 106.65 18.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.012 0.434 . . . . 0.0 111.204 -175.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 56.26 77.75 0.23 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.89 174.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.9 t -106.86 140.22 21.16 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 172.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.426 ' HD2' ' OG ' ' A' ' 24' ' ' SER . 36.2 Cg_exo -62.75 169.16 9.06 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.017 2.478 . . . . 0.0 112.91 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.1 6.87 27.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.534 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -107.5 -6.16 17.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.314 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.426 ' OG ' ' HD2' ' A' ' 21' ' ' PRO . 5.0 p -118.42 128.9 55.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.814 -176.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.0 ttp -115.66 131.86 56.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.652 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.5 mt -90.34 103.73 14.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.799 0.333 . . . . 0.0 110.665 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 81.3 mtp -75.58 -38.82 58.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.303 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.5 m -71.52 120.02 16.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.241 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.57 120.09 16.66 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.6 mt -54.71 117.76 14.78 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.513 -174.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.67 -163.2 0.2 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.976 2.45 . . . . 0.0 112.227 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 m -123.31 134.9 54.01 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 120.914 0.388 . . . . 0.0 110.363 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.808 HG12 HG11 ' A' ' 67' ' ' VAL . 33.2 m -85.94 133.04 30.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.979 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 34' ' ' ARG . 25.7 ttt180 -110.01 97.34 6.86 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.512 HG13 ' HA ' ' A' ' 80' ' ' ILE . 33.5 m -102.89 157.58 4.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.58 -171.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.484 ' HZ1' ' CG ' ' A' ' 8' ' ' ASP . 10.3 mmmt -98.37 128.25 44.68 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.472 ' O ' ' HD2' ' A' ' 9' ' ' PRO . 10.0 p -116.07 145.91 42.63 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.962 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.46 ' HB2' ' CG2' ' A' ' 78' ' ' VAL . 41.7 tt0 -110.39 107.0 16.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.598 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.36 -153.79 25.26 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.739 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.575 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 96.6 m-85 -121.8 135.82 54.92 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -105.57 96.33 11.88 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 6.1 Cg_exo -79.62 -71.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.801 2.334 . . . . 0.0 111.505 177.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.5 t -162.45 95.47 0.92 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.415 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.564 ' HB ' HG11 ' A' ' 46' ' ' VAL . 32.7 mt -132.67 160.78 42.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -76.9 46.16 0.46 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.329 0.585 . . . . 0.0 110.633 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.564 HG11 ' HB ' ' A' ' 44' ' ' ILE . 20.2 m -67.24 -32.29 56.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.273 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -81.94 -9.5 59.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.151 0.5 . . . . 0.0 110.252 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -95.13 -12.5 26.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.005 176.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.6 mt -78.6 136.36 37.49 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 166.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -130.24 171.24 13.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.221 0.534 . . . . 0.0 111.703 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.37 139.53 42.96 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.38 175.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.488 ' HB3' ' CG1' ' A' ' 16' ' ' ILE . 2.0 p90 -127.55 145.13 50.96 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.217 0.532 . . . . 0.0 111.99 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.739 HG13 HD11 ' A' ' 15' ' ' LEU . 17.0 m -119.56 129.05 75.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.049 174.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -76.45 119.42 20.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.975 0.416 . . . . 0.0 110.148 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.413 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 76.7 mt -112.16 26.88 10.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.301 -176.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.7 m -70.25 -33.74 71.99 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -169.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.89 86.61 0.14 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.231 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.4 m -143.43 155.95 44.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.554 0.216 . . . . 0.0 110.521 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.473 ' HB2' ' NE2' ' A' ' 63' ' ' HIS . 1.6 mp0 -64.97 145.42 99.07 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.392 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 59' ' ' GLU . 10.2 Cg_exo -71.27 91.19 0.66 Allowed 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.806 2.337 . . . . 0.0 112.045 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.28 -166.8 39.66 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.594 ' HG2' ' HB2' ' A' ' 88' ' ' GLN . 42.5 mt-10 -77.34 113.38 15.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.238 0.519 . . . . 0.0 110.336 177.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.473 ' NE2' ' HB2' ' A' ' 59' ' ' GLU . 94.3 m-70 -139.67 173.67 11.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.819 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -94.02 133.34 37.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.11 -173.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.416 ' CE2' ' HB2' ' A' ' 87' ' ' LEU . 74.0 m-85 -131.34 135.63 47.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.103 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -78.83 125.94 30.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.235 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.808 HG11 HG12 ' A' ' 33' ' ' VAL . 93.2 t -85.25 108.77 17.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.237 0.541 . . . . 0.0 110.566 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -99.75 115.86 30.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.782 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.8 t -101.49 148.71 7.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.89 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.28 144.23 97.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.056 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -83.41 149.64 13.16 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.908 2.405 . . . . 0.0 112.704 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.539 ' HB ' ' O ' ' A' ' 75' ' ' ILE . 23.4 mt -117.94 119.0 34.15 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.63 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -85.13 21.07 1.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.69 2.26 . . . . 0.0 112.911 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -131.17 -56.25 1.03 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.157 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.539 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 53.1 mt -105.61 137.84 33.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.182 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -89.71 133.25 34.77 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.707 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.5 tt -83.88 123.38 38.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.547 0.689 . . . . 0.0 109.635 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 38' ' ' GLU . 47.0 t -94.29 -60.84 2.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.943 -174.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.417 ' HB3' ' HB2' ' A' ' 36' ' ' LYS . 27.3 tt0 -118.76 134.48 55.11 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.216 -172.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.707 ' HB ' ' HG3' ' A' ' 83' ' ' ARG . 59.0 mt -109.26 109.59 28.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 54.8 m -133.34 124.52 18.26 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.626 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.505 ' HD2' HG11 ' A' ' 33' ' ' VAL . 4.5 Cg_exo -81.48 142.72 55.77 Favored 'Cis proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.29 -1.546 . . . . 0.0 111.641 -5.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.707 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 5.5 mtm180 -78.71 -37.8 40.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.221 0.534 . . . . 0.0 110.3 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.6 t -124.06 117.5 51.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.49 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.6 m -107.36 152.52 8.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.773 0.321 . . . . 0.0 111.034 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 14.5 m -109.05 99.31 8.64 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.966 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 89.8 mt -102.79 142.62 33.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.317 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.594 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 53.6 tt0 -98.03 106.45 18.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.0 0.429 . . . . 0.0 110.802 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.2 mt -88.79 151.19 22.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.014 174.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -131.7 167.57 19.26 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.511 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -73.36 113.34 10.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.957 0.408 . . . . 0.0 110.761 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -88.74 93.8 9.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.121 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -103.96 157.06 17.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.909 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -90.6 -28.35 18.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.915 0.388 . . . . 0.0 109.992 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -100.64 96.17 7.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.269 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.5 t60 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.379 -0.82 . . . . 0.0 109.468 175.389 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 m -120.95 175.96 5.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.917 0.389 . . . . 0.0 110.904 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -67.73 140.75 56.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.861 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.2 m -143.73 138.44 28.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.518 0.199 . . . . 0.0 110.715 -174.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.0 mt -66.71 -3.69 7.21 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -174.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -73.9 -16.87 61.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.303 0.573 . . . . 0.0 109.879 173.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -113.84 -39.54 3.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.228 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -119.67 80.61 23.89 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 121.417 0.627 . . . . 0.0 111.298 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -90.54 174.96 2.8 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.979 2.452 . . . . 0.0 112.873 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.0 m -107.38 122.22 46.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.76 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.683 HD21 HG11 ' A' ' 46' ' ' VAL . 67.4 mt -104.15 127.4 51.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.138 0.494 . . . . 0.0 110.907 -176.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.0 m -101.34 107.18 18.46 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.132 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.3 mt -108.02 149.17 28.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.36 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.6 p -82.78 141.24 32.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.646 0.26 . . . . 0.0 110.515 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.793 HD13 HG11 ' A' ' 53' ' ' VAL . 43.0 tp -90.09 133.04 35.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.516 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.3 pt -116.67 155.68 18.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.968 0.413 . . . . 0.0 111.006 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.457 ' HB3' ' OG1' ' A' ' 20' ' ' THR . . . -85.12 110.47 19.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.24 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -106.21 137.16 44.64 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.534 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 63.0 16.4 9.23 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.548 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.458 ' OG1' HD12 ' A' ' 55' ' ' LEU . 18.7 m -74.36 117.24 60.29 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.28 -176.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 5.7 Cg_exo -74.51 173.1 14.87 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.064 2.51 . . . . 0.0 112.449 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.69 -5.96 59.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.603 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -78.07 -9.2 59.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.562 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.503 ' HB2' HD22 ' A' ' 89' ' ' LEU . 11.9 p -129.78 128.73 42.98 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.992 -176.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.584 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 58.5 ttp -114.54 139.03 49.91 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.5 mt -110.19 99.13 8.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.523 -177.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 78.2 mtp -82.14 -15.35 53.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.982 0.42 . . . . 0.0 110.362 176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.4 m -81.05 106.28 12.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -63.44 123.0 17.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.011 -175.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.4 mt -62.02 119.26 47.03 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.504 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.75 -164.05 0.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.802 2.335 . . . . 0.0 112.655 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.1 p -106.43 142.03 36.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.757 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.0 p -99.0 139.4 20.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -110.74 101.67 10.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.303 0.573 . . . . 0.0 110.381 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 80' ' ' ILE . 33.4 m -105.09 130.83 55.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.388 -177.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.49 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 58.2 tttm -94.0 132.64 38.27 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.507 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 26.2 p -126.81 152.19 47.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.465 -174.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 76' ' ' LYS . 50.4 mt-10 -108.94 96.0 6.02 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.57 156.47 7.72 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -108.64 129.36 55.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 41.2 m-80 -70.89 114.06 23.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.96 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 41' ' ' ASN . 3.5 Cg_exo -80.14 -71.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.804 2.336 . . . . 0.0 111.833 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 p -113.04 10.16 18.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.482 0.658 . . . . 0.0 110.048 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.0 mt -92.94 133.37 34.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.111 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.535 ' HB2' ' HG3' ' A' ' 48' ' ' GLU . 53.6 m-80 -113.18 126.51 55.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.073 0.463 . . . . 0.0 110.061 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.683 HG11 HD21 ' A' ' 11' ' ' LEU . 34.4 m -77.41 -8.41 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.51 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -89.39 -4.14 58.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.27 0.557 . . . . 0.0 110.127 173.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.535 ' HG3' ' HB2' ' A' ' 45' ' ' ASN . 42.3 mt-10 -99.57 -34.56 10.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.571 174.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.7 mt -81.24 138.57 35.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.921 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -127.23 168.43 14.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.505 0.669 . . . . 0.0 111.299 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.6 147.59 29.31 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 171.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -140.46 146.88 38.82 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.19 0.519 . . . . 0.0 111.29 -174.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.793 HG11 HD13 ' A' ' 15' ' ' LEU . 4.3 m -112.25 130.64 65.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.405 175.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -79.47 91.56 5.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.043 -176.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.458 HD12 ' OG1' ' A' ' 20' ' ' THR . 52.0 mt -93.84 59.14 2.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.835 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 p -77.58 -4.72 47.25 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.332 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.66 -178.31 39.56 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.799 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.1 m -144.95 21.19 1.61 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.198 0.523 . . . . 0.0 109.786 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.11 115.84 52.28 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.342 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.13 158.51 56.24 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.955 2.436 . . . . 0.0 112.496 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.43 -163.29 22.82 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.47 ' HB3' HG23 ' A' ' 86' ' ' THR . 40.7 mt-10 -86.45 108.82 18.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.153 0.501 . . . . 0.0 110.293 177.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -117.68 143.03 46.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.652 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 10.0 m-20 -81.51 138.08 35.51 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -138.95 150.89 46.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.993 0.425 . . . . 0.0 111.18 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -90.33 123.03 33.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.69 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.9 t -81.24 134.74 26.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.556 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -125.45 153.44 43.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.095 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.7 t -127.28 146.44 33.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.415 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 43.6 mt-10 -63.04 125.49 86.92 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 32.2 Cg_exo -59.13 124.16 15.02 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.086 2.524 . . . . 0.0 112.857 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.0 mp -95.18 125.94 48.34 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.725 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.95 146.57 42.1 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.254 1.969 . . . . 0.0 111.98 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 72.78 -45.85 0.63 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.722 0.809 . . . . 0.0 112.197 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.507 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 51.2 mt -84.05 133.09 29.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.014 0.435 . . . . 0.0 110.514 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 94.7 mttt -87.07 142.04 28.22 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.206 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 tt -99.58 119.28 47.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.22 0.533 . . . . 0.0 110.316 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.5 t -94.17 -48.02 13.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.807 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.49 ' HB2' ' H ' ' A' ' 36' ' ' LYS . 20.3 mm-40 -118.7 148.66 42.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.173 -176.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.823 HG21 ' HG2' ' A' ' 83' ' ' ARG . 16.1 tt -138.96 27.54 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 122.361 1.077 . . . . 0.0 108.419 174.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.6 m -83.1 141.04 42.9 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.131 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.51 131.43 23.23 Favored 'Cis proline' 0 C--N 1.346 0.418 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.215 0.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.823 ' HG2' HG21 ' A' ' 80' ' ' ILE . 73.7 mtm180 -78.24 -49.55 13.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.306 -175.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.8 119.5 60.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.788 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.29 145.59 27.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.732 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.47 HG23 ' HB3' ' A' ' 62' ' ' GLU . 8.6 m -99.86 101.74 12.96 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.3 mt -94.08 145.74 24.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 -175.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -97.56 125.85 42.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.124 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.503 HD22 ' HB2' ' A' ' 24' ' ' SER . 90.0 mt -116.47 131.96 56.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.853 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -100.38 151.52 21.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.529 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -66.75 104.69 1.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.214 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.584 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 74.7 t60 -106.03 116.52 32.08 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -87.99 -76.67 0.38 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -168.47 -34.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.765 174.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -93.34 -30.54 15.06 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.472 -0.775 . . . . 0.0 109.47 175.247 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.477 0.909 0 CA-C-O 120.821 0.343 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.1 p -171.0 -162.4 0.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.562 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -136.54 117.67 14.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.847 0.356 . . . . 0.0 110.331 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.1 m -73.33 105.72 4.85 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.94 134.69 53.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.129 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -62.25 -52.63 62.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.362 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -124.33 -174.7 3.07 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 172.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 51.35 57.4 16.82 Favored Pre-proline 0 N--CA 1.467 0.381 0 O-C-N 123.418 0.449 . . . . 0.0 110.738 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.589 ' HG2' ' OG1' ' A' ' 37' ' ' THR . 29.6 Cg_endo -65.45 115.66 3.48 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.955 1.77 . . . . 0.0 112.816 -172.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.7 m -87.56 99.34 11.97 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 171.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.42 125.27 31.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.555 -175.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.2 m -95.26 89.85 5.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.88 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.42 HD22 HG12 ' A' ' 46' ' ' VAL . 60.2 mt -91.0 131.62 36.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.437 -174.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.4 m -74.41 139.8 44.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.839 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.876 HD11 HG11 ' A' ' 53' ' ' VAL . 30.0 tp -84.71 127.34 34.05 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.403 HD13 ' CE2' ' A' ' 52' ' ' TYR . 29.0 pt -120.68 142.51 36.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.445 0.641 . . . . 0.0 112.23 -176.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.552 ' HB3' ' OG1' ' A' ' 20' ' ' THR . . . -72.76 111.93 8.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.288 175.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -79.21 -78.24 0.16 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.094 0.473 . . . . 0.0 110.645 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -110.61 75.83 0.95 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.405 0.621 . . . . 0.0 109.571 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.623 ' HG1' ' HB2' ' A' ' 55' ' ' LEU . 94.6 m -99.62 113.04 64.74 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.225 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.11 155.2 52.15 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.13 2.553 . . . . 0.0 112.767 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.3 -1.82 11.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.947 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -104.6 -2.03 25.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.879 0.371 . . . . 0.0 110.567 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.4 m -107.3 115.49 30.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.468 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 55.7 ttp -107.55 117.39 33.97 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.014 0.435 . . . . 0.0 110.657 -177.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.5 mt -92.08 102.59 13.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.892 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 80.5 mtp -86.23 -33.33 20.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.747 0.308 . . . . 0.0 110.807 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.4 m -81.08 117.78 21.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.047 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -59.84 124.55 20.52 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 84.1 mt -59.66 121.16 55.42 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.289 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 12.4 Cg_exo -69.33 -179.36 2.67 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.865 2.377 . . . . 0.0 112.502 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 p -109.07 146.22 34.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.124 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.652 HG12 HG13 ' A' ' 67' ' ' VAL . 20.3 m -97.08 140.07 18.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.067 0.461 . . . . 0.0 109.993 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -109.56 98.28 7.68 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.661 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 80' ' ' ILE . 32.8 m -103.09 142.32 17.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.074 -176.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -92.53 129.84 38.35 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.589 ' OG1' ' HG2' ' A' ' 9' ' ' PRO . 27.3 p -121.46 161.46 22.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.592 0.234 . . . . 0.0 110.585 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.46 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 22.6 tt0 -123.79 143.1 50.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.056 -175.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.09 -118.93 1.91 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.336 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -144.48 131.74 20.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.445 ' HB3' ' HG3' ' A' ' 9' ' ' PRO . 2.5 p-10 -120.88 91.64 47.74 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 121.354 0.597 . . . . 0.0 112.154 -174.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -89.48 -51.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.731 2.287 . . . . 0.0 112.671 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -159.28 96.63 1.32 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.256 0.551 . . . . 0.0 110.243 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mp -117.21 126.38 74.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.597 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' A' ' 48' ' ' GLU . 58.0 t30 -80.01 94.47 5.93 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.762 0.791 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.42 HG12 HD22 ' A' ' 13' ' ' LEU . 19.1 t -68.59 -17.79 22.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.536 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -82.8 5.49 21.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.719 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.513 ' HB2' ' ND2' ' A' ' 45' ' ' ASN . 40.7 tt0 -119.17 -33.35 4.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.199 176.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.7 mt -79.51 127.84 32.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -136.81 166.87 22.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.628 0.727 . . . . 0.0 112.14 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.439 ' HB3' HG11 ' A' ' 67' ' ' VAL . . . -109.35 128.76 55.36 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.046 172.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.645 ' HE1' ' HB2' ' A' ' 70' ' ' GLU . 48.5 m-85 -103.42 138.51 40.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.934 0.397 . . . . 0.0 111.391 -173.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.876 HG11 HD11 ' A' ' 15' ' ' LEU . 3.0 m -125.86 129.76 72.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.815 169.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -88.49 91.61 8.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.303 0.573 . . . . 0.0 109.566 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.623 ' HB2' ' HG1' ' A' ' 20' ' ' THR . 52.4 mt -87.79 38.82 0.86 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.691 -174.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.9 p -68.77 -24.55 64.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.974 0.416 . . . . 0.0 109.982 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.2 111.93 3.8 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 m -96.97 26.22 4.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.996 0.427 . . . . 0.0 110.727 -173.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -87.27 115.38 62.54 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.671 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.06 140.88 55.75 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.446 2.098 . . . . 0.0 111.248 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.64 -150.66 19.05 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -116.5 105.79 12.87 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.997 0.427 . . . . 0.0 109.969 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -122.25 148.91 44.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.093 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -81.76 132.83 35.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.908 0.385 . . . . 0.0 110.703 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -127.91 137.15 52.19 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.499 ' HG2' HG22 ' A' ' 84' ' ' VAL . 40.3 mt-10 -88.71 134.85 33.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.036 0.446 . . . . 0.0 110.885 -173.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.652 HG13 HG12 ' A' ' 33' ' ' VAL . 65.2 t -71.81 102.2 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.732 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -92.67 101.69 14.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.554 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.2 t -87.27 143.64 10.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.146 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.645 ' HB2' ' HE1' ' A' ' 52' ' ' TYR . 32.2 tt0 -77.95 114.76 44.73 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -56.41 130.84 42.25 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.051 2.5 . . . . 0.0 112.738 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.7 mt -94.32 125.09 53.54 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.51 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.57 141.87 42.99 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.578 2.186 . . . . 0.0 111.504 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.3 t30 74.16 -44.03 0.55 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.368 0.667 . . . . 0.0 111.801 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.8 mm -83.86 119.22 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.125 0.488 . . . . 0.0 110.37 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.46 ' HD3' ' HB3' ' A' ' 38' ' ' GLU . 80.0 tttt -80.73 124.82 29.36 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.598 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.527 ' HA ' HG23 ' A' ' 37' ' ' THR . 17.0 tt -88.96 131.61 35.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.148 0.499 . . . . 0.0 110.233 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.7 t -100.78 -58.87 3.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.319 -175.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -138.14 147.24 43.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.881 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.545 ' HA ' HG12 ' A' ' 35' ' ' VAL . 58.9 mt -115.57 121.78 67.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.203 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 70.1 m -138.16 115.85 9.39 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.921 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.5 ' HD2' HG11 ' A' ' 33' ' ' VAL . 2.1 Cg_endo -86.31 170.94 40.95 Favored 'Cis proline' 0 N--CA 1.462 -0.347 0 C-N-CA 124.063 -1.224 . . . . 0.0 112.308 -1.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -98.83 -32.43 11.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.346 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.499 HG22 ' HG2' ' A' ' 66' ' ' GLU . 45.4 t -129.79 132.13 66.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.384 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 m -123.85 128.77 74.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.164 0.507 . . . . 0.0 111.139 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.4 m -82.54 103.89 12.41 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.449 HD13 HD22 ' A' ' 55' ' ' LEU . 90.1 mt -94.83 146.27 24.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.16 0.505 . . . . 0.0 111.237 -173.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.2 tm0? -98.23 119.43 36.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.282 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.8 mt -123.63 146.33 48.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.813 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -139.45 173.17 11.81 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 169.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.515 ' C ' ' H ' ' A' ' 93' ' ' HIS . 16.6 m80 -69.73 127.88 34.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.828 0.347 . . . . 0.0 110.632 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 11.9 t-80 -82.66 33.39 0.42 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.426 1.108 . . . . 0.0 108.131 171.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . 0.515 ' H ' ' C ' ' A' ' 91' ' ' HIS . 1.8 t-160 -151.57 117.44 5.49 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.003 -1.453 . . . . 0.0 107.225 -176.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -67.99 -18.13 64.63 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -170.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -136.84 105.21 5.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.725 171.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.9 t60 . . . . . 0 C--O 1.246 0.883 0 O-C-N 124.075 0.859 . . . . 0.0 111.06 177.253 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 t -97.23 102.85 14.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -77.72 119.35 21.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.12 0.486 . . . . 0.0 111.047 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -78.5 135.92 37.46 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.599 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.4 mt -85.77 129.0 34.95 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -67.18 -16.55 64.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.458 -174.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.522 ' HA ' ' HE1' ' A' ' 40' ' ' TYR . 92.4 mtt180 -89.8 -5.91 56.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.536 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.412 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 28.2 m-20 -123.72 86.63 52.93 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.975 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.82 101.82 0.19 Allowed 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.464 2.109 . . . . 0.0 112.153 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 m -98.2 109.0 21.83 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.283 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.1 mt -104.8 145.91 29.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.177 0.513 . . . . 0.0 111.042 -173.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 20.6 m -122.83 102.49 8.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.527 174.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.7 mt -96.17 140.05 31.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.334 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -73.21 135.95 44.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.325 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.709 HD11 HG11 ' A' ' 53' ' ' VAL . 42.4 tp -85.88 119.59 26.36 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.5 pt -112.58 155.65 13.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.166 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.86 114.73 24.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.048 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -117.37 143.28 46.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.8 t30 61.01 26.26 16.23 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.879 0.847 . . . . 0.0 109.698 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.469 HG21 HD13 ' A' ' 55' ' ' LEU . 85.1 m -85.86 117.41 68.67 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.736 -177.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -69.38 162.69 40.88 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.016 2.477 . . . . 0.0 112.575 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.39 -8.64 58.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.415 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -92.31 3.74 54.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.887 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 p -127.88 139.71 52.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.759 0.314 . . . . 0.0 111.212 -175.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.447 ' HB2' ' NE2' ' A' ' 92' ' ' HIS . 14.1 ttm -127.13 129.95 48.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.741 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.473 HG12 ' CD2' ' A' ' 89' ' ' LEU . 12.9 mt -88.17 97.47 6.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 86.9 mtp -62.85 -33.24 74.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.237 0.541 . . . . 0.0 110.05 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 m -74.49 104.71 5.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.624 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -64.33 121.0 13.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.092 0.472 . . . . 0.0 110.664 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.21 122.69 65.37 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.224 -171.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -87.05 -155.8 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.523 2.815 . . . . 0.0 112.093 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.5 m -120.19 150.51 40.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.85 0.357 . . . . 0.0 110.657 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 12' ' ' THR . 12.7 p -103.45 138.71 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.835 -177.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -98.38 119.91 37.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.073 177.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.429 HG13 ' HA ' ' A' ' 80' ' ' ILE . 25.1 m -128.59 123.77 60.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.651 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.412 ' HE3' ' HB3' ' A' ' 8' ' ' ASP . 87.8 tttt -95.84 138.83 32.93 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.519 HG22 ' HA ' ' A' ' 77' ' ' ILE . 35.5 p -126.73 155.2 43.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.993 0.425 . . . . 0.0 111.869 -175.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.521 ' HG3' ' CG2' ' A' ' 78' ' ' VAL . 42.8 mt-10 -105.81 120.59 42.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.797 174.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.2 -171.53 26.28 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.522 ' HE1' ' HA ' ' A' ' 7' ' ' ARG . 93.6 m-85 -135.03 101.07 4.76 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.76 112.36 6.0 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.228 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.11 -62.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.767 2.311 . . . . 0.0 111.143 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.5 t -145.7 79.09 1.56 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.131 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -121.85 130.73 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.795 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.43 ' ND2' ' HG3' ' A' ' 48' ' ' GLU . 59.0 t30 -94.59 103.93 15.87 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.729 0.776 . . . . 0.0 110.895 -175.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.4 t -62.91 -23.88 34.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.294 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -66.18 -20.78 66.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.951 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.43 ' HG3' ' ND2' ' A' ' 45' ' ' ASN . 48.3 mt-10 -105.28 -11.17 16.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.939 0.399 . . . . 0.0 110.831 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.9 128.68 33.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 170.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -136.67 173.3 11.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.31 0.576 . . . . 0.0 111.697 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -131.45 140.89 49.69 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -129.07 156.75 43.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.472 0.653 . . . . 0.0 112.102 -173.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.709 HG11 HD11 ' A' ' 15' ' ' LEU . 4.6 m -112.17 118.18 57.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.363 172.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.78 106.3 16.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.246 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.469 HD13 HG21 ' A' ' 20' ' ' THR . 63.4 mt -95.05 45.29 1.1 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.537 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 p -57.37 -44.64 84.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.806 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.88 67.19 0.49 Allowed Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.106 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 p -68.9 101.14 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.054 0.454 . . . . 0.0 111.126 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.5 129.99 23.54 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.527 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.413 ' HB3' ' HB2' ' A' ' 91' ' ' HIS . 33.7 Cg_endo -65.45 138.97 57.17 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.552 2.168 . . . . 0.0 112.22 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.46 178.16 19.81 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.02 99.13 4.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.862 0.363 . . . . 0.0 110.534 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -119.93 141.23 49.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.454 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -84.97 133.29 34.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.029 0.443 . . . . 0.0 109.994 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -126.11 157.75 37.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.809 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -84.73 128.05 34.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.619 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.1 t -78.25 99.37 2.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.114 0.483 . . . . 0.0 109.731 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -87.77 118.51 27.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.906 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.1 t -95.32 143.78 11.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.729 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.435 ' OE1' ' HD2' ' A' ' 71' ' ' PRO . 8.5 tp10 -70.32 113.89 21.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 174.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.435 ' HD2' ' OE1' ' A' ' 70' ' ' GLU . 11.7 Cg_endo -55.33 124.03 15.27 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.995 2.463 . . . . 0.0 112.646 -176.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -94.45 119.98 65.7 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.889 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.61 135.38 48.82 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.494 2.13 . . . . 0.0 112.537 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 t30 73.52 -33.96 0.27 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.771 0.828 . . . . 0.0 112.96 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.424 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 49.9 mm -84.16 136.4 22.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.048 0.451 . . . . 0.0 111.031 -177.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -97.6 121.12 39.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.446 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.519 ' HA ' HG22 ' A' ' 37' ' ' THR . 16.0 tt -90.75 125.38 43.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.408 0.623 . . . . 0.0 111.012 -176.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.521 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 38.3 t -100.62 -56.52 5.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.384 -175.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 71.7 mm-40 -109.65 139.35 44.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.092 -173.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.429 ' HA ' HG13 ' A' ' 35' ' ' VAL . 50.7 mt -129.13 97.57 3.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 5.7 m -127.21 112.74 21.53 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.211 -176.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 2.0 Cg_endo -85.14 171.6 43.39 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.763 -1.349 . . . . 0.0 112.37 0.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -110.85 -34.26 6.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.98 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.39 117.17 49.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.588 176.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.5 m -108.29 146.46 14.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.931 0.396 . . . . 0.0 110.871 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.5 m -97.97 109.01 21.84 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 84.9 mt -102.97 122.64 45.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.385 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -85.58 95.55 9.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.473 ' CD2' HG12 ' A' ' 26' ' ' ILE . 76.5 mt -90.43 128.68 36.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.517 -175.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -102.88 120.83 41.3 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.422 173.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 60' ' ' PRO . 27.5 t60 -72.42 110.41 6.81 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 173.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.447 ' NE2' ' HB2' ' A' ' 25' ' ' MET . 13.5 m-70 -48.91 116.75 1.76 Allowed 'General case' 0 CA--C 1.514 -0.404 0 O-C-N 123.886 0.741 . . . . 0.0 110.867 -176.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -73.14 -7.28 50.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.756 -172.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -76.14 -9.32 58.53 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 171.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -118.78 161.16 20.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.523 173.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.1 m170 . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.447 -0.787 . . . . 0.0 110.669 -178.273 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 N--CA 1.474 0.775 0 CA-C-O 121.107 0.479 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.9 m -105.07 -55.29 2.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.675 175.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -103.93 104.85 14.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.203 175.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.81 -59.44 0.16 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.625 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.625 HD12 ' HZ1' ' A' ' 36' ' ' LYS . 3.4 mm? -83.81 26.91 0.67 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -172.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -107.93 -29.11 9.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.078 0.466 . . . . 0.0 110.357 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.765 ' HG2' ' HH ' ' A' ' 40' ' ' TYR . 86.9 mtt180 -78.3 -10.69 59.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.317 0.579 . . . . 0.0 110.447 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -132.06 86.72 46.26 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-O 121.834 0.826 . . . . 0.0 109.116 171.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.76 162.66 32.37 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.547 2.831 . . . . 0.0 113.498 -170.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 14.6 m -118.62 123.57 45.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.972 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.492 ' HB2' HG23 ' A' ' 35' ' ' VAL . 98.1 mt -101.34 148.8 24.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.019 0.438 . . . . 0.0 110.631 -177.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.2 m -125.5 100.17 6.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.889 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.4 mt -101.16 156.43 17.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.357 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 t -88.53 137.35 32.4 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.858 HD12 HG12 ' A' ' 53' ' ' VAL . 42.6 tp -83.39 126.48 32.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.0 pt -108.32 143.0 19.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.113 0.482 . . . . 0.0 111.182 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.403 ' HB2' ' OG1' ' A' ' 20' ' ' THR . . . -77.07 105.21 8.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.838 176.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -99.06 127.73 45.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.13 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 61.87 23.75 14.02 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.404 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.527 ' OG1' HD13 ' A' ' 55' ' ' LEU . 25.7 m -74.51 124.04 89.51 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.452 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -81.2 171.45 13.88 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.711 2.274 . . . . 0.0 112.562 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.72 6.37 38.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.061 -177.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -92.85 -18.03 23.35 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.42 0.628 . . . . 0.0 110.107 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.2 p -119.2 121.37 39.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.716 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 52.8 ttp -102.79 131.0 49.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.337 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.5 mt -90.21 107.71 18.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 49.1 ttp -75.41 -33.27 60.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.055 0.455 . . . . 0.0 110.739 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.9 m -84.71 132.68 34.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.513 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -66.85 143.14 57.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 3.7 mm? -67.1 115.64 27.72 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.534 -178.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 3.0 Cg_exo -74.15 167.38 27.33 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.899 2.399 . . . . 0.0 112.666 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.4 m -94.7 129.12 41.74 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.784 175.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.0 m -86.28 143.54 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.121 0.486 . . . . 0.0 111.12 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.0 ttp85 -104.28 108.39 19.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.537 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.53 HG11 ' HA ' ' A' ' 80' ' ' ILE . 13.4 m -119.56 112.97 39.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.185 0.517 . . . . 0.0 110.227 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.625 ' HZ1' HD12 ' A' ' 5' ' ' LEU . 78.0 tttt -87.73 142.02 28.15 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.465 ' HB ' HG22 ' A' ' 75' ' ' ILE . 47.9 p -130.62 179.61 5.85 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.817 -172.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.62 ' HB2' ' HB2' ' A' ' 76' ' ' LYS . 55.7 mt-10 -132.74 130.3 39.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 175.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.54 -144.05 14.96 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.765 ' HH ' ' HG2' ' A' ' 7' ' ' ARG . 60.8 m-85 -136.13 158.6 44.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.781 0.324 . . . . 0.0 110.704 178.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -112.31 93.0 20.57 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.653 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.558 ' HD2' HG12 ' A' ' 44' ' ' ILE . 57.8 Cg_endo -79.76 -76.7 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.181 1.921 . . . . 0.0 112.846 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.1 p -107.76 24.22 13.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.402 0.62 . . . . 0.0 110.154 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.74 HG13 HD13 ' A' ' 75' ' ' ILE . 46.4 mm -79.79 112.08 17.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.396 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -91.64 108.62 20.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.28 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.58 -21.85 29.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.583 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -78.2 -13.24 59.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.642 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -105.9 -24.73 12.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.81 -175.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.2 mt -92.58 139.45 30.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.072 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -136.04 176.68 8.46 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.76 0.79 . . . . 0.0 112.145 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -122.6 133.97 54.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.375 172.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -121.75 141.41 51.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.13 0.491 . . . . 0.0 111.903 -173.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.858 HG12 HD12 ' A' ' 15' ' ' LEU . 6.8 m -114.38 119.7 62.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.19 174.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -74.55 100.69 3.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.479 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.527 HD13 ' OG1' ' A' ' 20' ' ' THR . 38.2 mt -89.96 36.18 0.86 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.935 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 p -61.49 -38.93 89.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.542 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.63 69.15 2.64 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 172.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 m -73.28 84.13 1.4 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.076 0.465 . . . . 0.0 111.847 -173.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -108.52 117.71 53.75 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.497 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.74 100.85 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.895 2.396 . . . . 0.0 112.166 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 159.02 177.33 32.0 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.859 ' HG2' ' HG2' ' A' ' 88' ' ' GLN . 41.2 mt-10 -74.66 99.64 3.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.104 0.452 . . . . 0.0 110.35 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -125.01 144.35 50.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.562 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.512 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 9.4 m-20 -89.23 115.06 26.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.713 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.443 ' HH ' HD13 ' A' ' 89' ' ' LEU . 92.5 m-85 -111.49 164.81 12.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.883 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -89.92 131.51 35.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.296 -176.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.0 t -90.0 123.14 42.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.101 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -111.72 110.66 21.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.068 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.418 HG21 HG12 ' A' ' 35' ' ' VAL . 42.1 t -90.44 142.3 13.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.013 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 46.5 mt-10 -68.75 117.24 49.02 Favored Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.627 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 11.4 Cg_exo -70.93 136.0 28.93 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.874 2.382 . . . . 0.0 111.862 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.451 ' C ' ' H ' ' A' ' 74' ' ' ASN . 4.3 mp -100.44 117.55 62.73 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.12 25.29 0.46 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.576 2.184 . . . . 0.0 112.396 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.451 ' H ' ' C ' ' A' ' 72' ' ' ILE . 88.1 m-20 -133.95 -8.91 2.71 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.503 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.74 HD13 HG13 ' A' ' 44' ' ' ILE . 26.5 mt -141.01 143.56 28.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.171 -172.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.62 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 43.5 mtpt -81.16 167.38 19.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.8 tt -129.6 135.84 60.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.079 0.466 . . . . 0.0 110.701 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.3 t -115.63 -53.97 4.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.412 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.06 142.55 50.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.216 -174.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.58 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 57.6 mt -123.67 94.22 2.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 169.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 36.6 m -115.49 112.04 43.71 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.53 -174.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.477 ' HG2' HG12 ' A' ' 85' ' ' VAL . 7.1 Cg_endo -93.24 165.03 22.8 Favored 'Cis proline' 0 CA--C 1.531 0.335 0 C-N-CA 124.831 -0.904 . . . . 0.0 112.393 -5.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.58 ' HG3' ' O ' ' A' ' 80' ' ' ILE . 39.6 mtm180 -92.25 -36.85 13.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.378 0.609 . . . . 0.0 109.833 176.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.512 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 62.1 t -117.52 121.44 67.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.626 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.477 HG12 ' HG2' ' A' ' 82' ' ' PRO . 13.9 m -116.1 133.2 63.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.181 0.515 . . . . 0.0 111.817 -177.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.7 m -83.54 95.9 8.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.682 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 90.4 mt -90.41 124.08 34.66 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.884 0.373 . . . . 0.0 110.385 -178.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.859 ' HG2' ' HG2' ' A' ' 62' ' ' GLU . 94.5 mt-30 -85.6 92.99 8.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.55 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.443 HD13 ' HH ' ' A' ' 65' ' ' TYR . 85.5 mt -92.37 157.63 16.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.497 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.69 163.63 32.3 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 178.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -67.4 132.17 47.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.348 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -76.84 -26.21 54.04 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 172.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -98.68 118.59 35.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.32 174.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -115.83 118.72 33.77 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.993 0.425 . . . . 0.0 111.054 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -84.46 54.76 3.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.184 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.6 m80 . . . . . 0 C--O 1.244 0.798 0 CA-C-O 118.662 -0.685 . . . . 0.0 109.743 177.905 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.476 0.84 0 CA-C-O 120.83 0.348 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -76.05 133.21 40.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.937 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -62.2 -40.25 95.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.0 110.267 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.4 m -108.27 107.98 18.8 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 172.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 25.9 tp -95.96 147.49 23.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.496 -174.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.77 -4.93 51.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.42 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 66.3 mtt180 -70.69 -76.0 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.812 0.339 . . . . 0.0 110.663 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.89 116.74 49.3 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.1 -176.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -75.84 118.31 5.01 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.795 2.33 . . . . 0.0 111.689 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.7 m -87.94 92.31 9.08 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.692 HD13 ' HB ' ' A' ' 46' ' ' VAL . 41.1 tp -84.06 123.06 29.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.312 -171.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.1 m -103.32 118.1 35.99 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.935 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.2 mt -120.18 141.54 49.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.237 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.0 t -74.89 135.25 41.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.26 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.601 HD12 HG12 ' A' ' 53' ' ' VAL . 50.0 tp -79.75 131.82 36.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.5 pt -128.08 148.35 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.261 0.553 . . . . 0.0 111.264 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.517 ' HB3' ' OG1' ' A' ' 20' ' ' THR . . . -85.83 108.69 18.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.443 175.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 22.9 tptm -97.41 -66.81 0.88 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.189 0.518 . . . . 0.0 110.712 -174.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.832 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 6.3 m-20 -84.0 57.42 4.16 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.887 -177.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.517 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 34.5 m -114.66 124.22 30.89 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.699 -174.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 16.5 Cg_exo -68.21 146.76 70.88 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.963 2.442 . . . . 0.0 111.516 174.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.63 -13.87 60.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.775 0.321 . . . . 0.0 111.821 -175.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -89.35 2.47 54.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.101 0.477 . . . . 0.0 110.662 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 p -125.97 122.9 37.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.158 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 42.4 ttp -113.87 126.86 55.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.653 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.8 mt -77.65 132.12 33.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.389 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.433 ' SD ' ' HB2' ' A' ' 90' ' ' GLU . 74.6 mtm -93.68 -26.11 17.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.149 0.5 . . . . 0.0 110.496 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.8 p -83.78 118.44 23.92 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.78 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.29 142.97 56.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.907 0.385 . . . . 0.0 110.244 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 85.4 mt -86.32 119.1 71.34 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.151 -171.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 3.0 Cg_exo -74.35 175.72 10.6 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.846 2.364 . . . . 0.0 112.484 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.2 m -98.23 128.4 44.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.76 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -85.83 129.53 37.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -112.41 108.84 18.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.074 0.464 . . . . 0.0 109.861 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.526 HG13 ' HA ' ' A' ' 80' ' ' ILE . 34.7 m -109.79 143.84 19.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.091 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -99.46 121.45 41.16 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.9 p -106.0 159.15 16.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.779 0.323 . . . . 0.0 111.589 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.669 ' HB3' ' HB2' ' A' ' 76' ' ' LYS . 32.6 tt0 -112.69 109.6 19.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.493 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.42 -144.25 14.98 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.898 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.423 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 40.9 t80 -155.13 116.05 3.93 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.89 105.54 15.35 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.929 179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 5.3 Cg_exo -77.85 -66.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.15 2.567 . . . . 0.0 112.986 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 t -125.63 39.36 3.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.322 0.582 . . . . 0.0 110.457 -175.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.8 mt -91.83 130.3 41.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.704 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.529 ' HB3' ' HG2' ' A' ' 48' ' ' GLU . 17.5 m120 -75.26 89.41 2.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.315 0.578 . . . . 0.0 111.096 -176.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.692 ' HB ' HD13 ' A' ' 11' ' ' LEU . 33.6 m -70.65 -13.94 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.178 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -87.6 -18.28 30.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.911 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.529 ' HG2' ' HB3' ' A' ' 45' ' ' ASN . 16.1 mm-40 -96.2 -20.83 18.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.387 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 99.0 mt -82.01 132.4 35.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.697 174.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -129.31 168.5 16.15 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.358 0.599 . . . . 0.0 111.506 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.461 ' O ' HD11 ' A' ' 15' ' ' LEU . . . -108.89 117.3 33.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.376 170.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 25.5 p90 -114.84 152.21 32.58 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.138 0.494 . . . . 0.0 111.666 -173.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.601 HG12 HD12 ' A' ' 15' ' ' LEU . 21.2 m -115.64 144.69 22.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.128 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.832 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 4.5 t70 -98.21 109.07 21.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.061 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.455 HD12 HG21 ' A' ' 20' ' ' THR . 53.0 mt -101.57 68.7 1.19 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.348 0.594 . . . . 0.0 109.946 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.1 p -82.64 -1.2 50.36 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.74 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.22 112.8 4.34 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.7 p -84.45 16.15 3.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.869 0.366 . . . . 0.0 111.768 -177.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -85.86 119.55 72.0 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.529 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.532 ' HA ' ' HB2' ' A' ' 89' ' ' LEU . 11.6 Cg_exo -70.91 -174.56 1.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.906 2.404 . . . . 0.0 112.329 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 88' ' ' GLN . . . 97.89 -137.6 13.39 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.691 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -125.96 113.86 17.72 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.781 0.324 . . . . 0.0 110.133 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -130.45 155.07 47.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.824 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -100.12 130.21 46.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.441 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -128.44 158.03 39.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.93 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.86 141.49 28.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.041 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.425 HG11 HD13 ' A' ' 15' ' ' LEU . 59.0 t -86.37 107.8 17.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.631 174.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.444 ' HD3' ' CE2' ' A' ' 52' ' ' TYR . 57.9 tttm -99.1 103.17 15.06 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.09 0.472 . . . . 0.0 110.264 -178.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.95 130.38 36.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.632 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.419 ' HG3' ' HD2' ' A' ' 71' ' ' PRO . 27.5 tt0 -68.57 128.33 93.02 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.419 ' HD2' ' HG3' ' A' ' 70' ' ' GLU . 12.1 Cg_endo -55.19 131.64 47.53 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.185 2.59 . . . . 0.0 113.158 -175.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.498 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.2 mp -81.5 125.9 77.47 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.062 177.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.85 109.86 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.291 2.66 . . . . 0.0 113.671 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.6 t30 71.9 2.82 4.45 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.721 173.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.469 ' HB ' ' HB ' ' A' ' 72' ' ' ILE . 48.9 mm -102.29 135.31 39.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 O-C-N 121.928 -0.482 . . . . 0.0 110.387 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.669 ' HB2' ' HB3' ' A' ' 38' ' ' GLU . 72.8 mttt -87.39 148.76 24.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.62 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.473 HD11 HG12 ' A' ' 80' ' ' ILE . 21.4 tt -110.21 128.19 66.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.293 0.568 . . . . 0.0 110.105 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.606 HG11 ' HG3' ' A' ' 79' ' ' GLU . 42.6 t -95.42 -63.84 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.988 -175.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.606 ' HG3' HG11 ' A' ' 78' ' ' VAL . 43.0 mt-10 -123.81 127.36 47.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.743 -175.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.526 ' HA ' HG13 ' A' ' 35' ' ' VAL . 26.3 mt -105.78 127.75 60.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 15.6 m -150.5 115.12 3.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.842 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 88.6 Cg_endo -85.87 177.21 26.36 Favored 'Cis proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.502 -1.458 . . . . 0.0 112.682 -0.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.445 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 84.8 mtm180 -119.97 -28.96 5.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.838 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.98 117.16 48.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.5 m -110.75 135.86 48.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.251 0.548 . . . . 0.0 111.254 -178.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.9 m -88.93 112.24 23.07 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.604 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 90.0 mt -111.55 145.67 38.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 -174.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 93.0 mt-30 -113.09 129.71 56.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.12 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 60' ' ' PRO . 82.8 mt -113.86 136.78 52.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.036 0.446 . . . . 0.0 111.616 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.433 ' HB2' ' SD ' ' A' ' 27' ' ' MET . 43.2 tt0 -119.21 162.96 17.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.163 176.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -80.35 151.3 29.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.538 0.685 . . . . 0.0 112.198 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -143.35 95.27 2.73 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.661 172.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -78.09 -54.93 5.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.924 0.393 . . . . 0.0 110.041 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -166.93 -64.8 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -86.41 -55.34 3.94 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.5 m80 . . . . . 0 C--O 1.248 0.976 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.792 173.038 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.9 m . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 120.693 0.282 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.4 m -120.04 169.27 10.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 175.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.8 tp60 59.97 32.03 20.94 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.609 0.719 . . . . 0.0 109.453 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 m -63.98 132.02 49.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.4 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.0 tp -86.82 133.85 33.6 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 174.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -93.72 135.77 34.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.232 0.539 . . . . 0.0 111.781 -176.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -127.59 -179.96 5.19 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.71 172.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.59 ' HB3' ' HE2' ' A' ' 36' ' ' LYS . 11.9 m-20 52.61 72.19 1.25 Allowed Pre-proline 0 N--CA 1.466 0.368 0 O-C-N 123.523 0.515 . . . . 0.0 111.255 176.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.71 124.47 10.26 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.13 1.887 . . . . 0.0 112.623 -178.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.0 m -101.37 103.69 14.65 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.2 mt -83.1 122.46 28.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.268 0.556 . . . . 0.0 110.715 -173.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.4 m -99.22 106.45 18.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.138 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.8 mt -107.94 -174.67 2.58 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.628 -177.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -114.79 145.37 42.19 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.535 HD12 HG13 ' A' ' 53' ' ' VAL . 45.6 tp -87.44 130.15 34.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.8 pt -128.0 144.8 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.22 0.534 . . . . 0.0 111.763 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.482 ' HB2' ' OG1' ' A' ' 20' ' ' THR . . . -81.29 102.82 10.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.233 173.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.418 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 59.6 tttm -91.65 -71.57 0.63 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.937 0.399 . . . . 0.0 110.874 -173.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.418 ' OD1' ' HG2' ' A' ' 18' ' ' LYS . 5.2 m-20 -94.27 67.09 3.5 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.623 0.725 . . . . 0.0 109.86 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.549 ' HG1' HD12 ' A' ' 55' ' ' LEU . 88.1 m -105.79 116.71 59.4 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.287 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 16.9 Cg_exo -67.87 156.39 66.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.168 2.578 . . . . 0.0 112.599 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.96 151.69 45.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.38 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 73.29 9.35 5.19 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.793 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.2 p -103.63 137.48 41.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 171.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.753 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 52.1 ttp -128.87 119.25 24.1 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.811 0.338 . . . . 0.0 110.405 -174.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.5 mt -85.31 124.75 40.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.448 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.537 ' HB2' ' HB2' ' A' ' 88' ' ' GLN . 86.1 mtp -85.36 -31.9 22.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.388 178.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 p -78.27 118.32 20.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.794 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.68 141.01 53.65 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.84 118.44 70.33 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.415 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -89.8 176.96 2.72 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.893 2.395 . . . . 0.0 112.741 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -83.06 135.28 34.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.147 176.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.528 HG11 ' HB1' ' A' ' 51' ' ' ALA . 9.5 p -104.03 152.99 6.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -128.54 134.27 48.61 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.957 0.408 . . . . 0.0 110.838 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 16.3 m -124.33 129.1 74.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.352 175.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.59 ' HE2' ' HB3' ' A' ' 8' ' ' ASP . 13.1 tmtt? -86.16 127.36 34.7 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.526 HG23 ' HA ' ' A' ' 77' ' ' ILE . 33.0 p -128.68 168.15 16.2 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -171.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 76' ' ' LYS . 40.3 mm-40 -114.21 127.32 55.84 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.38 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.97 -161.89 15.94 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.578 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -128.35 128.53 44.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.725 0.298 . . . . 0.0 110.27 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.418 ' HB3' HD13 ' A' ' 44' ' ' ILE . 3.0 p30 -122.41 77.34 44.92 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.261 0.553 . . . . 0.0 111.267 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.12 -47.04 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.649 2.233 . . . . 0.0 111.796 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 m -129.33 80.21 1.95 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.195 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.418 HD13 ' HB3' ' A' ' 41' ' ' ASN . 44.7 mt -134.64 157.5 41.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -73.85 55.59 0.54 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.457 0.646 . . . . 0.0 111.504 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.8 t -66.39 -26.27 37.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.76 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -89.9 5.08 47.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.152 0.501 . . . . 0.0 110.906 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -107.12 -24.29 12.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.506 0.669 . . . . 0.0 109.22 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.604 HD11 HG12 ' A' ' 72' ' ' ILE . 63.5 mt -88.11 132.67 34.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.66 177.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -143.51 178.03 8.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.934 0.397 . . . . 0.0 110.812 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.528 ' HB1' HG11 ' A' ' 33' ' ' VAL . . . -105.85 119.88 40.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.956 172.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -115.18 148.91 38.47 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.087 0.47 . . . . 0.0 110.946 -174.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.535 HG13 HD12 ' A' ' 15' ' ' LEU . 18.3 m -112.85 133.42 58.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.951 174.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -104.8 105.53 15.63 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.822 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.549 HD12 ' HG1' ' A' ' 20' ' ' THR . 61.6 mt -92.41 90.09 7.07 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.043 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.5 p -75.05 1.91 11.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.541 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.06 132.62 2.87 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.707 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 m -80.44 76.75 7.26 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 89' ' ' LEU . 30.9 mt-10 -91.36 108.91 32.3 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.53 -176.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.449 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 11.8 Cg_exo -69.07 131.29 21.88 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.761 2.307 . . . . 0.0 112.204 -176.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.91 174.15 17.59 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 1.008 ' HG2' ' HG2' ' A' ' 88' ' ' GLN . 33.2 mt-10 -76.78 106.42 8.43 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -118.62 156.03 29.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.149 0.5 . . . . 0.0 111.269 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -90.47 116.05 28.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.161 -176.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -127.15 157.42 39.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.052 0.453 . . . . 0.0 111.727 -176.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -89.33 144.5 26.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.692 -173.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.07 114.05 35.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.658 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -108.01 125.32 51.4 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.8 t -102.41 136.29 35.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.557 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -54.83 122.35 40.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.187 174.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.17 116.49 2.98 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.699 2.266 . . . . 0.0 111.973 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.604 HG12 HD11 ' A' ' 49' ' ' LEU . 55.8 mt -81.47 121.71 80.21 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.982 -175.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.59 143.09 37.43 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.463 2.108 . . . . 0.0 111.747 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 t30 75.17 -44.47 0.54 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.362 0.665 . . . . 0.0 111.901 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.52 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 48.9 mm -91.58 136.93 23.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.0 -176.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.6 ' HB3' ' HB2' ' A' ' 38' ' ' GLU . 74.7 tttt -85.17 135.13 34.09 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.526 ' HA ' HG23 ' A' ' 37' ' ' THR . 15.1 tt -96.03 133.69 36.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.953 0.406 . . . . 0.0 109.996 176.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -110.86 -57.97 3.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.339 0.59 . . . . 0.0 111.386 -176.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 38.6 tt0 -126.07 124.81 41.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.403 -170.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.55 ' HB ' ' HG2' ' A' ' 83' ' ' ARG . 61.0 mt -99.22 113.5 34.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 25.2 p -127.22 110.49 21.44 Favored Pre-proline 0 C--N 1.318 -0.782 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.035 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 98.1 Cg_endo -88.43 162.76 42.52 Favored 'Cis proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.77 -1.346 . . . . 0.0 112.716 -1.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.55 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 63.2 mtm180 -87.56 -25.47 23.61 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.947 0.404 . . . . 0.0 110.345 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.7 t -136.2 135.66 49.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.505 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 m -122.52 151.27 26.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.071 0.462 . . . . 0.0 110.963 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.8 m -101.28 107.28 18.61 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.579 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.4 mt -101.62 137.42 39.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.167 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 1.008 ' HG2' ' HG2' ' A' ' 62' ' ' GLU . 79.9 mt-30 -99.71 109.0 21.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.576 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 70.8 mt -104.62 142.85 33.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.088 0.47 . . . . 0.0 111.673 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.539 ' HG2' ' H ' ' A' ' 91' ' ' HIS . 27.0 tt0 -136.04 176.1 9.0 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 172.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.539 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 86.3 m-70 -99.72 118.83 37.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.753 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 63.8 t60 -72.63 115.2 11.62 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -83.5 148.52 27.18 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -74.49 -25.74 59.56 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -138.78 121.78 16.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.493 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 82.4 t60 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.542 -177.571 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.6 ' HB2' ' HD1' ' A' ' 40' ' ' TYR . 15.7 m . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 120.956 0.408 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.6 p -101.26 -158.77 0.69 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.912 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -62.92 -13.75 38.39 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.755 0.422 . . . . 0.0 112.02 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.3 p -68.74 -11.17 59.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.268 0.556 . . . . 0.0 110.921 176.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 49.0 tp -127.92 163.5 24.34 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -72.86 147.39 45.45 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.406 ' HG3' ' OH ' ' A' ' 40' ' ' TYR . 43.3 ttp180 -63.03 -37.33 86.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.767 0.794 . . . . 0.0 109.352 176.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -127.36 90.29 49.19 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.027 171.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -85.52 166.18 10.55 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.436 2.757 . . . . 0.0 113.34 -173.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 20.1 m -100.84 137.33 39.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.502 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.1 mt -107.45 137.89 44.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.072 0.463 . . . . 0.0 110.597 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -107.79 114.12 27.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.866 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.86 165.58 14.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.128 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.3 m -100.8 142.97 31.52 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.589 HD12 HG13 ' A' ' 53' ' ' VAL . 30.7 tp -91.44 128.22 37.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.159 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.7 pt -115.09 160.75 14.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.969 0.414 . . . . 0.0 111.43 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.538 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -92.64 100.08 12.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.445 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -101.61 135.41 43.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.149 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 66.5 t30 62.28 16.51 8.53 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.536 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.538 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 91.7 m -60.74 119.68 46.34 Favored Pre-proline 0 N--CA 1.447 -0.595 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.777 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.647 ' HG2' ' HA ' ' A' ' 58' ' ' SER . 51.7 Cg_exo -55.02 162.49 5.24 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.869 3.046 . . . . 0.0 113.456 -173.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.76 149.08 32.75 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.156 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 65.13 37.32 6.71 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.617 0.573 . . . . 0.0 111.297 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.0 p -123.36 160.04 27.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.796 0.332 . . . . 0.0 110.559 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.0 ttp -144.86 129.12 17.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.401 HG12 ' CD2' ' A' ' 89' ' ' LEU . 19.1 mt -95.44 109.88 23.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 83.9 mtp -71.63 -27.96 63.46 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 110.527 179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.8 m -77.95 123.99 27.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.719 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -71.79 130.54 41.35 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.531 -176.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.07 113.57 17.38 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.093 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.425 ' HD2' HD22 ' A' ' 15' ' ' LEU . 92.2 Cg_endo -85.15 -175.93 2.19 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.84 2.36 . . . . 0.0 112.79 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.4 m -105.76 126.31 52.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.356 174.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.509 HG13 ' HD2' ' A' ' 82' ' ' PRO . 13.4 m -85.91 148.24 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.474 -175.055 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -127.57 97.52 4.89 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' A' ' 80' ' ' ILE . 30.7 m -105.32 132.64 51.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.381 -176.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 71.2 tttt -81.46 136.13 35.64 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.526 HG23 ' HA ' ' A' ' 77' ' ' ILE . 22.4 p -125.9 162.69 24.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.316 -177.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.24 112.93 18.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.87 178.91 24.33 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.61 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.6 ' HD1' ' HB2' ' A' ' 1' ' ' SER . 88.3 m-85 -118.41 144.18 46.13 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -128.96 92.51 39.57 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 121.328 0.585 . . . . 0.0 111.756 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.09 -45.46 15.88 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.788 2.325 . . . . 0.0 111.096 174.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.7 m -117.63 -115.58 0.33 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.552 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.1 mt 56.52 99.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 111.795 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -73.21 100.96 3.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.698 0.761 . . . . 0.0 111.289 -177.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.0 t -64.2 -22.41 31.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.756 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -80.3 -11.61 59.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.87 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -98.13 -21.66 16.63 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 90.8 mt -70.03 132.35 45.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.887 174.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -130.47 152.97 49.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.281 0.562 . . . . 0.0 111.848 -177.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -115.45 141.28 48.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 170.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.435 ' CE1' ' HB2' ' A' ' 68' ' ' LYS . 47.0 p90 -133.24 161.31 34.82 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.028 -175.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.589 HG13 HD12 ' A' ' 15' ' ' LEU . 6.7 m -112.35 117.98 56.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -86.38 102.59 14.16 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.44 ' HB2' ' HA ' ' A' ' 20' ' ' THR . 43.5 mt -88.45 76.41 8.26 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.151 -175.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.8 m -84.09 9.69 11.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.565 0.698 . . . . 0.0 109.754 173.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.39 107.06 1.88 Allowed Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.162 175.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.647 ' HA ' ' HG2' ' A' ' 21' ' ' PRO . 16.1 m -85.7 9.5 16.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.223 0.535 . . . . 0.0 110.69 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.88 121.13 83.06 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.54 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.71 175.84 10.78 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.663 2.242 . . . . 0.0 112.304 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.81 -158.99 19.11 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -176.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -100.12 107.76 19.73 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -132.74 144.41 50.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.138 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 4.4 p30 -94.15 141.29 28.72 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.197 0.523 . . . . 0.0 110.787 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -133.69 164.23 27.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.06 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -93.3 140.27 29.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.246 -172.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 98.6 t -79.88 108.71 13.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 172.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.435 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 40.6 mtpt -108.77 114.06 27.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.711 -176.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.6 139.97 17.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.24 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.26 132.44 94.43 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.48 113.66 1.56 Allowed 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.966 2.444 . . . . 0.0 112.574 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.471 HD11 ' H ' ' A' ' 72' ' ' ILE . 4.4 mp -83.29 122.31 77.23 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.018 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 75' ' ' ILE . 54.0 Cg_endo -70.79 143.62 46.38 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.361 2.041 . . . . 0.0 111.716 176.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.4 t30 73.79 -23.38 0.22 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.097 0.559 . . . . 0.0 112.203 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.427 ' H ' ' C ' ' A' ' 73' ' ' PRO . 48.2 mm -108.38 125.66 65.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.758 0.313 . . . . 0.0 110.877 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -88.16 125.97 34.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.115 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.526 ' HA ' HG23 ' A' ' 37' ' ' THR . 16.6 tt -80.06 135.88 24.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.5 t -104.49 -64.91 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.263 0.554 . . . . 0.0 110.907 -178.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -122.5 137.71 54.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.434 -172.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.478 ' HA ' HG13 ' A' ' 35' ' ' VAL . 61.0 mt -103.06 109.44 26.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.675 176.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.447 ' HA ' ' C ' ' A' ' 82' ' ' PRO . 18.2 p -141.87 124.46 9.34 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.457 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.509 ' HD2' HG13 ' A' ' 33' ' ' VAL . 43.0 Cg_endo -67.72 160.36 81.16 Favored 'Cis proline' 0 C--N 1.344 0.315 0 C-N-CA 123.386 -1.506 . . . . 0.0 113.204 0.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -86.36 -70.21 0.62 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.538 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.441 HG11 ' HB2' ' A' ' 64' ' ' ASP . 62.6 t -121.48 129.34 75.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.374 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.3 m -110.21 134.93 50.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.972 0.415 . . . . 0.0 110.879 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 24.0 m -92.92 111.39 22.99 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.079 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.2 mt -106.12 138.88 41.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.155 0.502 . . . . 0.0 111.365 -173.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -94.77 109.83 21.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.066 174.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.401 ' CD2' HG12 ' A' ' 26' ' ' ILE . 80.0 mt -100.79 130.0 46.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.239 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -119.14 178.5 4.49 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.414 171.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -97.96 151.86 19.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.48 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -67.04 -31.26 71.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.989 0.423 . . . . 0.0 110.147 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -89.24 82.11 6.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.577 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -167.78 152.94 6.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.742 0.306 . . . . 0.0 110.268 177.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -125.04 122.63 37.79 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 173.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 . . . . . 0 C--O 1.246 0.885 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.51 176.876 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 120.677 0.275 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 p -159.07 -171.01 3.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.939 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -61.61 -56.38 20.48 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.6 m -95.19 124.48 39.26 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.8 mt -74.33 163.3 27.97 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.131 0.491 . . . . 0.0 110.994 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -78.96 2.6 19.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.657 -174.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.06 14.37 18.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.139 -176.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.574 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 9.1 m-20 -124.28 79.69 59.87 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.057 175.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -75.26 129.69 12.34 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.673 2.249 . . . . 0.0 112.553 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 43.1 m -102.33 109.68 21.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.672 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.538 HD23 ' ND2' ' A' ' 41' ' ' ASN . 83.7 mt -92.48 147.11 23.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.258 0.551 . . . . 0.0 111.528 -172.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.9 m -121.62 97.59 5.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.427 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 56.2 mt -99.17 162.9 12.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.319 -175.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.6 p -100.68 148.67 24.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.705 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.783 HD13 HG13 ' A' ' 53' ' ' VAL . 34.1 tp -94.34 125.03 38.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.189 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.6 pt -112.04 151.9 13.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.318 0.58 . . . . 0.0 111.768 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.62 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -83.69 102.19 12.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.116 176.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 86.4 tttt -83.34 115.24 21.92 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.312 -178.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 73.89 -68.27 0.23 Allowed 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.198 0.999 . . . . 0.0 109.668 -177.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.62 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 47.7 m 48.13 97.76 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.404 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.96 -172.16 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.776 2.984 . . . . 0.0 115.151 -169.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.74 105.82 0.16 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.422 -1.263 . . . . 0.0 113.598 -172.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.48 22.13 13.08 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.003 168.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.0 p -84.64 102.72 13.15 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 170.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.9 ttp -103.08 126.5 50.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.633 -172.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.446 HG12 ' CD2' ' A' ' 89' ' ' LEU . 5.8 mt -84.81 110.59 19.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.957 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 58.1 ttp -73.18 -32.11 64.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.9 m -69.3 131.68 45.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.169 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -75.65 119.84 20.23 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -56.96 114.35 7.86 Favored Pre-proline 0 C--N 1.328 -0.35 0 O-C-N 123.488 0.493 . . . . 0.0 110.064 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.27 -172.56 1.4 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.89 2.394 . . . . 0.0 112.792 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.8 p -99.1 149.54 22.93 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.821 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 13' ' ' LEU . 35.6 m -108.17 129.29 62.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.149 0.5 . . . . 0.0 109.804 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -106.88 110.35 22.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.218 0.533 . . . . 0.0 109.88 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.519 HG11 ' HA ' ' A' ' 80' ' ' ILE . 27.2 m -120.45 137.46 54.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.527 -176.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.574 ' HE3' ' HB3' ' A' ' 8' ' ' ASP . 83.3 tttt -93.19 136.24 33.64 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.502 HG23 ' HA ' ' A' ' 77' ' ' ILE . 22.5 p -124.56 168.42 13.13 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.278 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.443 ' HG3' ' CG2' ' A' ' 78' ' ' VAL . 42.1 mt-10 -122.5 123.13 40.55 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 176.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.0 -148.63 20.44 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.778 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.498 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 73.1 m-85 -129.57 129.07 43.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.804 0.335 . . . . 0.0 110.384 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.538 ' ND2' HD23 ' A' ' 11' ' ' LEU . 1.6 m-20 -116.71 77.98 8.67 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.629 -176.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.498 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 3.0 Cg_endo -86.63 -62.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.635 2.223 . . . . 0.0 112.2 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.0 p -91.5 -8.99 46.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.597 -177.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.21 116.11 33.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -111.63 150.34 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.58 -171.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.409 ' HB ' HD21 ' A' ' 13' ' ' LEU . 31.4 m -76.12 -5.34 7.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.964 178.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -85.31 -8.45 58.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.935 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -114.58 -29.15 6.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.737 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.411 ' HB2' HD22 ' A' ' 13' ' ' LEU . 79.0 mt -84.54 134.34 34.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -130.61 160.63 33.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.468 0.652 . . . . 0.0 111.828 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -117.42 133.95 55.39 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 170.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.408 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 48.7 p90 -122.04 152.01 40.24 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.018 -174.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.783 HG13 HD13 ' A' ' 15' ' ' LEU . 6.4 m -112.24 125.9 69.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.785 172.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -86.61 99.98 12.1 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.473 HD12 ' OG1' ' A' ' 20' ' ' THR . 64.6 mt -92.16 21.11 5.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.602 -173.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.5 p -60.37 115.9 3.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.153 0.501 . . . . 0.0 110.093 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.452 ' C ' ' HG ' ' A' ' 58' ' ' SER . . . 145.8 -28.5 1.74 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.594 -175.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.452 ' HG ' ' C ' ' A' ' 57' ' ' GLY . 51.9 p 49.98 38.29 16.04 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.438 0.695 . . . . 0.0 111.897 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -84.84 115.02 59.06 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.953 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.3 150.21 28.63 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.825 2.35 . . . . 0.0 112.092 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.82 -174.43 21.64 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.745 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -80.26 105.75 11.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.753 0.311 . . . . 0.0 110.27 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -125.18 151.68 45.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.523 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -91.98 123.11 35.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.519 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.495 ' HH ' HD13 ' A' ' 89' ' ' LEU . 98.1 m-85 -121.62 139.33 53.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.231 178.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.49 136.82 51.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.237 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 64.2 t -83.26 106.08 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -103.6 104.99 15.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.118 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.9 t -90.91 140.18 16.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.334 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 36.3 mt-10 -66.64 128.14 93.72 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.33 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 25.3 Cg_exo -62.58 115.88 3.18 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.829 2.352 . . . . 0.0 111.92 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.501 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.3 mp -81.33 122.62 81.33 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.073 -173.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.86 135.94 34.04 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.791 2.327 . . . . 0.0 112.221 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.4 m120 71.5 6.79 5.84 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.387 176.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.1 mt -135.9 131.23 49.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.823 0.344 . . . . 0.0 110.612 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -84.79 129.56 34.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.396 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.502 ' HA ' HG23 ' A' ' 37' ' ' THR . 17.7 tt -92.72 134.35 30.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.443 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 35.4 t -108.18 -60.46 2.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.904 0.383 . . . . 0.0 111.459 -174.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.408 ' HG3' HG13 ' A' ' 78' ' ' VAL . 41.8 mt-10 -118.58 128.44 54.56 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 -171.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.519 ' HA ' HG11 ' A' ' 35' ' ' VAL . 62.4 mt -111.92 109.47 28.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.273 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.8 p -139.75 126.96 12.7 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.601 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -80.63 159.78 84.8 Favored 'Cis proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.452 -1.479 . . . . 0.0 112.535 -0.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -80.34 -50.32 10.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.291 0.567 . . . . 0.0 110.527 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.1 t -131.11 137.1 56.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.377 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.5 m -117.77 134.11 62.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.159 0.504 . . . . 0.0 111.172 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.3 m -85.04 105.82 16.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.598 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.8 mt -104.89 130.49 53.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.271 -177.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -94.23 106.12 18.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.076 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.495 HD13 ' HH ' ' A' ' 65' ' ' TYR . 90.1 mt -91.96 126.82 37.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.59 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -118.55 150.33 39.82 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.377 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -77.43 137.93 38.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.954 0.407 . . . . 0.0 111.257 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -69.67 -20.89 63.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.012 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -92.68 86.65 5.62 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 170.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -71.09 101.44 2.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.09 0.471 . . . . 0.0 109.751 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -94.24 165.92 12.36 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.232 -175.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 66.1 m80 . . . . . 0 C--O 1.248 0.998 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.591 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.475 0.825 0 CA-C-O 120.765 0.317 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 m -147.55 102.45 3.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.849 0.357 . . . . 0.0 111.388 -175.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -91.82 122.47 34.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.957 0.408 . . . . 0.0 110.03 175.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.2 p -102.39 0.43 33.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.356 -177.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -87.7 -9.32 54.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -110.19 145.32 37.47 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.414 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 34.0 mmt180 -83.87 -19.97 33.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.721 0.296 . . . . 0.0 110.937 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -163.34 97.93 1.02 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.437 0.637 . . . . 0.0 110.188 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.19 161.97 11.45 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.627 2.218 . . . . 0.0 113.01 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.1 m -93.96 105.65 17.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.784 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.523 HD13 ' HB ' ' A' ' 46' ' ' VAL . 54.3 tp -83.2 139.02 33.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.632 -176.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.7 m -116.77 115.36 25.44 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.787 0.327 . . . . 0.0 110.561 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.6 mt -114.52 141.73 47.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.164 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.6 m -75.05 142.31 43.76 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.711 0.291 . . . . 0.0 110.472 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.79 HD11 HG11 ' A' ' 53' ' ' VAL . 38.6 tp -89.1 122.03 32.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.234 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.6 pt -104.42 148.38 9.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.149 0.499 . . . . 0.0 111.114 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.33 113.44 18.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.855 176.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -111.64 133.17 54.08 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 68.13 3.68 3.75 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.608 0.568 . . . . 0.0 112.067 174.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 27.1 m -62.3 113.66 9.44 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.995 -177.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 24.0 Cg_exo -65.16 166.88 17.59 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.373 2.716 . . . . 0.0 113.51 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.34 -23.02 60.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.123 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -85.46 3.61 39.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.84 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.2 m -117.01 124.55 49.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.612 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.5 ttp -117.18 113.03 21.65 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 17.8 mt -75.95 115.9 18.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.254 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 22.1 ttt -77.9 -35.58 50.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.073 0.463 . . . . 0.0 110.049 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.7 m -78.6 121.65 24.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.775 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -69.48 128.26 35.9 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.8 mt -67.95 126.4 92.58 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.196 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -90.99 -161.25 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.119 2.546 . . . . 0.0 112.397 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.8 m -117.83 141.96 47.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.405 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 p -97.75 145.22 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.965 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.6 mtp180 -114.93 118.43 33.44 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.551 HG13 ' HA ' ' A' ' 80' ' ' ILE . 17.3 m -117.3 134.45 60.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.057 -177.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.52 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 11.9 mmtt -79.09 122.21 25.95 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 173.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.3 p -120.95 129.83 53.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.773 0.321 . . . . 0.0 111.509 -176.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 28.3 tt0 -96.04 106.15 18.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.601 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 135.17 -178.41 18.59 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.029 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.414 ' OH ' ' HD3' ' A' ' 7' ' ' ARG . 95.0 m-85 -113.23 161.06 17.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.101 0.476 . . . . 0.0 111.043 -178.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.603 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 3.2 p30 -128.74 74.57 80.54 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.687 176.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.66 -45.46 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.585 2.19 . . . . 0.0 111.767 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 p -102.9 3.93 37.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.054 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.627 HD11 ' HB2' ' A' ' 74' ' ' ASN . 56.9 mt -106.69 121.51 59.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.629 -175.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.401 ' ND2' ' HG3' ' A' ' 48' ' ' GLU . 47.7 t30 -91.72 106.23 18.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.541 0.686 . . . . 0.0 110.665 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.523 ' HB ' HD13 ' A' ' 11' ' ' LEU . 33.2 m -69.66 -10.88 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.68 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -82.87 -11.01 58.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.978 0.418 . . . . 0.0 110.497 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.401 ' HG3' ' ND2' ' A' ' 45' ' ' ASN . 40.2 mt-10 -106.26 -16.46 14.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.213 174.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.8 mt -70.32 128.56 36.63 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 168.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -124.3 157.86 33.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.361 0.6 . . . . 0.0 112.044 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.88 129.54 56.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 169.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -129.57 143.78 50.98 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.466 0.651 . . . . 0.0 111.622 -173.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.79 HG11 HD11 ' A' ' 15' ' ' LEU . 3.2 m -112.52 119.52 60.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.94 172.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -84.84 100.3 11.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.571 -173.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.452 HD21 HD12 ' A' ' 89' ' ' LEU . 10.5 mp -90.6 76.26 6.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.0 m -57.3 -42.63 82.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.919 -174.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -112.21 172.56 14.82 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.041 -174.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.9 m -91.4 31.07 1.19 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.975 0.417 . . . . 0.0 110.168 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -59.73 112.28 5.08 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.521 -175.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.41 151.88 20.27 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.633 2.222 . . . . 0.0 112.055 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.82 179.3 19.13 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.351 176.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 88' ' ' GLN . 41.8 tt0 -87.08 107.99 18.68 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 65' ' ' TYR . 76.6 m-70 -117.33 161.76 19.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.818 -175.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -95.53 127.24 41.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 63' ' ' HIS . 95.3 m-85 -116.88 134.24 55.02 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.322 0.582 . . . . 0.0 111.165 -177.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -77.09 120.64 22.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.146 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.5 t -73.44 106.25 3.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.27 0.557 . . . . 0.0 110.044 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -100.5 126.02 46.88 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.554 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.9 146.73 10.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -58.94 115.38 11.69 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 173.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.19 108.0 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.713 2.276 . . . . 0.0 112.486 -176.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.496 HD12 ' H ' ' A' ' 72' ' ' ILE . 3.8 mp -81.06 111.11 21.09 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.9 24.51 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.829 2.353 . . . . 0.0 113.15 -172.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.627 ' HB2' HD11 ' A' ' 44' ' ' ILE . 21.8 m120 -144.38 -1.42 0.92 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.721 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.518 HD12 ' HB3' ' A' ' 41' ' ' ASN . 70.1 mt -129.96 134.23 63.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.874 0.368 . . . . 0.0 110.407 -176.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 52.2 tttm -83.18 112.83 20.2 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.802 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.9 tt -80.66 125.46 39.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.203 0.525 . . . . 0.0 110.163 -176.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 22.7 t -93.59 -54.18 7.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.35 -173.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -153.28 156.82 39.15 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.722 -174.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.557 ' HB ' ' HG2' ' A' ' 83' ' ' ARG . 60.9 mt -122.78 132.08 72.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 23.2 t -139.21 110.5 7.7 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.464 0.173 . . . . 0.0 110.642 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -87.35 153.38 42.07 Favored 'Cis proline' 0 N--CA 1.462 -0.379 0 C-N-CA 124.215 -1.161 . . . . 0.0 112.152 -2.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.557 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 85.1 mtm180 -76.33 -34.68 59.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.878 0.371 . . . . 0.0 111.392 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.8 t -129.23 129.62 67.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.913 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.3 m -116.11 133.44 62.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.971 0.415 . . . . 0.0 110.859 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.3 m -90.78 115.4 27.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.144 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.41 ' HB2' ' CE2' ' A' ' 65' ' ' TYR . 70.8 mt -118.82 138.86 52.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.178 -177.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 53.1 tt0 -93.83 115.78 28.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.951 0.405 . . . . 0.0 110.581 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.452 HD12 HD21 ' A' ' 55' ' ' LEU . 23.7 mt -100.42 135.68 41.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.282 0.563 . . . . 0.0 111.118 177.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -118.86 170.51 8.95 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 169.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -83.43 166.15 18.61 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.885 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -53.76 -46.27 70.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.201 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 51.0 t60 -161.92 122.09 2.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.187 176.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -107.2 160.97 15.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -78.44 169.22 18.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.152 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.3 m80 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.663 -0.684 . . . . 0.0 110.123 -179.82 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.6 m . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 120.993 0.425 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -88.78 84.97 6.68 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -72.42 130.85 41.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.4 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.5 m -72.71 -45.2 60.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.035 0.445 . . . . 0.0 110.69 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 44.5 tp -85.56 88.66 7.55 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -84.45 13.19 5.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.224 -174.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -77.26 -34.18 55.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.207 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.814 ' HB3' ' HG3' ' A' ' 38' ' ' GLU . 6.1 p-10 -134.37 89.52 27.11 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 121.737 0.779 . . . . 0.0 110.385 178.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.32 141.1 25.36 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.097 2.532 . . . . 0.0 113.36 -173.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 40.9 m -87.77 110.35 20.4 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.9 tp -108.92 144.69 36.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.538 -171.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 12.4 t -116.64 123.47 47.37 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.353 0.597 . . . . 0.0 109.796 174.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt -109.5 166.29 11.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.011 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.2 t -86.07 126.65 34.34 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.634 HD13 HG11 ' A' ' 53' ' ' VAL . 60.3 tp -80.82 104.24 11.2 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 174.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 36.2 pt -107.08 147.45 12.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.257 0.551 . . . . 0.0 111.599 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.557 ' HB3' ' OG1' ' A' ' 20' ' ' THR . . . -86.91 105.03 16.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.54 175.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -90.42 -77.84 0.39 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.859 -174.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -80.71 64.82 5.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.906 0.86 . . . . 0.0 109.253 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.557 ' OG1' ' HB3' ' A' ' 17' ' ' ALA . 46.5 m -112.0 111.48 53.47 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.564 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -71.25 -178.93 3.18 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.035 2.49 . . . . 0.0 111.979 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.56 ' O ' ' HB3' ' A' ' 23' ' ' ASN . . . -77.87 160.96 27.96 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.571 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.56 ' HB3' ' O ' ' A' ' 22' ' ' ALA . 18.1 t30 80.1 -38.09 0.16 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.847 0.717 . . . . 0.0 111.274 174.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 p -78.72 94.58 5.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.14 0.495 . . . . 0.0 110.123 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.4 ttp -102.94 133.0 48.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.244 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.9 mt -85.9 110.43 19.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.3 ttt -70.4 -32.5 70.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.088 0.47 . . . . 0.0 110.088 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.5 m -78.01 106.62 10.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.477 174.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.58 129.57 40.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.051 0.453 . . . . 0.0 111.175 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.441 ' HB3' ' O ' ' A' ' 15' ' ' LEU . 73.1 mt -55.94 122.72 48.98 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.856 -174.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -95.25 176.19 0.94 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.343 2.695 . . . . 0.0 112.82 176.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 m -87.0 140.08 29.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.925 173.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 12' ' ' THR . 14.4 p -101.83 148.09 7.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.044 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 34' ' ' ARG . 37.2 mtm-85 -103.17 120.45 40.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.904 0.383 . . . . 0.0 110.638 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 80' ' ' ILE . 6.9 m -133.77 116.67 24.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.236 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 16.7 ttpp -87.55 129.07 35.23 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.1 p -105.03 -178.05 3.54 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.814 ' HG3' ' HB3' ' A' ' 8' ' ' ASP . 3.4 tt0 -154.66 110.31 3.15 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.41 165.66 10.85 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.927 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -88.02 113.13 23.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.594 0.235 . . . . 0.0 110.529 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.515 ' HB3' HG13 ' A' ' 75' ' ' ILE . 5.1 p30 -135.5 82.01 40.89 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.537 0.684 . . . . 0.0 111.626 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -91.13 -6.18 3.98 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.096 2.531 . . . . 0.0 111.948 175.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.1 p -97.74 -52.16 3.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.238 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.31 126.35 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.243 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -86.24 128.78 34.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.926 -177.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.63 -13.08 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.451 -174.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -97.06 -9.53 27.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.688 0.28 . . . . 0.0 110.844 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.82 -25.13 22.37 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 172.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.6 128.51 34.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.743 172.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -130.85 157.61 42.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.987 0.422 . . . . 0.0 111.11 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -123.0 114.0 19.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.556 ' CZ ' ' HD2' ' A' ' 68' ' ' LYS . 53.1 p90 -118.55 159.53 23.39 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.121 0.486 . . . . 0.0 111.839 -171.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.634 HG11 HD13 ' A' ' 15' ' ' LEU . 17.0 m -112.43 139.46 37.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.695 172.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -103.68 106.69 17.27 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.458 HD12 HG21 ' A' ' 20' ' ' THR . 78.8 mt -98.49 44.18 1.04 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.947 0.403 . . . . 0.0 111.0 -174.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 t -56.56 -44.04 80.55 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.454 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.99 69.97 3.22 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 173.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 p -69.54 91.58 0.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.488 0.661 . . . . 0.0 110.779 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 42.5 tt0 -117.87 125.48 27.98 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.958 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 59' ' ' GLU . 25.3 Cg_exo -62.89 150.9 87.0 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.194 2.596 . . . . 0.0 112.818 -177.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.38 -177.27 27.15 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.862 ' HG2' ' HB2' ' A' ' 88' ' ' GLN . 42.6 mt-10 -87.68 107.49 18.65 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -124.15 148.76 46.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.414 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 39.4 m-20 -81.89 109.64 16.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.71 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -111.61 146.54 37.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.283 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -80.52 134.06 35.89 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.523 -174.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.461 HG12 HD11 ' A' ' 15' ' ' LEU . 60.1 t -81.75 112.36 19.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.556 ' HD2' ' CZ ' ' A' ' 52' ' ' TYR . 7.8 tmtt? -103.1 111.57 24.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.093 0.473 . . . . 0.0 109.885 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 34.9 t -92.4 143.13 12.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.421 -178.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -58.3 139.16 84.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.908 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.27 136.38 47.14 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.499 2.133 . . . . 0.0 111.702 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.444 ' CG2' ' HB ' ' A' ' 75' ' ' ILE . 41.2 mt -116.24 110.41 43.32 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.312 -177.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.52 137.31 50.1 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.763 2.308 . . . . 0.0 111.938 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 73.41 -45.3 0.61 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.524 0.729 . . . . 0.0 112.447 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.515 HG13 ' HB3' ' A' ' 41' ' ' ASN . 26.3 mm -84.33 129.36 37.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.031 0.443 . . . . 0.0 110.362 -175.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -81.8 141.48 33.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.562 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.2 tt -98.69 112.42 30.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.548 0.69 . . . . 0.0 109.144 174.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.6 t -86.42 -53.22 10.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.633 -170.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -133.86 147.71 51.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.099 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.688 ' HB ' ' HG2' ' A' ' 83' ' ' ARG . 55.0 mt -127.8 111.8 25.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 21.0 m -128.78 108.45 18.57 Favored Pre-proline 0 C--N 1.318 -0.771 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.145 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.479 ' HG2' HG13 ' A' ' 85' ' ' VAL . 4.1 Cg_endo -89.33 166.81 36.09 Favored 'Cis proline' 0 C--N 1.344 0.316 0 C-N-CA 124.459 -1.059 . . . . 0.0 112.344 -3.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.688 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 80.5 mtm180 -93.49 -28.62 15.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.081 0.467 . . . . 0.0 109.888 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.414 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 53.9 t -130.22 120.18 48.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.526 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.479 HG13 ' HG2' ' A' ' 82' ' ' PRO . 16.2 m -112.72 135.45 52.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.157 0.504 . . . . 0.0 111.219 -177.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.8 m -83.09 104.1 13.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.766 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.1 mt -101.51 133.02 46.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.61 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.862 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 42.8 tt0 -92.02 108.73 20.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.86 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 72.2 mt -94.31 120.65 34.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.532 177.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -109.12 152.33 25.24 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.592 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -84.13 100.44 11.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.647 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -92.56 137.71 32.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.804 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -78.42 141.31 38.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.44 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -102.69 137.78 40.46 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.134 0.493 . . . . 0.0 112.195 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -92.74 -32.99 14.49 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 161.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.2 m80 . . . . . 0 C--O 1.252 1.209 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.833 174.394 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 120.851 0.358 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.1 m -79.38 111.41 15.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 175.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -94.13 166.99 11.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.889 0.376 . . . . 0.0 111.121 -175.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.7 m -73.18 -28.94 62.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.372 0.606 . . . . 0.0 109.679 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -95.26 148.64 22.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.537 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -84.65 168.88 14.89 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -92.52 -18.27 23.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.878 0.37 . . . . 0.0 110.49 -178.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -116.23 93.09 38.17 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.798 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.14 130.38 18.78 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.398 2.065 . . . . 0.0 111.445 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.7 m -95.75 92.6 6.64 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 175.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.49 HD23 HD12 ' A' ' 49' ' ' LEU . 14.6 tp -82.85 114.98 21.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.953 -170.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.5 m -93.81 101.57 13.67 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.253 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.8 mt -100.83 177.91 4.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.482 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.9 m -105.35 137.63 42.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.521 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.805 HD13 HG11 ' A' ' 53' ' ' VAL . 50.7 tp -86.99 123.46 32.11 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.7 pt -119.79 146.7 24.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.133 0.492 . . . . 0.0 111.034 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.27 115.79 23.24 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -71.05 -76.46 0.1 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.063 -175.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.408 ' HB3' ' HG ' ' A' ' 56' ' ' SER . 31.5 t30 -126.19 81.11 1.97 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.893 0.378 . . . . 0.0 110.317 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.9 t -90.67 127.17 53.46 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 170.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.89 157.33 13.2 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.323 2.682 . . . . 0.0 113.158 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.507 ' HB2' ' HA ' ' A' ' 96' ' ' HIS . . . -68.97 -19.82 64.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.679 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -86.03 -5.8 59.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.26 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 p -118.59 144.61 46.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.106 0.479 . . . . 0.0 111.218 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.9 ttp -132.62 130.7 40.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.738 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.7 mt -82.84 116.92 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.652 0.263 . . . . 0.0 111.134 -176.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.493 ' HG2' ' HB2' ' A' ' 90' ' ' GLU . 95.9 mmm -82.94 -39.24 21.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.175 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.6 m -66.85 112.9 4.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.297 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -58.07 120.63 8.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.164 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.25 109.22 2.27 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.422 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -85.01 -170.87 0.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.879 2.386 . . . . 0.0 113.015 -173.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.2 m -97.2 134.31 40.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.147 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.489 HG11 HG11 ' A' ' 67' ' ' VAL . 17.8 m -96.85 142.39 14.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -120.94 119.26 32.08 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.352 -178.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.505 HG11 ' HA ' ' A' ' 80' ' ' ILE . 30.1 m -112.54 137.29 45.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.066 0.46 . . . . 0.0 111.527 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -87.53 122.2 30.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 173.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.427 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 24.1 p -126.34 159.15 33.99 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 123.368 0.417 . . . . 0.0 110.925 -177.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -114.86 112.04 22.14 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.87 -159.0 26.88 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.841 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -137.78 157.14 47.06 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.417 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 6.3 p30 -128.78 85.66 59.62 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 121.204 0.526 . . . . 0.0 111.768 -174.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.59 -67.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.018 2.478 . . . . 0.0 112.422 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.3 p -84.4 -11.41 56.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.153 0.501 . . . . 0.0 111.045 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 41' ' ' ASN . 70.1 mt -76.46 113.2 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.273 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.417 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 35.2 m-80 -84.77 121.6 27.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.747 -176.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.456 HG22 HD13 ' A' ' 11' ' ' LEU . 37.7 t -62.62 -36.53 75.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.455 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -71.15 -22.13 62.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.635 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -88.56 -17.31 30.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.449 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.49 HD12 HD23 ' A' ' 11' ' ' LEU . 91.3 mt -85.03 131.09 34.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.61 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -128.14 152.66 47.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.073 0.463 . . . . 0.0 111.447 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . . . -115.42 115.99 27.48 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 171.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -107.69 145.94 32.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.346 0.593 . . . . 0.0 112.023 -173.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.805 HG11 HD13 ' A' ' 15' ' ' LEU . 4.4 m -112.6 121.07 64.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.218 169.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 56' ' ' SER . 18.9 p-10 -87.35 86.28 7.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.218 1.009 . . . . 0.0 110.528 -177.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 mp -78.96 29.89 0.21 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.214 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 54' ' ' ASP . 20.1 m -65.52 95.65 0.23 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.208 0.527 . . . . 0.0 110.064 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.83 -74.1 0.44 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -173.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m 58.37 98.41 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 173.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -85.1 119.59 72.64 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.81 114.65 1.95 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.695 2.264 . . . . 0.0 112.183 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.08 -158.48 27.7 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -100.36 104.71 16.16 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -130.89 152.68 49.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.822 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.465 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 18.8 m-20 -91.69 130.29 37.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.765 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -123.99 151.78 43.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.209 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.422 ' O ' HG12 ' A' ' 53' ' ' VAL . 24.8 mt-10 -87.2 134.72 33.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.306 -175.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.489 HG11 HG11 ' A' ' 33' ' ' VAL . 90.6 t -79.86 109.51 14.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.932 173.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -108.92 109.67 20.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.023 0.44 . . . . 0.0 110.431 -177.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 31.8 t -87.27 149.83 3.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.293 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -53.03 128.97 48.44 Favored Pre-proline 0 C--O 1.232 0.138 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.67 124.91 15.99 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.373 2.049 . . . . 0.0 111.683 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.6 mt -113.79 95.47 37.46 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.544 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.02 24.43 0.71 Allowed 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 123.072 2.514 . . . . 0.0 111.751 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -118.28 -30.51 5.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.171 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.427 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 61.9 mt -130.95 142.11 44.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.201 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -80.73 128.13 33.29 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.149 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.9 tt -97.41 122.16 48.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.396 0.617 . . . . 0.0 109.889 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.816 HG13 ' HG3' ' A' ' 79' ' ' GLU . 41.4 t -94.87 -60.47 2.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.115 -175.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.816 ' HG3' HG13 ' A' ' 78' ' ' VAL . 43.8 mt-10 -141.87 139.37 32.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.28 -172.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.505 ' HA ' HG11 ' A' ' 35' ' ' VAL . 46.3 mt -107.31 120.27 58.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.496 175.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.469 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 15.1 m -118.18 108.01 42.74 Favored Pre-proline 0 C--N 1.323 -0.586 0 O-C-N 122.423 -0.173 . . . . 0.0 110.93 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 83.9 Cg_endo -91.74 174.54 18.92 Favored 'Cis proline' 0 C--N 1.346 0.439 0 C-N-CA 124.186 -1.172 . . . . 0.0 112.53 -2.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 83' ' ' ARG . 27.3 mtm105 -94.97 -50.66 5.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.46 0.648 . . . . 0.0 110.085 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.465 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 41.1 t -115.53 118.66 59.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.138 -177.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.7 m -107.44 134.69 48.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.024 0.44 . . . . 0.0 111.18 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.2 m -85.21 103.97 14.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.82 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.5 mt -97.92 124.64 42.45 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.102 0.477 . . . . 0.0 110.572 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -87.93 104.66 16.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.965 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 59.5 mt -94.31 134.33 36.91 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.941 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.493 ' HB2' ' HG2' ' A' ' 27' ' ' MET . 0.0 OUTLIER -110.72 170.99 7.73 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.656 179.242 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -84.98 110.74 19.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.358 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -84.33 110.47 18.62 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 177.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -80.04 61.51 3.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.21 0.529 . . . . 0.0 111.081 -173.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.96 155.45 16.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.352 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -89.87 9.53 27.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.03 0.443 . . . . 0.0 110.782 176.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.507 ' HA ' ' HB2' ' A' ' 22' ' ' ALA . 36.0 t60 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.129 -0.939 . . . . 0.0 109.062 174.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.5 t . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -56.35 -43.52 79.19 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.94 0.4 . . . . 0.0 110.568 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -103.31 130.93 50.7 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.6 p -96.86 124.98 40.99 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.021 0.439 . . . . 0.0 111.532 -173.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.1 mt -76.74 153.72 34.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.166 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -94.85 141.59 28.46 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -71.02 -34.6 71.48 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.226 0.536 . . . . 0.0 110.497 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.44 92.09 6.71 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.83 -178.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.95 154.82 33.79 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.874 2.383 . . . . 0.0 113.453 -174.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 35.3 m -100.23 123.28 44.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.826 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.2 mt -101.33 159.01 15.63 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.051 0.453 . . . . 0.0 110.496 -176.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 31.0 m -126.4 99.55 5.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.02 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.436 HD23 ' HB2' ' A' ' 49' ' ' LEU . 79.5 mt -95.8 141.84 28.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.244 -173.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 m -74.01 140.78 45.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.92 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.834 HD13 HG13 ' A' ' 53' ' ' VAL . 45.0 tp -96.32 125.19 40.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.035 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.499 HD12 ' CE2' ' A' ' 52' ' ' TYR . 39.7 pt -122.77 151.85 27.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.035 0.445 . . . . 0.0 111.507 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.428 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -78.99 132.91 36.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.537 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.541 ' HD2' ' CD2' ' A' ' 52' ' ' TYR . 60.6 tttm -129.73 140.15 51.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.213 178.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.549 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 65.0 m-20 60.91 20.17 10.47 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.719 0.637 . . . . 0.0 110.798 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.428 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 72.7 m -79.76 116.44 61.01 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.196 -174.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.1 178.0 3.93 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.911 2.407 . . . . 0.0 112.647 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.0 -28.44 27.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.114 -175.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -73.92 -10.15 59.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.674 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.6 p -100.93 110.12 22.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.128 0.489 . . . . 0.0 109.972 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.595 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 25.6 ttt -102.9 108.83 20.17 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.032 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.0 mt -78.35 108.19 11.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.665 -175.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.469 ' SD ' ' HB2' ' A' ' 90' ' ' GLU . 85.4 mtp -86.19 -32.9 20.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.553 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.9 m -71.87 111.39 7.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.985 176.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -65.9 117.88 8.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.5 114.53 13.41 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.507 -173.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -85.06 -161.99 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.903 2.402 . . . . 0.0 111.74 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.8 m -113.31 150.79 32.02 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.743 0.306 . . . . 0.0 110.911 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.603 HG12 HG13 ' A' ' 67' ' ' VAL . 35.7 m -94.38 152.48 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.777 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -110.53 102.02 10.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.988 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.523 HG13 ' HA ' ' A' ' 80' ' ' ILE . 23.7 m -120.12 132.79 68.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.786 -176.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 81.8 tttt -97.17 136.06 38.23 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.519 HG21 ' HA ' ' A' ' 77' ' ' ILE . 37.0 p -127.98 138.35 52.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.289 -175.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.46 ' HG3' HG22 ' A' ' 78' ' ' VAL . 53.6 mt-10 -97.37 100.27 11.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.183 0.516 . . . . 0.0 109.64 175.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.24 151.65 5.78 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.19 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -89.93 147.58 23.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.677 0.275 . . . . 0.0 110.385 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.445 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 4.6 p30 -109.46 111.49 59.53 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.562 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 41' ' ' ASN . 5.1 Cg_exo -79.87 -73.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.814 2.342 . . . . 0.0 112.072 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 p -105.11 6.13 32.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.787 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.2 126.22 40.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.47 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -114.95 153.38 30.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.83 0.348 . . . . 0.0 111.322 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.0 m -83.56 -9.71 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.695 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -93.58 -4.81 50.21 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -98.78 -37.4 9.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.668 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.446 HD11 HG12 ' A' ' 72' ' ' ILE . 20.0 mt -88.3 144.57 26.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.657 177.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -135.89 157.9 45.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.684 0.754 . . . . 0.0 112.419 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.18 135.61 48.43 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.981 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.541 ' CD2' ' HD2' ' A' ' 18' ' ' LYS . 29.6 m-85 -112.25 150.16 31.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.956 0.408 . . . . 0.0 111.022 -173.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.834 HG13 HD13 ' A' ' 15' ' ' LEU . 3.1 m -122.08 118.28 55.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.814 168.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -83.63 105.65 14.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.224 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.4 mt -101.87 15.58 28.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.605 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.549 ' HB2' ' HB3' ' A' ' 19' ' ' ASN . 12.7 t -72.26 96.81 1.89 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 173.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.52 51.34 1.44 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 -172.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.2 p -106.01 162.36 13.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.717 0.294 . . . . 0.0 110.833 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 63' ' ' HIS . 1.2 mp0 -120.38 132.89 23.98 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.4 147.74 66.25 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.775 2.316 . . . . 0.0 112.13 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.34 -171.02 17.05 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.491 -177.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -84.76 111.98 20.09 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.45 ' CE1' ' HB2' ' A' ' 59' ' ' GLU . 25.6 m80 -137.1 145.19 43.59 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.025 0.44 . . . . 0.0 110.932 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.529 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 11.5 m-20 -85.25 125.72 33.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.364 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -121.79 151.79 40.2 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.086 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -90.16 142.8 27.36 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.797 -170.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.603 HG13 HG12 ' A' ' 33' ' ' VAL . 67.5 t -83.15 121.77 36.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.946 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 50.4 tttm -95.4 112.66 24.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.331 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.5 t -92.53 127.09 44.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.695 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 37.5 tt0 -72.21 122.87 88.54 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.979 177.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 50.0 Cg_exo -55.99 125.66 19.82 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.134 2.556 . . . . 0.0 113.062 -176.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.446 HG12 HD11 ' A' ' 49' ' ' LEU . 52.1 mt -88.54 117.1 67.98 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.948 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.86 137.27 37.69 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.318 2.012 . . . . 0.0 112.551 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 71.15 4.38 5.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.264 173.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 58.3 mt -132.06 136.14 57.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -90.41 123.33 34.04 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.43 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.519 ' HA ' HG21 ' A' ' 37' ' ' THR . 16.6 tt -80.28 139.49 18.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.46 HG22 ' HG3' ' A' ' 38' ' ' GLU . 39.4 t -108.05 -69.13 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.069 0.462 . . . . 0.0 110.902 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -107.79 141.66 39.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.864 -171.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.523 ' HA ' HG13 ' A' ' 35' ' ' VAL . 66.3 mt -120.1 110.43 28.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.362 177.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 47.0 m -144.78 123.84 6.92 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.92 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 93.2 Cg_endo -85.32 158.68 63.04 Favored 'Cis proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.123 -3.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -81.58 -35.64 29.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.984 0.421 . . . . 0.0 110.453 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 71.3 t -130.54 130.61 65.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.445 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.7 m -116.92 141.2 36.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.098 0.475 . . . . 0.0 111.168 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.1 m -80.44 117.51 21.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.229 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.2 mt -113.92 123.44 49.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.854 0.359 . . . . 0.0 110.681 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -88.79 104.37 16.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.078 176.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.9 mt -94.77 127.44 40.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.403 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 25' ' ' MET . 10.4 tp10 -100.41 154.61 18.38 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.686 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -80.62 90.46 5.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.611 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.595 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 22.4 t60 -66.68 111.21 3.56 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -85.36 159.37 20.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.207 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -124.19 135.41 53.44 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.01 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -144.19 122.7 12.44 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.881 -0.58 . . . . 0.0 110.32 -178.166 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.5 p . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 120.985 0.421 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.0 m -84.07 163.98 19.53 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -81.55 4.16 22.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.422 0.63 . . . . 0.0 110.501 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.5 m -155.91 155.54 33.03 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -54.05 138.4 37.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.876 0.369 . . . . 0.0 110.621 176.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -75.11 -9.59 58.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.79 -171.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -97.48 -0.08 46.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.259 0.552 . . . . 0.0 110.191 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.15 87.44 29.16 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.57 -172.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.83 125.97 13.95 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.412 2.075 . . . . 0.0 111.983 -178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.4 m -90.74 116.39 28.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.648 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.523 HD12 HD22 ' A' ' 41' ' ' ASN . 88.8 mt -108.85 131.84 54.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.18 0.514 . . . . 0.0 111.316 -173.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 m -103.86 99.14 8.91 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.823 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.5 mt -106.25 134.35 49.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.043 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -73.45 142.49 46.87 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.787 0.327 . . . . 0.0 110.75 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.731 HD12 HG13 ' A' ' 53' ' ' VAL . 55.4 tp -87.02 122.25 30.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.028 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.4 pt -108.93 153.78 10.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.141 0.496 . . . . 0.0 111.398 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.03 111.22 17.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.968 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -109.37 134.76 51.43 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.981 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.1 t30 62.28 18.15 9.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.707 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.473 HG21 HD11 ' A' ' 55' ' ' LEU . 31.0 m -72.09 118.95 71.61 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.922 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 7.0 Cg_exo -72.89 -179.95 4.74 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.905 2.403 . . . . 0.0 112.365 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.427 ' O ' ' HB2' ' A' ' 23' ' ' ASN . . . -80.82 161.43 24.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.276 175.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 22' ' ' ALA . 95.3 m-20 75.28 -34.47 0.26 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.532 0.733 . . . . 0.0 111.639 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.4 p -76.91 98.49 4.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.369 0.604 . . . . 0.0 109.695 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' MET . . . . . 0.678 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 51.1 ttp -103.0 124.56 48.74 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.639 -174.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.402 HG12 ' CD2' ' A' ' 89' ' ' LEU . 17.4 mt -84.65 97.62 5.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 44.1 ttp -79.05 -20.23 49.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.027 0.441 . . . . 0.0 109.953 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.0 m -75.75 105.97 7.07 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -54.61 132.25 44.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.012 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.51 114.64 29.88 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.438 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -89.2 -161.24 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.936 2.424 . . . . 0.0 112.222 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.3 p -120.81 141.95 50.06 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.793 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.593 HG12 HG11 ' A' ' 67' ' ' VAL . 25.1 m -93.9 142.86 12.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.923 0.392 . . . . 0.0 109.964 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -112.05 93.25 4.36 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.456 0.646 . . . . 0.0 109.444 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' A' ' 80' ' ' ILE . 30.2 m -99.22 162.55 2.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.676 -175.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.495 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 36.0 tttm -123.17 122.99 39.8 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.422 HG22 ' HA ' ' A' ' 77' ' ' ILE . 30.5 p -112.77 175.04 5.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.78 -175.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 28.2 tt0 -123.84 117.51 25.02 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.74 -137.35 9.33 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.196 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.517 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 79.2 m-85 -145.02 157.66 44.05 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.523 HD22 HD12 ' A' ' 11' ' ' LEU . 8.2 m120 -114.44 82.03 7.29 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 1.2 Cg_endo -84.84 -68.53 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.781 2.321 . . . . 0.0 112.766 -176.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.6 p -93.72 -14.69 26.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.116 -178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.4 mt -86.58 117.63 31.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.619 -176.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -84.79 128.16 34.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.931 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.6 m -71.7 -17.11 19.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.198 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -91.2 -0.04 57.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.143 0.497 . . . . 0.0 110.158 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -102.88 -28.22 12.18 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.2 mt -81.99 135.8 35.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.791 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -128.05 156.88 42.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.522 0.677 . . . . 0.0 111.755 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.21 138.45 44.47 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 170.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -136.42 151.68 49.77 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.472 0.653 . . . . 0.0 112.294 -171.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.731 HG13 HD12 ' A' ' 15' ' ' LEU . 4.9 m -112.54 118.11 56.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.433 169.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -88.68 98.5 11.72 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.79 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.473 HD11 HG21 ' A' ' 20' ' ' THR . 60.1 mt -84.97 67.62 10.26 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.35 0.595 . . . . 0.0 110.248 -177.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.44 -20.73 59.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.18 176.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -99.36 142.51 16.05 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.248 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 m -92.94 38.12 1.03 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.636 ' HB2' ' OH ' ' A' ' 65' ' ' TYR . 11.1 mm-40 -66.16 110.22 4.38 Favored Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.765 -177.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -87.58 141.64 5.67 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.996 2.464 . . . . 0.0 111.994 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.21 -168.77 13.9 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.06 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 88' ' ' GLN . 36.3 mt-10 -82.51 97.73 8.58 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -122.77 143.13 50.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.956 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 28.5 m-20 -81.29 119.91 24.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.759 0.314 . . . . 0.0 110.297 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.636 ' OH ' ' HB2' ' A' ' 59' ' ' GLU . 53.6 m-85 -111.03 167.17 10.46 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.15 0.5 . . . . 0.0 111.04 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -106.77 122.63 46.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.626 -173.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.593 HG11 HG12 ' A' ' 33' ' ' VAL . 67.8 t -79.74 113.82 19.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.293 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -100.83 151.4 21.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.708 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.5 t -118.44 141.38 38.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.26 123.21 81.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.65 113.67 1.34 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.002 2.468 . . . . 0.0 112.382 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.7 mt -90.94 119.59 68.85 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.757 -176.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.94 149.57 53.52 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.733 2.289 . . . . 0.0 111.647 175.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 72.27 -51.22 0.7 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.589 0.756 . . . . 0.0 111.936 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.7 mt -83.89 134.25 27.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.348 0.594 . . . . 0.0 110.811 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 76.8 tttt -88.87 124.35 34.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.891 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.422 ' HA ' HG22 ' A' ' 37' ' ' THR . 18.0 tt -87.98 133.49 30.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.7 HG11 ' HG3' ' A' ' 79' ' ' GLU . 43.5 t -112.26 -59.89 3.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.106 0.479 . . . . 0.0 111.849 -171.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.7 ' HG3' HG11 ' A' ' 78' ' ' VAL . 46.2 mt-10 -125.23 102.79 7.62 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.084 -172.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.492 ' HA ' HG12 ' A' ' 35' ' ' VAL . 53.0 mt -80.18 118.79 28.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 171.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 36.5 m -141.58 116.48 7.0 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-O 120.548 0.213 . . . . 0.0 110.915 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.495 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 94.6 Cg_endo -87.68 -177.24 12.92 Favored 'Cis proline' 0 C--N 1.343 0.252 0 C-N-CA 123.701 -1.374 . . . . 0.0 112.358 -2.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 83' ' ' ARG . 52.0 mtm180 -122.7 -35.94 2.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.837 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.13 117.74 55.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.042 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.1 m -128.39 135.38 62.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.031 0.443 . . . . 0.0 110.846 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 3.9 m -80.09 99.53 7.76 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.097 177.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.55 ' HB2' ' HD2' ' A' ' 65' ' ' TYR . 80.2 mt -96.0 120.98 37.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.035 0.445 . . . . 0.0 109.892 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 59.3 tt0 -86.75 97.7 10.75 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.093 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.623 HD11 ' HH ' ' A' ' 65' ' ' TYR . 28.0 mt -82.04 109.57 16.49 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.626 0.727 . . . . 0.0 109.698 175.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -101.28 175.29 5.63 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.674 -175.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -91.55 110.44 21.75 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.603 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.678 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 36.7 t-80 -74.37 -15.59 60.93 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.29 100.63 9.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.243 171.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 70.61 88.97 0.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 O-C-N 124.129 0.893 . . . . 0.0 111.797 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -79.1 -12.37 60.0 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 171.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.4 m80 . . . . . 0 C--O 1.252 1.218 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.851 172.92 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.2 t . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.945 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 15.1 m -56.4 -54.89 40.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.163 0.506 . . . . 0.0 110.107 177.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -126.04 100.83 6.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 170.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.486 HG22 ' H ' ' A' ' 6' ' ' ASP . 4.1 m -95.57 154.62 17.12 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.836 -172.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.2 tp -65.6 -33.91 77.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 172.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.486 ' H ' HG22 ' A' ' 4' ' ' THR . 28.3 t70 -76.01 93.57 3.29 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 171.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.444 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 22.4 mtm180 -68.16 -56.07 10.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.603 -172.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -103.74 97.22 10.36 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.846 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 7' ' ' ARG . 89.8 Cg_endo -89.21 144.76 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.884 2.39 . . . . 0.0 113.85 -175.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 21.2 m -88.11 109.19 19.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.291 171.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.3 tp -86.64 136.2 33.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.981 -174.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.1 m -101.15 119.26 38.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.432 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.2 mt -129.45 152.92 48.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.218 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 p -88.55 151.5 22.46 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.98 0.419 . . . . 0.0 111.091 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.634 HD13 HG13 ' A' ' 53' ' ' VAL . 38.6 tp -92.63 139.31 30.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.293 178.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.0 pt -127.78 160.33 37.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.441 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -109.11 129.12 55.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.365 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -120.29 131.87 55.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.092 0.472 . . . . 0.0 111.248 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.6 t30 61.72 46.27 7.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.53 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.53 ' HB ' HD11 ' A' ' 55' ' ' LEU . 12.1 t -79.36 138.18 55.73 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -52.51 146.82 32.08 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.811 2.341 . . . . 0.0 112.74 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.54 -35.56 79.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.825 -176.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -100.74 20.31 15.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.796 0.331 . . . . 0.0 111.861 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.4 p -110.61 127.39 55.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 43.1 ttp -112.6 126.5 55.42 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.228 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.1 mt -84.95 111.7 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.396 -175.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 95.5 mmm -83.57 -42.52 16.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.993 0.425 . . . . 0.0 110.439 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.2 m -74.26 127.25 32.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.734 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -71.96 139.91 48.88 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.697 173.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.2 mt -71.78 115.73 40.83 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.79 -173.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.32 172.56 7.49 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.312 2.675 . . . . 0.0 113.627 -174.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.8 t -102.9 125.21 49.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.218 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.532 HG12 HG13 ' A' ' 67' ' ' VAL . 13.2 m -90.59 153.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.976 0.417 . . . . 0.0 110.615 -176.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -130.04 101.62 5.91 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.67 HG12 HG21 ' A' ' 69' ' ' VAL . 34.9 m -104.41 135.05 44.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.859 -175.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 62.9 tttp -83.62 121.35 27.13 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.468 HG22 ' HA ' ' A' ' 77' ' ' ILE . 20.9 p -121.95 155.35 35.7 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.497 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.498 ' HG3' ' HB3' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -121.1 119.44 32.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.978 0.418 . . . . 0.0 110.13 176.033 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.9 169.24 12.75 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.032 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -96.0 136.92 35.81 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.469 ' HB3' ' CD1' ' A' ' 75' ' ' ILE . 19.6 p30 -128.96 55.35 17.71 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.945 ' HB3' ' HA ' ' A' ' 2' ' ' SER . 34.3 Cg_endo -67.18 -56.71 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.689 1.593 . . . . 0.0 111.987 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.8 m -114.64 38.39 3.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.088 0.471 . . . . 0.0 111.06 -176.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.3 mt -114.66 142.71 26.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.798 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -80.63 41.28 0.55 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 111.008 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.433 HG21 ' OD1' ' A' ' 47' ' ' ASN . 11.9 m -61.27 -36.19 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.126 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.433 ' OD1' HG21 ' A' ' 46' ' ' VAL . 2.9 m-20 -79.4 -5.43 54.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.099 0.475 . . . . 0.0 110.604 -178.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -106.9 -10.84 15.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.736 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.2 mt -82.25 125.22 30.7 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 171.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -109.5 170.76 7.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.66 0.743 . . . . 0.0 112.353 -171.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.446 ' HB2' HG23 ' A' ' 69' ' ' VAL . . . -106.73 137.96 43.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.891 174.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.559 ' CZ ' ' HD3' ' A' ' 68' ' ' LYS . 27.2 p90 -135.29 158.08 45.28 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.615 -178.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.634 HG13 HD13 ' A' ' 15' ' ' LEU . 23.1 m -112.47 141.96 26.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.583 174.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -89.48 118.04 28.83 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.53 HD11 ' HB ' ' A' ' 20' ' ' THR . 85.6 mt -109.16 25.76 11.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.591 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.2 m -73.49 95.32 2.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.309 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.82 23.03 14.25 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.601 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.6 p -88.57 122.96 32.6 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.782 -0.246 . . . . 0.0 110.566 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -75.32 155.08 86.08 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.085 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.54 90.99 0.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.59 2.193 . . . . 0.0 112.029 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.05 172.87 42.86 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 88' ' ' GLN . 40.0 tt0 -82.24 105.47 13.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -130.61 167.9 17.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.347 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.411 ' HB3' HG12 ' A' ' 84' ' ' VAL . 13.6 m-20 -98.59 121.84 41.04 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.351 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.486 ' HH ' HD11 ' A' ' 89' ' ' LEU . 71.7 m-85 -116.89 128.09 54.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.104 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.42 ' HG2' HG23 ' A' ' 84' ' ' VAL . 46.8 mt-10 -69.95 134.61 48.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.204 -175.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.532 HG13 HG12 ' A' ' 33' ' ' VAL . 59.4 t -78.92 112.18 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.546 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.559 ' HD3' ' CZ ' ' A' ' 52' ' ' TYR . 53.6 tttm -102.88 102.63 12.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.388 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.67 HG21 HG12 ' A' ' 35' ' ' VAL . 39.4 t -86.86 125.5 40.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -63.86 127.67 91.93 Favored Pre-proline 0 C--N 1.323 -0.58 0 O-C-N 123.198 0.311 . . . . 0.0 110.958 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.35 137.52 47.28 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.617 2.878 . . . . 0.0 112.92 -175.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.461 ' CG2' ' HB ' ' A' ' 75' ' ' ILE . 30.5 mm -89.17 126.89 57.37 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.262 -177.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.1 131.04 29.1 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.286 1.991 . . . . 0.0 111.725 176.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.3 t30 73.79 -44.42 0.57 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.538 0.735 . . . . 0.0 111.998 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.469 ' CD1' ' HB3' ' A' ' 41' ' ' ASN . 71.5 mt -83.94 140.84 15.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.946 0.403 . . . . 0.0 110.682 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.498 ' HB3' ' HG3' ' A' ' 38' ' ' GLU . 57.3 tttp -94.84 125.71 39.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.387 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.468 ' HA ' HG22 ' A' ' 37' ' ' THR . 14.0 tt -88.36 122.21 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.498 0.666 . . . . 0.0 109.94 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.3 t -85.31 -64.57 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.069 -175.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -130.51 136.8 49.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.113 -170.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.561 ' HA ' HG11 ' A' ' 35' ' ' VAL . 67.5 mt -104.41 108.26 24.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.203 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.445 ' HA ' ' C ' ' A' ' 82' ' ' PRO . 11.6 p -136.13 126.93 16.74 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.735 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.445 ' C ' ' HA ' ' A' ' 81' ' ' SER . 15.3 Cg_exo -68.51 156.85 88.81 Favored 'Cis proline' 0 C--N 1.344 0.32 0 C-N-CA 123.55 -1.438 . . . . 0.0 112.508 0.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -85.23 -38.1 19.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.746 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.42 HG23 ' HG2' ' A' ' 66' ' ' GLU . 59.3 t -137.86 143.58 33.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.375 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 m -118.26 140.03 43.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.957 0.408 . . . . 0.0 111.011 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 m -92.36 105.2 17.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.04 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.9 mt -105.37 124.91 50.34 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.761 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 47.0 tt0 -85.8 99.88 11.66 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.012 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.486 HD11 ' HH ' ' A' ' 65' ' ' TYR . 84.2 mt -88.22 139.52 30.41 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.14 174.0 7.22 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.74 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -83.89 137.57 33.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.36 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -74.36 -1.01 19.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.686 0.755 . . . . 0.0 109.296 173.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -104.51 134.85 47.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.839 175.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -87.54 19.21 3.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.303 0.573 . . . . 0.0 110.738 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -117.97 22.97 11.94 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 . . . . . 0 C--O 1.245 0.832 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.487 -171.238 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 . . . . . 0 C--O 1.233 0.232 0 CA-C-O 121.341 0.591 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.72 152.97 59.37 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.603 2.202 . . . . 0.0 112.051 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.6 m -107.39 113.13 26.3 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.707 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.1 mt -90.23 127.84 36.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.087 0.47 . . . . 0.0 110.511 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -103.64 102.93 12.8 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.305 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -102.89 144.14 31.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.286 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.2 m -76.86 143.96 39.33 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.813 HD11 HG13 ' A' ' 53' ' ' VAL . 52.7 tp -88.32 127.32 35.48 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.8 pt -122.77 171.17 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.933 0.396 . . . . 0.0 110.842 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.506 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -107.11 122.21 46.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.158 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -114.95 139.89 49.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.594 0.235 . . . . 0.0 110.679 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.8 t30 56.13 32.04 19.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.392 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.506 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 89.6 m -90.02 114.74 61.96 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.311 -176.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.7 163.87 37.54 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.758 2.306 . . . . 0.0 111.561 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.92 -13.29 59.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.855 0.36 . . . . 0.0 110.598 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -67.19 -35.02 78.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.885 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.8 p -95.24 102.67 14.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.602 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 52.6 ttp -102.79 111.98 24.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.061 0.458 . . . . 0.0 110.56 -174.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 28' ' ' THR . 21.6 mt -75.44 113.46 14.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.414 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 84.9 mtp -99.78 10.86 40.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.426 0.631 . . . . 0.0 110.103 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 26' ' ' ILE . 9.3 m -105.39 119.19 38.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.827 176.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -60.78 136.07 57.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.713 0.292 . . . . 0.0 110.335 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.7 mt -81.86 122.9 80.47 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.419 -171.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.536 ' HD2' HD23 ' A' ' 15' ' ' LEU . 87.4 Cg_endo -83.55 -164.88 0.28 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.207 2.605 . . . . 0.0 112.803 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.2 t -125.35 144.91 50.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.074 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.21 144.42 14.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.808 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 35.6 mtm-85 -118.08 99.21 6.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 80' ' ' ILE . 21.2 m -98.85 128.76 50.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.328 0.585 . . . . 0.0 111.497 -174.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.526 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 85.4 tttt -80.6 124.26 28.83 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.461 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 13.1 p -126.11 138.91 53.72 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -173.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.869 ' HB2' ' HB2' ' A' ' 76' ' ' LYS . 40.1 mt-10 -93.95 89.62 6.15 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 172.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.7 136.56 2.02 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -104.39 135.8 45.16 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.101 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.617 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 3.5 p-10 -135.07 102.49 10.97 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 121.329 0.585 . . . . 0.0 111.158 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -88.01 -10.05 5.13 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.341 2.027 . . . . 0.0 111.693 174.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.9 p -113.19 -45.08 3.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.508 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' A' ' 41' ' ' ASN . 57.1 mt -57.85 136.5 21.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 120.96 0.41 . . . . 0.0 110.666 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 78.8 m-20 -101.67 147.38 26.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.816 -176.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.9 m -80.85 -5.88 9.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.293 0.568 . . . . 0.0 110.042 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -93.01 -19.27 21.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.996 169.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 76.9 tt0 -80.78 -32.61 35.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.219 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.6 mt -94.37 138.52 32.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.234 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -133.3 152.65 51.94 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.388 0.613 . . . . 0.0 111.552 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . . . -110.78 125.08 53.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.505 171.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -121.24 159.41 26.01 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.309 0.576 . . . . 0.0 111.718 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.813 HG13 HD11 ' A' ' 15' ' ' LEU . 11.4 m -112.5 123.52 68.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.048 171.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.0 110.47 12.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.441 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.436 HD22 HD11 ' A' ' 89' ' ' LEU . 55.4 mt -106.87 29.31 7.14 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.693 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m -57.85 -43.78 86.12 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.758 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.81 84.76 1.3 Allowed Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.6 p -71.09 91.09 0.89 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.045 0.45 . . . . 0.0 111.995 -173.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -101.33 107.73 52.0 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.01 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.32 152.18 75.83 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.904 2.402 . . . . 0.0 112.292 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.05 -179.38 20.52 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HG2' HG22 ' A' ' 86' ' ' THR . 32.2 tt0 -80.14 102.98 9.7 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 176.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -129.12 143.34 50.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.593 -172.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.493 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 26.8 m-20 -81.74 124.98 30.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.226 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -120.92 151.18 40.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.463 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.13 134.52 34.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.124 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.482 HG13 HD13 ' A' ' 15' ' ' LEU . 68.7 t -79.13 106.4 10.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 174.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -99.67 106.08 17.97 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.517 -177.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 42.4 t -87.12 134.9 26.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.088 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -63.73 135.33 96.24 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.323 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.54 132.3 44.76 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.083 2.522 . . . . 0.0 112.61 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.7 mp -97.53 121.05 59.36 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.052 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.56 119.32 6.47 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.979 2.453 . . . . 0.0 113.0 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.3 m120 69.17 15.08 8.68 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.207 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.511 HD11 ' HB3' ' A' ' 41' ' ' ASN . 57.4 mt -129.53 130.12 67.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.869 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 97.1 mttt -80.89 137.42 36.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.855 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.8 tt -93.41 116.88 35.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.408 0.623 . . . . 0.0 109.659 172.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.7 t -95.63 -50.29 11.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.253 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.526 ' HB2' ' H ' ' A' ' 36' ' ' LYS . 50.1 mt-10 -118.76 157.74 26.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.087 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.597 ' HA ' HG12 ' A' ' 35' ' ' VAL . 18.9 tt -144.55 25.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 122.163 0.982 . . . . 0.0 108.985 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.531 ' HA ' ' N ' ' A' ' 83' ' ' ARG . 16.1 m -85.79 142.86 37.19 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.377 -175.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 81' ' ' SER . 17.4 Cg_exo -67.15 124.39 5.97 Favored 'Cis proline' 0 C--N 1.346 0.425 0 C-N-CA 123.633 -1.403 . . . . 0.0 111.921 -1.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.531 ' N ' ' HA ' ' A' ' 81' ' ' SER . 70.3 mtm180 -69.72 -31.14 68.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.712 -173.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 43.9 t -127.58 134.98 64.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.699 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 m -120.73 133.26 67.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.195 0.521 . . . . 0.0 110.453 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.469 HG22 ' HG2' ' A' ' 62' ' ' GLU . 4.2 m -87.26 101.38 13.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.983 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.3 mt -107.05 134.52 50.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.226 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 62.4 tt0 -95.34 103.12 14.97 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.013 0.435 . . . . 0.0 110.443 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.436 HD11 HD22 ' A' ' 55' ' ' LEU . 49.4 mt -82.46 120.05 24.97 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.474 175.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.62 149.88 23.3 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.1 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -71.0 124.53 24.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.504 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 . . . . . 0 C--N 1.321 -0.672 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.792 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.426 ' HB3' ' HA ' ' A' ' 38' ' ' GLU . 10.2 m-20 . . . . . 0 N--CA 1.467 0.39 0 CA-C-O 121.145 0.498 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.18 147.88 23.82 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.647 2.231 . . . . 0.0 113.567 -173.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 67.9 m -90.72 109.18 20.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.522 171.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.6 mt -83.12 138.51 33.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.217 0.532 . . . . 0.0 110.876 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.3 m -109.96 102.05 10.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.926 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.44 HD22 ' HB2' ' A' ' 49' ' ' LEU . 44.3 mt -101.78 155.3 18.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.106 -176.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 m -88.53 143.48 26.94 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.831 HD11 HG13 ' A' ' 53' ' ' VAL . 52.6 tp -94.91 127.04 40.65 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.7 pt -124.05 160.61 27.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.036 0.446 . . . . 0.0 111.392 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -88.33 115.73 26.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.308 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 18.3 tptm -114.29 141.12 47.99 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 63.34 20.95 12.56 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.67 0.606 . . . . 0.0 110.579 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.456 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 43.1 m -83.17 118.77 72.66 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.845 -173.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 2.9 Cg_exo -76.12 154.58 37.44 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.298 2.665 . . . . 0.0 112.194 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.9 -1.93 21.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.224 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -80.92 -29.12 35.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.071 0.463 . . . . 0.0 110.553 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.8 p -107.16 128.71 54.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.152 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.773 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 58.0 ttp -119.11 126.78 52.44 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.033 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 28' ' ' THR . 13.9 mt -84.83 115.14 26.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.558 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 94.1 mmm -80.63 -7.98 59.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.306 0.574 . . . . 0.0 110.189 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.474 ' H ' HG22 ' A' ' 26' ' ' ILE . 19.2 m -99.23 118.39 35.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.579 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -66.31 132.89 49.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.781 0.324 . . . . 0.0 110.677 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.4 mt -75.45 122.26 86.85 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.415 -173.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HD2' HD23 ' A' ' 15' ' ' LEU . 95.2 Cg_endo -89.49 -157.71 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.183 2.588 . . . . 0.0 112.628 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.5 p -113.71 160.63 18.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.419 ' CG1' ' HB2' ' A' ' 13' ' ' LEU . 11.3 p -112.91 139.4 38.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.83 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -111.31 109.59 19.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.061 0.458 . . . . 0.0 110.8 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 80' ' ' ILE . 25.2 m -117.24 111.69 35.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.085 -177.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.606 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 6.5 ttpm? -74.77 125.95 29.86 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 174.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.532 HG22 ' HA ' ' A' ' 77' ' ' ILE . 25.3 p -124.66 138.07 54.32 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.056 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.426 ' HA ' ' HB3' ' A' ' 8' ' ' ASP . 48.9 mt-10 -94.64 135.46 36.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.366 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.35 -168.4 12.89 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.832 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -132.9 140.2 47.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.914 0.388 . . . . 0.0 110.673 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -160.92 80.47 2.19 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.996 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.66 -24.28 11.96 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.881 2.387 . . . . 0.0 112.53 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.9 p -84.35 -12.98 53.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.695 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.4 mt -103.21 111.08 31.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -95.47 151.72 19.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.096 0.474 . . . . 0.0 111.745 -174.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.5 m -69.4 -13.47 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.358 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -85.5 -9.63 57.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.24 0.543 . . . . 0.0 109.707 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -105.22 -26.33 12.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.754 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HB2' HD22 ' A' ' 13' ' ' LEU . 91.2 mt -88.64 132.32 34.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.831 175.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -125.19 154.06 42.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.613 0.72 . . . . 0.0 111.791 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -120.85 134.98 55.28 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.494 171.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.581 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 18.9 p90 -129.12 161.02 31.01 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.321 0.581 . . . . 0.0 111.411 -174.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.831 HG13 HD11 ' A' ' 15' ' ' LEU . 5.7 m -112.29 118.38 57.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.418 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 16.4 t0 -78.06 105.08 9.03 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.526 -175.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 58' ' ' SER . 64.0 mt -104.73 35.57 2.72 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.755 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.0 m -60.28 -38.63 84.18 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.56 53.33 0.78 Allowed Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.276 173.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.613 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 23.1 t -74.18 107.08 6.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.049 0.452 . . . . 0.0 110.865 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 44.2 mt-10 -104.69 126.2 31.91 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.26 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 59' ' ' GLU . 51.1 Cg_exo -55.3 141.23 81.57 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.961 2.441 . . . . 0.0 111.932 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.44 175.29 19.17 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.45 107.77 13.52 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -134.0 156.78 47.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.982 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -95.7 125.84 40.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.194 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -121.7 161.68 22.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.823 0.344 . . . . 0.0 110.664 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -93.86 138.13 32.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.987 -175.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.1 t -88.35 121.29 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.985 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.418 ' HD2' ' HB2' ' A' ' 54' ' ' ASP . 96.9 mttt -105.06 127.12 52.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.002 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.14 138.64 35.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.14 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -68.59 139.48 91.55 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.62 150.5 86.4 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.113 2.542 . . . . 0.0 112.577 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 75' ' ' ILE . 11.5 mt -122.26 118.58 28.89 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.9 114.81 2.09 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 123.277 2.651 . . . . 0.0 113.479 -175.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.3 m120 70.85 11.37 7.11 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.321 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 72' ' ' ILE . 41.3 mm -107.81 121.79 61.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.12 0.486 . . . . 0.0 110.472 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -80.66 114.81 19.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.425 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.532 ' HA ' HG22 ' A' ' 37' ' ' THR . 16.0 tt -87.94 115.7 28.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.466 0.651 . . . . 0.0 109.918 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.98 -53.02 9.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.64 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.606 ' HG2' ' HB3' ' A' ' 36' ' ' LYS . 66.8 mm-40 -106.64 146.76 30.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.509 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.565 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 26.8 mt -133.71 81.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 165.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 17.7 m -118.58 116.34 35.01 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.719 -175.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 72.8 Cg_endo -94.33 158.33 17.42 Favored 'Cis proline' 0 C--N 1.346 0.41 0 C-N-CA 124.131 -1.195 . . . . 0.0 113.302 -0.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 80' ' ' ILE . 61.2 mtm180 -96.43 -31.99 12.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.592 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.0 t -119.84 122.17 67.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.019 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.1 m -121.55 138.86 50.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.6 m -88.81 102.73 15.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.067 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.6 mt -101.22 128.44 47.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.016 0.436 . . . . 0.0 110.933 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -91.36 103.6 16.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.183 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.471 ' CD2' HG12 ' A' ' 26' ' ' ILE . 96.0 mt -97.05 128.68 44.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.064 0.459 . . . . 0.0 110.728 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -119.33 178.76 4.41 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.482 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -80.55 114.79 19.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.281 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.773 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 74.5 t60 . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 121.245 0.545 . . . . 0.0 109.66 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.488 ' HB3' ' HG2' ' A' ' 38' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.24 151.59 12.22 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.676 2.917 . . . . 0.0 113.509 -170.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 37.9 m -95.25 109.88 21.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.632 174.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.8 mt -87.43 137.99 31.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.027 0.441 . . . . 0.0 110.603 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 m -102.63 95.77 6.44 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.071 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.1 mt -101.74 120.11 39.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.192 -175.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 48.6 m -63.35 140.81 58.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.879 0.371 . . . . 0.0 111.406 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.826 HD11 HG13 ' A' ' 53' ' ' VAL . 40.3 tp -84.01 123.58 30.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.788 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.4 pt -109.83 146.17 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.04 0.448 . . . . 0.0 111.58 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.6 94.16 5.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.126 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -96.31 131.51 42.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.026 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.1 t30 58.62 39.18 24.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.755 0.788 . . . . 0.0 109.933 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 63.8 m -88.59 124.81 65.04 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.638 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.867 ' HG2' ' HB3' ' A' ' 58' ' ' SER . 17.0 Cg_exo -67.51 175.76 5.69 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.0 2.466 . . . . 0.0 112.756 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 92' ' ' HIS . . . -94.2 -6.59 44.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.88 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -88.65 -23.64 22.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.018 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.9 p -114.74 112.45 22.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.834 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.0 ttp -105.69 132.7 51.51 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.7 mt -81.31 118.77 29.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 120.759 0.314 . . . . 0.0 110.718 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 83.6 mtp -74.18 -52.5 12.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.106 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 m -70.27 110.14 5.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.4 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -63.26 133.96 55.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.089 0.471 . . . . 0.0 110.63 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.453 HD22 HD23 ' A' ' 15' ' ' LEU . 50.3 mt -71.54 129.41 88.69 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.454 -173.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -92.32 -170.89 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.37 2.713 . . . . 0.0 111.933 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 24.8 m -105.39 135.6 46.47 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.545 HG11 HG11 ' A' ' 67' ' ' VAL . 10.9 m -86.26 145.22 8.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.789 0.328 . . . . 0.0 110.201 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.5 mtp85 -111.51 101.59 10.0 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.123 0.487 . . . . 0.0 109.937 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 80' ' ' ILE . 26.8 m -110.7 137.04 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.757 -177.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 61.1 tttp -85.9 129.66 34.77 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.2 p -126.36 175.22 8.0 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.174 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.488 ' HG2' ' HB3' ' A' ' 8' ' ' ASP . 35.8 mt-10 -139.07 137.63 36.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.704 0.288 . . . . 0.0 110.651 176.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.5 -175.28 17.46 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.552 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -118.15 126.64 52.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.661 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 4.2 p30 -130.48 62.69 66.2 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.166 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.52 -29.83 36.55 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.139 1.893 . . . . 0.0 111.954 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.8 p -91.15 -1.25 57.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.57 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.661 ' HB ' ' HB2' ' A' ' 41' ' ' ASN . 61.2 mt -109.95 126.64 67.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.777 0.322 . . . . 0.0 110.47 -178.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.411 ' ND2' ' HG3' ' A' ' 48' ' ' GLU . 39.8 t30 -85.58 110.92 19.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.405 0.621 . . . . 0.0 110.912 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.6 t -59.93 -27.35 38.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.336 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -71.02 -28.03 64.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.862 0.363 . . . . 0.0 111.174 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.411 ' HG3' ' ND2' ' A' ' 45' ' ' ASN . 40.9 mt-10 -91.3 -12.17 35.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.096 0.474 . . . . 0.0 110.652 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 93.6 mt -77.06 129.7 36.42 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 167.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -131.92 162.38 30.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.86 0.838 . . . . 0.0 112.564 -174.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -109.74 127.86 54.9 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.907 169.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -123.66 144.03 49.89 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.355 0.598 . . . . 0.0 112.036 -172.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.826 HG13 HD11 ' A' ' 15' ' ' LEU . 7.0 m -112.47 131.48 63.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.159 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.53 115.73 28.39 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.679 -0.408 . . . . 0.0 109.982 -175.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 66.1 mt -105.6 51.97 0.74 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.44 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.1 m -57.32 -47.33 81.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.307 0.575 . . . . 0.0 109.661 173.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.11 100.14 2.47 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.501 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.867 ' HB3' ' HG2' ' A' ' 21' ' ' PRO . 1.5 p -73.18 87.8 1.45 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.969 0.414 . . . . 0.0 110.5 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.412 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 27.4 mt-10 -102.82 110.21 62.86 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.08 -174.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 59' ' ' GLU . 38.9 Cg_endo -66.95 141.32 57.95 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.59 2.194 . . . . 0.0 112.294 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.22 -172.24 17.64 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.67 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.513 ' HG3' ' HG2' ' A' ' 88' ' ' GLN . 1.9 mp0 -87.46 89.15 7.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.789 0.328 . . . . 0.0 110.253 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 38.1 m-70 -104.97 148.35 26.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.442 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -92.19 122.76 34.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.998 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -118.87 147.66 43.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.694 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.526 ' HG2' HG22 ' A' ' 84' ' ' VAL . 36.2 mt-10 -93.79 132.19 38.42 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.888 0.375 . . . . 0.0 110.513 -172.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.545 HG11 HG11 ' A' ' 33' ' ' VAL . 59.8 t -73.22 106.83 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.647 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -86.97 109.48 19.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.804 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.76 123.26 39.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.52 119.53 51.21 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.57 110.01 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.108 2.539 . . . . 0.0 112.704 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.3 mt -82.73 114.48 52.4 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.873 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.31 140.78 54.25 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.427 2.085 . . . . 0.0 112.141 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.4 t30 76.31 -2.78 2.66 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.86 0.725 . . . . 0.0 111.015 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.4 mm -116.62 144.85 23.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.982 0.42 . . . . 0.0 110.543 -177.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -98.91 137.39 37.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.211 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.6 tt -104.64 133.77 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.7 t -102.54 -63.36 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.916 0.389 . . . . 0.0 111.222 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -135.46 143.18 45.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.574 -170.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.633 ' HA ' HG12 ' A' ' 35' ' ' VAL . 57.9 mt -112.32 127.07 69.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.335 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 51.2 m -146.39 114.31 4.47 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.636 0.255 . . . . 0.0 110.957 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 2.8 Cg_endo -83.13 172.33 48.43 Favored 'Cis proline' 0 C--N 1.343 0.254 0 C-N-CA 123.803 -1.332 . . . . 0.0 111.964 -2.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -99.56 -45.25 5.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.369 0.604 . . . . 0.0 109.893 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.526 HG22 ' HG2' ' A' ' 66' ' ' GLU . 59.9 t -128.11 125.6 64.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.344 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 m -113.26 139.34 39.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.173 0.511 . . . . 0.0 111.006 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.4 m -86.61 106.54 17.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.068 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.7 mt -101.34 127.86 47.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.213 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.513 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 48.2 mt-30 -90.21 105.39 17.78 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.654 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.4 mt -95.24 126.42 40.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.217 0.532 . . . . 0.0 110.799 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -108.73 153.51 23.35 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.144 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -76.68 113.43 14.32 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.168 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.473 ' HB3' ' O ' ' A' ' 22' ' ' ALA . 79.4 t60 . . . . . 0 C--N 1.324 -0.517 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.488 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 8.0 p-10 . . . . . 0 C--O 1.234 0.284 0 CA-C-O 121.522 0.677 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 66.6 Cg_endo -99.42 173.53 0.41 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.693 2.928 . . . . 0.0 113.948 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 3.7 m -107.38 130.97 54.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.404 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.7 tp -102.87 135.38 44.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.894 0.378 . . . . 0.0 110.012 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.4 m -100.68 106.33 17.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.096 0.474 . . . . 0.0 110.754 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.493 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 92.0 mt -102.8 158.32 16.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.068 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.4 t -97.86 138.61 34.95 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.501 HD11 HG13 ' A' ' 53' ' ' VAL . 46.9 tp -79.93 124.59 28.81 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.45 HG13 ' HB3' ' A' ' 52' ' ' TYR . 43.8 pt -116.61 156.95 17.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.146 0.498 . . . . 0.0 111.249 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.474 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -87.84 118.68 27.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.668 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -115.78 132.1 56.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.542 -176.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.732 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 95.3 m-20 60.34 26.31 15.83 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.104 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.474 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 50.7 m -79.58 119.51 77.12 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.937 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 27.9 Cg_exo -62.56 158.74 39.81 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 123.14 2.56 . . . . 0.0 112.356 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.77 -8.03 59.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.026 0.441 . . . . 0.0 110.635 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -88.19 -5.86 58.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.611 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.0 p -114.55 131.2 56.75 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.863 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.548 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 49.7 ttp -124.93 120.58 32.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.96 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.458 HG12 ' CD2' ' A' ' 89' ' ' LEU . 8.1 mt -82.08 123.5 38.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 45.6 ttp -74.81 -57.47 3.89 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.091 0.472 . . . . 0.0 110.011 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -70.58 154.14 42.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.57 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -94.15 141.16 28.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.889 0.376 . . . . 0.0 110.6 -178.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 65.4 mt -67.4 114.32 18.51 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.229 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 2.8 Cg_exo -73.76 172.95 14.78 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.695 2.263 . . . . 0.0 112.906 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.2 m -82.48 134.35 35.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.364 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.493 ' CG2' ' HB2' ' A' ' 13' ' ' LEU . 33.7 m -95.32 138.12 21.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.149 0.499 . . . . 0.0 110.038 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.437 ' HG3' ' CG2' ' A' ' 10' ' ' THR . 9.7 ttp180 -104.84 103.66 13.29 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.958 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.553 HG12 ' HA ' ' A' ' 80' ' ' ILE . 25.9 m -117.38 126.11 74.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.096 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 42.3 tttt -93.08 141.92 27.88 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 8' ' ' ASP . 32.9 p -118.33 144.56 45.77 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 123.357 0.41 . . . . 0.0 110.996 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 31.6 tt0 -96.37 107.36 19.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 146.0 -138.71 7.69 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -148.81 126.77 11.94 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -104.78 109.16 62.65 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.318 0.58 . . . . 0.0 111.77 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.39 -47.98 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.749 2.299 . . . . 0.0 111.691 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.1 m -131.64 -68.7 0.64 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.753 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.7 mm 64.91 117.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.398 0.618 . . . . 0.0 111.504 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.458 ' ND2' ' HG2' ' A' ' 48' ' ' GLU . 59.4 t30 -84.5 90.65 7.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.642 0.734 . . . . 0.0 110.681 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.42 ' O ' HG12 ' A' ' 46' ' ' VAL . 11.2 t -78.34 7.11 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.333 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -82.63 -20.24 36.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.814 174.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.458 ' HG2' ' ND2' ' A' ' 45' ' ' ASN . 12.6 mm-40 -107.0 -35.15 6.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.304 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.419 HD13 HD12 ' A' ' 72' ' ' ILE . 80.3 mt -83.01 124.63 30.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.301 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -147.36 175.62 10.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.777 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -123.59 137.36 54.76 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 170.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.45 ' HB3' HG13 ' A' ' 16' ' ' ILE . 20.1 p90 -136.41 160.87 37.44 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.642 0.734 . . . . 0.0 112.917 -173.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.501 HG13 HD11 ' A' ' 15' ' ' LEU . 14.6 m -113.12 125.95 70.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.313 167.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -91.67 102.35 14.98 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -175.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 71.4 mt -92.84 15.13 15.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.572 -173.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.732 ' HB2' ' HB3' ' A' ' 19' ' ' ASN . 8.0 t -73.74 106.19 5.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 175.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.08 35.32 6.76 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.266 -175.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.1 m -120.16 145.84 46.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.725 0.297 . . . . 0.0 110.663 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.91 154.25 37.87 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.978 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.561 ' HA ' ' HB2' ' A' ' 89' ' ' LEU . 26.1 Cg_exo -64.93 169.86 11.17 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.936 2.424 . . . . 0.0 112.159 175.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.37 -177.73 27.41 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -175.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -86.56 111.39 20.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.004 0.431 . . . . 0.0 110.396 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 65' ' ' TYR . 35.5 m80 -129.03 151.79 49.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.953 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.466 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 19.2 m-20 -90.11 103.22 15.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.847 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 63' ' ' HIS . 72.5 m-85 -97.39 147.33 24.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.766 -176.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -87.9 125.26 34.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.807 -172.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 64.6 t -74.74 110.63 9.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.134 0.493 . . . . 0.0 110.094 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -101.82 106.14 17.08 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.111 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.2 t -91.91 136.36 24.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.491 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -75.1 122.05 86.58 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 171.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.42 142.35 88.97 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.705 2.27 . . . . 0.0 112.063 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.419 HD12 HD13 ' A' ' 49' ' ' LEU . 32.7 mm -82.18 120.1 76.44 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.571 -177.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 22.0 Cg_exo -66.08 146.04 80.9 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.23 1.953 . . . . 0.0 111.307 175.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 73' ' ' PRO . 84.5 m-20 76.8 -41.19 0.39 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.491 0.716 . . . . 0.0 112.079 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.7 mt -103.08 157.4 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 58.4 tttm -92.88 146.07 23.91 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 tt -95.18 144.51 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 122.094 -0.379 . . . . 0.0 109.979 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.401 ' CG2' ' HB2' ' A' ' 38' ' ' GLU . 45.4 t -114.62 -70.89 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.951 0.405 . . . . 0.0 111.349 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -116.51 148.76 40.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.226 -169.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.553 ' HA ' HG12 ' A' ' 35' ' ' VAL . 73.8 mt -132.08 107.04 12.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.025 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.4 t -137.66 126.66 14.86 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.092 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.422 ' HD2' HG12 ' A' ' 33' ' ' VAL . 97.3 Cg_endo -81.51 177.52 34.53 Favored 'Cis proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.065 -1.639 . . . . 0.0 112.637 -0.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -112.6 -47.32 3.08 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.627 -173.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.466 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 61.4 t -125.45 121.49 60.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 m -111.69 135.6 50.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.021 0.439 . . . . 0.0 111.575 -175.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.7 m -83.12 110.25 17.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.687 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.404 ' HB2' ' HD2' ' A' ' 65' ' ' TYR . 93.6 mt -110.66 129.11 55.9 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.406 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -93.46 107.24 19.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.91 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' A' ' 60' ' ' PRO . 80.7 mt -93.29 123.66 36.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.993 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.64 162.04 13.19 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.192 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.469 ' CE1' ' HG2' ' A' ' 60' ' ' PRO . 55.6 m-70 -82.55 117.93 22.9 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.907 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 17.2 t-80 . . . . . 0 C--N 1.323 -0.55 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 175.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 121.466 0.651 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -79.05 169.87 18.63 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.66 2.24 . . . . 0.0 112.631 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 m -105.21 103.7 13.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.998 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.619 ' HB2' HG23 ' A' ' 35' ' ' VAL . 83.4 mt -83.24 134.7 34.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.067 0.46 . . . . 0.0 110.156 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.3 m -110.63 104.57 13.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.233 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 60.1 mt -104.68 157.91 16.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.242 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 m -91.01 143.78 26.35 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.588 HD11 HG13 ' A' ' 53' ' ' VAL . 49.9 tp -92.56 133.23 36.15 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.0 pt -132.26 162.61 39.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.012 0.434 . . . . 0.0 110.893 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.429 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -97.26 126.28 42.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.224 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -124.27 139.82 53.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 64.45 19.06 11.66 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.61 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.429 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 49.2 m -83.9 120.5 75.06 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.821 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.97 177.44 8.73 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.578 2.185 . . . . 0.0 112.72 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.23 -14.38 53.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.336 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -77.9 -16.18 58.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.314 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 p -110.38 113.39 26.0 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.363 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 56.1 ttp -102.98 123.9 47.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.569 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.524 HG12 ' CD2' ' A' ' 89' ' ' LEU . 26.3 mt -86.8 119.56 34.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.052 -173.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 89.4 mmm -92.57 -30.8 15.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.402 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -72.33 105.45 4.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.31 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.42 129.51 39.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.388 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 84.4 mt -72.19 127.77 89.91 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.832 -170.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 95.2 Cg_endo -96.5 -162.49 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.684 2.923 . . . . 0.0 112.4 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.6 p -104.24 158.64 16.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.086 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.3 m -111.55 152.78 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -112.95 97.42 6.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.943 0.401 . . . . 0.0 110.149 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.619 HG23 ' HB2' ' A' ' 11' ' ' LEU . 17.8 m -96.98 107.97 20.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.917 0.865 . . . . 0.0 110.205 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.549 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 1.2 mmmp? -75.02 130.98 40.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.745 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.453 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 26.3 p -135.21 128.43 31.95 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.974 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.557 ' HG3' ' CG2' ' A' ' 78' ' ' VAL . 40.2 mt-10 -86.45 94.23 9.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.462 ' HA3' HG23 ' A' ' 75' ' ' ILE . . . 160.06 157.1 8.45 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.899 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -98.65 118.51 35.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -126.99 82.42 68.09 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -89.63 -15.8 2.14 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.542 2.161 . . . . 0.0 112.281 171.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.3 t -98.1 15.55 23.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.013 0.435 . . . . 0.0 110.823 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.4 mt -124.58 137.92 55.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.235 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -94.79 114.58 26.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.312 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.458 HG11 HD22 ' A' ' 11' ' ' LEU . 35.1 m -76.23 -24.34 16.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -75.19 -24.58 57.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.142 0.496 . . . . 0.0 109.929 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -83.6 -34.0 25.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.843 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.69 126.12 28.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.533 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -115.98 147.78 40.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.268 0.556 . . . . 0.0 111.378 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -109.71 124.44 51.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -121.53 160.29 24.58 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.381 0.61 . . . . 0.0 111.865 -174.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.588 HG13 HD11 ' A' ' 15' ' ' LEU . 6.0 m -112.29 123.35 67.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.111 172.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -86.48 108.77 18.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.18 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.8 34.97 2.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.368 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.3 m -64.91 107.57 1.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.896 0.379 . . . . 0.0 110.337 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.92 48.31 5.51 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.908 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.3 p -101.29 113.8 27.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.815 0.34 . . . . 0.0 111.336 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -79.31 128.27 76.13 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 173.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -49.84 100.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.681 2.921 . . . . 0.0 113.265 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.45 ' H ' ' HB2' ' A' ' 89' ' ' LEU . . . -177.76 175.36 47.5 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -80.28 114.48 19.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.02 0.41 . . . . 0.0 109.979 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 65' ' ' TYR . 31.6 m170 -134.15 160.12 38.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.54 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.0 t70 -97.0 108.19 20.88 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 63' ' ' HIS . 78.1 m-85 -109.72 152.58 25.46 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 111.291 -171.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.84 139.4 37.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.098 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 97.4 t -92.14 120.53 41.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -117.36 108.88 16.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.422 -175.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 59.1 t -89.2 148.96 4.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.914 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -61.81 118.61 40.16 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 171.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.55 128.99 30.12 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.979 2.453 . . . . 0.0 112.53 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.28 114.71 63.98 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.906 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.8 151.09 18.86 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.066 2.511 . . . . 0.0 111.657 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 74.37 -39.73 0.43 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.653 0.781 . . . . 0.0 111.712 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.462 HG23 ' HA3' ' A' ' 39' ' ' GLY . 40.0 mm -92.39 136.02 25.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 38' ' ' GLU . 58.3 tttm -87.6 118.49 27.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.616 0.246 . . . . 0.0 110.448 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.3 tt -81.31 123.84 38.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.346 0.594 . . . . 0.0 110.907 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.557 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 31.6 t -86.19 -60.9 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.441 0.639 . . . . 0.0 109.916 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -121.01 153.31 37.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.585 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.644 HG23 ' HG2' ' A' ' 83' ' ' ARG . 14.8 tt -127.39 18.41 3.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 173.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.5 m -64.18 134.65 96.03 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.695 -175.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.59 133.14 30.02 Favored 'Cis proline' 0 C--N 1.343 0.267 0 C-N-CA 123.382 -1.507 . . . . 0.0 111.988 -0.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.644 ' HG2' HG23 ' A' ' 80' ' ' ILE . 58.8 mtm180 -72.05 -38.14 69.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.208 0.528 . . . . 0.0 110.517 -176.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -134.59 136.45 52.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.068 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.5 m -129.04 141.79 45.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.141 0.495 . . . . 0.0 111.144 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 15.8 m -89.72 109.41 20.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.138 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.406 HD11 HG21 ' A' ' 53' ' ' VAL . 97.6 mt -100.29 124.9 46.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.631 -176.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -85.67 99.03 11.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.01 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.524 ' CD2' HG12 ' A' ' 26' ' ' ILE . 89.8 mt -95.57 139.8 31.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.901 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.752 ' HG2' ' H ' ' A' ' 91' ' ' HIS . 22.4 tt0 -117.67 176.84 4.99 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.752 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 25.9 m-70 -82.46 151.65 26.45 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.909 -176.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.5 p80 . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 121.644 0.735 . . . . 0.0 109.958 178.33 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 C--O 1.235 0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' A' ' 37' ' ' THR . 6.2 Cg_exo -80.22 130.37 8.17 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.925 2.417 . . . . 0.0 112.29 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 m -105.88 110.32 22.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.925 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 40.1 tp -93.63 135.52 34.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.745 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 16.3 m -117.02 109.6 17.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.896 0.379 . . . . 0.0 110.631 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.7 mt -111.64 144.16 41.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.192 -174.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -75.98 147.26 38.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.924 0.392 . . . . 0.0 110.771 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.75 HD11 HG13 ' A' ' 53' ' ' VAL . 41.4 tp -90.49 133.51 35.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.114 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.5 ' CG1' ' HB3' ' A' ' 52' ' ' TYR . 48.0 pt -112.63 153.55 14.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.979 0.419 . . . . 0.0 110.725 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.38 105.66 17.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.547 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 62.0 tttm -93.82 106.65 18.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.012 0.434 . . . . 0.0 111.204 -175.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 56.26 77.75 0.23 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.89 174.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.9 t -106.86 140.22 21.16 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 172.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 55' ' ' LEU . 36.2 Cg_exo -62.75 169.16 9.06 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.017 2.478 . . . . 0.0 112.91 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.1 6.87 27.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.534 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -107.5 -6.16 17.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.314 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.415 ' OG ' ' HD2' ' A' ' 21' ' ' PRO . 5.0 p -118.42 128.9 55.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.814 -176.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.0 ttp -115.66 131.86 56.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.652 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.5 mt -90.34 103.73 14.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.799 0.333 . . . . 0.0 110.665 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 81.3 mtp -75.58 -38.82 58.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.303 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.5 m -71.52 120.02 16.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.241 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.57 120.09 16.66 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.6 mt -54.71 117.76 14.78 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.513 -174.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.67 -163.2 0.2 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.976 2.45 . . . . 0.0 112.227 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 m -123.31 134.9 54.01 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 120.914 0.388 . . . . 0.0 110.363 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.829 HG11 HG11 ' A' ' 67' ' ' VAL . 33.2 m -85.94 133.04 30.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.979 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 34' ' ' ARG . 25.7 ttt180 -110.01 97.34 6.86 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 80' ' ' ILE . 33.5 m -102.89 157.58 4.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.58 -171.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.476 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 10.3 mmmt -98.37 128.25 44.68 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.487 ' O ' ' HD2' ' A' ' 9' ' ' PRO . 10.0 p -116.07 145.91 42.63 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.962 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.478 ' HB2' ' CG2' ' A' ' 78' ' ' VAL . 41.7 tt0 -110.39 107.0 16.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.598 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.36 -153.79 25.26 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.739 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.586 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 96.6 m-85 -121.8 135.82 54.92 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -105.57 96.33 11.88 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 6.1 Cg_exo -79.62 -71.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.801 2.334 . . . . 0.0 111.505 177.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.5 t -162.45 95.47 0.92 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.415 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.578 ' HB ' HG13 ' A' ' 46' ' ' VAL . 32.7 mt -132.67 160.78 42.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.405 ' N ' HG22 ' A' ' 44' ' ' ILE . 11.7 m120 -76.9 46.16 0.46 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.329 0.585 . . . . 0.0 110.633 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.578 HG13 ' HB ' ' A' ' 44' ' ' ILE . 20.2 m -67.24 -32.29 56.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.273 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -81.94 -9.5 59.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.151 0.5 . . . . 0.0 110.252 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -95.13 -12.5 26.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.005 176.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.4 ' CD1' HG12 ' A' ' 72' ' ' ILE . 91.6 mt -78.6 136.36 37.49 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 166.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -130.24 171.24 13.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.221 0.534 . . . . 0.0 111.703 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.37 139.53 42.96 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.38 175.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.501 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 2.0 p90 -127.55 145.13 50.96 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.217 0.532 . . . . 0.0 111.99 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.75 HG13 HD11 ' A' ' 15' ' ' LEU . 17.0 m -119.56 129.05 75.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.049 174.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -76.45 119.42 20.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.975 0.416 . . . . 0.0 110.148 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.443 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 76.7 mt -112.16 26.88 10.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.301 -176.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.7 m -70.25 -33.74 71.99 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -169.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.89 86.61 0.14 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.231 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.4 m -143.43 155.95 44.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.554 0.216 . . . . 0.0 110.521 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.487 ' HB2' ' NE2' ' A' ' 63' ' ' HIS . 1.6 mp0 -64.97 145.42 99.07 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.392 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 59' ' ' GLU . 10.2 Cg_exo -71.27 91.19 0.66 Allowed 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.806 2.337 . . . . 0.0 112.045 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.28 -166.8 39.66 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 88' ' ' GLN . 42.5 mt-10 -77.34 113.38 15.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.238 0.519 . . . . 0.0 110.336 177.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.487 ' NE2' ' HB2' ' A' ' 59' ' ' GLU . 94.3 m-70 -139.67 173.67 11.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.819 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -94.02 133.34 37.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.11 -173.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.422 ' CE2' ' HB2' ' A' ' 87' ' ' LEU . 74.0 m-85 -131.34 135.63 47.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.103 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -78.83 125.94 30.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.235 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.829 HG11 HG11 ' A' ' 33' ' ' VAL . 93.2 t -85.25 108.77 17.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.237 0.541 . . . . 0.0 110.566 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -99.75 115.86 30.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.782 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.8 t -101.49 148.71 7.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.89 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.28 144.23 97.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.056 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -83.41 149.64 13.16 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.908 2.405 . . . . 0.0 112.704 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 75' ' ' ILE . 23.4 mt -117.94 119.0 34.15 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.63 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -85.13 21.07 1.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.69 2.26 . . . . 0.0 112.911 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -131.17 -56.25 1.03 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.157 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.545 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 53.1 mt -105.61 137.84 33.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.182 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -89.71 133.25 34.77 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.707 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.5 tt -83.88 123.38 38.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.547 0.689 . . . . 0.0 109.635 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.478 ' CG2' ' HB2' ' A' ' 38' ' ' GLU . 47.0 t -94.29 -60.84 2.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.943 -174.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 36' ' ' LYS . 27.3 tt0 -118.76 134.48 55.11 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.216 -172.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.715 ' HB ' ' HG3' ' A' ' 83' ' ' ARG . 59.0 mt -109.26 109.59 28.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 54.8 m -133.34 124.52 18.26 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.626 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.541 ' HD2' HG12 ' A' ' 33' ' ' VAL . 4.5 Cg_exo -81.48 142.72 55.77 Favored 'Cis proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.29 -1.546 . . . . 0.0 111.641 -5.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.715 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 5.5 mtm180 -78.71 -37.8 40.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.221 0.534 . . . . 0.0 110.3 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.6 t -124.06 117.5 51.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.49 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.6 m -107.36 152.52 8.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.773 0.321 . . . . 0.0 111.034 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 14.5 m -109.05 99.31 8.64 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.966 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 89.8 mt -102.79 142.62 33.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.317 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.609 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 53.6 tt0 -98.03 106.45 18.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.0 0.429 . . . . 0.0 110.802 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.2 mt -88.79 151.19 22.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.014 174.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -131.7 167.57 19.26 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.511 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -73.36 113.34 10.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.957 0.408 . . . . 0.0 110.761 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 21.6 t60 . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.121 -179.213 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 . . . . . 0 CA--C 1.532 0.277 0 CA-C-O 121.417 0.627 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -90.54 174.96 2.8 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.979 2.452 . . . . 0.0 112.873 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.0 m -107.38 122.22 46.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.76 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.683 HD22 HG11 ' A' ' 46' ' ' VAL . 67.4 mt -104.15 127.4 51.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.138 0.494 . . . . 0.0 110.907 -176.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.0 m -101.34 107.18 18.46 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.132 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.3 mt -108.02 149.17 28.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.36 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.6 p -82.78 141.24 32.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.646 0.26 . . . . 0.0 110.515 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.813 HD11 HG13 ' A' ' 53' ' ' VAL . 43.0 tp -90.09 133.04 35.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.516 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.3 pt -116.67 155.68 18.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.968 0.413 . . . . 0.0 111.006 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -85.12 110.47 19.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.24 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -106.21 137.16 44.64 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.534 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 63.0 16.4 9.23 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.548 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.47 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 18.7 m -74.36 117.24 60.29 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.28 -176.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 5.7 Cg_exo -74.51 173.1 14.87 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.064 2.51 . . . . 0.0 112.449 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.69 -5.96 59.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.603 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -78.07 -9.2 59.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.562 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.524 ' HB2' HD22 ' A' ' 89' ' ' LEU . 11.9 p -129.78 128.73 42.98 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.992 -176.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.609 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 58.5 ttp -114.54 139.03 49.91 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.404 HG12 ' CD2' ' A' ' 89' ' ' LEU . 8.5 mt -110.19 99.13 8.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.523 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 78.2 mtp -82.14 -15.35 53.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.982 0.42 . . . . 0.0 110.362 176.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.4 m -81.05 106.28 12.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -63.44 123.0 17.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.011 -175.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.4 mt -62.02 119.26 47.03 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.504 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.75 -164.05 0.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.802 2.335 . . . . 0.0 112.655 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.1 p -106.43 142.03 36.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.757 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.0 p -99.0 139.4 20.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -110.74 101.67 10.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.303 0.573 . . . . 0.0 110.381 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 80' ' ' ILE . 33.4 m -105.09 130.83 55.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.388 -177.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.563 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 58.2 tttm -94.0 132.64 38.27 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.512 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 26.2 p -126.81 152.19 47.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.465 -174.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 76' ' ' LYS . 50.4 mt-10 -108.94 96.0 6.02 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.57 156.47 7.72 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -108.64 129.36 55.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.439 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 41.2 m-80 -70.89 114.06 23.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.96 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 41' ' ' ASN . 3.5 Cg_exo -80.14 -71.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.804 2.336 . . . . 0.0 111.833 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 p -113.04 10.16 18.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.482 0.658 . . . . 0.0 110.048 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.0 mt -92.94 133.37 34.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.111 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.549 ' HB2' ' HG3' ' A' ' 48' ' ' GLU . 53.6 m-80 -113.18 126.51 55.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.073 0.463 . . . . 0.0 110.061 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.683 HG11 HD22 ' A' ' 11' ' ' LEU . 34.4 m -77.41 -8.41 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.51 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -89.39 -4.14 58.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.27 0.557 . . . . 0.0 110.127 173.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.549 ' HG3' ' HB2' ' A' ' 45' ' ' ASN . 42.3 mt-10 -99.57 -34.56 10.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.571 174.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.7 mt -81.24 138.57 35.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.921 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -127.23 168.43 14.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.505 0.669 . . . . 0.0 111.299 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.6 147.59 29.31 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 171.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -140.46 146.88 38.82 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.19 0.519 . . . . 0.0 111.29 -174.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.813 HG13 HD11 ' A' ' 15' ' ' LEU . 4.3 m -112.25 130.64 65.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.405 175.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -79.47 91.56 5.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.043 -176.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.468 HD12 ' OG1' ' A' ' 20' ' ' THR . 52.0 mt -93.84 59.14 2.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.835 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 p -77.58 -4.72 47.25 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.332 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.66 -178.31 39.56 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.799 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.1 m -144.95 21.19 1.61 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.198 0.523 . . . . 0.0 109.786 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.11 115.84 52.28 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.342 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.13 158.51 56.24 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.955 2.436 . . . . 0.0 112.496 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.43 -163.29 22.82 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.516 ' HB3' HG22 ' A' ' 86' ' ' THR . 40.7 mt-10 -86.45 108.82 18.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.153 0.501 . . . . 0.0 110.293 177.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -117.68 143.03 46.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.652 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 10.0 m-20 -81.51 138.08 35.51 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -138.95 150.89 46.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.993 0.425 . . . . 0.0 111.18 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -90.33 123.03 33.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.69 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.9 t -81.24 134.74 26.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.556 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -125.45 153.44 43.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.095 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.7 t -127.28 146.44 33.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 43.6 mt-10 -63.04 125.49 86.92 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 32.2 Cg_exo -59.13 124.16 15.02 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.086 2.524 . . . . 0.0 112.857 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.403 HD12 ' H ' ' A' ' 72' ' ' ILE . 4.0 mp -95.18 125.94 48.34 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.725 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.95 146.57 42.1 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.254 1.969 . . . . 0.0 111.98 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 72.78 -45.85 0.63 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.722 0.809 . . . . 0.0 112.197 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.512 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 51.2 mt -84.05 133.09 29.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.014 0.435 . . . . 0.0 110.514 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 94.7 mttt -87.07 142.04 28.22 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.206 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 tt -99.58 119.28 47.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.22 0.533 . . . . 0.0 110.316 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.5 t -94.17 -48.02 13.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.807 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.563 ' HB2' ' H ' ' A' ' 36' ' ' LYS . 20.3 mm-40 -118.7 148.66 42.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.173 -176.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.842 HG23 ' HG2' ' A' ' 83' ' ' ARG . 16.1 tt -138.96 27.54 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 122.361 1.077 . . . . 0.0 108.419 174.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.6 m -83.1 141.04 42.9 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.131 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.51 131.43 23.23 Favored 'Cis proline' 0 C--N 1.346 0.418 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.215 0.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.842 ' HG2' HG23 ' A' ' 80' ' ' ILE . 73.7 mtm180 -78.24 -49.55 13.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.306 -175.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.8 119.5 60.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.788 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.29 145.59 27.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.732 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 62' ' ' GLU . 8.6 m -99.86 101.74 12.96 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.3 mt -94.08 145.74 24.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 -175.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -97.56 125.85 42.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.124 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.524 HD22 ' HB2' ' A' ' 24' ' ' SER . 90.0 mt -116.47 131.96 56.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.853 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -100.38 151.52 21.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.529 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -66.75 104.69 1.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.214 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.609 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 23.5 t-80 . . . . . 0 C--N 1.321 -0.644 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 120.483 0.182 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.593 ' HG2' ' OG1' ' A' ' 37' ' ' THR . 29.6 Cg_endo -65.45 115.66 3.48 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.955 1.77 . . . . 0.0 112.816 -172.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.7 m -87.56 99.34 11.97 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 171.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.42 125.27 31.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.555 -175.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.2 m -95.26 89.85 5.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.88 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.429 HD23 HG13 ' A' ' 46' ' ' VAL . 60.2 mt -91.0 131.62 36.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.437 -174.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.4 m -74.41 139.8 44.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.839 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.897 HD11 HG13 ' A' ' 53' ' ' VAL . 30.0 tp -84.71 127.34 34.05 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.411 HD11 ' CE2' ' A' ' 52' ' ' TYR . 29.0 pt -120.68 142.51 36.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.445 0.641 . . . . 0.0 112.23 -176.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.555 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -72.76 111.93 8.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.288 175.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -79.21 -78.24 0.16 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.094 0.473 . . . . 0.0 110.645 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -110.61 75.83 0.95 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.405 0.621 . . . . 0.0 109.571 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.555 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 94.6 m -99.62 113.04 64.74 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.225 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.11 155.2 52.15 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.13 2.553 . . . . 0.0 112.767 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.3 -1.82 11.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.947 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -104.6 -2.03 25.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.879 0.371 . . . . 0.0 110.567 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.4 m -107.3 115.49 30.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.458 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 55.7 ttp -107.55 117.39 33.97 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.014 0.435 . . . . 0.0 110.657 -177.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.5 mt -92.08 102.59 13.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.892 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 80.5 mtp -86.23 -33.33 20.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.747 0.308 . . . . 0.0 110.807 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.4 m -81.08 117.78 21.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.047 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -59.84 124.55 20.52 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 84.1 mt -59.66 121.16 55.42 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.289 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 12.4 Cg_exo -69.33 -179.36 2.67 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.865 2.377 . . . . 0.0 112.502 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 p -109.07 146.22 34.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.124 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.668 HG11 HG11 ' A' ' 67' ' ' VAL . 20.3 m -97.08 140.07 18.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.067 0.461 . . . . 0.0 109.993 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -109.56 98.28 7.68 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.661 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.623 HG12 ' HA ' ' A' ' 80' ' ' ILE . 32.8 m -103.09 142.32 17.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.074 -176.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -92.53 129.84 38.35 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.593 ' OG1' ' HG2' ' A' ' 9' ' ' PRO . 27.3 p -121.46 161.46 22.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.592 0.234 . . . . 0.0 110.585 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.465 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 22.6 tt0 -123.79 143.1 50.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.056 -175.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.09 -118.93 1.91 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.336 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -144.48 131.74 20.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.439 ' HB3' ' HG3' ' A' ' 9' ' ' PRO . 2.5 p-10 -120.88 91.64 47.74 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 121.354 0.597 . . . . 0.0 112.154 -174.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -89.48 -51.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.731 2.287 . . . . 0.0 112.671 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -159.28 96.63 1.32 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.256 0.551 . . . . 0.0 110.243 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mp -117.21 126.38 74.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.597 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.531 ' ND2' ' HB2' ' A' ' 48' ' ' GLU . 58.0 t30 -80.01 94.47 5.93 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.762 0.791 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.429 HG13 HD23 ' A' ' 13' ' ' LEU . 19.1 t -68.59 -17.79 22.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.536 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -82.8 5.49 21.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.719 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.531 ' HB2' ' ND2' ' A' ' 45' ' ' ASN . 40.7 tt0 -119.17 -33.35 4.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.199 176.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.7 mt -79.51 127.84 32.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -136.81 166.87 22.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.628 0.727 . . . . 0.0 112.14 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.457 ' HB1' HG13 ' A' ' 67' ' ' VAL . . . -109.35 128.76 55.36 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.046 172.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.657 ' HE1' ' HB2' ' A' ' 70' ' ' GLU . 48.5 m-85 -103.42 138.51 40.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.934 0.397 . . . . 0.0 111.391 -173.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.897 HG13 HD11 ' A' ' 15' ' ' LEU . 3.0 m -125.86 129.76 72.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.815 169.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -88.49 91.61 8.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.303 0.573 . . . . 0.0 109.566 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.508 HD21 HD12 ' A' ' 87' ' ' LEU . 52.4 mt -87.79 38.82 0.86 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.691 -174.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.9 p -68.77 -24.55 64.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.974 0.416 . . . . 0.0 109.982 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.2 111.93 3.8 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 m -96.97 26.22 4.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.996 0.427 . . . . 0.0 110.727 -173.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -87.27 115.38 62.54 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.671 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.06 140.88 55.75 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.446 2.098 . . . . 0.0 111.248 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.64 -150.66 19.05 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -116.5 105.79 12.87 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.997 0.427 . . . . 0.0 109.969 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -122.25 148.91 44.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.093 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 44.9 m-20 -81.76 132.83 35.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.908 0.385 . . . . 0.0 110.703 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -127.91 137.15 52.19 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.521 ' HG2' HG22 ' A' ' 84' ' ' VAL . 40.3 mt-10 -88.71 134.85 33.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.036 0.446 . . . . 0.0 110.885 -173.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.668 HG11 HG11 ' A' ' 33' ' ' VAL . 65.2 t -71.81 102.2 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.732 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -92.67 101.69 14.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.554 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.2 t -87.27 143.64 10.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.146 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.657 ' HB2' ' HE1' ' A' ' 52' ' ' TYR . 32.2 tt0 -77.95 114.76 44.73 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -56.41 130.84 42.25 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.051 2.5 . . . . 0.0 112.738 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.7 mt -94.32 125.09 53.54 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.51 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.57 141.87 42.99 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.578 2.186 . . . . 0.0 111.504 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.3 t30 74.16 -44.03 0.55 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.368 0.667 . . . . 0.0 111.801 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.8 mm -83.86 119.22 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.125 0.488 . . . . 0.0 110.37 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.465 ' HD3' ' HB3' ' A' ' 38' ' ' GLU . 80.0 tttt -80.73 124.82 29.36 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.598 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.556 ' HA ' HG22 ' A' ' 37' ' ' THR . 17.0 tt -88.96 131.61 35.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.148 0.499 . . . . 0.0 110.233 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.7 t -100.78 -58.87 3.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.319 -175.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -138.14 147.24 43.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.881 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.623 ' HA ' HG12 ' A' ' 35' ' ' VAL . 58.9 mt -115.57 121.78 67.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.203 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 70.1 m -138.16 115.85 9.39 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.921 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.534 ' HD2' HG12 ' A' ' 33' ' ' VAL . 2.1 Cg_endo -86.31 170.94 40.95 Favored 'Cis proline' 0 N--CA 1.462 -0.347 0 C-N-CA 124.063 -1.224 . . . . 0.0 112.308 -1.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -98.83 -32.43 11.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.346 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.521 HG22 ' HG2' ' A' ' 66' ' ' GLU . 45.4 t -129.79 132.13 66.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.384 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 m -123.85 128.77 74.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.164 0.507 . . . . 0.0 111.139 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 7.4 m -82.54 103.89 12.41 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.508 HD12 HD21 ' A' ' 55' ' ' LEU . 90.1 mt -94.83 146.27 24.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.16 0.505 . . . . 0.0 111.237 -173.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.2 tm0? -98.23 119.43 36.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.282 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.8 mt -123.63 146.33 48.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.813 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -139.45 173.17 11.81 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 169.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -69.73 127.88 34.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.828 0.347 . . . . 0.0 110.632 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 11.9 t-80 . . . . . 0 C--N 1.323 -0.582 0 CA-C-O 122.426 1.108 . . . . 0.0 108.131 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.426 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 28.2 m-20 . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.417 0.151 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.82 101.82 0.19 Allowed 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.464 2.109 . . . . 0.0 112.153 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 m -98.2 109.0 21.83 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.283 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.1 mt -104.8 145.91 29.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.177 0.513 . . . . 0.0 111.042 -173.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 20.6 m -122.83 102.49 8.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.527 174.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.7 mt -96.17 140.05 31.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.334 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -73.21 135.95 44.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.325 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.726 HD11 HG13 ' A' ' 53' ' ' VAL . 42.4 tp -85.88 119.59 26.36 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.5 pt -112.58 155.65 13.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.166 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.422 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -87.86 114.73 24.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.048 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -117.37 143.28 46.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.8 t30 61.01 26.26 16.23 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.879 0.847 . . . . 0.0 109.698 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.514 HG23 HD12 ' A' ' 55' ' ' LEU . 85.1 m -85.86 117.41 68.67 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.736 -177.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 11.7 Cg_exo -69.38 162.69 40.88 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.016 2.477 . . . . 0.0 112.575 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.39 -8.64 58.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.415 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -92.31 3.74 54.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.887 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 p -127.88 139.71 52.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.759 0.314 . . . . 0.0 111.212 -175.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.457 ' HB2' ' NE2' ' A' ' 92' ' ' HIS . 14.1 ttm -127.13 129.95 48.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.741 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.488 HG12 ' CD2' ' A' ' 89' ' ' LEU . 12.9 mt -88.17 97.47 6.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 86.9 mtp -62.85 -33.24 74.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.237 0.541 . . . . 0.0 110.05 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 m -74.49 104.71 5.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.624 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -64.33 121.0 13.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.092 0.472 . . . . 0.0 110.664 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.21 122.69 65.37 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.224 -171.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -87.05 -155.8 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.523 2.815 . . . . 0.0 112.093 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.5 m -120.19 150.51 40.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.85 0.357 . . . . 0.0 110.657 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' THR . 12.7 p -103.45 138.71 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.835 -177.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 34' ' ' ARG . 19.6 mtp180 -98.38 119.91 37.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.073 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 80' ' ' ILE . 25.1 m -128.59 123.77 60.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.651 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 8' ' ' ASP . 87.8 tttt -95.84 138.83 32.93 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.542 HG22 ' HA ' ' A' ' 77' ' ' ILE . 35.5 p -126.73 155.2 43.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.993 0.425 . . . . 0.0 111.869 -175.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.531 ' HG3' ' CG2' ' A' ' 78' ' ' VAL . 42.8 mt-10 -105.81 120.59 42.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.797 174.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.2 -171.53 26.28 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -135.03 101.07 4.76 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.76 112.36 6.0 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.228 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.11 -62.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.767 2.311 . . . . 0.0 111.143 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.5 t -145.7 79.09 1.56 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.131 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -121.85 130.73 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.795 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.428 ' ND2' ' HG3' ' A' ' 48' ' ' GLU . 59.0 t30 -94.59 103.93 15.87 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.729 0.776 . . . . 0.0 110.895 -175.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.4 t -62.91 -23.88 34.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.294 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -66.18 -20.78 66.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.951 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.428 ' HG3' ' ND2' ' A' ' 45' ' ' ASN . 48.3 mt-10 -105.28 -11.17 16.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.939 0.399 . . . . 0.0 110.831 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.9 128.68 33.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 170.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -136.67 173.3 11.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.31 0.576 . . . . 0.0 111.697 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -131.45 140.89 49.69 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -129.07 156.75 43.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.472 0.653 . . . . 0.0 112.102 -173.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.726 HG13 HD11 ' A' ' 15' ' ' LEU . 4.6 m -112.17 118.18 57.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.363 172.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.78 106.3 16.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.246 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.514 HD12 HG23 ' A' ' 20' ' ' THR . 63.4 mt -95.05 45.29 1.1 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.537 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 p -57.37 -44.64 84.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.806 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.88 67.19 0.49 Allowed Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.106 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 p -68.9 101.14 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.054 0.454 . . . . 0.0 111.126 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.5 129.99 23.54 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.527 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.449 ' HB3' ' HB2' ' A' ' 91' ' ' HIS . 33.7 Cg_endo -65.45 138.97 57.17 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.552 2.168 . . . . 0.0 112.22 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.46 178.16 19.81 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.02 99.13 4.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.862 0.363 . . . . 0.0 110.534 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -119.93 141.23 49.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.454 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -84.97 133.29 34.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.029 0.443 . . . . 0.0 109.994 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -126.11 157.75 37.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.809 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -84.73 128.05 34.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.619 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.1 t -78.25 99.37 2.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.114 0.483 . . . . 0.0 109.731 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -87.77 118.51 27.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.906 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.1 t -95.32 143.78 11.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.729 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.427 ' OE1' ' HD2' ' A' ' 71' ' ' PRO . 8.5 tp10 -70.32 113.89 21.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 174.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.427 ' HD2' ' OE1' ' A' ' 70' ' ' GLU . 11.7 Cg_endo -55.33 124.03 15.27 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.995 2.463 . . . . 0.0 112.646 -176.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -94.45 119.98 65.7 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.889 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.61 135.38 48.82 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.494 2.13 . . . . 0.0 112.537 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 t30 73.52 -33.96 0.27 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.771 0.828 . . . . 0.0 112.96 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.424 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 49.9 mm -84.16 136.4 22.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.048 0.451 . . . . 0.0 111.031 -177.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -97.6 121.12 39.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.446 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.542 ' HA ' HG22 ' A' ' 37' ' ' THR . 16.0 tt -90.75 125.38 43.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.408 0.623 . . . . 0.0 111.012 -176.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.531 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 38.3 t -100.62 -56.52 5.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.384 -175.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.417 ' HB2' ' H ' ' A' ' 36' ' ' LYS . 71.7 mm-40 -109.65 139.35 44.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.092 -173.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.459 ' HA ' HG12 ' A' ' 35' ' ' VAL . 50.7 mt -129.13 97.57 3.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 5.7 m -127.21 112.74 21.53 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.211 -176.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 2.0 Cg_endo -85.14 171.6 43.39 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.763 -1.349 . . . . 0.0 112.37 0.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -110.85 -34.26 6.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.98 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.39 117.17 49.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.588 176.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.5 m -108.29 146.46 14.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.931 0.396 . . . . 0.0 110.871 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.5 m -97.97 109.01 21.84 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 84.9 mt -102.97 122.64 45.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.385 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -85.58 95.55 9.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.488 ' CD2' HG12 ' A' ' 26' ' ' ILE . 76.5 mt -90.43 128.68 36.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.517 -175.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -102.88 120.83 41.3 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.422 173.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 60' ' ' PRO . 27.5 t60 -72.42 110.41 6.81 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 173.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.457 ' NE2' ' HB2' ' A' ' 25' ' ' MET . 13.5 m-70 . . . . . 0 CA--C 1.514 -0.404 0 O-C-N 123.886 0.741 . . . . 0.0 110.867 -176.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.834 0.826 . . . . 0.0 109.116 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.76 162.66 32.37 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.547 2.831 . . . . 0.0 113.498 -170.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 14.6 m -118.62 123.57 45.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.972 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.513 ' HB2' HG23 ' A' ' 35' ' ' VAL . 98.1 mt -101.34 148.8 24.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.019 0.438 . . . . 0.0 110.631 -177.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.2 m -125.5 100.17 6.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.889 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.4 mt -101.16 156.43 17.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.357 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 t -88.53 137.35 32.4 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.87 HD11 HG13 ' A' ' 53' ' ' VAL . 42.6 tp -83.39 126.48 32.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.0 pt -108.32 143.0 19.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.113 0.482 . . . . 0.0 111.182 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.42 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -77.07 105.21 8.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.838 176.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -99.06 127.73 45.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.13 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 61.87 23.75 14.02 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.404 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.536 ' OG1' HD12 ' A' ' 55' ' ' LEU . 25.7 m -74.51 124.04 89.51 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.452 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -81.2 171.45 13.88 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.711 2.274 . . . . 0.0 112.562 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.72 6.37 38.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.061 -177.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -92.85 -18.03 23.35 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.42 0.628 . . . . 0.0 110.107 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.2 p -119.2 121.37 39.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.716 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 52.8 ttp -102.79 131.0 49.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.337 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.405 HG12 ' CD2' ' A' ' 89' ' ' LEU . 9.5 mt -90.21 107.71 18.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 49.1 ttp -75.41 -33.27 60.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.055 0.455 . . . . 0.0 110.739 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.9 m -84.71 132.68 34.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.513 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -66.85 143.14 57.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 3.7 mm? -67.1 115.64 27.72 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.534 -178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 3.0 Cg_exo -74.15 167.38 27.33 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.899 2.399 . . . . 0.0 112.666 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.4 m -94.7 129.12 41.74 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.784 175.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.0 m -86.28 143.54 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.121 0.486 . . . . 0.0 111.12 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.0 ttp85 -104.28 108.39 19.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.537 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 80' ' ' ILE . 13.4 m -119.56 112.97 39.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.185 0.517 . . . . 0.0 110.227 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 78.0 tttt -87.73 142.02 28.15 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.51 ' HB ' HG22 ' A' ' 75' ' ' ILE . 47.9 p -130.62 179.61 5.85 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.817 -172.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 76' ' ' LYS . 55.7 mt-10 -132.74 130.3 39.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 175.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.54 -144.05 14.96 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -136.13 158.6 44.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.781 0.324 . . . . 0.0 110.704 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -112.31 93.0 20.57 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.653 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.578 ' HD2' HG12 ' A' ' 44' ' ' ILE . 57.8 Cg_endo -79.76 -76.7 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.181 1.921 . . . . 0.0 112.846 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.1 p -107.76 24.22 13.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.402 0.62 . . . . 0.0 110.154 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.755 HG13 HD11 ' A' ' 75' ' ' ILE . 46.4 mm -79.79 112.08 17.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.396 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -91.64 108.62 20.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.28 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.58 -21.85 29.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.583 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -78.2 -13.24 59.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.642 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -105.9 -24.73 12.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.81 -175.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.405 HD11 HG23 ' A' ' 44' ' ' ILE . 38.2 mt -92.58 139.45 30.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.072 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -136.04 176.68 8.46 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.76 0.79 . . . . 0.0 112.145 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -122.6 133.97 54.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.375 172.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -121.75 141.41 51.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.13 0.491 . . . . 0.0 111.903 -173.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.87 HG13 HD11 ' A' ' 15' ' ' LEU . 6.8 m -114.38 119.7 62.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.19 174.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -74.55 100.69 3.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.479 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.536 HD12 ' OG1' ' A' ' 20' ' ' THR . 38.2 mt -89.96 36.18 0.86 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.935 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 p -61.49 -38.93 89.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.542 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.63 69.15 2.64 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 172.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 m -73.28 84.13 1.4 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.076 0.465 . . . . 0.0 111.847 -173.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -108.52 117.71 53.75 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.497 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.74 100.85 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.895 2.396 . . . . 0.0 112.166 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.418 ' H ' ' HB2' ' A' ' 89' ' ' LEU . . . 159.02 177.33 32.0 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.883 ' HG2' ' HG2' ' A' ' 88' ' ' GLN . 41.2 mt-10 -74.66 99.64 3.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.104 0.452 . . . . 0.0 110.35 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -125.01 144.35 50.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.562 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.519 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 9.4 m-20 -89.23 115.06 26.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.713 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -111.49 164.81 12.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.883 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -89.92 131.51 35.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.296 -176.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.0 t -90.0 123.14 42.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.101 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -111.72 110.66 21.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.068 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.436 HG21 HG11 ' A' ' 35' ' ' VAL . 42.1 t -90.44 142.3 13.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.013 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 46.5 mt-10 -68.75 117.24 49.02 Favored Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.627 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 11.4 Cg_exo -70.93 136.0 28.93 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.874 2.382 . . . . 0.0 111.862 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.413 HG22 ' H ' ' A' ' 74' ' ' ASN . 4.3 mp -100.44 117.55 62.73 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.12 25.29 0.46 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.576 2.184 . . . . 0.0 112.396 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.413 ' H ' HG22 ' A' ' 72' ' ' ILE . 88.1 m-20 -133.95 -8.91 2.71 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.503 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.755 HD11 HG13 ' A' ' 44' ' ' ILE . 26.5 mt -141.01 143.56 28.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.171 -172.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.642 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 43.5 mtpt -81.16 167.38 19.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.8 tt -129.6 135.84 60.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.079 0.466 . . . . 0.0 110.701 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.3 t -115.63 -53.97 4.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.412 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.06 142.55 50.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.216 -174.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.6 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 57.6 mt -123.67 94.22 2.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 169.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 36.6 m -115.49 112.04 43.71 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.53 -174.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 7.1 Cg_endo -93.24 165.03 22.8 Favored 'Cis proline' 0 CA--C 1.531 0.335 0 C-N-CA 124.831 -0.904 . . . . 0.0 112.393 -5.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.6 ' HG3' ' O ' ' A' ' 80' ' ' ILE . 39.6 mtm180 -92.25 -36.85 13.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.378 0.609 . . . . 0.0 109.833 176.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.519 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 62.1 t -117.52 121.44 67.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.626 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.49 HG12 ' HG2' ' A' ' 82' ' ' PRO . 13.9 m -116.1 133.2 63.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.181 0.515 . . . . 0.0 111.817 -177.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.7 m -83.54 95.9 8.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.682 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 90.4 mt -90.41 124.08 34.66 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.884 0.373 . . . . 0.0 110.385 -178.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.883 ' HG2' ' HG2' ' A' ' 62' ' ' GLU . 94.5 mt-30 -85.6 92.99 8.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.55 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.418 ' HB2' ' H ' ' A' ' 61' ' ' GLY . 85.5 mt -92.37 157.63 16.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.497 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.69 163.63 32.3 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 178.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -67.4 132.17 47.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.348 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 79.1 t60 . . . . . 0 C--N 1.323 -0.548 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 172.593 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--O 1.234 0.265 0 CA-C-O 120.419 0.152 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -75.84 118.31 5.01 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.795 2.33 . . . . 0.0 111.689 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.7 m -87.94 92.31 9.08 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.709 HD11 ' HB ' ' A' ' 46' ' ' VAL . 41.1 tp -84.06 123.06 29.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.312 -171.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.1 m -103.32 118.1 35.99 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.935 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.2 mt -120.18 141.54 49.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.237 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.0 t -74.89 135.25 41.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.26 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.618 HD11 HG13 ' A' ' 53' ' ' VAL . 50.0 tp -79.75 131.82 36.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.5 pt -128.08 148.35 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.261 0.553 . . . . 0.0 111.264 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.528 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -85.83 108.69 18.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.443 175.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 22.9 tptm -97.41 -66.81 0.88 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.189 0.518 . . . . 0.0 110.712 -174.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.848 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 6.3 m-20 -84.0 57.42 4.16 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.887 -177.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.528 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 34.5 m -114.66 124.22 30.89 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.699 -174.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 16.5 Cg_exo -68.21 146.76 70.88 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.963 2.442 . . . . 0.0 111.516 174.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.63 -13.87 60.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.775 0.321 . . . . 0.0 111.821 -175.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -89.35 2.47 54.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.101 0.477 . . . . 0.0 110.662 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 p -125.97 122.9 37.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.158 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 42.4 ttp -113.87 126.86 55.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.653 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.8 mt -77.65 132.12 33.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.389 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.441 ' SD ' ' HB2' ' A' ' 90' ' ' GLU . 74.6 mtm -93.68 -26.11 17.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.149 0.5 . . . . 0.0 110.496 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.8 p -83.78 118.44 23.92 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.78 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.29 142.97 56.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.907 0.385 . . . . 0.0 110.244 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 85.4 mt -86.32 119.1 71.34 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.151 -171.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 3.0 Cg_exo -74.35 175.72 10.6 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.846 2.364 . . . . 0.0 112.484 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.2 m -98.23 128.4 44.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.76 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -85.83 129.53 37.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -112.41 108.84 18.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.074 0.464 . . . . 0.0 109.861 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 80' ' ' ILE . 34.7 m -109.79 143.84 19.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.091 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -99.46 121.45 41.16 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.9 p -106.0 159.15 16.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.779 0.323 . . . . 0.0 111.589 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.693 ' HB3' ' HB2' ' A' ' 76' ' ' LYS . 32.6 tt0 -112.69 109.6 19.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.493 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.42 -144.25 14.98 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.898 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.417 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 40.9 t80 -155.13 116.05 3.93 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.41 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -92.89 105.54 15.35 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.929 179.112 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 5.3 Cg_exo -77.85 -66.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.15 2.567 . . . . 0.0 112.986 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 t -125.63 39.36 3.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.322 0.582 . . . . 0.0 110.457 -175.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.8 mt -91.83 130.3 41.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.704 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.557 ' HB3' ' HG2' ' A' ' 48' ' ' GLU . 17.5 m120 -75.26 89.41 2.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.315 0.578 . . . . 0.0 111.096 -176.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.709 ' HB ' HD11 ' A' ' 11' ' ' LEU . 33.6 m -70.65 -13.94 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.178 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -87.6 -18.28 30.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.911 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.557 ' HG2' ' HB3' ' A' ' 45' ' ' ASN . 16.1 mm-40 -96.2 -20.83 18.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.387 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 99.0 mt -82.01 132.4 35.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.697 174.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -129.31 168.5 16.15 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.358 0.599 . . . . 0.0 111.506 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.47 ' O ' HD12 ' A' ' 15' ' ' LEU . . . -108.89 117.3 33.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.376 170.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.586 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 25.5 p90 -114.84 152.21 32.58 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.138 0.494 . . . . 0.0 111.666 -173.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.618 HG13 HD11 ' A' ' 15' ' ' LEU . 21.2 m -115.64 144.69 22.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.128 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.848 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 4.5 t70 -98.21 109.07 21.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.061 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.466 HD12 HG23 ' A' ' 20' ' ' THR . 53.0 mt -101.57 68.7 1.19 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.348 0.594 . . . . 0.0 109.946 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.1 p -82.64 -1.2 50.36 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.74 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.22 112.8 4.34 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.7 p -84.45 16.15 3.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.869 0.366 . . . . 0.0 111.768 -177.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -85.86 119.55 72.0 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.529 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.573 ' HA ' ' HB2' ' A' ' 89' ' ' LEU . 11.6 Cg_exo -70.91 -174.56 1.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.906 2.404 . . . . 0.0 112.329 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 88' ' ' GLN . . . 97.89 -137.6 13.39 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.691 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -125.96 113.86 17.72 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.781 0.324 . . . . 0.0 110.133 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -130.45 155.07 47.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.824 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -100.12 130.21 46.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.441 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -128.44 158.03 39.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.93 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.86 141.49 28.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.041 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.439 HG13 HD13 ' A' ' 15' ' ' LEU . 59.0 t -86.37 107.8 17.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.631 174.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.453 ' HD3' ' CE2' ' A' ' 52' ' ' TYR . 57.9 tttm -99.1 103.17 15.06 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.09 0.472 . . . . 0.0 110.264 -178.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.95 130.38 36.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.632 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.435 ' HG3' ' HD2' ' A' ' 71' ' ' PRO . 27.5 tt0 -68.57 128.33 93.02 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.435 ' HD2' ' HG3' ' A' ' 70' ' ' GLU . 12.1 Cg_endo -55.19 131.64 47.53 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.185 2.59 . . . . 0.0 113.158 -175.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.547 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.2 mp -81.5 125.9 77.47 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.062 177.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.85 109.86 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.291 2.66 . . . . 0.0 113.671 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.6 t30 71.9 2.82 4.45 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.721 173.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.463 ' HB ' ' HB ' ' A' ' 72' ' ' ILE . 48.9 mm -102.29 135.31 39.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 O-C-N 121.928 -0.482 . . . . 0.0 110.387 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.693 ' HB2' ' HB3' ' A' ' 38' ' ' GLU . 72.8 mttt -87.39 148.76 24.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.62 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.489 HD11 HG12 ' A' ' 80' ' ' ILE . 21.4 tt -110.21 128.19 66.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.293 0.568 . . . . 0.0 110.105 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.619 HG12 ' HG3' ' A' ' 79' ' ' GLU . 42.6 t -95.42 -63.84 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.988 -175.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.619 ' HG3' HG12 ' A' ' 78' ' ' VAL . 43.0 mt-10 -123.81 127.36 47.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.743 -175.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.555 ' HA ' HG12 ' A' ' 35' ' ' VAL . 26.3 mt -105.78 127.75 60.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 15.6 m -150.5 115.12 3.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.842 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 88.6 Cg_endo -85.87 177.21 26.36 Favored 'Cis proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.502 -1.458 . . . . 0.0 112.682 -0.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.456 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 84.8 mtm180 -119.97 -28.96 5.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.838 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.98 117.16 48.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.5 m -110.75 135.86 48.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.251 0.548 . . . . 0.0 111.254 -178.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.9 m -88.93 112.24 23.07 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.604 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 90.0 mt -111.55 145.67 38.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 -174.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 93.0 mt-30 -113.09 129.71 56.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.12 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.573 ' HB2' ' HA ' ' A' ' 60' ' ' PRO . 82.8 mt -113.86 136.78 52.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.036 0.446 . . . . 0.0 111.616 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.441 ' HB2' ' SD ' ' A' ' 27' ' ' MET . 43.2 tt0 -119.21 162.96 17.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.163 176.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -80.35 151.3 29.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.538 0.685 . . . . 0.0 112.198 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 43.0 t60 . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.661 172.09 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.608 ' HB3' ' HE2' ' A' ' 36' ' ' LYS . 11.9 m-20 . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 120.523 0.201 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.71 124.47 10.26 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.13 1.887 . . . . 0.0 112.623 -178.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.0 m -101.37 103.69 14.65 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.2 mt -83.1 122.46 28.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.268 0.556 . . . . 0.0 110.715 -173.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.4 m -99.22 106.45 18.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.138 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.8 mt -107.94 -174.67 2.58 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.628 -177.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -114.79 145.37 42.19 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.543 HD11 HG13 ' A' ' 53' ' ' VAL . 45.6 tp -87.44 130.15 34.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.8 pt -128.0 144.8 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.22 0.534 . . . . 0.0 111.763 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.488 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -81.29 102.82 10.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.233 173.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.425 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 59.6 tttm -91.65 -71.57 0.63 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.937 0.399 . . . . 0.0 110.874 -173.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.425 ' OD1' ' HG2' ' A' ' 18' ' ' LYS . 5.2 m-20 -94.27 67.09 3.5 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.623 0.725 . . . . 0.0 109.86 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.488 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 88.1 m -105.79 116.71 59.4 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.287 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 16.9 Cg_exo -67.87 156.39 66.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.168 2.578 . . . . 0.0 112.599 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.96 151.69 45.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.38 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 73.29 9.35 5.19 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.793 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.2 p -103.63 137.48 41.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 171.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.764 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 52.1 ttp -128.87 119.25 24.1 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.811 0.338 . . . . 0.0 110.405 -174.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.5 mt -85.31 124.75 40.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.448 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.572 ' HB2' ' HB2' ' A' ' 88' ' ' GLN . 86.1 mtp -85.36 -31.9 22.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.388 178.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 p -78.27 118.32 20.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.794 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.68 141.01 53.65 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.84 118.44 70.33 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.415 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -89.8 176.96 2.72 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.893 2.395 . . . . 0.0 112.741 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -83.06 135.28 34.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.147 176.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.539 HG11 ' HB2' ' A' ' 51' ' ' ALA . 9.5 p -104.03 152.99 6.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -128.54 134.27 48.61 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.957 0.408 . . . . 0.0 110.838 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 16.3 m -124.33 129.1 74.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.352 175.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.608 ' HE2' ' HB3' ' A' ' 8' ' ' ASP . 13.1 tmtt? -86.16 127.36 34.7 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.551 HG22 ' HA ' ' A' ' 77' ' ' ILE . 33.0 p -128.68 168.15 16.2 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -171.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 76' ' ' LYS . 40.3 mm-40 -114.21 127.32 55.84 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.38 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.97 -161.89 15.94 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.578 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -128.35 128.53 44.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.725 0.298 . . . . 0.0 110.27 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.444 ' HB3' HD12 ' A' ' 44' ' ' ILE . 3.0 p30 -122.41 77.34 44.92 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.261 0.553 . . . . 0.0 111.267 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.12 -47.04 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.649 2.233 . . . . 0.0 111.796 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 m -129.33 80.21 1.95 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.195 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 41' ' ' ASN . 44.7 mt -134.64 157.5 41.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -73.85 55.59 0.54 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.457 0.646 . . . . 0.0 111.504 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.8 t -66.39 -26.27 37.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.76 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -89.9 5.08 47.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.152 0.501 . . . . 0.0 110.906 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -107.12 -24.29 12.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.506 0.669 . . . . 0.0 109.22 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.622 HD13 HG12 ' A' ' 72' ' ' ILE . 63.5 mt -88.11 132.67 34.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.66 177.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -143.51 178.03 8.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.934 0.397 . . . . 0.0 110.812 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.539 ' HB2' HG11 ' A' ' 33' ' ' VAL . . . -105.85 119.88 40.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.956 172.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.424 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 28.7 p90 -115.18 148.91 38.47 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.087 0.47 . . . . 0.0 110.946 -174.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.543 HG13 HD11 ' A' ' 15' ' ' LEU . 18.3 m -112.85 133.42 58.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.951 174.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -104.8 105.53 15.63 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.822 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.436 HD12 HG23 ' A' ' 20' ' ' THR . 61.6 mt -92.41 90.09 7.07 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.043 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.5 p -75.05 1.91 11.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.541 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.06 132.62 2.87 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.707 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 m -80.44 76.75 7.26 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 89' ' ' LEU . 30.9 mt-10 -91.36 108.91 32.3 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.53 -176.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 11.8 Cg_exo -69.07 131.29 21.88 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.761 2.307 . . . . 0.0 112.204 -176.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.91 174.15 17.59 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.998 ' HG2' ' HG2' ' A' ' 88' ' ' GLN . 33.2 mt-10 -76.78 106.42 8.43 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -118.62 156.03 29.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.149 0.5 . . . . 0.0 111.269 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -90.47 116.05 28.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.161 -176.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -127.15 157.42 39.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.052 0.453 . . . . 0.0 111.727 -176.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -89.33 144.5 26.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.692 -173.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.07 114.05 35.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.658 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -108.01 125.32 51.4 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.8 t -102.41 136.29 35.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.557 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -54.83 122.35 40.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.187 174.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.17 116.49 2.98 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.699 2.266 . . . . 0.0 111.973 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.622 HG12 HD13 ' A' ' 49' ' ' LEU . 55.8 mt -81.47 121.71 80.21 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.982 -175.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.59 143.09 37.43 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.463 2.108 . . . . 0.0 111.747 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 t30 75.17 -44.47 0.54 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.362 0.665 . . . . 0.0 111.901 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.522 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 48.9 mm -91.58 136.93 23.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.0 -176.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.615 ' HB3' ' HB2' ' A' ' 38' ' ' GLU . 74.7 tttt -85.17 135.13 34.09 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.551 ' HA ' HG22 ' A' ' 37' ' ' THR . 15.1 tt -96.03 133.69 36.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.953 0.406 . . . . 0.0 109.996 176.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -110.86 -57.97 3.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.339 0.59 . . . . 0.0 111.386 -176.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 38.6 tt0 -126.07 124.81 41.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.403 -170.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.579 ' HB ' ' HG2' ' A' ' 83' ' ' ARG . 61.0 mt -99.22 113.5 34.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 25.2 p -127.22 110.49 21.44 Favored Pre-proline 0 C--N 1.318 -0.782 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.035 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 98.1 Cg_endo -88.43 162.76 42.52 Favored 'Cis proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.77 -1.346 . . . . 0.0 112.716 -1.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.579 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 63.2 mtm180 -87.56 -25.47 23.61 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.947 0.404 . . . . 0.0 110.345 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.7 t -136.2 135.66 49.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.505 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 m -122.52 151.27 26.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.071 0.462 . . . . 0.0 110.963 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.8 m -101.28 107.28 18.61 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.579 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.4 mt -101.62 137.42 39.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.167 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.998 ' HG2' ' HG2' ' A' ' 62' ' ' GLU . 79.9 mt-30 -99.71 109.0 21.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.576 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 70.8 mt -104.62 142.85 33.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.088 0.47 . . . . 0.0 111.673 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.518 ' HG2' ' H ' ' A' ' 91' ' ' HIS . 27.0 tt0 -136.04 176.1 9.0 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 172.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.518 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 86.3 m-70 -99.72 118.83 37.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.764 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 63.8 t60 . . . . . 0 C--N 1.324 -0.512 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -85.52 166.18 10.55 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.436 2.757 . . . . 0.0 113.34 -173.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 20.1 m -100.84 137.33 39.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.502 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.1 mt -107.45 137.89 44.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.072 0.463 . . . . 0.0 110.597 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -107.79 114.12 27.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.866 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.86 165.58 14.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.128 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.3 m -100.8 142.97 31.52 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.61 HD11 HG13 ' A' ' 53' ' ' VAL . 30.7 tp -91.44 128.22 37.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.159 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.7 pt -115.09 160.75 14.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.969 0.414 . . . . 0.0 111.43 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.554 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -92.64 100.08 12.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.445 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.4 ' HD3' ' CD1' ' A' ' 52' ' ' TYR . 59.3 tttm -101.61 135.41 43.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.149 -176.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 66.5 t30 62.28 16.51 8.53 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.536 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.554 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 91.7 m -60.74 119.68 46.34 Favored Pre-proline 0 N--CA 1.447 -0.595 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.777 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.668 ' HG2' ' HA ' ' A' ' 58' ' ' SER . 51.7 Cg_exo -55.02 162.49 5.24 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.869 3.046 . . . . 0.0 113.456 -173.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.76 149.08 32.75 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.156 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 65.13 37.32 6.71 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.617 0.573 . . . . 0.0 111.297 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.0 p -123.36 160.04 27.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.796 0.332 . . . . 0.0 110.559 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.0 ttp -144.86 129.12 17.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' A' ' 89' ' ' LEU . 19.1 mt -95.44 109.88 23.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.407 ' HB2' ' HB3' ' A' ' 88' ' ' GLN . 83.9 mtp -71.63 -27.96 63.46 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 110.527 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.8 m -77.95 123.99 27.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.719 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -71.79 130.54 41.35 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.531 -176.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.07 113.57 17.38 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.093 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.43 ' HD2' HD23 ' A' ' 15' ' ' LEU . 92.2 Cg_endo -85.15 -175.93 2.19 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.84 2.36 . . . . 0.0 112.79 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.4 m -105.76 126.31 52.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.356 174.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.503 HG12 ' HD2' ' A' ' 82' ' ' PRO . 13.4 m -85.91 148.24 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.474 -175.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -127.57 97.52 4.89 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 80' ' ' ILE . 30.7 m -105.32 132.64 51.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.381 -176.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 71.2 tttt -81.46 136.13 35.64 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.547 HG22 ' HA ' ' A' ' 77' ' ' ILE . 22.4 p -125.9 162.69 24.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.316 -177.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.24 112.93 18.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.87 178.91 24.33 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.61 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -118.41 144.18 46.13 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -128.96 92.51 39.57 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 121.328 0.585 . . . . 0.0 111.756 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.09 -45.46 15.88 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.788 2.325 . . . . 0.0 111.096 174.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.7 m -117.63 -115.58 0.33 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.552 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.1 mt 56.52 99.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 111.795 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -73.21 100.96 3.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.698 0.761 . . . . 0.0 111.289 -177.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.0 t -64.2 -22.41 31.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.756 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -80.3 -11.61 59.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.87 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -98.13 -21.66 16.63 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 90.8 mt -70.03 132.35 45.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.887 174.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -130.47 152.97 49.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.281 0.562 . . . . 0.0 111.848 -177.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -115.45 141.28 48.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 170.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 68' ' ' LYS . 47.0 p90 -133.24 161.31 34.82 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.028 -175.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.61 HG13 HD11 ' A' ' 15' ' ' LEU . 6.7 m -112.35 117.98 56.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -86.38 102.59 14.16 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 20' ' ' THR . 43.5 mt -88.45 76.41 8.26 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.151 -175.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.8 m -84.09 9.69 11.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.565 0.698 . . . . 0.0 109.754 173.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.39 107.06 1.88 Allowed Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.162 175.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.668 ' HA ' ' HG2' ' A' ' 21' ' ' PRO . 16.1 m -85.7 9.5 16.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.223 0.535 . . . . 0.0 110.69 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.88 121.13 83.06 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.54 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.71 175.84 10.78 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.663 2.242 . . . . 0.0 112.304 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.81 -158.99 19.11 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -176.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.404 ' HG2' ' CG2' ' A' ' 86' ' ' THR . 37.3 tt0 -100.12 107.76 19.73 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -132.74 144.41 50.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.138 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 4.4 p30 -94.15 141.29 28.72 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.197 0.523 . . . . 0.0 110.787 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -133.69 164.23 27.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.06 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -93.3 140.27 29.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.246 -172.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 98.6 t -79.88 108.71 13.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 172.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.449 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 40.6 mtpt -108.77 114.06 27.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.711 -176.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.6 139.97 17.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.24 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.26 132.44 94.43 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.48 113.66 1.56 Allowed 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.966 2.444 . . . . 0.0 112.574 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.518 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.4 mp -83.29 122.31 77.23 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.018 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.79 143.62 46.38 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.361 2.041 . . . . 0.0 111.716 176.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.4 t30 73.79 -23.38 0.22 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.097 0.559 . . . . 0.0 112.203 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.419 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 48.2 mm -108.38 125.66 65.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.758 0.313 . . . . 0.0 110.877 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -88.16 125.97 34.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.115 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.547 ' HA ' HG22 ' A' ' 37' ' ' THR . 16.6 tt -80.06 135.88 24.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.5 t -104.49 -64.91 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.263 0.554 . . . . 0.0 110.907 -178.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -122.5 137.71 54.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.434 -172.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.478 ' HA ' HG12 ' A' ' 35' ' ' VAL . 61.0 mt -103.06 109.44 26.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.675 176.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.45 ' HA ' ' C ' ' A' ' 82' ' ' PRO . 18.2 p -141.87 124.46 9.34 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.457 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.503 ' HD2' HG12 ' A' ' 33' ' ' VAL . 43.0 Cg_endo -67.72 160.36 81.16 Favored 'Cis proline' 0 C--N 1.344 0.315 0 C-N-CA 123.386 -1.506 . . . . 0.0 113.204 0.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -86.36 -70.21 0.62 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.538 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 64' ' ' ASP . 62.6 t -121.48 129.34 75.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.374 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.3 m -110.21 134.93 50.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.972 0.415 . . . . 0.0 110.879 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 24.0 m -92.92 111.39 22.99 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.079 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.2 mt -106.12 138.88 41.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.155 0.502 . . . . 0.0 111.365 -173.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 27' ' ' MET . 55.9 tp60 -94.77 109.83 21.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.066 174.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.418 ' CD2' HG12 ' A' ' 26' ' ' ILE . 80.0 mt -100.79 130.0 46.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.239 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -119.14 178.5 4.49 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.414 171.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -97.96 151.86 19.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.48 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 14.4 t60 . . . . . 0 C--N 1.323 -0.558 0 CA-C-O 120.989 0.423 . . . . 0.0 110.147 -178.909 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.593 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 9.1 m-20 . . . . . 0 C--O 1.233 0.225 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -75.26 129.69 12.34 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.673 2.249 . . . . 0.0 112.553 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 43.1 m -102.33 109.68 21.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.672 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.546 HD21 ' ND2' ' A' ' 41' ' ' ASN . 83.7 mt -92.48 147.11 23.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.258 0.551 . . . . 0.0 111.528 -172.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.9 m -121.62 97.59 5.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.451 HD22 ' HB2' ' A' ' 49' ' ' LEU . 56.2 mt -99.17 162.9 12.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.319 -175.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.6 p -100.68 148.67 24.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.705 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.814 HD11 HG13 ' A' ' 53' ' ' VAL . 34.1 tp -94.34 125.03 38.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.189 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.6 pt -112.04 151.9 13.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.318 0.58 . . . . 0.0 111.768 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.627 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -83.69 102.19 12.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.116 176.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 86.4 tttt -83.34 115.24 21.92 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.312 -178.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.9 m120 73.89 -68.27 0.23 Allowed 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.198 0.999 . . . . 0.0 109.668 -177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.627 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 47.7 m 48.13 97.76 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.404 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.96 -172.16 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.776 2.984 . . . . 0.0 115.151 -169.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.74 105.82 0.16 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.422 -1.263 . . . . 0.0 113.598 -172.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.48 22.13 13.08 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.003 168.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.0 p -84.64 102.72 13.15 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 170.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.9 ttp -103.08 126.5 50.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.633 -172.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.463 HG12 ' CD2' ' A' ' 89' ' ' LEU . 5.8 mt -84.81 110.59 19.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.957 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 58.1 ttp -73.18 -32.11 64.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.9 m -69.3 131.68 45.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.169 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -75.65 119.84 20.23 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -56.96 114.35 7.86 Favored Pre-proline 0 C--N 1.328 -0.35 0 O-C-N 123.488 0.493 . . . . 0.0 110.064 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.27 -172.56 1.4 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.89 2.394 . . . . 0.0 112.792 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.8 p -99.1 149.54 22.93 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.821 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.436 ' CG2' ' HB2' ' A' ' 13' ' ' LEU . 35.6 m -108.17 129.29 62.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.149 0.5 . . . . 0.0 109.804 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -106.88 110.35 22.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.218 0.533 . . . . 0.0 109.88 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 80' ' ' ILE . 27.2 m -120.45 137.46 54.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.527 -176.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.593 ' HE3' ' HB3' ' A' ' 8' ' ' ASP . 83.3 tttt -93.19 136.24 33.64 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 77' ' ' ILE . 22.5 p -124.56 168.42 13.13 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.278 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.448 ' HG3' ' CG2' ' A' ' 78' ' ' VAL . 42.1 mt-10 -122.5 123.13 40.55 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 176.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.0 -148.63 20.44 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.778 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.515 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 73.1 m-85 -129.57 129.07 43.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.804 0.335 . . . . 0.0 110.384 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.546 ' ND2' HD21 ' A' ' 11' ' ' LEU . 1.6 m-20 -116.71 77.98 8.67 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.629 -176.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 3.0 Cg_endo -86.63 -62.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.635 2.223 . . . . 0.0 112.2 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.0 p -91.5 -8.99 46.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.597 -177.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.21 116.11 33.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -111.63 150.34 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.58 -171.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.422 ' HB ' HD23 ' A' ' 13' ' ' LEU . 31.4 m -76.12 -5.34 7.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.964 178.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -85.31 -8.45 58.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.935 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -114.58 -29.15 6.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.737 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.451 ' HB2' HD22 ' A' ' 13' ' ' LEU . 79.0 mt -84.54 134.34 34.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -130.61 160.63 33.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.468 0.652 . . . . 0.0 111.828 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -117.42 133.95 55.39 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 170.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.432 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 48.7 p90 -122.04 152.01 40.24 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.018 -174.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.814 HG13 HD11 ' A' ' 15' ' ' LEU . 6.4 m -112.24 125.9 69.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.785 172.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -86.61 99.98 12.1 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.48 HD12 ' OG1' ' A' ' 20' ' ' THR . 64.6 mt -92.16 21.11 5.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.602 -173.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.5 p -60.37 115.9 3.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.153 0.501 . . . . 0.0 110.093 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.8 -28.5 1.74 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.594 -175.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.9 p 49.98 38.29 16.04 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.438 0.695 . . . . 0.0 111.897 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -84.84 115.02 59.06 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.953 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.3 150.21 28.63 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.825 2.35 . . . . 0.0 112.092 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.82 -174.43 21.64 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.745 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -80.26 105.75 11.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.753 0.311 . . . . 0.0 110.27 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -125.18 151.68 45.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.523 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -91.98 123.11 35.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.519 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -121.62 139.33 53.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.231 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.49 136.82 51.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.237 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 64.2 t -83.26 106.08 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -103.6 104.99 15.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.118 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.9 t -90.91 140.18 16.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.334 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 36.3 mt-10 -66.64 128.14 93.72 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.33 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 25.3 Cg_exo -62.58 115.88 3.18 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.829 2.352 . . . . 0.0 111.92 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.3 mp -81.33 122.62 81.33 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.073 -173.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.86 135.94 34.04 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.791 2.327 . . . . 0.0 112.221 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 71.5 6.79 5.84 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.387 176.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.1 mt -135.9 131.23 49.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.823 0.344 . . . . 0.0 110.612 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -84.79 129.56 34.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.396 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.546 ' HA ' HG22 ' A' ' 37' ' ' THR . 17.7 tt -92.72 134.35 30.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.448 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 35.4 t -108.18 -60.46 2.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.904 0.383 . . . . 0.0 111.459 -174.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HG3' HG12 ' A' ' 78' ' ' VAL . 41.8 mt-10 -118.58 128.44 54.56 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 -171.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.543 ' HA ' HG12 ' A' ' 35' ' ' VAL . 62.4 mt -111.92 109.47 28.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.273 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 14.8 p -139.75 126.96 12.7 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.601 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.408 ' HD2' HG12 ' A' ' 33' ' ' VAL . 4.2 Cg_exo -80.63 159.78 84.8 Favored 'Cis proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.452 -1.479 . . . . 0.0 112.535 -0.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -80.34 -50.32 10.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.291 0.567 . . . . 0.0 110.527 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.1 t -131.11 137.1 56.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.377 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.5 m -117.77 134.11 62.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.159 0.504 . . . . 0.0 111.172 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.3 m -85.04 105.82 16.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.598 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.8 mt -104.89 130.49 53.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.271 -177.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -94.23 106.12 18.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.076 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.463 ' CD2' HG12 ' A' ' 26' ' ' ILE . 90.1 mt -91.96 126.82 37.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.59 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -118.55 150.33 39.82 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.377 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -77.43 137.93 38.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.954 0.407 . . . . 0.0 111.257 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.012 177.244 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 . . . . . 0 CA--C 1.528 0.108 0 CA-C-O 121.437 0.637 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.19 161.97 11.45 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.627 2.218 . . . . 0.0 113.01 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.1 m -93.96 105.65 17.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.784 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.536 HD11 ' HB ' ' A' ' 46' ' ' VAL . 54.3 tp -83.2 139.02 33.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.632 -176.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.7 m -116.77 115.36 25.44 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.787 0.327 . . . . 0.0 110.561 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.6 mt -114.52 141.73 47.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.164 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.6 m -75.05 142.31 43.76 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.711 0.291 . . . . 0.0 110.472 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.804 HD11 HG13 ' A' ' 53' ' ' VAL . 38.6 tp -89.1 122.03 32.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.234 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.6 pt -104.42 148.38 9.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.149 0.499 . . . . 0.0 111.114 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.33 113.44 18.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.855 176.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -111.64 133.17 54.08 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 68.13 3.68 3.75 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.608 0.568 . . . . 0.0 112.067 174.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 27.1 m -62.3 113.66 9.44 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.995 -177.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 24.0 Cg_exo -65.16 166.88 17.59 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.373 2.716 . . . . 0.0 113.51 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.34 -23.02 60.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.123 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -85.46 3.61 39.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.84 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.2 m -117.01 124.55 49.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.612 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.5 ttp -117.18 113.03 21.65 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.406 HG12 ' CD2' ' A' ' 89' ' ' LEU . 17.8 mt -75.95 115.9 18.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.254 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 22.1 ttt -77.9 -35.58 50.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.073 0.463 . . . . 0.0 110.049 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.7 m -78.6 121.65 24.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.775 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -69.48 128.26 35.9 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.8 mt -67.95 126.4 92.58 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.196 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -90.99 -161.25 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.119 2.546 . . . . 0.0 112.397 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.8 m -117.83 141.96 47.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.405 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 p -97.75 145.22 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.965 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.6 mtp180 -114.93 118.43 33.44 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 80' ' ' ILE . 17.3 m -117.3 134.45 60.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.057 -177.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.543 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 11.9 mmtt -79.09 122.21 25.95 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 173.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.3 p -120.95 129.83 53.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.773 0.321 . . . . 0.0 111.509 -176.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.518 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 28.3 tt0 -96.04 106.15 18.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.601 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 135.17 -178.41 18.59 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.029 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -113.23 161.06 17.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.101 0.476 . . . . 0.0 111.043 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.628 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 3.2 p30 -128.74 74.57 80.54 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.687 176.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.66 -45.46 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.585 2.19 . . . . 0.0 111.767 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 p -102.9 3.93 37.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.054 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.654 HD11 ' HB2' ' A' ' 74' ' ' ASN . 56.9 mt -106.69 121.51 59.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.629 -175.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -91.72 106.23 18.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.541 0.686 . . . . 0.0 110.665 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.536 ' HB ' HD11 ' A' ' 11' ' ' LEU . 33.2 m -69.66 -10.88 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.68 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -82.87 -11.01 58.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.978 0.418 . . . . 0.0 110.497 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -106.26 -16.46 14.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.213 174.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.8 mt -70.32 128.56 36.63 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 168.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -124.3 157.86 33.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.361 0.6 . . . . 0.0 112.044 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.88 129.54 56.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 169.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -129.57 143.78 50.98 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.466 0.651 . . . . 0.0 111.622 -173.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.804 HG13 HD11 ' A' ' 15' ' ' LEU . 3.2 m -112.52 119.52 60.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.94 172.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -84.84 100.3 11.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.571 -173.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.509 HD23 HD11 ' A' ' 89' ' ' LEU . 10.5 mp -90.6 76.26 6.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.0 m -57.3 -42.63 82.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.919 -174.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -112.21 172.56 14.82 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.041 -174.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.9 m -91.4 31.07 1.19 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.975 0.417 . . . . 0.0 110.168 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -59.73 112.28 5.08 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.521 -175.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.41 151.88 20.27 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.633 2.222 . . . . 0.0 112.055 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.82 179.3 19.13 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.351 176.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 88' ' ' GLN . 41.8 tt0 -87.08 107.99 18.68 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 65' ' ' TYR . 76.6 m-70 -117.33 161.76 19.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.818 -175.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -95.53 127.24 41.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 63' ' ' HIS . 95.3 m-85 -116.88 134.24 55.02 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.322 0.582 . . . . 0.0 111.165 -177.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -77.09 120.64 22.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.146 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.5 t -73.44 106.25 3.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.27 0.557 . . . . 0.0 110.044 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -100.5 126.02 46.88 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.554 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.9 146.73 10.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -58.94 115.38 11.69 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 173.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.19 108.0 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.713 2.276 . . . . 0.0 112.486 -176.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.535 ' H ' HD12 ' A' ' 72' ' ' ILE . 3.8 mp -81.06 111.11 21.09 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.9 24.51 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.829 2.353 . . . . 0.0 113.15 -172.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.654 ' HB2' HD11 ' A' ' 44' ' ' ILE . 21.8 m120 -144.38 -1.42 0.92 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.721 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.544 HD11 ' HB3' ' A' ' 41' ' ' ASN . 70.1 mt -129.96 134.23 63.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.874 0.368 . . . . 0.0 110.407 -176.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 52.2 tttm -83.18 112.83 20.2 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.802 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.9 tt -80.66 125.46 39.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.203 0.525 . . . . 0.0 110.163 -176.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 22.7 t -93.59 -54.18 7.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.35 -173.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -153.28 156.82 39.15 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.722 -174.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.609 ' HA ' HG12 ' A' ' 35' ' ' VAL . 60.9 mt -122.78 132.08 72.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 23.2 t -139.21 110.5 7.7 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.464 0.173 . . . . 0.0 110.642 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 2.3 Cg_endo -87.35 153.38 42.07 Favored 'Cis proline' 0 N--CA 1.462 -0.379 0 C-N-CA 124.215 -1.161 . . . . 0.0 112.152 -2.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.593 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 85.1 mtm180 -76.33 -34.68 59.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.878 0.371 . . . . 0.0 111.392 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.8 t -129.23 129.62 67.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.913 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.3 m -116.11 133.44 62.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.971 0.415 . . . . 0.0 110.859 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.3 m -90.78 115.4 27.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.144 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.418 ' HB2' ' CE2' ' A' ' 65' ' ' TYR . 70.8 mt -118.82 138.86 52.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.178 -177.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 53.1 tt0 -93.83 115.78 28.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.951 0.405 . . . . 0.0 110.581 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.509 HD11 HD23 ' A' ' 55' ' ' LEU . 23.7 mt -100.42 135.68 41.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.282 0.563 . . . . 0.0 111.118 177.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -118.86 170.51 8.95 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 169.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -83.43 166.15 18.61 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.885 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.2 t60 . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.201 -178.735 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.838 ' HB3' ' HG3' ' A' ' 38' ' ' GLU . 6.1 p-10 . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 121.737 0.779 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.32 141.1 25.36 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.097 2.532 . . . . 0.0 113.36 -173.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 40.9 m -87.77 110.35 20.4 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.9 tp -108.92 144.69 36.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.538 -171.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 12.4 t -116.64 123.47 47.37 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.353 0.597 . . . . 0.0 109.796 174.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt -109.5 166.29 11.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.011 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.2 t -86.07 126.65 34.34 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.642 HD11 HG13 ' A' ' 53' ' ' VAL . 60.3 tp -80.82 104.24 11.2 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 174.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 36.2 pt -107.08 147.45 12.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.257 0.551 . . . . 0.0 111.599 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.568 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -86.91 105.03 16.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.54 175.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -90.42 -77.84 0.39 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.859 -174.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -80.71 64.82 5.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.906 0.86 . . . . 0.0 109.253 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.568 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 46.5 m -112.0 111.48 53.47 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.564 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -71.25 -178.93 3.18 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.035 2.49 . . . . 0.0 111.979 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 23' ' ' ASN . . . -77.87 160.96 27.96 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.571 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.567 ' HB3' ' O ' ' A' ' 22' ' ' ALA . 18.1 t30 80.1 -38.09 0.16 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.847 0.717 . . . . 0.0 111.274 174.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 p -78.72 94.58 5.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.14 0.495 . . . . 0.0 110.123 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.4 ttp -102.94 133.0 48.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.244 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.9 mt -85.9 110.43 19.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.3 ttt -70.4 -32.5 70.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.088 0.47 . . . . 0.0 110.088 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.5 m -78.01 106.62 10.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.477 174.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.58 129.57 40.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.051 0.453 . . . . 0.0 111.175 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 15' ' ' LEU . 73.1 mt -55.94 122.72 48.98 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.856 -174.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -95.25 176.19 0.94 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.343 2.695 . . . . 0.0 112.82 176.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 m -87.0 140.08 29.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.925 173.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 12' ' ' THR . 14.4 p -101.83 148.09 7.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.044 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 34' ' ' ARG . 37.2 mtm-85 -103.17 120.45 40.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.904 0.383 . . . . 0.0 110.638 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 80' ' ' ILE . 6.9 m -133.77 116.67 24.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.236 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 16.7 ttpp -87.55 129.07 35.23 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.1 p -105.03 -178.05 3.54 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.838 ' HG3' ' HB3' ' A' ' 8' ' ' ASP . 3.4 tt0 -154.66 110.31 3.15 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.41 165.66 10.85 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.927 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -88.02 113.13 23.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.594 0.235 . . . . 0.0 110.529 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.523 ' HB3' HG13 ' A' ' 75' ' ' ILE . 5.1 p30 -135.5 82.01 40.89 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.537 0.684 . . . . 0.0 111.626 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -91.13 -6.18 3.98 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.096 2.531 . . . . 0.0 111.948 175.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.1 p -97.74 -52.16 3.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.238 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.31 126.35 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.243 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -86.24 128.78 34.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.926 -177.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.63 -13.08 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.451 -174.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -97.06 -9.53 27.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.688 0.28 . . . . 0.0 110.844 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.82 -25.13 22.37 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 172.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.6 128.51 34.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.743 172.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -130.85 157.61 42.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.987 0.422 . . . . 0.0 111.11 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -123.0 114.0 19.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.557 ' CZ ' ' HD2' ' A' ' 68' ' ' LYS . 53.1 p90 -118.55 159.53 23.39 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.121 0.486 . . . . 0.0 111.839 -171.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.642 HG13 HD11 ' A' ' 15' ' ' LEU . 17.0 m -112.43 139.46 37.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.695 172.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -103.68 106.69 17.27 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.471 HD12 HG23 ' A' ' 20' ' ' THR . 78.8 mt -98.49 44.18 1.04 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.947 0.403 . . . . 0.0 111.0 -174.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 t -56.56 -44.04 80.55 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.454 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.99 69.97 3.22 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 173.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 p -69.54 91.58 0.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.488 0.661 . . . . 0.0 110.779 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 42.5 tt0 -117.87 125.48 27.98 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.958 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 59' ' ' GLU . 25.3 Cg_exo -62.89 150.9 87.0 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.194 2.596 . . . . 0.0 112.818 -177.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.38 -177.27 27.15 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.863 ' HG2' ' HB2' ' A' ' 88' ' ' GLN . 42.6 mt-10 -87.68 107.49 18.65 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -124.15 148.76 46.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 39.4 m-20 -81.89 109.64 16.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.71 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -111.61 146.54 37.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.283 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -80.52 134.06 35.89 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.523 -174.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.482 HG13 HD13 ' A' ' 15' ' ' LEU . 60.1 t -81.75 112.36 19.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.557 ' HD2' ' CZ ' ' A' ' 52' ' ' TYR . 7.8 tmtt? -103.1 111.57 24.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.093 0.473 . . . . 0.0 109.885 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 34.9 t -92.4 143.13 12.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.421 -178.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -58.3 139.16 84.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.908 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.27 136.38 47.14 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.499 2.133 . . . . 0.0 111.702 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.458 ' CG2' ' HB ' ' A' ' 75' ' ' ILE . 41.2 mt -116.24 110.41 43.32 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.312 -177.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.52 137.31 50.1 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.763 2.308 . . . . 0.0 111.938 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 73.41 -45.3 0.61 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.524 0.729 . . . . 0.0 112.447 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.523 HG13 ' HB3' ' A' ' 41' ' ' ASN . 26.3 mm -84.33 129.36 37.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.031 0.443 . . . . 0.0 110.362 -175.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -81.8 141.48 33.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.562 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.2 tt -98.69 112.42 30.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.548 0.69 . . . . 0.0 109.144 174.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.6 t -86.42 -53.22 10.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.633 -170.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -133.86 147.71 51.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.099 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.718 ' HB ' ' HG2' ' A' ' 83' ' ' ARG . 55.0 mt -127.8 111.8 25.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 21.0 m -128.78 108.45 18.57 Favored Pre-proline 0 C--N 1.318 -0.771 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.145 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 4.1 Cg_endo -89.33 166.81 36.09 Favored 'Cis proline' 0 C--N 1.344 0.316 0 C-N-CA 124.459 -1.059 . . . . 0.0 112.344 -3.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.718 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 80.5 mtm180 -93.49 -28.62 15.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.081 0.467 . . . . 0.0 109.888 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.425 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 53.9 t -130.22 120.18 48.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.526 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.489 HG12 ' HG2' ' A' ' 82' ' ' PRO . 16.2 m -112.72 135.45 52.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.157 0.504 . . . . 0.0 111.219 -177.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.8 m -83.09 104.1 13.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.766 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.1 mt -101.51 133.02 46.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.61 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.863 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 42.8 tt0 -92.02 108.73 20.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.86 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 72.2 mt -94.31 120.65 34.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.532 177.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -109.12 152.33 25.24 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.592 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -84.13 100.44 11.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.647 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 83.4 t60 . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.804 -176.373 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 . . . . . 0 CA--C 1.517 -0.308 0 CA-C-O 120.425 0.155 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.14 130.38 18.78 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.398 2.065 . . . . 0.0 111.445 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.7 m -95.75 92.6 6.64 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 175.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.507 HD21 HD12 ' A' ' 49' ' ' LEU . 14.6 tp -82.85 114.98 21.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.953 -170.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.405 HG23 ' HG2' ' A' ' 34' ' ' ARG . 26.5 m -93.81 101.57 13.67 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.253 178.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.8 mt -100.83 177.91 4.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.482 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.9 m -105.35 137.63 42.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.521 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.824 HD11 HG13 ' A' ' 53' ' ' VAL . 50.7 tp -86.99 123.46 32.11 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.7 pt -119.79 146.7 24.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.133 0.492 . . . . 0.0 111.034 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.27 115.79 23.24 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -71.05 -76.46 0.1 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.063 -175.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -126.19 81.11 1.97 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.893 0.378 . . . . 0.0 110.317 177.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.9 t -90.67 127.17 53.46 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 170.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.89 157.33 13.2 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.323 2.682 . . . . 0.0 113.158 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.97 -19.82 64.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.679 -177.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -86.03 -5.8 59.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.26 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 p -118.59 144.61 46.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.106 0.479 . . . . 0.0 111.218 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.9 ttp -132.62 130.7 40.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.738 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.42 ' HA ' HD23 ' A' ' 89' ' ' LEU . 19.7 mt -82.84 116.92 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.652 0.263 . . . . 0.0 111.134 -176.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.52 ' HG2' ' HB2' ' A' ' 90' ' ' GLU . 95.9 mmm -82.94 -39.24 21.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.175 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.6 m -66.85 112.9 4.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.297 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -58.07 120.63 8.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.164 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.25 109.22 2.27 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.422 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -85.01 -170.87 0.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.879 2.386 . . . . 0.0 113.015 -173.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.2 m -97.2 134.31 40.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.147 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.538 HG11 HG11 ' A' ' 67' ' ' VAL . 17.8 m -96.85 142.39 14.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.405 ' HG2' HG23 ' A' ' 12' ' ' THR . 48.2 mtp180 -120.94 119.26 32.08 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.352 -178.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.53 HG12 ' HA ' ' A' ' 80' ' ' ILE . 30.1 m -112.54 137.29 45.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.066 0.46 . . . . 0.0 111.527 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -87.53 122.2 30.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 173.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.434 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 24.1 p -126.34 159.15 33.99 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 123.368 0.417 . . . . 0.0 110.925 -177.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -114.86 112.04 22.14 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.87 -159.0 26.88 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.841 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -137.78 157.14 47.06 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.448 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 6.3 p30 -128.78 85.66 59.62 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 121.204 0.526 . . . . 0.0 111.768 -174.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.59 -67.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.018 2.478 . . . . 0.0 112.422 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.3 p -84.4 -11.41 56.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.153 0.501 . . . . 0.0 111.045 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' A' ' 41' ' ' ASN . 70.1 mt -76.46 113.2 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.273 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.428 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 35.2 m-80 -84.77 121.6 27.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.747 -176.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.478 HG22 HD11 ' A' ' 11' ' ' LEU . 37.7 t -62.62 -36.53 75.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.455 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -71.15 -22.13 62.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.635 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -88.56 -17.31 30.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.449 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.507 HD12 HD21 ' A' ' 11' ' ' LEU . 91.3 mt -85.03 131.09 34.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.61 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -128.14 152.66 47.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.073 0.463 . . . . 0.0 111.447 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . . . -115.42 115.99 27.48 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 171.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -107.69 145.94 32.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.346 0.593 . . . . 0.0 112.023 -173.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.824 HG13 HD11 ' A' ' 15' ' ' LEU . 4.4 m -112.6 121.07 64.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.218 169.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -87.35 86.28 7.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.218 1.009 . . . . 0.0 110.528 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 mp -78.96 29.89 0.21 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.214 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.1 m -65.52 95.65 0.23 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.208 0.527 . . . . 0.0 110.064 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.83 -74.1 0.44 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -173.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m 58.37 98.41 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 173.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -85.1 119.59 72.64 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.81 114.65 1.95 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.695 2.264 . . . . 0.0 112.183 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.08 -158.48 27.7 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -100.36 104.71 16.16 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -130.89 152.68 49.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.822 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.478 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 18.8 m-20 -91.69 130.29 37.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.765 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -123.99 151.78 43.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.209 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.429 ' O ' HG12 ' A' ' 53' ' ' VAL . 24.8 mt-10 -87.2 134.72 33.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.306 -175.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.538 HG11 HG11 ' A' ' 33' ' ' VAL . 90.6 t -79.86 109.51 14.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.932 173.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -108.92 109.67 20.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.023 0.44 . . . . 0.0 110.431 -177.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 31.8 t -87.27 149.83 3.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.293 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -53.03 128.97 48.44 Favored Pre-proline 0 C--O 1.232 0.138 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.67 124.91 15.99 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.373 2.049 . . . . 0.0 111.683 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.6 mt -113.79 95.47 37.46 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.544 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.02 24.43 0.71 Allowed 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 123.072 2.514 . . . . 0.0 111.751 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -118.28 -30.51 5.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.171 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.434 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 61.9 mt -130.95 142.11 44.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.201 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -80.73 128.13 33.29 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.149 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.9 tt -97.41 122.16 48.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.396 0.617 . . . . 0.0 109.889 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.836 HG12 ' HG3' ' A' ' 79' ' ' GLU . 41.4 t -94.87 -60.47 2.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.115 -175.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.836 ' HG3' HG12 ' A' ' 78' ' ' VAL . 43.8 mt-10 -141.87 139.37 32.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.28 -172.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.53 ' HA ' HG12 ' A' ' 35' ' ' VAL . 46.3 mt -107.31 120.27 58.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.496 175.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 15.1 m -118.18 108.01 42.74 Favored Pre-proline 0 C--N 1.323 -0.586 0 O-C-N 122.423 -0.173 . . . . 0.0 110.93 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 83.9 Cg_endo -91.74 174.54 18.92 Favored 'Cis proline' 0 C--N 1.346 0.439 0 C-N-CA 124.186 -1.172 . . . . 0.0 112.53 -2.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 83' ' ' ARG . 27.3 mtm105 -94.97 -50.66 5.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.46 0.648 . . . . 0.0 110.085 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.478 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 41.1 t -115.53 118.66 59.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.138 -177.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.7 m -107.44 134.69 48.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.024 0.44 . . . . 0.0 111.18 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.2 m -85.21 103.97 14.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.82 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.5 mt -97.92 124.64 42.45 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.102 0.477 . . . . 0.0 110.572 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -87.93 104.66 16.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.965 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 26' ' ' ILE . 59.5 mt -94.31 134.33 36.91 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.941 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.52 ' HB2' ' HG2' ' A' ' 27' ' ' MET . 0.0 OUTLIER -110.72 170.99 7.73 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.656 179.242 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -84.98 110.74 19.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.358 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 177.514 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.419 ' HB3' ' HG2' ' A' ' 38' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.464 0.65 . . . . 0.0 109.83 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.95 154.82 33.79 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.874 2.383 . . . . 0.0 113.453 -174.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 35.3 m -100.23 123.28 44.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.826 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.2 mt -101.33 159.01 15.63 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.051 0.453 . . . . 0.0 110.496 -176.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 31.0 m -126.4 99.55 5.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.02 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.529 HD22 ' HB2' ' A' ' 49' ' ' LEU . 79.5 mt -95.8 141.84 28.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.244 -173.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 m -74.01 140.78 45.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.92 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.851 HD11 HG13 ' A' ' 53' ' ' VAL . 45.0 tp -96.32 125.19 40.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.035 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.5 HD11 ' CE2' ' A' ' 52' ' ' TYR . 39.7 pt -122.77 151.85 27.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.035 0.445 . . . . 0.0 111.507 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.444 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -78.99 132.91 36.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.537 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.55 ' HD2' ' CD2' ' A' ' 52' ' ' TYR . 60.6 tttm -129.73 140.15 51.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.213 178.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.557 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 65.0 m-20 60.91 20.17 10.47 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.719 0.637 . . . . 0.0 110.798 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.444 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 72.7 m -79.76 116.44 61.01 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.196 -174.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.1 178.0 3.93 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.911 2.407 . . . . 0.0 112.647 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.0 -28.44 27.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.114 -175.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -73.92 -10.15 59.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.674 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.6 p -100.93 110.12 22.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.128 0.489 . . . . 0.0 109.972 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.622 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 25.6 ttt -102.9 108.83 20.17 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.032 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.0 mt -78.35 108.19 11.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.665 -175.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.476 ' SD ' ' HB2' ' A' ' 90' ' ' GLU . 85.4 mtp -86.19 -32.9 20.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.553 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.9 m -71.87 111.39 7.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.985 176.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -65.9 117.88 8.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.5 114.53 13.41 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.507 -173.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -85.06 -161.99 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.903 2.402 . . . . 0.0 111.74 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.8 m -113.31 150.79 32.02 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.743 0.306 . . . . 0.0 110.911 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.626 HG11 HG11 ' A' ' 67' ' ' VAL . 35.7 m -94.38 152.48 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.777 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -110.53 102.02 10.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.988 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 80' ' ' ILE . 23.7 m -120.12 132.79 68.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.786 -176.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 81.8 tttt -97.17 136.06 38.23 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.553 HG22 ' HA ' ' A' ' 77' ' ' ILE . 37.0 p -127.98 138.35 52.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.289 -175.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.466 ' HG3' HG21 ' A' ' 78' ' ' VAL . 53.6 mt-10 -97.37 100.27 11.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.183 0.516 . . . . 0.0 109.64 175.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.24 151.65 5.78 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.19 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -89.93 147.58 23.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.677 0.275 . . . . 0.0 110.385 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 4.6 p30 -109.46 111.49 59.53 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.562 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 41' ' ' ASN . 5.1 Cg_exo -79.87 -73.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.814 2.342 . . . . 0.0 112.072 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 p -105.11 6.13 32.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.787 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.2 126.22 40.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.47 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -114.95 153.38 30.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.83 0.348 . . . . 0.0 111.322 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.0 m -83.56 -9.71 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.695 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -93.58 -4.81 50.21 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -98.78 -37.4 9.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.668 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.529 ' HB2' HD22 ' A' ' 13' ' ' LEU . 20.0 mt -88.3 144.57 26.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.657 177.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -135.89 157.9 45.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.684 0.754 . . . . 0.0 112.419 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.18 135.61 48.43 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.981 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.55 ' CD2' ' HD2' ' A' ' 18' ' ' LYS . 29.6 m-85 -112.25 150.16 31.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.956 0.408 . . . . 0.0 111.022 -173.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.851 HG13 HD11 ' A' ' 15' ' ' LEU . 3.1 m -122.08 118.28 55.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.814 168.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -83.63 105.65 14.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.224 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.4 mt -101.87 15.58 28.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.605 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.557 ' HB2' ' HB3' ' A' ' 19' ' ' ASN . 12.7 t -72.26 96.81 1.89 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 173.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.52 51.34 1.44 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 -172.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.2 p -106.01 162.36 13.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.717 0.294 . . . . 0.0 110.833 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.466 ' HB2' ' CE1' ' A' ' 63' ' ' HIS . 1.2 mp0 -120.38 132.89 23.98 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.4 147.74 66.25 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.775 2.316 . . . . 0.0 112.13 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.34 -171.02 17.05 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.491 -177.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -84.76 111.98 20.09 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' HIS . . . . . 0.466 ' CE1' ' HB2' ' A' ' 59' ' ' GLU . 25.6 m80 -137.1 145.19 43.59 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.025 0.44 . . . . 0.0 110.932 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.54 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 11.5 m-20 -85.25 125.72 33.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.364 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -121.79 151.79 40.2 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.086 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -90.16 142.8 27.36 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.797 -170.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.626 HG11 HG11 ' A' ' 33' ' ' VAL . 67.5 t -83.15 121.77 36.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.946 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 50.4 tttm -95.4 112.66 24.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.331 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.5 t -92.53 127.09 44.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.695 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 37.5 tt0 -72.21 122.87 88.54 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.979 177.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 50.0 Cg_exo -55.99 125.66 19.82 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.134 2.556 . . . . 0.0 113.062 -176.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.444 HG12 HD13 ' A' ' 49' ' ' LEU . 52.1 mt -88.54 117.1 67.98 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.948 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.86 137.27 37.69 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.318 2.012 . . . . 0.0 112.551 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 71.15 4.38 5.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.264 173.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 58.3 mt -132.06 136.14 57.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -90.41 123.33 34.04 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.43 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.553 ' HA ' HG22 ' A' ' 37' ' ' THR . 16.6 tt -80.28 139.49 18.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.466 HG21 ' HG3' ' A' ' 38' ' ' GLU . 39.4 t -108.05 -69.13 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.069 0.462 . . . . 0.0 110.902 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -107.79 141.66 39.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.864 -171.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.54 ' HA ' HG12 ' A' ' 35' ' ' VAL . 66.3 mt -120.1 110.43 28.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.362 177.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 47.0 m -144.78 123.84 6.92 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.92 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 93.2 Cg_endo -85.32 158.68 63.04 Favored 'Cis proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.123 -3.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -81.58 -35.64 29.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.984 0.421 . . . . 0.0 110.453 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.54 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 71.3 t -130.54 130.61 65.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.445 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.7 m -116.92 141.2 36.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.098 0.475 . . . . 0.0 111.168 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.1 m -80.44 117.51 21.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.229 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.2 mt -113.92 123.44 49.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.854 0.359 . . . . 0.0 110.681 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -88.79 104.37 16.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.078 176.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.9 mt -94.77 127.44 40.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.403 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 25' ' ' MET . 10.4 tp10 -100.41 154.61 18.38 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.686 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -80.62 90.46 5.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.611 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.622 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 22.4 t60 . . . . . 0 C--N 1.326 -0.452 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 120.62 0.248 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.83 125.97 13.95 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.412 2.075 . . . . 0.0 111.983 -178.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.4 m -90.74 116.39 28.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.648 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -108.85 131.84 54.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.18 0.514 . . . . 0.0 111.316 -173.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 m -103.86 99.14 8.91 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.823 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.5 mt -106.25 134.35 49.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.043 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -73.45 142.49 46.87 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.787 0.327 . . . . 0.0 110.75 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.751 HD11 HG13 ' A' ' 53' ' ' VAL . 55.4 tp -87.02 122.25 30.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.028 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.4 pt -108.93 153.78 10.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.141 0.496 . . . . 0.0 111.398 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.03 111.22 17.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.968 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -109.37 134.76 51.43 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.981 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.1 t30 62.28 18.15 9.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.707 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.502 HG23 HD12 ' A' ' 55' ' ' LEU . 31.0 m -72.09 118.95 71.61 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.922 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 7.0 Cg_exo -72.89 -179.95 4.74 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.905 2.403 . . . . 0.0 112.365 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 23' ' ' ASN . . . -80.82 161.43 24.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.276 175.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 22' ' ' ALA . 95.3 m-20 75.28 -34.47 0.26 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.532 0.733 . . . . 0.0 111.639 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.4 p -76.91 98.49 4.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.369 0.604 . . . . 0.0 109.695 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' MET . . . . . 0.692 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 51.1 ttp -103.0 124.56 48.74 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.639 -174.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.422 HG12 ' CD2' ' A' ' 89' ' ' LEU . 17.4 mt -84.65 97.62 5.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 44.1 ttp -79.05 -20.23 49.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.027 0.441 . . . . 0.0 109.953 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.0 m -75.75 105.97 7.07 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -54.61 132.25 44.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.012 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.51 114.64 29.88 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.438 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -89.2 -161.24 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.936 2.424 . . . . 0.0 112.222 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.3 p -120.81 141.95 50.06 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.793 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.608 HG11 HG11 ' A' ' 67' ' ' VAL . 25.1 m -93.9 142.86 12.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.923 0.392 . . . . 0.0 109.964 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -112.05 93.25 4.36 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.456 0.646 . . . . 0.0 109.444 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 80' ' ' ILE . 30.2 m -99.22 162.55 2.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.676 -175.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 36.0 tttm -123.17 122.99 39.8 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 77' ' ' ILE . 30.5 p -112.77 175.04 5.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.78 -175.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 28.2 tt0 -123.84 117.51 25.02 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.74 -137.35 9.33 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.196 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.531 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 79.2 m-85 -145.02 157.66 44.05 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -114.44 82.03 7.29 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 1.2 Cg_endo -84.84 -68.53 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.781 2.321 . . . . 0.0 112.766 -176.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.6 p -93.72 -14.69 26.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.116 -178.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.4 mt -86.58 117.63 31.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.619 -176.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -84.79 128.16 34.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.931 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.6 m -71.7 -17.11 19.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.198 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -91.2 -0.04 57.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.143 0.497 . . . . 0.0 110.158 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -102.88 -28.22 12.18 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.2 mt -81.99 135.8 35.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.791 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -128.05 156.88 42.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.522 0.677 . . . . 0.0 111.755 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.21 138.45 44.47 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 170.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -136.42 151.68 49.77 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.472 0.653 . . . . 0.0 112.294 -171.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.751 HG13 HD11 ' A' ' 15' ' ' LEU . 4.9 m -112.54 118.11 56.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.433 169.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -88.68 98.5 11.72 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.79 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.502 HD12 HG23 ' A' ' 20' ' ' THR . 60.1 mt -84.97 67.62 10.26 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.35 0.595 . . . . 0.0 110.248 -177.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.44 -20.73 59.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.18 176.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -99.36 142.51 16.05 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.248 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 m -92.94 38.12 1.03 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.646 ' HB2' ' OH ' ' A' ' 65' ' ' TYR . 11.1 mm-40 -66.16 110.22 4.38 Favored Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.765 -177.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -87.58 141.64 5.67 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.996 2.464 . . . . 0.0 111.994 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.21 -168.77 13.9 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.06 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 88' ' ' GLN . 36.3 mt-10 -82.51 97.73 8.58 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -122.77 143.13 50.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.956 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 28.5 m-20 -81.29 119.91 24.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.759 0.314 . . . . 0.0 110.297 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.646 ' OH ' ' HB2' ' A' ' 59' ' ' GLU . 53.6 m-85 -111.03 167.17 10.46 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.15 0.5 . . . . 0.0 111.04 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -106.77 122.63 46.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.626 -173.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.608 HG11 HG11 ' A' ' 33' ' ' VAL . 67.8 t -79.74 113.82 19.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.293 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -100.83 151.4 21.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.708 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.5 t -118.44 141.38 38.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.26 123.21 81.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.65 113.67 1.34 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.002 2.468 . . . . 0.0 112.382 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 48.7 mt -90.94 119.59 68.85 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.757 -176.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 72' ' ' ILE . 11.3 Cg_exo -71.94 149.57 53.52 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.733 2.289 . . . . 0.0 111.647 175.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 72.27 -51.22 0.7 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.589 0.756 . . . . 0.0 111.936 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.7 mt -83.89 134.25 27.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.348 0.594 . . . . 0.0 110.811 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 76.8 tttt -88.87 124.35 34.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.891 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.457 ' HA ' HG22 ' A' ' 37' ' ' THR . 18.0 tt -87.98 133.49 30.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.701 HG12 ' HG3' ' A' ' 79' ' ' GLU . 43.5 t -112.26 -59.89 3.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.106 0.479 . . . . 0.0 111.849 -171.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.701 ' HG3' HG12 ' A' ' 78' ' ' VAL . 46.2 mt-10 -125.23 102.79 7.62 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.084 -172.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.563 ' HA ' HG12 ' A' ' 35' ' ' VAL . 53.0 mt -80.18 118.79 28.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 171.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 36.5 m -141.58 116.48 7.0 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-O 120.548 0.213 . . . . 0.0 110.915 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.479 ' HD2' HG12 ' A' ' 33' ' ' VAL . 94.6 Cg_endo -87.68 -177.24 12.92 Favored 'Cis proline' 0 C--N 1.343 0.252 0 C-N-CA 123.701 -1.374 . . . . 0.0 112.358 -2.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 83' ' ' ARG . 52.0 mtm180 -122.7 -35.94 2.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.837 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.13 117.74 55.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.042 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.1 m -128.39 135.38 62.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.031 0.443 . . . . 0.0 110.846 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 3.9 m -80.09 99.53 7.76 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.097 177.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.554 ' HB2' ' HD2' ' A' ' 65' ' ' TYR . 80.2 mt -96.0 120.98 37.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.035 0.445 . . . . 0.0 109.892 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 59.3 tt0 -86.75 97.7 10.75 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.093 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 89' ' ' LEU . 28.0 mt -82.04 109.57 16.49 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.626 0.727 . . . . 0.0 109.698 175.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -101.28 175.29 5.63 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.674 -175.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -91.55 110.44 21.75 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.603 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.692 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 36.7 t-80 . . . . . 0 C--N 1.328 -0.357 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.009 0.433 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -89.21 144.76 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.884 2.39 . . . . 0.0 113.85 -175.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 21.2 m -88.11 109.19 19.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.291 171.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.3 tp -86.64 136.2 33.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.981 -174.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.1 m -101.15 119.26 38.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.432 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.2 mt -129.45 152.92 48.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.218 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 p -88.55 151.5 22.46 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.98 0.419 . . . . 0.0 111.091 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.651 HD11 HG13 ' A' ' 53' ' ' VAL . 38.6 tp -92.63 139.31 30.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.293 178.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.0 pt -127.78 160.33 37.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.441 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.417 ' HB1' HD12 ' A' ' 55' ' ' LEU . . . -109.11 129.12 55.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.365 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -120.29 131.87 55.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.092 0.472 . . . . 0.0 111.248 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.6 t30 61.72 46.27 7.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.53 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.524 ' HB ' HD12 ' A' ' 55' ' ' LEU . 12.1 t -79.36 138.18 55.73 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -52.51 146.82 32.08 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.811 2.341 . . . . 0.0 112.74 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.54 -35.56 79.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.825 -176.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -100.74 20.31 15.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.796 0.331 . . . . 0.0 111.861 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.4 p -110.61 127.39 55.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 43.1 ttp -112.6 126.5 55.42 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.228 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.1 mt -84.95 111.7 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.396 -175.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 95.5 mmm -83.57 -42.52 16.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.993 0.425 . . . . 0.0 110.439 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.2 m -74.26 127.25 32.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.734 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -71.96 139.91 48.88 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.697 173.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 64.2 mt -71.78 115.73 40.83 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.79 -173.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 22.5 Cg_exo -65.32 172.56 7.49 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.312 2.675 . . . . 0.0 113.627 -174.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.8 t -102.9 125.21 49.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.218 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.581 HG11 HG11 ' A' ' 67' ' ' VAL . 13.2 m -90.59 153.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.976 0.417 . . . . 0.0 110.615 -176.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -130.04 101.62 5.91 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.705 HG11 HG21 ' A' ' 69' ' ' VAL . 34.9 m -104.41 135.05 44.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.859 -175.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 62.9 tttp -83.62 121.35 27.13 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.501 HG22 ' HA ' ' A' ' 77' ' ' ILE . 20.9 p -121.95 155.35 35.7 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.497 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.51 ' HG3' ' HB3' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -121.1 119.44 32.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.978 0.418 . . . . 0.0 110.13 176.033 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.9 169.24 12.75 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.032 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -96.0 136.92 35.81 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.481 ' HB3' ' CD1' ' A' ' 75' ' ' ILE . 19.6 p30 -128.96 55.35 17.71 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.18 -56.71 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.689 1.593 . . . . 0.0 111.987 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.8 m -114.64 38.39 3.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.088 0.471 . . . . 0.0 111.06 -176.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.3 mt -114.66 142.71 26.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.798 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -80.63 41.28 0.55 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 111.008 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.442 HG23 ' OD1' ' A' ' 47' ' ' ASN . 11.9 m -61.27 -36.19 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.126 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.442 ' OD1' HG23 ' A' ' 46' ' ' VAL . 2.9 m-20 -79.4 -5.43 54.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.099 0.475 . . . . 0.0 110.604 -178.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -106.9 -10.84 15.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.736 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.2 mt -82.25 125.22 30.7 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 171.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -109.5 170.76 7.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.66 0.743 . . . . 0.0 112.353 -171.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.478 ' HB2' HG22 ' A' ' 69' ' ' VAL . . . -106.73 137.96 43.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.891 174.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.558 ' CZ ' ' HD3' ' A' ' 68' ' ' LYS . 27.2 p90 -135.29 158.08 45.28 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.615 -178.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.651 HG13 HD11 ' A' ' 15' ' ' LEU . 23.1 m -112.47 141.96 26.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.583 174.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -89.48 118.04 28.83 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.524 HD12 ' HB ' ' A' ' 20' ' ' THR . 85.6 mt -109.16 25.76 11.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.591 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.2 m -73.49 95.32 2.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.309 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.82 23.03 14.25 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.601 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.6 p -88.57 122.96 32.6 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.782 -0.246 . . . . 0.0 110.566 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -75.32 155.08 86.08 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.085 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.54 90.99 0.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.59 2.193 . . . . 0.0 112.029 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.05 172.87 42.86 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 88' ' ' GLN . 40.0 tt0 -82.24 105.47 13.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -130.61 167.9 17.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.347 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.431 ' HB3' HG11 ' A' ' 84' ' ' VAL . 13.6 m-20 -98.59 121.84 41.04 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.351 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -116.89 128.09 54.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.104 -178.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.425 ' HG2' HG22 ' A' ' 84' ' ' VAL . 46.8 mt-10 -69.95 134.61 48.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.204 -175.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.581 HG11 HG11 ' A' ' 33' ' ' VAL . 59.4 t -78.92 112.18 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.546 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.558 ' HD3' ' CZ ' ' A' ' 52' ' ' TYR . 53.6 tttm -102.88 102.63 12.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.388 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.705 HG21 HG11 ' A' ' 35' ' ' VAL . 39.4 t -86.86 125.5 40.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -63.86 127.67 91.93 Favored Pre-proline 0 C--N 1.323 -0.58 0 O-C-N 123.198 0.311 . . . . 0.0 110.958 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.35 137.52 47.28 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.617 2.878 . . . . 0.0 112.92 -175.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.471 ' CG2' ' HB ' ' A' ' 75' ' ' ILE . 30.5 mm -89.17 126.89 57.37 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.262 -177.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.1 131.04 29.1 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.286 1.991 . . . . 0.0 111.725 176.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.3 t30 73.79 -44.42 0.57 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.538 0.735 . . . . 0.0 111.998 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.481 ' CD1' ' HB3' ' A' ' 41' ' ' ASN . 71.5 mt -83.94 140.84 15.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.946 0.403 . . . . 0.0 110.682 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.51 ' HB3' ' HG3' ' A' ' 38' ' ' GLU . 57.3 tttp -94.84 125.71 39.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.387 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.501 ' HA ' HG22 ' A' ' 37' ' ' THR . 14.0 tt -88.36 122.21 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.498 0.666 . . . . 0.0 109.94 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.3 t -85.31 -64.57 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.069 -175.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -130.51 136.8 49.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.113 -170.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.635 ' HA ' HG12 ' A' ' 35' ' ' VAL . 67.5 mt -104.41 108.26 24.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.203 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.455 ' HA ' ' C ' ' A' ' 82' ' ' PRO . 11.6 p -136.13 126.93 16.74 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.735 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.455 ' C ' ' HA ' ' A' ' 81' ' ' SER . 15.3 Cg_exo -68.51 156.85 88.81 Favored 'Cis proline' 0 C--N 1.344 0.32 0 C-N-CA 123.55 -1.438 . . . . 0.0 112.508 0.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -85.23 -38.1 19.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.746 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.431 HG11 ' HB3' ' A' ' 64' ' ' ASP . 59.3 t -137.86 143.58 33.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.375 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 m -118.26 140.03 43.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.957 0.408 . . . . 0.0 111.011 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 m -92.36 105.2 17.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.04 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.9 mt -105.37 124.91 50.34 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.761 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 47.0 tt0 -85.8 99.88 11.66 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.012 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.2 mt -88.22 139.52 30.41 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.14 174.0 7.22 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.74 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -83.89 137.57 33.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.36 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 68.6 t60 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.686 0.755 . . . . 0.0 109.296 173.788 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 120.541 0.21 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 p -114.15 152.99 30.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.523 0.201 . . . . 0.0 110.671 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -66.28 -49.6 66.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.095 0.474 . . . . 0.0 109.971 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.5 m -107.91 111.09 23.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.612 173.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.04 153.16 44.24 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -65.68 -28.76 69.31 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.526 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 37.5 ttt180 62.14 34.67 16.14 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.227 175.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -112.82 85.96 8.27 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.799 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 7' ' ' ARG . 8.1 Cg_exo -71.72 152.97 59.37 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.603 2.202 . . . . 0.0 112.051 -178.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.6 m -107.39 113.13 26.3 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.707 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 93.1 mt -90.23 127.84 36.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.087 0.47 . . . . 0.0 110.511 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -103.64 102.93 12.8 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.305 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -102.89 144.14 31.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.286 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.2 m -76.86 143.96 39.33 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.813 HD11 HG13 ' A' ' 53' ' ' VAL . 52.7 tp -88.32 127.32 35.48 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.8 pt -122.77 171.17 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.933 0.396 . . . . 0.0 110.842 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.506 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -107.11 122.21 46.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.158 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -114.95 139.89 49.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.594 0.235 . . . . 0.0 110.679 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.8 t30 56.13 32.04 19.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.392 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.506 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 89.6 m -90.02 114.74 61.96 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.311 -176.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.7 163.87 37.54 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.758 2.306 . . . . 0.0 111.561 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.92 -13.29 59.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.855 0.36 . . . . 0.0 110.598 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -67.19 -35.02 78.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.885 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.8 p -95.24 102.67 14.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.602 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 52.6 ttp -102.79 111.98 24.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.061 0.458 . . . . 0.0 110.56 -174.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 28' ' ' THR . 21.6 mt -75.44 113.46 14.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.414 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 84.9 mtp -99.78 10.86 40.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.426 0.631 . . . . 0.0 110.103 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 26' ' ' ILE . 9.3 m -105.39 119.19 38.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.827 176.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -60.78 136.07 57.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.713 0.292 . . . . 0.0 110.335 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.7 mt -81.86 122.9 80.47 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.419 -171.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.536 ' HD2' HD23 ' A' ' 15' ' ' LEU . 87.4 Cg_endo -83.55 -164.88 0.28 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.207 2.605 . . . . 0.0 112.803 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.2 t -125.35 144.91 50.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.074 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.21 144.42 14.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.808 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 35.6 mtm-85 -118.08 99.21 6.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 80' ' ' ILE . 21.2 m -98.85 128.76 50.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.328 0.585 . . . . 0.0 111.497 -174.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.526 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 85.4 tttt -80.6 124.26 28.83 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.461 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 13.1 p -126.11 138.91 53.72 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -173.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.869 ' HB2' ' HB2' ' A' ' 76' ' ' LYS . 40.1 mt-10 -93.95 89.62 6.15 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 172.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.7 136.56 2.02 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -104.39 135.8 45.16 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.101 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.617 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 3.5 p-10 -135.07 102.49 10.97 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 121.329 0.585 . . . . 0.0 111.158 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -88.01 -10.05 5.13 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.341 2.027 . . . . 0.0 111.693 174.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.9 p -113.19 -45.08 3.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.508 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' A' ' 41' ' ' ASN . 57.1 mt -57.85 136.5 21.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 120.96 0.41 . . . . 0.0 110.666 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 78.8 m-20 -101.67 147.38 26.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.816 -176.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.9 m -80.85 -5.88 9.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.293 0.568 . . . . 0.0 110.042 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -93.01 -19.27 21.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.996 169.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 76.9 tt0 -80.78 -32.61 35.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.219 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.6 mt -94.37 138.52 32.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.234 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -133.3 152.65 51.94 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.388 0.613 . . . . 0.0 111.552 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . . . -110.78 125.08 53.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.505 171.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -121.24 159.41 26.01 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.309 0.576 . . . . 0.0 111.718 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.813 HG13 HD11 ' A' ' 15' ' ' LEU . 11.4 m -112.5 123.52 68.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.048 171.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.0 110.47 12.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.441 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.436 HD22 HD11 ' A' ' 89' ' ' LEU . 55.4 mt -106.87 29.31 7.14 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.693 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m -57.85 -43.78 86.12 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.758 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.81 84.76 1.3 Allowed Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.6 p -71.09 91.09 0.89 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.045 0.45 . . . . 0.0 111.995 -173.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -101.33 107.73 52.0 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.01 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.32 152.18 75.83 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.904 2.402 . . . . 0.0 112.292 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.05 -179.38 20.52 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HG2' HG22 ' A' ' 86' ' ' THR . 32.2 tt0 -80.14 102.98 9.7 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 176.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -129.12 143.34 50.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.593 -172.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.493 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 26.8 m-20 -81.74 124.98 30.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.226 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -120.92 151.18 40.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.463 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.13 134.52 34.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.124 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.482 HG13 HD13 ' A' ' 15' ' ' LEU . 68.7 t -79.13 106.4 10.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 174.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -99.67 106.08 17.97 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.517 -177.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 42.4 t -87.12 134.9 26.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.088 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -63.73 135.33 96.24 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.323 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.54 132.3 44.76 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.083 2.522 . . . . 0.0 112.61 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.7 mp -97.53 121.05 59.36 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.052 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.56 119.32 6.47 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.979 2.453 . . . . 0.0 113.0 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.3 m120 69.17 15.08 8.68 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.207 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.511 HD11 ' HB3' ' A' ' 41' ' ' ASN . 57.4 mt -129.53 130.12 67.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.869 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 97.1 mttt -80.89 137.42 36.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.855 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.8 tt -93.41 116.88 35.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.408 0.623 . . . . 0.0 109.659 172.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.7 t -95.63 -50.29 11.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.253 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.526 ' HB2' ' H ' ' A' ' 36' ' ' LYS . 50.1 mt-10 -118.76 157.74 26.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.087 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.597 ' HA ' HG12 ' A' ' 35' ' ' VAL . 18.9 tt -144.55 25.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 122.163 0.982 . . . . 0.0 108.985 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.531 ' HA ' ' N ' ' A' ' 83' ' ' ARG . 16.1 m -85.79 142.86 37.19 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.377 -175.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 81' ' ' SER . 17.4 Cg_exo -67.15 124.39 5.97 Favored 'Cis proline' 0 C--N 1.346 0.425 0 C-N-CA 123.633 -1.403 . . . . 0.0 111.921 -1.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.531 ' N ' ' HA ' ' A' ' 81' ' ' SER . 70.3 mtm180 -69.72 -31.14 68.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.712 -173.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 43.9 t -127.58 134.98 64.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.699 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 m -120.73 133.26 67.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.195 0.521 . . . . 0.0 110.453 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.469 HG22 ' HG2' ' A' ' 62' ' ' GLU . 4.2 m -87.26 101.38 13.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.983 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.3 mt -107.05 134.52 50.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.226 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 62.4 tt0 -95.34 103.12 14.97 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.013 0.435 . . . . 0.0 110.443 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.436 HD11 HD22 ' A' ' 55' ' ' LEU . 49.4 mt -82.46 120.05 24.97 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.474 175.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.62 149.88 23.3 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.1 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -71.0 124.53 24.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.504 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -85.35 -8.96 58.19 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -114.18 120.55 40.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.874 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -124.91 173.24 8.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.788 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' HIS . . . . . 0.485 ' O ' ' HB2' ' A' ' 96' ' ' HIS . 68.0 m-70 -91.98 -65.97 0.96 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 172.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 95' ' ' HIS . 36.2 t-80 . . . . . 0 C--O 1.242 0.704 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.624 169.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.8 m . . . . . 0 N--CA 1.475 0.782 0 CA-C-O 120.607 0.242 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m -70.76 132.74 45.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.375 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -74.9 -45.82 40.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.074 0.464 . . . . 0.0 110.936 -174.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.1 p -75.96 -0.42 21.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.628 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.0 tp -85.66 -18.02 34.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.21 0.529 . . . . 0.0 109.69 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.75 -14.96 59.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.55 0.691 . . . . 0.0 109.936 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -108.34 133.1 53.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.519 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.426 ' HB3' ' HA ' ' A' ' 38' ' ' GLU . 10.2 m-20 52.32 85.46 0.19 Allowed Pre-proline 0 N--CA 1.467 0.39 0 O-C-N 123.909 0.756 . . . . 0.0 111.245 172.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.18 147.88 23.82 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.647 2.231 . . . . 0.0 113.567 -173.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 67.9 m -90.72 109.18 20.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.522 171.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.6 mt -83.12 138.51 33.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.217 0.532 . . . . 0.0 110.876 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.3 m -109.96 102.05 10.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.926 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.44 HD22 ' HB2' ' A' ' 49' ' ' LEU . 44.3 mt -101.78 155.3 18.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.106 -176.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 m -88.53 143.48 26.94 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.831 HD11 HG13 ' A' ' 53' ' ' VAL . 52.6 tp -94.91 127.04 40.65 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.7 pt -124.05 160.61 27.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.036 0.446 . . . . 0.0 111.392 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -88.33 115.73 26.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.308 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 18.3 tptm -114.29 141.12 47.99 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 63.34 20.95 12.56 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.67 0.606 . . . . 0.0 110.579 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.456 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 43.1 m -83.17 118.77 72.66 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.845 -173.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 2.9 Cg_exo -76.12 154.58 37.44 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.298 2.665 . . . . 0.0 112.194 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.9 -1.93 21.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.224 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -80.92 -29.12 35.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.071 0.463 . . . . 0.0 110.553 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.8 p -107.16 128.71 54.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.152 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.773 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 58.0 ttp -119.11 126.78 52.44 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.033 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 28' ' ' THR . 13.9 mt -84.83 115.14 26.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.558 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 94.1 mmm -80.63 -7.98 59.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.306 0.574 . . . . 0.0 110.189 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.474 ' H ' HG22 ' A' ' 26' ' ' ILE . 19.2 m -99.23 118.39 35.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.579 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -66.31 132.89 49.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.781 0.324 . . . . 0.0 110.677 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.4 mt -75.45 122.26 86.85 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.415 -173.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HD2' HD23 ' A' ' 15' ' ' LEU . 95.2 Cg_endo -89.49 -157.71 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.183 2.588 . . . . 0.0 112.628 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.5 p -113.71 160.63 18.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.419 ' CG1' ' HB2' ' A' ' 13' ' ' LEU . 11.3 p -112.91 139.4 38.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.83 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -111.31 109.59 19.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.061 0.458 . . . . 0.0 110.8 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 80' ' ' ILE . 25.2 m -117.24 111.69 35.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.085 -177.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.606 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 6.5 ttpm? -74.77 125.95 29.86 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 174.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.532 HG22 ' HA ' ' A' ' 77' ' ' ILE . 25.3 p -124.66 138.07 54.32 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.056 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.426 ' HA ' ' HB3' ' A' ' 8' ' ' ASP . 48.9 mt-10 -94.64 135.46 36.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.366 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.35 -168.4 12.89 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.832 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -132.9 140.2 47.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.914 0.388 . . . . 0.0 110.673 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -160.92 80.47 2.19 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.996 178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.66 -24.28 11.96 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.881 2.387 . . . . 0.0 112.53 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.9 p -84.35 -12.98 53.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.695 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.4 mt -103.21 111.08 31.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -95.47 151.72 19.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.096 0.474 . . . . 0.0 111.745 -174.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.5 m -69.4 -13.47 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.358 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -85.5 -9.63 57.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.24 0.543 . . . . 0.0 109.707 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -105.22 -26.33 12.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.754 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HB2' HD22 ' A' ' 13' ' ' LEU . 91.2 mt -88.64 132.32 34.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.831 175.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -125.19 154.06 42.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.613 0.72 . . . . 0.0 111.791 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -120.85 134.98 55.28 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.494 171.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.581 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 18.9 p90 -129.12 161.02 31.01 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.321 0.581 . . . . 0.0 111.411 -174.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.831 HG13 HD11 ' A' ' 15' ' ' LEU . 5.7 m -112.29 118.38 57.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.418 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 16.4 t0 -78.06 105.08 9.03 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.526 -175.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 58' ' ' SER . 64.0 mt -104.73 35.57 2.72 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.755 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.0 m -60.28 -38.63 84.18 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.56 53.33 0.78 Allowed Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.276 173.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.613 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 23.1 t -74.18 107.08 6.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.049 0.452 . . . . 0.0 110.865 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 44.2 mt-10 -104.69 126.2 31.91 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.26 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 59' ' ' GLU . 51.1 Cg_exo -55.3 141.23 81.57 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.961 2.441 . . . . 0.0 111.932 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.44 175.29 19.17 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.45 107.77 13.52 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -134.0 156.78 47.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.982 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -95.7 125.84 40.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.194 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -121.7 161.68 22.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.823 0.344 . . . . 0.0 110.664 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -93.86 138.13 32.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.987 -175.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.1 t -88.35 121.29 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.985 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.418 ' HD2' ' HB2' ' A' ' 54' ' ' ASP . 96.9 mttt -105.06 127.12 52.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.002 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.14 138.64 35.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.14 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -68.59 139.48 91.55 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.62 150.5 86.4 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.113 2.542 . . . . 0.0 112.577 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 75' ' ' ILE . 11.5 mt -122.26 118.58 28.89 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.9 114.81 2.09 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 123.277 2.651 . . . . 0.0 113.479 -175.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.3 m120 70.85 11.37 7.11 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.321 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 72' ' ' ILE . 41.3 mm -107.81 121.79 61.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.12 0.486 . . . . 0.0 110.472 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -80.66 114.81 19.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.425 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.532 ' HA ' HG22 ' A' ' 37' ' ' THR . 16.0 tt -87.94 115.7 28.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.466 0.651 . . . . 0.0 109.918 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.98 -53.02 9.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.64 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.606 ' HG2' ' HB3' ' A' ' 36' ' ' LYS . 66.8 mm-40 -106.64 146.76 30.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.509 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.565 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 26.8 mt -133.71 81.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 165.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 17.7 m -118.58 116.34 35.01 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.719 -175.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 72.8 Cg_endo -94.33 158.33 17.42 Favored 'Cis proline' 0 C--N 1.346 0.41 0 C-N-CA 124.131 -1.195 . . . . 0.0 113.302 -0.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 80' ' ' ILE . 61.2 mtm180 -96.43 -31.99 12.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.592 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.0 t -119.84 122.17 67.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.019 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.1 m -121.55 138.86 50.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.6 m -88.81 102.73 15.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.067 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.6 mt -101.22 128.44 47.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.016 0.436 . . . . 0.0 110.933 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -91.36 103.6 16.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.183 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.471 ' CD2' HG12 ' A' ' 26' ' ' ILE . 96.0 mt -97.05 128.68 44.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.064 0.459 . . . . 0.0 110.728 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -119.33 178.76 4.41 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.482 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -80.55 114.79 19.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.281 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.773 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 74.5 t60 -83.55 -16.57 44.92 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.245 0.545 . . . . 0.0 109.66 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -122.78 101.94 7.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.572 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 68.25 110.13 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 O-C-N 124.075 0.859 . . . . 0.0 111.11 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -110.19 -62.22 1.55 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.175 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 78.7 t60 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.03 -179.811 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.7 p . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.677 0.275 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.1 p -148.13 -30.6 0.29 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.414 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 66.27 15.46 10.1 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.537 -173.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.3 m -86.44 90.29 8.16 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.601 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.8 mt -67.32 -56.08 11.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.344 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -85.03 122.45 29.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.528 174.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.48 ' HG2' ' OH ' ' A' ' 40' ' ' TYR . 7.1 mtt180 -91.65 -3.82 55.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.615 0.721 . . . . 0.0 110.568 -170.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.488 ' HB3' ' HG2' ' A' ' 38' ' ' GLU . 0.9 OUTLIER -127.29 75.35 77.14 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.848 168.395 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.24 151.59 12.22 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.676 2.917 . . . . 0.0 113.509 -170.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 37.9 m -95.25 109.88 21.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.632 174.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.8 mt -87.43 137.99 31.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.027 0.441 . . . . 0.0 110.603 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 m -102.63 95.77 6.44 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.071 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.1 mt -101.74 120.11 39.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.192 -175.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 48.6 m -63.35 140.81 58.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.879 0.371 . . . . 0.0 111.406 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.826 HD11 HG13 ' A' ' 53' ' ' VAL . 40.3 tp -84.01 123.58 30.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.788 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.4 pt -109.83 146.17 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.04 0.448 . . . . 0.0 111.58 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.6 94.16 5.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.126 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -96.31 131.51 42.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.026 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.1 t30 58.62 39.18 24.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.755 0.788 . . . . 0.0 109.933 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 63.8 m -88.59 124.81 65.04 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.638 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.867 ' HG2' ' HB3' ' A' ' 58' ' ' SER . 17.0 Cg_exo -67.51 175.76 5.69 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.0 2.466 . . . . 0.0 112.756 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 92' ' ' HIS . . . -94.2 -6.59 44.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.88 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -88.65 -23.64 22.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.018 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.9 p -114.74 112.45 22.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.834 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.0 ttp -105.69 132.7 51.51 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.7 mt -81.31 118.77 29.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 120.759 0.314 . . . . 0.0 110.718 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 83.6 mtp -74.18 -52.5 12.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.106 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 m -70.27 110.14 5.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.4 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -63.26 133.96 55.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.089 0.471 . . . . 0.0 110.63 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.453 HD22 HD23 ' A' ' 15' ' ' LEU . 50.3 mt -71.54 129.41 88.69 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.454 -173.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -92.32 -170.89 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.37 2.713 . . . . 0.0 111.933 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 24.8 m -105.39 135.6 46.47 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.545 HG11 HG11 ' A' ' 67' ' ' VAL . 10.9 m -86.26 145.22 8.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.789 0.328 . . . . 0.0 110.201 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.5 mtp85 -111.51 101.59 10.0 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.123 0.487 . . . . 0.0 109.937 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 80' ' ' ILE . 26.8 m -110.7 137.04 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.757 -177.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 61.1 tttp -85.9 129.66 34.77 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.2 p -126.36 175.22 8.0 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.174 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.488 ' HG2' ' HB3' ' A' ' 8' ' ' ASP . 35.8 mt-10 -139.07 137.63 36.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.704 0.288 . . . . 0.0 110.651 176.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.5 -175.28 17.46 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.552 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.48 ' OH ' ' HG2' ' A' ' 7' ' ' ARG . 82.0 m-85 -118.15 126.64 52.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.661 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 4.2 p30 -130.48 62.69 66.2 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.166 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.52 -29.83 36.55 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.139 1.893 . . . . 0.0 111.954 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.8 p -91.15 -1.25 57.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.57 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.661 ' HB ' ' HB2' ' A' ' 41' ' ' ASN . 61.2 mt -109.95 126.64 67.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.777 0.322 . . . . 0.0 110.47 -178.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.411 ' ND2' ' HG3' ' A' ' 48' ' ' GLU . 39.8 t30 -85.58 110.92 19.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.405 0.621 . . . . 0.0 110.912 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.6 t -59.93 -27.35 38.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.336 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -71.02 -28.03 64.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.862 0.363 . . . . 0.0 111.174 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.411 ' HG3' ' ND2' ' A' ' 45' ' ' ASN . 40.9 mt-10 -91.3 -12.17 35.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.096 0.474 . . . . 0.0 110.652 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 93.6 mt -77.06 129.7 36.42 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 167.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -131.92 162.38 30.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.86 0.838 . . . . 0.0 112.564 -174.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -109.74 127.86 54.9 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.907 169.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -123.66 144.03 49.89 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.355 0.598 . . . . 0.0 112.036 -172.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.826 HG13 HD11 ' A' ' 15' ' ' LEU . 7.0 m -112.47 131.48 63.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.159 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.53 115.73 28.39 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.679 -0.408 . . . . 0.0 109.982 -175.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 66.1 mt -105.6 51.97 0.74 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.44 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.1 m -57.32 -47.33 81.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.307 0.575 . . . . 0.0 109.661 173.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.11 100.14 2.47 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.501 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.867 ' HB3' ' HG2' ' A' ' 21' ' ' PRO . 1.5 p -73.18 87.8 1.45 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.969 0.414 . . . . 0.0 110.5 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.412 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 27.4 mt-10 -102.82 110.21 62.86 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.08 -174.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 59' ' ' GLU . 38.9 Cg_endo -66.95 141.32 57.95 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.59 2.194 . . . . 0.0 112.294 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.22 -172.24 17.64 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.67 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.513 ' HG3' ' HG2' ' A' ' 88' ' ' GLN . 1.9 mp0 -87.46 89.15 7.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.789 0.328 . . . . 0.0 110.253 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 38.1 m-70 -104.97 148.35 26.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.442 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -92.19 122.76 34.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.998 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -118.87 147.66 43.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.694 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.526 ' HG2' HG22 ' A' ' 84' ' ' VAL . 36.2 mt-10 -93.79 132.19 38.42 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.888 0.375 . . . . 0.0 110.513 -172.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.545 HG11 HG11 ' A' ' 33' ' ' VAL . 59.8 t -73.22 106.83 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.647 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -86.97 109.48 19.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.804 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.76 123.26 39.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.52 119.53 51.21 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.57 110.01 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.108 2.539 . . . . 0.0 112.704 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.3 mt -82.73 114.48 52.4 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.873 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.31 140.78 54.25 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.427 2.085 . . . . 0.0 112.141 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.4 t30 76.31 -2.78 2.66 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.86 0.725 . . . . 0.0 111.015 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.4 mm -116.62 144.85 23.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.982 0.42 . . . . 0.0 110.543 -177.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -98.91 137.39 37.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.211 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.6 tt -104.64 133.77 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.7 t -102.54 -63.36 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.916 0.389 . . . . 0.0 111.222 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -135.46 143.18 45.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.574 -170.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.633 ' HA ' HG12 ' A' ' 35' ' ' VAL . 57.9 mt -112.32 127.07 69.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.335 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 51.2 m -146.39 114.31 4.47 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.636 0.255 . . . . 0.0 110.957 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 2.8 Cg_endo -83.13 172.33 48.43 Favored 'Cis proline' 0 C--N 1.343 0.254 0 C-N-CA 123.803 -1.332 . . . . 0.0 111.964 -2.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -99.56 -45.25 5.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.369 0.604 . . . . 0.0 109.893 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.526 HG22 ' HG2' ' A' ' 66' ' ' GLU . 59.9 t -128.11 125.6 64.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.344 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 m -113.26 139.34 39.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.173 0.511 . . . . 0.0 111.006 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.4 m -86.61 106.54 17.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.068 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.7 mt -101.34 127.86 47.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.213 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.513 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 48.2 mt-30 -90.21 105.39 17.78 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.654 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.4 mt -95.24 126.42 40.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.217 0.532 . . . . 0.0 110.799 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -108.73 153.51 23.35 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.144 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -76.68 113.43 14.32 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.168 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.473 ' HB3' ' O ' ' A' ' 22' ' ' ALA . 79.4 t60 -72.71 -25.27 61.17 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -138.31 124.67 20.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.163 -1.381 . . . . 0.0 107.904 165.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -67.99 -76.71 0.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.941 0.401 . . . . 0.0 110.051 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -178.28 -36.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 25.8 t60 . . . . . 0 C--O 1.244 0.765 0 CA-C-O 118.489 -0.767 . . . . 0.0 108.969 175.455 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.475 0.812 0 CA-C-O 121.151 0.501 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.0 t -92.46 173.58 7.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.368 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -85.78 -1.37 57.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.246 0.546 . . . . 0.0 110.297 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.0 p -83.51 16.68 2.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.005 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 5' ' ' LEU . 38.5 tp -112.17 16.07 20.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.193 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -114.03 99.13 7.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.815 -177.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 63.71 -78.95 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.488 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 8.0 p-10 -63.46 112.11 6.46 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-O 121.522 0.677 . . . . 0.0 111.135 -171.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 66.6 Cg_endo -99.42 173.53 0.41 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.693 2.928 . . . . 0.0 113.948 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 3.7 m -107.38 130.97 54.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.404 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.7 tp -102.87 135.38 44.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.894 0.378 . . . . 0.0 110.012 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.4 m -100.68 106.33 17.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.096 0.474 . . . . 0.0 110.754 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.493 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 92.0 mt -102.8 158.32 16.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.068 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.4 t -97.86 138.61 34.95 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.501 HD11 HG13 ' A' ' 53' ' ' VAL . 46.9 tp -79.93 124.59 28.81 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.45 HG13 ' HB3' ' A' ' 52' ' ' TYR . 43.8 pt -116.61 156.95 17.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.146 0.498 . . . . 0.0 111.249 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.474 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -87.84 118.68 27.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.668 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -115.78 132.1 56.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.542 -176.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.732 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 95.3 m-20 60.34 26.31 15.83 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.104 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.474 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 50.7 m -79.58 119.51 77.12 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.937 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 27.9 Cg_exo -62.56 158.74 39.81 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 123.14 2.56 . . . . 0.0 112.356 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.77 -8.03 59.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.026 0.441 . . . . 0.0 110.635 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -88.19 -5.86 58.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.611 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.0 p -114.55 131.2 56.75 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.863 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.548 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 49.7 ttp -124.93 120.58 32.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.96 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.458 HG12 ' CD2' ' A' ' 89' ' ' LEU . 8.1 mt -82.08 123.5 38.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 45.6 ttp -74.81 -57.47 3.89 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.091 0.472 . . . . 0.0 110.011 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -70.58 154.14 42.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.57 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -94.15 141.16 28.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.889 0.376 . . . . 0.0 110.6 -178.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 65.4 mt -67.4 114.32 18.51 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.229 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 2.8 Cg_exo -73.76 172.95 14.78 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.695 2.263 . . . . 0.0 112.906 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.2 m -82.48 134.35 35.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.364 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.493 ' CG2' ' HB2' ' A' ' 13' ' ' LEU . 33.7 m -95.32 138.12 21.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.149 0.499 . . . . 0.0 110.038 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.437 ' HG3' ' CG2' ' A' ' 10' ' ' THR . 9.7 ttp180 -104.84 103.66 13.29 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.958 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.553 HG12 ' HA ' ' A' ' 80' ' ' ILE . 25.9 m -117.38 126.11 74.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.096 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 42.3 tttt -93.08 141.92 27.88 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 8' ' ' ASP . 32.9 p -118.33 144.56 45.77 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 123.357 0.41 . . . . 0.0 110.996 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 31.6 tt0 -96.37 107.36 19.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 146.0 -138.71 7.69 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -148.81 126.77 11.94 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -104.78 109.16 62.65 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.318 0.58 . . . . 0.0 111.77 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.39 -47.98 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.749 2.299 . . . . 0.0 111.691 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.1 m -131.64 -68.7 0.64 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.753 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.7 mm 64.91 117.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.398 0.618 . . . . 0.0 111.504 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.458 ' ND2' ' HG2' ' A' ' 48' ' ' GLU . 59.4 t30 -84.5 90.65 7.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.642 0.734 . . . . 0.0 110.681 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.42 ' O ' HG12 ' A' ' 46' ' ' VAL . 11.2 t -78.34 7.11 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.333 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -82.63 -20.24 36.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.814 174.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.458 ' HG2' ' ND2' ' A' ' 45' ' ' ASN . 12.6 mm-40 -107.0 -35.15 6.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.304 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.419 HD13 HD12 ' A' ' 72' ' ' ILE . 80.3 mt -83.01 124.63 30.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.301 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -147.36 175.62 10.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.777 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -123.59 137.36 54.76 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 170.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.45 ' HB3' HG13 ' A' ' 16' ' ' ILE . 20.1 p90 -136.41 160.87 37.44 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.642 0.734 . . . . 0.0 112.917 -173.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.501 HG13 HD11 ' A' ' 15' ' ' LEU . 14.6 m -113.12 125.95 70.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.313 167.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -91.67 102.35 14.98 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -175.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 71.4 mt -92.84 15.13 15.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.572 -173.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.732 ' HB2' ' HB3' ' A' ' 19' ' ' ASN . 8.0 t -73.74 106.19 5.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 175.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.08 35.32 6.76 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.266 -175.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.1 m -120.16 145.84 46.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.725 0.297 . . . . 0.0 110.663 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.91 154.25 37.87 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.978 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.561 ' HA ' ' HB2' ' A' ' 89' ' ' LEU . 26.1 Cg_exo -64.93 169.86 11.17 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.936 2.424 . . . . 0.0 112.159 175.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.37 -177.73 27.41 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -175.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -86.56 111.39 20.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.004 0.431 . . . . 0.0 110.396 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 65' ' ' TYR . 35.5 m80 -129.03 151.79 49.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.953 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.466 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 19.2 m-20 -90.11 103.22 15.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.847 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 63' ' ' HIS . 72.5 m-85 -97.39 147.33 24.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.766 -176.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -87.9 125.26 34.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.807 -172.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 64.6 t -74.74 110.63 9.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.134 0.493 . . . . 0.0 110.094 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -101.82 106.14 17.08 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.111 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.2 t -91.91 136.36 24.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.491 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -75.1 122.05 86.58 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 171.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.42 142.35 88.97 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.705 2.27 . . . . 0.0 112.063 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.419 HD12 HD13 ' A' ' 49' ' ' LEU . 32.7 mm -82.18 120.1 76.44 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.571 -177.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 22.0 Cg_exo -66.08 146.04 80.9 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.23 1.953 . . . . 0.0 111.307 175.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 73' ' ' PRO . 84.5 m-20 76.8 -41.19 0.39 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.491 0.716 . . . . 0.0 112.079 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.7 mt -103.08 157.4 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 58.4 tttm -92.88 146.07 23.91 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 tt -95.18 144.51 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 122.094 -0.379 . . . . 0.0 109.979 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.401 ' CG2' ' HB2' ' A' ' 38' ' ' GLU . 45.4 t -114.62 -70.89 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.951 0.405 . . . . 0.0 111.349 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -116.51 148.76 40.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.226 -169.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.553 ' HA ' HG12 ' A' ' 35' ' ' VAL . 73.8 mt -132.08 107.04 12.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.025 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.4 t -137.66 126.66 14.86 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.092 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.422 ' HD2' HG12 ' A' ' 33' ' ' VAL . 97.3 Cg_endo -81.51 177.52 34.53 Favored 'Cis proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.065 -1.639 . . . . 0.0 112.637 -0.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -112.6 -47.32 3.08 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.627 -173.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.466 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 61.4 t -125.45 121.49 60.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 m -111.69 135.6 50.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.021 0.439 . . . . 0.0 111.575 -175.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.7 m -83.12 110.25 17.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.687 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.404 ' HB2' ' HD2' ' A' ' 65' ' ' TYR . 93.6 mt -110.66 129.11 55.9 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.406 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -93.46 107.24 19.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.91 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' A' ' 60' ' ' PRO . 80.7 mt -93.29 123.66 36.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.993 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.64 162.04 13.19 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.192 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.469 ' CE1' ' HG2' ' A' ' 60' ' ' PRO . 55.6 m-70 -82.55 117.93 22.9 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.907 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 17.2 t-80 -89.03 91.89 9.0 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 175.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -98.1 124.11 42.47 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.103 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -104.52 121.91 44.46 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 170.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -56.47 -64.69 0.78 Allowed 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.437 0.461 . . . . 0.0 110.386 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.101 178.859 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.478 0.932 0 CA-C-O 120.926 0.394 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.4 t -126.41 151.22 47.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.659 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -109.81 118.58 36.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.91 0.386 . . . . 0.0 110.885 -177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 p -83.34 6.46 19.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.771 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.8 mt -103.61 3.23 34.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.506 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -116.88 144.13 44.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.674 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.1 ttm105 -64.63 -29.24 70.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.615 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -147.83 93.05 4.58 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.466 0.651 . . . . 0.0 111.214 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -79.05 169.87 18.63 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.66 2.24 . . . . 0.0 112.631 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 m -105.21 103.7 13.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.998 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.619 ' HB2' HG23 ' A' ' 35' ' ' VAL . 83.4 mt -83.24 134.7 34.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.067 0.46 . . . . 0.0 110.156 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.3 m -110.63 104.57 13.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.233 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 60.1 mt -104.68 157.91 16.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.242 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 m -91.01 143.78 26.35 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.588 HD11 HG13 ' A' ' 53' ' ' VAL . 49.9 tp -92.56 133.23 36.15 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.0 pt -132.26 162.61 39.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.012 0.434 . . . . 0.0 110.893 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.429 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -97.26 126.28 42.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.224 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -124.27 139.82 53.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 64.45 19.06 11.66 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.61 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.429 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 49.2 m -83.9 120.5 75.06 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.821 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.97 177.44 8.73 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.578 2.185 . . . . 0.0 112.72 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.23 -14.38 53.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.336 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -77.9 -16.18 58.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.314 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 p -110.38 113.39 26.0 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.363 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 56.1 ttp -102.98 123.9 47.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.569 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.524 HG12 ' CD2' ' A' ' 89' ' ' LEU . 26.3 mt -86.8 119.56 34.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.052 -173.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 89.4 mmm -92.57 -30.8 15.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.402 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -72.33 105.45 4.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.31 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.42 129.51 39.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.388 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 84.4 mt -72.19 127.77 89.91 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.832 -170.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 95.2 Cg_endo -96.5 -162.49 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.684 2.923 . . . . 0.0 112.4 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.6 p -104.24 158.64 16.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.086 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.3 m -111.55 152.78 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -112.95 97.42 6.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.943 0.401 . . . . 0.0 110.149 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.619 HG23 ' HB2' ' A' ' 11' ' ' LEU . 17.8 m -96.98 107.97 20.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.917 0.865 . . . . 0.0 110.205 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.549 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 1.2 mmmp? -75.02 130.98 40.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.745 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.453 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 26.3 p -135.21 128.43 31.95 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.974 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.557 ' HG3' ' CG2' ' A' ' 78' ' ' VAL . 40.2 mt-10 -86.45 94.23 9.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.462 ' HA3' HG23 ' A' ' 75' ' ' ILE . . . 160.06 157.1 8.45 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.899 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -98.65 118.51 35.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -126.99 82.42 68.09 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -89.63 -15.8 2.14 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.542 2.161 . . . . 0.0 112.281 171.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.3 t -98.1 15.55 23.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.013 0.435 . . . . 0.0 110.823 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.4 mt -124.58 137.92 55.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.235 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -94.79 114.58 26.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.312 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.458 HG11 HD22 ' A' ' 11' ' ' LEU . 35.1 m -76.23 -24.34 16.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -75.19 -24.58 57.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.142 0.496 . . . . 0.0 109.929 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -83.6 -34.0 25.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.843 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.69 126.12 28.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.533 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -115.98 147.78 40.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.268 0.556 . . . . 0.0 111.378 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -109.71 124.44 51.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -121.53 160.29 24.58 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.381 0.61 . . . . 0.0 111.865 -174.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.588 HG13 HD11 ' A' ' 15' ' ' LEU . 6.0 m -112.29 123.35 67.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.111 172.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -86.48 108.77 18.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.18 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.8 34.97 2.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.368 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.3 m -64.91 107.57 1.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.896 0.379 . . . . 0.0 110.337 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.92 48.31 5.51 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.908 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.3 p -101.29 113.8 27.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.815 0.34 . . . . 0.0 111.336 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -79.31 128.27 76.13 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 173.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -49.84 100.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.681 2.921 . . . . 0.0 113.265 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.45 ' H ' ' HB2' ' A' ' 89' ' ' LEU . . . -177.76 175.36 47.5 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -80.28 114.48 19.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.02 0.41 . . . . 0.0 109.979 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 65' ' ' TYR . 31.6 m170 -134.15 160.12 38.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.54 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.0 t70 -97.0 108.19 20.88 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 63' ' ' HIS . 78.1 m-85 -109.72 152.58 25.46 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 111.291 -171.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.84 139.4 37.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.098 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 97.4 t -92.14 120.53 41.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -117.36 108.88 16.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.422 -175.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 59.1 t -89.2 148.96 4.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.914 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -61.81 118.61 40.16 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 171.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.55 128.99 30.12 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.979 2.453 . . . . 0.0 112.53 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.28 114.71 63.98 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.906 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.8 151.09 18.86 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.066 2.511 . . . . 0.0 111.657 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 74.37 -39.73 0.43 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.653 0.781 . . . . 0.0 111.712 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.462 HG23 ' HA3' ' A' ' 39' ' ' GLY . 40.0 mm -92.39 136.02 25.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 38' ' ' GLU . 58.3 tttm -87.6 118.49 27.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.616 0.246 . . . . 0.0 110.448 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.3 tt -81.31 123.84 38.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.346 0.594 . . . . 0.0 110.907 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.557 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 31.6 t -86.19 -60.9 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.441 0.639 . . . . 0.0 109.916 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -121.01 153.31 37.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.585 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.644 HG23 ' HG2' ' A' ' 83' ' ' ARG . 14.8 tt -127.39 18.41 3.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 173.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.5 m -64.18 134.65 96.03 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.695 -175.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.59 133.14 30.02 Favored 'Cis proline' 0 C--N 1.343 0.267 0 C-N-CA 123.382 -1.507 . . . . 0.0 111.988 -0.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.644 ' HG2' HG23 ' A' ' 80' ' ' ILE . 58.8 mtm180 -72.05 -38.14 69.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.208 0.528 . . . . 0.0 110.517 -176.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -134.59 136.45 52.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.068 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.5 m -129.04 141.79 45.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.141 0.495 . . . . 0.0 111.144 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 15.8 m -89.72 109.41 20.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.138 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.406 HD11 HG21 ' A' ' 53' ' ' VAL . 97.6 mt -100.29 124.9 46.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.631 -176.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -85.67 99.03 11.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.01 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.524 ' CD2' HG12 ' A' ' 26' ' ' ILE . 89.8 mt -95.57 139.8 31.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.901 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.752 ' HG2' ' H ' ' A' ' 91' ' ' HIS . 22.4 tt0 -117.67 176.84 4.99 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.752 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 25.9 m-70 -82.46 151.65 26.45 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.909 -176.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -79.5 19.19 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.644 0.735 . . . . 0.0 109.958 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.445 ' H ' ' C ' ' A' ' 91' ' ' HIS . 6.2 t60 -87.18 -21.69 25.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.532 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -132.41 -170.64 2.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.155 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -164.85 107.97 0.87 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 66.9 t60 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.627 -176.748 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.2 m . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 121.226 0.536 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.1 p -95.29 -67.49 0.85 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.711 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -85.11 -175.77 5.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.924 0.392 . . . . 0.0 111.338 -173.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.4 m -72.51 -32.82 66.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 69.0 mt -66.15 -18.29 65.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.019 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.04 -28.87 62.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.216 0.532 . . . . 0.0 109.941 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 7' ' ' ARG . 15.6 ttm-85 -102.33 -12.3 18.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.941 -177.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -140.95 92.88 8.46 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.735 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' A' ' 37' ' ' THR . 6.2 Cg_exo -80.22 130.37 8.17 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.925 2.417 . . . . 0.0 112.29 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 m -105.88 110.32 22.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.925 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 40.1 tp -93.63 135.52 34.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.745 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 16.3 m -117.02 109.6 17.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.896 0.379 . . . . 0.0 110.631 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.7 mt -111.64 144.16 41.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.192 -174.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -75.98 147.26 38.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.924 0.392 . . . . 0.0 110.771 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.75 HD11 HG13 ' A' ' 53' ' ' VAL . 41.4 tp -90.49 133.51 35.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.114 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.5 ' CG1' ' HB3' ' A' ' 52' ' ' TYR . 48.0 pt -112.63 153.55 14.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.979 0.419 . . . . 0.0 110.725 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.38 105.66 17.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.547 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 62.0 tttm -93.82 106.65 18.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.012 0.434 . . . . 0.0 111.204 -175.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 56.26 77.75 0.23 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.89 174.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.9 t -106.86 140.22 21.16 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 172.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 55' ' ' LEU . 36.2 Cg_exo -62.75 169.16 9.06 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.017 2.478 . . . . 0.0 112.91 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.1 6.87 27.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.534 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -107.5 -6.16 17.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.314 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.415 ' OG ' ' HD2' ' A' ' 21' ' ' PRO . 5.0 p -118.42 128.9 55.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.814 -176.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.0 ttp -115.66 131.86 56.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.652 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.5 mt -90.34 103.73 14.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.799 0.333 . . . . 0.0 110.665 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 81.3 mtp -75.58 -38.82 58.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.303 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.5 m -71.52 120.02 16.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.241 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.57 120.09 16.66 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.6 mt -54.71 117.76 14.78 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.513 -174.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.67 -163.2 0.2 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.976 2.45 . . . . 0.0 112.227 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 m -123.31 134.9 54.01 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 120.914 0.388 . . . . 0.0 110.363 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.829 HG11 HG11 ' A' ' 67' ' ' VAL . 33.2 m -85.94 133.04 30.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.979 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 34' ' ' ARG . 25.7 ttt180 -110.01 97.34 6.86 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 80' ' ' ILE . 33.5 m -102.89 157.58 4.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.58 -171.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.476 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 10.3 mmmt -98.37 128.25 44.68 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.487 ' O ' ' HD2' ' A' ' 9' ' ' PRO . 10.0 p -116.07 145.91 42.63 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.962 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.478 ' HB2' ' CG2' ' A' ' 78' ' ' VAL . 41.7 tt0 -110.39 107.0 16.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.598 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.36 -153.79 25.26 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.739 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.586 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 96.6 m-85 -121.8 135.82 54.92 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -105.57 96.33 11.88 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 6.1 Cg_exo -79.62 -71.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.801 2.334 . . . . 0.0 111.505 177.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.5 t -162.45 95.47 0.92 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.415 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.578 ' HB ' HG13 ' A' ' 46' ' ' VAL . 32.7 mt -132.67 160.78 42.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.405 ' N ' HG22 ' A' ' 44' ' ' ILE . 11.7 m120 -76.9 46.16 0.46 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.329 0.585 . . . . 0.0 110.633 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.578 HG13 ' HB ' ' A' ' 44' ' ' ILE . 20.2 m -67.24 -32.29 56.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.273 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -81.94 -9.5 59.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.151 0.5 . . . . 0.0 110.252 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -95.13 -12.5 26.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.005 176.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.4 ' CD1' HG12 ' A' ' 72' ' ' ILE . 91.6 mt -78.6 136.36 37.49 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 166.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -130.24 171.24 13.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.221 0.534 . . . . 0.0 111.703 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.37 139.53 42.96 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.38 175.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.501 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 2.0 p90 -127.55 145.13 50.96 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.217 0.532 . . . . 0.0 111.99 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.75 HG13 HD11 ' A' ' 15' ' ' LEU . 17.0 m -119.56 129.05 75.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.049 174.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -76.45 119.42 20.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.975 0.416 . . . . 0.0 110.148 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.443 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 76.7 mt -112.16 26.88 10.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.301 -176.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.7 m -70.25 -33.74 71.99 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -169.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.89 86.61 0.14 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.231 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.4 m -143.43 155.95 44.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.554 0.216 . . . . 0.0 110.521 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.487 ' HB2' ' NE2' ' A' ' 63' ' ' HIS . 1.6 mp0 -64.97 145.42 99.07 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.392 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 59' ' ' GLU . 10.2 Cg_exo -71.27 91.19 0.66 Allowed 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.806 2.337 . . . . 0.0 112.045 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.28 -166.8 39.66 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 88' ' ' GLN . 42.5 mt-10 -77.34 113.38 15.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.238 0.519 . . . . 0.0 110.336 177.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.487 ' NE2' ' HB2' ' A' ' 59' ' ' GLU . 94.3 m-70 -139.67 173.67 11.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.819 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -94.02 133.34 37.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.11 -173.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.422 ' CE2' ' HB2' ' A' ' 87' ' ' LEU . 74.0 m-85 -131.34 135.63 47.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.103 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -78.83 125.94 30.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.235 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.829 HG11 HG11 ' A' ' 33' ' ' VAL . 93.2 t -85.25 108.77 17.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.237 0.541 . . . . 0.0 110.566 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -99.75 115.86 30.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.782 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.8 t -101.49 148.71 7.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.89 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.28 144.23 97.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.056 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -83.41 149.64 13.16 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.908 2.405 . . . . 0.0 112.704 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 75' ' ' ILE . 23.4 mt -117.94 119.0 34.15 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.63 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -85.13 21.07 1.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.69 2.26 . . . . 0.0 112.911 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -131.17 -56.25 1.03 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.157 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.545 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 53.1 mt -105.61 137.84 33.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.182 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -89.71 133.25 34.77 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.707 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.5 tt -83.88 123.38 38.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.547 0.689 . . . . 0.0 109.635 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.478 ' CG2' ' HB2' ' A' ' 38' ' ' GLU . 47.0 t -94.29 -60.84 2.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.943 -174.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 36' ' ' LYS . 27.3 tt0 -118.76 134.48 55.11 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.216 -172.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.715 ' HB ' ' HG3' ' A' ' 83' ' ' ARG . 59.0 mt -109.26 109.59 28.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 54.8 m -133.34 124.52 18.26 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.626 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.541 ' HD2' HG12 ' A' ' 33' ' ' VAL . 4.5 Cg_exo -81.48 142.72 55.77 Favored 'Cis proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.29 -1.546 . . . . 0.0 111.641 -5.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.715 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 5.5 mtm180 -78.71 -37.8 40.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.221 0.534 . . . . 0.0 110.3 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.6 t -124.06 117.5 51.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.49 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.6 m -107.36 152.52 8.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.773 0.321 . . . . 0.0 111.034 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 14.5 m -109.05 99.31 8.64 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.966 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 89.8 mt -102.79 142.62 33.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.317 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.609 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 53.6 tt0 -98.03 106.45 18.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.0 0.429 . . . . 0.0 110.802 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.2 mt -88.79 151.19 22.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.014 174.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -131.7 167.57 19.26 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.511 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -73.36 113.34 10.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.957 0.408 . . . . 0.0 110.761 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -88.74 93.8 9.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.121 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -103.96 157.06 17.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.909 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -90.6 -28.35 18.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.915 0.388 . . . . 0.0 109.992 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -100.64 96.17 7.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.269 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.5 t60 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.379 -0.82 . . . . 0.0 109.468 175.389 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 m -120.95 175.96 5.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.917 0.389 . . . . 0.0 110.904 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -67.73 140.75 56.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.861 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.2 m -143.73 138.44 28.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.518 0.199 . . . . 0.0 110.715 -174.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.0 mt -66.71 -3.69 7.21 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -174.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -73.9 -16.87 61.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.303 0.573 . . . . 0.0 109.879 173.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -113.84 -39.54 3.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.228 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -119.67 80.61 23.89 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 121.417 0.627 . . . . 0.0 111.298 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -90.54 174.96 2.8 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.979 2.452 . . . . 0.0 112.873 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.0 m -107.38 122.22 46.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.76 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.683 HD22 HG11 ' A' ' 46' ' ' VAL . 67.4 mt -104.15 127.4 51.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.138 0.494 . . . . 0.0 110.907 -176.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.0 m -101.34 107.18 18.46 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.132 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.3 mt -108.02 149.17 28.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.36 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.6 p -82.78 141.24 32.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.646 0.26 . . . . 0.0 110.515 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.813 HD11 HG13 ' A' ' 53' ' ' VAL . 43.0 tp -90.09 133.04 35.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.516 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.3 pt -116.67 155.68 18.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.968 0.413 . . . . 0.0 111.006 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -85.12 110.47 19.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.24 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -106.21 137.16 44.64 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.534 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 63.0 16.4 9.23 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.548 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.47 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 18.7 m -74.36 117.24 60.29 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.28 -176.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 5.7 Cg_exo -74.51 173.1 14.87 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.064 2.51 . . . . 0.0 112.449 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.69 -5.96 59.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.603 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -78.07 -9.2 59.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.562 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.524 ' HB2' HD22 ' A' ' 89' ' ' LEU . 11.9 p -129.78 128.73 42.98 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.992 -176.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.609 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 58.5 ttp -114.54 139.03 49.91 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.404 HG12 ' CD2' ' A' ' 89' ' ' LEU . 8.5 mt -110.19 99.13 8.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.523 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 78.2 mtp -82.14 -15.35 53.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.982 0.42 . . . . 0.0 110.362 176.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.4 m -81.05 106.28 12.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -63.44 123.0 17.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.011 -175.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.4 mt -62.02 119.26 47.03 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.504 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.75 -164.05 0.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.802 2.335 . . . . 0.0 112.655 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.1 p -106.43 142.03 36.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.757 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.0 p -99.0 139.4 20.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -110.74 101.67 10.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.303 0.573 . . . . 0.0 110.381 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 80' ' ' ILE . 33.4 m -105.09 130.83 55.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.388 -177.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.563 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 58.2 tttm -94.0 132.64 38.27 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.512 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 26.2 p -126.81 152.19 47.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.465 -174.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 76' ' ' LYS . 50.4 mt-10 -108.94 96.0 6.02 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.57 156.47 7.72 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -108.64 129.36 55.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.439 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 41.2 m-80 -70.89 114.06 23.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.96 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 41' ' ' ASN . 3.5 Cg_exo -80.14 -71.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.804 2.336 . . . . 0.0 111.833 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 p -113.04 10.16 18.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.482 0.658 . . . . 0.0 110.048 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.0 mt -92.94 133.37 34.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.111 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.549 ' HB2' ' HG3' ' A' ' 48' ' ' GLU . 53.6 m-80 -113.18 126.51 55.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.073 0.463 . . . . 0.0 110.061 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.683 HG11 HD22 ' A' ' 11' ' ' LEU . 34.4 m -77.41 -8.41 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.51 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -89.39 -4.14 58.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.27 0.557 . . . . 0.0 110.127 173.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.549 ' HG3' ' HB2' ' A' ' 45' ' ' ASN . 42.3 mt-10 -99.57 -34.56 10.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.571 174.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.7 mt -81.24 138.57 35.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.921 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -127.23 168.43 14.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.505 0.669 . . . . 0.0 111.299 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.6 147.59 29.31 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 171.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -140.46 146.88 38.82 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.19 0.519 . . . . 0.0 111.29 -174.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.813 HG13 HD11 ' A' ' 15' ' ' LEU . 4.3 m -112.25 130.64 65.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.405 175.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -79.47 91.56 5.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.043 -176.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.468 HD12 ' OG1' ' A' ' 20' ' ' THR . 52.0 mt -93.84 59.14 2.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.835 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 p -77.58 -4.72 47.25 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.332 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.66 -178.31 39.56 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.799 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.1 m -144.95 21.19 1.61 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.198 0.523 . . . . 0.0 109.786 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.11 115.84 52.28 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.342 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.13 158.51 56.24 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.955 2.436 . . . . 0.0 112.496 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.43 -163.29 22.82 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.516 ' HB3' HG22 ' A' ' 86' ' ' THR . 40.7 mt-10 -86.45 108.82 18.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.153 0.501 . . . . 0.0 110.293 177.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -117.68 143.03 46.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.652 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 10.0 m-20 -81.51 138.08 35.51 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -138.95 150.89 46.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.993 0.425 . . . . 0.0 111.18 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -90.33 123.03 33.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.69 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.9 t -81.24 134.74 26.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.556 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -125.45 153.44 43.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.095 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.7 t -127.28 146.44 33.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 43.6 mt-10 -63.04 125.49 86.92 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 32.2 Cg_exo -59.13 124.16 15.02 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.086 2.524 . . . . 0.0 112.857 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.403 HD12 ' H ' ' A' ' 72' ' ' ILE . 4.0 mp -95.18 125.94 48.34 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.725 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.95 146.57 42.1 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.254 1.969 . . . . 0.0 111.98 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 72.78 -45.85 0.63 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.722 0.809 . . . . 0.0 112.197 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.512 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 51.2 mt -84.05 133.09 29.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.014 0.435 . . . . 0.0 110.514 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 94.7 mttt -87.07 142.04 28.22 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.206 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 tt -99.58 119.28 47.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.22 0.533 . . . . 0.0 110.316 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.5 t -94.17 -48.02 13.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.807 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.563 ' HB2' ' H ' ' A' ' 36' ' ' LYS . 20.3 mm-40 -118.7 148.66 42.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.173 -176.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.842 HG23 ' HG2' ' A' ' 83' ' ' ARG . 16.1 tt -138.96 27.54 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 122.361 1.077 . . . . 0.0 108.419 174.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.6 m -83.1 141.04 42.9 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.131 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.51 131.43 23.23 Favored 'Cis proline' 0 C--N 1.346 0.418 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.215 0.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.842 ' HG2' HG23 ' A' ' 80' ' ' ILE . 73.7 mtm180 -78.24 -49.55 13.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.306 -175.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.8 119.5 60.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.788 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.29 145.59 27.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.732 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 62' ' ' GLU . 8.6 m -99.86 101.74 12.96 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.3 mt -94.08 145.74 24.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 -175.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -97.56 125.85 42.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.124 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.524 HD22 ' HB2' ' A' ' 24' ' ' SER . 90.0 mt -116.47 131.96 56.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.853 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -100.38 151.52 21.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.529 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -66.75 104.69 1.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.214 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.609 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 74.7 t60 -106.03 116.52 32.08 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -87.99 -76.67 0.38 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -168.47 -34.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.765 174.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -93.34 -30.54 15.06 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.472 -0.775 . . . . 0.0 109.47 175.247 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.477 0.909 0 CA-C-O 120.821 0.343 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.1 p -171.0 -162.4 0.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.562 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -136.54 117.67 14.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.847 0.356 . . . . 0.0 110.331 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.1 m -73.33 105.72 4.85 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.94 134.69 53.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.129 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -62.25 -52.63 62.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.362 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -124.33 -174.7 3.07 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 172.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 51.35 57.4 16.82 Favored Pre-proline 0 N--CA 1.467 0.381 0 O-C-N 123.418 0.449 . . . . 0.0 110.738 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.593 ' HG2' ' OG1' ' A' ' 37' ' ' THR . 29.6 Cg_endo -65.45 115.66 3.48 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.955 1.77 . . . . 0.0 112.816 -172.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.7 m -87.56 99.34 11.97 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 171.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.42 125.27 31.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.555 -175.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.2 m -95.26 89.85 5.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.88 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.429 HD23 HG13 ' A' ' 46' ' ' VAL . 60.2 mt -91.0 131.62 36.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.437 -174.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.4 m -74.41 139.8 44.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.839 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.897 HD11 HG13 ' A' ' 53' ' ' VAL . 30.0 tp -84.71 127.34 34.05 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.411 HD11 ' CE2' ' A' ' 52' ' ' TYR . 29.0 pt -120.68 142.51 36.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.445 0.641 . . . . 0.0 112.23 -176.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.555 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -72.76 111.93 8.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.288 175.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -79.21 -78.24 0.16 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.094 0.473 . . . . 0.0 110.645 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -110.61 75.83 0.95 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.405 0.621 . . . . 0.0 109.571 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.555 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 94.6 m -99.62 113.04 64.74 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.225 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.11 155.2 52.15 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.13 2.553 . . . . 0.0 112.767 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.3 -1.82 11.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.947 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -104.6 -2.03 25.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.879 0.371 . . . . 0.0 110.567 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.4 m -107.3 115.49 30.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.458 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 55.7 ttp -107.55 117.39 33.97 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.014 0.435 . . . . 0.0 110.657 -177.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.5 mt -92.08 102.59 13.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.892 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 80.5 mtp -86.23 -33.33 20.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.747 0.308 . . . . 0.0 110.807 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.4 m -81.08 117.78 21.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.047 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -59.84 124.55 20.52 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 84.1 mt -59.66 121.16 55.42 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.289 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 12.4 Cg_exo -69.33 -179.36 2.67 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.865 2.377 . . . . 0.0 112.502 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 p -109.07 146.22 34.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.124 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.668 HG11 HG11 ' A' ' 67' ' ' VAL . 20.3 m -97.08 140.07 18.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.067 0.461 . . . . 0.0 109.993 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -109.56 98.28 7.68 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.661 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.623 HG12 ' HA ' ' A' ' 80' ' ' ILE . 32.8 m -103.09 142.32 17.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.074 -176.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -92.53 129.84 38.35 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.593 ' OG1' ' HG2' ' A' ' 9' ' ' PRO . 27.3 p -121.46 161.46 22.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.592 0.234 . . . . 0.0 110.585 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 22.6 tt0 -123.79 143.1 50.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.056 -175.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.09 -118.93 1.91 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.336 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -144.48 131.74 20.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.439 ' HB3' ' HG3' ' A' ' 9' ' ' PRO . 2.5 p-10 -120.88 91.64 47.74 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 121.354 0.597 . . . . 0.0 112.154 -174.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -89.48 -51.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.731 2.287 . . . . 0.0 112.671 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -159.28 96.63 1.32 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.256 0.551 . . . . 0.0 110.243 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mp -117.21 126.38 74.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.597 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.531 ' ND2' ' HB2' ' A' ' 48' ' ' GLU . 58.0 t30 -80.01 94.47 5.93 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.762 0.791 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.429 HG13 HD23 ' A' ' 13' ' ' LEU . 19.1 t -68.59 -17.79 22.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.536 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -82.8 5.49 21.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.719 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.531 ' HB2' ' ND2' ' A' ' 45' ' ' ASN . 40.7 tt0 -119.17 -33.35 4.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.199 176.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.7 mt -79.51 127.84 32.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -136.81 166.87 22.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.628 0.727 . . . . 0.0 112.14 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.457 ' HB1' HG13 ' A' ' 67' ' ' VAL . . . -109.35 128.76 55.36 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.046 172.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.657 ' HE1' ' HB2' ' A' ' 70' ' ' GLU . 48.5 m-85 -103.42 138.51 40.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.934 0.397 . . . . 0.0 111.391 -173.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.897 HG13 HD11 ' A' ' 15' ' ' LEU . 3.0 m -125.86 129.76 72.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.815 169.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -88.49 91.61 8.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.303 0.573 . . . . 0.0 109.566 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.508 HD21 HD12 ' A' ' 87' ' ' LEU . 52.4 mt -87.79 38.82 0.86 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.691 -174.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.9 p -68.77 -24.55 64.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.974 0.416 . . . . 0.0 109.982 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.2 111.93 3.8 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 m -96.97 26.22 4.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.996 0.427 . . . . 0.0 110.727 -173.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -87.27 115.38 62.54 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.671 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.06 140.88 55.75 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.446 2.098 . . . . 0.0 111.248 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.64 -150.66 19.05 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -116.5 105.79 12.87 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.997 0.427 . . . . 0.0 109.969 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -122.25 148.91 44.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.093 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 44.9 m-20 -81.76 132.83 35.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.908 0.385 . . . . 0.0 110.703 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -127.91 137.15 52.19 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.521 ' HG2' HG22 ' A' ' 84' ' ' VAL . 40.3 mt-10 -88.71 134.85 33.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.036 0.446 . . . . 0.0 110.885 -173.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.668 HG11 HG11 ' A' ' 33' ' ' VAL . 65.2 t -71.81 102.2 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.732 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -92.67 101.69 14.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.554 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.2 t -87.27 143.64 10.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.146 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.657 ' HB2' ' HE1' ' A' ' 52' ' ' TYR . 32.2 tt0 -77.95 114.76 44.73 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -56.41 130.84 42.25 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.051 2.5 . . . . 0.0 112.738 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.7 mt -94.32 125.09 53.54 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.51 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.57 141.87 42.99 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.578 2.186 . . . . 0.0 111.504 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.3 t30 74.16 -44.03 0.55 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.368 0.667 . . . . 0.0 111.801 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.8 mm -83.86 119.22 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.125 0.488 . . . . 0.0 110.37 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.465 ' HD3' ' HB3' ' A' ' 38' ' ' GLU . 80.0 tttt -80.73 124.82 29.36 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.598 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.556 ' HA ' HG22 ' A' ' 37' ' ' THR . 17.0 tt -88.96 131.61 35.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.148 0.499 . . . . 0.0 110.233 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.7 t -100.78 -58.87 3.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.319 -175.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -138.14 147.24 43.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.881 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.623 ' HA ' HG12 ' A' ' 35' ' ' VAL . 58.9 mt -115.57 121.78 67.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.203 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 70.1 m -138.16 115.85 9.39 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.921 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.534 ' HD2' HG12 ' A' ' 33' ' ' VAL . 2.1 Cg_endo -86.31 170.94 40.95 Favored 'Cis proline' 0 N--CA 1.462 -0.347 0 C-N-CA 124.063 -1.224 . . . . 0.0 112.308 -1.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -98.83 -32.43 11.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.346 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.521 HG22 ' HG2' ' A' ' 66' ' ' GLU . 45.4 t -129.79 132.13 66.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.384 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 m -123.85 128.77 74.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.164 0.507 . . . . 0.0 111.139 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 7.4 m -82.54 103.89 12.41 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.508 HD12 HD21 ' A' ' 55' ' ' LEU . 90.1 mt -94.83 146.27 24.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.16 0.505 . . . . 0.0 111.237 -173.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.2 tm0? -98.23 119.43 36.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.282 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.8 mt -123.63 146.33 48.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.813 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -139.45 173.17 11.81 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 169.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.514 ' C ' ' H ' ' A' ' 93' ' ' HIS . 16.6 m80 -69.73 127.88 34.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.828 0.347 . . . . 0.0 110.632 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 11.9 t-80 -82.66 33.39 0.42 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.426 1.108 . . . . 0.0 108.131 171.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . 0.514 ' H ' ' C ' ' A' ' 91' ' ' HIS . 1.8 t-160 -151.57 117.44 5.49 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.003 -1.453 . . . . 0.0 107.225 -176.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -67.99 -18.13 64.63 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -170.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -136.84 105.21 5.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.725 171.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.9 t60 . . . . . 0 C--O 1.246 0.883 0 O-C-N 124.075 0.859 . . . . 0.0 111.06 177.253 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 t -97.23 102.85 14.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -77.72 119.35 21.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.12 0.486 . . . . 0.0 111.047 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -78.5 135.92 37.46 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.599 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.4 mt -85.77 129.0 34.95 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -67.18 -16.55 64.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.458 -174.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.523 ' HA ' ' HE1' ' A' ' 40' ' ' TYR . 92.4 mtt180 -89.8 -5.91 56.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.536 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.426 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 28.2 m-20 -123.72 86.63 52.93 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.975 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.82 101.82 0.19 Allowed 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.464 2.109 . . . . 0.0 112.153 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 m -98.2 109.0 21.83 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.283 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.1 mt -104.8 145.91 29.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.177 0.513 . . . . 0.0 111.042 -173.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 20.6 m -122.83 102.49 8.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.527 174.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.7 mt -96.17 140.05 31.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.334 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -73.21 135.95 44.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.325 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.726 HD11 HG13 ' A' ' 53' ' ' VAL . 42.4 tp -85.88 119.59 26.36 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.5 pt -112.58 155.65 13.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.166 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.422 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -87.86 114.73 24.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.048 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -117.37 143.28 46.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.8 t30 61.01 26.26 16.23 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.879 0.847 . . . . 0.0 109.698 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.514 HG23 HD12 ' A' ' 55' ' ' LEU . 85.1 m -85.86 117.41 68.67 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.736 -177.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 11.7 Cg_exo -69.38 162.69 40.88 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.016 2.477 . . . . 0.0 112.575 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.39 -8.64 58.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.415 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -92.31 3.74 54.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.887 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 p -127.88 139.71 52.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.759 0.314 . . . . 0.0 111.212 -175.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.457 ' HB2' ' NE2' ' A' ' 92' ' ' HIS . 14.1 ttm -127.13 129.95 48.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.741 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.488 HG12 ' CD2' ' A' ' 89' ' ' LEU . 12.9 mt -88.17 97.47 6.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 86.9 mtp -62.85 -33.24 74.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.237 0.541 . . . . 0.0 110.05 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 m -74.49 104.71 5.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.624 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -64.33 121.0 13.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.092 0.472 . . . . 0.0 110.664 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.21 122.69 65.37 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.224 -171.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -87.05 -155.8 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.523 2.815 . . . . 0.0 112.093 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.5 m -120.19 150.51 40.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.85 0.357 . . . . 0.0 110.657 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' THR . 12.7 p -103.45 138.71 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.835 -177.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 34' ' ' ARG . 19.6 mtp180 -98.38 119.91 37.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.073 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 80' ' ' ILE . 25.1 m -128.59 123.77 60.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.651 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 8' ' ' ASP . 87.8 tttt -95.84 138.83 32.93 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.542 HG22 ' HA ' ' A' ' 77' ' ' ILE . 35.5 p -126.73 155.2 43.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.993 0.425 . . . . 0.0 111.869 -175.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.531 ' HG3' ' CG2' ' A' ' 78' ' ' VAL . 42.8 mt-10 -105.81 120.59 42.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.797 174.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.2 -171.53 26.28 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.523 ' HE1' ' HA ' ' A' ' 7' ' ' ARG . 93.6 m-85 -135.03 101.07 4.76 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.76 112.36 6.0 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.228 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.11 -62.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.767 2.311 . . . . 0.0 111.143 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.5 t -145.7 79.09 1.56 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.131 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -121.85 130.73 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.795 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.428 ' ND2' ' HG3' ' A' ' 48' ' ' GLU . 59.0 t30 -94.59 103.93 15.87 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.729 0.776 . . . . 0.0 110.895 -175.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.4 t -62.91 -23.88 34.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.294 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -66.18 -20.78 66.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.951 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.428 ' HG3' ' ND2' ' A' ' 45' ' ' ASN . 48.3 mt-10 -105.28 -11.17 16.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.939 0.399 . . . . 0.0 110.831 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.9 128.68 33.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 170.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -136.67 173.3 11.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.31 0.576 . . . . 0.0 111.697 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -131.45 140.89 49.69 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -129.07 156.75 43.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.472 0.653 . . . . 0.0 112.102 -173.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.726 HG13 HD11 ' A' ' 15' ' ' LEU . 4.6 m -112.17 118.18 57.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.363 172.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.78 106.3 16.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.246 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.514 HD12 HG23 ' A' ' 20' ' ' THR . 63.4 mt -95.05 45.29 1.1 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.537 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 p -57.37 -44.64 84.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.806 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.88 67.19 0.49 Allowed Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.106 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 p -68.9 101.14 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.054 0.454 . . . . 0.0 111.126 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.5 129.99 23.54 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.527 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.449 ' HB3' ' HB2' ' A' ' 91' ' ' HIS . 33.7 Cg_endo -65.45 138.97 57.17 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.552 2.168 . . . . 0.0 112.22 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.46 178.16 19.81 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.02 99.13 4.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.862 0.363 . . . . 0.0 110.534 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -119.93 141.23 49.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.454 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -84.97 133.29 34.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.029 0.443 . . . . 0.0 109.994 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -126.11 157.75 37.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.809 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -84.73 128.05 34.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.619 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.1 t -78.25 99.37 2.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.114 0.483 . . . . 0.0 109.731 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -87.77 118.51 27.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.906 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.1 t -95.32 143.78 11.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.729 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.427 ' OE1' ' HD2' ' A' ' 71' ' ' PRO . 8.5 tp10 -70.32 113.89 21.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 174.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.427 ' HD2' ' OE1' ' A' ' 70' ' ' GLU . 11.7 Cg_endo -55.33 124.03 15.27 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.995 2.463 . . . . 0.0 112.646 -176.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -94.45 119.98 65.7 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.889 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.61 135.38 48.82 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.494 2.13 . . . . 0.0 112.537 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 t30 73.52 -33.96 0.27 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.771 0.828 . . . . 0.0 112.96 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.424 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 49.9 mm -84.16 136.4 22.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.048 0.451 . . . . 0.0 111.031 -177.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -97.6 121.12 39.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.446 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.542 ' HA ' HG22 ' A' ' 37' ' ' THR . 16.0 tt -90.75 125.38 43.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.408 0.623 . . . . 0.0 111.012 -176.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.531 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 38.3 t -100.62 -56.52 5.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.384 -175.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.417 ' HB2' ' H ' ' A' ' 36' ' ' LYS . 71.7 mm-40 -109.65 139.35 44.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.092 -173.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.459 ' HA ' HG12 ' A' ' 35' ' ' VAL . 50.7 mt -129.13 97.57 3.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 5.7 m -127.21 112.74 21.53 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.211 -176.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 2.0 Cg_endo -85.14 171.6 43.39 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.763 -1.349 . . . . 0.0 112.37 0.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -110.85 -34.26 6.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.98 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.39 117.17 49.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.588 176.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.5 m -108.29 146.46 14.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.931 0.396 . . . . 0.0 110.871 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.5 m -97.97 109.01 21.84 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 84.9 mt -102.97 122.64 45.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.385 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -85.58 95.55 9.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.488 ' CD2' HG12 ' A' ' 26' ' ' ILE . 76.5 mt -90.43 128.68 36.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.517 -175.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -102.88 120.83 41.3 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.422 173.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 60' ' ' PRO . 27.5 t60 -72.42 110.41 6.81 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 173.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.457 ' NE2' ' HB2' ' A' ' 25' ' ' MET . 13.5 m-70 -48.91 116.75 1.76 Allowed 'General case' 0 CA--C 1.514 -0.404 0 O-C-N 123.886 0.741 . . . . 0.0 110.867 -176.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -73.14 -7.28 50.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.756 -172.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -76.14 -9.32 58.53 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 171.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -118.78 161.16 20.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.523 173.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.1 m170 . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.447 -0.787 . . . . 0.0 110.669 -178.273 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 N--CA 1.474 0.775 0 CA-C-O 121.107 0.479 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.9 m -105.07 -55.29 2.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.675 175.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -103.93 104.85 14.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.203 175.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.81 -59.44 0.16 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.625 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.81 26.91 0.67 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -172.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -107.93 -29.11 9.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.078 0.466 . . . . 0.0 110.357 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -78.3 -10.69 59.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.317 0.579 . . . . 0.0 110.447 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -132.06 86.72 46.26 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-O 121.834 0.826 . . . . 0.0 109.116 171.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.76 162.66 32.37 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.547 2.831 . . . . 0.0 113.498 -170.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 14.6 m -118.62 123.57 45.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.972 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.513 ' HB2' HG23 ' A' ' 35' ' ' VAL . 98.1 mt -101.34 148.8 24.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.019 0.438 . . . . 0.0 110.631 -177.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.2 m -125.5 100.17 6.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.889 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.4 mt -101.16 156.43 17.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.357 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 t -88.53 137.35 32.4 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.87 HD11 HG13 ' A' ' 53' ' ' VAL . 42.6 tp -83.39 126.48 32.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.0 pt -108.32 143.0 19.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.113 0.482 . . . . 0.0 111.182 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.42 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -77.07 105.21 8.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.838 176.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -99.06 127.73 45.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.13 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 61.87 23.75 14.02 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.404 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.536 ' OG1' HD12 ' A' ' 55' ' ' LEU . 25.7 m -74.51 124.04 89.51 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.452 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -81.2 171.45 13.88 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.711 2.274 . . . . 0.0 112.562 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.72 6.37 38.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.061 -177.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -92.85 -18.03 23.35 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.42 0.628 . . . . 0.0 110.107 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.2 p -119.2 121.37 39.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.716 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 52.8 ttp -102.79 131.0 49.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.337 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.405 HG12 ' CD2' ' A' ' 89' ' ' LEU . 9.5 mt -90.21 107.71 18.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 49.1 ttp -75.41 -33.27 60.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.055 0.455 . . . . 0.0 110.739 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.9 m -84.71 132.68 34.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.513 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -66.85 143.14 57.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 3.7 mm? -67.1 115.64 27.72 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.534 -178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 3.0 Cg_exo -74.15 167.38 27.33 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.899 2.399 . . . . 0.0 112.666 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.4 m -94.7 129.12 41.74 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.784 175.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.0 m -86.28 143.54 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.121 0.486 . . . . 0.0 111.12 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.0 ttp85 -104.28 108.39 19.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.537 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 80' ' ' ILE . 13.4 m -119.56 112.97 39.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.185 0.517 . . . . 0.0 110.227 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 78.0 tttt -87.73 142.02 28.15 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.51 ' HB ' HG22 ' A' ' 75' ' ' ILE . 47.9 p -130.62 179.61 5.85 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.817 -172.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 76' ' ' LYS . 55.7 mt-10 -132.74 130.3 39.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 175.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.54 -144.05 14.96 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -136.13 158.6 44.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.781 0.324 . . . . 0.0 110.704 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.2 m-20 -112.31 93.0 20.57 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.653 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.578 ' HD2' HG12 ' A' ' 44' ' ' ILE . 57.8 Cg_endo -79.76 -76.7 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.181 1.921 . . . . 0.0 112.846 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.1 p -107.76 24.22 13.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.402 0.62 . . . . 0.0 110.154 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.755 HG13 HD11 ' A' ' 75' ' ' ILE . 46.4 mm -79.79 112.08 17.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.396 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -91.64 108.62 20.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.28 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.58 -21.85 29.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.583 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -78.2 -13.24 59.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.642 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -105.9 -24.73 12.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.81 -175.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.405 HD11 HG23 ' A' ' 44' ' ' ILE . 38.2 mt -92.58 139.45 30.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.072 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -136.04 176.68 8.46 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.76 0.79 . . . . 0.0 112.145 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -122.6 133.97 54.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.375 172.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -121.75 141.41 51.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.13 0.491 . . . . 0.0 111.903 -173.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.87 HG13 HD11 ' A' ' 15' ' ' LEU . 6.8 m -114.38 119.7 62.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.19 174.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -74.55 100.69 3.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.479 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.536 HD12 ' OG1' ' A' ' 20' ' ' THR . 38.2 mt -89.96 36.18 0.86 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.935 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 p -61.49 -38.93 89.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.542 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.63 69.15 2.64 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 172.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 m -73.28 84.13 1.4 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.076 0.465 . . . . 0.0 111.847 -173.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -108.52 117.71 53.75 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.497 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.74 100.85 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.895 2.396 . . . . 0.0 112.166 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.418 ' H ' ' HB2' ' A' ' 89' ' ' LEU . . . 159.02 177.33 32.0 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.883 ' HG2' ' HG2' ' A' ' 88' ' ' GLN . 41.2 mt-10 -74.66 99.64 3.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.104 0.452 . . . . 0.0 110.35 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -125.01 144.35 50.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.562 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.519 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 9.4 m-20 -89.23 115.06 26.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.713 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -111.49 164.81 12.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.883 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -89.92 131.51 35.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.296 -176.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.0 t -90.0 123.14 42.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.101 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -111.72 110.66 21.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.068 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.436 HG21 HG11 ' A' ' 35' ' ' VAL . 42.1 t -90.44 142.3 13.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.013 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 46.5 mt-10 -68.75 117.24 49.02 Favored Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.627 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 11.4 Cg_exo -70.93 136.0 28.93 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.874 2.382 . . . . 0.0 111.862 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.413 HG22 ' H ' ' A' ' 74' ' ' ASN . 4.3 mp -100.44 117.55 62.73 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.12 25.29 0.46 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.576 2.184 . . . . 0.0 112.396 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.413 ' H ' HG22 ' A' ' 72' ' ' ILE . 88.1 m-20 -133.95 -8.91 2.71 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.503 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.755 HD11 HG13 ' A' ' 44' ' ' ILE . 26.5 mt -141.01 143.56 28.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.171 -172.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.642 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 43.5 mtpt -81.16 167.38 19.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.8 tt -129.6 135.84 60.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.079 0.466 . . . . 0.0 110.701 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.3 t -115.63 -53.97 4.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.412 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.06 142.55 50.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.216 -174.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.6 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 57.6 mt -123.67 94.22 2.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 169.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 36.6 m -115.49 112.04 43.71 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.53 -174.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 7.1 Cg_endo -93.24 165.03 22.8 Favored 'Cis proline' 0 CA--C 1.531 0.335 0 C-N-CA 124.831 -0.904 . . . . 0.0 112.393 -5.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.6 ' HG3' ' O ' ' A' ' 80' ' ' ILE . 39.6 mtm180 -92.25 -36.85 13.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.378 0.609 . . . . 0.0 109.833 176.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.519 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 62.1 t -117.52 121.44 67.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.626 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.49 HG12 ' HG2' ' A' ' 82' ' ' PRO . 13.9 m -116.1 133.2 63.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.181 0.515 . . . . 0.0 111.817 -177.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.7 m -83.54 95.9 8.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.682 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 90.4 mt -90.41 124.08 34.66 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.884 0.373 . . . . 0.0 110.385 -178.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.883 ' HG2' ' HG2' ' A' ' 62' ' ' GLU . 94.5 mt-30 -85.6 92.99 8.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.55 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.418 ' HB2' ' H ' ' A' ' 61' ' ' GLY . 85.5 mt -92.37 157.63 16.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.497 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.69 163.63 32.3 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 178.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -67.4 132.17 47.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.348 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -76.84 -26.21 54.04 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 172.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -98.68 118.59 35.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.32 174.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -115.83 118.72 33.77 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.993 0.425 . . . . 0.0 111.054 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -84.46 54.76 3.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.184 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.6 m80 . . . . . 0 C--O 1.244 0.798 0 CA-C-O 118.662 -0.685 . . . . 0.0 109.743 177.905 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.476 0.84 0 CA-C-O 120.83 0.348 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -76.05 133.21 40.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.937 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -62.2 -40.25 95.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.0 110.267 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.4 m -108.27 107.98 18.8 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 172.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.432 ' HG ' ' H ' ' A' ' 7' ' ' ARG . 25.9 tp -95.96 147.49 23.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.496 -174.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.77 -4.93 51.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.42 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.432 ' H ' ' HG ' ' A' ' 5' ' ' LEU . 66.3 mtt180 -70.69 -76.0 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.812 0.339 . . . . 0.0 110.663 178.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.89 116.74 49.3 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.1 -176.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -75.84 118.31 5.01 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.795 2.33 . . . . 0.0 111.689 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.7 m -87.94 92.31 9.08 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.709 HD11 ' HB ' ' A' ' 46' ' ' VAL . 41.1 tp -84.06 123.06 29.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.312 -171.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.1 m -103.32 118.1 35.99 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.935 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.2 mt -120.18 141.54 49.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.237 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.0 t -74.89 135.25 41.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.26 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.618 HD11 HG13 ' A' ' 53' ' ' VAL . 50.0 tp -79.75 131.82 36.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.5 pt -128.08 148.35 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.261 0.553 . . . . 0.0 111.264 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.528 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -85.83 108.69 18.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.443 175.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 22.9 tptm -97.41 -66.81 0.88 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.189 0.518 . . . . 0.0 110.712 -174.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.848 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 6.3 m-20 -84.0 57.42 4.16 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.887 -177.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.528 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 34.5 m -114.66 124.22 30.89 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.699 -174.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 16.5 Cg_exo -68.21 146.76 70.88 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.963 2.442 . . . . 0.0 111.516 174.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.63 -13.87 60.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.775 0.321 . . . . 0.0 111.821 -175.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -89.35 2.47 54.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.101 0.477 . . . . 0.0 110.662 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 p -125.97 122.9 37.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.158 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 42.4 ttp -113.87 126.86 55.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.653 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.8 mt -77.65 132.12 33.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.389 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.441 ' SD ' ' HB2' ' A' ' 90' ' ' GLU . 74.6 mtm -93.68 -26.11 17.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.149 0.5 . . . . 0.0 110.496 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.8 p -83.78 118.44 23.92 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.78 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.29 142.97 56.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.907 0.385 . . . . 0.0 110.244 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 85.4 mt -86.32 119.1 71.34 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.151 -171.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 3.0 Cg_exo -74.35 175.72 10.6 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.846 2.364 . . . . 0.0 112.484 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.2 m -98.23 128.4 44.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.76 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -85.83 129.53 37.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -112.41 108.84 18.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.074 0.464 . . . . 0.0 109.861 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 80' ' ' ILE . 34.7 m -109.79 143.84 19.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.091 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -99.46 121.45 41.16 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.9 p -106.0 159.15 16.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.779 0.323 . . . . 0.0 111.589 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.693 ' HB3' ' HB2' ' A' ' 76' ' ' LYS . 32.6 tt0 -112.69 109.6 19.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.493 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.42 -144.25 14.98 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.898 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.417 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 40.9 t80 -155.13 116.05 3.93 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.41 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -92.89 105.54 15.35 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.929 179.112 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 5.3 Cg_exo -77.85 -66.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.15 2.567 . . . . 0.0 112.986 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 t -125.63 39.36 3.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.322 0.582 . . . . 0.0 110.457 -175.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.8 mt -91.83 130.3 41.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.704 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.557 ' HB3' ' HG2' ' A' ' 48' ' ' GLU . 17.5 m120 -75.26 89.41 2.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.315 0.578 . . . . 0.0 111.096 -176.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.709 ' HB ' HD11 ' A' ' 11' ' ' LEU . 33.6 m -70.65 -13.94 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.178 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -87.6 -18.28 30.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.911 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.557 ' HG2' ' HB3' ' A' ' 45' ' ' ASN . 16.1 mm-40 -96.2 -20.83 18.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.387 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 99.0 mt -82.01 132.4 35.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.697 174.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -129.31 168.5 16.15 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.358 0.599 . . . . 0.0 111.506 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.47 ' O ' HD12 ' A' ' 15' ' ' LEU . . . -108.89 117.3 33.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.376 170.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.586 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 25.5 p90 -114.84 152.21 32.58 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.138 0.494 . . . . 0.0 111.666 -173.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.618 HG13 HD11 ' A' ' 15' ' ' LEU . 21.2 m -115.64 144.69 22.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.128 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.848 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 4.5 t70 -98.21 109.07 21.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.061 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.466 HD12 HG23 ' A' ' 20' ' ' THR . 53.0 mt -101.57 68.7 1.19 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.348 0.594 . . . . 0.0 109.946 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.1 p -82.64 -1.2 50.36 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.74 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.22 112.8 4.34 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.7 p -84.45 16.15 3.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.869 0.366 . . . . 0.0 111.768 -177.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -85.86 119.55 72.0 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.529 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.573 ' HA ' ' HB2' ' A' ' 89' ' ' LEU . 11.6 Cg_exo -70.91 -174.56 1.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.906 2.404 . . . . 0.0 112.329 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 88' ' ' GLN . . . 97.89 -137.6 13.39 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.691 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -125.96 113.86 17.72 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.781 0.324 . . . . 0.0 110.133 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -130.45 155.07 47.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.824 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -100.12 130.21 46.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.441 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -128.44 158.03 39.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.93 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.86 141.49 28.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.041 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.439 HG13 HD13 ' A' ' 15' ' ' LEU . 59.0 t -86.37 107.8 17.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.631 174.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.453 ' HD3' ' CE2' ' A' ' 52' ' ' TYR . 57.9 tttm -99.1 103.17 15.06 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.09 0.472 . . . . 0.0 110.264 -178.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.95 130.38 36.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.632 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.435 ' HG3' ' HD2' ' A' ' 71' ' ' PRO . 27.5 tt0 -68.57 128.33 93.02 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.435 ' HD2' ' HG3' ' A' ' 70' ' ' GLU . 12.1 Cg_endo -55.19 131.64 47.53 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.185 2.59 . . . . 0.0 113.158 -175.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.547 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.2 mp -81.5 125.9 77.47 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.062 177.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.85 109.86 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.291 2.66 . . . . 0.0 113.671 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.6 t30 71.9 2.82 4.45 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.721 173.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.463 ' HB ' ' HB ' ' A' ' 72' ' ' ILE . 48.9 mm -102.29 135.31 39.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 O-C-N 121.928 -0.482 . . . . 0.0 110.387 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.693 ' HB2' ' HB3' ' A' ' 38' ' ' GLU . 72.8 mttt -87.39 148.76 24.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.62 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.489 HD11 HG12 ' A' ' 80' ' ' ILE . 21.4 tt -110.21 128.19 66.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.293 0.568 . . . . 0.0 110.105 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.619 HG12 ' HG3' ' A' ' 79' ' ' GLU . 42.6 t -95.42 -63.84 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.988 -175.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.619 ' HG3' HG12 ' A' ' 78' ' ' VAL . 43.0 mt-10 -123.81 127.36 47.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.743 -175.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.555 ' HA ' HG12 ' A' ' 35' ' ' VAL . 26.3 mt -105.78 127.75 60.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 15.6 m -150.5 115.12 3.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.842 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 88.6 Cg_endo -85.87 177.21 26.36 Favored 'Cis proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.502 -1.458 . . . . 0.0 112.682 -0.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.456 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 84.8 mtm180 -119.97 -28.96 5.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.838 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.98 117.16 48.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.5 m -110.75 135.86 48.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.251 0.548 . . . . 0.0 111.254 -178.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.9 m -88.93 112.24 23.07 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.604 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 90.0 mt -111.55 145.67 38.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 -174.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 93.0 mt-30 -113.09 129.71 56.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.12 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.573 ' HB2' ' HA ' ' A' ' 60' ' ' PRO . 82.8 mt -113.86 136.78 52.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.036 0.446 . . . . 0.0 111.616 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.441 ' HB2' ' SD ' ' A' ' 27' ' ' MET . 43.2 tt0 -119.21 162.96 17.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.163 176.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -80.35 151.3 29.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.538 0.685 . . . . 0.0 112.198 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -143.35 95.27 2.73 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.661 172.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -78.09 -54.93 5.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.924 0.393 . . . . 0.0 110.041 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -166.93 -64.8 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -86.41 -55.34 3.94 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.5 m80 . . . . . 0 C--O 1.248 0.976 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.792 173.038 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.9 m . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 120.693 0.282 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.4 m -120.04 169.27 10.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 175.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.8 tp60 59.97 32.03 20.94 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.609 0.719 . . . . 0.0 109.453 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 m -63.98 132.02 49.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.4 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.0 tp -86.82 133.85 33.6 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 174.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -93.72 135.77 34.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.232 0.539 . . . . 0.0 111.781 -176.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -127.59 -179.96 5.19 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.71 172.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.608 ' HB3' ' HE2' ' A' ' 36' ' ' LYS . 11.9 m-20 52.61 72.19 1.25 Allowed Pre-proline 0 N--CA 1.466 0.368 0 O-C-N 123.523 0.515 . . . . 0.0 111.255 176.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.71 124.47 10.26 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.13 1.887 . . . . 0.0 112.623 -178.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.0 m -101.37 103.69 14.65 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.2 mt -83.1 122.46 28.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.268 0.556 . . . . 0.0 110.715 -173.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.4 m -99.22 106.45 18.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.138 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.8 mt -107.94 -174.67 2.58 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.628 -177.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -114.79 145.37 42.19 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.543 HD11 HG13 ' A' ' 53' ' ' VAL . 45.6 tp -87.44 130.15 34.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.8 pt -128.0 144.8 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.22 0.534 . . . . 0.0 111.763 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.488 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -81.29 102.82 10.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.233 173.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.425 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 59.6 tttm -91.65 -71.57 0.63 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.937 0.399 . . . . 0.0 110.874 -173.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.425 ' OD1' ' HG2' ' A' ' 18' ' ' LYS . 5.2 m-20 -94.27 67.09 3.5 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.623 0.725 . . . . 0.0 109.86 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.488 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 88.1 m -105.79 116.71 59.4 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.287 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 16.9 Cg_exo -67.87 156.39 66.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.168 2.578 . . . . 0.0 112.599 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.96 151.69 45.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.38 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 73.29 9.35 5.19 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.793 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.2 p -103.63 137.48 41.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 171.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.764 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 52.1 ttp -128.87 119.25 24.1 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.811 0.338 . . . . 0.0 110.405 -174.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.5 mt -85.31 124.75 40.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.448 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.572 ' HB2' ' HB2' ' A' ' 88' ' ' GLN . 86.1 mtp -85.36 -31.9 22.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.388 178.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 p -78.27 118.32 20.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.794 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.68 141.01 53.65 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.84 118.44 70.33 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.415 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -89.8 176.96 2.72 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.893 2.395 . . . . 0.0 112.741 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -83.06 135.28 34.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.147 176.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.539 HG11 ' HB2' ' A' ' 51' ' ' ALA . 9.5 p -104.03 152.99 6.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -128.54 134.27 48.61 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.957 0.408 . . . . 0.0 110.838 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 16.3 m -124.33 129.1 74.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.352 175.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.608 ' HE2' ' HB3' ' A' ' 8' ' ' ASP . 13.1 tmtt? -86.16 127.36 34.7 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.551 HG22 ' HA ' ' A' ' 77' ' ' ILE . 33.0 p -128.68 168.15 16.2 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -171.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 76' ' ' LYS . 40.3 mm-40 -114.21 127.32 55.84 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.38 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.97 -161.89 15.94 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.578 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -128.35 128.53 44.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.725 0.298 . . . . 0.0 110.27 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.444 ' HB3' HD12 ' A' ' 44' ' ' ILE . 3.0 p30 -122.41 77.34 44.92 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.261 0.553 . . . . 0.0 111.267 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.12 -47.04 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.649 2.233 . . . . 0.0 111.796 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 m -129.33 80.21 1.95 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.195 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 41' ' ' ASN . 44.7 mt -134.64 157.5 41.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -73.85 55.59 0.54 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.457 0.646 . . . . 0.0 111.504 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.8 t -66.39 -26.27 37.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.76 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -89.9 5.08 47.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.152 0.501 . . . . 0.0 110.906 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -107.12 -24.29 12.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.506 0.669 . . . . 0.0 109.22 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.622 HD13 HG12 ' A' ' 72' ' ' ILE . 63.5 mt -88.11 132.67 34.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.66 177.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -143.51 178.03 8.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.934 0.397 . . . . 0.0 110.812 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.539 ' HB2' HG11 ' A' ' 33' ' ' VAL . . . -105.85 119.88 40.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.956 172.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.424 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 28.7 p90 -115.18 148.91 38.47 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.087 0.47 . . . . 0.0 110.946 -174.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.543 HG13 HD11 ' A' ' 15' ' ' LEU . 18.3 m -112.85 133.42 58.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.951 174.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -104.8 105.53 15.63 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.822 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.436 HD12 HG23 ' A' ' 20' ' ' THR . 61.6 mt -92.41 90.09 7.07 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.043 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.5 p -75.05 1.91 11.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.541 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.06 132.62 2.87 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.707 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 m -80.44 76.75 7.26 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 89' ' ' LEU . 30.9 mt-10 -91.36 108.91 32.3 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.53 -176.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 11.8 Cg_exo -69.07 131.29 21.88 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.761 2.307 . . . . 0.0 112.204 -176.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.91 174.15 17.59 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.998 ' HG2' ' HG2' ' A' ' 88' ' ' GLN . 33.2 mt-10 -76.78 106.42 8.43 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -118.62 156.03 29.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.149 0.5 . . . . 0.0 111.269 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -90.47 116.05 28.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.161 -176.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -127.15 157.42 39.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.052 0.453 . . . . 0.0 111.727 -176.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -89.33 144.5 26.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.692 -173.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.07 114.05 35.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.658 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -108.01 125.32 51.4 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.8 t -102.41 136.29 35.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.557 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -54.83 122.35 40.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.187 174.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.17 116.49 2.98 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.699 2.266 . . . . 0.0 111.973 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.622 HG12 HD13 ' A' ' 49' ' ' LEU . 55.8 mt -81.47 121.71 80.21 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.982 -175.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.59 143.09 37.43 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.463 2.108 . . . . 0.0 111.747 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 t30 75.17 -44.47 0.54 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.362 0.665 . . . . 0.0 111.901 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.522 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 48.9 mm -91.58 136.93 23.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.0 -176.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.615 ' HB3' ' HB2' ' A' ' 38' ' ' GLU . 74.7 tttt -85.17 135.13 34.09 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.551 ' HA ' HG22 ' A' ' 37' ' ' THR . 15.1 tt -96.03 133.69 36.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.953 0.406 . . . . 0.0 109.996 176.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -110.86 -57.97 3.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.339 0.59 . . . . 0.0 111.386 -176.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 38.6 tt0 -126.07 124.81 41.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.403 -170.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.579 ' HB ' ' HG2' ' A' ' 83' ' ' ARG . 61.0 mt -99.22 113.5 34.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 25.2 p -127.22 110.49 21.44 Favored Pre-proline 0 C--N 1.318 -0.782 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.035 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 98.1 Cg_endo -88.43 162.76 42.52 Favored 'Cis proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.77 -1.346 . . . . 0.0 112.716 -1.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.579 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 63.2 mtm180 -87.56 -25.47 23.61 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.947 0.404 . . . . 0.0 110.345 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.7 t -136.2 135.66 49.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.505 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 m -122.52 151.27 26.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.071 0.462 . . . . 0.0 110.963 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.8 m -101.28 107.28 18.61 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.579 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.4 mt -101.62 137.42 39.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.167 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.998 ' HG2' ' HG2' ' A' ' 62' ' ' GLU . 79.9 mt-30 -99.71 109.0 21.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.576 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 70.8 mt -104.62 142.85 33.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.088 0.47 . . . . 0.0 111.673 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.518 ' HG2' ' H ' ' A' ' 91' ' ' HIS . 27.0 tt0 -136.04 176.1 9.0 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 172.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.518 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 86.3 m-70 -99.72 118.83 37.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.764 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 63.8 t60 -72.63 115.2 11.62 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -83.5 148.52 27.18 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -74.49 -25.74 59.56 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -138.78 121.78 16.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.493 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 82.4 t60 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.542 -177.571 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.617 ' HB2' ' HD1' ' A' ' 40' ' ' TYR . 15.7 m . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 120.956 0.408 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.6 p -101.26 -158.77 0.69 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.912 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -62.92 -13.75 38.39 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.755 0.422 . . . . 0.0 112.02 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.3 p -68.74 -11.17 59.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.268 0.556 . . . . 0.0 110.921 176.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 49.0 tp -127.92 163.5 24.34 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -72.86 147.39 45.45 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.409 ' HG3' ' OH ' ' A' ' 40' ' ' TYR . 43.3 ttp180 -63.03 -37.33 86.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.767 0.794 . . . . 0.0 109.352 176.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -127.36 90.29 49.19 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.027 171.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -85.52 166.18 10.55 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.436 2.757 . . . . 0.0 113.34 -173.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 20.1 m -100.84 137.33 39.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.502 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.1 mt -107.45 137.89 44.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.072 0.463 . . . . 0.0 110.597 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -107.79 114.12 27.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.866 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.86 165.58 14.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.128 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.3 m -100.8 142.97 31.52 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.61 HD11 HG13 ' A' ' 53' ' ' VAL . 30.7 tp -91.44 128.22 37.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.159 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.7 pt -115.09 160.75 14.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.969 0.414 . . . . 0.0 111.43 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.554 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -92.64 100.08 12.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.445 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.4 ' HD3' ' CD1' ' A' ' 52' ' ' TYR . 59.3 tttm -101.61 135.41 43.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.149 -176.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 66.5 t30 62.28 16.51 8.53 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.536 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.554 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 91.7 m -60.74 119.68 46.34 Favored Pre-proline 0 N--CA 1.447 -0.595 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.777 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.668 ' HG2' ' HA ' ' A' ' 58' ' ' SER . 51.7 Cg_exo -55.02 162.49 5.24 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.869 3.046 . . . . 0.0 113.456 -173.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.76 149.08 32.75 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.156 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 65.13 37.32 6.71 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.617 0.573 . . . . 0.0 111.297 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.0 p -123.36 160.04 27.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.796 0.332 . . . . 0.0 110.559 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.0 ttp -144.86 129.12 17.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' A' ' 89' ' ' LEU . 19.1 mt -95.44 109.88 23.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.407 ' HB2' ' HB3' ' A' ' 88' ' ' GLN . 83.9 mtp -71.63 -27.96 63.46 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 110.527 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.8 m -77.95 123.99 27.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.719 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -71.79 130.54 41.35 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.531 -176.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.07 113.57 17.38 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.093 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.43 ' HD2' HD23 ' A' ' 15' ' ' LEU . 92.2 Cg_endo -85.15 -175.93 2.19 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.84 2.36 . . . . 0.0 112.79 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.4 m -105.76 126.31 52.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.356 174.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.503 HG12 ' HD2' ' A' ' 82' ' ' PRO . 13.4 m -85.91 148.24 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.474 -175.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -127.57 97.52 4.89 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 80' ' ' ILE . 30.7 m -105.32 132.64 51.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.381 -176.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 71.2 tttt -81.46 136.13 35.64 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.547 HG22 ' HA ' ' A' ' 77' ' ' ILE . 22.4 p -125.9 162.69 24.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.316 -177.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.24 112.93 18.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.87 178.91 24.33 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.61 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.617 ' HD1' ' HB2' ' A' ' 1' ' ' SER . 88.3 m-85 -118.41 144.18 46.13 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -128.96 92.51 39.57 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 121.328 0.585 . . . . 0.0 111.756 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.09 -45.46 15.88 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.788 2.325 . . . . 0.0 111.096 174.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.7 m -117.63 -115.58 0.33 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.552 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.1 mt 56.52 99.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 111.795 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -73.21 100.96 3.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.698 0.761 . . . . 0.0 111.289 -177.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.0 t -64.2 -22.41 31.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.756 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -80.3 -11.61 59.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.87 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -98.13 -21.66 16.63 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 90.8 mt -70.03 132.35 45.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.887 174.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -130.47 152.97 49.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.281 0.562 . . . . 0.0 111.848 -177.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -115.45 141.28 48.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 170.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 68' ' ' LYS . 47.0 p90 -133.24 161.31 34.82 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.028 -175.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.61 HG13 HD11 ' A' ' 15' ' ' LEU . 6.7 m -112.35 117.98 56.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -86.38 102.59 14.16 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 20' ' ' THR . 43.5 mt -88.45 76.41 8.26 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.151 -175.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.8 m -84.09 9.69 11.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.565 0.698 . . . . 0.0 109.754 173.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.39 107.06 1.88 Allowed Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.162 175.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.668 ' HA ' ' HG2' ' A' ' 21' ' ' PRO . 16.1 m -85.7 9.5 16.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.223 0.535 . . . . 0.0 110.69 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.88 121.13 83.06 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.54 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.71 175.84 10.78 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.663 2.242 . . . . 0.0 112.304 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.81 -158.99 19.11 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -176.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.404 ' HG2' ' CG2' ' A' ' 86' ' ' THR . 37.3 tt0 -100.12 107.76 19.73 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -132.74 144.41 50.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.138 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 4.4 p30 -94.15 141.29 28.72 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.197 0.523 . . . . 0.0 110.787 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -133.69 164.23 27.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.06 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -93.3 140.27 29.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.246 -172.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 98.6 t -79.88 108.71 13.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 172.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.449 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 40.6 mtpt -108.77 114.06 27.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.711 -176.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.6 139.97 17.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.24 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.26 132.44 94.43 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.48 113.66 1.56 Allowed 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.966 2.444 . . . . 0.0 112.574 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.518 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.4 mp -83.29 122.31 77.23 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.018 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.79 143.62 46.38 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.361 2.041 . . . . 0.0 111.716 176.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.4 t30 73.79 -23.38 0.22 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.097 0.559 . . . . 0.0 112.203 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.419 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 48.2 mm -108.38 125.66 65.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.758 0.313 . . . . 0.0 110.877 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -88.16 125.97 34.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.115 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.547 ' HA ' HG22 ' A' ' 37' ' ' THR . 16.6 tt -80.06 135.88 24.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.5 t -104.49 -64.91 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.263 0.554 . . . . 0.0 110.907 -178.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -122.5 137.71 54.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.434 -172.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.478 ' HA ' HG12 ' A' ' 35' ' ' VAL . 61.0 mt -103.06 109.44 26.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.675 176.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.45 ' HA ' ' C ' ' A' ' 82' ' ' PRO . 18.2 p -141.87 124.46 9.34 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.457 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.503 ' HD2' HG12 ' A' ' 33' ' ' VAL . 43.0 Cg_endo -67.72 160.36 81.16 Favored 'Cis proline' 0 C--N 1.344 0.315 0 C-N-CA 123.386 -1.506 . . . . 0.0 113.204 0.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -86.36 -70.21 0.62 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.538 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 64' ' ' ASP . 62.6 t -121.48 129.34 75.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.374 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.3 m -110.21 134.93 50.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.972 0.415 . . . . 0.0 110.879 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 24.0 m -92.92 111.39 22.99 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.079 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.2 mt -106.12 138.88 41.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.155 0.502 . . . . 0.0 111.365 -173.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 27' ' ' MET . 55.9 tp60 -94.77 109.83 21.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.066 174.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.418 ' CD2' HG12 ' A' ' 26' ' ' ILE . 80.0 mt -100.79 130.0 46.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.239 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -119.14 178.5 4.49 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.414 171.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -97.96 151.86 19.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.48 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -67.04 -31.26 71.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.989 0.423 . . . . 0.0 110.147 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -89.24 82.11 6.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.577 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -167.78 152.94 6.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.742 0.306 . . . . 0.0 110.268 177.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -125.04 122.63 37.79 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 173.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 . . . . . 0 C--O 1.246 0.885 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.51 176.876 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 120.677 0.275 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 p -159.07 -171.01 3.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.939 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -61.61 -56.38 20.48 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.6 m -95.19 124.48 39.26 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.8 mt -74.33 163.3 27.97 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.131 0.491 . . . . 0.0 110.994 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -78.96 2.6 19.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.657 -174.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.06 14.37 18.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.139 -176.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.593 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 9.1 m-20 -124.28 79.69 59.87 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.057 175.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -75.26 129.69 12.34 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.673 2.249 . . . . 0.0 112.553 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 43.1 m -102.33 109.68 21.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.672 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.546 HD21 ' ND2' ' A' ' 41' ' ' ASN . 83.7 mt -92.48 147.11 23.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.258 0.551 . . . . 0.0 111.528 -172.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.9 m -121.62 97.59 5.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.451 HD22 ' HB2' ' A' ' 49' ' ' LEU . 56.2 mt -99.17 162.9 12.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.319 -175.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.6 p -100.68 148.67 24.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.705 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.814 HD11 HG13 ' A' ' 53' ' ' VAL . 34.1 tp -94.34 125.03 38.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.189 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.6 pt -112.04 151.9 13.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.318 0.58 . . . . 0.0 111.768 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.627 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -83.69 102.19 12.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.116 176.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 86.4 tttt -83.34 115.24 21.92 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.312 -178.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.9 m120 73.89 -68.27 0.23 Allowed 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.198 0.999 . . . . 0.0 109.668 -177.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.627 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 47.7 m 48.13 97.76 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.404 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.96 -172.16 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.776 2.984 . . . . 0.0 115.151 -169.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.74 105.82 0.16 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.422 -1.263 . . . . 0.0 113.598 -172.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.463 ' ND2' ' HB3' ' A' ' 92' ' ' HIS . 5.3 m-20 63.48 22.13 13.08 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.003 168.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.0 p -84.64 102.72 13.15 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 170.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.9 ttp -103.08 126.5 50.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.633 -172.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.463 HG12 ' CD2' ' A' ' 89' ' ' LEU . 5.8 mt -84.81 110.59 19.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.957 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 58.1 ttp -73.18 -32.11 64.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.9 m -69.3 131.68 45.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.169 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -75.65 119.84 20.23 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -56.96 114.35 7.86 Favored Pre-proline 0 C--N 1.328 -0.35 0 O-C-N 123.488 0.493 . . . . 0.0 110.064 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.27 -172.56 1.4 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.89 2.394 . . . . 0.0 112.792 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.8 p -99.1 149.54 22.93 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.821 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.436 ' CG2' ' HB2' ' A' ' 13' ' ' LEU . 35.6 m -108.17 129.29 62.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.149 0.5 . . . . 0.0 109.804 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -106.88 110.35 22.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.218 0.533 . . . . 0.0 109.88 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 80' ' ' ILE . 27.2 m -120.45 137.46 54.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.527 -176.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.593 ' HE3' ' HB3' ' A' ' 8' ' ' ASP . 83.3 tttt -93.19 136.24 33.64 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 77' ' ' ILE . 22.5 p -124.56 168.42 13.13 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.278 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.448 ' HG3' ' CG2' ' A' ' 78' ' ' VAL . 42.1 mt-10 -122.5 123.13 40.55 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 176.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.0 -148.63 20.44 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.778 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.515 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 73.1 m-85 -129.57 129.07 43.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.804 0.335 . . . . 0.0 110.384 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.546 ' ND2' HD21 ' A' ' 11' ' ' LEU . 1.6 m-20 -116.71 77.98 8.67 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.629 -176.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 3.0 Cg_endo -86.63 -62.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.635 2.223 . . . . 0.0 112.2 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.0 p -91.5 -8.99 46.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.597 -177.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.21 116.11 33.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -111.63 150.34 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.58 -171.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.422 ' HB ' HD23 ' A' ' 13' ' ' LEU . 31.4 m -76.12 -5.34 7.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.964 178.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -85.31 -8.45 58.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.935 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -114.58 -29.15 6.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.737 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.451 ' HB2' HD22 ' A' ' 13' ' ' LEU . 79.0 mt -84.54 134.34 34.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -130.61 160.63 33.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.468 0.652 . . . . 0.0 111.828 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -117.42 133.95 55.39 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 170.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.432 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 48.7 p90 -122.04 152.01 40.24 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.018 -174.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.814 HG13 HD11 ' A' ' 15' ' ' LEU . 6.4 m -112.24 125.9 69.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.785 172.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -86.61 99.98 12.1 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.48 HD12 ' OG1' ' A' ' 20' ' ' THR . 64.6 mt -92.16 21.11 5.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.602 -173.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.5 p -60.37 115.9 3.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.153 0.501 . . . . 0.0 110.093 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.8 -28.5 1.74 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.594 -175.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.9 p 49.98 38.29 16.04 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.438 0.695 . . . . 0.0 111.897 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -84.84 115.02 59.06 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.953 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.3 150.21 28.63 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.825 2.35 . . . . 0.0 112.092 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.82 -174.43 21.64 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.745 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -80.26 105.75 11.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.753 0.311 . . . . 0.0 110.27 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -125.18 151.68 45.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.523 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -91.98 123.11 35.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.519 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -121.62 139.33 53.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.231 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.49 136.82 51.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.237 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 64.2 t -83.26 106.08 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -103.6 104.99 15.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.118 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.9 t -90.91 140.18 16.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.334 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 36.3 mt-10 -66.64 128.14 93.72 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.33 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 25.3 Cg_exo -62.58 115.88 3.18 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.829 2.352 . . . . 0.0 111.92 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.3 mp -81.33 122.62 81.33 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.073 -173.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.86 135.94 34.04 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.791 2.327 . . . . 0.0 112.221 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 71.5 6.79 5.84 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.387 176.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.1 mt -135.9 131.23 49.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.823 0.344 . . . . 0.0 110.612 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -84.79 129.56 34.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.396 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.546 ' HA ' HG22 ' A' ' 37' ' ' THR . 17.7 tt -92.72 134.35 30.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.448 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 35.4 t -108.18 -60.46 2.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.904 0.383 . . . . 0.0 111.459 -174.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HG3' HG12 ' A' ' 78' ' ' VAL . 41.8 mt-10 -118.58 128.44 54.56 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 -171.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.543 ' HA ' HG12 ' A' ' 35' ' ' VAL . 62.4 mt -111.92 109.47 28.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.273 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 14.8 p -139.75 126.96 12.7 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.601 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.408 ' HD2' HG12 ' A' ' 33' ' ' VAL . 4.2 Cg_exo -80.63 159.78 84.8 Favored 'Cis proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.452 -1.479 . . . . 0.0 112.535 -0.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -80.34 -50.32 10.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.291 0.567 . . . . 0.0 110.527 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.1 t -131.11 137.1 56.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.377 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.5 m -117.77 134.11 62.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.159 0.504 . . . . 0.0 111.172 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.3 m -85.04 105.82 16.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.598 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.8 mt -104.89 130.49 53.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.271 -177.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -94.23 106.12 18.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.076 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.463 ' CD2' HG12 ' A' ' 26' ' ' ILE . 90.1 mt -91.96 126.82 37.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.59 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -118.55 150.33 39.82 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.377 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -77.43 137.93 38.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.954 0.407 . . . . 0.0 111.257 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.463 ' HB3' ' ND2' ' A' ' 23' ' ' ASN . 30.9 t-80 -69.67 -20.89 63.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.012 177.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -92.68 86.65 5.62 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 170.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -71.09 101.44 2.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.09 0.471 . . . . 0.0 109.751 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -94.24 165.92 12.36 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.232 -175.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 66.1 m80 . . . . . 0 C--O 1.248 0.998 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.591 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.475 0.825 0 CA-C-O 120.765 0.317 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 m -147.55 102.45 3.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.849 0.357 . . . . 0.0 111.388 -175.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -91.82 122.47 34.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.957 0.408 . . . . 0.0 110.03 175.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.2 p -102.39 0.43 33.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.356 -177.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -87.7 -9.32 54.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -110.19 145.32 37.47 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.433 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 34.0 mmt180 -83.87 -19.97 33.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.721 0.296 . . . . 0.0 110.937 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -163.34 97.93 1.02 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.437 0.637 . . . . 0.0 110.188 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.19 161.97 11.45 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.627 2.218 . . . . 0.0 113.01 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.1 m -93.96 105.65 17.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.784 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.536 HD11 ' HB ' ' A' ' 46' ' ' VAL . 54.3 tp -83.2 139.02 33.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.632 -176.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.7 m -116.77 115.36 25.44 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.787 0.327 . . . . 0.0 110.561 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.6 mt -114.52 141.73 47.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.164 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.6 m -75.05 142.31 43.76 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.711 0.291 . . . . 0.0 110.472 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.804 HD11 HG13 ' A' ' 53' ' ' VAL . 38.6 tp -89.1 122.03 32.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.234 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.6 pt -104.42 148.38 9.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.149 0.499 . . . . 0.0 111.114 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.33 113.44 18.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.855 176.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -111.64 133.17 54.08 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 68.13 3.68 3.75 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.608 0.568 . . . . 0.0 112.067 174.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 27.1 m -62.3 113.66 9.44 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.995 -177.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 24.0 Cg_exo -65.16 166.88 17.59 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.373 2.716 . . . . 0.0 113.51 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.34 -23.02 60.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.123 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -85.46 3.61 39.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.84 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.2 m -117.01 124.55 49.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.612 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.5 ttp -117.18 113.03 21.65 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.406 HG12 ' CD2' ' A' ' 89' ' ' LEU . 17.8 mt -75.95 115.9 18.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.254 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 22.1 ttt -77.9 -35.58 50.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.073 0.463 . . . . 0.0 110.049 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.7 m -78.6 121.65 24.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.775 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -69.48 128.26 35.9 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.8 mt -67.95 126.4 92.58 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.196 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -90.99 -161.25 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.119 2.546 . . . . 0.0 112.397 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.8 m -117.83 141.96 47.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.405 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 p -97.75 145.22 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.965 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.6 mtp180 -114.93 118.43 33.44 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 80' ' ' ILE . 17.3 m -117.3 134.45 60.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.057 -177.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.543 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 11.9 mmtt -79.09 122.21 25.95 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 173.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.3 p -120.95 129.83 53.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.773 0.321 . . . . 0.0 111.509 -176.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.518 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 28.3 tt0 -96.04 106.15 18.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.601 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 135.17 -178.41 18.59 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.029 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.433 ' OH ' ' HD3' ' A' ' 7' ' ' ARG . 95.0 m-85 -113.23 161.06 17.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.101 0.476 . . . . 0.0 111.043 -178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.628 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 3.2 p30 -128.74 74.57 80.54 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.687 176.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.66 -45.46 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.585 2.19 . . . . 0.0 111.767 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 p -102.9 3.93 37.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.054 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.654 HD11 ' HB2' ' A' ' 74' ' ' ASN . 56.9 mt -106.69 121.51 59.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.629 -175.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -91.72 106.23 18.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.541 0.686 . . . . 0.0 110.665 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.536 ' HB ' HD11 ' A' ' 11' ' ' LEU . 33.2 m -69.66 -10.88 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.68 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -82.87 -11.01 58.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.978 0.418 . . . . 0.0 110.497 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -106.26 -16.46 14.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.213 174.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.8 mt -70.32 128.56 36.63 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 168.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -124.3 157.86 33.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.361 0.6 . . . . 0.0 112.044 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.88 129.54 56.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 169.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -129.57 143.78 50.98 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.466 0.651 . . . . 0.0 111.622 -173.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.804 HG13 HD11 ' A' ' 15' ' ' LEU . 3.2 m -112.52 119.52 60.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.94 172.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -84.84 100.3 11.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.571 -173.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.509 HD23 HD11 ' A' ' 89' ' ' LEU . 10.5 mp -90.6 76.26 6.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.0 m -57.3 -42.63 82.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.919 -174.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -112.21 172.56 14.82 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.041 -174.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.9 m -91.4 31.07 1.19 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.975 0.417 . . . . 0.0 110.168 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -59.73 112.28 5.08 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.521 -175.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.41 151.88 20.27 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.633 2.222 . . . . 0.0 112.055 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.82 179.3 19.13 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.351 176.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 88' ' ' GLN . 41.8 tt0 -87.08 107.99 18.68 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 65' ' ' TYR . 76.6 m-70 -117.33 161.76 19.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.818 -175.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -95.53 127.24 41.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 63' ' ' HIS . 95.3 m-85 -116.88 134.24 55.02 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.322 0.582 . . . . 0.0 111.165 -177.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -77.09 120.64 22.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.146 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.5 t -73.44 106.25 3.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.27 0.557 . . . . 0.0 110.044 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -100.5 126.02 46.88 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.554 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.9 146.73 10.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -58.94 115.38 11.69 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 173.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.19 108.0 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.713 2.276 . . . . 0.0 112.486 -176.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.535 ' H ' HD12 ' A' ' 72' ' ' ILE . 3.8 mp -81.06 111.11 21.09 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.9 24.51 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.829 2.353 . . . . 0.0 113.15 -172.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.654 ' HB2' HD11 ' A' ' 44' ' ' ILE . 21.8 m120 -144.38 -1.42 0.92 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.721 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.544 HD11 ' HB3' ' A' ' 41' ' ' ASN . 70.1 mt -129.96 134.23 63.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.874 0.368 . . . . 0.0 110.407 -176.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 52.2 tttm -83.18 112.83 20.2 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.802 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.9 tt -80.66 125.46 39.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.203 0.525 . . . . 0.0 110.163 -176.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 22.7 t -93.59 -54.18 7.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.35 -173.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -153.28 156.82 39.15 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.722 -174.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.609 ' HA ' HG12 ' A' ' 35' ' ' VAL . 60.9 mt -122.78 132.08 72.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 23.2 t -139.21 110.5 7.7 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.464 0.173 . . . . 0.0 110.642 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 2.3 Cg_endo -87.35 153.38 42.07 Favored 'Cis proline' 0 N--CA 1.462 -0.379 0 C-N-CA 124.215 -1.161 . . . . 0.0 112.152 -2.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.593 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 85.1 mtm180 -76.33 -34.68 59.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.878 0.371 . . . . 0.0 111.392 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.8 t -129.23 129.62 67.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.913 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.3 m -116.11 133.44 62.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.971 0.415 . . . . 0.0 110.859 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.3 m -90.78 115.4 27.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.144 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.418 ' HB2' ' CE2' ' A' ' 65' ' ' TYR . 70.8 mt -118.82 138.86 52.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.178 -177.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 53.1 tt0 -93.83 115.78 28.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.951 0.405 . . . . 0.0 110.581 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.509 HD11 HD23 ' A' ' 55' ' ' LEU . 23.7 mt -100.42 135.68 41.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.282 0.563 . . . . 0.0 111.118 177.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -118.86 170.51 8.95 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 169.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -83.43 166.15 18.61 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.885 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -53.76 -46.27 70.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.201 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 51.0 t60 -161.92 122.09 2.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.187 176.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -107.2 160.97 15.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -78.44 169.22 18.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.152 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.3 m80 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.663 -0.684 . . . . 0.0 110.123 -179.82 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.6 m . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 120.993 0.425 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -88.78 84.97 6.68 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -72.42 130.85 41.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.4 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.5 m -72.71 -45.2 60.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.035 0.445 . . . . 0.0 110.69 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 44.5 tp -85.56 88.66 7.55 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -84.45 13.19 5.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.224 -174.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -77.26 -34.18 55.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.207 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.838 ' HB3' ' HG3' ' A' ' 38' ' ' GLU . 6.1 p-10 -134.37 89.52 27.11 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 121.737 0.779 . . . . 0.0 110.385 178.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.32 141.1 25.36 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.097 2.532 . . . . 0.0 113.36 -173.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 40.9 m -87.77 110.35 20.4 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.9 tp -108.92 144.69 36.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.538 -171.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 12.4 t -116.64 123.47 47.37 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.353 0.597 . . . . 0.0 109.796 174.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt -109.5 166.29 11.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.011 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.2 t -86.07 126.65 34.34 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.642 HD11 HG13 ' A' ' 53' ' ' VAL . 60.3 tp -80.82 104.24 11.2 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 174.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 36.2 pt -107.08 147.45 12.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.257 0.551 . . . . 0.0 111.599 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.568 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -86.91 105.03 16.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.54 175.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -90.42 -77.84 0.39 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.859 -174.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -80.71 64.82 5.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.906 0.86 . . . . 0.0 109.253 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.568 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 46.5 m -112.0 111.48 53.47 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.564 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -71.25 -178.93 3.18 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.035 2.49 . . . . 0.0 111.979 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 23' ' ' ASN . . . -77.87 160.96 27.96 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.571 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.567 ' HB3' ' O ' ' A' ' 22' ' ' ALA . 18.1 t30 80.1 -38.09 0.16 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.847 0.717 . . . . 0.0 111.274 174.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 p -78.72 94.58 5.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.14 0.495 . . . . 0.0 110.123 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.4 ttp -102.94 133.0 48.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.244 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.9 mt -85.9 110.43 19.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.3 ttt -70.4 -32.5 70.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.088 0.47 . . . . 0.0 110.088 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.5 m -78.01 106.62 10.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.477 174.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.58 129.57 40.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.051 0.453 . . . . 0.0 111.175 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 15' ' ' LEU . 73.1 mt -55.94 122.72 48.98 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.856 -174.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -95.25 176.19 0.94 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.343 2.695 . . . . 0.0 112.82 176.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 m -87.0 140.08 29.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.925 173.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 12' ' ' THR . 14.4 p -101.83 148.09 7.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.044 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 34' ' ' ARG . 37.2 mtm-85 -103.17 120.45 40.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.904 0.383 . . . . 0.0 110.638 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 80' ' ' ILE . 6.9 m -133.77 116.67 24.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.236 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 16.7 ttpp -87.55 129.07 35.23 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.1 p -105.03 -178.05 3.54 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.838 ' HG3' ' HB3' ' A' ' 8' ' ' ASP . 3.4 tt0 -154.66 110.31 3.15 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.41 165.66 10.85 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.927 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -88.02 113.13 23.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.594 0.235 . . . . 0.0 110.529 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.523 ' HB3' HG13 ' A' ' 75' ' ' ILE . 5.1 p30 -135.5 82.01 40.89 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.537 0.684 . . . . 0.0 111.626 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -91.13 -6.18 3.98 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.096 2.531 . . . . 0.0 111.948 175.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.1 p -97.74 -52.16 3.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.238 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.31 126.35 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.243 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -86.24 128.78 34.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.926 -177.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.63 -13.08 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.451 -174.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -97.06 -9.53 27.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.688 0.28 . . . . 0.0 110.844 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.82 -25.13 22.37 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 172.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.6 128.51 34.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.743 172.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -130.85 157.61 42.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.987 0.422 . . . . 0.0 111.11 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -123.0 114.0 19.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.557 ' CZ ' ' HD2' ' A' ' 68' ' ' LYS . 53.1 p90 -118.55 159.53 23.39 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.121 0.486 . . . . 0.0 111.839 -171.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.642 HG13 HD11 ' A' ' 15' ' ' LEU . 17.0 m -112.43 139.46 37.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.695 172.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -103.68 106.69 17.27 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.471 HD12 HG23 ' A' ' 20' ' ' THR . 78.8 mt -98.49 44.18 1.04 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.947 0.403 . . . . 0.0 111.0 -174.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 t -56.56 -44.04 80.55 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.454 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.99 69.97 3.22 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 173.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 p -69.54 91.58 0.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.488 0.661 . . . . 0.0 110.779 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 42.5 tt0 -117.87 125.48 27.98 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.958 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 59' ' ' GLU . 25.3 Cg_exo -62.89 150.9 87.0 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.194 2.596 . . . . 0.0 112.818 -177.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.38 -177.27 27.15 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.863 ' HG2' ' HB2' ' A' ' 88' ' ' GLN . 42.6 mt-10 -87.68 107.49 18.65 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -124.15 148.76 46.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 39.4 m-20 -81.89 109.64 16.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.71 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -111.61 146.54 37.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.283 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -80.52 134.06 35.89 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.523 -174.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.482 HG13 HD13 ' A' ' 15' ' ' LEU . 60.1 t -81.75 112.36 19.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.557 ' HD2' ' CZ ' ' A' ' 52' ' ' TYR . 7.8 tmtt? -103.1 111.57 24.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.093 0.473 . . . . 0.0 109.885 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 34.9 t -92.4 143.13 12.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.421 -178.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -58.3 139.16 84.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.908 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.27 136.38 47.14 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.499 2.133 . . . . 0.0 111.702 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.458 ' CG2' ' HB ' ' A' ' 75' ' ' ILE . 41.2 mt -116.24 110.41 43.32 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.312 -177.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.52 137.31 50.1 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.763 2.308 . . . . 0.0 111.938 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 73.41 -45.3 0.61 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.524 0.729 . . . . 0.0 112.447 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.523 HG13 ' HB3' ' A' ' 41' ' ' ASN . 26.3 mm -84.33 129.36 37.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.031 0.443 . . . . 0.0 110.362 -175.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -81.8 141.48 33.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.562 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.2 tt -98.69 112.42 30.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.548 0.69 . . . . 0.0 109.144 174.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.6 t -86.42 -53.22 10.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.633 -170.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -133.86 147.71 51.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.099 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.718 ' HB ' ' HG2' ' A' ' 83' ' ' ARG . 55.0 mt -127.8 111.8 25.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 21.0 m -128.78 108.45 18.57 Favored Pre-proline 0 C--N 1.318 -0.771 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.145 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 4.1 Cg_endo -89.33 166.81 36.09 Favored 'Cis proline' 0 C--N 1.344 0.316 0 C-N-CA 124.459 -1.059 . . . . 0.0 112.344 -3.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.718 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 80.5 mtm180 -93.49 -28.62 15.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.081 0.467 . . . . 0.0 109.888 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.425 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 53.9 t -130.22 120.18 48.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.526 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.489 HG12 ' HG2' ' A' ' 82' ' ' PRO . 16.2 m -112.72 135.45 52.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.157 0.504 . . . . 0.0 111.219 -177.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.8 m -83.09 104.1 13.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.766 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.1 mt -101.51 133.02 46.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.61 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.863 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 42.8 tt0 -92.02 108.73 20.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.86 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 72.2 mt -94.31 120.65 34.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.532 177.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -109.12 152.33 25.24 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.592 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -84.13 100.44 11.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.647 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -92.56 137.71 32.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.804 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -78.42 141.31 38.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.44 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -102.69 137.78 40.46 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.134 0.493 . . . . 0.0 112.195 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -92.74 -32.99 14.49 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 161.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.2 m80 . . . . . 0 C--O 1.252 1.209 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.833 174.394 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 120.851 0.358 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.1 m -79.38 111.41 15.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 175.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -94.13 166.99 11.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.889 0.376 . . . . 0.0 111.121 -175.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.7 m -73.18 -28.94 62.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.372 0.606 . . . . 0.0 109.679 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -95.26 148.64 22.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.537 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -84.65 168.88 14.89 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -92.52 -18.27 23.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.878 0.37 . . . . 0.0 110.49 -178.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -116.23 93.09 38.17 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.798 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.14 130.38 18.78 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.398 2.065 . . . . 0.0 111.445 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.7 m -95.75 92.6 6.64 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 175.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.507 HD21 HD12 ' A' ' 49' ' ' LEU . 14.6 tp -82.85 114.98 21.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.953 -170.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.405 HG23 ' HG2' ' A' ' 34' ' ' ARG . 26.5 m -93.81 101.57 13.67 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.253 178.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.8 mt -100.83 177.91 4.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.482 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.9 m -105.35 137.63 42.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.521 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.824 HD11 HG13 ' A' ' 53' ' ' VAL . 50.7 tp -86.99 123.46 32.11 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.7 pt -119.79 146.7 24.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.133 0.492 . . . . 0.0 111.034 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.27 115.79 23.24 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -71.05 -76.46 0.1 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.063 -175.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -126.19 81.11 1.97 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.893 0.378 . . . . 0.0 110.317 177.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.9 t -90.67 127.17 53.46 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 170.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.89 157.33 13.2 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.323 2.682 . . . . 0.0 113.158 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' A' ' 96' ' ' HIS . . . -68.97 -19.82 64.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.679 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -86.03 -5.8 59.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.26 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 p -118.59 144.61 46.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.106 0.479 . . . . 0.0 111.218 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.9 ttp -132.62 130.7 40.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.738 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.42 ' HA ' HD23 ' A' ' 89' ' ' LEU . 19.7 mt -82.84 116.92 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.652 0.263 . . . . 0.0 111.134 -176.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.52 ' HG2' ' HB2' ' A' ' 90' ' ' GLU . 95.9 mmm -82.94 -39.24 21.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.175 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.6 m -66.85 112.9 4.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.297 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -58.07 120.63 8.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.164 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.25 109.22 2.27 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.422 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -85.01 -170.87 0.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.879 2.386 . . . . 0.0 113.015 -173.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.2 m -97.2 134.31 40.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.147 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.538 HG11 HG11 ' A' ' 67' ' ' VAL . 17.8 m -96.85 142.39 14.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.405 ' HG2' HG23 ' A' ' 12' ' ' THR . 48.2 mtp180 -120.94 119.26 32.08 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.352 -178.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.53 HG12 ' HA ' ' A' ' 80' ' ' ILE . 30.1 m -112.54 137.29 45.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.066 0.46 . . . . 0.0 111.527 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -87.53 122.2 30.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 173.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.434 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 24.1 p -126.34 159.15 33.99 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 123.368 0.417 . . . . 0.0 110.925 -177.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -114.86 112.04 22.14 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.87 -159.0 26.88 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.841 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -137.78 157.14 47.06 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.448 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 6.3 p30 -128.78 85.66 59.62 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 121.204 0.526 . . . . 0.0 111.768 -174.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.59 -67.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.018 2.478 . . . . 0.0 112.422 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.3 p -84.4 -11.41 56.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.153 0.501 . . . . 0.0 111.045 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' A' ' 41' ' ' ASN . 70.1 mt -76.46 113.2 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.273 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.428 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 35.2 m-80 -84.77 121.6 27.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.747 -176.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.478 HG22 HD11 ' A' ' 11' ' ' LEU . 37.7 t -62.62 -36.53 75.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.455 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -71.15 -22.13 62.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.635 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -88.56 -17.31 30.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.449 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.507 HD12 HD21 ' A' ' 11' ' ' LEU . 91.3 mt -85.03 131.09 34.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.61 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -128.14 152.66 47.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.073 0.463 . . . . 0.0 111.447 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . . . -115.42 115.99 27.48 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 171.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -107.69 145.94 32.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.346 0.593 . . . . 0.0 112.023 -173.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.824 HG13 HD11 ' A' ' 15' ' ' LEU . 4.4 m -112.6 121.07 64.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.218 169.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -87.35 86.28 7.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.218 1.009 . . . . 0.0 110.528 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 mp -78.96 29.89 0.21 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.214 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.1 m -65.52 95.65 0.23 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.208 0.527 . . . . 0.0 110.064 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.83 -74.1 0.44 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -173.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m 58.37 98.41 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 173.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -85.1 119.59 72.64 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.81 114.65 1.95 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.695 2.264 . . . . 0.0 112.183 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.08 -158.48 27.7 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -100.36 104.71 16.16 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -130.89 152.68 49.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.822 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.478 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 18.8 m-20 -91.69 130.29 37.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.765 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -123.99 151.78 43.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.209 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.429 ' O ' HG12 ' A' ' 53' ' ' VAL . 24.8 mt-10 -87.2 134.72 33.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.306 -175.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.538 HG11 HG11 ' A' ' 33' ' ' VAL . 90.6 t -79.86 109.51 14.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.932 173.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -108.92 109.67 20.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.023 0.44 . . . . 0.0 110.431 -177.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 31.8 t -87.27 149.83 3.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.293 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -53.03 128.97 48.44 Favored Pre-proline 0 C--O 1.232 0.138 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.67 124.91 15.99 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.373 2.049 . . . . 0.0 111.683 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.6 mt -113.79 95.47 37.46 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.544 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.02 24.43 0.71 Allowed 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 123.072 2.514 . . . . 0.0 111.751 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -118.28 -30.51 5.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.171 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.434 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 61.9 mt -130.95 142.11 44.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.201 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -80.73 128.13 33.29 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.149 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.9 tt -97.41 122.16 48.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.396 0.617 . . . . 0.0 109.889 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.836 HG12 ' HG3' ' A' ' 79' ' ' GLU . 41.4 t -94.87 -60.47 2.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.115 -175.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.836 ' HG3' HG12 ' A' ' 78' ' ' VAL . 43.8 mt-10 -141.87 139.37 32.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.28 -172.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.53 ' HA ' HG12 ' A' ' 35' ' ' VAL . 46.3 mt -107.31 120.27 58.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.496 175.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 15.1 m -118.18 108.01 42.74 Favored Pre-proline 0 C--N 1.323 -0.586 0 O-C-N 122.423 -0.173 . . . . 0.0 110.93 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 83.9 Cg_endo -91.74 174.54 18.92 Favored 'Cis proline' 0 C--N 1.346 0.439 0 C-N-CA 124.186 -1.172 . . . . 0.0 112.53 -2.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 83' ' ' ARG . 27.3 mtm105 -94.97 -50.66 5.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.46 0.648 . . . . 0.0 110.085 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.478 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 41.1 t -115.53 118.66 59.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.138 -177.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.7 m -107.44 134.69 48.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.024 0.44 . . . . 0.0 111.18 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.2 m -85.21 103.97 14.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.82 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.5 mt -97.92 124.64 42.45 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.102 0.477 . . . . 0.0 110.572 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -87.93 104.66 16.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.965 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 26' ' ' ILE . 59.5 mt -94.31 134.33 36.91 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.941 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.52 ' HB2' ' HG2' ' A' ' 27' ' ' MET . 0.0 OUTLIER -110.72 170.99 7.73 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.656 179.242 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -84.98 110.74 19.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.358 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -84.33 110.47 18.62 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 177.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -80.04 61.51 3.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.21 0.529 . . . . 0.0 111.081 -173.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.96 155.45 16.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.352 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -89.87 9.53 27.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.03 0.443 . . . . 0.0 110.782 176.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.461 ' HA ' ' HB1' ' A' ' 22' ' ' ALA . 36.0 t60 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.129 -0.939 . . . . 0.0 109.062 174.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.5 t . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -56.35 -43.52 79.19 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.94 0.4 . . . . 0.0 110.568 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -103.31 130.93 50.7 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.6 p -96.86 124.98 40.99 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.021 0.439 . . . . 0.0 111.532 -173.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.1 mt -76.74 153.72 34.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.166 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -94.85 141.59 28.46 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -71.02 -34.6 71.48 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.226 0.536 . . . . 0.0 110.497 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.419 ' HB3' ' HG2' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -143.44 92.09 6.71 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.83 -178.823 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.95 154.82 33.79 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.874 2.383 . . . . 0.0 113.453 -174.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 35.3 m -100.23 123.28 44.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.826 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.2 mt -101.33 159.01 15.63 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.051 0.453 . . . . 0.0 110.496 -176.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 31.0 m -126.4 99.55 5.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.02 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.529 HD22 ' HB2' ' A' ' 49' ' ' LEU . 79.5 mt -95.8 141.84 28.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.244 -173.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 m -74.01 140.78 45.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.92 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.851 HD11 HG13 ' A' ' 53' ' ' VAL . 45.0 tp -96.32 125.19 40.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.035 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.5 HD11 ' CE2' ' A' ' 52' ' ' TYR . 39.7 pt -122.77 151.85 27.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.035 0.445 . . . . 0.0 111.507 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.444 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -78.99 132.91 36.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.537 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.55 ' HD2' ' CD2' ' A' ' 52' ' ' TYR . 60.6 tttm -129.73 140.15 51.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.213 178.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.557 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 65.0 m-20 60.91 20.17 10.47 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.719 0.637 . . . . 0.0 110.798 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.444 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 72.7 m -79.76 116.44 61.01 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.196 -174.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.1 178.0 3.93 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.911 2.407 . . . . 0.0 112.647 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.0 -28.44 27.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.114 -175.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -73.92 -10.15 59.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.674 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.6 p -100.93 110.12 22.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.128 0.489 . . . . 0.0 109.972 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.622 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 25.6 ttt -102.9 108.83 20.17 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.032 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.0 mt -78.35 108.19 11.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.665 -175.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.476 ' SD ' ' HB2' ' A' ' 90' ' ' GLU . 85.4 mtp -86.19 -32.9 20.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.553 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.9 m -71.87 111.39 7.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.985 176.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -65.9 117.88 8.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.5 114.53 13.41 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.507 -173.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -85.06 -161.99 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.903 2.402 . . . . 0.0 111.74 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.8 m -113.31 150.79 32.02 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.743 0.306 . . . . 0.0 110.911 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.626 HG11 HG11 ' A' ' 67' ' ' VAL . 35.7 m -94.38 152.48 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.777 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -110.53 102.02 10.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.988 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 80' ' ' ILE . 23.7 m -120.12 132.79 68.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.786 -176.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 81.8 tttt -97.17 136.06 38.23 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.553 HG22 ' HA ' ' A' ' 77' ' ' ILE . 37.0 p -127.98 138.35 52.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.289 -175.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.466 ' HG3' HG21 ' A' ' 78' ' ' VAL . 53.6 mt-10 -97.37 100.27 11.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.183 0.516 . . . . 0.0 109.64 175.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.24 151.65 5.78 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.19 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -89.93 147.58 23.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.677 0.275 . . . . 0.0 110.385 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 4.6 p30 -109.46 111.49 59.53 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.562 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 41' ' ' ASN . 5.1 Cg_exo -79.87 -73.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.814 2.342 . . . . 0.0 112.072 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 p -105.11 6.13 32.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.787 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.2 126.22 40.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.47 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -114.95 153.38 30.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.83 0.348 . . . . 0.0 111.322 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.0 m -83.56 -9.71 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.695 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -93.58 -4.81 50.21 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -98.78 -37.4 9.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.668 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.529 ' HB2' HD22 ' A' ' 13' ' ' LEU . 20.0 mt -88.3 144.57 26.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.657 177.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -135.89 157.9 45.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.684 0.754 . . . . 0.0 112.419 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.18 135.61 48.43 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.981 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.55 ' CD2' ' HD2' ' A' ' 18' ' ' LYS . 29.6 m-85 -112.25 150.16 31.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.956 0.408 . . . . 0.0 111.022 -173.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.851 HG13 HD11 ' A' ' 15' ' ' LEU . 3.1 m -122.08 118.28 55.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.814 168.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -83.63 105.65 14.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.224 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.4 mt -101.87 15.58 28.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.605 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.557 ' HB2' ' HB3' ' A' ' 19' ' ' ASN . 12.7 t -72.26 96.81 1.89 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 173.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.52 51.34 1.44 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 -172.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.2 p -106.01 162.36 13.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.717 0.294 . . . . 0.0 110.833 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.466 ' HB2' ' CE1' ' A' ' 63' ' ' HIS . 1.2 mp0 -120.38 132.89 23.98 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.4 147.74 66.25 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.775 2.316 . . . . 0.0 112.13 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.34 -171.02 17.05 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.491 -177.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -84.76 111.98 20.09 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.466 ' CE1' ' HB2' ' A' ' 59' ' ' GLU . 25.6 m80 -137.1 145.19 43.59 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.025 0.44 . . . . 0.0 110.932 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.54 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 11.5 m-20 -85.25 125.72 33.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.364 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -121.79 151.79 40.2 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.086 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -90.16 142.8 27.36 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.797 -170.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.626 HG11 HG11 ' A' ' 33' ' ' VAL . 67.5 t -83.15 121.77 36.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.946 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 50.4 tttm -95.4 112.66 24.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.331 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.5 t -92.53 127.09 44.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.695 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 37.5 tt0 -72.21 122.87 88.54 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.979 177.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 50.0 Cg_exo -55.99 125.66 19.82 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.134 2.556 . . . . 0.0 113.062 -176.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.444 HG12 HD13 ' A' ' 49' ' ' LEU . 52.1 mt -88.54 117.1 67.98 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.948 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.86 137.27 37.69 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.318 2.012 . . . . 0.0 112.551 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 71.15 4.38 5.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.264 173.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 58.3 mt -132.06 136.14 57.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -90.41 123.33 34.04 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.43 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.553 ' HA ' HG22 ' A' ' 37' ' ' THR . 16.6 tt -80.28 139.49 18.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.466 HG21 ' HG3' ' A' ' 38' ' ' GLU . 39.4 t -108.05 -69.13 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.069 0.462 . . . . 0.0 110.902 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -107.79 141.66 39.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.864 -171.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.54 ' HA ' HG12 ' A' ' 35' ' ' VAL . 66.3 mt -120.1 110.43 28.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.362 177.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 47.0 m -144.78 123.84 6.92 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.92 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 93.2 Cg_endo -85.32 158.68 63.04 Favored 'Cis proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.123 -3.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -81.58 -35.64 29.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.984 0.421 . . . . 0.0 110.453 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.54 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 71.3 t -130.54 130.61 65.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.445 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.7 m -116.92 141.2 36.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.098 0.475 . . . . 0.0 111.168 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.1 m -80.44 117.51 21.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.229 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.2 mt -113.92 123.44 49.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.854 0.359 . . . . 0.0 110.681 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -88.79 104.37 16.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.078 176.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.9 mt -94.77 127.44 40.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.403 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 25' ' ' MET . 10.4 tp10 -100.41 154.61 18.38 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.686 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.8 m80 -80.62 90.46 5.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.611 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.622 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 22.4 t60 -66.68 111.21 3.56 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -85.36 159.37 20.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.207 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -124.19 135.41 53.44 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.01 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -144.19 122.7 12.44 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.881 -0.58 . . . . 0.0 110.32 -178.166 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.5 p . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 120.985 0.421 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.0 m -84.07 163.98 19.53 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -81.55 4.16 22.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.422 0.63 . . . . 0.0 110.501 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.5 m -155.91 155.54 33.03 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -54.05 138.4 37.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.876 0.369 . . . . 0.0 110.621 176.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -75.11 -9.59 58.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.79 -171.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.415 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 84.0 mtt85 -97.48 -0.08 46.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.259 0.552 . . . . 0.0 110.191 177.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.15 87.44 29.16 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.57 -172.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 7' ' ' ARG . 16.8 Cg_exo -67.83 125.97 13.95 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.412 2.075 . . . . 0.0 111.983 -178.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.4 m -90.74 116.39 28.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.648 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 88.8 mt -108.85 131.84 54.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.18 0.514 . . . . 0.0 111.316 -173.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 m -103.86 99.14 8.91 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.823 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.5 mt -106.25 134.35 49.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.043 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -73.45 142.49 46.87 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.787 0.327 . . . . 0.0 110.75 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.751 HD11 HG13 ' A' ' 53' ' ' VAL . 55.4 tp -87.02 122.25 30.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.028 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.4 pt -108.93 153.78 10.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.141 0.496 . . . . 0.0 111.398 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.03 111.22 17.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.968 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -109.37 134.76 51.43 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.981 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.1 t30 62.28 18.15 9.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.707 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.502 HG23 HD12 ' A' ' 55' ' ' LEU . 31.0 m -72.09 118.95 71.61 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.922 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 7.0 Cg_exo -72.89 -179.95 4.74 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.905 2.403 . . . . 0.0 112.365 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 23' ' ' ASN . . . -80.82 161.43 24.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.276 175.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 22' ' ' ALA . 95.3 m-20 75.28 -34.47 0.26 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.532 0.733 . . . . 0.0 111.639 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.4 p -76.91 98.49 4.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.369 0.604 . . . . 0.0 109.695 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' MET . . . . . 0.692 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 51.1 ttp -103.0 124.56 48.74 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.639 -174.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.422 HG12 ' CD2' ' A' ' 89' ' ' LEU . 17.4 mt -84.65 97.62 5.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 44.1 ttp -79.05 -20.23 49.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.027 0.441 . . . . 0.0 109.953 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.0 m -75.75 105.97 7.07 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -54.61 132.25 44.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.012 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.51 114.64 29.88 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.438 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -89.2 -161.24 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.936 2.424 . . . . 0.0 112.222 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.3 p -120.81 141.95 50.06 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.793 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.608 HG11 HG11 ' A' ' 67' ' ' VAL . 25.1 m -93.9 142.86 12.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.923 0.392 . . . . 0.0 109.964 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -112.05 93.25 4.36 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.456 0.646 . . . . 0.0 109.444 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 80' ' ' ILE . 30.2 m -99.22 162.55 2.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.676 -175.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 36.0 tttm -123.17 122.99 39.8 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 77' ' ' ILE . 30.5 p -112.77 175.04 5.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.78 -175.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 28.2 tt0 -123.84 117.51 25.02 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.74 -137.35 9.33 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.196 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.531 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 79.2 m-85 -145.02 157.66 44.05 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -114.44 82.03 7.29 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 1.2 Cg_endo -84.84 -68.53 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.781 2.321 . . . . 0.0 112.766 -176.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.6 p -93.72 -14.69 26.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.116 -178.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.4 mt -86.58 117.63 31.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.619 -176.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -84.79 128.16 34.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.931 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.6 m -71.7 -17.11 19.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.198 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -91.2 -0.04 57.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.143 0.497 . . . . 0.0 110.158 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -102.88 -28.22 12.18 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.2 mt -81.99 135.8 35.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.791 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -128.05 156.88 42.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.522 0.677 . . . . 0.0 111.755 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.21 138.45 44.47 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 170.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -136.42 151.68 49.77 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.472 0.653 . . . . 0.0 112.294 -171.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.751 HG13 HD11 ' A' ' 15' ' ' LEU . 4.9 m -112.54 118.11 56.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.433 169.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -88.68 98.5 11.72 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.79 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.502 HD12 HG23 ' A' ' 20' ' ' THR . 60.1 mt -84.97 67.62 10.26 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.35 0.595 . . . . 0.0 110.248 -177.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.44 -20.73 59.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.18 176.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -99.36 142.51 16.05 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.248 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 m -92.94 38.12 1.03 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.646 ' HB2' ' OH ' ' A' ' 65' ' ' TYR . 11.1 mm-40 -66.16 110.22 4.38 Favored Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.765 -177.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -87.58 141.64 5.67 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.996 2.464 . . . . 0.0 111.994 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.21 -168.77 13.9 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.06 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 88' ' ' GLN . 36.3 mt-10 -82.51 97.73 8.58 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -122.77 143.13 50.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.956 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 28.5 m-20 -81.29 119.91 24.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.759 0.314 . . . . 0.0 110.297 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.646 ' OH ' ' HB2' ' A' ' 59' ' ' GLU . 53.6 m-85 -111.03 167.17 10.46 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.15 0.5 . . . . 0.0 111.04 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -106.77 122.63 46.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.626 -173.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.608 HG11 HG11 ' A' ' 33' ' ' VAL . 67.8 t -79.74 113.82 19.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.293 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -100.83 151.4 21.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.708 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.5 t -118.44 141.38 38.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.26 123.21 81.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.65 113.67 1.34 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.002 2.468 . . . . 0.0 112.382 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 48.7 mt -90.94 119.59 68.85 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.757 -176.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 72' ' ' ILE . 11.3 Cg_exo -71.94 149.57 53.52 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.733 2.289 . . . . 0.0 111.647 175.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 72.27 -51.22 0.7 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.589 0.756 . . . . 0.0 111.936 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.7 mt -83.89 134.25 27.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.348 0.594 . . . . 0.0 110.811 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 76.8 tttt -88.87 124.35 34.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.891 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.457 ' HA ' HG22 ' A' ' 37' ' ' THR . 18.0 tt -87.98 133.49 30.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.701 HG12 ' HG3' ' A' ' 79' ' ' GLU . 43.5 t -112.26 -59.89 3.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.106 0.479 . . . . 0.0 111.849 -171.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.701 ' HG3' HG12 ' A' ' 78' ' ' VAL . 46.2 mt-10 -125.23 102.79 7.62 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.084 -172.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.563 ' HA ' HG12 ' A' ' 35' ' ' VAL . 53.0 mt -80.18 118.79 28.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 171.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 36.5 m -141.58 116.48 7.0 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-O 120.548 0.213 . . . . 0.0 110.915 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.479 ' HD2' HG12 ' A' ' 33' ' ' VAL . 94.6 Cg_endo -87.68 -177.24 12.92 Favored 'Cis proline' 0 C--N 1.343 0.252 0 C-N-CA 123.701 -1.374 . . . . 0.0 112.358 -2.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 83' ' ' ARG . 52.0 mtm180 -122.7 -35.94 2.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.837 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.13 117.74 55.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.042 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.1 m -128.39 135.38 62.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.031 0.443 . . . . 0.0 110.846 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 3.9 m -80.09 99.53 7.76 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.097 177.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.554 ' HB2' ' HD2' ' A' ' 65' ' ' TYR . 80.2 mt -96.0 120.98 37.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.035 0.445 . . . . 0.0 109.892 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 59.3 tt0 -86.75 97.7 10.75 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.093 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 89' ' ' LEU . 28.0 mt -82.04 109.57 16.49 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.626 0.727 . . . . 0.0 109.698 175.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -101.28 175.29 5.63 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.674 -175.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -91.55 110.44 21.75 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.603 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.692 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 36.7 t-80 -74.37 -15.59 60.93 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.29 100.63 9.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.243 171.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 70.61 88.97 0.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 O-C-N 124.129 0.893 . . . . 0.0 111.797 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -79.1 -12.37 60.0 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 171.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.4 m80 . . . . . 0 C--O 1.252 1.218 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.851 172.92 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.2 t . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.949 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 15.1 m -56.4 -54.89 40.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.163 0.506 . . . . 0.0 110.107 177.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -126.04 100.83 6.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 170.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.534 HG22 ' H ' ' A' ' 6' ' ' ASP . 4.1 m -95.57 154.62 17.12 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.836 -172.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.2 tp -65.6 -33.91 77.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 172.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.534 ' H ' HG22 ' A' ' 4' ' ' THR . 28.3 t70 -76.01 93.57 3.29 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 171.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.46 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 22.4 mtm180 -68.16 -56.07 10.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.603 -172.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -103.74 97.22 10.36 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.846 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 7' ' ' ARG . 89.8 Cg_endo -89.21 144.76 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.884 2.39 . . . . 0.0 113.85 -175.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 21.2 m -88.11 109.19 19.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.291 171.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.3 tp -86.64 136.2 33.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.981 -174.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.1 m -101.15 119.26 38.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.432 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.2 mt -129.45 152.92 48.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.218 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 p -88.55 151.5 22.46 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.98 0.419 . . . . 0.0 111.091 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.651 HD11 HG13 ' A' ' 53' ' ' VAL . 38.6 tp -92.63 139.31 30.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.293 178.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.0 pt -127.78 160.33 37.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.441 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.417 ' HB1' HD12 ' A' ' 55' ' ' LEU . . . -109.11 129.12 55.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.365 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -120.29 131.87 55.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.092 0.472 . . . . 0.0 111.248 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.6 t30 61.72 46.27 7.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.53 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.524 ' HB ' HD12 ' A' ' 55' ' ' LEU . 12.1 t -79.36 138.18 55.73 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -52.51 146.82 32.08 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.811 2.341 . . . . 0.0 112.74 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.54 -35.56 79.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.825 -176.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -100.74 20.31 15.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.796 0.331 . . . . 0.0 111.861 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.4 p -110.61 127.39 55.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 43.1 ttp -112.6 126.5 55.42 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.228 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.1 mt -84.95 111.7 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.396 -175.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 95.5 mmm -83.57 -42.52 16.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.993 0.425 . . . . 0.0 110.439 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.2 m -74.26 127.25 32.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.734 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -71.96 139.91 48.88 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.697 173.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 64.2 mt -71.78 115.73 40.83 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.79 -173.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 22.5 Cg_exo -65.32 172.56 7.49 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.312 2.675 . . . . 0.0 113.627 -174.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.8 t -102.9 125.21 49.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.218 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.581 HG11 HG11 ' A' ' 67' ' ' VAL . 13.2 m -90.59 153.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.976 0.417 . . . . 0.0 110.615 -176.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -130.04 101.62 5.91 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.705 HG11 HG21 ' A' ' 69' ' ' VAL . 34.9 m -104.41 135.05 44.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.859 -175.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 62.9 tttp -83.62 121.35 27.13 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.501 HG22 ' HA ' ' A' ' 77' ' ' ILE . 20.9 p -121.95 155.35 35.7 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.497 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.51 ' HG3' ' HB3' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -121.1 119.44 32.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.978 0.418 . . . . 0.0 110.13 176.033 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.9 169.24 12.75 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.032 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -96.0 136.92 35.81 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.481 ' HB3' ' CD1' ' A' ' 75' ' ' ILE . 19.6 p30 -128.96 55.35 17.71 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.949 ' HB3' ' HA ' ' A' ' 2' ' ' SER . 34.3 Cg_endo -67.18 -56.71 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.689 1.593 . . . . 0.0 111.987 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.8 m -114.64 38.39 3.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.088 0.471 . . . . 0.0 111.06 -176.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.3 mt -114.66 142.71 26.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.798 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -80.63 41.28 0.55 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 111.008 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.442 HG23 ' OD1' ' A' ' 47' ' ' ASN . 11.9 m -61.27 -36.19 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.126 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.442 ' OD1' HG23 ' A' ' 46' ' ' VAL . 2.9 m-20 -79.4 -5.43 54.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.099 0.475 . . . . 0.0 110.604 -178.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -106.9 -10.84 15.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.736 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.2 mt -82.25 125.22 30.7 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 171.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -109.5 170.76 7.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.66 0.743 . . . . 0.0 112.353 -171.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.478 ' HB2' HG22 ' A' ' 69' ' ' VAL . . . -106.73 137.96 43.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.891 174.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.558 ' CZ ' ' HD3' ' A' ' 68' ' ' LYS . 27.2 p90 -135.29 158.08 45.28 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.615 -178.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.651 HG13 HD11 ' A' ' 15' ' ' LEU . 23.1 m -112.47 141.96 26.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.583 174.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -89.48 118.04 28.83 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.524 HD12 ' HB ' ' A' ' 20' ' ' THR . 85.6 mt -109.16 25.76 11.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.591 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.2 m -73.49 95.32 2.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.309 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.82 23.03 14.25 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.601 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.6 p -88.57 122.96 32.6 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.782 -0.246 . . . . 0.0 110.566 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -75.32 155.08 86.08 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.085 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.54 90.99 0.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.59 2.193 . . . . 0.0 112.029 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.05 172.87 42.86 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 88' ' ' GLN . 40.0 tt0 -82.24 105.47 13.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -130.61 167.9 17.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.347 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.431 ' HB3' HG11 ' A' ' 84' ' ' VAL . 13.6 m-20 -98.59 121.84 41.04 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.351 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -116.89 128.09 54.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.104 -178.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.425 ' HG2' HG22 ' A' ' 84' ' ' VAL . 46.8 mt-10 -69.95 134.61 48.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.204 -175.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.581 HG11 HG11 ' A' ' 33' ' ' VAL . 59.4 t -78.92 112.18 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.546 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.558 ' HD3' ' CZ ' ' A' ' 52' ' ' TYR . 53.6 tttm -102.88 102.63 12.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.388 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.705 HG21 HG11 ' A' ' 35' ' ' VAL . 39.4 t -86.86 125.5 40.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -63.86 127.67 91.93 Favored Pre-proline 0 C--N 1.323 -0.58 0 O-C-N 123.198 0.311 . . . . 0.0 110.958 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.35 137.52 47.28 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.617 2.878 . . . . 0.0 112.92 -175.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.471 ' CG2' ' HB ' ' A' ' 75' ' ' ILE . 30.5 mm -89.17 126.89 57.37 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.262 -177.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.1 131.04 29.1 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.286 1.991 . . . . 0.0 111.725 176.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.3 t30 73.79 -44.42 0.57 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.538 0.735 . . . . 0.0 111.998 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.481 ' CD1' ' HB3' ' A' ' 41' ' ' ASN . 71.5 mt -83.94 140.84 15.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.946 0.403 . . . . 0.0 110.682 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.51 ' HB3' ' HG3' ' A' ' 38' ' ' GLU . 57.3 tttp -94.84 125.71 39.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.387 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.501 ' HA ' HG22 ' A' ' 37' ' ' THR . 14.0 tt -88.36 122.21 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.498 0.666 . . . . 0.0 109.94 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.3 t -85.31 -64.57 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.069 -175.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -130.51 136.8 49.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.113 -170.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.635 ' HA ' HG12 ' A' ' 35' ' ' VAL . 67.5 mt -104.41 108.26 24.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.203 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.455 ' HA ' ' C ' ' A' ' 82' ' ' PRO . 11.6 p -136.13 126.93 16.74 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.735 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.455 ' C ' ' HA ' ' A' ' 81' ' ' SER . 15.3 Cg_exo -68.51 156.85 88.81 Favored 'Cis proline' 0 C--N 1.344 0.32 0 C-N-CA 123.55 -1.438 . . . . 0.0 112.508 0.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -85.23 -38.1 19.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.746 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.431 HG11 ' HB3' ' A' ' 64' ' ' ASP . 59.3 t -137.86 143.58 33.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.375 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 m -118.26 140.03 43.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.957 0.408 . . . . 0.0 111.011 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 m -92.36 105.2 17.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.04 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.9 mt -105.37 124.91 50.34 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.761 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 47.0 tt0 -85.8 99.88 11.66 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.012 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.2 mt -88.22 139.52 30.41 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.14 174.0 7.22 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.74 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -83.89 137.57 33.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.36 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -74.36 -1.01 19.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.686 0.755 . . . . 0.0 109.296 173.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -104.51 134.85 47.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.839 175.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -87.54 19.21 3.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.303 0.573 . . . . 0.0 110.738 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -117.97 22.97 11.94 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 . . . . . 0 C--O 1.245 0.832 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.487 -171.238 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 . . . . . 0 C--O 1.233 0.232 0 CA-C-O 121.341 0.591 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.72 152.97 59.37 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.603 2.202 . . . . 0.0 112.051 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.6 m -107.39 113.13 26.3 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.707 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.514 HD21 HD21 ' A' ' 41' ' ' ASN . 93.1 mt -90.23 127.84 36.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.087 0.47 . . . . 0.0 110.511 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -103.64 102.93 12.8 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.305 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -102.89 144.14 31.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.286 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.2 m -76.86 143.96 39.33 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.813 HD11 HG13 ' A' ' 53' ' ' VAL . 52.7 tp -88.32 127.32 35.48 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.8 pt -122.77 171.17 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.933 0.396 . . . . 0.0 110.842 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.506 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -107.11 122.21 46.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.158 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -114.95 139.89 49.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.594 0.235 . . . . 0.0 110.679 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.8 t30 56.13 32.04 19.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.392 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.506 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 89.6 m -90.02 114.74 61.96 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.311 -176.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.7 163.87 37.54 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.758 2.306 . . . . 0.0 111.561 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.92 -13.29 59.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.855 0.36 . . . . 0.0 110.598 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -67.19 -35.02 78.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.885 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.8 p -95.24 102.67 14.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.602 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 52.6 ttp -102.79 111.98 24.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.061 0.458 . . . . 0.0 110.56 -174.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 28' ' ' THR . 21.6 mt -75.44 113.46 14.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.414 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 84.9 mtp -99.78 10.86 40.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.426 0.631 . . . . 0.0 110.103 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 26' ' ' ILE . 9.3 m -105.39 119.19 38.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.827 176.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -60.78 136.07 57.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.713 0.292 . . . . 0.0 110.335 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.7 mt -81.86 122.9 80.47 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.419 -171.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.536 ' HD2' HD23 ' A' ' 15' ' ' LEU . 87.4 Cg_endo -83.55 -164.88 0.28 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.207 2.605 . . . . 0.0 112.803 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.2 t -125.35 144.91 50.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.074 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.21 144.42 14.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.808 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 35.6 mtm-85 -118.08 99.21 6.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 80' ' ' ILE . 21.2 m -98.85 128.76 50.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.328 0.585 . . . . 0.0 111.497 -174.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.526 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 85.4 tttt -80.6 124.26 28.83 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.461 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 13.1 p -126.11 138.91 53.72 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -173.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.869 ' HB2' ' HB2' ' A' ' 76' ' ' LYS . 40.1 mt-10 -93.95 89.62 6.15 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 172.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.7 136.56 2.02 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -104.39 135.8 45.16 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.101 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.617 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 6.1 p30 -135.07 102.49 10.97 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 121.329 0.585 . . . . 0.0 111.158 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -88.01 -10.05 5.13 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.341 2.027 . . . . 0.0 111.693 174.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.9 p -113.19 -45.08 3.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.508 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' A' ' 41' ' ' ASN . 57.1 mt -57.85 136.5 21.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 120.96 0.41 . . . . 0.0 110.666 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 14.3 m120 -101.67 147.38 26.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.816 -176.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.9 m -80.85 -5.88 9.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.293 0.568 . . . . 0.0 110.042 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -93.01 -19.27 21.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.996 169.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 76.9 tt0 -80.78 -32.61 35.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.219 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.6 mt -94.37 138.52 32.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.234 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -133.3 152.65 51.94 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.388 0.613 . . . . 0.0 111.552 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . . . -110.78 125.08 53.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.505 171.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -121.24 159.41 26.01 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.309 0.576 . . . . 0.0 111.718 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.813 HG13 HD11 ' A' ' 15' ' ' LEU . 11.4 m -112.5 123.52 68.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.048 171.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.0 110.47 12.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.441 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.436 HD22 HD11 ' A' ' 89' ' ' LEU . 55.4 mt -106.87 29.31 7.14 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.693 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m -57.85 -43.78 86.12 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.758 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.81 84.76 1.3 Allowed Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.6 p -71.09 91.09 0.89 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.045 0.45 . . . . 0.0 111.995 -173.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -101.33 107.73 52.0 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.01 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.32 152.18 75.83 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.904 2.402 . . . . 0.0 112.292 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.05 -179.38 20.52 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HG2' HG22 ' A' ' 86' ' ' THR . 32.2 tt0 -80.14 102.98 9.7 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 176.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -129.12 143.34 50.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.593 -172.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.493 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 26.8 m-20 -81.74 124.98 30.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.226 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -120.92 151.18 40.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.463 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.13 134.52 34.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.124 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.482 HG13 HD13 ' A' ' 15' ' ' LEU . 68.7 t -79.13 106.4 10.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 174.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -99.67 106.08 17.97 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.517 -177.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 42.4 t -87.12 134.9 26.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.088 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -63.73 135.33 96.24 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.323 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.54 132.3 44.76 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.083 2.522 . . . . 0.0 112.61 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.7 mp -97.53 121.05 59.36 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.052 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.56 119.32 6.47 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.979 2.453 . . . . 0.0 113.0 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.3 m120 69.17 15.08 8.68 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.207 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.511 HD11 ' HB3' ' A' ' 41' ' ' ASN . 57.4 mt -129.53 130.12 67.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.869 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 97.1 mttt -80.89 137.42 36.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.855 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.8 tt -93.41 116.88 35.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.408 0.623 . . . . 0.0 109.659 172.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.7 t -95.63 -50.29 11.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.253 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.526 ' HB2' ' H ' ' A' ' 36' ' ' LYS . 50.1 mt-10 -118.76 157.74 26.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.087 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.597 ' HA ' HG12 ' A' ' 35' ' ' VAL . 18.9 tt -144.55 25.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 122.163 0.982 . . . . 0.0 108.985 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.531 ' HA ' ' N ' ' A' ' 83' ' ' ARG . 16.1 m -85.79 142.86 37.19 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.377 -175.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 81' ' ' SER . 17.4 Cg_exo -67.15 124.39 5.97 Favored 'Cis proline' 0 C--N 1.346 0.425 0 C-N-CA 123.633 -1.403 . . . . 0.0 111.921 -1.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.531 ' N ' ' HA ' ' A' ' 81' ' ' SER . 70.3 mtm180 -69.72 -31.14 68.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.712 -173.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 43.9 t -127.58 134.98 64.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.699 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 m -120.73 133.26 67.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.195 0.521 . . . . 0.0 110.453 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.469 HG22 ' HG2' ' A' ' 62' ' ' GLU . 4.2 m -87.26 101.38 13.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.983 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.3 mt -107.05 134.52 50.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.226 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 62.4 tt0 -95.34 103.12 14.97 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.013 0.435 . . . . 0.0 110.443 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.436 HD11 HD22 ' A' ' 55' ' ' LEU . 49.4 mt -82.46 120.05 24.97 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.474 175.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.62 149.88 23.3 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.1 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -71.0 124.53 24.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.504 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 . . . . . 0 C--N 1.321 -0.672 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.792 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.426 ' HB3' ' HA ' ' A' ' 38' ' ' GLU . 10.2 m-20 . . . . . 0 N--CA 1.467 0.39 0 CA-C-O 121.145 0.498 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.18 147.88 23.82 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.647 2.231 . . . . 0.0 113.567 -173.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 67.9 m -90.72 109.18 20.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.522 171.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.6 mt -83.12 138.51 33.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.217 0.532 . . . . 0.0 110.876 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.3 m -109.96 102.05 10.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.926 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.44 HD22 ' HB2' ' A' ' 49' ' ' LEU . 44.3 mt -101.78 155.3 18.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.106 -176.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 m -88.53 143.48 26.94 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.831 HD11 HG13 ' A' ' 53' ' ' VAL . 52.6 tp -94.91 127.04 40.65 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.7 pt -124.05 160.61 27.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.036 0.446 . . . . 0.0 111.392 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -88.33 115.73 26.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.308 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 18.3 tptm -114.29 141.12 47.99 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 63.34 20.95 12.56 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.67 0.606 . . . . 0.0 110.579 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.456 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 43.1 m -83.17 118.77 72.66 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.845 -173.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 2.9 Cg_exo -76.12 154.58 37.44 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.298 2.665 . . . . 0.0 112.194 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.9 -1.93 21.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.224 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -80.92 -29.12 35.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.071 0.463 . . . . 0.0 110.553 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.8 p -107.16 128.71 54.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.152 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.773 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 58.0 ttp -119.11 126.78 52.44 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.033 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 28' ' ' THR . 13.9 mt -84.83 115.14 26.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.558 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 94.1 mmm -80.63 -7.98 59.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.306 0.574 . . . . 0.0 110.189 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.474 ' H ' HG22 ' A' ' 26' ' ' ILE . 19.2 m -99.23 118.39 35.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.579 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -66.31 132.89 49.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.781 0.324 . . . . 0.0 110.677 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.4 mt -75.45 122.26 86.85 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.415 -173.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HD2' HD23 ' A' ' 15' ' ' LEU . 95.2 Cg_endo -89.49 -157.71 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.183 2.588 . . . . 0.0 112.628 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.5 p -113.71 160.63 18.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.419 ' CG1' ' HB2' ' A' ' 13' ' ' LEU . 11.3 p -112.91 139.4 38.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.83 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -111.31 109.59 19.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.061 0.458 . . . . 0.0 110.8 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 80' ' ' ILE . 25.2 m -117.24 111.69 35.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.085 -177.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.606 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 6.5 ttpm? -74.77 125.95 29.86 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 174.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.532 HG22 ' HA ' ' A' ' 77' ' ' ILE . 25.3 p -124.66 138.07 54.32 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.056 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.426 ' HA ' ' HB3' ' A' ' 8' ' ' ASP . 48.9 mt-10 -94.64 135.46 36.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.366 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.35 -168.4 12.89 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.832 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -132.9 140.2 47.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.914 0.388 . . . . 0.0 110.673 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.58 ' N ' HD22 ' A' ' 41' ' ' ASN . 0.0 OUTLIER -160.92 80.47 2.19 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.996 178.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.66 -24.28 11.96 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.881 2.387 . . . . 0.0 112.53 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.9 p -84.35 -12.98 53.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.695 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.4 mt -103.21 111.08 31.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -95.47 151.72 19.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.096 0.474 . . . . 0.0 111.745 -174.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.5 m -69.4 -13.47 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.358 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -85.5 -9.63 57.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.24 0.543 . . . . 0.0 109.707 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -105.22 -26.33 12.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.754 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HB2' HD22 ' A' ' 13' ' ' LEU . 91.2 mt -88.64 132.32 34.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.831 175.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -125.19 154.06 42.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.613 0.72 . . . . 0.0 111.791 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -120.85 134.98 55.28 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.494 171.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.581 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 18.9 p90 -129.12 161.02 31.01 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.321 0.581 . . . . 0.0 111.411 -174.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.831 HG13 HD11 ' A' ' 15' ' ' LEU . 5.7 m -112.29 118.38 57.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.418 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 16.4 t0 -78.06 105.08 9.03 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.526 -175.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 58' ' ' SER . 64.0 mt -104.73 35.57 2.72 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.755 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.0 m -60.28 -38.63 84.18 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.56 53.33 0.78 Allowed Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.276 173.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.613 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 23.1 t -74.18 107.08 6.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.049 0.452 . . . . 0.0 110.865 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 44.2 mt-10 -104.69 126.2 31.91 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.26 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 59' ' ' GLU . 51.1 Cg_exo -55.3 141.23 81.57 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.961 2.441 . . . . 0.0 111.932 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.44 175.29 19.17 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.45 107.77 13.52 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -134.0 156.78 47.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.982 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -95.7 125.84 40.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.194 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -121.7 161.68 22.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.823 0.344 . . . . 0.0 110.664 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -93.86 138.13 32.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.987 -175.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.1 t -88.35 121.29 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.985 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.418 ' HD2' ' HB2' ' A' ' 54' ' ' ASP . 96.9 mttt -105.06 127.12 52.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.002 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.14 138.64 35.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.14 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -68.59 139.48 91.55 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.62 150.5 86.4 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.113 2.542 . . . . 0.0 112.577 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 75' ' ' ILE . 11.5 mt -122.26 118.58 28.89 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.9 114.81 2.09 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 123.277 2.651 . . . . 0.0 113.479 -175.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.3 m120 70.85 11.37 7.11 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.321 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 72' ' ' ILE . 41.3 mm -107.81 121.79 61.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.12 0.486 . . . . 0.0 110.472 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -80.66 114.81 19.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.425 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.532 ' HA ' HG22 ' A' ' 37' ' ' THR . 16.0 tt -87.94 115.7 28.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.466 0.651 . . . . 0.0 109.918 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.98 -53.02 9.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.64 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.606 ' HG2' ' HB3' ' A' ' 36' ' ' LYS . 66.8 mm-40 -106.64 146.76 30.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.509 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.565 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 26.8 mt -133.71 81.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 165.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 17.7 m -118.58 116.34 35.01 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.719 -175.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 72.8 Cg_endo -94.33 158.33 17.42 Favored 'Cis proline' 0 C--N 1.346 0.41 0 C-N-CA 124.131 -1.195 . . . . 0.0 113.302 -0.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 80' ' ' ILE . 61.2 mtm180 -96.43 -31.99 12.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.592 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.0 t -119.84 122.17 67.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.019 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.1 m -121.55 138.86 50.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.6 m -88.81 102.73 15.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.067 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.6 mt -101.22 128.44 47.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.016 0.436 . . . . 0.0 110.933 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -91.36 103.6 16.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.183 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.471 ' CD2' HG12 ' A' ' 26' ' ' ILE . 96.0 mt -97.05 128.68 44.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.064 0.459 . . . . 0.0 110.728 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -119.33 178.76 4.41 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.482 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -80.55 114.79 19.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.281 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.773 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 74.5 t60 . . . . . 0 C--N 1.323 -0.557 0 CA-C-O 121.245 0.545 . . . . 0.0 109.66 176.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.488 ' HB3' ' HG2' ' A' ' 38' ' ' GLU . 0.9 OUTLIER . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.24 151.59 12.22 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.676 2.917 . . . . 0.0 113.509 -170.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 37.9 m -95.25 109.88 21.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.632 174.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.8 mt -87.43 137.99 31.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.027 0.441 . . . . 0.0 110.603 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 m -102.63 95.77 6.44 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.071 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.1 mt -101.74 120.11 39.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.192 -175.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 48.6 m -63.35 140.81 58.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.879 0.371 . . . . 0.0 111.406 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.826 HD11 HG13 ' A' ' 53' ' ' VAL . 40.3 tp -84.01 123.58 30.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.788 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.4 pt -109.83 146.17 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.04 0.448 . . . . 0.0 111.58 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.6 94.16 5.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.126 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -96.31 131.51 42.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.026 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.1 t30 58.62 39.18 24.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.755 0.788 . . . . 0.0 109.933 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 63.8 m -88.59 124.81 65.04 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.638 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.867 ' HG2' ' HB3' ' A' ' 58' ' ' SER . 17.0 Cg_exo -67.51 175.76 5.69 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.0 2.466 . . . . 0.0 112.756 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 92' ' ' HIS . . . -94.2 -6.59 44.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.88 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -88.65 -23.64 22.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.018 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.9 p -114.74 112.45 22.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.834 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.0 ttp -105.69 132.7 51.51 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.7 mt -81.31 118.77 29.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 120.759 0.314 . . . . 0.0 110.718 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 83.6 mtp -74.18 -52.5 12.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.106 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 m -70.27 110.14 5.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.4 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -63.26 133.96 55.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.089 0.471 . . . . 0.0 110.63 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.453 HD22 HD23 ' A' ' 15' ' ' LEU . 50.3 mt -71.54 129.41 88.69 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.454 -173.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -92.32 -170.89 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.37 2.713 . . . . 0.0 111.933 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 24.8 m -105.39 135.6 46.47 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.545 HG11 HG11 ' A' ' 67' ' ' VAL . 10.9 m -86.26 145.22 8.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.789 0.328 . . . . 0.0 110.201 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.5 mtp85 -111.51 101.59 10.0 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.123 0.487 . . . . 0.0 109.937 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 80' ' ' ILE . 26.8 m -110.7 137.04 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.757 -177.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 61.1 tttp -85.9 129.66 34.77 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.2 p -126.36 175.22 8.0 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.174 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.488 ' HG2' ' HB3' ' A' ' 8' ' ' ASP . 35.8 mt-10 -139.07 137.63 36.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.704 0.288 . . . . 0.0 110.651 176.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.5 -175.28 17.46 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.552 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -118.15 126.64 52.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.661 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 4.2 p30 -130.48 62.69 66.2 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.166 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.52 -29.83 36.55 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.139 1.893 . . . . 0.0 111.954 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.8 p -91.15 -1.25 57.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.57 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.661 ' HB ' ' HB2' ' A' ' 41' ' ' ASN . 61.2 mt -109.95 126.64 67.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.777 0.322 . . . . 0.0 110.47 -178.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.411 ' ND2' ' HG3' ' A' ' 48' ' ' GLU . 39.8 t30 -85.58 110.92 19.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.405 0.621 . . . . 0.0 110.912 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.6 t -59.93 -27.35 38.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.336 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -71.02 -28.03 64.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.862 0.363 . . . . 0.0 111.174 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.411 ' HG3' ' ND2' ' A' ' 45' ' ' ASN . 40.9 mt-10 -91.3 -12.17 35.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.096 0.474 . . . . 0.0 110.652 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 93.6 mt -77.06 129.7 36.42 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 167.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -131.92 162.38 30.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.86 0.838 . . . . 0.0 112.564 -174.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -109.74 127.86 54.9 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.907 169.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -123.66 144.03 49.89 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.355 0.598 . . . . 0.0 112.036 -172.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.826 HG13 HD11 ' A' ' 15' ' ' LEU . 7.0 m -112.47 131.48 63.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.159 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.53 115.73 28.39 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.679 -0.408 . . . . 0.0 109.982 -175.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 66.1 mt -105.6 51.97 0.74 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.44 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.1 m -57.32 -47.33 81.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.307 0.575 . . . . 0.0 109.661 173.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.11 100.14 2.47 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.501 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.867 ' HB3' ' HG2' ' A' ' 21' ' ' PRO . 1.5 p -73.18 87.8 1.45 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.969 0.414 . . . . 0.0 110.5 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.412 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 27.4 mt-10 -102.82 110.21 62.86 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.08 -174.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 59' ' ' GLU . 38.9 Cg_endo -66.95 141.32 57.95 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.59 2.194 . . . . 0.0 112.294 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.22 -172.24 17.64 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.67 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.513 ' HG3' ' HG2' ' A' ' 88' ' ' GLN . 1.9 mp0 -87.46 89.15 7.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.789 0.328 . . . . 0.0 110.253 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 38.1 m-70 -104.97 148.35 26.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.442 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -92.19 122.76 34.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.998 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -118.87 147.66 43.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.694 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.526 ' HG2' HG22 ' A' ' 84' ' ' VAL . 36.2 mt-10 -93.79 132.19 38.42 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.888 0.375 . . . . 0.0 110.513 -172.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.545 HG11 HG11 ' A' ' 33' ' ' VAL . 59.8 t -73.22 106.83 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.647 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -86.97 109.48 19.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.804 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.76 123.26 39.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.52 119.53 51.21 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.57 110.01 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.108 2.539 . . . . 0.0 112.704 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.3 mt -82.73 114.48 52.4 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.873 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.31 140.78 54.25 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.427 2.085 . . . . 0.0 112.141 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.4 t30 76.31 -2.78 2.66 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.86 0.725 . . . . 0.0 111.015 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.4 mm -116.62 144.85 23.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.982 0.42 . . . . 0.0 110.543 -177.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -98.91 137.39 37.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.211 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.6 tt -104.64 133.77 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.7 t -102.54 -63.36 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.916 0.389 . . . . 0.0 111.222 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -135.46 143.18 45.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.574 -170.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.633 ' HA ' HG12 ' A' ' 35' ' ' VAL . 57.9 mt -112.32 127.07 69.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.335 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 51.2 m -146.39 114.31 4.47 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.636 0.255 . . . . 0.0 110.957 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 2.8 Cg_endo -83.13 172.33 48.43 Favored 'Cis proline' 0 C--N 1.343 0.254 0 C-N-CA 123.803 -1.332 . . . . 0.0 111.964 -2.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -99.56 -45.25 5.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.369 0.604 . . . . 0.0 109.893 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.526 HG22 ' HG2' ' A' ' 66' ' ' GLU . 59.9 t -128.11 125.6 64.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.344 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 m -113.26 139.34 39.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.173 0.511 . . . . 0.0 111.006 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.4 m -86.61 106.54 17.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.068 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.7 mt -101.34 127.86 47.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.213 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.513 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 48.2 mt-30 -90.21 105.39 17.78 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.654 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.4 mt -95.24 126.42 40.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.217 0.532 . . . . 0.0 110.799 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -108.73 153.51 23.35 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.144 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -76.68 113.43 14.32 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.168 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.473 ' HB3' ' O ' ' A' ' 22' ' ' ALA . 79.4 t60 . . . . . 0 C--N 1.324 -0.517 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.488 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 8.0 p-10 . . . . . 0 C--O 1.234 0.284 0 CA-C-O 121.522 0.677 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 66.6 Cg_endo -99.42 173.53 0.41 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.693 2.928 . . . . 0.0 113.948 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 3.7 m -107.38 130.97 54.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.404 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.7 tp -102.87 135.38 44.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.894 0.378 . . . . 0.0 110.012 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.4 m -100.68 106.33 17.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.096 0.474 . . . . 0.0 110.754 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.493 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 92.0 mt -102.8 158.32 16.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.068 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.4 t -97.86 138.61 34.95 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.501 HD11 HG13 ' A' ' 53' ' ' VAL . 46.9 tp -79.93 124.59 28.81 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.45 HG13 ' HB3' ' A' ' 52' ' ' TYR . 43.8 pt -116.61 156.95 17.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.146 0.498 . . . . 0.0 111.249 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.474 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -87.84 118.68 27.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.668 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -115.78 132.1 56.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.542 -176.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.732 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 95.3 m-20 60.34 26.31 15.83 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.104 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.474 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 50.7 m -79.58 119.51 77.12 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.937 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 27.9 Cg_exo -62.56 158.74 39.81 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 123.14 2.56 . . . . 0.0 112.356 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.77 -8.03 59.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.026 0.441 . . . . 0.0 110.635 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -88.19 -5.86 58.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.611 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.0 p -114.55 131.2 56.75 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.863 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.548 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 49.7 ttp -124.93 120.58 32.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.96 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.458 HG12 ' CD2' ' A' ' 89' ' ' LEU . 8.1 mt -82.08 123.5 38.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 45.6 ttp -74.81 -57.47 3.89 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.091 0.472 . . . . 0.0 110.011 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -70.58 154.14 42.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.57 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -94.15 141.16 28.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.889 0.376 . . . . 0.0 110.6 -178.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 65.4 mt -67.4 114.32 18.51 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.229 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 2.8 Cg_exo -73.76 172.95 14.78 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.695 2.263 . . . . 0.0 112.906 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.2 m -82.48 134.35 35.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.364 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.493 ' CG2' ' HB2' ' A' ' 13' ' ' LEU . 33.7 m -95.32 138.12 21.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.149 0.499 . . . . 0.0 110.038 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.437 ' HG3' ' CG2' ' A' ' 10' ' ' THR . 9.7 ttp180 -104.84 103.66 13.29 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.958 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.553 HG12 ' HA ' ' A' ' 80' ' ' ILE . 25.9 m -117.38 126.11 74.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.096 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 42.3 tttt -93.08 141.92 27.88 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 8' ' ' ASP . 32.9 p -118.33 144.56 45.77 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 123.357 0.41 . . . . 0.0 110.996 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 31.6 tt0 -96.37 107.36 19.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 146.0 -138.71 7.69 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -148.81 126.77 11.94 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -104.78 109.16 62.65 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.318 0.58 . . . . 0.0 111.77 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.39 -47.98 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.749 2.299 . . . . 0.0 111.691 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.1 m -131.64 -68.7 0.64 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.753 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.7 mm 64.91 117.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.398 0.618 . . . . 0.0 111.504 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.458 ' ND2' ' HG2' ' A' ' 48' ' ' GLU . 59.4 t30 -84.5 90.65 7.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.642 0.734 . . . . 0.0 110.681 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.42 ' O ' HG12 ' A' ' 46' ' ' VAL . 11.2 t -78.34 7.11 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.333 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -82.63 -20.24 36.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.814 174.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.458 ' HG2' ' ND2' ' A' ' 45' ' ' ASN . 12.6 mm-40 -107.0 -35.15 6.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.304 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.419 HD13 HD12 ' A' ' 72' ' ' ILE . 80.3 mt -83.01 124.63 30.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.301 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -147.36 175.62 10.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.777 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -123.59 137.36 54.76 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 170.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.45 ' HB3' HG13 ' A' ' 16' ' ' ILE . 20.1 p90 -136.41 160.87 37.44 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.642 0.734 . . . . 0.0 112.917 -173.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.501 HG13 HD11 ' A' ' 15' ' ' LEU . 14.6 m -113.12 125.95 70.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.313 167.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -91.67 102.35 14.98 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -175.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 71.4 mt -92.84 15.13 15.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.572 -173.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.732 ' HB2' ' HB3' ' A' ' 19' ' ' ASN . 8.0 t -73.74 106.19 5.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 175.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.08 35.32 6.76 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.266 -175.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.1 m -120.16 145.84 46.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.725 0.297 . . . . 0.0 110.663 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.91 154.25 37.87 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.978 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.561 ' HA ' ' HB2' ' A' ' 89' ' ' LEU . 26.1 Cg_exo -64.93 169.86 11.17 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.936 2.424 . . . . 0.0 112.159 175.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.37 -177.73 27.41 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -175.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -86.56 111.39 20.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.004 0.431 . . . . 0.0 110.396 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 65' ' ' TYR . 35.5 m80 -129.03 151.79 49.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.953 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.466 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 19.2 m-20 -90.11 103.22 15.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.847 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 63' ' ' HIS . 72.5 m-85 -97.39 147.33 24.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.766 -176.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -87.9 125.26 34.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.807 -172.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 64.6 t -74.74 110.63 9.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.134 0.493 . . . . 0.0 110.094 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -101.82 106.14 17.08 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.111 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.2 t -91.91 136.36 24.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.491 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -75.1 122.05 86.58 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 171.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.42 142.35 88.97 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.705 2.27 . . . . 0.0 112.063 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.419 HD12 HD13 ' A' ' 49' ' ' LEU . 32.7 mm -82.18 120.1 76.44 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.571 -177.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 22.0 Cg_exo -66.08 146.04 80.9 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.23 1.953 . . . . 0.0 111.307 175.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 73' ' ' PRO . 84.5 m-20 76.8 -41.19 0.39 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.491 0.716 . . . . 0.0 112.079 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.7 mt -103.08 157.4 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 58.4 tttm -92.88 146.07 23.91 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 tt -95.18 144.51 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 122.094 -0.379 . . . . 0.0 109.979 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.401 ' CG2' ' HB2' ' A' ' 38' ' ' GLU . 45.4 t -114.62 -70.89 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.951 0.405 . . . . 0.0 111.349 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -116.51 148.76 40.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.226 -169.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.553 ' HA ' HG12 ' A' ' 35' ' ' VAL . 73.8 mt -132.08 107.04 12.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.025 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.4 t -137.66 126.66 14.86 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.092 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.422 ' HD2' HG12 ' A' ' 33' ' ' VAL . 97.3 Cg_endo -81.51 177.52 34.53 Favored 'Cis proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.065 -1.639 . . . . 0.0 112.637 -0.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -112.6 -47.32 3.08 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.627 -173.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.466 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 61.4 t -125.45 121.49 60.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 m -111.69 135.6 50.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.021 0.439 . . . . 0.0 111.575 -175.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.7 m -83.12 110.25 17.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.687 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.404 ' HB2' ' HD2' ' A' ' 65' ' ' TYR . 93.6 mt -110.66 129.11 55.9 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.406 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -93.46 107.24 19.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.91 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' A' ' 60' ' ' PRO . 80.7 mt -93.29 123.66 36.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.993 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.64 162.04 13.19 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.192 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.469 ' CE1' ' HG2' ' A' ' 60' ' ' PRO . 55.6 m-70 -82.55 117.93 22.9 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.907 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 5.5 t60 . . . . . 0 C--N 1.323 -0.55 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 175.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 121.466 0.651 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -79.05 169.87 18.63 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.66 2.24 . . . . 0.0 112.631 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 m -105.21 103.7 13.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.998 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.619 ' HB2' HG23 ' A' ' 35' ' ' VAL . 83.4 mt -83.24 134.7 34.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.067 0.46 . . . . 0.0 110.156 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.3 m -110.63 104.57 13.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.233 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 60.1 mt -104.68 157.91 16.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.242 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 m -91.01 143.78 26.35 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.588 HD11 HG13 ' A' ' 53' ' ' VAL . 49.9 tp -92.56 133.23 36.15 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.0 pt -132.26 162.61 39.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.012 0.434 . . . . 0.0 110.893 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.429 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -97.26 126.28 42.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.224 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -124.27 139.82 53.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 64.45 19.06 11.66 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.61 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.429 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 49.2 m -83.9 120.5 75.06 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.821 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.97 177.44 8.73 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.578 2.185 . . . . 0.0 112.72 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.23 -14.38 53.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.336 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -77.9 -16.18 58.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.314 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 p -110.38 113.39 26.0 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.363 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 56.1 ttp -102.98 123.9 47.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.569 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.524 HG12 ' CD2' ' A' ' 89' ' ' LEU . 26.3 mt -86.8 119.56 34.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.052 -173.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 89.4 mmm -92.57 -30.8 15.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.402 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -72.33 105.45 4.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.31 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.42 129.51 39.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.388 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 84.4 mt -72.19 127.77 89.91 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.832 -170.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 95.2 Cg_endo -96.5 -162.49 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.684 2.923 . . . . 0.0 112.4 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.6 p -104.24 158.64 16.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.086 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.3 m -111.55 152.78 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -112.95 97.42 6.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.943 0.401 . . . . 0.0 110.149 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.619 HG23 ' HB2' ' A' ' 11' ' ' LEU . 17.8 m -96.98 107.97 20.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.917 0.865 . . . . 0.0 110.205 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.549 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 1.2 mmmp? -75.02 130.98 40.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.745 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.453 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 26.3 p -135.21 128.43 31.95 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.974 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.557 ' HG3' ' CG2' ' A' ' 78' ' ' VAL . 40.2 mt-10 -86.45 94.23 9.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.462 ' HA3' HG23 ' A' ' 75' ' ' ILE . . . 160.06 157.1 8.45 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.899 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -98.65 118.51 35.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -126.99 82.42 68.09 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -89.63 -15.8 2.14 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.542 2.161 . . . . 0.0 112.281 171.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.3 t -98.1 15.55 23.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.013 0.435 . . . . 0.0 110.823 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.4 mt -124.58 137.92 55.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.235 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -94.79 114.58 26.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.312 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.458 HG11 HD22 ' A' ' 11' ' ' LEU . 35.1 m -76.23 -24.34 16.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -75.19 -24.58 57.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.142 0.496 . . . . 0.0 109.929 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -83.6 -34.0 25.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.843 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.69 126.12 28.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.533 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -115.98 147.78 40.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.268 0.556 . . . . 0.0 111.378 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -109.71 124.44 51.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -121.53 160.29 24.58 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.381 0.61 . . . . 0.0 111.865 -174.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.588 HG13 HD11 ' A' ' 15' ' ' LEU . 6.0 m -112.29 123.35 67.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.111 172.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -86.48 108.77 18.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.18 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.8 34.97 2.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.368 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.3 m -64.91 107.57 1.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.896 0.379 . . . . 0.0 110.337 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.92 48.31 5.51 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.908 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.3 p -101.29 113.8 27.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.815 0.34 . . . . 0.0 111.336 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -79.31 128.27 76.13 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 173.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -49.84 100.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.681 2.921 . . . . 0.0 113.265 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.45 ' H ' ' HB2' ' A' ' 89' ' ' LEU . . . -177.76 175.36 47.5 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -80.28 114.48 19.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.02 0.41 . . . . 0.0 109.979 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 65' ' ' TYR . 31.6 m170 -134.15 160.12 38.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.54 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.0 t70 -97.0 108.19 20.88 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 63' ' ' HIS . 78.1 m-85 -109.72 152.58 25.46 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 111.291 -171.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.84 139.4 37.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.098 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 97.4 t -92.14 120.53 41.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -117.36 108.88 16.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.422 -175.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 59.1 t -89.2 148.96 4.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.914 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -61.81 118.61 40.16 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 171.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.55 128.99 30.12 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.979 2.453 . . . . 0.0 112.53 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.28 114.71 63.98 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.906 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.8 151.09 18.86 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.066 2.511 . . . . 0.0 111.657 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 74.37 -39.73 0.43 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.653 0.781 . . . . 0.0 111.712 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.462 HG23 ' HA3' ' A' ' 39' ' ' GLY . 40.0 mm -92.39 136.02 25.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 38' ' ' GLU . 58.3 tttm -87.6 118.49 27.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.616 0.246 . . . . 0.0 110.448 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.3 tt -81.31 123.84 38.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.346 0.594 . . . . 0.0 110.907 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.557 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 31.6 t -86.19 -60.9 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.441 0.639 . . . . 0.0 109.916 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -121.01 153.31 37.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.585 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.644 HG23 ' HG2' ' A' ' 83' ' ' ARG . 14.8 tt -127.39 18.41 3.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 173.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.5 m -64.18 134.65 96.03 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.695 -175.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.59 133.14 30.02 Favored 'Cis proline' 0 C--N 1.343 0.267 0 C-N-CA 123.382 -1.507 . . . . 0.0 111.988 -0.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.644 ' HG2' HG23 ' A' ' 80' ' ' ILE . 58.8 mtm180 -72.05 -38.14 69.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.208 0.528 . . . . 0.0 110.517 -176.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -134.59 136.45 52.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.068 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.5 m -129.04 141.79 45.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.141 0.495 . . . . 0.0 111.144 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 15.8 m -89.72 109.41 20.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.138 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.406 HD11 HG21 ' A' ' 53' ' ' VAL . 97.6 mt -100.29 124.9 46.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.631 -176.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -85.67 99.03 11.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.01 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.524 ' CD2' HG12 ' A' ' 26' ' ' ILE . 89.8 mt -95.57 139.8 31.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.901 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.752 ' HG2' ' H ' ' A' ' 91' ' ' HIS . 22.4 tt0 -117.67 176.84 4.99 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.752 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 25.9 m-70 -82.46 151.65 26.45 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.909 -176.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.5 p80 . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 121.644 0.735 . . . . 0.0 109.958 178.33 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.1 t70 . . . . . 0 C--O 1.235 0.293 0 CA-C-O 120.847 0.356 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' A' ' 37' ' ' THR . 6.2 Cg_exo -80.22 130.37 8.17 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.925 2.417 . . . . 0.0 112.29 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 m -105.88 110.32 22.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.925 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 40.1 tp -93.63 135.52 34.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.745 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 16.3 m -117.02 109.6 17.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.896 0.379 . . . . 0.0 110.631 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.7 mt -111.64 144.16 41.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.192 -174.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -75.98 147.26 38.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.924 0.392 . . . . 0.0 110.771 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.75 HD11 HG13 ' A' ' 53' ' ' VAL . 41.4 tp -90.49 133.51 35.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.114 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.5 ' CG1' ' HB3' ' A' ' 52' ' ' TYR . 48.0 pt -112.63 153.55 14.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.979 0.419 . . . . 0.0 110.725 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.38 105.66 17.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.547 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 62.0 tttm -93.82 106.65 18.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.012 0.434 . . . . 0.0 111.204 -175.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 56.26 77.75 0.23 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.89 174.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.9 t -106.86 140.22 21.16 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 172.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 55' ' ' LEU . 36.2 Cg_exo -62.75 169.16 9.06 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.017 2.478 . . . . 0.0 112.91 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.1 6.87 27.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.534 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -107.5 -6.16 17.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.314 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.415 ' OG ' ' HD2' ' A' ' 21' ' ' PRO . 5.0 p -118.42 128.9 55.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.814 -176.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.0 ttp -115.66 131.86 56.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.652 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.5 mt -90.34 103.73 14.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.799 0.333 . . . . 0.0 110.665 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 81.3 mtp -75.58 -38.82 58.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.303 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.5 m -71.52 120.02 16.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.241 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.57 120.09 16.66 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.6 mt -54.71 117.76 14.78 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.513 -174.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.67 -163.2 0.2 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.976 2.45 . . . . 0.0 112.227 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 m -123.31 134.9 54.01 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 120.914 0.388 . . . . 0.0 110.363 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.829 HG11 HG11 ' A' ' 67' ' ' VAL . 33.2 m -85.94 133.04 30.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.979 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 34' ' ' ARG . 25.7 ttt180 -110.01 97.34 6.86 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 80' ' ' ILE . 33.5 m -102.89 157.58 4.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.58 -171.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.476 ' HE3' ' HB3' ' A' ' 36' ' ' LYS . 10.3 mmmt -98.37 128.25 44.68 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.487 ' O ' ' HD2' ' A' ' 9' ' ' PRO . 10.0 p -116.07 145.91 42.63 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.962 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.478 ' HB2' ' CG2' ' A' ' 78' ' ' VAL . 41.7 tt0 -110.39 107.0 16.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.598 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.36 -153.79 25.26 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.739 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.586 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 96.6 m-85 -121.8 135.82 54.92 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -105.57 96.33 11.88 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 6.1 Cg_exo -79.62 -71.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.801 2.334 . . . . 0.0 111.505 177.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.5 t -162.45 95.47 0.92 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.415 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.578 ' HB ' HG13 ' A' ' 46' ' ' VAL . 32.7 mt -132.67 160.78 42.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.405 ' N ' HG22 ' A' ' 44' ' ' ILE . 11.7 m120 -76.9 46.16 0.46 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.329 0.585 . . . . 0.0 110.633 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.578 HG13 ' HB ' ' A' ' 44' ' ' ILE . 20.2 m -67.24 -32.29 56.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.273 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -81.94 -9.5 59.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.151 0.5 . . . . 0.0 110.252 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -95.13 -12.5 26.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.005 176.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.4 ' CD1' HG12 ' A' ' 72' ' ' ILE . 91.6 mt -78.6 136.36 37.49 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 166.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -130.24 171.24 13.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.221 0.534 . . . . 0.0 111.703 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.37 139.53 42.96 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.38 175.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.501 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 2.0 p90 -127.55 145.13 50.96 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.217 0.532 . . . . 0.0 111.99 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.75 HG13 HD11 ' A' ' 15' ' ' LEU . 17.0 m -119.56 129.05 75.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.049 174.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -76.45 119.42 20.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.975 0.416 . . . . 0.0 110.148 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.443 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 76.7 mt -112.16 26.88 10.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.301 -176.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.7 m -70.25 -33.74 71.99 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -169.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.89 86.61 0.14 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.231 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.4 m -143.43 155.95 44.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.554 0.216 . . . . 0.0 110.521 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.487 ' HB2' ' NE2' ' A' ' 63' ' ' HIS . 1.6 mp0 -64.97 145.42 99.07 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.392 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 59' ' ' GLU . 10.2 Cg_exo -71.27 91.19 0.66 Allowed 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.806 2.337 . . . . 0.0 112.045 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.28 -166.8 39.66 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 88' ' ' GLN . 42.5 mt-10 -77.34 113.38 15.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.238 0.519 . . . . 0.0 110.336 177.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.487 ' NE2' ' HB2' ' A' ' 59' ' ' GLU . 94.3 m-70 -139.67 173.67 11.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.819 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -94.02 133.34 37.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.11 -173.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.422 ' CE2' ' HB2' ' A' ' 87' ' ' LEU . 74.0 m-85 -131.34 135.63 47.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.103 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -78.83 125.94 30.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.235 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.829 HG11 HG11 ' A' ' 33' ' ' VAL . 93.2 t -85.25 108.77 17.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.237 0.541 . . . . 0.0 110.566 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -99.75 115.86 30.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.782 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.8 t -101.49 148.71 7.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.89 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.28 144.23 97.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.056 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -83.41 149.64 13.16 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.908 2.405 . . . . 0.0 112.704 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 75' ' ' ILE . 23.4 mt -117.94 119.0 34.15 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.63 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -85.13 21.07 1.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.69 2.26 . . . . 0.0 112.911 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -131.17 -56.25 1.03 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.157 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.545 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 53.1 mt -105.61 137.84 33.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.182 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -89.71 133.25 34.77 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.707 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.5 tt -83.88 123.38 38.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.547 0.689 . . . . 0.0 109.635 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.478 ' CG2' ' HB2' ' A' ' 38' ' ' GLU . 47.0 t -94.29 -60.84 2.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.943 -174.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 36' ' ' LYS . 27.3 tt0 -118.76 134.48 55.11 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.216 -172.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.715 ' HB ' ' HG3' ' A' ' 83' ' ' ARG . 59.0 mt -109.26 109.59 28.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 54.8 m -133.34 124.52 18.26 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.626 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.541 ' HD2' HG12 ' A' ' 33' ' ' VAL . 4.5 Cg_exo -81.48 142.72 55.77 Favored 'Cis proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.29 -1.546 . . . . 0.0 111.641 -5.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.715 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 5.5 mtm180 -78.71 -37.8 40.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.221 0.534 . . . . 0.0 110.3 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.6 t -124.06 117.5 51.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.49 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.6 m -107.36 152.52 8.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.773 0.321 . . . . 0.0 111.034 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 14.5 m -109.05 99.31 8.64 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.966 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 89.8 mt -102.79 142.62 33.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.317 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.609 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 53.6 tt0 -98.03 106.45 18.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.0 0.429 . . . . 0.0 110.802 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.2 mt -88.79 151.19 22.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.014 174.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -131.7 167.57 19.26 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.511 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -73.36 113.34 10.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.957 0.408 . . . . 0.0 110.761 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 21.6 t60 . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.121 -179.213 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 . . . . . 0 CA--C 1.532 0.277 0 CA-C-O 121.417 0.627 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -90.54 174.96 2.8 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.979 2.452 . . . . 0.0 112.873 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.0 m -107.38 122.22 46.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.76 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.683 HD22 HG11 ' A' ' 46' ' ' VAL . 67.4 mt -104.15 127.4 51.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.138 0.494 . . . . 0.0 110.907 -176.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.0 m -101.34 107.18 18.46 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.132 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.3 mt -108.02 149.17 28.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.36 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.6 p -82.78 141.24 32.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.646 0.26 . . . . 0.0 110.515 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.813 HD11 HG13 ' A' ' 53' ' ' VAL . 43.0 tp -90.09 133.04 35.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.516 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.3 pt -116.67 155.68 18.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.968 0.413 . . . . 0.0 111.006 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -85.12 110.47 19.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.24 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -106.21 137.16 44.64 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.534 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 63.0 16.4 9.23 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.548 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.47 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 18.7 m -74.36 117.24 60.29 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.28 -176.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 5.7 Cg_exo -74.51 173.1 14.87 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.064 2.51 . . . . 0.0 112.449 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.69 -5.96 59.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.603 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -78.07 -9.2 59.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.562 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.524 ' HB2' HD22 ' A' ' 89' ' ' LEU . 11.9 p -129.78 128.73 42.98 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.992 -176.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.609 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 58.5 ttp -114.54 139.03 49.91 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.404 HG12 ' CD2' ' A' ' 89' ' ' LEU . 8.5 mt -110.19 99.13 8.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.523 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 78.2 mtp -82.14 -15.35 53.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.982 0.42 . . . . 0.0 110.362 176.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.4 m -81.05 106.28 12.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -63.44 123.0 17.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.011 -175.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.4 mt -62.02 119.26 47.03 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.504 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.75 -164.05 0.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.802 2.335 . . . . 0.0 112.655 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.1 p -106.43 142.03 36.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.757 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.0 p -99.0 139.4 20.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -110.74 101.67 10.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.303 0.573 . . . . 0.0 110.381 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 80' ' ' ILE . 33.4 m -105.09 130.83 55.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.388 -177.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.563 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 58.2 tttm -94.0 132.64 38.27 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.512 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 26.2 p -126.81 152.19 47.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.465 -174.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 76' ' ' LYS . 50.4 mt-10 -108.94 96.0 6.02 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.57 156.47 7.72 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -108.64 129.36 55.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.439 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 41.2 m-80 -70.89 114.06 23.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.96 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 41' ' ' ASN . 3.5 Cg_exo -80.14 -71.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.804 2.336 . . . . 0.0 111.833 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 p -113.04 10.16 18.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.482 0.658 . . . . 0.0 110.048 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.0 mt -92.94 133.37 34.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.111 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.549 ' HB2' ' HG3' ' A' ' 48' ' ' GLU . 53.6 m-80 -113.18 126.51 55.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.073 0.463 . . . . 0.0 110.061 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.683 HG11 HD22 ' A' ' 11' ' ' LEU . 34.4 m -77.41 -8.41 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.51 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -89.39 -4.14 58.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.27 0.557 . . . . 0.0 110.127 173.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.549 ' HG3' ' HB2' ' A' ' 45' ' ' ASN . 42.3 mt-10 -99.57 -34.56 10.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.571 174.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.7 mt -81.24 138.57 35.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.921 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -127.23 168.43 14.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.505 0.669 . . . . 0.0 111.299 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.6 147.59 29.31 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 171.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -140.46 146.88 38.82 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.19 0.519 . . . . 0.0 111.29 -174.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.813 HG13 HD11 ' A' ' 15' ' ' LEU . 4.3 m -112.25 130.64 65.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.405 175.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -79.47 91.56 5.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.043 -176.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.468 HD12 ' OG1' ' A' ' 20' ' ' THR . 52.0 mt -93.84 59.14 2.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.835 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 p -77.58 -4.72 47.25 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.332 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.66 -178.31 39.56 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.799 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.1 m -144.95 21.19 1.61 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.198 0.523 . . . . 0.0 109.786 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.11 115.84 52.28 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.342 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.13 158.51 56.24 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.955 2.436 . . . . 0.0 112.496 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.43 -163.29 22.82 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.516 ' HB3' HG22 ' A' ' 86' ' ' THR . 40.7 mt-10 -86.45 108.82 18.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.153 0.501 . . . . 0.0 110.293 177.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -117.68 143.03 46.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.652 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 10.0 m-20 -81.51 138.08 35.51 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -138.95 150.89 46.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.993 0.425 . . . . 0.0 111.18 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -90.33 123.03 33.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.69 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.9 t -81.24 134.74 26.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.556 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -125.45 153.44 43.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.095 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.7 t -127.28 146.44 33.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 43.6 mt-10 -63.04 125.49 86.92 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 32.2 Cg_exo -59.13 124.16 15.02 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.086 2.524 . . . . 0.0 112.857 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.403 HD12 ' H ' ' A' ' 72' ' ' ILE . 4.0 mp -95.18 125.94 48.34 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.725 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.95 146.57 42.1 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.254 1.969 . . . . 0.0 111.98 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 72.78 -45.85 0.63 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.722 0.809 . . . . 0.0 112.197 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.512 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 51.2 mt -84.05 133.09 29.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.014 0.435 . . . . 0.0 110.514 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 94.7 mttt -87.07 142.04 28.22 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.206 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 tt -99.58 119.28 47.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.22 0.533 . . . . 0.0 110.316 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.5 t -94.17 -48.02 13.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.807 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.563 ' HB2' ' H ' ' A' ' 36' ' ' LYS . 20.3 mm-40 -118.7 148.66 42.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.173 -176.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.842 HG23 ' HG2' ' A' ' 83' ' ' ARG . 16.1 tt -138.96 27.54 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 122.361 1.077 . . . . 0.0 108.419 174.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.6 m -83.1 141.04 42.9 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.131 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.51 131.43 23.23 Favored 'Cis proline' 0 C--N 1.346 0.418 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.215 0.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.842 ' HG2' HG23 ' A' ' 80' ' ' ILE . 73.7 mtm180 -78.24 -49.55 13.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.306 -175.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.8 119.5 60.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.788 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.29 145.59 27.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.732 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 62' ' ' GLU . 8.6 m -99.86 101.74 12.96 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.3 mt -94.08 145.74 24.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 -175.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -97.56 125.85 42.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.124 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.524 HD22 ' HB2' ' A' ' 24' ' ' SER . 90.0 mt -116.47 131.96 56.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.853 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -100.38 151.52 21.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.529 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -66.75 104.69 1.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.214 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.609 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 74.7 t60 . . . . . 0 C--N 1.321 -0.644 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 120.483 0.182 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.593 ' HG2' ' OG1' ' A' ' 37' ' ' THR . 29.6 Cg_endo -65.45 115.66 3.48 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.955 1.77 . . . . 0.0 112.816 -172.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.7 m -87.56 99.34 11.97 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 171.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.42 125.27 31.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.555 -175.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.2 m -95.26 89.85 5.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.88 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.429 HD23 HG13 ' A' ' 46' ' ' VAL . 60.2 mt -91.0 131.62 36.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.437 -174.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.4 m -74.41 139.8 44.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.839 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.897 HD11 HG13 ' A' ' 53' ' ' VAL . 30.0 tp -84.71 127.34 34.05 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.411 HD11 ' CE2' ' A' ' 52' ' ' TYR . 29.0 pt -120.68 142.51 36.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.445 0.641 . . . . 0.0 112.23 -176.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.555 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -72.76 111.93 8.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.288 175.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -79.21 -78.24 0.16 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.094 0.473 . . . . 0.0 110.645 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -110.61 75.83 0.95 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.405 0.621 . . . . 0.0 109.571 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.555 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 94.6 m -99.62 113.04 64.74 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.225 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.11 155.2 52.15 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.13 2.553 . . . . 0.0 112.767 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.3 -1.82 11.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.947 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -104.6 -2.03 25.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.879 0.371 . . . . 0.0 110.567 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.4 m -107.3 115.49 30.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.458 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 55.7 ttp -107.55 117.39 33.97 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.014 0.435 . . . . 0.0 110.657 -177.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.5 mt -92.08 102.59 13.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.892 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 80.5 mtp -86.23 -33.33 20.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.747 0.308 . . . . 0.0 110.807 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.4 m -81.08 117.78 21.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.047 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -59.84 124.55 20.52 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 84.1 mt -59.66 121.16 55.42 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.289 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 12.4 Cg_exo -69.33 -179.36 2.67 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.865 2.377 . . . . 0.0 112.502 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 p -109.07 146.22 34.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.124 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.668 HG11 HG11 ' A' ' 67' ' ' VAL . 20.3 m -97.08 140.07 18.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.067 0.461 . . . . 0.0 109.993 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -109.56 98.28 7.68 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.661 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.623 HG12 ' HA ' ' A' ' 80' ' ' ILE . 32.8 m -103.09 142.32 17.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.074 -176.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -92.53 129.84 38.35 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.593 ' OG1' ' HG2' ' A' ' 9' ' ' PRO . 27.3 p -121.46 161.46 22.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.592 0.234 . . . . 0.0 110.585 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.465 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 22.6 tt0 -123.79 143.1 50.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.056 -175.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.09 -118.93 1.91 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.336 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -144.48 131.74 20.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.439 ' HB3' ' HG3' ' A' ' 9' ' ' PRO . 2.5 p-10 -120.88 91.64 47.74 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 121.354 0.597 . . . . 0.0 112.154 -174.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -89.48 -51.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.731 2.287 . . . . 0.0 112.671 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -159.28 96.63 1.32 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.256 0.551 . . . . 0.0 110.243 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mp -117.21 126.38 74.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.597 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.531 ' ND2' ' HB2' ' A' ' 48' ' ' GLU . 58.0 t30 -80.01 94.47 5.93 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.762 0.791 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.429 HG13 HD23 ' A' ' 13' ' ' LEU . 19.1 t -68.59 -17.79 22.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.536 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -82.8 5.49 21.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.719 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.531 ' HB2' ' ND2' ' A' ' 45' ' ' ASN . 40.7 tt0 -119.17 -33.35 4.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.199 176.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.7 mt -79.51 127.84 32.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -136.81 166.87 22.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.628 0.727 . . . . 0.0 112.14 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.457 ' HB1' HG13 ' A' ' 67' ' ' VAL . . . -109.35 128.76 55.36 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.046 172.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.657 ' HE1' ' HB2' ' A' ' 70' ' ' GLU . 48.5 m-85 -103.42 138.51 40.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.934 0.397 . . . . 0.0 111.391 -173.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.897 HG13 HD11 ' A' ' 15' ' ' LEU . 3.0 m -125.86 129.76 72.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.815 169.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -88.49 91.61 8.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.303 0.573 . . . . 0.0 109.566 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.508 HD21 HD12 ' A' ' 87' ' ' LEU . 52.4 mt -87.79 38.82 0.86 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.691 -174.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.9 p -68.77 -24.55 64.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.974 0.416 . . . . 0.0 109.982 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.2 111.93 3.8 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 m -96.97 26.22 4.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.996 0.427 . . . . 0.0 110.727 -173.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -87.27 115.38 62.54 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.671 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.06 140.88 55.75 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.446 2.098 . . . . 0.0 111.248 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.64 -150.66 19.05 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -116.5 105.79 12.87 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.997 0.427 . . . . 0.0 109.969 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -122.25 148.91 44.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.093 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 44.9 m-20 -81.76 132.83 35.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.908 0.385 . . . . 0.0 110.703 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -127.91 137.15 52.19 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.521 ' HG2' HG22 ' A' ' 84' ' ' VAL . 40.3 mt-10 -88.71 134.85 33.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.036 0.446 . . . . 0.0 110.885 -173.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.668 HG11 HG11 ' A' ' 33' ' ' VAL . 65.2 t -71.81 102.2 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.732 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -92.67 101.69 14.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.554 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.2 t -87.27 143.64 10.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.146 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.657 ' HB2' ' HE1' ' A' ' 52' ' ' TYR . 32.2 tt0 -77.95 114.76 44.73 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -56.41 130.84 42.25 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.051 2.5 . . . . 0.0 112.738 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.7 mt -94.32 125.09 53.54 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.51 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.57 141.87 42.99 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.578 2.186 . . . . 0.0 111.504 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.3 t30 74.16 -44.03 0.55 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.368 0.667 . . . . 0.0 111.801 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.8 mm -83.86 119.22 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.125 0.488 . . . . 0.0 110.37 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.465 ' HD3' ' HB3' ' A' ' 38' ' ' GLU . 80.0 tttt -80.73 124.82 29.36 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.598 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.556 ' HA ' HG22 ' A' ' 37' ' ' THR . 17.0 tt -88.96 131.61 35.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.148 0.499 . . . . 0.0 110.233 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.7 t -100.78 -58.87 3.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.319 -175.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -138.14 147.24 43.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.881 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.623 ' HA ' HG12 ' A' ' 35' ' ' VAL . 58.9 mt -115.57 121.78 67.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.203 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 70.1 m -138.16 115.85 9.39 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.921 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.534 ' HD2' HG12 ' A' ' 33' ' ' VAL . 2.1 Cg_endo -86.31 170.94 40.95 Favored 'Cis proline' 0 N--CA 1.462 -0.347 0 C-N-CA 124.063 -1.224 . . . . 0.0 112.308 -1.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -98.83 -32.43 11.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.346 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.521 HG22 ' HG2' ' A' ' 66' ' ' GLU . 45.4 t -129.79 132.13 66.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.384 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 m -123.85 128.77 74.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.164 0.507 . . . . 0.0 111.139 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 7.4 m -82.54 103.89 12.41 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.508 HD12 HD21 ' A' ' 55' ' ' LEU . 90.1 mt -94.83 146.27 24.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.16 0.505 . . . . 0.0 111.237 -173.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.2 tm0? -98.23 119.43 36.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.282 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.8 mt -123.63 146.33 48.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.813 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -139.45 173.17 11.81 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 169.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 16.6 m80 -69.73 127.88 34.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.828 0.347 . . . . 0.0 110.632 178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 11.9 t-80 . . . . . 0 C--N 1.323 -0.582 0 CA-C-O 122.426 1.108 . . . . 0.0 108.131 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.426 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 28.2 m-20 . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.417 0.151 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.82 101.82 0.19 Allowed 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.464 2.109 . . . . 0.0 112.153 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 m -98.2 109.0 21.83 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.283 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.1 mt -104.8 145.91 29.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.177 0.513 . . . . 0.0 111.042 -173.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 20.6 m -122.83 102.49 8.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.527 174.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.7 mt -96.17 140.05 31.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.334 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -73.21 135.95 44.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.325 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.726 HD11 HG13 ' A' ' 53' ' ' VAL . 42.4 tp -85.88 119.59 26.36 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.5 pt -112.58 155.65 13.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.166 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.422 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -87.86 114.73 24.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.048 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -117.37 143.28 46.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.8 t30 61.01 26.26 16.23 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.879 0.847 . . . . 0.0 109.698 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.514 HG23 HD12 ' A' ' 55' ' ' LEU . 85.1 m -85.86 117.41 68.67 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.736 -177.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 11.7 Cg_exo -69.38 162.69 40.88 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.016 2.477 . . . . 0.0 112.575 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.39 -8.64 58.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.415 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -92.31 3.74 54.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.887 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 p -127.88 139.71 52.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.759 0.314 . . . . 0.0 111.212 -175.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.457 ' HB2' ' NE2' ' A' ' 92' ' ' HIS . 14.1 ttm -127.13 129.95 48.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.741 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.488 HG12 ' CD2' ' A' ' 89' ' ' LEU . 12.9 mt -88.17 97.47 6.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 86.9 mtp -62.85 -33.24 74.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.237 0.541 . . . . 0.0 110.05 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 m -74.49 104.71 5.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.624 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -64.33 121.0 13.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.092 0.472 . . . . 0.0 110.664 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.21 122.69 65.37 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.224 -171.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -87.05 -155.8 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.523 2.815 . . . . 0.0 112.093 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.5 m -120.19 150.51 40.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.85 0.357 . . . . 0.0 110.657 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' THR . 12.7 p -103.45 138.71 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.835 -177.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 34' ' ' ARG . 19.6 mtp180 -98.38 119.91 37.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.073 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 80' ' ' ILE . 25.1 m -128.59 123.77 60.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.651 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 8' ' ' ASP . 87.8 tttt -95.84 138.83 32.93 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.542 HG22 ' HA ' ' A' ' 77' ' ' ILE . 35.5 p -126.73 155.2 43.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.993 0.425 . . . . 0.0 111.869 -175.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.531 ' HG3' ' CG2' ' A' ' 78' ' ' VAL . 42.8 mt-10 -105.81 120.59 42.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.797 174.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.2 -171.53 26.28 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -135.03 101.07 4.76 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.76 112.36 6.0 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.228 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.11 -62.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.767 2.311 . . . . 0.0 111.143 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.5 t -145.7 79.09 1.56 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.131 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -121.85 130.73 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.795 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.428 ' ND2' ' HG3' ' A' ' 48' ' ' GLU . 59.0 t30 -94.59 103.93 15.87 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.729 0.776 . . . . 0.0 110.895 -175.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.4 t -62.91 -23.88 34.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.294 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -66.18 -20.78 66.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.951 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.428 ' HG3' ' ND2' ' A' ' 45' ' ' ASN . 48.3 mt-10 -105.28 -11.17 16.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.939 0.399 . . . . 0.0 110.831 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.9 128.68 33.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 170.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -136.67 173.3 11.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.31 0.576 . . . . 0.0 111.697 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -131.45 140.89 49.69 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -129.07 156.75 43.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.472 0.653 . . . . 0.0 112.102 -173.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.726 HG13 HD11 ' A' ' 15' ' ' LEU . 4.6 m -112.17 118.18 57.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.363 172.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.78 106.3 16.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.246 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.514 HD12 HG23 ' A' ' 20' ' ' THR . 63.4 mt -95.05 45.29 1.1 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.537 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 p -57.37 -44.64 84.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.806 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.88 67.19 0.49 Allowed Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.106 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 p -68.9 101.14 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.054 0.454 . . . . 0.0 111.126 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.5 129.99 23.54 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.527 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.449 ' HB3' ' HB2' ' A' ' 91' ' ' HIS . 33.7 Cg_endo -65.45 138.97 57.17 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.552 2.168 . . . . 0.0 112.22 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.46 178.16 19.81 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.02 99.13 4.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.862 0.363 . . . . 0.0 110.534 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -119.93 141.23 49.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.454 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -84.97 133.29 34.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.029 0.443 . . . . 0.0 109.994 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -126.11 157.75 37.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.809 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -84.73 128.05 34.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.619 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.1 t -78.25 99.37 2.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.114 0.483 . . . . 0.0 109.731 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -87.77 118.51 27.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.906 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.1 t -95.32 143.78 11.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.729 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.427 ' OE1' ' HD2' ' A' ' 71' ' ' PRO . 8.5 tp10 -70.32 113.89 21.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 174.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.427 ' HD2' ' OE1' ' A' ' 70' ' ' GLU . 11.7 Cg_endo -55.33 124.03 15.27 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.995 2.463 . . . . 0.0 112.646 -176.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -94.45 119.98 65.7 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.889 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.61 135.38 48.82 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.494 2.13 . . . . 0.0 112.537 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 t30 73.52 -33.96 0.27 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.771 0.828 . . . . 0.0 112.96 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.424 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 49.9 mm -84.16 136.4 22.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.048 0.451 . . . . 0.0 111.031 -177.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -97.6 121.12 39.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.446 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.542 ' HA ' HG22 ' A' ' 37' ' ' THR . 16.0 tt -90.75 125.38 43.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.408 0.623 . . . . 0.0 111.012 -176.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.531 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 38.3 t -100.62 -56.52 5.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.384 -175.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.417 ' HB2' ' H ' ' A' ' 36' ' ' LYS . 71.7 mm-40 -109.65 139.35 44.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.092 -173.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.459 ' HA ' HG12 ' A' ' 35' ' ' VAL . 50.7 mt -129.13 97.57 3.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 5.7 m -127.21 112.74 21.53 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.211 -176.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 2.0 Cg_endo -85.14 171.6 43.39 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.763 -1.349 . . . . 0.0 112.37 0.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -110.85 -34.26 6.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.98 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.39 117.17 49.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.588 176.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.5 m -108.29 146.46 14.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.931 0.396 . . . . 0.0 110.871 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.5 m -97.97 109.01 21.84 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 84.9 mt -102.97 122.64 45.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.385 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -85.58 95.55 9.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.488 ' CD2' HG12 ' A' ' 26' ' ' ILE . 76.5 mt -90.43 128.68 36.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.517 -175.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -102.88 120.83 41.3 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.422 173.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 60' ' ' PRO . 27.5 t60 -72.42 110.41 6.81 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 173.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.457 ' NE2' ' HB2' ' A' ' 25' ' ' MET . 13.5 m-70 . . . . . 0 CA--C 1.514 -0.404 0 O-C-N 123.886 0.741 . . . . 0.0 110.867 -176.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.834 0.826 . . . . 0.0 109.116 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.76 162.66 32.37 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.547 2.831 . . . . 0.0 113.498 -170.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 14.6 m -118.62 123.57 45.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.972 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.513 ' HB2' HG23 ' A' ' 35' ' ' VAL . 98.1 mt -101.34 148.8 24.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.019 0.438 . . . . 0.0 110.631 -177.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.2 m -125.5 100.17 6.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.889 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.4 mt -101.16 156.43 17.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.357 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 t -88.53 137.35 32.4 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.87 HD11 HG13 ' A' ' 53' ' ' VAL . 42.6 tp -83.39 126.48 32.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.0 pt -108.32 143.0 19.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.113 0.482 . . . . 0.0 111.182 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.42 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -77.07 105.21 8.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.838 176.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -99.06 127.73 45.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.13 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 61.87 23.75 14.02 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.404 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.536 ' OG1' HD12 ' A' ' 55' ' ' LEU . 25.7 m -74.51 124.04 89.51 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.452 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -81.2 171.45 13.88 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.711 2.274 . . . . 0.0 112.562 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.72 6.37 38.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.061 -177.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -92.85 -18.03 23.35 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.42 0.628 . . . . 0.0 110.107 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.2 p -119.2 121.37 39.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.716 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 52.8 ttp -102.79 131.0 49.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.337 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.405 HG12 ' CD2' ' A' ' 89' ' ' LEU . 9.5 mt -90.21 107.71 18.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 49.1 ttp -75.41 -33.27 60.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.055 0.455 . . . . 0.0 110.739 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.9 m -84.71 132.68 34.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.513 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -66.85 143.14 57.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 3.7 mm? -67.1 115.64 27.72 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.534 -178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 3.0 Cg_exo -74.15 167.38 27.33 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.899 2.399 . . . . 0.0 112.666 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.4 m -94.7 129.12 41.74 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.784 175.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.0 m -86.28 143.54 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.121 0.486 . . . . 0.0 111.12 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.0 ttp85 -104.28 108.39 19.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.537 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 80' ' ' ILE . 13.4 m -119.56 112.97 39.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.185 0.517 . . . . 0.0 110.227 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 78.0 tttt -87.73 142.02 28.15 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.51 ' HB ' HG22 ' A' ' 75' ' ' ILE . 47.9 p -130.62 179.61 5.85 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.817 -172.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 76' ' ' LYS . 55.7 mt-10 -132.74 130.3 39.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 175.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.54 -144.05 14.96 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -136.13 158.6 44.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.781 0.324 . . . . 0.0 110.704 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -112.31 93.0 20.57 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.653 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.578 ' HD2' HG12 ' A' ' 44' ' ' ILE . 57.8 Cg_endo -79.76 -76.7 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.181 1.921 . . . . 0.0 112.846 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.1 p -107.76 24.22 13.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.402 0.62 . . . . 0.0 110.154 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.755 HG13 HD11 ' A' ' 75' ' ' ILE . 46.4 mm -79.79 112.08 17.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.396 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -91.64 108.62 20.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.28 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.58 -21.85 29.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.583 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -78.2 -13.24 59.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.642 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -105.9 -24.73 12.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.81 -175.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.405 HD11 HG23 ' A' ' 44' ' ' ILE . 38.2 mt -92.58 139.45 30.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.072 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -136.04 176.68 8.46 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.76 0.79 . . . . 0.0 112.145 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -122.6 133.97 54.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.375 172.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -121.75 141.41 51.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.13 0.491 . . . . 0.0 111.903 -173.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.87 HG13 HD11 ' A' ' 15' ' ' LEU . 6.8 m -114.38 119.7 62.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.19 174.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -74.55 100.69 3.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.479 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.536 HD12 ' OG1' ' A' ' 20' ' ' THR . 38.2 mt -89.96 36.18 0.86 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.935 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 p -61.49 -38.93 89.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.542 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.63 69.15 2.64 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 172.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 m -73.28 84.13 1.4 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.076 0.465 . . . . 0.0 111.847 -173.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -108.52 117.71 53.75 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.497 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.74 100.85 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.895 2.396 . . . . 0.0 112.166 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.418 ' H ' ' HB2' ' A' ' 89' ' ' LEU . . . 159.02 177.33 32.0 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.883 ' HG2' ' HG2' ' A' ' 88' ' ' GLN . 41.2 mt-10 -74.66 99.64 3.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.104 0.452 . . . . 0.0 110.35 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -125.01 144.35 50.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.562 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.519 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 9.4 m-20 -89.23 115.06 26.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.713 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -111.49 164.81 12.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.883 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -89.92 131.51 35.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.296 -176.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.0 t -90.0 123.14 42.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.101 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -111.72 110.66 21.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.068 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.436 HG21 HG11 ' A' ' 35' ' ' VAL . 42.1 t -90.44 142.3 13.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.013 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 46.5 mt-10 -68.75 117.24 49.02 Favored Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.627 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 11.4 Cg_exo -70.93 136.0 28.93 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.874 2.382 . . . . 0.0 111.862 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.413 HG22 ' H ' ' A' ' 74' ' ' ASN . 4.3 mp -100.44 117.55 62.73 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.12 25.29 0.46 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.576 2.184 . . . . 0.0 112.396 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.413 ' H ' HG22 ' A' ' 72' ' ' ILE . 88.1 m-20 -133.95 -8.91 2.71 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.503 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.755 HD11 HG13 ' A' ' 44' ' ' ILE . 26.5 mt -141.01 143.56 28.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.171 -172.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.642 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 43.5 mtpt -81.16 167.38 19.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.8 tt -129.6 135.84 60.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.079 0.466 . . . . 0.0 110.701 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.3 t -115.63 -53.97 4.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.412 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.06 142.55 50.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.216 -174.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.6 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 57.6 mt -123.67 94.22 2.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 169.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 36.6 m -115.49 112.04 43.71 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.53 -174.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 7.1 Cg_endo -93.24 165.03 22.8 Favored 'Cis proline' 0 CA--C 1.531 0.335 0 C-N-CA 124.831 -0.904 . . . . 0.0 112.393 -5.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.6 ' HG3' ' O ' ' A' ' 80' ' ' ILE . 39.6 mtm180 -92.25 -36.85 13.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.378 0.609 . . . . 0.0 109.833 176.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.519 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 62.1 t -117.52 121.44 67.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.626 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.49 HG12 ' HG2' ' A' ' 82' ' ' PRO . 13.9 m -116.1 133.2 63.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.181 0.515 . . . . 0.0 111.817 -177.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.7 m -83.54 95.9 8.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.682 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 90.4 mt -90.41 124.08 34.66 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.884 0.373 . . . . 0.0 110.385 -178.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.883 ' HG2' ' HG2' ' A' ' 62' ' ' GLU . 94.5 mt-30 -85.6 92.99 8.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.55 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.418 ' HB2' ' H ' ' A' ' 61' ' ' GLY . 85.5 mt -92.37 157.63 16.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.497 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.69 163.63 32.3 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 178.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -67.4 132.17 47.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.348 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 79.1 t60 . . . . . 0 C--N 1.323 -0.548 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 172.593 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--O 1.234 0.265 0 CA-C-O 120.419 0.152 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -75.84 118.31 5.01 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.795 2.33 . . . . 0.0 111.689 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.7 m -87.94 92.31 9.08 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.709 HD11 ' HB ' ' A' ' 46' ' ' VAL . 41.1 tp -84.06 123.06 29.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.312 -171.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.1 m -103.32 118.1 35.99 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.935 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.2 mt -120.18 141.54 49.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.237 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.0 t -74.89 135.25 41.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.26 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.618 HD11 HG13 ' A' ' 53' ' ' VAL . 50.0 tp -79.75 131.82 36.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.5 pt -128.08 148.35 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.261 0.553 . . . . 0.0 111.264 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.528 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -85.83 108.69 18.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.443 175.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 22.9 tptm -97.41 -66.81 0.88 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.189 0.518 . . . . 0.0 110.712 -174.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.848 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 6.3 m-20 -84.0 57.42 4.16 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.887 -177.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.528 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 34.5 m -114.66 124.22 30.89 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.699 -174.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 16.5 Cg_exo -68.21 146.76 70.88 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.963 2.442 . . . . 0.0 111.516 174.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.63 -13.87 60.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.775 0.321 . . . . 0.0 111.821 -175.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -89.35 2.47 54.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.101 0.477 . . . . 0.0 110.662 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 p -125.97 122.9 37.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.158 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 42.4 ttp -113.87 126.86 55.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.653 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.8 mt -77.65 132.12 33.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.389 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.441 ' SD ' ' HB2' ' A' ' 90' ' ' GLU . 74.6 mtm -93.68 -26.11 17.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.149 0.5 . . . . 0.0 110.496 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.8 p -83.78 118.44 23.92 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.78 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.29 142.97 56.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.907 0.385 . . . . 0.0 110.244 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 85.4 mt -86.32 119.1 71.34 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.151 -171.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 3.0 Cg_exo -74.35 175.72 10.6 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.846 2.364 . . . . 0.0 112.484 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.2 m -98.23 128.4 44.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.76 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -85.83 129.53 37.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -112.41 108.84 18.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.074 0.464 . . . . 0.0 109.861 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 80' ' ' ILE . 34.7 m -109.79 143.84 19.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.091 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -99.46 121.45 41.16 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.9 p -106.0 159.15 16.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.779 0.323 . . . . 0.0 111.589 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.693 ' HB3' ' HB2' ' A' ' 76' ' ' LYS . 32.6 tt0 -112.69 109.6 19.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.493 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.42 -144.25 14.98 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.898 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.417 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 40.9 t80 -155.13 116.05 3.93 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.41 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -92.89 105.54 15.35 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.929 179.112 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 5.3 Cg_exo -77.85 -66.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.15 2.567 . . . . 0.0 112.986 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 t -125.63 39.36 3.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.322 0.582 . . . . 0.0 110.457 -175.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.8 mt -91.83 130.3 41.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.704 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.557 ' HB3' ' HG2' ' A' ' 48' ' ' GLU . 17.5 m120 -75.26 89.41 2.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.315 0.578 . . . . 0.0 111.096 -176.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.709 ' HB ' HD11 ' A' ' 11' ' ' LEU . 33.6 m -70.65 -13.94 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.178 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -87.6 -18.28 30.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.911 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.557 ' HG2' ' HB3' ' A' ' 45' ' ' ASN . 16.1 mm-40 -96.2 -20.83 18.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.387 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 99.0 mt -82.01 132.4 35.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.697 174.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -129.31 168.5 16.15 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.358 0.599 . . . . 0.0 111.506 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.47 ' O ' HD12 ' A' ' 15' ' ' LEU . . . -108.89 117.3 33.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.376 170.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.586 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 25.5 p90 -114.84 152.21 32.58 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.138 0.494 . . . . 0.0 111.666 -173.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.618 HG13 HD11 ' A' ' 15' ' ' LEU . 21.2 m -115.64 144.69 22.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.128 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.848 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 4.5 t70 -98.21 109.07 21.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.061 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.466 HD12 HG23 ' A' ' 20' ' ' THR . 53.0 mt -101.57 68.7 1.19 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.348 0.594 . . . . 0.0 109.946 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.1 p -82.64 -1.2 50.36 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.74 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.22 112.8 4.34 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.7 p -84.45 16.15 3.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.869 0.366 . . . . 0.0 111.768 -177.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -85.86 119.55 72.0 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.529 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.573 ' HA ' ' HB2' ' A' ' 89' ' ' LEU . 11.6 Cg_exo -70.91 -174.56 1.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.906 2.404 . . . . 0.0 112.329 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 88' ' ' GLN . . . 97.89 -137.6 13.39 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.691 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -125.96 113.86 17.72 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.781 0.324 . . . . 0.0 110.133 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -130.45 155.07 47.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.824 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -100.12 130.21 46.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.441 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -128.44 158.03 39.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.93 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.86 141.49 28.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.041 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.439 HG13 HD13 ' A' ' 15' ' ' LEU . 59.0 t -86.37 107.8 17.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.631 174.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.453 ' HD3' ' CE2' ' A' ' 52' ' ' TYR . 57.9 tttm -99.1 103.17 15.06 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.09 0.472 . . . . 0.0 110.264 -178.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.95 130.38 36.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.632 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.435 ' HG3' ' HD2' ' A' ' 71' ' ' PRO . 27.5 tt0 -68.57 128.33 93.02 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.435 ' HD2' ' HG3' ' A' ' 70' ' ' GLU . 12.1 Cg_endo -55.19 131.64 47.53 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.185 2.59 . . . . 0.0 113.158 -175.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.547 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.2 mp -81.5 125.9 77.47 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.062 177.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.85 109.86 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.291 2.66 . . . . 0.0 113.671 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.6 t30 71.9 2.82 4.45 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.721 173.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.463 ' HB ' ' HB ' ' A' ' 72' ' ' ILE . 48.9 mm -102.29 135.31 39.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 O-C-N 121.928 -0.482 . . . . 0.0 110.387 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.693 ' HB2' ' HB3' ' A' ' 38' ' ' GLU . 72.8 mttt -87.39 148.76 24.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.62 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.489 HD11 HG12 ' A' ' 80' ' ' ILE . 21.4 tt -110.21 128.19 66.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.293 0.568 . . . . 0.0 110.105 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.619 HG12 ' HG3' ' A' ' 79' ' ' GLU . 42.6 t -95.42 -63.84 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.988 -175.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.619 ' HG3' HG12 ' A' ' 78' ' ' VAL . 43.0 mt-10 -123.81 127.36 47.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.743 -175.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.555 ' HA ' HG12 ' A' ' 35' ' ' VAL . 26.3 mt -105.78 127.75 60.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 15.6 m -150.5 115.12 3.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.842 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 88.6 Cg_endo -85.87 177.21 26.36 Favored 'Cis proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.502 -1.458 . . . . 0.0 112.682 -0.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.456 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 84.8 mtm180 -119.97 -28.96 5.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.838 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.98 117.16 48.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.5 m -110.75 135.86 48.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.251 0.548 . . . . 0.0 111.254 -178.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.9 m -88.93 112.24 23.07 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.604 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 90.0 mt -111.55 145.67 38.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 -174.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 93.0 mt-30 -113.09 129.71 56.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.12 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.573 ' HB2' ' HA ' ' A' ' 60' ' ' PRO . 82.8 mt -113.86 136.78 52.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.036 0.446 . . . . 0.0 111.616 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.441 ' HB2' ' SD ' ' A' ' 27' ' ' MET . 43.2 tt0 -119.21 162.96 17.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.163 176.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -80.35 151.3 29.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.538 0.685 . . . . 0.0 112.198 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 43.0 t60 . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.661 172.09 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.608 ' HB3' ' HE2' ' A' ' 36' ' ' LYS . 11.9 m-20 . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 120.523 0.201 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.71 124.47 10.26 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.13 1.887 . . . . 0.0 112.623 -178.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.0 m -101.37 103.69 14.65 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.2 mt -83.1 122.46 28.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.268 0.556 . . . . 0.0 110.715 -173.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.4 m -99.22 106.45 18.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.138 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.8 mt -107.94 -174.67 2.58 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.628 -177.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -114.79 145.37 42.19 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.543 HD11 HG13 ' A' ' 53' ' ' VAL . 45.6 tp -87.44 130.15 34.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.8 pt -128.0 144.8 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.22 0.534 . . . . 0.0 111.763 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.488 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -81.29 102.82 10.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.233 173.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.425 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 59.6 tttm -91.65 -71.57 0.63 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.937 0.399 . . . . 0.0 110.874 -173.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.425 ' OD1' ' HG2' ' A' ' 18' ' ' LYS . 5.2 m-20 -94.27 67.09 3.5 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.623 0.725 . . . . 0.0 109.86 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.488 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 88.1 m -105.79 116.71 59.4 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.287 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 16.9 Cg_exo -67.87 156.39 66.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.168 2.578 . . . . 0.0 112.599 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.96 151.69 45.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.38 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 73.29 9.35 5.19 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.793 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.2 p -103.63 137.48 41.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 171.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.764 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 52.1 ttp -128.87 119.25 24.1 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.811 0.338 . . . . 0.0 110.405 -174.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.5 mt -85.31 124.75 40.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.448 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.572 ' HB2' ' HB2' ' A' ' 88' ' ' GLN . 86.1 mtp -85.36 -31.9 22.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.388 178.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 p -78.27 118.32 20.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.794 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.68 141.01 53.65 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.84 118.44 70.33 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.415 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -89.8 176.96 2.72 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.893 2.395 . . . . 0.0 112.741 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -83.06 135.28 34.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.147 176.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.539 HG11 ' HB2' ' A' ' 51' ' ' ALA . 9.5 p -104.03 152.99 6.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -128.54 134.27 48.61 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.957 0.408 . . . . 0.0 110.838 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 16.3 m -124.33 129.1 74.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.352 175.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.608 ' HE2' ' HB3' ' A' ' 8' ' ' ASP . 13.1 tmtt? -86.16 127.36 34.7 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.551 HG22 ' HA ' ' A' ' 77' ' ' ILE . 33.0 p -128.68 168.15 16.2 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -171.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 76' ' ' LYS . 40.3 mm-40 -114.21 127.32 55.84 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.38 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.97 -161.89 15.94 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.578 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -128.35 128.53 44.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.725 0.298 . . . . 0.0 110.27 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.444 ' HB3' HD12 ' A' ' 44' ' ' ILE . 3.0 p30 -122.41 77.34 44.92 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.261 0.553 . . . . 0.0 111.267 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.12 -47.04 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.649 2.233 . . . . 0.0 111.796 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 m -129.33 80.21 1.95 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.195 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 41' ' ' ASN . 44.7 mt -134.64 157.5 41.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -73.85 55.59 0.54 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.457 0.646 . . . . 0.0 111.504 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.8 t -66.39 -26.27 37.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.76 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -89.9 5.08 47.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.152 0.501 . . . . 0.0 110.906 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -107.12 -24.29 12.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.506 0.669 . . . . 0.0 109.22 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.622 HD13 HG12 ' A' ' 72' ' ' ILE . 63.5 mt -88.11 132.67 34.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.66 177.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -143.51 178.03 8.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.934 0.397 . . . . 0.0 110.812 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.539 ' HB2' HG11 ' A' ' 33' ' ' VAL . . . -105.85 119.88 40.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.956 172.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.424 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 28.7 p90 -115.18 148.91 38.47 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.087 0.47 . . . . 0.0 110.946 -174.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.543 HG13 HD11 ' A' ' 15' ' ' LEU . 18.3 m -112.85 133.42 58.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.951 174.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -104.8 105.53 15.63 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.822 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.436 HD12 HG23 ' A' ' 20' ' ' THR . 61.6 mt -92.41 90.09 7.07 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.043 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.5 p -75.05 1.91 11.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.541 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.06 132.62 2.87 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.707 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 m -80.44 76.75 7.26 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 89' ' ' LEU . 30.9 mt-10 -91.36 108.91 32.3 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.53 -176.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 11.8 Cg_exo -69.07 131.29 21.88 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.761 2.307 . . . . 0.0 112.204 -176.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.91 174.15 17.59 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.998 ' HG2' ' HG2' ' A' ' 88' ' ' GLN . 33.2 mt-10 -76.78 106.42 8.43 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -118.62 156.03 29.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.149 0.5 . . . . 0.0 111.269 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -90.47 116.05 28.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.161 -176.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -127.15 157.42 39.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.052 0.453 . . . . 0.0 111.727 -176.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -89.33 144.5 26.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.692 -173.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.07 114.05 35.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.658 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -108.01 125.32 51.4 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.8 t -102.41 136.29 35.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.557 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -54.83 122.35 40.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.187 174.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.17 116.49 2.98 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.699 2.266 . . . . 0.0 111.973 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.622 HG12 HD13 ' A' ' 49' ' ' LEU . 55.8 mt -81.47 121.71 80.21 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.982 -175.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.59 143.09 37.43 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.463 2.108 . . . . 0.0 111.747 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 t30 75.17 -44.47 0.54 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.362 0.665 . . . . 0.0 111.901 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.522 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 48.9 mm -91.58 136.93 23.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.0 -176.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.615 ' HB3' ' HB2' ' A' ' 38' ' ' GLU . 74.7 tttt -85.17 135.13 34.09 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.551 ' HA ' HG22 ' A' ' 37' ' ' THR . 15.1 tt -96.03 133.69 36.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.953 0.406 . . . . 0.0 109.996 176.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -110.86 -57.97 3.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.339 0.59 . . . . 0.0 111.386 -176.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 38.6 tt0 -126.07 124.81 41.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.403 -170.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.579 ' HB ' ' HG2' ' A' ' 83' ' ' ARG . 61.0 mt -99.22 113.5 34.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 25.2 p -127.22 110.49 21.44 Favored Pre-proline 0 C--N 1.318 -0.782 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.035 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 98.1 Cg_endo -88.43 162.76 42.52 Favored 'Cis proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.77 -1.346 . . . . 0.0 112.716 -1.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.579 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 63.2 mtm180 -87.56 -25.47 23.61 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.947 0.404 . . . . 0.0 110.345 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.7 t -136.2 135.66 49.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.505 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 m -122.52 151.27 26.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.071 0.462 . . . . 0.0 110.963 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.8 m -101.28 107.28 18.61 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.579 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.4 mt -101.62 137.42 39.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.167 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.998 ' HG2' ' HG2' ' A' ' 62' ' ' GLU . 79.9 mt-30 -99.71 109.0 21.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.576 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 70.8 mt -104.62 142.85 33.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.088 0.47 . . . . 0.0 111.673 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.518 ' HG2' ' H ' ' A' ' 91' ' ' HIS . 27.0 tt0 -136.04 176.1 9.0 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 172.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.518 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 86.3 m-70 -99.72 118.83 37.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.764 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 63.8 t60 . . . . . 0 C--N 1.324 -0.512 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -85.52 166.18 10.55 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.436 2.757 . . . . 0.0 113.34 -173.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 20.1 m -100.84 137.33 39.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.502 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.1 mt -107.45 137.89 44.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.072 0.463 . . . . 0.0 110.597 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -107.79 114.12 27.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.866 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.86 165.58 14.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.128 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.3 m -100.8 142.97 31.52 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.61 HD11 HG13 ' A' ' 53' ' ' VAL . 30.7 tp -91.44 128.22 37.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.159 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.7 pt -115.09 160.75 14.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.969 0.414 . . . . 0.0 111.43 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.554 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -92.64 100.08 12.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.445 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.4 ' HD3' ' CD1' ' A' ' 52' ' ' TYR . 59.3 tttm -101.61 135.41 43.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.149 -176.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 66.5 t30 62.28 16.51 8.53 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.536 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.554 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 91.7 m -60.74 119.68 46.34 Favored Pre-proline 0 N--CA 1.447 -0.595 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.777 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.668 ' HG2' ' HA ' ' A' ' 58' ' ' SER . 51.7 Cg_exo -55.02 162.49 5.24 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.869 3.046 . . . . 0.0 113.456 -173.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.76 149.08 32.75 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.156 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 65.13 37.32 6.71 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.617 0.573 . . . . 0.0 111.297 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.0 p -123.36 160.04 27.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.796 0.332 . . . . 0.0 110.559 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.0 ttp -144.86 129.12 17.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' A' ' 89' ' ' LEU . 19.1 mt -95.44 109.88 23.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.407 ' HB2' ' HB3' ' A' ' 88' ' ' GLN . 83.9 mtp -71.63 -27.96 63.46 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 110.527 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.8 m -77.95 123.99 27.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.719 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -71.79 130.54 41.35 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.531 -176.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.07 113.57 17.38 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.093 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.43 ' HD2' HD23 ' A' ' 15' ' ' LEU . 92.2 Cg_endo -85.15 -175.93 2.19 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.84 2.36 . . . . 0.0 112.79 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.4 m -105.76 126.31 52.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.356 174.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.503 HG12 ' HD2' ' A' ' 82' ' ' PRO . 13.4 m -85.91 148.24 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.474 -175.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -127.57 97.52 4.89 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 80' ' ' ILE . 30.7 m -105.32 132.64 51.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.381 -176.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 71.2 tttt -81.46 136.13 35.64 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.547 HG22 ' HA ' ' A' ' 77' ' ' ILE . 22.4 p -125.9 162.69 24.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.316 -177.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.24 112.93 18.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.87 178.91 24.33 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.61 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -118.41 144.18 46.13 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -128.96 92.51 39.57 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 121.328 0.585 . . . . 0.0 111.756 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.09 -45.46 15.88 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.788 2.325 . . . . 0.0 111.096 174.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.7 m -117.63 -115.58 0.33 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.552 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.1 mt 56.52 99.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 111.795 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -73.21 100.96 3.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.698 0.761 . . . . 0.0 111.289 -177.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.0 t -64.2 -22.41 31.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.756 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -80.3 -11.61 59.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.87 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -98.13 -21.66 16.63 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 90.8 mt -70.03 132.35 45.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.887 174.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -130.47 152.97 49.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.281 0.562 . . . . 0.0 111.848 -177.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -115.45 141.28 48.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 170.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 68' ' ' LYS . 47.0 p90 -133.24 161.31 34.82 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.028 -175.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.61 HG13 HD11 ' A' ' 15' ' ' LEU . 6.7 m -112.35 117.98 56.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -86.38 102.59 14.16 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 20' ' ' THR . 43.5 mt -88.45 76.41 8.26 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.151 -175.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.8 m -84.09 9.69 11.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.565 0.698 . . . . 0.0 109.754 173.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.39 107.06 1.88 Allowed Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.162 175.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.668 ' HA ' ' HG2' ' A' ' 21' ' ' PRO . 16.1 m -85.7 9.5 16.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.223 0.535 . . . . 0.0 110.69 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.88 121.13 83.06 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.54 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.71 175.84 10.78 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.663 2.242 . . . . 0.0 112.304 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.81 -158.99 19.11 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -176.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.404 ' HG2' ' CG2' ' A' ' 86' ' ' THR . 37.3 tt0 -100.12 107.76 19.73 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -132.74 144.41 50.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.138 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 4.4 p30 -94.15 141.29 28.72 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.197 0.523 . . . . 0.0 110.787 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -133.69 164.23 27.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.06 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -93.3 140.27 29.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.246 -172.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 98.6 t -79.88 108.71 13.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 172.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.449 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 40.6 mtpt -108.77 114.06 27.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.711 -176.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.6 139.97 17.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.24 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.26 132.44 94.43 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.48 113.66 1.56 Allowed 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.966 2.444 . . . . 0.0 112.574 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.518 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.4 mp -83.29 122.31 77.23 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.018 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.79 143.62 46.38 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.361 2.041 . . . . 0.0 111.716 176.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.4 t30 73.79 -23.38 0.22 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.097 0.559 . . . . 0.0 112.203 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.419 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 48.2 mm -108.38 125.66 65.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.758 0.313 . . . . 0.0 110.877 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -88.16 125.97 34.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.115 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.547 ' HA ' HG22 ' A' ' 37' ' ' THR . 16.6 tt -80.06 135.88 24.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.5 t -104.49 -64.91 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.263 0.554 . . . . 0.0 110.907 -178.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -122.5 137.71 54.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.434 -172.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.478 ' HA ' HG12 ' A' ' 35' ' ' VAL . 61.0 mt -103.06 109.44 26.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.675 176.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.45 ' HA ' ' C ' ' A' ' 82' ' ' PRO . 18.2 p -141.87 124.46 9.34 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.457 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.503 ' HD2' HG12 ' A' ' 33' ' ' VAL . 43.0 Cg_endo -67.72 160.36 81.16 Favored 'Cis proline' 0 C--N 1.344 0.315 0 C-N-CA 123.386 -1.506 . . . . 0.0 113.204 0.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -86.36 -70.21 0.62 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.538 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 64' ' ' ASP . 62.6 t -121.48 129.34 75.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.374 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.3 m -110.21 134.93 50.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.972 0.415 . . . . 0.0 110.879 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 24.0 m -92.92 111.39 22.99 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.079 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.2 mt -106.12 138.88 41.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.155 0.502 . . . . 0.0 111.365 -173.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 27' ' ' MET . 55.9 tp60 -94.77 109.83 21.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.066 174.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.418 ' CD2' HG12 ' A' ' 26' ' ' ILE . 80.0 mt -100.79 130.0 46.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.239 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -119.14 178.5 4.49 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.414 171.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -97.96 151.86 19.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.48 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 14.4 t60 . . . . . 0 C--N 1.323 -0.558 0 CA-C-O 120.989 0.423 . . . . 0.0 110.147 -178.909 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.593 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 9.1 m-20 . . . . . 0 C--O 1.233 0.225 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -75.26 129.69 12.34 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.673 2.249 . . . . 0.0 112.553 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 43.1 m -102.33 109.68 21.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.672 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.546 HD21 ' ND2' ' A' ' 41' ' ' ASN . 83.7 mt -92.48 147.11 23.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.258 0.551 . . . . 0.0 111.528 -172.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.9 m -121.62 97.59 5.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.451 HD22 ' HB2' ' A' ' 49' ' ' LEU . 56.2 mt -99.17 162.9 12.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.319 -175.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.6 p -100.68 148.67 24.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.705 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.814 HD11 HG13 ' A' ' 53' ' ' VAL . 34.1 tp -94.34 125.03 38.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.189 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.6 pt -112.04 151.9 13.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.318 0.58 . . . . 0.0 111.768 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.627 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -83.69 102.19 12.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.116 176.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 86.4 tttt -83.34 115.24 21.92 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.312 -178.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.4 ' ND2' ' HG2' ' A' ' 18' ' ' LYS . 61.7 m-80 73.89 -68.27 0.23 Allowed 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.198 0.999 . . . . 0.0 109.668 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.627 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 47.7 m 48.13 97.76 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.404 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.96 -172.16 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.776 2.984 . . . . 0.0 115.151 -169.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.74 105.82 0.16 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.422 -1.263 . . . . 0.0 113.598 -172.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.48 22.13 13.08 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.003 168.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.0 p -84.64 102.72 13.15 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 170.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.9 ttp -103.08 126.5 50.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.633 -172.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.463 HG12 ' CD2' ' A' ' 89' ' ' LEU . 5.8 mt -84.81 110.59 19.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.957 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 58.1 ttp -73.18 -32.11 64.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.9 m -69.3 131.68 45.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.169 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -75.65 119.84 20.23 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -56.96 114.35 7.86 Favored Pre-proline 0 C--N 1.328 -0.35 0 O-C-N 123.488 0.493 . . . . 0.0 110.064 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.27 -172.56 1.4 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.89 2.394 . . . . 0.0 112.792 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.8 p -99.1 149.54 22.93 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.821 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.436 ' CG2' ' HB2' ' A' ' 13' ' ' LEU . 35.6 m -108.17 129.29 62.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.149 0.5 . . . . 0.0 109.804 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -106.88 110.35 22.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.218 0.533 . . . . 0.0 109.88 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 80' ' ' ILE . 27.2 m -120.45 137.46 54.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.527 -176.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.593 ' HE3' ' HB3' ' A' ' 8' ' ' ASP . 83.3 tttt -93.19 136.24 33.64 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 77' ' ' ILE . 22.5 p -124.56 168.42 13.13 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.278 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.448 ' HG3' ' CG2' ' A' ' 78' ' ' VAL . 42.1 mt-10 -122.5 123.13 40.55 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 176.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.0 -148.63 20.44 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.778 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.515 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 73.1 m-85 -129.57 129.07 43.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.804 0.335 . . . . 0.0 110.384 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.546 ' ND2' HD21 ' A' ' 11' ' ' LEU . 1.6 m-20 -116.71 77.98 8.67 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.629 -176.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 3.0 Cg_endo -86.63 -62.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.635 2.223 . . . . 0.0 112.2 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.0 p -91.5 -8.99 46.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.597 -177.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.21 116.11 33.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -111.63 150.34 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.58 -171.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.422 ' HB ' HD23 ' A' ' 13' ' ' LEU . 31.4 m -76.12 -5.34 7.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.964 178.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -85.31 -8.45 58.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.935 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -114.58 -29.15 6.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.737 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.451 ' HB2' HD22 ' A' ' 13' ' ' LEU . 79.0 mt -84.54 134.34 34.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -130.61 160.63 33.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.468 0.652 . . . . 0.0 111.828 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -117.42 133.95 55.39 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 170.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.432 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 48.7 p90 -122.04 152.01 40.24 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.018 -174.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.814 HG13 HD11 ' A' ' 15' ' ' LEU . 6.4 m -112.24 125.9 69.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.785 172.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -86.61 99.98 12.1 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.48 HD12 ' OG1' ' A' ' 20' ' ' THR . 64.6 mt -92.16 21.11 5.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.602 -173.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.5 p -60.37 115.9 3.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.153 0.501 . . . . 0.0 110.093 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.8 -28.5 1.74 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.594 -175.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.9 p 49.98 38.29 16.04 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.438 0.695 . . . . 0.0 111.897 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -84.84 115.02 59.06 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.953 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.3 150.21 28.63 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.825 2.35 . . . . 0.0 112.092 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.82 -174.43 21.64 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.745 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -80.26 105.75 11.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.753 0.311 . . . . 0.0 110.27 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -125.18 151.68 45.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.523 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -91.98 123.11 35.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.519 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -121.62 139.33 53.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.231 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.49 136.82 51.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.237 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 64.2 t -83.26 106.08 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -103.6 104.99 15.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.118 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.9 t -90.91 140.18 16.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.334 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 36.3 mt-10 -66.64 128.14 93.72 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.33 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 25.3 Cg_exo -62.58 115.88 3.18 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.829 2.352 . . . . 0.0 111.92 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.3 mp -81.33 122.62 81.33 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.073 -173.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.86 135.94 34.04 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.791 2.327 . . . . 0.0 112.221 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.4 m120 71.5 6.79 5.84 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.387 176.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.1 mt -135.9 131.23 49.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.823 0.344 . . . . 0.0 110.612 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -84.79 129.56 34.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.396 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.546 ' HA ' HG22 ' A' ' 37' ' ' THR . 17.7 tt -92.72 134.35 30.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.448 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 35.4 t -108.18 -60.46 2.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.904 0.383 . . . . 0.0 111.459 -174.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HG3' HG12 ' A' ' 78' ' ' VAL . 41.8 mt-10 -118.58 128.44 54.56 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 -171.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.543 ' HA ' HG12 ' A' ' 35' ' ' VAL . 62.4 mt -111.92 109.47 28.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.273 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 14.8 p -139.75 126.96 12.7 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.601 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.408 ' HD2' HG12 ' A' ' 33' ' ' VAL . 4.2 Cg_exo -80.63 159.78 84.8 Favored 'Cis proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.452 -1.479 . . . . 0.0 112.535 -0.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -80.34 -50.32 10.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.291 0.567 . . . . 0.0 110.527 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.1 t -131.11 137.1 56.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.377 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.5 m -117.77 134.11 62.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.159 0.504 . . . . 0.0 111.172 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.3 m -85.04 105.82 16.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.598 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.8 mt -104.89 130.49 53.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.271 -177.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -94.23 106.12 18.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.076 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.463 ' CD2' HG12 ' A' ' 26' ' ' ILE . 90.1 mt -91.96 126.82 37.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.59 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -118.55 150.33 39.82 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.377 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -77.43 137.93 38.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.954 0.407 . . . . 0.0 111.257 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.012 177.244 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 . . . . . 0 CA--C 1.528 0.108 0 CA-C-O 121.437 0.637 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.19 161.97 11.45 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.627 2.218 . . . . 0.0 113.01 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.1 m -93.96 105.65 17.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.784 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.536 HD11 ' HB ' ' A' ' 46' ' ' VAL . 54.3 tp -83.2 139.02 33.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.632 -176.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.7 m -116.77 115.36 25.44 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.787 0.327 . . . . 0.0 110.561 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.6 mt -114.52 141.73 47.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.164 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.6 m -75.05 142.31 43.76 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.711 0.291 . . . . 0.0 110.472 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.804 HD11 HG13 ' A' ' 53' ' ' VAL . 38.6 tp -89.1 122.03 32.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.234 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.6 pt -104.42 148.38 9.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.149 0.499 . . . . 0.0 111.114 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.33 113.44 18.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.855 176.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -111.64 133.17 54.08 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 68.13 3.68 3.75 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.608 0.568 . . . . 0.0 112.067 174.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 27.1 m -62.3 113.66 9.44 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.995 -177.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 24.0 Cg_exo -65.16 166.88 17.59 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.373 2.716 . . . . 0.0 113.51 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.34 -23.02 60.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.123 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -85.46 3.61 39.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.84 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.2 m -117.01 124.55 49.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.612 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.5 ttp -117.18 113.03 21.65 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.406 HG12 ' CD2' ' A' ' 89' ' ' LEU . 17.8 mt -75.95 115.9 18.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.254 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 22.1 ttt -77.9 -35.58 50.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.073 0.463 . . . . 0.0 110.049 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.7 m -78.6 121.65 24.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.775 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -69.48 128.26 35.9 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.8 mt -67.95 126.4 92.58 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.196 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -90.99 -161.25 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.119 2.546 . . . . 0.0 112.397 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.8 m -117.83 141.96 47.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.405 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 p -97.75 145.22 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.965 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.6 mtp180 -114.93 118.43 33.44 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 80' ' ' ILE . 17.3 m -117.3 134.45 60.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.057 -177.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.543 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 11.9 mmtt -79.09 122.21 25.95 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 173.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.3 p -120.95 129.83 53.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.773 0.321 . . . . 0.0 111.509 -176.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.518 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 28.3 tt0 -96.04 106.15 18.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.601 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 135.17 -178.41 18.59 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.029 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -113.23 161.06 17.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.101 0.476 . . . . 0.0 111.043 -178.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.628 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 3.2 p30 -128.74 74.57 80.54 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.687 176.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.66 -45.46 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.585 2.19 . . . . 0.0 111.767 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 p -102.9 3.93 37.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.054 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.654 HD11 ' HB2' ' A' ' 74' ' ' ASN . 56.9 mt -106.69 121.51 59.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.629 -175.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -91.72 106.23 18.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.541 0.686 . . . . 0.0 110.665 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.536 ' HB ' HD11 ' A' ' 11' ' ' LEU . 33.2 m -69.66 -10.88 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.68 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -82.87 -11.01 58.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.978 0.418 . . . . 0.0 110.497 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -106.26 -16.46 14.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.213 174.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.8 mt -70.32 128.56 36.63 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 168.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -124.3 157.86 33.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.361 0.6 . . . . 0.0 112.044 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.88 129.54 56.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 169.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -129.57 143.78 50.98 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.466 0.651 . . . . 0.0 111.622 -173.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.804 HG13 HD11 ' A' ' 15' ' ' LEU . 3.2 m -112.52 119.52 60.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.94 172.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -84.84 100.3 11.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.571 -173.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.509 HD23 HD11 ' A' ' 89' ' ' LEU . 10.5 mp -90.6 76.26 6.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.0 m -57.3 -42.63 82.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.919 -174.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -112.21 172.56 14.82 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.041 -174.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.9 m -91.4 31.07 1.19 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.975 0.417 . . . . 0.0 110.168 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -59.73 112.28 5.08 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.521 -175.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.41 151.88 20.27 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.633 2.222 . . . . 0.0 112.055 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.82 179.3 19.13 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.351 176.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 88' ' ' GLN . 41.8 tt0 -87.08 107.99 18.68 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 65' ' ' TYR . 76.6 m-70 -117.33 161.76 19.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.818 -175.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -95.53 127.24 41.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 63' ' ' HIS . 95.3 m-85 -116.88 134.24 55.02 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.322 0.582 . . . . 0.0 111.165 -177.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -77.09 120.64 22.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.146 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.5 t -73.44 106.25 3.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.27 0.557 . . . . 0.0 110.044 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -100.5 126.02 46.88 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.554 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.9 146.73 10.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -58.94 115.38 11.69 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 173.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.19 108.0 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.713 2.276 . . . . 0.0 112.486 -176.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.535 HD12 ' H ' ' A' ' 72' ' ' ILE . 3.8 mp -81.06 111.11 21.09 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.9 24.51 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.829 2.353 . . . . 0.0 113.15 -172.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.654 ' HB2' HD11 ' A' ' 44' ' ' ILE . 21.8 m120 -144.38 -1.42 0.92 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.721 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.544 HD11 ' HB3' ' A' ' 41' ' ' ASN . 70.1 mt -129.96 134.23 63.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.874 0.368 . . . . 0.0 110.407 -176.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 52.2 tttm -83.18 112.83 20.2 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.802 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.9 tt -80.66 125.46 39.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.203 0.525 . . . . 0.0 110.163 -176.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 22.7 t -93.59 -54.18 7.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.35 -173.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -153.28 156.82 39.15 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.722 -174.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.609 ' HA ' HG12 ' A' ' 35' ' ' VAL . 60.9 mt -122.78 132.08 72.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 23.2 t -139.21 110.5 7.7 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.464 0.173 . . . . 0.0 110.642 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 2.3 Cg_endo -87.35 153.38 42.07 Favored 'Cis proline' 0 N--CA 1.462 -0.379 0 C-N-CA 124.215 -1.161 . . . . 0.0 112.152 -2.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.593 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 85.1 mtm180 -76.33 -34.68 59.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.878 0.371 . . . . 0.0 111.392 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.8 t -129.23 129.62 67.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.913 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.3 m -116.11 133.44 62.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.971 0.415 . . . . 0.0 110.859 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.3 m -90.78 115.4 27.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.144 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.418 ' HB2' ' CE2' ' A' ' 65' ' ' TYR . 70.8 mt -118.82 138.86 52.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.178 -177.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 53.1 tt0 -93.83 115.78 28.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.951 0.405 . . . . 0.0 110.581 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.509 HD11 HD23 ' A' ' 55' ' ' LEU . 23.7 mt -100.42 135.68 41.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.282 0.563 . . . . 0.0 111.118 177.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -118.86 170.51 8.95 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 169.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -83.43 166.15 18.61 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.885 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.2 t60 . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.201 -178.735 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.838 ' HB3' ' HG3' ' A' ' 38' ' ' GLU . 6.1 p-10 . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 121.737 0.779 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.32 141.1 25.36 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.097 2.532 . . . . 0.0 113.36 -173.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 40.9 m -87.77 110.35 20.4 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.9 tp -108.92 144.69 36.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.538 -171.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 12.4 t -116.64 123.47 47.37 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.353 0.597 . . . . 0.0 109.796 174.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt -109.5 166.29 11.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.011 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.2 t -86.07 126.65 34.34 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.642 HD11 HG13 ' A' ' 53' ' ' VAL . 60.3 tp -80.82 104.24 11.2 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 174.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 36.2 pt -107.08 147.45 12.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.257 0.551 . . . . 0.0 111.599 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.568 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -86.91 105.03 16.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.54 175.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -90.42 -77.84 0.39 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.859 -174.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -80.71 64.82 5.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.906 0.86 . . . . 0.0 109.253 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.568 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 46.5 m -112.0 111.48 53.47 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.564 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -71.25 -178.93 3.18 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.035 2.49 . . . . 0.0 111.979 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 23' ' ' ASN . . . -77.87 160.96 27.96 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.571 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.567 ' HB3' ' O ' ' A' ' 22' ' ' ALA . 18.1 t30 80.1 -38.09 0.16 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.847 0.717 . . . . 0.0 111.274 174.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 p -78.72 94.58 5.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.14 0.495 . . . . 0.0 110.123 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.4 ttp -102.94 133.0 48.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.244 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.9 mt -85.9 110.43 19.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.3 ttt -70.4 -32.5 70.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.088 0.47 . . . . 0.0 110.088 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.5 m -78.01 106.62 10.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.477 174.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.58 129.57 40.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.051 0.453 . . . . 0.0 111.175 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 15' ' ' LEU . 73.1 mt -55.94 122.72 48.98 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.856 -174.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -95.25 176.19 0.94 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.343 2.695 . . . . 0.0 112.82 176.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 m -87.0 140.08 29.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.925 173.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 12' ' ' THR . 14.4 p -101.83 148.09 7.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.044 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 34' ' ' ARG . 37.2 mtm-85 -103.17 120.45 40.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.904 0.383 . . . . 0.0 110.638 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 80' ' ' ILE . 6.9 m -133.77 116.67 24.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.236 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 16.7 ttpp -87.55 129.07 35.23 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.1 p -105.03 -178.05 3.54 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.838 ' HG3' ' HB3' ' A' ' 8' ' ' ASP . 3.4 tt0 -154.66 110.31 3.15 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.41 165.66 10.85 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.927 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -88.02 113.13 23.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.594 0.235 . . . . 0.0 110.529 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.523 ' HB3' HG13 ' A' ' 75' ' ' ILE . 5.1 p30 -135.5 82.01 40.89 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.537 0.684 . . . . 0.0 111.626 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -91.13 -6.18 3.98 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.096 2.531 . . . . 0.0 111.948 175.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.1 p -97.74 -52.16 3.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.238 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.31 126.35 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.243 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -86.24 128.78 34.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.926 -177.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.63 -13.08 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.451 -174.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -97.06 -9.53 27.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.688 0.28 . . . . 0.0 110.844 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.82 -25.13 22.37 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 172.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.6 128.51 34.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.743 172.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -130.85 157.61 42.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.987 0.422 . . . . 0.0 111.11 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -123.0 114.0 19.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.557 ' CZ ' ' HD2' ' A' ' 68' ' ' LYS . 53.1 p90 -118.55 159.53 23.39 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.121 0.486 . . . . 0.0 111.839 -171.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.642 HG13 HD11 ' A' ' 15' ' ' LEU . 17.0 m -112.43 139.46 37.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.695 172.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -103.68 106.69 17.27 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.471 HD12 HG23 ' A' ' 20' ' ' THR . 78.8 mt -98.49 44.18 1.04 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.947 0.403 . . . . 0.0 111.0 -174.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 t -56.56 -44.04 80.55 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.454 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.99 69.97 3.22 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 173.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 p -69.54 91.58 0.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.488 0.661 . . . . 0.0 110.779 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 42.5 tt0 -117.87 125.48 27.98 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.958 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 59' ' ' GLU . 25.3 Cg_exo -62.89 150.9 87.0 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.194 2.596 . . . . 0.0 112.818 -177.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.38 -177.27 27.15 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.863 ' HG2' ' HB2' ' A' ' 88' ' ' GLN . 42.6 mt-10 -87.68 107.49 18.65 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -124.15 148.76 46.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.425 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 39.4 m-20 -81.89 109.64 16.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.71 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -111.61 146.54 37.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.283 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -80.52 134.06 35.89 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.523 -174.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.482 HG13 HD13 ' A' ' 15' ' ' LEU . 60.1 t -81.75 112.36 19.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.557 ' HD2' ' CZ ' ' A' ' 52' ' ' TYR . 7.8 tmtt? -103.1 111.57 24.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.093 0.473 . . . . 0.0 109.885 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 34.9 t -92.4 143.13 12.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.421 -178.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -58.3 139.16 84.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.908 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.27 136.38 47.14 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.499 2.133 . . . . 0.0 111.702 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.458 ' CG2' ' HB ' ' A' ' 75' ' ' ILE . 41.2 mt -116.24 110.41 43.32 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.312 -177.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.52 137.31 50.1 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.763 2.308 . . . . 0.0 111.938 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 73.41 -45.3 0.61 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.524 0.729 . . . . 0.0 112.447 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.523 HG13 ' HB3' ' A' ' 41' ' ' ASN . 26.3 mm -84.33 129.36 37.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.031 0.443 . . . . 0.0 110.362 -175.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -81.8 141.48 33.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.562 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.2 tt -98.69 112.42 30.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.548 0.69 . . . . 0.0 109.144 174.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.6 t -86.42 -53.22 10.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.633 -170.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -133.86 147.71 51.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.099 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.718 ' HB ' ' HG2' ' A' ' 83' ' ' ARG . 55.0 mt -127.8 111.8 25.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 21.0 m -128.78 108.45 18.57 Favored Pre-proline 0 C--N 1.318 -0.771 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.145 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 4.1 Cg_endo -89.33 166.81 36.09 Favored 'Cis proline' 0 C--N 1.344 0.316 0 C-N-CA 124.459 -1.059 . . . . 0.0 112.344 -3.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.718 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 80.5 mtm180 -93.49 -28.62 15.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.081 0.467 . . . . 0.0 109.888 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.425 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 53.9 t -130.22 120.18 48.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.526 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.489 HG12 ' HG2' ' A' ' 82' ' ' PRO . 16.2 m -112.72 135.45 52.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.157 0.504 . . . . 0.0 111.219 -177.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.8 m -83.09 104.1 13.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.766 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.1 mt -101.51 133.02 46.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.61 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.863 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 42.8 tt0 -92.02 108.73 20.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.86 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 72.2 mt -94.31 120.65 34.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.532 177.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -109.12 152.33 25.24 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.592 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -84.13 100.44 11.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.647 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 83.4 t60 . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.804 -176.373 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 . . . . . 0 CA--C 1.517 -0.308 0 CA-C-O 120.425 0.155 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.14 130.38 18.78 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.398 2.065 . . . . 0.0 111.445 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.7 m -95.75 92.6 6.64 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 175.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.507 HD21 HD12 ' A' ' 49' ' ' LEU . 14.6 tp -82.85 114.98 21.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.953 -170.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.405 HG23 ' HG2' ' A' ' 34' ' ' ARG . 26.5 m -93.81 101.57 13.67 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.253 178.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.8 mt -100.83 177.91 4.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.482 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.9 m -105.35 137.63 42.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.521 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.824 HD11 HG13 ' A' ' 53' ' ' VAL . 50.7 tp -86.99 123.46 32.11 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.7 pt -119.79 146.7 24.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.133 0.492 . . . . 0.0 111.034 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.27 115.79 23.24 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -71.05 -76.46 0.1 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.063 -175.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -126.19 81.11 1.97 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.893 0.378 . . . . 0.0 110.317 177.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.9 t -90.67 127.17 53.46 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 170.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.89 157.33 13.2 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.323 2.682 . . . . 0.0 113.158 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.97 -19.82 64.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.679 -177.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -86.03 -5.8 59.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.26 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 p -118.59 144.61 46.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.106 0.479 . . . . 0.0 111.218 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.9 ttp -132.62 130.7 40.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.738 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.42 ' HA ' HD23 ' A' ' 89' ' ' LEU . 19.7 mt -82.84 116.92 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.652 0.263 . . . . 0.0 111.134 -176.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.52 ' HG2' ' HB2' ' A' ' 90' ' ' GLU . 95.9 mmm -82.94 -39.24 21.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.175 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.6 m -66.85 112.9 4.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.297 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -58.07 120.63 8.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.164 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.25 109.22 2.27 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.422 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -85.01 -170.87 0.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.879 2.386 . . . . 0.0 113.015 -173.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.2 m -97.2 134.31 40.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.147 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.538 HG11 HG11 ' A' ' 67' ' ' VAL . 17.8 m -96.85 142.39 14.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.405 ' HG2' HG23 ' A' ' 12' ' ' THR . 48.2 mtp180 -120.94 119.26 32.08 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.352 -178.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.53 HG12 ' HA ' ' A' ' 80' ' ' ILE . 30.1 m -112.54 137.29 45.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.066 0.46 . . . . 0.0 111.527 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -87.53 122.2 30.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 173.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.434 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 24.1 p -126.34 159.15 33.99 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 123.368 0.417 . . . . 0.0 110.925 -177.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -114.86 112.04 22.14 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.87 -159.0 26.88 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.841 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -137.78 157.14 47.06 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.448 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 6.3 p30 -128.78 85.66 59.62 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 121.204 0.526 . . . . 0.0 111.768 -174.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.59 -67.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.018 2.478 . . . . 0.0 112.422 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.3 p -84.4 -11.41 56.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.153 0.501 . . . . 0.0 111.045 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' A' ' 41' ' ' ASN . 70.1 mt -76.46 113.2 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.273 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.428 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 35.2 m-80 -84.77 121.6 27.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.747 -176.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.478 HG22 HD11 ' A' ' 11' ' ' LEU . 37.7 t -62.62 -36.53 75.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.455 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -71.15 -22.13 62.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.635 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -88.56 -17.31 30.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.449 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.507 HD12 HD21 ' A' ' 11' ' ' LEU . 91.3 mt -85.03 131.09 34.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.61 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -128.14 152.66 47.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.073 0.463 . . . . 0.0 111.447 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . . . -115.42 115.99 27.48 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 171.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -107.69 145.94 32.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.346 0.593 . . . . 0.0 112.023 -173.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.824 HG13 HD11 ' A' ' 15' ' ' LEU . 4.4 m -112.6 121.07 64.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.218 169.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -87.35 86.28 7.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.218 1.009 . . . . 0.0 110.528 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 mp -78.96 29.89 0.21 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.214 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.1 m -65.52 95.65 0.23 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.208 0.527 . . . . 0.0 110.064 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.83 -74.1 0.44 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -173.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m 58.37 98.41 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 173.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -85.1 119.59 72.64 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.81 114.65 1.95 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.695 2.264 . . . . 0.0 112.183 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.08 -158.48 27.7 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -100.36 104.71 16.16 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -130.89 152.68 49.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.822 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.478 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 18.8 m-20 -91.69 130.29 37.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.765 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -123.99 151.78 43.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.209 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.429 ' O ' HG12 ' A' ' 53' ' ' VAL . 24.8 mt-10 -87.2 134.72 33.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.306 -175.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.538 HG11 HG11 ' A' ' 33' ' ' VAL . 90.6 t -79.86 109.51 14.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.932 173.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -108.92 109.67 20.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.023 0.44 . . . . 0.0 110.431 -177.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 31.8 t -87.27 149.83 3.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.293 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -53.03 128.97 48.44 Favored Pre-proline 0 C--O 1.232 0.138 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.67 124.91 15.99 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.373 2.049 . . . . 0.0 111.683 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.6 mt -113.79 95.47 37.46 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.544 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.02 24.43 0.71 Allowed 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 123.072 2.514 . . . . 0.0 111.751 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -118.28 -30.51 5.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.171 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.434 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 61.9 mt -130.95 142.11 44.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.201 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -80.73 128.13 33.29 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.149 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.9 tt -97.41 122.16 48.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.396 0.617 . . . . 0.0 109.889 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.836 HG12 ' HG3' ' A' ' 79' ' ' GLU . 41.4 t -94.87 -60.47 2.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.115 -175.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.836 ' HG3' HG12 ' A' ' 78' ' ' VAL . 43.8 mt-10 -141.87 139.37 32.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.28 -172.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.53 ' HA ' HG12 ' A' ' 35' ' ' VAL . 46.3 mt -107.31 120.27 58.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.496 175.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 15.1 m -118.18 108.01 42.74 Favored Pre-proline 0 C--N 1.323 -0.586 0 O-C-N 122.423 -0.173 . . . . 0.0 110.93 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 83.9 Cg_endo -91.74 174.54 18.92 Favored 'Cis proline' 0 C--N 1.346 0.439 0 C-N-CA 124.186 -1.172 . . . . 0.0 112.53 -2.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 83' ' ' ARG . 27.3 mtm105 -94.97 -50.66 5.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.46 0.648 . . . . 0.0 110.085 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.478 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 41.1 t -115.53 118.66 59.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.138 -177.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.7 m -107.44 134.69 48.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.024 0.44 . . . . 0.0 111.18 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.2 m -85.21 103.97 14.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.82 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.5 mt -97.92 124.64 42.45 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.102 0.477 . . . . 0.0 110.572 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -87.93 104.66 16.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.965 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 26' ' ' ILE . 59.5 mt -94.31 134.33 36.91 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.941 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.52 ' HB2' ' HG2' ' A' ' 27' ' ' MET . 0.0 OUTLIER -110.72 170.99 7.73 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.656 179.242 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -84.98 110.74 19.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.358 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 177.514 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.419 ' HB3' ' HG2' ' A' ' 38' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.464 0.65 . . . . 0.0 109.83 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.95 154.82 33.79 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.874 2.383 . . . . 0.0 113.453 -174.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 35.3 m -100.23 123.28 44.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.826 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.2 mt -101.33 159.01 15.63 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.051 0.453 . . . . 0.0 110.496 -176.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 31.0 m -126.4 99.55 5.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.02 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.529 HD22 ' HB2' ' A' ' 49' ' ' LEU . 79.5 mt -95.8 141.84 28.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.244 -173.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 m -74.01 140.78 45.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.92 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.851 HD11 HG13 ' A' ' 53' ' ' VAL . 45.0 tp -96.32 125.19 40.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.035 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.5 HD11 ' CE2' ' A' ' 52' ' ' TYR . 39.7 pt -122.77 151.85 27.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.035 0.445 . . . . 0.0 111.507 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.444 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -78.99 132.91 36.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.537 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.55 ' HD2' ' CD2' ' A' ' 52' ' ' TYR . 60.6 tttm -129.73 140.15 51.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.213 178.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.557 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 65.0 m-20 60.91 20.17 10.47 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.719 0.637 . . . . 0.0 110.798 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.444 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 72.7 m -79.76 116.44 61.01 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.196 -174.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.1 178.0 3.93 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.911 2.407 . . . . 0.0 112.647 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.0 -28.44 27.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.114 -175.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -73.92 -10.15 59.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.674 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.6 p -100.93 110.12 22.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.128 0.489 . . . . 0.0 109.972 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.622 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 25.6 ttt -102.9 108.83 20.17 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.032 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.0 mt -78.35 108.19 11.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.665 -175.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.476 ' SD ' ' HB2' ' A' ' 90' ' ' GLU . 85.4 mtp -86.19 -32.9 20.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.553 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.9 m -71.87 111.39 7.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.985 176.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -65.9 117.88 8.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.5 114.53 13.41 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.507 -173.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -85.06 -161.99 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.903 2.402 . . . . 0.0 111.74 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.8 m -113.31 150.79 32.02 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.743 0.306 . . . . 0.0 110.911 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.626 HG11 HG11 ' A' ' 67' ' ' VAL . 35.7 m -94.38 152.48 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.777 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -110.53 102.02 10.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.988 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 80' ' ' ILE . 23.7 m -120.12 132.79 68.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.786 -176.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 81.8 tttt -97.17 136.06 38.23 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.553 HG22 ' HA ' ' A' ' 77' ' ' ILE . 37.0 p -127.98 138.35 52.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.289 -175.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.466 ' HG3' HG21 ' A' ' 78' ' ' VAL . 53.6 mt-10 -97.37 100.27 11.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.183 0.516 . . . . 0.0 109.64 175.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.24 151.65 5.78 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.19 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -89.93 147.58 23.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.677 0.275 . . . . 0.0 110.385 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 4.6 p30 -109.46 111.49 59.53 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.562 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 41' ' ' ASN . 5.1 Cg_exo -79.87 -73.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.814 2.342 . . . . 0.0 112.072 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 p -105.11 6.13 32.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.787 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.2 126.22 40.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.47 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -114.95 153.38 30.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.83 0.348 . . . . 0.0 111.322 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.0 m -83.56 -9.71 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.695 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -93.58 -4.81 50.21 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -98.78 -37.4 9.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.668 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.529 ' HB2' HD22 ' A' ' 13' ' ' LEU . 20.0 mt -88.3 144.57 26.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.657 177.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -135.89 157.9 45.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.684 0.754 . . . . 0.0 112.419 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.18 135.61 48.43 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.981 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.55 ' CD2' ' HD2' ' A' ' 18' ' ' LYS . 29.6 m-85 -112.25 150.16 31.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.956 0.408 . . . . 0.0 111.022 -173.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.851 HG13 HD11 ' A' ' 15' ' ' LEU . 3.1 m -122.08 118.28 55.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.814 168.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -83.63 105.65 14.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.224 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.4 mt -101.87 15.58 28.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.605 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.557 ' HB2' ' HB3' ' A' ' 19' ' ' ASN . 12.7 t -72.26 96.81 1.89 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 173.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.52 51.34 1.44 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 -172.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.2 p -106.01 162.36 13.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.717 0.294 . . . . 0.0 110.833 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.466 ' HB2' ' CE1' ' A' ' 63' ' ' HIS . 1.2 mp0 -120.38 132.89 23.98 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.4 147.74 66.25 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.775 2.316 . . . . 0.0 112.13 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.34 -171.02 17.05 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.491 -177.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -84.76 111.98 20.09 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . 0.466 ' CE1' ' HB2' ' A' ' 59' ' ' GLU . 25.6 m80 -137.1 145.19 43.59 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.025 0.44 . . . . 0.0 110.932 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.54 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 11.5 m-20 -85.25 125.72 33.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.364 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -121.79 151.79 40.2 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.086 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -90.16 142.8 27.36 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.797 -170.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.626 HG11 HG11 ' A' ' 33' ' ' VAL . 67.5 t -83.15 121.77 36.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.946 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 50.4 tttm -95.4 112.66 24.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.331 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.5 t -92.53 127.09 44.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.695 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 37.5 tt0 -72.21 122.87 88.54 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.979 177.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 50.0 Cg_exo -55.99 125.66 19.82 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.134 2.556 . . . . 0.0 113.062 -176.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.444 HG12 HD13 ' A' ' 49' ' ' LEU . 52.1 mt -88.54 117.1 67.98 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.948 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.86 137.27 37.69 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.318 2.012 . . . . 0.0 112.551 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 71.15 4.38 5.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.264 173.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 58.3 mt -132.06 136.14 57.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -90.41 123.33 34.04 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.43 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.553 ' HA ' HG22 ' A' ' 37' ' ' THR . 16.6 tt -80.28 139.49 18.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.466 HG21 ' HG3' ' A' ' 38' ' ' GLU . 39.4 t -108.05 -69.13 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.069 0.462 . . . . 0.0 110.902 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -107.79 141.66 39.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.864 -171.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.54 ' HA ' HG12 ' A' ' 35' ' ' VAL . 66.3 mt -120.1 110.43 28.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.362 177.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 47.0 m -144.78 123.84 6.92 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.92 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 93.2 Cg_endo -85.32 158.68 63.04 Favored 'Cis proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.123 -3.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -81.58 -35.64 29.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.984 0.421 . . . . 0.0 110.453 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.54 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 71.3 t -130.54 130.61 65.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.445 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.7 m -116.92 141.2 36.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.098 0.475 . . . . 0.0 111.168 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.1 m -80.44 117.51 21.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.229 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.2 mt -113.92 123.44 49.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.854 0.359 . . . . 0.0 110.681 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -88.79 104.37 16.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.078 176.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.9 mt -94.77 127.44 40.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.403 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 25' ' ' MET . 10.4 tp10 -100.41 154.61 18.38 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.686 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -80.62 90.46 5.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.611 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.622 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 22.4 t60 . . . . . 0 C--N 1.326 -0.452 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 120.62 0.248 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.83 125.97 13.95 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.412 2.075 . . . . 0.0 111.983 -178.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.4 m -90.74 116.39 28.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.648 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.585 HD11 HD21 ' A' ' 41' ' ' ASN . 88.8 mt -108.85 131.84 54.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.18 0.514 . . . . 0.0 111.316 -173.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 m -103.86 99.14 8.91 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.823 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.5 mt -106.25 134.35 49.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.043 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -73.45 142.49 46.87 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.787 0.327 . . . . 0.0 110.75 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.751 HD11 HG13 ' A' ' 53' ' ' VAL . 55.4 tp -87.02 122.25 30.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.028 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.4 pt -108.93 153.78 10.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.141 0.496 . . . . 0.0 111.398 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.03 111.22 17.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.968 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -109.37 134.76 51.43 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.981 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.1 t30 62.28 18.15 9.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.707 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.502 HG23 HD12 ' A' ' 55' ' ' LEU . 31.0 m -72.09 118.95 71.61 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.922 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 7.0 Cg_exo -72.89 -179.95 4.74 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.905 2.403 . . . . 0.0 112.365 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 23' ' ' ASN . . . -80.82 161.43 24.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.276 175.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 22' ' ' ALA . 95.3 m-20 75.28 -34.47 0.26 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.532 0.733 . . . . 0.0 111.639 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.4 p -76.91 98.49 4.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.369 0.604 . . . . 0.0 109.695 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . 0.692 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 51.1 ttp -103.0 124.56 48.74 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.639 -174.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.422 HG12 ' CD2' ' A' ' 89' ' ' LEU . 17.4 mt -84.65 97.62 5.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 44.1 ttp -79.05 -20.23 49.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.027 0.441 . . . . 0.0 109.953 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.0 m -75.75 105.97 7.07 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -54.61 132.25 44.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.012 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.51 114.64 29.88 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.438 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -89.2 -161.24 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.936 2.424 . . . . 0.0 112.222 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.3 p -120.81 141.95 50.06 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.793 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.608 HG11 HG11 ' A' ' 67' ' ' VAL . 25.1 m -93.9 142.86 12.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.923 0.392 . . . . 0.0 109.964 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -112.05 93.25 4.36 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.456 0.646 . . . . 0.0 109.444 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 80' ' ' ILE . 30.2 m -99.22 162.55 2.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.676 -175.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 36.0 tttm -123.17 122.99 39.8 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 77' ' ' ILE . 30.5 p -112.77 175.04 5.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.78 -175.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 28.2 tt0 -123.84 117.51 25.02 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.74 -137.35 9.33 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.196 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.531 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 79.2 m-85 -145.02 157.66 44.05 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.585 HD21 HD11 ' A' ' 11' ' ' LEU . 8.2 m120 -114.44 82.03 7.29 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 1.2 Cg_endo -84.84 -68.53 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.781 2.321 . . . . 0.0 112.766 -176.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.6 p -93.72 -14.69 26.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.116 -178.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.4 mt -86.58 117.63 31.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.619 -176.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -84.79 128.16 34.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.931 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.6 m -71.7 -17.11 19.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.198 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -91.2 -0.04 57.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.143 0.497 . . . . 0.0 110.158 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -102.88 -28.22 12.18 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.2 mt -81.99 135.8 35.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.791 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -128.05 156.88 42.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.522 0.677 . . . . 0.0 111.755 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.21 138.45 44.47 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 170.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -136.42 151.68 49.77 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.472 0.653 . . . . 0.0 112.294 -171.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.751 HG13 HD11 ' A' ' 15' ' ' LEU . 4.9 m -112.54 118.11 56.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.433 169.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -88.68 98.5 11.72 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.79 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.502 HD12 HG23 ' A' ' 20' ' ' THR . 60.1 mt -84.97 67.62 10.26 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.35 0.595 . . . . 0.0 110.248 -177.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.44 -20.73 59.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.18 176.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -99.36 142.51 16.05 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.248 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 m -92.94 38.12 1.03 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.646 ' HB2' ' OH ' ' A' ' 65' ' ' TYR . 11.1 mm-40 -66.16 110.22 4.38 Favored Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.765 -177.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -87.58 141.64 5.67 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.996 2.464 . . . . 0.0 111.994 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.21 -168.77 13.9 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.06 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 88' ' ' GLN . 36.3 mt-10 -82.51 97.73 8.58 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -122.77 143.13 50.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.956 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 28.5 m-20 -81.29 119.91 24.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.759 0.314 . . . . 0.0 110.297 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.646 ' OH ' ' HB2' ' A' ' 59' ' ' GLU . 53.6 m-85 -111.03 167.17 10.46 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.15 0.5 . . . . 0.0 111.04 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -106.77 122.63 46.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.626 -173.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.608 HG11 HG11 ' A' ' 33' ' ' VAL . 67.8 t -79.74 113.82 19.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.293 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -100.83 151.4 21.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.708 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.5 t -118.44 141.38 38.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.26 123.21 81.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.65 113.67 1.34 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.002 2.468 . . . . 0.0 112.382 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 48.7 mt -90.94 119.59 68.85 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.757 -176.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 72' ' ' ILE . 11.3 Cg_exo -71.94 149.57 53.52 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.733 2.289 . . . . 0.0 111.647 175.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 72.27 -51.22 0.7 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.589 0.756 . . . . 0.0 111.936 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.7 mt -83.89 134.25 27.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.348 0.594 . . . . 0.0 110.811 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 76.8 tttt -88.87 124.35 34.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.891 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.457 ' HA ' HG22 ' A' ' 37' ' ' THR . 18.0 tt -87.98 133.49 30.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.701 HG12 ' HG3' ' A' ' 79' ' ' GLU . 43.5 t -112.26 -59.89 3.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.106 0.479 . . . . 0.0 111.849 -171.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.701 ' HG3' HG12 ' A' ' 78' ' ' VAL . 46.2 mt-10 -125.23 102.79 7.62 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.084 -172.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.563 ' HA ' HG12 ' A' ' 35' ' ' VAL . 53.0 mt -80.18 118.79 28.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 171.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 36.5 m -141.58 116.48 7.0 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-O 120.548 0.213 . . . . 0.0 110.915 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.479 ' HD2' HG12 ' A' ' 33' ' ' VAL . 94.6 Cg_endo -87.68 -177.24 12.92 Favored 'Cis proline' 0 C--N 1.343 0.252 0 C-N-CA 123.701 -1.374 . . . . 0.0 112.358 -2.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 83' ' ' ARG . 52.0 mtm180 -122.7 -35.94 2.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.837 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.13 117.74 55.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.042 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.1 m -128.39 135.38 62.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.031 0.443 . . . . 0.0 110.846 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 3.9 m -80.09 99.53 7.76 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.097 177.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.554 ' HB2' ' HD2' ' A' ' 65' ' ' TYR . 80.2 mt -96.0 120.98 37.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.035 0.445 . . . . 0.0 109.892 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 59.3 tt0 -86.75 97.7 10.75 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.093 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 89' ' ' LEU . 28.0 mt -82.04 109.57 16.49 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.626 0.727 . . . . 0.0 109.698 175.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -101.28 175.29 5.63 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.674 -175.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -91.55 110.44 21.75 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.603 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.692 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 36.7 t-80 . . . . . 0 C--N 1.328 -0.357 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.009 0.433 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -89.21 144.76 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.884 2.39 . . . . 0.0 113.85 -175.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 21.2 m -88.11 109.19 19.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.291 171.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.3 tp -86.64 136.2 33.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.981 -174.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.1 m -101.15 119.26 38.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.432 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.2 mt -129.45 152.92 48.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.218 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 p -88.55 151.5 22.46 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.98 0.419 . . . . 0.0 111.091 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.651 HD11 HG13 ' A' ' 53' ' ' VAL . 38.6 tp -92.63 139.31 30.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.293 178.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.0 pt -127.78 160.33 37.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.441 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.417 ' HB1' HD12 ' A' ' 55' ' ' LEU . . . -109.11 129.12 55.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.365 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -120.29 131.87 55.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.092 0.472 . . . . 0.0 111.248 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.6 t30 61.72 46.27 7.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.53 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.524 ' HB ' HD12 ' A' ' 55' ' ' LEU . 12.1 t -79.36 138.18 55.73 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -52.51 146.82 32.08 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.811 2.341 . . . . 0.0 112.74 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.54 -35.56 79.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.825 -176.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -100.74 20.31 15.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.796 0.331 . . . . 0.0 111.861 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.4 p -110.61 127.39 55.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 43.1 ttp -112.6 126.5 55.42 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.228 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.1 mt -84.95 111.7 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.396 -175.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 95.5 mmm -83.57 -42.52 16.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.993 0.425 . . . . 0.0 110.439 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.2 m -74.26 127.25 32.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.734 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -71.96 139.91 48.88 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.697 173.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 64.2 mt -71.78 115.73 40.83 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.79 -173.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 22.5 Cg_exo -65.32 172.56 7.49 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.312 2.675 . . . . 0.0 113.627 -174.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.8 t -102.9 125.21 49.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.218 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.581 HG11 HG11 ' A' ' 67' ' ' VAL . 13.2 m -90.59 153.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.976 0.417 . . . . 0.0 110.615 -176.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -130.04 101.62 5.91 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.705 HG11 HG21 ' A' ' 69' ' ' VAL . 34.9 m -104.41 135.05 44.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.859 -175.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 62.9 tttp -83.62 121.35 27.13 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.501 HG22 ' HA ' ' A' ' 77' ' ' ILE . 20.9 p -121.95 155.35 35.7 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.497 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.51 ' HG3' ' HB3' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -121.1 119.44 32.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.978 0.418 . . . . 0.0 110.13 176.033 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.9 169.24 12.75 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.032 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -96.0 136.92 35.81 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.481 ' HB3' ' CD1' ' A' ' 75' ' ' ILE . 19.6 p30 -128.96 55.35 17.71 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -67.18 -56.71 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.689 1.593 . . . . 0.0 111.987 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.8 m -114.64 38.39 3.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.088 0.471 . . . . 0.0 111.06 -176.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.3 mt -114.66 142.71 26.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.798 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -80.63 41.28 0.55 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 111.008 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.442 HG23 ' OD1' ' A' ' 47' ' ' ASN . 11.9 m -61.27 -36.19 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.126 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.442 ' OD1' HG23 ' A' ' 46' ' ' VAL . 2.9 m-20 -79.4 -5.43 54.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.099 0.475 . . . . 0.0 110.604 -178.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -106.9 -10.84 15.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.736 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.2 mt -82.25 125.22 30.7 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 171.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -109.5 170.76 7.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.66 0.743 . . . . 0.0 112.353 -171.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.478 ' HB2' HG22 ' A' ' 69' ' ' VAL . . . -106.73 137.96 43.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.891 174.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.558 ' CZ ' ' HD3' ' A' ' 68' ' ' LYS . 27.2 p90 -135.29 158.08 45.28 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.615 -178.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.651 HG13 HD11 ' A' ' 15' ' ' LEU . 23.1 m -112.47 141.96 26.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.583 174.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -89.48 118.04 28.83 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.524 HD12 ' HB ' ' A' ' 20' ' ' THR . 85.6 mt -109.16 25.76 11.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.591 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.2 m -73.49 95.32 2.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.309 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.82 23.03 14.25 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.601 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.6 p -88.57 122.96 32.6 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.782 -0.246 . . . . 0.0 110.566 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -75.32 155.08 86.08 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.085 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.54 90.99 0.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.59 2.193 . . . . 0.0 112.029 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.05 172.87 42.86 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 88' ' ' GLN . 40.0 tt0 -82.24 105.47 13.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -130.61 167.9 17.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.347 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.431 ' HB3' HG11 ' A' ' 84' ' ' VAL . 13.6 m-20 -98.59 121.84 41.04 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.351 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -116.89 128.09 54.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.104 -178.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.425 ' HG2' HG22 ' A' ' 84' ' ' VAL . 46.8 mt-10 -69.95 134.61 48.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.204 -175.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.581 HG11 HG11 ' A' ' 33' ' ' VAL . 59.4 t -78.92 112.18 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.546 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.558 ' HD3' ' CZ ' ' A' ' 52' ' ' TYR . 53.6 tttm -102.88 102.63 12.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.388 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.705 HG21 HG11 ' A' ' 35' ' ' VAL . 39.4 t -86.86 125.5 40.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -63.86 127.67 91.93 Favored Pre-proline 0 C--N 1.323 -0.58 0 O-C-N 123.198 0.311 . . . . 0.0 110.958 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.35 137.52 47.28 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.617 2.878 . . . . 0.0 112.92 -175.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.471 ' CG2' ' HB ' ' A' ' 75' ' ' ILE . 30.5 mm -89.17 126.89 57.37 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.262 -177.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.1 131.04 29.1 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.286 1.991 . . . . 0.0 111.725 176.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.3 t30 73.79 -44.42 0.57 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.538 0.735 . . . . 0.0 111.998 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.481 ' CD1' ' HB3' ' A' ' 41' ' ' ASN . 71.5 mt -83.94 140.84 15.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.946 0.403 . . . . 0.0 110.682 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.51 ' HB3' ' HG3' ' A' ' 38' ' ' GLU . 57.3 tttp -94.84 125.71 39.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.387 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.501 ' HA ' HG22 ' A' ' 37' ' ' THR . 14.0 tt -88.36 122.21 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.498 0.666 . . . . 0.0 109.94 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.3 t -85.31 -64.57 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.069 -175.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -130.51 136.8 49.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.113 -170.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.635 ' HA ' HG12 ' A' ' 35' ' ' VAL . 67.5 mt -104.41 108.26 24.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.203 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.455 ' HA ' ' C ' ' A' ' 82' ' ' PRO . 11.6 p -136.13 126.93 16.74 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.735 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.455 ' C ' ' HA ' ' A' ' 81' ' ' SER . 15.3 Cg_exo -68.51 156.85 88.81 Favored 'Cis proline' 0 C--N 1.344 0.32 0 C-N-CA 123.55 -1.438 . . . . 0.0 112.508 0.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -85.23 -38.1 19.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.746 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.431 HG11 ' HB3' ' A' ' 64' ' ' ASP . 59.3 t -137.86 143.58 33.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.375 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 m -118.26 140.03 43.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.957 0.408 . . . . 0.0 111.011 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 m -92.36 105.2 17.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.04 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.9 mt -105.37 124.91 50.34 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.761 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 47.0 tt0 -85.8 99.88 11.66 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.012 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.2 mt -88.22 139.52 30.41 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.14 174.0 7.22 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.74 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -83.89 137.57 33.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.36 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 68.6 t60 . . . . . 0 C--N 1.328 -0.327 0 CA-C-O 121.686 0.755 . . . . 0.0 109.296 173.788 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.476 0.857 0 CA-C-O 120.541 0.21 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.3 p -114.15 152.99 30.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.523 0.201 . . . . 0.0 110.671 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -66.28 -49.6 66.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.095 0.474 . . . . 0.0 109.971 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.5 m -107.91 111.09 23.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.612 173.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -69.04 153.16 44.24 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -65.68 -28.76 69.31 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.526 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 37.5 ttt180 62.14 34.67 16.14 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.227 175.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 26.6 p-10 -112.82 85.96 8.27 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.799 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.526 ' HD3' ' O ' ' A' ' 7' ' ' ARG . 8.1 Cg_exo -71.72 152.97 59.37 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.603 2.202 . . . . 0.0 112.051 -178.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.6 m -107.39 113.13 26.3 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.707 175.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.514 HD21 HD21 ' A' ' 41' ' ' ASN . 93.1 mt -90.23 127.84 36.23 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.087 0.47 . . . . 0.0 110.511 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -103.64 102.93 12.8 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.305 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -102.89 144.14 31.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.286 -177.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.2 m -76.86 143.96 39.33 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 175.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.813 HD11 HG13 ' A' ' 53' ' ' VAL . 52.7 tp -88.32 127.32 35.48 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.8 pt -122.77 171.17 12.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.933 0.396 . . . . 0.0 110.842 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.506 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -107.11 122.21 46.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.158 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -114.95 139.89 49.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.594 0.235 . . . . 0.0 110.679 -177.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.8 t30 56.13 32.04 19.38 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.392 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.506 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 89.6 m -90.02 114.74 61.96 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.311 -176.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.7 163.87 37.54 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.758 2.306 . . . . 0.0 111.561 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.92 -13.29 59.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.855 0.36 . . . . 0.0 110.598 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -67.19 -35.02 78.74 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.885 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.8 p -95.24 102.67 14.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.602 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 52.6 ttp -102.79 111.98 24.56 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.061 0.458 . . . . 0.0 110.56 -174.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 28' ' ' THR . 21.6 mt -75.44 113.46 14.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.414 -179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 84.9 mtp -99.78 10.86 40.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.426 0.631 . . . . 0.0 110.103 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 26' ' ' ILE . 9.3 m -105.39 119.19 38.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.827 176.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -60.78 136.07 57.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.713 0.292 . . . . 0.0 110.335 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 97.7 mt -81.86 122.9 80.47 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.419 -171.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.536 ' HD2' HD23 ' A' ' 15' ' ' LEU . 87.4 Cg_endo -83.55 -164.88 0.28 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 123.207 2.605 . . . . 0.0 112.803 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 15.2 t -125.35 144.91 50.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.074 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.4 p -104.21 144.42 14.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.187 -0.46 . . . . 0.0 109.808 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 35.6 mtm-85 -118.08 99.21 6.74 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 80' ' ' ILE . 21.2 m -98.85 128.76 50.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.328 0.585 . . . . 0.0 111.497 -174.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.526 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 85.4 tttt -80.6 124.26 28.83 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.461 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 13.1 p -126.11 138.91 53.72 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 112.473 0.545 . . . . 0.0 112.473 -173.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.869 ' HB2' ' HB2' ' A' ' 76' ' ' LYS . 40.1 mt-10 -93.95 89.62 6.15 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 172.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 161.7 136.56 2.02 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -178.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -104.39 135.8 45.16 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.101 -175.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.617 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 6.1 p30 -135.07 102.49 10.97 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-O 121.329 0.585 . . . . 0.0 111.158 -177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -88.01 -10.05 5.13 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.341 2.027 . . . . 0.0 111.693 174.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.9 p -113.19 -45.08 3.18 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.508 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' A' ' 41' ' ' ASN . 57.1 mt -57.85 136.5 21.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 120.96 0.41 . . . . 0.0 110.666 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.451 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 14.3 m120 -101.67 147.38 26.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.816 -176.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 30.9 m -80.85 -5.88 9.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.293 0.568 . . . . 0.0 110.042 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -93.01 -19.27 21.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.996 169.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 45' ' ' ASN . 76.9 tt0 -80.78 -32.61 35.39 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.219 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.6 mt -94.37 138.52 32.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.234 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -133.3 152.65 51.94 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.388 0.613 . . . . 0.0 111.552 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . . . -110.78 125.08 53.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.138 -0.937 . . . . 0.0 108.505 171.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -121.24 159.41 26.01 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.309 0.576 . . . . 0.0 111.718 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.813 HG13 HD11 ' A' ' 15' ' ' LEU . 11.4 m -112.5 123.52 68.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.048 171.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -78.0 110.47 12.97 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.441 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.436 HD22 HD11 ' A' ' 89' ' ' LEU . 55.4 mt -106.87 29.31 7.14 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.693 -179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 48.8 m -57.85 -43.78 86.12 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.758 174.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.81 84.76 1.3 Allowed Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 173.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.6 p -71.09 91.09 0.89 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.045 0.45 . . . . 0.0 111.995 -173.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -101.33 107.73 52.0 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.01 175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.32 152.18 75.83 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.904 2.402 . . . . 0.0 112.292 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 110.05 -179.38 20.52 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' HG2' HG22 ' A' ' 86' ' ' THR . 32.2 tt0 -80.14 102.98 9.7 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 176.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -129.12 143.34 50.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.593 -172.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.493 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 26.8 m-20 -81.74 124.98 30.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.226 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -120.92 151.18 40.0 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.463 178.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -85.13 134.52 34.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.124 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.482 HG13 HD13 ' A' ' 15' ' ' LEU . 68.7 t -79.13 106.4 10.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 174.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -99.67 106.08 17.97 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.517 -177.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 42.4 t -87.12 134.9 26.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.088 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -63.73 135.33 96.24 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.323 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.54 132.3 44.76 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 123.083 2.522 . . . . 0.0 112.61 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.7 mp -97.53 121.05 59.36 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.052 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.56 119.32 6.47 Favored 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.979 2.453 . . . . 0.0 113.0 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.3 m120 69.17 15.08 8.68 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.207 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.511 HD11 ' HB3' ' A' ' 41' ' ' ASN . 57.4 mt -129.53 130.12 67.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.869 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 97.1 mttt -80.89 137.42 36.16 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.855 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.8 tt -93.41 116.88 35.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.408 0.623 . . . . 0.0 109.659 172.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.7 t -95.63 -50.29 11.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.253 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.526 ' HB2' ' H ' ' A' ' 36' ' ' LYS . 50.1 mt-10 -118.76 157.74 26.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.087 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.597 ' HA ' HG12 ' A' ' 35' ' ' VAL . 18.9 tt -144.55 25.21 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 122.163 0.982 . . . . 0.0 108.985 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.531 ' HA ' ' N ' ' A' ' 83' ' ' ARG . 16.1 m -85.79 142.86 37.19 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.377 -175.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 81' ' ' SER . 17.4 Cg_exo -67.15 124.39 5.97 Favored 'Cis proline' 0 C--N 1.346 0.425 0 C-N-CA 123.633 -1.403 . . . . 0.0 111.921 -1.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.531 ' N ' ' HA ' ' A' ' 81' ' ' SER . 70.3 mtm180 -69.72 -31.14 68.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.712 -173.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 43.9 t -127.58 134.98 64.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.699 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 m -120.73 133.26 67.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.195 0.521 . . . . 0.0 110.453 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.469 HG22 ' HG2' ' A' ' 62' ' ' GLU . 4.2 m -87.26 101.38 13.48 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.983 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.3 mt -107.05 134.52 50.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.226 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 62.4 tt0 -95.34 103.12 14.97 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.013 0.435 . . . . 0.0 110.443 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.436 HD11 HD22 ' A' ' 55' ' ' LEU . 49.4 mt -82.46 120.05 24.97 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.474 175.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.62 149.88 23.3 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.1 -178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -71.0 124.53 24.58 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.504 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.3 t-80 -85.35 -8.96 58.19 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -114.18 120.55 40.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.874 172.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -124.91 173.24 8.77 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.788 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . 0.485 ' O ' ' HB2' ' A' ' 96' ' ' HIS . 68.0 m-70 -91.98 -65.97 0.96 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 172.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 95' ' ' HIS . 36.2 t-80 . . . . . 0 C--O 1.242 0.704 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.624 169.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 38.8 m . . . . . 0 N--CA 1.475 0.782 0 CA-C-O 120.607 0.242 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 m -70.76 132.74 45.8 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.375 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -74.9 -45.82 40.11 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.074 0.464 . . . . 0.0 110.936 -174.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.1 p -75.96 -0.42 21.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.628 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 48.0 tp -85.66 -18.02 34.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.21 0.529 . . . . 0.0 109.69 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.75 -14.96 59.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.55 0.691 . . . . 0.0 109.936 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 81.2 mtt-85 -108.34 133.1 53.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.519 177.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.426 ' HB3' ' HA ' ' A' ' 38' ' ' GLU . 10.2 m-20 52.32 85.46 0.19 Allowed Pre-proline 0 N--CA 1.467 0.39 0 O-C-N 123.909 0.756 . . . . 0.0 111.245 172.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.18 147.88 23.82 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.647 2.231 . . . . 0.0 113.567 -173.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 67.9 m -90.72 109.18 20.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.522 171.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 69.6 mt -83.12 138.51 33.65 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.217 0.532 . . . . 0.0 110.876 -175.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.3 m -109.96 102.05 10.83 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.926 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.44 HD22 ' HB2' ' A' ' 49' ' ' LEU . 44.3 mt -101.78 155.3 18.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.106 -176.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 9.6 m -88.53 143.48 26.94 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.831 HD11 HG13 ' A' ' 53' ' ' VAL . 52.6 tp -94.91 127.04 40.65 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.7 pt -124.05 160.61 27.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.036 0.446 . . . . 0.0 111.392 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -88.33 115.73 26.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.308 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.581 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 18.3 tptm -114.29 141.12 47.99 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 -177.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.3 m-20 63.34 20.95 12.56 Favored 'General case' 0 N--CA 1.466 0.375 0 O-C-N 123.67 0.606 . . . . 0.0 110.579 178.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.456 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 43.1 m -83.17 118.77 72.66 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.845 -173.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 2.9 Cg_exo -76.12 154.58 37.44 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.298 2.665 . . . . 0.0 112.194 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.9 -1.93 21.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.224 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -80.92 -29.12 35.59 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.071 0.463 . . . . 0.0 110.553 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.8 p -107.16 128.71 54.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.152 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.773 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 58.0 ttp -119.11 126.78 52.44 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.033 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 28' ' ' THR . 13.9 mt -84.83 115.14 26.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.558 -174.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 94.1 mmm -80.63 -7.98 59.47 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.306 0.574 . . . . 0.0 110.189 178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.474 ' H ' HG22 ' A' ' 26' ' ' ILE . 19.2 m -99.23 118.39 35.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.579 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -66.31 132.89 49.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.781 0.324 . . . . 0.0 110.677 177.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.4 mt -75.45 122.26 86.85 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.415 -173.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HD2' HD23 ' A' ' 15' ' ' LEU . 95.2 Cg_endo -89.49 -157.71 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.183 2.588 . . . . 0.0 112.628 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 14.5 p -113.71 160.63 18.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.419 ' CG1' ' HB2' ' A' ' 13' ' ' LEU . 11.3 p -112.91 139.4 38.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.83 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 84.0 mtt85 -111.31 109.59 19.67 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.061 0.458 . . . . 0.0 110.8 -178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 80' ' ' ILE . 25.2 m -117.24 111.69 35.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.085 -177.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.606 ' HB3' ' HG2' ' A' ' 79' ' ' GLU . 6.5 ttpm? -74.77 125.95 29.86 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 174.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.532 HG22 ' HA ' ' A' ' 77' ' ' ILE . 25.3 p -124.66 138.07 54.32 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.649 -0.25 . . . . 0.0 111.056 -176.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.426 ' HA ' ' HB3' ' A' ' 8' ' ' ASP . 48.9 mt-10 -94.64 135.46 36.08 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.366 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.35 -168.4 12.89 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.832 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -132.9 140.2 47.76 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.914 0.388 . . . . 0.0 110.673 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.58 ' N ' HD22 ' A' ' 41' ' ' ASN . 0.0 OUTLIER -160.92 80.47 2.19 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.996 178.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.66 -24.28 11.96 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.881 2.387 . . . . 0.0 112.53 -176.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.9 p -84.35 -12.98 53.57 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.695 -176.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.4 mt -103.21 111.08 31.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 178.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -95.47 151.72 19.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.096 0.474 . . . . 0.0 111.745 -174.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.5 m -69.4 -13.47 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.358 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -85.5 -9.63 57.17 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.24 0.543 . . . . 0.0 109.707 177.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -105.22 -26.33 12.09 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.754 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.44 ' HB2' HD22 ' A' ' 13' ' ' LEU . 91.2 mt -88.64 132.32 34.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.831 175.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -125.19 154.06 42.14 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.613 0.72 . . . . 0.0 111.791 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -120.85 134.98 55.28 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.494 171.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.581 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 18.9 p90 -129.12 161.02 31.01 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 121.321 0.581 . . . . 0.0 111.411 -174.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.831 HG13 HD11 ' A' ' 15' ' ' LEU . 5.7 m -112.29 118.38 57.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 175.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.418 ' HB2' ' HD2' ' A' ' 68' ' ' LYS . 16.4 t0 -78.06 105.08 9.03 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.526 -175.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 58' ' ' SER . 64.0 mt -104.73 35.57 2.72 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.755 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.0 m -60.28 -38.63 84.18 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -102.56 53.33 0.78 Allowed Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.276 173.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.613 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 23.1 t -74.18 107.08 6.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.049 0.452 . . . . 0.0 110.865 -177.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 44.2 mt-10 -104.69 126.2 31.91 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.26 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 59' ' ' GLU . 51.1 Cg_exo -55.3 141.23 81.57 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.961 2.441 . . . . 0.0 111.932 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.44 175.29 19.17 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 -176.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.45 107.77 13.52 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 34.6 m80 -134.0 156.78 47.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.982 -176.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -95.7 125.84 40.56 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.194 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -121.7 161.68 22.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.823 0.344 . . . . 0.0 110.664 -178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -93.86 138.13 32.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.987 -175.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.1 t -88.35 121.29 38.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.985 174.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.418 ' HD2' ' HB2' ' A' ' 54' ' ' ASP . 96.9 mttt -105.06 127.12 52.74 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.002 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.3 t -109.14 138.64 35.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.14 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -68.59 139.48 91.55 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.62 150.5 86.4 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.113 2.542 . . . . 0.0 112.577 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 75' ' ' ILE . 11.5 mt -122.26 118.58 28.89 Favored Pre-proline 0 C--N 1.327 -0.407 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -56.9 114.81 2.09 Favored 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 123.277 2.651 . . . . 0.0 113.479 -175.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.3 m120 70.85 11.37 7.11 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.321 174.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 72' ' ' ILE . 41.3 mm -107.81 121.79 61.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.12 0.486 . . . . 0.0 110.472 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -80.66 114.81 19.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.425 -177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.532 ' HA ' HG22 ' A' ' 37' ' ' THR . 16.0 tt -87.94 115.7 28.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.466 0.651 . . . . 0.0 109.918 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.98 -53.02 9.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.64 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.606 ' HG2' ' HB3' ' A' ' 36' ' ' LYS . 66.8 mm-40 -106.64 146.76 30.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.509 -176.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.565 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 26.8 mt -133.71 81.83 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 165.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 17.7 m -118.58 116.34 35.01 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.719 -175.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 72.8 Cg_endo -94.33 158.33 17.42 Favored 'Cis proline' 0 C--N 1.346 0.41 0 C-N-CA 124.131 -1.195 . . . . 0.0 113.302 -0.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.565 ' HG3' ' O ' ' A' ' 80' ' ' ILE . 61.2 mtm180 -96.43 -31.99 12.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.592 174.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 46.0 t -119.84 122.17 67.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.019 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.1 m -121.55 138.86 50.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.917 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.6 m -88.81 102.73 15.31 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.067 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.6 mt -101.22 128.44 47.34 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.016 0.436 . . . . 0.0 110.933 -175.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -91.36 103.6 16.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.183 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.471 ' CD2' HG12 ' A' ' 26' ' ' ILE . 96.0 mt -97.05 128.68 44.24 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.064 0.459 . . . . 0.0 110.728 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -119.33 178.76 4.41 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.482 178.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 59.1 m80 -80.55 114.79 19.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.281 -176.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.773 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 74.5 t60 -83.55 -16.57 44.92 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.245 0.545 . . . . 0.0 109.66 176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -122.78 101.94 7.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.572 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 68.25 110.13 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 O-C-N 124.075 0.859 . . . . 0.0 111.11 -176.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -110.19 -62.22 1.55 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.175 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 78.7 t60 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.03 -179.811 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.7 p . . . . . 0 N--CA 1.478 0.946 0 CA-C-O 120.677 0.275 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.1 p -148.13 -30.6 0.29 Allowed 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.169 -0.212 . . . . 0.0 111.414 -177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 66.27 15.46 10.1 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.537 -173.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.3 m -86.44 90.29 8.16 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.601 177.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 82.8 mt -67.32 -56.08 11.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.344 -178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -85.03 122.45 29.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.528 174.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.48 ' HG2' ' OH ' ' A' ' 40' ' ' TYR . 7.1 mtt180 -91.65 -3.82 55.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.615 0.721 . . . . 0.0 110.568 -170.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.488 ' HB3' ' HG2' ' A' ' 38' ' ' GLU . 0.9 OUTLIER -127.29 75.35 77.14 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.848 168.395 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -84.24 151.59 12.22 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 123.676 2.917 . . . . 0.0 113.509 -170.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 37.9 m -95.25 109.88 21.94 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.632 174.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 89.8 mt -87.43 137.99 31.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.027 0.441 . . . . 0.0 110.603 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 m -102.63 95.77 6.44 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.071 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 45.1 mt -101.74 120.11 39.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.192 -175.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 32' ' ' SER . 48.6 m -63.35 140.81 58.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.879 0.371 . . . . 0.0 111.406 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.826 HD11 HG13 ' A' ' 53' ' ' VAL . 40.3 tp -84.01 123.58 30.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.788 178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.4 pt -109.83 146.17 15.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.04 0.448 . . . . 0.0 111.58 -177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.6 94.16 5.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.126 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -96.31 131.51 42.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.026 -176.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.1 t30 58.62 39.18 24.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.755 0.788 . . . . 0.0 109.933 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 63.8 m -88.59 124.81 65.04 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.638 -177.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.867 ' HG2' ' HB3' ' A' ' 58' ' ' SER . 17.0 Cg_exo -67.51 175.76 5.69 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.0 2.466 . . . . 0.0 112.756 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' A' ' 92' ' ' HIS . . . -94.2 -6.59 44.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.88 179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 67.7 m-20 -88.65 -23.64 22.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.018 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.9 p -114.74 112.45 22.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.834 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.0 ttp -105.69 132.7 51.51 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.7 mt -81.31 118.77 29.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 120.759 0.314 . . . . 0.0 110.718 -176.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 83.6 mtp -74.18 -52.5 12.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.106 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 m -70.27 110.14 5.08 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.4 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -63.26 133.96 55.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.089 0.471 . . . . 0.0 110.63 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.453 HD22 HD23 ' A' ' 15' ' ' LEU . 50.3 mt -71.54 129.41 88.69 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.454 -173.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -92.32 -170.89 0.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 123.37 2.713 . . . . 0.0 111.933 175.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.622 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 24.8 m -105.39 135.6 46.47 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.545 HG11 HG11 ' A' ' 67' ' ' VAL . 10.9 m -86.26 145.22 8.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.789 0.328 . . . . 0.0 110.201 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.5 mtp85 -111.51 101.59 10.0 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.123 0.487 . . . . 0.0 109.937 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.633 HG12 ' HA ' ' A' ' 80' ' ' ILE . 26.8 m -110.7 137.04 44.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.757 -177.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 61.1 tttp -85.9 129.66 34.77 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 27.2 p -126.36 175.22 8.0 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.174 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.488 ' HG2' ' HB3' ' A' ' 8' ' ' ASP . 35.8 mt-10 -139.07 137.63 36.39 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.704 0.288 . . . . 0.0 110.651 176.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.5 -175.28 17.46 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.552 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.48 ' OH ' ' HG2' ' A' ' 7' ' ' ARG . 82.0 m-85 -118.15 126.64 52.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.661 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 4.2 p30 -130.48 62.69 66.2 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.166 178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.52 -29.83 36.55 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.139 1.893 . . . . 0.0 111.954 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.8 p -91.15 -1.25 57.77 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.57 -177.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.661 ' HB ' ' HB2' ' A' ' 41' ' ' ASN . 61.2 mt -109.95 126.64 67.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.777 0.322 . . . . 0.0 110.47 -178.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.411 ' ND2' ' HG3' ' A' ' 48' ' ' GLU . 39.8 t30 -85.58 110.92 19.58 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.405 0.621 . . . . 0.0 110.912 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.6 t -59.93 -27.35 38.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.336 -177.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -71.02 -28.03 64.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.862 0.363 . . . . 0.0 111.174 -178.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.411 ' HG3' ' ND2' ' A' ' 45' ' ' ASN . 40.9 mt-10 -91.3 -12.17 35.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.096 0.474 . . . . 0.0 110.652 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 93.6 mt -77.06 129.7 36.42 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 167.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -131.92 162.38 30.79 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.86 0.838 . . . . 0.0 112.564 -174.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -109.74 127.86 54.9 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.481 -1.236 . . . . 0.0 107.907 169.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -123.66 144.03 49.89 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.355 0.598 . . . . 0.0 112.036 -172.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.826 HG13 HD11 ' A' ' 15' ' ' LEU . 7.0 m -112.47 131.48 63.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.159 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.53 115.73 28.39 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.679 -0.408 . . . . 0.0 109.982 -175.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 66.1 mt -105.6 51.97 0.74 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.44 -175.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.1 m -57.32 -47.33 81.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.307 0.575 . . . . 0.0 109.661 173.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -86.11 100.14 2.47 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.501 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.867 ' HB3' ' HG2' ' A' ' 21' ' ' PRO . 1.5 p -73.18 87.8 1.45 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.969 0.414 . . . . 0.0 110.5 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.412 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 27.4 mt-10 -102.82 110.21 62.86 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.08 -174.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 59' ' ' GLU . 38.9 Cg_endo -66.95 141.32 57.95 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.59 2.194 . . . . 0.0 112.294 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 107.22 -172.24 17.64 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.67 -178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.513 ' HG3' ' HG2' ' A' ' 88' ' ' GLN . 1.9 mp0 -87.46 89.15 7.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.789 0.328 . . . . 0.0 110.253 -178.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 38.1 m-70 -104.97 148.35 26.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.442 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -92.19 122.76 34.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.998 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -118.87 147.66 43.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.694 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.526 ' HG2' HG22 ' A' ' 84' ' ' VAL . 36.2 mt-10 -93.79 132.19 38.42 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.888 0.375 . . . . 0.0 110.513 -172.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.545 HG11 HG11 ' A' ' 33' ' ' VAL . 59.8 t -73.22 106.83 3.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.647 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -86.97 109.48 19.39 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.804 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.4 t -86.76 123.26 39.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -62.52 119.53 51.21 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.57 110.01 0.52 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.108 2.539 . . . . 0.0 112.704 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.3 mt -82.73 114.48 52.4 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.873 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.31 140.78 54.25 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.427 2.085 . . . . 0.0 112.141 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.4 t30 76.31 -2.78 2.66 Favored 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.86 0.725 . . . . 0.0 111.015 177.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.4 mm -116.62 144.85 23.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.982 0.42 . . . . 0.0 110.543 -177.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -98.91 137.39 37.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.211 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.6 tt -104.64 133.77 47.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 37.7 t -102.54 -63.36 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.916 0.389 . . . . 0.0 111.222 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -135.46 143.18 45.74 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.574 -170.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.633 ' HA ' HG12 ' A' ' 35' ' ' VAL . 57.9 mt -112.32 127.07 69.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.335 -178.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 51.2 m -146.39 114.31 4.47 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 120.636 0.255 . . . . 0.0 110.957 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.461 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 2.8 Cg_endo -83.13 172.33 48.43 Favored 'Cis proline' 0 C--N 1.343 0.254 0 C-N-CA 123.803 -1.332 . . . . 0.0 111.964 -2.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.8 mtt180 -99.56 -45.25 5.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.369 0.604 . . . . 0.0 109.893 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.526 HG22 ' HG2' ' A' ' 66' ' ' GLU . 59.9 t -128.11 125.6 64.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.344 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.5 m -113.26 139.34 39.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.173 0.511 . . . . 0.0 111.006 -177.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.4 m -86.61 106.54 17.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.068 178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 87.7 mt -101.34 127.86 47.78 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.213 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.513 ' HG2' ' HG3' ' A' ' 62' ' ' GLU . 48.2 mt-30 -90.21 105.39 17.78 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.654 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 76.4 mt -95.24 126.42 40.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.217 0.532 . . . . 0.0 110.799 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -108.73 153.51 23.35 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.144 177.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -76.68 113.43 14.32 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.168 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.473 ' HB3' ' O ' ' A' ' 22' ' ' ALA . 79.4 t60 -72.71 -25.27 61.17 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 169.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -138.31 124.67 20.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.163 -1.381 . . . . 0.0 107.904 165.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -67.99 -76.71 0.08 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.941 0.401 . . . . 0.0 110.051 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -178.28 -36.79 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 25.8 t60 . . . . . 0 C--O 1.244 0.765 0 CA-C-O 118.489 -0.767 . . . . 0.0 108.969 175.455 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.475 0.812 0 CA-C-O 121.151 0.501 . . . . 0.0 109.886 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.0 t -92.46 173.58 7.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.368 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -85.78 -1.37 57.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.246 0.546 . . . . 0.0 110.297 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.0 p -83.51 16.68 2.49 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.005 178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 5' ' ' LEU . 38.5 tp -112.17 16.07 20.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.193 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -114.03 99.13 7.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.815 -177.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 63.71 -78.95 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.488 ' HA ' ' HD3' ' A' ' 9' ' ' PRO . 8.0 p-10 -63.46 112.11 6.46 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-O 121.522 0.677 . . . . 0.0 111.135 -171.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 8' ' ' ASP . 66.6 Cg_endo -99.42 173.53 0.41 Allowed 'Trans proline' 0 N--CA 1.451 -1.027 0 C-N-CA 123.693 2.928 . . . . 0.0 113.948 -175.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 3.7 m -107.38 130.97 54.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.404 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 45.7 tp -102.87 135.38 44.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.894 0.378 . . . . 0.0 110.012 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.4 m -100.68 106.33 17.78 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.096 0.474 . . . . 0.0 110.754 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.493 ' HB2' ' CG2' ' A' ' 33' ' ' VAL . 92.0 mt -102.8 158.32 16.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.068 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.4 t -97.86 138.61 34.95 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.501 HD11 HG13 ' A' ' 53' ' ' VAL . 46.9 tp -79.93 124.59 28.81 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 173.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.45 HG13 ' HB3' ' A' ' 52' ' ' TYR . 43.8 pt -116.61 156.95 17.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.146 0.498 . . . . 0.0 111.249 -178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.474 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -87.84 118.68 27.53 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.668 177.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -115.78 132.1 56.74 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.542 -176.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.732 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 95.3 m-20 60.34 26.31 15.83 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.104 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.474 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 50.7 m -79.58 119.51 77.12 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.937 -177.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 27.9 Cg_exo -62.56 158.74 39.81 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 123.14 2.56 . . . . 0.0 112.356 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.77 -8.03 59.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.026 0.441 . . . . 0.0 110.635 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 -88.19 -5.86 58.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.611 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.0 p -114.55 131.2 56.75 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.863 -178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.548 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 49.7 ttp -124.93 120.58 32.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.96 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.458 HG12 ' CD2' ' A' ' 89' ' ' LEU . 8.1 mt -82.08 123.5 38.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 45.6 ttp -74.81 -57.47 3.89 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.091 0.472 . . . . 0.0 110.011 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.3 t -70.58 154.14 42.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.57 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -94.15 141.16 28.87 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.889 0.376 . . . . 0.0 110.6 -178.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 65.4 mt -67.4 114.32 18.51 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.229 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 2.8 Cg_exo -73.76 172.95 14.78 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.695 2.263 . . . . 0.0 112.906 -174.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.2 m -82.48 134.35 35.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.364 175.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.493 ' CG2' ' HB2' ' A' ' 13' ' ' LEU . 33.7 m -95.32 138.12 21.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.149 0.499 . . . . 0.0 110.038 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.437 ' HG3' ' CG2' ' A' ' 10' ' ' THR . 9.7 ttp180 -104.84 103.66 13.29 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.958 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.553 HG12 ' HA ' ' A' ' 80' ' ' ILE . 25.9 m -117.38 126.11 74.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.096 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 42.3 tttt -93.08 141.92 27.88 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 8' ' ' ASP . 32.9 p -118.33 144.56 45.77 Favored 'General case' 0 C--N 1.321 -0.651 0 O-C-N 123.357 0.41 . . . . 0.0 110.996 -177.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.608 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 31.6 tt0 -96.37 107.36 19.72 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 146.0 -138.71 7.69 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -148.81 126.77 11.94 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -104.78 109.16 62.65 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-O 121.318 0.58 . . . . 0.0 111.77 -177.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.39 -47.98 0.47 Allowed 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.749 2.299 . . . . 0.0 111.691 176.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.1 m -131.64 -68.7 0.64 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.753 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.7 mm 64.91 117.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.398 0.618 . . . . 0.0 111.504 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.458 ' ND2' ' HG2' ' A' ' 48' ' ' GLU . 59.4 t30 -84.5 90.65 7.67 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.642 0.734 . . . . 0.0 110.681 -177.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.42 ' O ' HG12 ' A' ' 46' ' ' VAL . 11.2 t -78.34 7.11 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.333 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -82.63 -20.24 36.73 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.814 174.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.458 ' HG2' ' ND2' ' A' ' 45' ' ' ASN . 12.6 mm-40 -107.0 -35.15 6.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.304 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.419 HD13 HD12 ' A' ' 72' ' ' ILE . 80.3 mt -83.01 124.63 30.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.301 -177.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -147.36 175.62 10.65 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.777 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -123.59 137.36 54.76 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 170.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.45 ' HB3' HG13 ' A' ' 16' ' ' ILE . 20.1 p90 -136.41 160.87 37.44 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.642 0.734 . . . . 0.0 112.917 -173.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.501 HG13 HD11 ' A' ' 15' ' ' LEU . 14.6 m -113.12 125.95 70.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 114.438 -1.255 . . . . 0.0 108.313 167.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -91.67 102.35 14.98 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -175.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 71.4 mt -92.84 15.13 15.43 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.572 -173.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.732 ' HB2' ' HB3' ' A' ' 19' ' ' ASN . 8.0 t -73.74 106.19 5.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 175.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 92.08 35.32 6.76 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.266 -175.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.1 m -120.16 145.84 46.57 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.725 0.297 . . . . 0.0 110.663 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -97.91 154.25 37.87 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.978 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.561 ' HA ' ' HB2' ' A' ' 89' ' ' LEU . 26.1 Cg_exo -64.93 169.86 11.17 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.936 2.424 . . . . 0.0 112.159 175.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.37 -177.73 27.41 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -175.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -86.56 111.39 20.56 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.004 0.431 . . . . 0.0 110.396 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 65' ' ' TYR . 35.5 m80 -129.03 151.79 49.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.953 177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.466 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 19.2 m-20 -90.11 103.22 15.92 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.847 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 63' ' ' HIS . 72.5 m-85 -97.39 147.33 24.3 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.766 -176.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -87.9 125.26 34.4 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.807 -172.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 64.6 t -74.74 110.63 9.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.134 0.493 . . . . 0.0 110.094 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -101.82 106.14 17.08 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.111 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 42.2 t -91.91 136.36 24.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.491 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -75.1 122.05 86.58 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 171.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -56.42 142.35 88.97 Favored 'Trans proline' 0 N--CA 1.463 -0.278 0 C-N-CA 122.705 2.27 . . . . 0.0 112.063 -178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.419 HD12 HD13 ' A' ' 49' ' ' LEU . 32.7 mm -82.18 120.1 76.44 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.571 -177.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' A' ' 74' ' ' ASN . 22.0 Cg_exo -66.08 146.04 80.9 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.23 1.953 . . . . 0.0 111.307 175.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 73' ' ' PRO . 84.5 m-20 76.8 -41.19 0.39 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.491 0.716 . . . . 0.0 112.079 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.7 mt -103.08 157.4 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 58.4 tttm -92.88 146.07 23.91 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 177.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 tt -95.18 144.51 9.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 122.094 -0.379 . . . . 0.0 109.979 177.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.401 ' CG2' ' HB2' ' A' ' 38' ' ' GLU . 45.4 t -114.62 -70.89 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.951 0.405 . . . . 0.0 111.349 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -116.51 148.76 40.51 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.226 -169.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.553 ' HA ' HG12 ' A' ' 35' ' ' VAL . 73.8 mt -132.08 107.04 12.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.025 178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 30.4 t -137.66 126.66 14.86 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.092 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.422 ' HD2' HG12 ' A' ' 33' ' ' VAL . 97.3 Cg_endo -81.51 177.52 34.53 Favored 'Cis proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.065 -1.639 . . . . 0.0 112.637 -0.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -112.6 -47.32 3.08 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.627 -173.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.466 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 61.4 t -125.45 121.49 60.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 m -111.69 135.6 50.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.021 0.439 . . . . 0.0 111.575 -175.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.7 m -83.12 110.25 17.86 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.687 176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.404 ' HB2' ' HD2' ' A' ' 65' ' ' TYR . 93.6 mt -110.66 129.11 55.9 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.406 -178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -93.46 107.24 19.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.91 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' A' ' 60' ' ' PRO . 80.7 mt -93.29 123.66 36.73 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.993 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -100.64 162.04 13.19 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.192 176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.469 ' CE1' ' HG2' ' A' ' 60' ' ' PRO . 55.6 m-70 -82.55 117.93 22.9 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.907 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 5.5 t60 -89.03 91.89 9.0 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 175.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 62.3 m-70 -98.1 124.11 42.47 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.103 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -104.52 121.91 44.46 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 170.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -56.47 -64.69 0.78 Allowed 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.437 0.461 . . . . 0.0 110.386 -175.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.8 t-80 . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.101 178.859 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.478 0.932 0 CA-C-O 120.926 0.394 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.4 t -126.41 151.22 47.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.659 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -109.81 118.58 36.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.91 0.386 . . . . 0.0 110.885 -177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 p -83.34 6.46 19.8 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.771 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 76.8 mt -103.61 3.23 34.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.506 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -116.88 144.13 44.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.674 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.1 ttm105 -64.63 -29.24 70.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.615 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -147.83 93.05 4.58 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.466 0.651 . . . . 0.0 111.214 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -79.05 169.87 18.63 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.66 2.24 . . . . 0.0 112.631 178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 m -105.21 103.7 13.29 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.998 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.619 ' HB2' HG23 ' A' ' 35' ' ' VAL . 83.4 mt -83.24 134.7 34.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.067 0.46 . . . . 0.0 110.156 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.3 m -110.63 104.57 13.27 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.233 -177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 60.1 mt -104.68 157.91 16.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.242 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 7.3 m -91.01 143.78 26.35 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.588 HD11 HG13 ' A' ' 53' ' ' VAL . 49.9 tp -92.56 133.23 36.15 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 178.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 42.0 pt -132.26 162.61 39.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.012 0.434 . . . . 0.0 110.893 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.429 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -97.26 126.28 42.37 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.224 178.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -124.27 139.82 53.55 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -177.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 64.45 19.06 11.66 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.61 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.429 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 49.2 m -83.9 120.5 75.06 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.821 -178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -75.97 177.44 8.73 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.578 2.185 . . . . 0.0 112.72 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.23 -14.38 53.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.336 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -77.9 -16.18 58.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.314 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 p -110.38 113.39 26.0 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.363 -176.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 56.1 ttp -102.98 123.9 47.47 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.569 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.524 HG12 ' CD2' ' A' ' 89' ' ' LEU . 26.3 mt -86.8 119.56 34.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.052 -173.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 89.4 mmm -92.57 -30.8 15.46 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.402 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -72.33 105.45 4.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.31 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -65.42 129.51 39.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.388 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 84.4 mt -72.19 127.77 89.91 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.832 -170.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 95.2 Cg_endo -96.5 -162.49 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 123.684 2.923 . . . . 0.0 112.4 176.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 21.6 p -104.24 158.64 16.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.086 174.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.3 m -111.55 152.78 13.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -112.95 97.42 6.52 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.943 0.401 . . . . 0.0 110.149 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.619 HG23 ' HB2' ' A' ' 11' ' ' LEU . 17.8 m -96.98 107.97 20.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.917 0.865 . . . . 0.0 110.205 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.549 ' HB2' ' HB ' ' A' ' 78' ' ' VAL . 1.2 mmmp? -75.02 130.98 40.26 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.893 -1.049 . . . . 0.0 108.745 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.453 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 26.3 p -135.21 128.43 31.95 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.974 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.557 ' HG3' ' CG2' ' A' ' 78' ' ' VAL . 40.2 mt-10 -86.45 94.23 9.35 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 175.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.462 ' HA3' HG23 ' A' ' 75' ' ' ILE . . . 160.06 157.1 8.45 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.899 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -98.65 118.51 35.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.8 p30 -126.99 82.42 68.09 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -89.63 -15.8 2.14 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.542 2.161 . . . . 0.0 112.281 171.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.3 t -98.1 15.55 23.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.013 0.435 . . . . 0.0 110.823 -178.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.4 mt -124.58 137.92 55.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.235 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -94.79 114.58 26.49 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.312 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.458 HG11 HD22 ' A' ' 11' ' ' LEU . 35.1 m -76.23 -24.34 16.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.16 -178.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -75.19 -24.58 57.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.142 0.496 . . . . 0.0 109.929 176.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -83.6 -34.0 25.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.843 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.9 mt -70.69 126.12 28.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.533 179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -115.98 147.78 40.83 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.268 0.556 . . . . 0.0 111.378 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -109.71 124.44 51.23 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 169.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -121.53 160.29 24.58 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.381 0.61 . . . . 0.0 111.865 -174.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.588 HG13 HD11 ' A' ' 15' ' ' LEU . 6.0 m -112.29 123.35 67.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.111 172.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -86.48 108.77 18.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.18 -175.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.2 mp -104.8 34.97 2.93 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.368 -177.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 24.3 m -64.91 107.57 1.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.896 0.379 . . . . 0.0 110.337 177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.92 48.31 5.51 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.915 -0.659 . . . . 0.0 111.908 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 65.3 p -101.29 113.8 27.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.815 0.34 . . . . 0.0 111.336 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -79.31 128.27 76.13 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 173.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -49.84 100.28 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.681 2.921 . . . . 0.0 113.265 -176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.45 ' H ' ' HB2' ' A' ' 89' ' ' LEU . . . -177.76 175.36 47.5 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -80.28 114.48 19.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.02 0.41 . . . . 0.0 109.979 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 65' ' ' TYR . 31.6 m170 -134.15 160.12 38.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.54 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 24.0 t70 -97.0 108.19 20.88 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 63' ' ' HIS . 78.1 m-85 -109.72 152.58 25.46 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.802 0.334 . . . . 0.0 111.291 -171.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -79.84 139.4 37.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.098 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 97.4 t -92.14 120.53 41.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 173.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -117.36 108.88 16.12 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.422 -175.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 59.1 t -89.2 148.96 4.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.914 178.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -61.81 118.61 40.16 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 171.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -52.55 128.99 30.12 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.979 2.453 . . . . 0.0 112.53 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.28 114.71 63.98 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.906 -178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.8 151.09 18.86 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.066 2.511 . . . . 0.0 111.657 177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 74.37 -39.73 0.43 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.653 0.781 . . . . 0.0 111.712 176.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.462 HG23 ' HA3' ' A' ' 39' ' ' GLY . 40.0 mm -92.39 136.02 25.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.412 ' HB3' ' HB2' ' A' ' 38' ' ' GLU . 58.3 tttm -87.6 118.49 27.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.616 0.246 . . . . 0.0 110.448 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.3 tt -81.31 123.84 38.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.346 0.594 . . . . 0.0 110.907 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.557 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 31.6 t -86.19 -60.9 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.441 0.639 . . . . 0.0 109.916 178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -121.01 153.31 37.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.585 -175.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.644 HG23 ' HG2' ' A' ' 83' ' ' ARG . 14.8 tt -127.39 18.41 3.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 173.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.5 m -64.18 134.65 96.03 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 114.255 -1.338 . . . . 0.0 111.695 -175.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.59 133.14 30.02 Favored 'Cis proline' 0 C--N 1.343 0.267 0 C-N-CA 123.382 -1.507 . . . . 0.0 111.988 -0.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.644 ' HG2' HG23 ' A' ' 80' ' ' ILE . 58.8 mtm180 -72.05 -38.14 69.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.208 0.528 . . . . 0.0 110.517 -176.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 t -134.59 136.45 52.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.068 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.5 m -129.04 141.79 45.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.141 0.495 . . . . 0.0 111.144 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 15.8 m -89.72 109.41 20.39 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.138 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.406 HD11 HG21 ' A' ' 53' ' ' VAL . 97.6 mt -100.29 124.9 46.31 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.631 -176.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -85.67 99.03 11.02 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.01 178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.524 ' CD2' HG12 ' A' ' 26' ' ' ILE . 89.8 mt -95.57 139.8 31.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.901 177.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.752 ' HG2' ' H ' ' A' ' 91' ' ' HIS . 22.4 tt0 -117.67 176.84 4.99 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 173.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.752 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 25.9 m-70 -82.46 151.65 26.45 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.909 -176.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -79.5 19.19 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.644 0.735 . . . . 0.0 109.958 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.445 ' H ' ' C ' ' A' ' 91' ' ' HIS . 6.2 t60 -87.18 -21.69 25.75 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.532 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -132.41 -170.64 2.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.155 -177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -164.85 107.97 0.87 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 173.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 66.9 t60 . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.627 -176.748 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 42.2 m . . . . . 0 N--CA 1.48 1.025 0 CA-C-O 121.226 0.536 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.1 p -95.29 -67.49 0.85 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.711 -174.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -85.11 -175.77 5.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.924 0.392 . . . . 0.0 111.338 -173.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.4 m -72.51 -32.82 66.47 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 174.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 69.0 mt -66.15 -18.29 65.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.019 -179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.04 -28.87 62.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.216 0.532 . . . . 0.0 109.941 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 7' ' ' ARG . 15.6 ttm-85 -102.33 -12.3 18.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.941 -177.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -140.95 92.88 8.46 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.735 -176.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' A' ' 37' ' ' THR . 6.2 Cg_exo -80.22 130.37 8.17 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.925 2.417 . . . . 0.0 112.29 178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.7 m -105.88 110.32 22.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.925 175.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 40.1 tp -93.63 135.52 34.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.745 -174.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 16.3 m -117.02 109.6 17.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.896 0.379 . . . . 0.0 110.631 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.7 mt -111.64 144.16 41.36 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.192 -174.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.8 m -75.98 147.26 38.97 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.924 0.392 . . . . 0.0 110.771 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.75 HD11 HG13 ' A' ' 53' ' ' VAL . 41.4 tp -90.49 133.51 35.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.114 178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.5 ' CG1' ' HB3' ' A' ' 52' ' ' TYR . 48.0 pt -112.63 153.55 14.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.979 0.419 . . . . 0.0 110.725 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.38 105.66 17.94 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.547 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 62.0 tttm -93.82 106.65 18.61 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.012 0.434 . . . . 0.0 111.204 -175.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.3 t-20 56.26 77.75 0.23 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.89 174.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.9 t -106.86 140.22 21.16 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 172.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 55' ' ' LEU . 36.2 Cg_exo -62.75 169.16 9.06 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.017 2.478 . . . . 0.0 112.91 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -86.1 6.87 27.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.534 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -107.5 -6.16 17.19 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.314 -178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.415 ' OG ' ' HD2' ' A' ' 21' ' ' PRO . 5.0 p -118.42 128.9 55.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.814 -176.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.0 ttp -115.66 131.86 56.81 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.652 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.5 mt -90.34 103.73 14.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.799 0.333 . . . . 0.0 110.665 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 81.3 mtp -75.58 -38.82 58.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.952 0.406 . . . . 0.0 110.303 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 8.5 m -71.52 120.02 16.51 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.241 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -71.57 120.09 16.66 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 176.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.6 mt -54.71 117.76 14.78 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.513 -174.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -77.67 -163.2 0.2 Allowed 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.976 2.45 . . . . 0.0 112.227 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.6 m -123.31 134.9 54.01 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 120.914 0.388 . . . . 0.0 110.363 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.829 HG11 HG11 ' A' ' 67' ' ' VAL . 33.2 m -85.94 133.04 30.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.979 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 34' ' ' ARG . 25.7 ttt180 -110.01 97.34 6.86 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.538 HG12 ' HA ' ' A' ' 80' ' ' ILE . 33.5 m -102.89 157.58 4.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.58 -171.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.476 ' HE3' ' HB3' ' A' ' 36' ' ' LYS . 10.3 mmmt -98.37 128.25 44.68 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.487 ' O ' ' HD2' ' A' ' 9' ' ' PRO . 10.0 p -116.07 145.91 42.63 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.962 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.478 ' HB2' ' CG2' ' A' ' 78' ' ' VAL . 41.7 tt0 -110.39 107.0 16.55 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.598 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 150.36 -153.79 25.26 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.739 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.586 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 96.6 m-85 -121.8 135.82 54.92 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -105.57 96.33 11.88 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.586 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 6.1 Cg_exo -79.62 -71.95 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.801 2.334 . . . . 0.0 111.505 177.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.5 t -162.45 95.47 0.92 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.415 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.578 ' HB ' HG13 ' A' ' 46' ' ' VAL . 32.7 mt -132.67 160.78 42.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.405 ' N ' HG22 ' A' ' 44' ' ' ILE . 11.7 m120 -76.9 46.16 0.46 Allowed 'General case' 0 C--O 1.237 0.416 0 CA-C-O 121.329 0.585 . . . . 0.0 110.633 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.578 HG13 ' HB ' ' A' ' 44' ' ' ILE . 20.2 m -67.24 -32.29 56.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.273 -175.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -81.94 -9.5 59.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.151 0.5 . . . . 0.0 110.252 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -95.13 -12.5 26.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.005 176.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.4 ' CD1' HG12 ' A' ' 72' ' ' ILE . 91.6 mt -78.6 136.36 37.49 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 166.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -130.24 171.24 13.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.221 0.534 . . . . 0.0 111.703 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.37 139.53 42.96 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.38 175.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.501 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 2.0 p90 -127.55 145.13 50.96 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.217 0.532 . . . . 0.0 111.99 -177.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.75 HG13 HD11 ' A' ' 15' ' ' LEU . 17.0 m -119.56 129.05 75.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.049 174.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -76.45 119.42 20.28 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.975 0.416 . . . . 0.0 110.148 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.443 ' O ' ' HD3' ' A' ' 21' ' ' PRO . 76.7 mt -112.16 26.88 10.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.301 -176.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.7 m -70.25 -33.74 71.99 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -169.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.89 86.61 0.14 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 119.828 -1.177 . . . . 0.0 113.231 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 58.4 m -143.43 155.95 44.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.554 0.216 . . . . 0.0 110.521 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.487 ' HB2' ' NE2' ' A' ' 63' ' ' HIS . 1.6 mp0 -64.97 145.42 99.07 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.392 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 59' ' ' GLU . 10.2 Cg_exo -71.27 91.19 0.66 Allowed 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.806 2.337 . . . . 0.0 112.045 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.28 -166.8 39.66 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.609 ' HG2' ' HB2' ' A' ' 88' ' ' GLN . 42.5 mt-10 -77.34 113.38 15.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 117.238 0.519 . . . . 0.0 110.336 177.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.487 ' NE2' ' HB2' ' A' ' 59' ' ' GLU . 94.3 m-70 -139.67 173.67 11.3 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.819 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -94.02 133.34 37.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.11 -173.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.422 ' CE2' ' HB2' ' A' ' 87' ' ' LEU . 74.0 m-85 -131.34 135.63 47.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.103 178.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -78.83 125.94 30.04 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.235 178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.829 HG11 HG11 ' A' ' 33' ' ' VAL . 93.2 t -85.25 108.77 17.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.237 0.541 . . . . 0.0 110.566 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -99.75 115.86 30.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.782 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.8 t -101.49 148.71 7.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.89 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -63.28 144.23 97.53 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.056 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -83.41 149.64 13.16 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.908 2.405 . . . . 0.0 112.704 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 75' ' ' ILE . 23.4 mt -117.94 119.0 34.15 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.63 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -85.13 21.07 1.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.69 2.26 . . . . 0.0 112.911 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -131.17 -56.25 1.03 Allowed 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.157 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.545 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 53.1 mt -105.61 137.84 33.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.182 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -89.71 133.25 34.77 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.707 -178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.5 tt -83.88 123.38 38.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.547 0.689 . . . . 0.0 109.635 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.478 ' CG2' ' HB2' ' A' ' 38' ' ' GLU . 47.0 t -94.29 -60.84 2.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.943 -174.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.427 ' HB3' ' HB2' ' A' ' 36' ' ' LYS . 27.3 tt0 -118.76 134.48 55.11 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.216 -172.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.715 ' HB ' ' HG3' ' A' ' 83' ' ' ARG . 59.0 mt -109.26 109.59 28.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 175.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 54.8 m -133.34 124.52 18.26 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.626 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.541 ' HD2' HG12 ' A' ' 33' ' ' VAL . 4.5 Cg_exo -81.48 142.72 55.77 Favored 'Cis proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.29 -1.546 . . . . 0.0 111.641 -5.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.715 ' HG3' ' HB ' ' A' ' 80' ' ' ILE . 5.5 mtm180 -78.71 -37.8 40.66 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.221 0.534 . . . . 0.0 110.3 178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 47.6 t -124.06 117.5 51.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.49 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 23.6 m -107.36 152.52 8.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 120.773 0.321 . . . . 0.0 111.034 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 63' ' ' HIS . 14.5 m -109.05 99.31 8.64 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.966 178.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 62' ' ' GLU . 89.8 mt -102.79 142.62 33.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.317 -177.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.609 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 53.6 tt0 -98.03 106.45 18.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.0 0.429 . . . . 0.0 110.802 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.2 mt -88.79 151.19 22.54 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.014 174.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -131.7 167.57 19.26 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.511 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -73.36 113.34 10.34 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.957 0.408 . . . . 0.0 110.761 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 21.6 t60 -88.74 93.8 9.69 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.121 -179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 87.4 m-70 -103.96 157.06 17.36 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.909 176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -90.6 -28.35 18.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.915 0.388 . . . . 0.0 109.992 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -100.64 96.17 7.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.269 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.5 t60 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.379 -0.82 . . . . 0.0 109.468 175.389 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.477 0.914 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 m -120.95 175.96 5.79 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.917 0.389 . . . . 0.0 110.904 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -67.73 140.75 56.74 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.861 178.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.2 m -143.73 138.44 28.84 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.518 0.199 . . . . 0.0 110.715 -174.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.0 mt -66.71 -3.69 7.21 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -174.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -73.9 -16.87 61.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.303 0.573 . . . . 0.0 109.879 173.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 47.6 mtt180 -113.84 -39.54 3.97 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.228 -175.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -119.67 80.61 23.89 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 121.417 0.627 . . . . 0.0 111.298 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -90.54 174.96 2.8 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.979 2.452 . . . . 0.0 112.873 -178.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.0 m -107.38 122.22 46.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.76 176.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.683 HD22 HG11 ' A' ' 46' ' ' VAL . 67.4 mt -104.15 127.4 51.74 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.138 0.494 . . . . 0.0 110.907 -176.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.0 m -101.34 107.18 18.46 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.132 178.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 56.3 mt -108.02 149.17 28.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.36 -176.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.6 p -82.78 141.24 32.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.646 0.26 . . . . 0.0 110.515 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.813 HD11 HG13 ' A' ' 53' ' ' VAL . 43.0 tp -90.09 133.04 35.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.516 -179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.3 pt -116.67 155.68 18.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.968 0.413 . . . . 0.0 111.006 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -85.12 110.47 19.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.24 177.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -106.21 137.16 44.64 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.534 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 63.0 16.4 9.23 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.548 176.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.47 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 18.7 m -74.36 117.24 60.29 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.28 -176.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 5.7 Cg_exo -74.51 173.1 14.87 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.064 2.51 . . . . 0.0 112.449 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.69 -5.96 59.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.603 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -78.07 -9.2 59.03 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.562 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.524 ' HB2' HD22 ' A' ' 89' ' ' LEU . 11.9 p -129.78 128.73 42.98 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.992 -176.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.609 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 58.5 ttp -114.54 139.03 49.91 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.404 HG12 ' CD2' ' A' ' 89' ' ' LEU . 8.5 mt -110.19 99.13 8.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.523 -177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 78.2 mtp -82.14 -15.35 53.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.982 0.42 . . . . 0.0 110.362 176.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.4 m -81.05 106.28 12.93 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -63.44 123.0 17.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.011 -175.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 75.4 mt -62.02 119.26 47.03 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.504 -178.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.75 -164.05 0.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.802 2.335 . . . . 0.0 112.655 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.1 p -106.43 142.03 36.77 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.757 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.0 p -99.0 139.4 20.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -110.74 101.67 10.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.303 0.573 . . . . 0.0 110.381 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 80' ' ' ILE . 33.4 m -105.09 130.83 55.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.388 -177.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.563 ' H ' ' HB2' ' A' ' 79' ' ' GLU . 58.2 tttm -94.0 132.64 38.27 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.512 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 26.2 p -126.81 152.19 47.29 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.465 -174.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 76' ' ' LYS . 50.4 mt-10 -108.94 96.0 6.02 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 154.57 156.47 7.72 Favored Glycine 0 N--CA 1.447 -0.581 0 N-CA-C 111.68 -0.568 . . . . 0.0 111.68 -177.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -108.64 129.36 55.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -177.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.439 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 41.2 m-80 -70.89 114.06 23.92 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.96 -178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 41' ' ' ASN . 3.5 Cg_exo -80.14 -71.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.804 2.336 . . . . 0.0 111.833 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 p -113.04 10.16 18.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.482 0.658 . . . . 0.0 110.048 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 44.0 mt -92.94 133.37 34.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.111 -177.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.549 ' HB2' ' HG3' ' A' ' 48' ' ' GLU . 53.6 m-80 -113.18 126.51 55.51 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.073 0.463 . . . . 0.0 110.061 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.683 HG11 HD22 ' A' ' 11' ' ' LEU . 34.4 m -77.41 -8.41 11.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.51 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -89.39 -4.14 58.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.27 0.557 . . . . 0.0 110.127 173.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.549 ' HG3' ' HB2' ' A' ' 45' ' ' ASN . 42.3 mt-10 -99.57 -34.56 10.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.571 174.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.7 mt -81.24 138.57 35.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.921 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -127.23 168.43 14.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.505 0.669 . . . . 0.0 111.299 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.6 147.59 29.31 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 171.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -140.46 146.88 38.82 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.19 0.519 . . . . 0.0 111.29 -174.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.813 HG13 HD11 ' A' ' 15' ' ' LEU . 4.3 m -112.25 130.64 65.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.405 175.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -79.47 91.56 5.15 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.043 -176.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.468 HD12 ' OG1' ' A' ' 20' ' ' THR . 52.0 mt -93.84 59.14 2.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.835 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 p -77.58 -4.72 47.25 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.332 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.66 -178.31 39.56 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.799 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 32.1 m -144.95 21.19 1.61 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.198 0.523 . . . . 0.0 109.786 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -77.11 115.84 52.28 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.342 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.13 158.51 56.24 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.955 2.436 . . . . 0.0 112.496 -178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 96.43 -163.29 22.82 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 111.069 -0.812 . . . . 0.0 111.069 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.516 ' HB3' HG22 ' A' ' 86' ' ' THR . 40.7 mt-10 -86.45 108.82 18.68 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.153 0.501 . . . . 0.0 110.293 177.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 66.4 t-80 -117.68 143.03 46.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.652 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 10.0 m-20 -81.51 138.08 35.51 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -178.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -138.95 150.89 46.4 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.993 0.425 . . . . 0.0 111.18 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -90.33 123.03 33.75 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.69 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.9 t -81.24 134.74 26.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.556 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -125.45 153.44 43.51 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.095 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.7 t -127.28 146.44 33.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 43.6 mt-10 -63.04 125.49 86.92 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 32.2 Cg_exo -59.13 124.16 15.02 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.086 2.524 . . . . 0.0 112.857 -177.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.403 HD12 ' H ' ' A' ' 72' ' ' ILE . 4.0 mp -95.18 125.94 48.34 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.725 178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -72.95 146.57 42.1 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.254 1.969 . . . . 0.0 111.98 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 72.78 -45.85 0.63 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.722 0.809 . . . . 0.0 112.197 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.512 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 51.2 mt -84.05 133.09 29.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.014 0.435 . . . . 0.0 110.514 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 94.7 mttt -87.07 142.04 28.22 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.206 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.2 tt -99.58 119.28 47.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.22 0.533 . . . . 0.0 110.316 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.5 t -94.17 -48.02 13.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.807 -177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.563 ' HB2' ' H ' ' A' ' 36' ' ' LYS . 20.3 mm-40 -118.7 148.66 42.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.173 -176.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.842 HG23 ' HG2' ' A' ' 83' ' ' ARG . 16.1 tt -138.96 27.54 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 122.361 1.077 . . . . 0.0 108.419 174.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.6 m -83.1 141.04 42.9 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.131 -176.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -73.51 131.43 23.23 Favored 'Cis proline' 0 C--N 1.346 0.418 0 C-N-CA 123.769 -1.346 . . . . 0.0 112.215 0.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.842 ' HG2' HG23 ' A' ' 80' ' ' ILE . 73.7 mtm180 -78.24 -49.55 13.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.306 -175.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.5 t -112.8 119.5 60.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.788 178.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.8 m -121.29 145.59 27.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.732 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.516 HG22 ' HB3' ' A' ' 62' ' ' GLU . 8.6 m -99.86 101.74 12.96 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 97.3 mt -94.08 145.74 24.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.806 -175.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -97.56 125.85 42.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.124 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.524 HD22 ' HB2' ' A' ' 24' ' ' SER . 90.0 mt -116.47 131.96 56.81 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.853 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -100.38 151.52 21.42 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.529 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 -66.75 104.69 1.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.214 176.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.609 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 74.7 t60 -106.03 116.52 32.08 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -87.99 -76.67 0.38 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -168.47 -34.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.765 174.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -93.34 -30.54 15.06 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 175.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.472 -0.775 . . . . 0.0 109.47 175.247 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.477 0.909 0 CA-C-O 120.821 0.343 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.1 p -171.0 -162.4 0.25 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.562 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -136.54 117.67 14.42 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.847 0.356 . . . . 0.0 110.331 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.1 m -73.33 105.72 4.85 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.1 mt -65.94 134.69 53.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.129 -177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -62.25 -52.63 62.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.362 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -124.33 -174.7 3.07 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 172.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 51.35 57.4 16.82 Favored Pre-proline 0 N--CA 1.467 0.381 0 O-C-N 123.418 0.449 . . . . 0.0 110.738 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.593 ' HG2' ' OG1' ' A' ' 37' ' ' THR . 29.6 Cg_endo -65.45 115.66 3.48 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.955 1.77 . . . . 0.0 112.816 -172.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 85.7 m -87.56 99.34 11.97 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 171.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.42 125.27 31.52 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.555 -175.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.2 m -95.26 89.85 5.64 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.88 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.429 HD23 HG13 ' A' ' 46' ' ' VAL . 60.2 mt -91.0 131.62 36.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.437 -174.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.4 m -74.41 139.8 44.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.839 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.897 HD11 HG13 ' A' ' 53' ' ' VAL . 30.0 tp -84.71 127.34 34.05 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.411 HD11 ' CE2' ' A' ' 52' ' ' TYR . 29.0 pt -120.68 142.51 36.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.445 0.641 . . . . 0.0 112.23 -176.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.555 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -72.76 111.93 8.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.288 175.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -79.21 -78.24 0.16 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.094 0.473 . . . . 0.0 110.645 -179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -110.61 75.83 0.95 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.405 0.621 . . . . 0.0 109.571 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.555 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 94.6 m -99.62 113.04 64.74 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.225 177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.11 155.2 52.15 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.13 2.553 . . . . 0.0 112.767 -178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.3 -1.82 11.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.947 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -104.6 -2.03 25.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.879 0.371 . . . . 0.0 110.567 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.4 m -107.3 115.49 30.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.458 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 55.7 ttp -107.55 117.39 33.97 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.014 0.435 . . . . 0.0 110.657 -177.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.5 mt -92.08 102.59 13.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.892 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 80.5 mtp -86.23 -33.33 20.77 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.747 0.308 . . . . 0.0 110.807 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 61.4 m -81.08 117.78 21.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.047 176.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -59.84 124.55 20.52 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 84.1 mt -59.66 121.16 55.42 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.289 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 12.4 Cg_exo -69.33 -179.36 2.67 Favored 'Trans proline' 0 N--CA 1.464 -0.259 0 C-N-CA 122.865 2.377 . . . . 0.0 112.502 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 17.9 p -109.07 146.22 34.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.124 177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.668 HG11 HG11 ' A' ' 67' ' ' VAL . 20.3 m -97.08 140.07 18.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.067 0.461 . . . . 0.0 109.993 178.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -109.56 98.28 7.68 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.661 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.623 HG12 ' HA ' ' A' ' 80' ' ' ILE . 32.8 m -103.09 142.32 17.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.074 -176.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.2 tttp -92.53 129.84 38.35 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.593 ' OG1' ' HG2' ' A' ' 9' ' ' PRO . 27.3 p -121.46 161.46 22.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.592 0.234 . . . . 0.0 110.585 177.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' HB3' ' HD3' ' A' ' 76' ' ' LYS . 22.6 tt0 -123.79 143.1 50.52 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.056 -175.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.09 -118.93 1.91 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.336 177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -144.48 131.74 20.69 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.439 ' HB3' ' HG3' ' A' ' 9' ' ' PRO . 2.5 p-10 -120.88 91.64 47.74 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 121.354 0.597 . . . . 0.0 112.154 -174.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -89.48 -51.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.731 2.287 . . . . 0.0 112.671 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.7 t -159.28 96.63 1.32 Allowed 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 121.256 0.551 . . . . 0.0 110.243 -176.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mp -117.21 126.38 74.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.597 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.531 ' ND2' ' HB2' ' A' ' 48' ' ' GLU . 58.0 t30 -80.01 94.47 5.93 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.762 0.791 . . . . 0.0 110.886 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.429 HG13 HD23 ' A' ' 13' ' ' LEU . 19.1 t -68.59 -17.79 22.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.536 -179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -82.8 5.49 21.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.719 179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.531 ' HB2' ' ND2' ' A' ' 45' ' ' ASN . 40.7 tt0 -119.17 -33.35 4.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.199 176.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.7 mt -79.51 127.84 32.64 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 175.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -136.81 166.87 22.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.628 0.727 . . . . 0.0 112.14 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.457 ' HB1' HG13 ' A' ' 67' ' ' VAL . . . -109.35 128.76 55.36 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.046 172.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.657 ' HE1' ' HB2' ' A' ' 70' ' ' GLU . 48.5 m-85 -103.42 138.51 40.05 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.934 0.397 . . . . 0.0 111.391 -173.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.897 HG13 HD11 ' A' ' 15' ' ' LEU . 3.0 m -125.86 129.76 72.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.815 169.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -88.49 91.61 8.87 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.303 0.573 . . . . 0.0 109.566 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.508 HD21 HD12 ' A' ' 87' ' ' LEU . 52.4 mt -87.79 38.82 0.86 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.691 -174.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.9 p -68.77 -24.55 64.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.974 0.416 . . . . 0.0 109.982 176.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -59.2 111.93 3.8 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 m -96.97 26.22 4.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.996 0.427 . . . . 0.0 110.727 -173.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -87.27 115.38 62.54 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.671 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.06 140.88 55.75 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.446 2.098 . . . . 0.0 111.248 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 129.64 -150.66 19.05 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -116.5 105.79 12.87 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.997 0.427 . . . . 0.0 109.969 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 50.2 m-70 -122.25 148.91 44.41 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.093 -176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 44.9 m-20 -81.76 132.83 35.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.908 0.385 . . . . 0.0 110.703 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -127.91 137.15 52.19 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 172.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.521 ' HG2' HG22 ' A' ' 84' ' ' VAL . 40.3 mt-10 -88.71 134.85 33.78 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.036 0.446 . . . . 0.0 110.885 -173.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.668 HG11 HG11 ' A' ' 33' ' ' VAL . 65.2 t -71.81 102.2 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.732 -177.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -92.67 101.69 14.1 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.554 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.2 t -87.27 143.64 10.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.146 -175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.657 ' HB2' ' HE1' ' A' ' 52' ' ' TYR . 32.2 tt0 -77.95 114.76 44.73 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -56.41 130.84 42.25 Favored 'Trans proline' 0 C--O 1.235 0.334 0 C-N-CA 123.051 2.5 . . . . 0.0 112.738 -176.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.7 mt -94.32 125.09 53.54 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.51 -177.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.57 141.87 42.99 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.578 2.186 . . . . 0.0 111.504 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 8.3 t30 74.16 -44.03 0.55 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.368 0.667 . . . . 0.0 111.801 178.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 48.8 mm -83.86 119.22 32.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.125 0.488 . . . . 0.0 110.37 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.465 ' HD3' ' HB3' ' A' ' 38' ' ' GLU . 80.0 tttt -80.73 124.82 29.36 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.598 -177.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.556 ' HA ' HG22 ' A' ' 37' ' ' THR . 17.0 tt -88.96 131.61 35.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.148 0.499 . . . . 0.0 110.233 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.7 t -100.78 -58.87 3.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.319 -175.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -138.14 147.24 43.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.881 -174.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.623 ' HA ' HG12 ' A' ' 35' ' ' VAL . 58.9 mt -115.57 121.78 67.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.203 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 70.1 m -138.16 115.85 9.39 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.921 179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.534 ' HD2' HG12 ' A' ' 33' ' ' VAL . 2.1 Cg_endo -86.31 170.94 40.95 Favored 'Cis proline' 0 N--CA 1.462 -0.347 0 C-N-CA 124.063 -1.224 . . . . 0.0 112.308 -1.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -98.83 -32.43 11.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.346 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.521 HG22 ' HG2' ' A' ' 66' ' ' GLU . 45.4 t -129.79 132.13 66.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.384 178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 m -123.85 128.77 74.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.164 0.507 . . . . 0.0 111.139 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 7.4 m -82.54 103.89 12.41 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.508 HD12 HD21 ' A' ' 55' ' ' LEU . 90.1 mt -94.83 146.27 24.32 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.16 0.505 . . . . 0.0 111.237 -173.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.2 tm0? -98.23 119.43 36.88 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.282 -178.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 86.8 mt -123.63 146.33 48.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.813 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -139.45 173.17 11.81 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 169.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.514 ' C ' ' H ' ' A' ' 93' ' ' HIS . 16.6 m80 -69.73 127.88 34.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.828 0.347 . . . . 0.0 110.632 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.458 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 11.9 t-80 -82.66 33.39 0.42 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 122.426 1.108 . . . . 0.0 108.131 171.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . 0.514 ' H ' ' C ' ' A' ' 91' ' ' HIS . 1.8 t-160 -151.57 117.44 5.49 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.003 -1.453 . . . . 0.0 107.225 -176.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 29.0 m80 -67.99 -18.13 64.63 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -170.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -136.84 105.21 5.74 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.725 171.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.9 t60 . . . . . 0 C--O 1.246 0.883 0 O-C-N 124.075 0.859 . . . . 0.0 111.06 177.253 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.477 0.891 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 t -97.23 102.85 14.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -77.72 119.35 21.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.12 0.486 . . . . 0.0 111.047 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.4 m -78.5 135.92 37.46 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.599 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.4 mt -85.77 129.0 34.95 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -67.18 -16.55 64.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.458 -174.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.523 ' HA ' ' HE1' ' A' ' 40' ' ' TYR . 92.4 mtt180 -89.8 -5.91 56.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.536 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.426 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 28.2 m-20 -123.72 86.63 52.93 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 121.163 -0.215 . . . . 0.0 110.975 -179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.82 101.82 0.19 Allowed 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.464 2.109 . . . . 0.0 112.153 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.6 m -98.2 109.0 21.83 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.751 -0.658 . . . . 0.0 109.283 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 79.1 mt -104.8 145.91 29.72 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.177 0.513 . . . . 0.0 111.042 -173.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 20.6 m -122.83 102.49 8.05 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.527 174.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 52.7 mt -96.17 140.05 31.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.334 -174.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.9 m -73.21 135.95 44.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.325 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.726 HD11 HG13 ' A' ' 53' ' ' VAL . 42.4 tp -85.88 119.59 26.36 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.5 pt -112.58 155.65 13.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.166 -178.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.422 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -87.86 114.73 24.75 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.048 178.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -117.37 143.28 46.14 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.8 t30 61.01 26.26 16.23 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.879 0.847 . . . . 0.0 109.698 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.514 HG23 HD12 ' A' ' 55' ' ' LEU . 85.1 m -85.86 117.41 68.67 Favored Pre-proline 0 N--CA 1.448 -0.535 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.736 -177.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 11.7 Cg_exo -69.38 162.69 40.88 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 123.016 2.477 . . . . 0.0 112.575 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.39 -8.64 58.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.415 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -92.31 3.74 54.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.887 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.4 p -127.88 139.71 52.46 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.759 0.314 . . . . 0.0 111.212 -175.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.457 ' HB2' ' NE2' ' A' ' 92' ' ' HIS . 14.1 ttm -127.13 129.95 48.9 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.741 175.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.488 HG12 ' CD2' ' A' ' 89' ' ' LEU . 12.9 mt -88.17 97.47 6.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 176.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 86.9 mtp -62.85 -33.24 74.85 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.237 0.541 . . . . 0.0 110.05 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 4.3 m -74.49 104.71 5.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.624 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -64.33 121.0 13.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.092 0.472 . . . . 0.0 110.664 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.21 122.69 65.37 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.224 -171.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -87.05 -155.8 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.471 0 C-N-CA 123.523 2.815 . . . . 0.0 112.093 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 18.5 m -120.19 150.51 40.53 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.85 0.357 . . . . 0.0 110.657 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 12' ' ' THR . 12.7 p -103.45 138.71 26.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.835 -177.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 34' ' ' ARG . 19.6 mtp180 -98.38 119.91 37.88 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.073 177.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 80' ' ' ILE . 25.1 m -128.59 123.77 60.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.651 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 8' ' ' ASP . 87.8 tttt -95.84 138.83 32.93 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 176.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.542 HG22 ' HA ' ' A' ' 77' ' ' ILE . 35.5 p -126.73 155.2 43.1 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.993 0.425 . . . . 0.0 111.869 -175.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.531 ' HG3' ' CG2' ' A' ' 78' ' ' VAL . 42.8 mt-10 -105.81 120.59 42.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.797 174.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 145.2 -171.53 26.28 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.523 ' HE1' ' HA ' ' A' ' 7' ' ' ARG . 93.6 m-85 -135.03 101.07 4.76 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.76 112.36 6.0 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.228 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.11 -62.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.767 2.311 . . . . 0.0 111.143 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.5 t -145.7 79.09 1.56 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.131 175.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.8 mt -121.85 130.73 74.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.795 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.428 ' ND2' ' HG3' ' A' ' 48' ' ' GLU . 59.0 t30 -94.59 103.93 15.87 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.729 0.776 . . . . 0.0 110.895 -175.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.4 t -62.91 -23.88 34.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.294 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -66.18 -20.78 66.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.951 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.428 ' HG3' ' ND2' ' A' ' 45' ' ' ASN . 48.3 mt-10 -105.28 -11.17 16.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.939 0.399 . . . . 0.0 110.831 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.9 128.68 33.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 170.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -136.67 173.3 11.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.31 0.576 . . . . 0.0 111.697 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -131.45 140.89 49.69 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -129.07 156.75 43.35 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.472 0.653 . . . . 0.0 112.102 -173.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.726 HG13 HD11 ' A' ' 15' ' ' LEU . 4.6 m -112.17 118.18 57.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.333 -0.849 . . . . 0.0 109.363 172.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.78 106.3 16.21 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.246 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.514 HD12 HG23 ' A' ' 20' ' ' THR . 63.4 mt -95.05 45.29 1.1 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.537 -178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.3 p -57.37 -44.64 84.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.806 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.88 67.19 0.49 Allowed Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.106 173.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.7 p -68.9 101.14 1.3 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.054 0.454 . . . . 0.0 111.126 -178.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -111.5 129.99 23.54 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.527 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.449 ' HB3' ' HB2' ' A' ' 91' ' ' HIS . 33.7 Cg_endo -65.45 138.97 57.17 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.552 2.168 . . . . 0.0 112.22 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 112.46 178.16 19.81 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.02 99.13 4.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.862 0.363 . . . . 0.0 110.534 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -119.93 141.23 49.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.454 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -84.97 133.29 34.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.029 0.443 . . . . 0.0 109.994 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -126.11 157.75 37.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.809 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -84.73 128.05 34.41 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.619 -177.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.1 t -78.25 99.37 2.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.114 0.483 . . . . 0.0 109.731 175.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -87.77 118.51 27.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.906 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.1 t -95.32 143.78 11.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.729 -174.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.427 ' OE1' ' HD2' ' A' ' 71' ' ' PRO . 8.5 tp10 -70.32 113.89 21.58 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 174.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.427 ' HD2' ' OE1' ' A' ' 70' ' ' GLU . 11.7 Cg_endo -55.33 124.03 15.27 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.995 2.463 . . . . 0.0 112.646 -176.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 mp -94.45 119.98 65.7 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.889 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -63.61 135.38 48.82 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.494 2.13 . . . . 0.0 112.537 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.7 t30 73.52 -33.96 0.27 Allowed 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.771 0.828 . . . . 0.0 112.96 176.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.424 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 49.9 mm -84.16 136.4 22.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.048 0.451 . . . . 0.0 111.031 -177.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -97.6 121.12 39.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.446 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.542 ' HA ' HG22 ' A' ' 37' ' ' THR . 16.0 tt -90.75 125.38 43.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.408 0.623 . . . . 0.0 111.012 -176.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.531 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 38.3 t -100.62 -56.52 5.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.384 -175.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.417 ' HB2' ' H ' ' A' ' 36' ' ' LYS . 71.7 mm-40 -109.65 139.35 44.78 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.092 -173.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.459 ' HA ' HG12 ' A' ' 35' ' ' VAL . 50.7 mt -129.13 97.57 3.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 171.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 5.7 m -127.21 112.74 21.53 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.211 -176.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 2.0 Cg_endo -85.14 171.6 43.39 Favored 'Cis proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.763 -1.349 . . . . 0.0 112.37 0.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 7.2 ttm180 -110.85 -34.26 6.29 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.98 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 61.3 t -124.39 117.17 49.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.588 176.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.5 m -108.29 146.46 14.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 120.931 0.396 . . . . 0.0 110.871 -177.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 29.5 m -97.97 109.01 21.84 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 84.9 mt -102.97 122.64 45.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.385 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -85.58 95.55 9.36 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 175.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.488 ' CD2' HG12 ' A' ' 26' ' ' ILE . 76.5 mt -90.43 128.68 36.57 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.517 -175.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -102.88 120.83 41.3 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.422 173.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 60' ' ' PRO . 27.5 t60 -72.42 110.41 6.81 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 173.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.457 ' NE2' ' HB2' ' A' ' 25' ' ' MET . 13.5 m-70 -48.91 116.75 1.76 Allowed 'General case' 0 CA--C 1.514 -0.404 0 O-C-N 123.886 0.741 . . . . 0.0 110.867 -176.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -73.14 -7.28 50.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.756 -172.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -76.14 -9.32 58.53 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 171.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -118.78 161.16 20.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.139 -0.937 . . . . 0.0 108.523 173.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 40.1 m170 . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.447 -0.787 . . . . 0.0 110.669 -178.273 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.8 m . . . . . 0 N--CA 1.474 0.775 0 CA-C-O 121.107 0.479 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.9 m -105.07 -55.29 2.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.675 175.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -103.93 104.85 14.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.203 175.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.81 -59.44 0.16 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.625 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.81 26.91 0.67 Allowed 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -172.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -107.93 -29.11 9.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.078 0.466 . . . . 0.0 110.357 176.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 86.9 mtt180 -78.3 -10.69 59.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.317 0.579 . . . . 0.0 110.447 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -132.06 86.72 46.26 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-O 121.834 0.826 . . . . 0.0 109.116 171.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.76 162.66 32.37 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.547 2.831 . . . . 0.0 113.498 -170.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 14.6 m -118.62 123.57 45.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.972 178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.513 ' HB2' HG23 ' A' ' 35' ' ' VAL . 98.1 mt -101.34 148.8 24.72 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.019 0.438 . . . . 0.0 110.631 -177.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.2 m -125.5 100.17 6.35 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.889 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.4 mt -101.16 156.43 17.43 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.357 -176.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.5 t -88.53 137.35 32.4 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.87 HD11 HG13 ' A' ' 53' ' ' VAL . 42.6 tp -83.39 126.48 32.77 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 178.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.0 pt -108.32 143.0 19.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.113 0.482 . . . . 0.0 111.182 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.42 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -77.07 105.21 8.01 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.838 176.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -99.06 127.73 45.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.13 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 61.87 23.75 14.02 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.404 176.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.536 ' OG1' HD12 ' A' ' 55' ' ' LEU . 25.7 m -74.51 124.04 89.51 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.452 -179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -81.2 171.45 13.88 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 122.711 2.274 . . . . 0.0 112.562 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.72 6.37 38.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.061 -177.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -92.85 -18.03 23.35 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.42 0.628 . . . . 0.0 110.107 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.2 p -119.2 121.37 39.55 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.716 -176.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 52.8 ttp -102.79 131.0 49.96 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.337 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.405 HG12 ' CD2' ' A' ' 89' ' ' LEU . 9.5 mt -90.21 107.71 18.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 49.1 ttp -75.41 -33.27 60.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.055 0.455 . . . . 0.0 110.739 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.9 m -84.71 132.68 34.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.513 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -66.85 143.14 57.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 174.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.463 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 3.7 mm? -67.1 115.64 27.72 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.534 -178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 3.0 Cg_exo -74.15 167.38 27.33 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.899 2.399 . . . . 0.0 112.666 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 16.4 m -94.7 129.12 41.74 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.784 175.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.0 m -86.28 143.54 11.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.121 0.486 . . . . 0.0 111.12 -176.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 59.0 ttp85 -104.28 108.39 19.76 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.537 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 80' ' ' ILE . 13.4 m -119.56 112.97 39.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.185 0.517 . . . . 0.0 110.227 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 78.0 tttt -87.73 142.02 28.15 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.51 ' HB ' HG22 ' A' ' 75' ' ' ILE . 47.9 p -130.62 179.61 5.85 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.817 -172.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 76' ' ' LYS . 55.7 mt-10 -132.74 130.3 39.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 175.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 128.54 -144.05 14.96 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.451 -0.659 . . . . 0.0 111.451 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -136.13 158.6 44.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.781 0.324 . . . . 0.0 110.704 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -112.31 93.0 20.57 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.653 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.578 ' HD2' HG12 ' A' ' 44' ' ' ILE . 57.8 Cg_endo -79.76 -76.7 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.181 1.921 . . . . 0.0 112.846 -178.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.1 p -107.76 24.22 13.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.402 0.62 . . . . 0.0 110.154 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.755 HG13 HD11 ' A' ' 75' ' ' ILE . 46.4 mm -79.79 112.08 17.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.396 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -91.64 108.62 20.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.28 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.58 -21.85 29.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.583 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -78.2 -13.24 59.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.642 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -105.9 -24.73 12.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.81 -175.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.405 HD11 HG23 ' A' ' 44' ' ' ILE . 38.2 mt -92.58 139.45 30.56 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.072 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -136.04 176.68 8.46 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 121.76 0.79 . . . . 0.0 112.145 -178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -122.6 133.97 54.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.375 172.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -121.75 141.41 51.22 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.13 0.491 . . . . 0.0 111.903 -173.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.87 HG13 HD11 ' A' ' 15' ' ' LEU . 6.8 m -114.38 119.7 62.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.19 174.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -74.55 100.69 3.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.479 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.536 HD12 ' OG1' ' A' ' 20' ' ' THR . 38.2 mt -89.96 36.18 0.86 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.935 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 p -61.49 -38.93 89.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.542 176.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -77.63 69.15 2.64 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 172.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 m -73.28 84.13 1.4 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.076 0.465 . . . . 0.0 111.847 -173.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -108.52 117.71 53.75 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.497 175.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.74 100.85 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.895 2.396 . . . . 0.0 112.166 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.418 ' H ' ' HB2' ' A' ' 89' ' ' LEU . . . 159.02 177.33 32.0 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.883 ' HG2' ' HG2' ' A' ' 88' ' ' GLN . 41.2 mt-10 -74.66 99.64 3.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.104 0.452 . . . . 0.0 110.35 178.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -125.01 144.35 50.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.562 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.519 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 9.4 m-20 -89.23 115.06 26.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.713 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -111.49 164.81 12.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.883 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -89.92 131.51 35.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.296 -176.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.0 t -90.0 123.14 42.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.101 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -111.72 110.66 21.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.068 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.436 HG21 HG11 ' A' ' 35' ' ' VAL . 42.1 t -90.44 142.3 13.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.013 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 46.5 mt-10 -68.75 117.24 49.02 Favored Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 121.303 -0.159 . . . . 0.0 110.627 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 11.4 Cg_exo -70.93 136.0 28.93 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.874 2.382 . . . . 0.0 111.862 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.413 HG22 ' H ' ' A' ' 74' ' ' ASN . 4.3 mp -100.44 117.55 62.73 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.12 25.29 0.46 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.576 2.184 . . . . 0.0 112.396 -178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.413 ' H ' HG22 ' A' ' 72' ' ' ILE . 88.1 m-20 -133.95 -8.91 2.71 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.503 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.755 HD11 HG13 ' A' ' 44' ' ' ILE . 26.5 mt -141.01 143.56 28.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.171 -172.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.642 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 43.5 mtpt -81.16 167.38 19.73 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.8 tt -129.6 135.84 60.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.079 0.466 . . . . 0.0 110.701 -178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 24.3 t -115.63 -53.97 4.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.412 -176.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -123.06 142.55 50.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.216 -174.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.6 ' O ' ' HG3' ' A' ' 83' ' ' ARG . 57.6 mt -123.67 94.22 2.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 169.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 36.6 m -115.49 112.04 43.71 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.53 -174.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.504 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 7.1 Cg_endo -93.24 165.03 22.8 Favored 'Cis proline' 0 CA--C 1.531 0.335 0 C-N-CA 124.831 -0.904 . . . . 0.0 112.393 -5.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.6 ' HG3' ' O ' ' A' ' 80' ' ' ILE . 39.6 mtm180 -92.25 -36.85 13.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.378 0.609 . . . . 0.0 109.833 176.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.519 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 62.1 t -117.52 121.44 67.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.626 178.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.49 HG12 ' HG2' ' A' ' 82' ' ' PRO . 13.9 m -116.1 133.2 63.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.181 0.515 . . . . 0.0 111.817 -177.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.7 m -83.54 95.9 8.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.682 175.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 90.4 mt -90.41 124.08 34.66 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.884 0.373 . . . . 0.0 110.385 -178.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.883 ' HG2' ' HG2' ' A' ' 62' ' ' GLU . 94.5 mt-30 -85.6 92.99 8.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.55 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.418 ' HB2' ' H ' ' A' ' 61' ' ' GLY . 85.5 mt -92.37 157.63 16.51 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.497 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.69 163.63 32.3 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 110.191 -0.299 . . . . 0.0 110.191 178.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -67.4 132.17 47.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.348 177.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -76.84 -26.21 54.04 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 172.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -98.68 118.59 35.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.32 174.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -115.83 118.72 33.77 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.993 0.425 . . . . 0.0 111.054 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -84.46 54.76 3.11 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.184 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.6 m80 . . . . . 0 C--O 1.244 0.798 0 CA-C-O 118.662 -0.685 . . . . 0.0 109.743 177.905 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 N--CA 1.476 0.84 0 CA-C-O 120.83 0.348 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -76.05 133.21 40.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.937 177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -62.2 -40.25 95.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 0.0 110.267 179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.4 m -108.27 107.98 18.8 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 172.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.432 ' HG ' ' H ' ' A' ' 7' ' ' ARG . 25.9 tp -95.96 147.49 23.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.496 -174.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.77 -4.93 51.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.42 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.432 ' H ' ' HG ' ' A' ' 5' ' ' LEU . 66.3 mtt180 -70.69 -76.0 0.11 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.812 0.339 . . . . 0.0 110.663 178.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.89 116.74 49.3 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.1 -176.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -75.84 118.31 5.01 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.795 2.33 . . . . 0.0 111.689 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.7 m -87.94 92.31 9.08 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 176.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.709 HD11 ' HB ' ' A' ' 46' ' ' VAL . 41.1 tp -84.06 123.06 29.63 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.312 -171.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.1 m -103.32 118.1 35.99 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.935 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.2 mt -120.18 141.54 49.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.237 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 26.0 t -74.89 135.25 41.51 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.26 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.618 HD11 HG13 ' A' ' 53' ' ' VAL . 50.0 tp -79.75 131.82 36.02 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 174.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.5 pt -128.08 148.35 32.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.261 0.553 . . . . 0.0 111.264 -179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.528 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -85.83 108.69 18.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.443 175.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.586 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 22.9 tptm -97.41 -66.81 0.88 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.189 0.518 . . . . 0.0 110.712 -174.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.848 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 6.3 m-20 -84.0 57.42 4.16 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.454 -0.793 . . . . 0.0 109.887 -177.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.528 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 34.5 m -114.66 124.22 30.89 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.699 -174.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 16.5 Cg_exo -68.21 146.76 70.88 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.963 2.442 . . . . 0.0 111.516 174.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -75.63 -13.87 60.35 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.775 0.321 . . . . 0.0 111.821 -175.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -89.35 2.47 54.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.101 0.477 . . . . 0.0 110.662 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.7 p -125.97 122.9 37.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.158 177.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 42.4 ttp -113.87 126.86 55.65 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.653 -175.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.8 mt -77.65 132.12 33.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.389 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.441 ' SD ' ' HB2' ' A' ' 90' ' ' GLU . 74.6 mtm -93.68 -26.11 17.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.149 0.5 . . . . 0.0 110.496 177.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.8 p -83.78 118.44 23.92 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.78 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -67.29 142.97 56.68 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.907 0.385 . . . . 0.0 110.244 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 85.4 mt -86.32 119.1 71.34 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.151 -171.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 3.0 Cg_exo -74.35 175.72 10.6 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.846 2.364 . . . . 0.0 112.484 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.2 m -98.23 128.4 44.67 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.76 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.0 p -85.83 129.53 37.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.6 mtm-85 -112.41 108.84 18.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.074 0.464 . . . . 0.0 109.861 -179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 80' ' ' ILE . 34.7 m -109.79 143.84 19.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.091 -176.068 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -99.46 121.45 41.16 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 24.9 p -106.0 159.15 16.27 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.779 0.323 . . . . 0.0 111.589 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.693 ' HB3' ' HB2' ' A' ' 76' ' ' LYS . 32.6 tt0 -112.69 109.6 19.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.493 179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 139.42 -144.25 14.98 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.898 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.417 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 40.9 t80 -155.13 116.05 3.93 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.41 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 0.5 OUTLIER -92.89 105.54 15.35 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.929 179.112 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 5.3 Cg_exo -77.85 -66.24 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.15 2.567 . . . . 0.0 112.986 -176.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.5 t -125.63 39.36 3.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.322 0.582 . . . . 0.0 110.457 -175.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 69.8 mt -91.83 130.3 41.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.704 178.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.557 ' HB3' ' HG2' ' A' ' 48' ' ' GLU . 17.5 m120 -75.26 89.41 2.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.315 0.578 . . . . 0.0 111.096 -176.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.709 ' HB ' HD11 ' A' ' 11' ' ' LEU . 33.6 m -70.65 -13.94 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.178 -179.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -87.6 -18.28 30.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.911 177.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.557 ' HG2' ' HB3' ' A' ' 45' ' ' ASN . 16.1 mm-40 -96.2 -20.83 18.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.387 -179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 99.0 mt -82.01 132.4 35.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.697 174.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -129.31 168.5 16.15 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.358 0.599 . . . . 0.0 111.506 -178.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.47 ' O ' HD12 ' A' ' 15' ' ' LEU . . . -108.89 117.3 33.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.046 -0.979 . . . . 0.0 108.376 170.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.586 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 25.5 p90 -114.84 152.21 32.58 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.138 0.494 . . . . 0.0 111.666 -173.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.618 HG13 HD11 ' A' ' 15' ' ' LEU . 21.2 m -115.64 144.69 22.66 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.128 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.848 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 4.5 t70 -98.21 109.07 21.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.061 176.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.466 HD12 HG23 ' A' ' 20' ' ' THR . 53.0 mt -101.57 68.7 1.19 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.348 0.594 . . . . 0.0 109.946 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.1 p -82.64 -1.2 50.36 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.74 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.22 112.8 4.34 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 175.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 12.7 p -84.45 16.15 3.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.869 0.366 . . . . 0.0 111.768 -177.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -85.86 119.55 72.0 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.529 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.573 ' HA ' ' HB2' ' A' ' 89' ' ' LEU . 11.6 Cg_exo -70.91 -174.56 1.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.906 2.404 . . . . 0.0 112.329 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 88' ' ' GLN . . . 97.89 -137.6 13.39 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.691 -179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -125.96 113.86 17.72 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.781 0.324 . . . . 0.0 110.133 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -130.45 155.07 47.05 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.824 -176.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -100.12 130.21 46.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.441 178.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -128.44 158.03 39.45 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.93 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.86 141.49 28.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.041 -177.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.439 HG13 HD13 ' A' ' 15' ' ' LEU . 59.0 t -86.37 107.8 17.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.631 174.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.453 ' HD3' ' CE2' ' A' ' 52' ' ' TYR . 57.9 tttm -99.1 103.17 15.06 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.09 0.472 . . . . 0.0 110.264 -178.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.95 130.38 36.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.632 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.435 ' HG3' ' HD2' ' A' ' 71' ' ' PRO . 27.5 tt0 -68.57 128.33 93.02 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.435 ' HD2' ' HG3' ' A' ' 70' ' ' GLU . 12.1 Cg_endo -55.19 131.64 47.53 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 123.185 2.59 . . . . 0.0 113.158 -175.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.547 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.2 mp -81.5 125.9 77.47 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.062 177.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.85 109.86 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 123.291 2.66 . . . . 0.0 113.671 -175.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.6 t30 71.9 2.82 4.45 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.721 173.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.463 ' HB ' ' HB ' ' A' ' 72' ' ' ILE . 48.9 mm -102.29 135.31 39.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 O-C-N 121.928 -0.482 . . . . 0.0 110.387 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.693 ' HB2' ' HB3' ' A' ' 38' ' ' GLU . 72.8 mttt -87.39 148.76 24.87 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.62 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.489 HD11 HG12 ' A' ' 80' ' ' ILE . 21.4 tt -110.21 128.19 66.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-O 121.293 0.568 . . . . 0.0 110.105 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.619 HG12 ' HG3' ' A' ' 79' ' ' GLU . 42.6 t -95.42 -63.84 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.988 -175.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.619 ' HG3' HG12 ' A' ' 78' ' ' VAL . 43.0 mt-10 -123.81 127.36 47.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.743 -175.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.555 ' HA ' HG12 ' A' ' 35' ' ' VAL . 26.3 mt -105.78 127.75 60.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 174.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 15.6 m -150.5 115.12 3.3 Favored Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 121.2 -0.2 . . . . 0.0 110.842 -178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.48 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 88.6 Cg_endo -85.87 177.21 26.36 Favored 'Cis proline' 0 CA--C 1.531 0.367 0 C-N-CA 123.502 -1.458 . . . . 0.0 112.682 -0.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.456 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 84.8 mtm180 -119.97 -28.96 5.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.838 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.98 117.16 48.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.5 m -110.75 135.86 48.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.251 0.548 . . . . 0.0 111.254 -178.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.9 m -88.93 112.24 23.07 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.604 177.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 90.0 mt -111.55 145.67 38.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.903 -174.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 61' ' ' GLY . 93.0 mt-30 -113.09 129.71 56.41 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.12 179.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.573 ' HB2' ' HA ' ' A' ' 60' ' ' PRO . 82.8 mt -113.86 136.78 52.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.036 0.446 . . . . 0.0 111.616 -176.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.441 ' HB2' ' SD ' ' A' ' 27' ' ' MET . 43.2 tt0 -119.21 162.96 17.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.163 176.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -80.35 151.3 29.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.538 0.685 . . . . 0.0 112.198 -177.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 43.0 t60 -143.35 95.27 2.73 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.661 172.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -78.09 -54.93 5.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.924 0.393 . . . . 0.0 110.041 -179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -166.93 -64.8 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -86.41 -55.34 3.94 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 170.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 21.5 m80 . . . . . 0 C--O 1.248 0.976 0 CA-C-N 114.503 -1.226 . . . . 0.0 108.792 173.038 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.9 m . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 120.693 0.282 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.4 m -120.04 169.27 10.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 175.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.8 tp60 59.97 32.03 20.94 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 121.609 0.719 . . . . 0.0 109.453 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.3 m -63.98 132.02 49.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.4 -175.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 56.0 tp -86.82 133.85 33.6 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 174.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -93.72 135.77 34.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.232 0.539 . . . . 0.0 111.781 -176.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -127.59 -179.96 5.19 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.175 -0.92 . . . . 0.0 108.71 172.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.608 ' HB3' ' HE2' ' A' ' 36' ' ' LYS . 11.9 m-20 52.61 72.19 1.25 Allowed Pre-proline 0 N--CA 1.466 0.368 0 O-C-N 123.523 0.515 . . . . 0.0 111.255 176.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.71 124.47 10.26 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.13 1.887 . . . . 0.0 112.623 -178.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 28.0 m -101.37 103.69 14.65 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 95.2 mt -83.1 122.46 28.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.268 0.556 . . . . 0.0 110.715 -173.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.4 m -99.22 106.45 18.6 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.138 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.8 mt -107.94 -174.67 2.58 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.628 -177.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.2 t -114.79 145.37 42.19 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.543 HD11 HG13 ' A' ' 53' ' ' VAL . 45.6 tp -87.44 130.15 34.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 175.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 27.8 pt -128.0 144.8 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.22 0.534 . . . . 0.0 111.763 -176.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.488 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -81.29 102.82 10.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.233 173.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.425 ' HG2' ' OD1' ' A' ' 19' ' ' ASN . 59.6 tttm -91.65 -71.57 0.63 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.937 0.399 . . . . 0.0 110.874 -173.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.425 ' OD1' ' HG2' ' A' ' 18' ' ' LYS . 5.2 m-20 -94.27 67.09 3.5 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.623 0.725 . . . . 0.0 109.86 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.488 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 88.1 m -105.79 116.71 59.4 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.287 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 16.9 Cg_exo -67.87 156.39 66.12 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.168 2.578 . . . . 0.0 112.599 -178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.96 151.69 45.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.38 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 73.29 9.35 5.19 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.793 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 96.2 p -103.63 137.48 41.62 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 171.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.764 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 52.1 ttp -128.87 119.25 24.1 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.811 0.338 . . . . 0.0 110.405 -174.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.5 mt -85.31 124.75 40.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.448 -178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.572 ' HB2' ' HB2' ' A' ' 88' ' ' GLN . 86.1 mtp -85.36 -31.9 22.72 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.388 178.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.1 p -78.27 118.32 20.37 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.794 178.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.68 141.01 53.65 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.84 118.44 70.33 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.415 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -89.8 176.96 2.72 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.893 2.395 . . . . 0.0 112.741 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.8 m -83.06 135.28 34.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.147 176.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.539 HG11 ' HB2' ' A' ' 51' ' ' ALA . 9.5 p -104.03 152.99 6.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 83.0 mtm180 -128.54 134.27 48.61 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.957 0.408 . . . . 0.0 110.838 178.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 79' ' ' GLU . 16.3 m -124.33 129.1 74.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.352 175.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.608 ' HE2' ' HB3' ' A' ' 8' ' ' ASP . 13.1 tmtt? -86.16 127.36 34.7 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.551 HG22 ' HA ' ' A' ' 77' ' ' ILE . 33.0 p -128.68 168.15 16.2 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -171.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.615 ' HB2' ' HB3' ' A' ' 76' ' ' LYS . 40.3 mm-40 -114.21 127.32 55.84 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.38 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.97 -161.89 15.94 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.578 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -128.35 128.53 44.72 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.725 0.298 . . . . 0.0 110.27 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.444 ' HB3' HD12 ' A' ' 44' ' ' ILE . 3.0 p30 -122.41 77.34 44.92 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-O 121.261 0.553 . . . . 0.0 111.267 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.12 -47.04 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.649 2.233 . . . . 0.0 111.796 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.9 m -129.33 80.21 1.95 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.195 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.444 HD12 ' HB3' ' A' ' 41' ' ' ASN . 44.7 mt -134.64 157.5 41.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -73.85 55.59 0.54 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.457 0.646 . . . . 0.0 111.504 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.8 t -66.39 -26.27 37.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.76 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 70.5 m-20 -89.9 5.08 47.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.152 0.501 . . . . 0.0 110.906 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -107.12 -24.29 12.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.506 0.669 . . . . 0.0 109.22 174.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.622 HD13 HG12 ' A' ' 72' ' ' ILE . 63.5 mt -88.11 132.67 34.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.66 177.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -143.51 178.03 8.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.934 0.397 . . . . 0.0 110.812 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.539 ' HB2' HG11 ' A' ' 33' ' ' VAL . . . -105.85 119.88 40.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.431 -0.804 . . . . 0.0 108.956 172.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.424 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 28.7 p90 -115.18 148.91 38.47 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.087 0.47 . . . . 0.0 110.946 -174.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.543 HG13 HD11 ' A' ' 15' ' ' LEU . 18.3 m -112.85 133.42 58.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.951 174.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -104.8 105.53 15.63 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.822 178.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.436 HD12 HG23 ' A' ' 20' ' ' THR . 61.6 mt -92.41 90.09 7.07 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.043 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.5 p -75.05 1.91 11.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.541 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.06 132.62 2.87 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 121.014 -0.612 . . . . 0.0 111.707 177.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 m -80.44 76.75 7.26 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 89' ' ' LEU . 30.9 mt-10 -91.36 108.91 32.3 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.53 -176.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 89' ' ' LEU . 11.8 Cg_exo -69.07 131.29 21.88 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.761 2.307 . . . . 0.0 112.204 -176.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 115.91 174.15 17.59 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -177.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.998 ' HG2' ' HG2' ' A' ' 88' ' ' GLN . 33.2 mt-10 -76.78 106.42 8.43 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -118.62 156.03 29.93 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.149 0.5 . . . . 0.0 111.269 -177.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -90.47 116.05 28.1 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.161 -176.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -127.15 157.42 39.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.052 0.453 . . . . 0.0 111.727 -176.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -89.33 144.5 26.03 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.692 -173.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.07 114.05 35.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.658 173.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -108.01 125.32 51.4 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.8 t -102.41 136.29 35.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.686 -0.234 . . . . 0.0 110.557 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -54.83 122.35 40.1 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.187 174.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.17 116.49 2.98 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.699 2.266 . . . . 0.0 111.973 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.622 HG12 HD13 ' A' ' 49' ' ' LEU . 55.8 mt -81.47 121.71 80.21 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.982 -175.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.59 143.09 37.43 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.463 2.108 . . . . 0.0 111.747 176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 t30 75.17 -44.47 0.54 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.362 0.665 . . . . 0.0 111.901 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.522 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 48.9 mm -91.58 136.93 23.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.0 -176.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.615 ' HB3' ' HB2' ' A' ' 38' ' ' GLU . 74.7 tttt -85.17 135.13 34.09 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.551 ' HA ' HG22 ' A' ' 37' ' ' THR . 15.1 tt -96.03 133.69 36.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.953 0.406 . . . . 0.0 109.996 176.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.3 t -110.86 -57.97 3.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.339 0.59 . . . . 0.0 111.386 -176.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 38.6 tt0 -126.07 124.81 41.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.403 -170.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.579 ' HB ' ' HG2' ' A' ' 83' ' ' ARG . 61.0 mt -99.22 113.5 34.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 171.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 25.2 p -127.22 110.49 21.44 Favored Pre-proline 0 C--N 1.318 -0.782 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.035 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.489 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 98.1 Cg_endo -88.43 162.76 42.52 Favored 'Cis proline' 0 CA--C 1.533 0.444 0 C-N-CA 123.77 -1.346 . . . . 0.0 112.716 -1.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.579 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 63.2 mtm180 -87.56 -25.47 23.61 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.947 0.404 . . . . 0.0 110.345 178.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.7 t -136.2 135.66 49.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.505 -177.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 m -122.52 151.27 26.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.071 0.462 . . . . 0.0 110.963 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 23.8 m -101.28 107.28 18.61 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.579 177.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.4 mt -101.62 137.42 39.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.167 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.998 ' HG2' ' HG2' ' A' ' 62' ' ' GLU . 79.9 mt-30 -99.71 109.0 21.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.576 177.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 59' ' ' GLU . 70.8 mt -104.62 142.85 33.92 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.088 0.47 . . . . 0.0 111.673 -177.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.518 ' HG2' ' H ' ' A' ' 91' ' ' HIS . 27.0 tt0 -136.04 176.1 9.0 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 172.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.518 ' H ' ' HG2' ' A' ' 90' ' ' GLU . 86.3 m-70 -99.72 118.83 37.07 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.764 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 63.8 t60 -72.63 115.2 11.62 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 73.0 m-70 -83.5 148.52 27.18 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 19.2 t60 -74.49 -25.74 59.56 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 178.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -138.78 121.78 16.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.493 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 82.4 t60 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.542 -177.571 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.617 ' HB2' ' HD1' ' A' ' 40' ' ' TYR . 15.7 m . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 120.956 0.408 . . . . 0.0 110.242 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.6 p -101.26 -158.77 0.69 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.912 -177.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -62.92 -13.75 38.39 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.755 0.422 . . . . 0.0 112.02 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.3 p -68.74 -11.17 59.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.268 0.556 . . . . 0.0 110.921 176.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 49.0 tp -127.92 163.5 24.34 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -72.86 147.39 45.45 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 177.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.409 ' HG3' ' OH ' ' A' ' 40' ' ' TYR . 43.3 ttp180 -63.03 -37.33 86.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.767 0.794 . . . . 0.0 109.352 176.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -127.36 90.29 49.19 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 114.614 -1.176 . . . . 0.0 109.027 171.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -85.52 166.18 10.55 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.436 2.757 . . . . 0.0 113.34 -173.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 20.1 m -100.84 137.33 39.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.502 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 96.1 mt -107.45 137.89 44.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.072 0.463 . . . . 0.0 110.597 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -107.79 114.12 27.85 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.866 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 73.3 mt -119.86 165.58 14.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.128 -176.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.3 m -100.8 142.97 31.52 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.61 HD11 HG13 ' A' ' 53' ' ' VAL . 30.7 tp -91.44 128.22 37.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.159 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 43.7 pt -115.09 160.75 14.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.969 0.414 . . . . 0.0 111.43 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.554 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -92.64 100.08 12.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.445 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.4 ' HD3' ' CD1' ' A' ' 52' ' ' TYR . 59.3 tttm -101.61 135.41 43.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.149 -176.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 66.5 t30 62.28 16.51 8.53 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.536 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.554 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 91.7 m -60.74 119.68 46.34 Favored Pre-proline 0 N--CA 1.447 -0.595 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.777 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.668 ' HG2' ' HA ' ' A' ' 58' ' ' SER . 51.7 Cg_exo -55.02 162.49 5.24 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.869 3.046 . . . . 0.0 113.456 -173.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.76 149.08 32.75 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.156 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 65.13 37.32 6.71 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 123.617 0.573 . . . . 0.0 111.297 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.0 p -123.36 160.04 27.61 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.796 0.332 . . . . 0.0 110.559 178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 54.0 ttp -144.86 129.12 17.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.418 HG12 ' CD2' ' A' ' 89' ' ' LEU . 19.1 mt -95.44 109.88 23.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.407 ' HB2' ' HB3' ' A' ' 88' ' ' GLN . 83.9 mtp -71.63 -27.96 63.46 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.012 0.434 . . . . 0.0 110.527 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.8 m -77.95 123.99 27.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.719 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -71.79 130.54 41.35 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 121.094 -0.242 . . . . 0.0 110.531 -176.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.07 113.57 17.38 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.093 177.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.43 ' HD2' HD23 ' A' ' 15' ' ' LEU . 92.2 Cg_endo -85.15 -175.93 2.19 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.84 2.36 . . . . 0.0 112.79 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 34.4 m -105.76 126.31 52.02 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.356 174.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.503 HG12 ' HD2' ' A' ' 82' ' ' PRO . 13.4 m -85.91 148.24 4.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.474 -175.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 63.3 mtp180 -127.57 97.52 4.89 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.478 HG12 ' HA ' ' A' ' 80' ' ' ILE . 30.7 m -105.32 132.64 51.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.381 -176.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 71.2 tttt -81.46 136.13 35.64 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.547 HG22 ' HA ' ' A' ' 77' ' ' ILE . 22.4 p -125.9 162.69 24.63 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.316 -177.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -122.24 112.93 18.76 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 148.87 178.91 24.33 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.61 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.617 ' HD1' ' HB2' ' A' ' 1' ' ' SER . 88.3 m-85 -118.41 144.18 46.13 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -128.96 92.51 39.57 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 121.328 0.585 . . . . 0.0 111.756 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -62.09 -45.46 15.88 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.788 2.325 . . . . 0.0 111.096 174.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.7 m -117.63 -115.58 0.33 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.552 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.1 mt 56.52 99.96 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-O 121.268 0.556 . . . . 0.0 111.795 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -73.21 100.96 3.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.698 0.761 . . . . 0.0 111.289 -177.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.0 t -64.2 -22.41 31.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.756 -178.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -80.3 -11.61 59.7 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.87 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -98.13 -21.66 16.63 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 175.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 90.8 mt -70.03 132.35 45.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.887 174.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -130.47 152.97 49.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.281 0.562 . . . . 0.0 111.848 -177.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -115.45 141.28 48.26 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 170.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 68' ' ' LYS . 47.0 p90 -133.24 161.31 34.82 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 120.152 -0.619 . . . . 0.0 112.028 -175.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.61 HG13 HD11 ' A' ' 15' ' ' LEU . 6.7 m -112.35 117.98 56.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 167.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -86.38 102.59 14.16 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.447 ' HB2' ' HA ' ' A' ' 20' ' ' THR . 43.5 mt -88.45 76.41 8.26 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.151 -175.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 72.8 m -84.09 9.69 11.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.565 0.698 . . . . 0.0 109.754 173.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.39 107.06 1.88 Allowed Glycine 0 N--CA 1.443 -0.9 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.162 175.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.668 ' HA ' ' HG2' ' A' ' 21' ' ' PRO . 16.1 m -85.7 9.5 16.15 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.223 0.535 . . . . 0.0 110.69 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.88 121.13 83.06 Favored Pre-proline 0 C--N 1.32 -0.679 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.54 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.71 175.84 10.78 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.663 2.242 . . . . 0.0 112.304 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 100.81 -158.99 19.11 Favored Glycine 0 N--CA 1.442 -0.925 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -176.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.404 ' HG2' ' CG2' ' A' ' 86' ' ' THR . 37.3 tt0 -100.12 107.76 19.73 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -132.74 144.41 50.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.138 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.567 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 4.4 p30 -94.15 141.29 28.72 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.197 0.523 . . . . 0.0 110.787 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -133.69 164.23 27.69 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.06 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -93.3 140.27 29.73 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.246 -172.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 98.6 t -79.88 108.71 13.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 172.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.449 ' HB2' ' CE1' ' A' ' 52' ' ' TYR . 40.6 mtpt -108.77 114.06 27.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.711 -176.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 38.6 t -92.6 139.97 17.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.24 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -66.26 132.44 94.43 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 175.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.48 113.66 1.56 Allowed 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.966 2.444 . . . . 0.0 112.574 -176.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.518 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.4 mp -83.29 122.31 77.23 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.018 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.79 143.62 46.38 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.361 2.041 . . . . 0.0 111.716 176.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.4 t30 73.79 -23.38 0.22 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.097 0.559 . . . . 0.0 112.203 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.419 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 48.2 mm -108.38 125.66 65.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.758 0.313 . . . . 0.0 110.877 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -88.16 125.97 34.89 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.115 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.547 ' HA ' HG22 ' A' ' 37' ' ' THR . 16.6 tt -80.06 135.88 24.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 178.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.5 t -104.49 -64.91 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.263 0.554 . . . . 0.0 110.907 -178.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -122.5 137.71 54.79 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.434 -172.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.478 ' HA ' HG12 ' A' ' 35' ' ' VAL . 61.0 mt -103.06 109.44 26.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.675 176.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.45 ' HA ' ' C ' ' A' ' 82' ' ' PRO . 18.2 p -141.87 124.46 9.34 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.457 178.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.503 ' HD2' HG12 ' A' ' 33' ' ' VAL . 43.0 Cg_endo -67.72 160.36 81.16 Favored 'Cis proline' 0 C--N 1.344 0.315 0 C-N-CA 123.386 -1.506 . . . . 0.0 113.204 0.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 24.0 mtm180 -86.36 -70.21 0.62 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.538 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.454 HG12 ' HB2' ' A' ' 64' ' ' ASP . 62.6 t -121.48 129.34 75.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.374 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.3 m -110.21 134.93 50.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.972 0.415 . . . . 0.0 110.879 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 24.0 m -92.92 111.39 22.99 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.079 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 86.2 mt -106.12 138.88 41.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.155 0.502 . . . . 0.0 111.365 -173.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 27' ' ' MET . 55.9 tp60 -94.77 109.83 21.75 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.066 174.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.418 ' CD2' HG12 ' A' ' 26' ' ' ILE . 80.0 mt -100.79 130.0 46.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.239 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -119.14 178.5 4.49 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.414 171.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -97.96 151.86 19.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.48 176.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -67.04 -31.26 71.67 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.989 0.423 . . . . 0.0 110.147 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -89.24 82.11 6.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.577 178.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -167.78 152.94 6.94 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.742 0.306 . . . . 0.0 110.268 177.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -125.04 122.63 37.79 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 173.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 . . . . . 0 C--O 1.246 0.885 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.51 176.876 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 120.677 0.275 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 p -159.07 -171.01 3.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.939 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -61.61 -56.38 20.48 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.6 m -95.19 124.48 39.26 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 170.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.8 mt -74.33 163.3 27.97 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.131 0.491 . . . . 0.0 110.994 -176.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -78.96 2.6 19.75 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.657 -174.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.06 14.37 18.32 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.139 -176.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.593 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 9.1 m-20 -124.28 79.69 59.87 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.057 175.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -75.26 129.69 12.34 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.673 2.249 . . . . 0.0 112.553 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 43.1 m -102.33 109.68 21.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.672 176.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.546 HD21 ' ND2' ' A' ' 41' ' ' ASN . 83.7 mt -92.48 147.11 23.16 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.258 0.551 . . . . 0.0 111.528 -172.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.9 m -121.62 97.59 5.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.733 176.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.451 HD22 ' HB2' ' A' ' 49' ' ' LEU . 56.2 mt -99.17 162.9 12.8 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.319 -175.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.6 p -100.68 148.67 24.6 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.705 178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.814 HD11 HG13 ' A' ' 53' ' ' VAL . 34.1 tp -94.34 125.03 38.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.189 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.6 pt -112.04 151.9 13.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.318 0.58 . . . . 0.0 111.768 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.627 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -83.69 102.19 12.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.116 176.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 52' ' ' TYR . 86.4 tttt -83.34 115.24 21.92 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.312 -178.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.4 ' ND2' ' HG2' ' A' ' 18' ' ' LYS . 61.7 m-80 73.89 -68.27 0.23 Allowed 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.198 0.999 . . . . 0.0 109.668 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.627 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 47.7 m 48.13 97.76 0.04 OUTLIER Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.404 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.96 -172.16 0.16 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.776 2.984 . . . . 0.0 115.151 -169.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.74 105.82 0.16 Allowed 'General case' 0 C--O 1.235 0.325 0 CA-C-N 114.422 -1.263 . . . . 0.0 113.598 -172.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.48 22.13 13.08 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.134 -0.939 . . . . 0.0 113.003 168.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.0 p -84.64 102.72 13.15 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 170.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 55.9 ttp -103.08 126.5 50.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.633 -172.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.463 HG12 ' CD2' ' A' ' 89' ' ' LEU . 5.8 mt -84.81 110.59 19.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.957 -178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 58.1 ttp -73.18 -32.11 64.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 26.9 m -69.3 131.68 45.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.169 175.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -75.65 119.84 20.23 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 176.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 95.1 mt -56.96 114.35 7.86 Favored Pre-proline 0 C--N 1.328 -0.35 0 O-C-N 123.488 0.493 . . . . 0.0 110.064 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -83.27 -172.56 1.4 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.89 2.394 . . . . 0.0 112.792 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.8 p -99.1 149.54 22.93 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.821 175.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.436 ' CG2' ' HB2' ' A' ' 13' ' ' LEU . 35.6 m -108.17 129.29 62.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.149 0.5 . . . . 0.0 109.804 177.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -106.88 110.35 22.49 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.218 0.533 . . . . 0.0 109.88 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.543 HG12 ' HA ' ' A' ' 80' ' ' ILE . 27.2 m -120.45 137.46 54.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.527 -176.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.593 ' HE3' ' HB3' ' A' ' 8' ' ' ASP . 83.3 tttt -93.19 136.24 33.64 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.546 HG22 ' HA ' ' A' ' 77' ' ' ILE . 22.5 p -124.56 168.42 13.13 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.278 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.448 ' HG3' ' CG2' ' A' ' 78' ' ' VAL . 42.1 mt-10 -122.5 123.13 40.55 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 176.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.0 -148.63 20.44 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.076 -0.583 . . . . 0.0 111.778 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.515 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 73.1 m-85 -129.57 129.07 43.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.804 0.335 . . . . 0.0 110.384 178.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.546 ' ND2' HD21 ' A' ' 11' ' ' LEU . 1.6 m-20 -116.71 77.98 8.67 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.629 -176.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 3.0 Cg_endo -86.63 -62.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.635 2.223 . . . . 0.0 112.2 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.0 p -91.5 -8.99 46.05 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.597 -177.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 61.1 mt -93.21 116.11 33.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -111.63 150.34 30.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.58 -171.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.422 ' HB ' HD23 ' A' ' 13' ' ' LEU . 31.4 m -76.12 -5.34 7.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.964 178.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -85.31 -8.45 58.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.935 176.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -114.58 -29.15 6.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.737 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.451 ' HB2' HD22 ' A' ' 13' ' ' LEU . 79.0 mt -84.54 134.34 34.42 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -130.61 160.63 33.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.468 0.652 . . . . 0.0 111.828 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -117.42 133.95 55.39 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 170.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.432 ' HB2' ' HB2' ' A' ' 18' ' ' LYS . 48.7 p90 -122.04 152.01 40.24 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 120.234 -0.586 . . . . 0.0 112.018 -174.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.814 HG13 HD11 ' A' ' 15' ' ' LEU . 6.4 m -112.24 125.9 69.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.785 172.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -86.61 99.98 12.1 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.48 HD12 ' OG1' ' A' ' 20' ' ' THR . 64.6 mt -92.16 21.11 5.33 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.602 -173.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 12.5 p -60.37 115.9 3.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.153 0.501 . . . . 0.0 110.093 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 145.8 -28.5 1.74 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.594 -175.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 51.9 p 49.98 38.29 16.04 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.438 0.695 . . . . 0.0 111.897 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -84.84 115.02 59.06 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.953 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -77.3 150.21 28.63 Favored 'Trans proline' 0 C--O 1.236 0.402 0 C-N-CA 122.825 2.35 . . . . 0.0 112.092 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 104.82 -174.43 21.64 Favored Glycine 0 N--CA 1.444 -0.789 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.745 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -80.26 105.75 11.77 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.753 0.311 . . . . 0.0 110.27 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 50.4 m-70 -125.18 151.68 45.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.523 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -91.98 123.11 35.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.519 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -121.62 139.33 53.67 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.231 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -69.49 136.82 51.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.237 -177.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 64.2 t -83.26 106.08 13.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 171.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -103.6 104.99 15.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.118 -176.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 45.9 t -90.91 140.18 16.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.334 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 36.3 mt-10 -66.64 128.14 93.72 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.33 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 25.3 Cg_exo -62.58 115.88 3.18 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.829 2.352 . . . . 0.0 111.92 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.542 ' H ' HD12 ' A' ' 72' ' ' ILE . 4.3 mp -81.33 122.62 81.33 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.073 -173.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.86 135.94 34.04 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.791 2.327 . . . . 0.0 112.221 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.4 m120 71.5 6.79 5.84 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.387 176.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 63.1 mt -135.9 131.23 49.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 120.823 0.344 . . . . 0.0 110.612 179.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -84.79 129.56 34.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.396 179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.546 ' HA ' HG22 ' A' ' 37' ' ' THR . 17.7 tt -92.72 134.35 30.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.448 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 35.4 t -108.18 -60.46 2.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.904 0.383 . . . . 0.0 111.459 -174.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HG3' HG12 ' A' ' 78' ' ' VAL . 41.8 mt-10 -118.58 128.44 54.56 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.097 -171.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.543 ' HA ' HG12 ' A' ' 35' ' ' VAL . 62.4 mt -111.92 109.47 28.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.273 178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 14.8 p -139.75 126.96 12.7 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.601 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.408 ' HD2' HG12 ' A' ' 33' ' ' VAL . 4.2 Cg_exo -80.63 159.78 84.8 Favored 'Cis proline' 0 CA--C 1.53 0.291 0 C-N-CA 123.452 -1.479 . . . . 0.0 112.535 -0.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -80.34 -50.32 10.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.291 0.567 . . . . 0.0 110.527 178.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 65.1 t -131.11 137.1 56.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.377 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.5 m -117.77 134.11 62.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.159 0.504 . . . . 0.0 111.172 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.3 m -85.04 105.82 16.07 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.598 175.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.8 mt -104.89 130.49 53.04 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.271 -177.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -94.23 106.12 18.1 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.076 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.463 ' CD2' HG12 ' A' ' 26' ' ' ILE . 90.1 mt -91.96 126.82 37.19 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.59 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -118.55 150.33 39.82 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.377 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -77.43 137.93 38.97 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.954 0.407 . . . . 0.0 111.257 -176.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -69.67 -20.89 63.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.012 177.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -92.68 86.65 5.62 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 170.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -71.09 101.44 2.24 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.09 0.471 . . . . 0.0 109.751 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -94.24 165.92 12.36 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.232 -175.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 66.1 m80 . . . . . 0 C--O 1.248 0.998 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 175.591 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.475 0.825 0 CA-C-O 120.765 0.317 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.2 m -147.55 102.45 3.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.849 0.357 . . . . 0.0 111.388 -175.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -91.82 122.47 34.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.957 0.408 . . . . 0.0 110.03 175.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.2 p -102.39 0.43 33.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.356 -177.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -87.7 -9.32 54.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.915 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -110.19 145.32 37.47 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 178.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.433 ' HD3' ' OH ' ' A' ' 40' ' ' TYR . 34.0 mmt180 -83.87 -19.97 33.91 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.721 0.296 . . . . 0.0 110.937 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -163.34 97.93 1.02 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.437 0.637 . . . . 0.0 110.188 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.19 161.97 11.45 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.627 2.218 . . . . 0.0 113.01 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 40.1 m -93.96 105.65 17.66 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.784 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.536 HD11 ' HB ' ' A' ' 46' ' ' VAL . 54.3 tp -83.2 139.02 33.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.632 -176.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.7 m -116.77 115.36 25.44 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.787 0.327 . . . . 0.0 110.561 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 85.6 mt -114.52 141.73 47.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.164 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.6 m -75.05 142.31 43.76 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.711 0.291 . . . . 0.0 110.472 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.804 HD11 HG13 ' A' ' 53' ' ' VAL . 38.6 tp -89.1 122.03 32.01 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.234 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.6 pt -104.42 148.38 9.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.149 0.499 . . . . 0.0 111.114 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.33 113.44 18.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.855 176.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 38.8 tttt -111.64 133.17 54.08 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.458 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 68.13 3.68 3.75 Favored 'General case' 0 N--CA 1.47 0.556 0 O-C-N 123.608 0.568 . . . . 0.0 112.067 174.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 21' ' ' PRO . 27.1 m -62.3 113.66 9.44 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.995 -177.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 24.0 Cg_exo -65.16 166.88 17.59 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.373 2.716 . . . . 0.0 113.51 -175.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.34 -23.02 60.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.123 -179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -85.46 3.61 39.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.84 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.2 m -117.01 124.55 49.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.612 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.5 ttp -117.18 113.03 21.65 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.406 HG12 ' CD2' ' A' ' 89' ' ' LEU . 17.8 mt -75.95 115.9 18.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.254 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 22.1 ttt -77.9 -35.58 50.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.073 0.463 . . . . 0.0 110.049 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.7 m -78.6 121.65 24.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.775 -178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -69.48 128.26 35.9 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 82.8 mt -67.95 126.4 92.58 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.196 -176.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -90.99 -161.25 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.119 2.546 . . . . 0.0 112.397 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.8 m -117.83 141.96 47.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.405 176.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.1 p -97.75 145.22 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.965 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 37.6 mtp180 -114.93 118.43 33.44 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 80' ' ' ILE . 17.3 m -117.3 134.45 60.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.057 -177.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.543 ' HB3' ' HB ' ' A' ' 78' ' ' VAL . 11.9 mmtt -79.09 122.21 25.95 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 173.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.3 p -120.95 129.83 53.6 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.773 0.321 . . . . 0.0 111.509 -176.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.518 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 28.3 tt0 -96.04 106.15 18.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.601 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 135.17 -178.41 18.59 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.029 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.433 ' OH ' ' HD3' ' A' ' 7' ' ' ARG . 95.0 m-85 -113.23 161.06 17.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.101 0.476 . . . . 0.0 111.043 -178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.628 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 3.2 p30 -128.74 74.57 80.54 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.687 176.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.66 -45.46 0.31 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.585 2.19 . . . . 0.0 111.767 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 p -102.9 3.93 37.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.054 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.654 HD11 ' HB2' ' A' ' 74' ' ' ASN . 56.9 mt -106.69 121.51 59.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.629 -175.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -91.72 106.23 18.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.541 0.686 . . . . 0.0 110.665 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.536 ' HB ' HD11 ' A' ' 11' ' ' LEU . 33.2 m -69.66 -10.88 14.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.68 -176.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -82.87 -11.01 58.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.978 0.418 . . . . 0.0 110.497 177.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -106.26 -16.46 14.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.213 174.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.8 mt -70.32 128.56 36.63 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 168.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -124.3 157.86 33.94 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.361 0.6 . . . . 0.0 112.044 -175.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -111.88 129.54 56.13 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 169.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -129.57 143.78 50.98 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.466 0.651 . . . . 0.0 111.622 -173.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.804 HG13 HD11 ' A' ' 15' ' ' LEU . 3.2 m -112.52 119.52 60.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.94 172.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -84.84 100.3 11.48 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.571 -173.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.509 HD23 HD11 ' A' ' 89' ' ' LEU . 10.5 mp -90.6 76.26 6.56 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.0 m -57.3 -42.63 82.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.919 -174.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -112.21 172.56 14.82 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.041 -174.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.9 m -91.4 31.07 1.19 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.975 0.417 . . . . 0.0 110.168 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -59.73 112.28 5.08 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.521 -175.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -80.41 151.88 20.27 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.633 2.222 . . . . 0.0 112.055 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 113.82 179.3 19.13 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.531 -0.842 . . . . 0.0 112.351 176.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 88' ' ' GLN . 41.8 tt0 -87.08 107.99 18.68 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 65' ' ' TYR . 76.6 m-70 -117.33 161.76 19.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.818 -175.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -95.53 127.24 41.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 63' ' ' HIS . 95.3 m-85 -116.88 134.24 55.02 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.322 0.582 . . . . 0.0 111.165 -177.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -77.09 120.64 22.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.146 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 75.5 t -73.44 106.25 3.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.27 0.557 . . . . 0.0 110.044 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 52.3 mttp -100.5 126.02 46.88 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.554 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.9 146.73 10.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -58.94 115.38 11.69 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 173.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.19 108.0 0.4 Allowed 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.713 2.276 . . . . 0.0 112.486 -176.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.535 ' H ' HD12 ' A' ' 72' ' ' ILE . 3.8 mp -81.06 111.11 21.09 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 177.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.9 24.51 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.829 2.353 . . . . 0.0 113.15 -172.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.654 ' HB2' HD11 ' A' ' 44' ' ' ILE . 21.8 m120 -144.38 -1.42 0.92 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.721 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.544 HD11 ' HB3' ' A' ' 41' ' ' ASN . 70.1 mt -129.96 134.23 63.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.874 0.368 . . . . 0.0 110.407 -176.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 52.2 tttm -83.18 112.83 20.2 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.802 178.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.9 tt -80.66 125.46 39.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.203 0.525 . . . . 0.0 110.163 -176.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 36' ' ' LYS . 22.7 t -93.59 -54.18 7.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.35 -173.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -153.28 156.82 39.15 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.722 -174.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.609 ' HA ' HG12 ' A' ' 35' ' ' VAL . 60.9 mt -122.78 132.08 72.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 176.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 23.2 t -139.21 110.5 7.7 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.464 0.173 . . . . 0.0 110.642 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 2.3 Cg_endo -87.35 153.38 42.07 Favored 'Cis proline' 0 N--CA 1.462 -0.379 0 C-N-CA 124.215 -1.161 . . . . 0.0 112.152 -2.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.593 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 85.1 mtm180 -76.33 -34.68 59.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.878 0.371 . . . . 0.0 111.392 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 90.8 t -129.23 129.62 67.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.913 179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.3 m -116.11 133.44 62.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.971 0.415 . . . . 0.0 110.859 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.3 m -90.78 115.4 27.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.144 178.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.418 ' HB2' ' CE2' ' A' ' 65' ' ' TYR . 70.8 mt -118.82 138.86 52.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.178 -177.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 53.1 tt0 -93.83 115.78 28.2 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.951 0.405 . . . . 0.0 110.581 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.509 HD11 HD23 ' A' ' 55' ' ' LEU . 23.7 mt -100.42 135.68 41.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.282 0.563 . . . . 0.0 111.118 177.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -118.86 170.51 8.95 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 169.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -83.43 166.15 18.61 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.885 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -53.76 -46.27 70.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.201 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 51.0 t60 -161.92 122.09 2.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.187 176.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -107.2 160.97 15.18 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -78.44 169.22 18.59 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.152 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.3 m80 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.663 -0.684 . . . . 0.0 110.123 -179.82 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 36.6 m . . . . . 0 N--CA 1.476 0.845 0 CA-C-O 120.993 0.425 . . . . 0.0 110.657 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -88.78 84.97 6.68 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 177.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -72.42 130.85 41.67 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.4 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.5 m -72.71 -45.2 60.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.035 0.445 . . . . 0.0 110.69 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 44.5 tp -85.56 88.66 7.55 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -84.45 13.19 5.72 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.224 -174.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 49.6 ttt180 -77.26 -34.18 55.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.207 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.838 ' HB3' ' HG3' ' A' ' 38' ' ' GLU . 6.1 p-10 -134.37 89.52 27.11 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 121.737 0.779 . . . . 0.0 110.385 178.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.32 141.1 25.36 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.097 2.532 . . . . 0.0 113.36 -173.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 40.9 m -87.77 110.35 20.4 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 171.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 63.9 tp -108.92 144.69 36.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.538 -171.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 12.4 t -116.64 123.47 47.37 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.353 0.597 . . . . 0.0 109.796 174.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.9 mt -109.5 166.29 11.0 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.011 -179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.2 t -86.07 126.65 34.34 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 178.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.642 HD11 HG13 ' A' ' 53' ' ' VAL . 60.3 tp -80.82 104.24 11.2 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 174.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 36.2 pt -107.08 147.45 12.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.257 0.551 . . . . 0.0 111.599 -175.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.568 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -86.91 105.03 16.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.54 175.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -90.42 -77.84 0.39 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.859 -174.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -80.71 64.82 5.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.906 0.86 . . . . 0.0 109.253 -179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.568 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 46.5 m -112.0 111.48 53.47 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 114.654 -1.157 . . . . 0.0 110.564 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -71.25 -178.93 3.18 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.035 2.49 . . . . 0.0 111.979 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 23' ' ' ASN . . . -77.87 160.96 27.96 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.571 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.567 ' HB3' ' O ' ' A' ' 22' ' ' ALA . 18.1 t30 80.1 -38.09 0.16 Allowed 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.847 0.717 . . . . 0.0 111.274 174.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 11.3 p -78.72 94.58 5.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.14 0.495 . . . . 0.0 110.123 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 51.4 ttp -102.94 133.0 48.77 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.244 -177.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 12.9 mt -85.9 110.43 19.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 28.3 ttt -70.4 -32.5 70.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.088 0.47 . . . . 0.0 110.088 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.5 m -78.01 106.62 10.0 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.477 174.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -63.58 129.57 40.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.051 0.453 . . . . 0.0 111.175 -176.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 15' ' ' LEU . 73.1 mt -55.94 122.72 48.98 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.856 -174.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -95.25 176.19 0.94 Allowed 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 123.343 2.695 . . . . 0.0 112.82 176.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.0 m -87.0 140.08 29.92 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.925 173.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 12' ' ' THR . 14.4 p -101.83 148.09 7.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.044 -175.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 34' ' ' ARG . 37.2 mtm-85 -103.17 120.45 40.73 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.904 0.383 . . . . 0.0 110.638 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.551 HG12 ' HA ' ' A' ' 80' ' ' ILE . 6.9 m -133.77 116.67 24.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.236 178.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 16.7 ttpp -87.55 129.07 35.23 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 22.1 p -105.03 -178.05 3.54 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 178.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.838 ' HG3' ' HB3' ' A' ' 8' ' ' ASP . 3.4 tt0 -154.66 110.31 3.15 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.41 165.66 10.85 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.927 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -88.02 113.13 23.36 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.594 0.235 . . . . 0.0 110.529 -177.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.523 ' HB3' HG13 ' A' ' 75' ' ' ILE . 5.1 p30 -135.5 82.01 40.89 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.537 0.684 . . . . 0.0 111.626 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -91.13 -6.18 3.98 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.096 2.531 . . . . 0.0 111.948 175.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 6.1 p -97.74 -52.16 3.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.238 -177.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.31 126.35 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.243 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -86.24 128.78 34.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.926 -177.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.9 m -67.63 -13.08 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.451 -174.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -97.06 -9.53 27.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.688 0.28 . . . . 0.0 110.844 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.82 -25.13 22.37 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 172.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.7 mt -77.6 128.51 34.25 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.743 172.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -130.85 157.61 42.43 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.987 0.422 . . . . 0.0 111.11 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 15' ' ' LEU . . . -123.0 114.0 19.82 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 170.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.557 ' CZ ' ' HD2' ' A' ' 68' ' ' LYS . 53.1 p90 -118.55 159.53 23.39 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.121 0.486 . . . . 0.0 111.839 -171.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.642 HG13 HD11 ' A' ' 15' ' ' LEU . 17.0 m -112.43 139.46 37.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.695 172.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -103.68 106.69 17.27 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.471 HD12 HG23 ' A' ' 20' ' ' THR . 78.8 mt -98.49 44.18 1.04 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.947 0.403 . . . . 0.0 111.0 -174.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.0 t -56.56 -44.04 80.55 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.454 174.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.99 69.97 3.22 Favored Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 173.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 p -69.54 91.58 0.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.488 0.661 . . . . 0.0 110.779 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 42.5 tt0 -117.87 125.48 27.98 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.958 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 59' ' ' GLU . 25.3 Cg_exo -62.89 150.9 87.0 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 123.194 2.596 . . . . 0.0 112.818 -177.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 101.38 -177.27 27.15 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.46 -0.656 . . . . 0.0 111.46 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.863 ' HG2' ' HB2' ' A' ' 88' ' ' GLN . 42.6 mt-10 -87.68 107.49 18.65 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -124.15 148.76 46.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.425 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 39.4 m-20 -81.89 109.64 16.44 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.71 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -111.61 146.54 37.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.283 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -80.52 134.06 35.89 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.523 -174.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.482 HG13 HD13 ' A' ' 15' ' ' LEU . 60.1 t -81.75 112.36 19.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 175.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.557 ' HD2' ' CZ ' ' A' ' 52' ' ' TYR . 7.8 tmtt? -103.1 111.57 24.0 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.093 0.473 . . . . 0.0 109.885 -176.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 34.9 t -92.4 143.13 12.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.421 -178.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -58.3 139.16 84.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.908 175.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.27 136.38 47.14 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.499 2.133 . . . . 0.0 111.702 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.458 ' CG2' ' HB ' ' A' ' 75' ' ' ILE . 41.2 mt -116.24 110.41 43.32 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.312 -177.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.52 137.31 50.1 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.763 2.308 . . . . 0.0 111.938 178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 73.41 -45.3 0.61 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.524 0.729 . . . . 0.0 112.447 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.523 HG13 ' HB3' ' A' ' 41' ' ' ASN . 26.3 mm -84.33 129.36 37.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.031 0.443 . . . . 0.0 110.362 -175.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -81.8 141.48 33.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.562 -177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.2 tt -98.69 112.42 30.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.548 0.69 . . . . 0.0 109.144 174.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.6 t -86.42 -53.22 10.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.633 -170.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -133.86 147.71 51.2 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.099 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.718 ' HB ' ' HG2' ' A' ' 83' ' ' ARG . 55.0 mt -127.8 111.8 25.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 172.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 21.0 m -128.78 108.45 18.57 Favored Pre-proline 0 C--N 1.318 -0.771 0 C-N-CA 121.09 -0.244 . . . . 0.0 111.145 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.503 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 4.1 Cg_endo -89.33 166.81 36.09 Favored 'Cis proline' 0 C--N 1.344 0.316 0 C-N-CA 124.459 -1.059 . . . . 0.0 112.344 -3.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.718 ' HG2' ' HB ' ' A' ' 80' ' ' ILE . 80.5 mtm180 -93.49 -28.62 15.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.081 0.467 . . . . 0.0 109.888 176.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.425 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 53.9 t -130.22 120.18 48.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.526 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.489 HG12 ' HG2' ' A' ' 82' ' ' PRO . 16.2 m -112.72 135.45 52.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.157 0.504 . . . . 0.0 111.219 -177.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.8 m -83.09 104.1 13.02 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.766 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.1 mt -101.51 133.02 46.8 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.61 -177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.863 ' HB2' ' HG2' ' A' ' 62' ' ' GLU . 42.8 tt0 -92.02 108.73 20.15 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.86 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 72.2 mt -94.31 120.65 34.85 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.532 177.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -109.12 152.33 25.24 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.592 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 26.5 t60 -84.13 100.44 11.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.647 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -92.56 137.71 32.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.804 -176.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 39.7 m-70 -78.42 141.31 38.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.44 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -102.69 137.78 40.46 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.134 0.493 . . . . 0.0 112.195 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -92.74 -32.99 14.49 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 161.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.2 m80 . . . . . 0 C--O 1.252 1.209 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.833 174.394 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.477 0.91 0 CA-C-O 120.851 0.358 . . . . 0.0 110.467 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.1 m -79.38 111.41 15.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 175.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -94.13 166.99 11.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.889 0.376 . . . . 0.0 111.121 -175.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.7 m -73.18 -28.94 62.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.372 0.606 . . . . 0.0 109.679 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -95.26 148.64 22.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.537 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -84.65 168.88 14.89 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -177.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -92.52 -18.27 23.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.878 0.37 . . . . 0.0 110.49 -178.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -116.23 93.09 38.17 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.798 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -70.14 130.38 18.78 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.398 2.065 . . . . 0.0 111.445 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.7 m -95.75 92.6 6.64 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 175.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.507 HD21 HD12 ' A' ' 49' ' ' LEU . 14.6 tp -82.85 114.98 21.53 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.953 -170.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.405 HG23 ' HG2' ' A' ' 34' ' ' ARG . 26.5 m -93.81 101.57 13.67 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.253 178.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.8 mt -100.83 177.91 4.84 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.482 -178.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.9 m -105.35 137.63 42.84 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.521 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.824 HD11 HG13 ' A' ' 53' ' ' VAL . 50.7 tp -86.99 123.46 32.11 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 176.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.7 pt -119.79 146.7 24.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.133 0.492 . . . . 0.0 111.034 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -85.27 115.79 23.24 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 176.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -71.05 -76.46 0.1 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.063 -175.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -126.19 81.11 1.97 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.893 0.378 . . . . 0.0 110.317 177.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.9 t -90.67 127.17 53.46 Favored Pre-proline 0 C--N 1.318 -0.8 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 170.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.89 157.33 13.2 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 123.323 2.682 . . . . 0.0 113.158 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.461 ' HB1' ' HA ' ' A' ' 96' ' ' HIS . . . -68.97 -19.82 64.17 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.679 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -86.03 -5.8 59.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.26 -177.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 6.8 p -118.59 144.61 46.0 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.106 0.479 . . . . 0.0 111.218 -176.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 53.9 ttp -132.62 130.7 40.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.738 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.42 ' HA ' HD23 ' A' ' 89' ' ' LEU . 19.7 mt -82.84 116.92 27.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-O 120.652 0.263 . . . . 0.0 111.134 -176.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.52 ' HG2' ' HB2' ' A' ' 90' ' ' GLU . 95.9 mmm -82.94 -39.24 21.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.175 177.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 41.6 m -66.85 112.9 4.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.297 177.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -58.07 120.63 8.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.164 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.6 mt -63.25 109.22 2.27 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.422 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -85.01 -170.87 0.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.879 2.386 . . . . 0.0 113.015 -173.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.2 m -97.2 134.31 40.68 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.147 177.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.538 HG11 HG11 ' A' ' 67' ' ' VAL . 17.8 m -96.85 142.39 14.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.405 ' HG2' HG23 ' A' ' 12' ' ' THR . 48.2 mtp180 -120.94 119.26 32.08 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.352 -178.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.53 HG12 ' HA ' ' A' ' 80' ' ' ILE . 30.1 m -112.54 137.29 45.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 121.066 0.46 . . . . 0.0 111.527 -178.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -87.53 122.2 30.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 173.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.434 ' HB ' ' CG2' ' A' ' 75' ' ' ILE . 24.1 p -126.34 159.15 33.99 Favored 'General case' 0 C--N 1.32 -0.717 0 O-C-N 123.368 0.417 . . . . 0.0 110.925 -177.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -114.86 112.04 22.14 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 176.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 141.87 -159.0 26.88 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.841 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -137.78 157.14 47.06 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.448 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 6.3 p30 -128.78 85.66 59.62 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-O 121.204 0.526 . . . . 0.0 111.768 -174.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.59 -67.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.018 2.478 . . . . 0.0 112.422 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.3 p -84.4 -11.41 56.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.153 0.501 . . . . 0.0 111.045 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' A' ' 41' ' ' ASN . 70.1 mt -76.46 113.2 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.273 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.428 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 35.2 m-80 -84.77 121.6 27.92 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.747 -176.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.478 HG22 HD11 ' A' ' 11' ' ' LEU . 37.7 t -62.62 -36.53 75.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.455 179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -71.15 -22.13 62.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.635 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -88.56 -17.31 30.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.449 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.507 HD12 HD21 ' A' ' 11' ' ' LEU . 91.3 mt -85.03 131.09 34.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.61 176.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -128.14 152.66 47.75 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.073 0.463 . . . . 0.0 111.447 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . . . -115.42 115.99 27.48 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 171.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 55.8 p90 -107.69 145.94 32.74 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.346 0.593 . . . . 0.0 112.023 -173.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.824 HG13 HD11 ' A' ' 15' ' ' LEU . 4.4 m -112.6 121.07 64.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.218 169.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -87.35 86.28 7.24 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.218 1.009 . . . . 0.0 110.528 -177.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 mp -78.96 29.89 0.21 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.214 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.1 m -65.52 95.65 0.23 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.208 0.527 . . . . 0.0 110.064 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.83 -74.1 0.44 Allowed Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -173.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 72.7 m 58.37 98.41 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 173.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -85.1 119.59 72.64 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 169.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.81 114.65 1.95 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.695 2.264 . . . . 0.0 112.183 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 148.08 -158.48 27.7 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -100.36 104.71 16.16 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -130.89 152.68 49.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.822 -175.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.478 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 18.8 m-20 -91.69 130.29 37.52 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.765 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -123.99 151.78 43.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.209 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.429 ' O ' HG12 ' A' ' 53' ' ' VAL . 24.8 mt-10 -87.2 134.72 33.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.306 -175.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.538 HG11 HG11 ' A' ' 33' ' ' VAL . 90.6 t -79.86 109.51 14.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.932 173.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -108.92 109.67 20.8 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.023 0.44 . . . . 0.0 110.431 -177.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 51' ' ' ALA . 31.8 t -87.27 149.83 3.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.293 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -53.03 128.97 48.44 Favored Pre-proline 0 C--O 1.232 0.138 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.67 124.91 15.99 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.373 2.049 . . . . 0.0 111.683 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.6 mt -113.79 95.47 37.46 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.544 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -82.02 24.43 0.71 Allowed 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 123.072 2.514 . . . . 0.0 111.751 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -118.28 -30.51 5.24 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.171 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.434 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 61.9 mt -130.95 142.11 44.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.201 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.6 mttp -80.73 128.13 33.29 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.149 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.9 tt -97.41 122.16 48.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 121.396 0.617 . . . . 0.0 109.889 -178.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.836 HG12 ' HG3' ' A' ' 79' ' ' GLU . 41.4 t -94.87 -60.47 2.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.115 -175.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.836 ' HG3' HG12 ' A' ' 78' ' ' VAL . 43.8 mt-10 -141.87 139.37 32.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.28 -172.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.53 ' HA ' HG12 ' A' ' 35' ' ' VAL . 46.3 mt -107.31 120.27 58.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.496 175.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 15.1 m -118.18 108.01 42.74 Favored Pre-proline 0 C--N 1.323 -0.586 0 O-C-N 122.423 -0.173 . . . . 0.0 110.93 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 83.9 Cg_endo -91.74 174.54 18.92 Favored 'Cis proline' 0 C--N 1.346 0.439 0 C-N-CA 124.186 -1.172 . . . . 0.0 112.53 -2.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 83' ' ' ARG . 27.3 mtm105 -94.97 -50.66 5.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.46 0.648 . . . . 0.0 110.085 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.478 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 41.1 t -115.53 118.66 59.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.138 -177.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.7 m -107.44 134.69 48.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.024 0.44 . . . . 0.0 111.18 -177.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.2 m -85.21 103.97 14.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.82 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 94.5 mt -97.92 124.64 42.45 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.102 0.477 . . . . 0.0 110.572 -177.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -87.93 104.66 16.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.965 177.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 26' ' ' ILE . 59.5 mt -94.31 134.33 36.91 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.941 -179.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.52 ' HB2' ' HG2' ' A' ' 27' ' ' MET . 0.0 OUTLIER -110.72 170.99 7.73 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.656 179.242 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -84.98 110.74 19.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.358 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -84.33 110.47 18.62 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 177.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -80.04 61.51 3.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.21 0.529 . . . . 0.0 111.081 -173.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -163.96 155.45 16.36 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.352 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -89.87 9.53 27.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.03 0.443 . . . . 0.0 110.782 176.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.461 ' HA ' ' HB1' ' A' ' 22' ' ' ALA . 36.0 t60 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.129 -0.939 . . . . 0.0 109.062 174.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.5 t . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -56.35 -43.52 79.19 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.94 0.4 . . . . 0.0 110.568 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -103.31 130.93 50.7 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.6 p -96.86 124.98 40.99 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.021 0.439 . . . . 0.0 111.532 -173.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.1 mt -76.74 153.72 34.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.166 178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -94.85 141.59 28.46 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -71.02 -34.6 71.48 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.226 0.536 . . . . 0.0 110.497 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.419 ' HB3' ' HG2' ' A' ' 38' ' ' GLU . 0.1 OUTLIER -143.44 92.09 6.71 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.83 -178.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.95 154.82 33.79 Favored 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.874 2.383 . . . . 0.0 113.453 -174.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 35.3 m -100.23 123.28 44.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.826 175.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 81.2 mt -101.33 159.01 15.63 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.051 0.453 . . . . 0.0 110.496 -176.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 31.0 m -126.4 99.55 5.89 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.02 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.529 HD22 ' HB2' ' A' ' 49' ' ' LEU . 79.5 mt -95.8 141.84 28.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.244 -173.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.8 m -74.01 140.78 45.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.92 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.851 HD11 HG13 ' A' ' 53' ' ' VAL . 45.0 tp -96.32 125.19 40.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.035 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.5 HD11 ' CE2' ' A' ' 52' ' ' TYR . 39.7 pt -122.77 151.85 27.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.035 0.445 . . . . 0.0 111.507 -178.25 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.444 ' HB1' ' OG1' ' A' ' 20' ' ' THR . . . -78.99 132.91 36.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.537 178.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.55 ' HD2' ' CD2' ' A' ' 52' ' ' TYR . 60.6 tttm -129.73 140.15 51.16 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.213 178.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.557 ' HB3' ' HB2' ' A' ' 56' ' ' SER . 65.0 m-20 60.91 20.17 10.47 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.719 0.637 . . . . 0.0 110.798 179.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.444 ' OG1' ' HB1' ' A' ' 17' ' ' ALA . 72.7 m -79.76 116.44 61.01 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.196 -174.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -68.1 178.0 3.93 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.911 2.407 . . . . 0.0 112.647 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.0 -28.44 27.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.114 -175.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -73.92 -10.15 59.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.674 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 16.6 p -100.93 110.12 22.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.128 0.489 . . . . 0.0 109.972 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.622 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 25.6 ttt -102.9 108.83 20.17 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.032 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 54.0 mt -78.35 108.19 11.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.665 -175.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.476 ' SD ' ' HB2' ' A' ' 90' ' ' GLU . 85.4 mtp -86.19 -32.9 20.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.553 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.9 m -71.87 111.39 7.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.985 176.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -65.9 117.88 8.92 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.4 mt -63.5 114.53 13.41 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.507 -173.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -85.06 -161.99 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.903 2.402 . . . . 0.0 111.74 177.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.8 m -113.31 150.79 32.02 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.743 0.306 . . . . 0.0 110.911 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.626 HG11 HG11 ' A' ' 67' ' ' VAL . 35.7 m -94.38 152.48 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.777 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -110.53 102.02 10.65 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.988 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 80' ' ' ILE . 23.7 m -120.12 132.79 68.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.786 -176.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 81.8 tttt -97.17 136.06 38.23 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.553 HG22 ' HA ' ' A' ' 77' ' ' ILE . 37.0 p -127.98 138.35 52.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.289 -175.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.466 ' HG3' HG21 ' A' ' 78' ' ' VAL . 53.6 mt-10 -97.37 100.27 11.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.183 0.516 . . . . 0.0 109.64 175.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 153.24 151.65 5.78 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.19 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -89.93 147.58 23.64 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.677 0.275 . . . . 0.0 110.385 -178.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 4.6 p30 -109.46 111.49 59.53 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.562 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 41' ' ' ASN . 5.1 Cg_exo -79.87 -73.64 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.814 2.342 . . . . 0.0 112.072 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 p -105.11 6.13 32.94 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.787 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.2 126.22 40.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.47 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -114.95 153.38 30.69 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.83 0.348 . . . . 0.0 111.322 -176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.0 m -83.56 -9.71 11.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.695 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 17.4 m-80 -93.58 -4.81 50.21 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -98.78 -37.4 9.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.668 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.529 ' HB2' HD22 ' A' ' 13' ' ' LEU . 20.0 mt -88.3 144.57 26.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.657 177.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -135.89 157.9 45.71 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.684 0.754 . . . . 0.0 112.419 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -107.18 135.61 48.43 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.981 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.55 ' CD2' ' HD2' ' A' ' 18' ' ' LYS . 29.6 m-85 -112.25 150.16 31.31 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.956 0.408 . . . . 0.0 111.022 -173.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.851 HG13 HD11 ' A' ' 15' ' ' LEU . 3.1 m -122.08 118.28 55.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.814 168.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -83.63 105.65 14.72 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.224 -177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.4 mt -101.87 15.58 28.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.605 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.557 ' HB2' ' HB3' ' A' ' 19' ' ' ASN . 12.7 t -72.26 96.81 1.89 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 173.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 98.52 51.34 1.44 Allowed Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.941 -0.863 . . . . 0.0 110.941 -172.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 8.2 p -106.01 162.36 13.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.717 0.294 . . . . 0.0 110.833 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.466 ' HB2' ' CE1' ' A' ' 63' ' ' HIS . 1.2 mp0 -120.38 132.89 23.98 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -56.4 147.74 66.25 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 122.775 2.316 . . . . 0.0 112.13 178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.34 -171.02 17.05 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.491 -177.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -84.76 111.98 20.09 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.466 ' CE1' ' HB2' ' A' ' 59' ' ' GLU . 25.6 m80 -137.1 145.19 43.59 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.025 0.44 . . . . 0.0 110.932 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.54 ' HB3' ' CG1' ' A' ' 84' ' ' VAL . 11.5 m-20 -85.25 125.72 33.11 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.364 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -121.79 151.79 40.2 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.086 178.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -90.16 142.8 27.36 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.797 -170.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.626 HG11 HG11 ' A' ' 33' ' ' VAL . 67.5 t -83.15 121.77 36.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.946 -178.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 52' ' ' TYR . 50.4 tttm -95.4 112.66 24.34 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.331 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 46.5 t -92.53 127.09 44.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.695 -175.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.456 ' HA ' ' HD3' ' A' ' 71' ' ' PRO . 37.5 tt0 -72.21 122.87 88.54 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.979 177.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 70' ' ' GLU . 50.0 Cg_exo -55.99 125.66 19.82 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.134 2.556 . . . . 0.0 113.062 -176.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.444 HG12 HD13 ' A' ' 49' ' ' LEU . 52.1 mt -88.54 117.1 67.98 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.948 178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.86 137.27 37.69 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.318 2.012 . . . . 0.0 112.551 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 71.15 4.38 5.05 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.264 173.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 58.3 mt -132.06 136.14 57.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 177.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.5 ttpt -90.41 123.33 34.04 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.43 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.553 ' HA ' HG22 ' A' ' 37' ' ' THR . 16.6 tt -80.28 139.49 18.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.466 HG21 ' HG3' ' A' ' 38' ' ' GLU . 39.4 t -108.05 -69.13 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.069 0.462 . . . . 0.0 110.902 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -107.79 141.66 39.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.864 -171.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.54 ' HA ' HG12 ' A' ' 35' ' ' VAL . 66.3 mt -120.1 110.43 28.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.362 177.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 47.0 m -144.78 123.84 6.92 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.92 -178.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 81' ' ' SER . 93.2 Cg_endo -85.32 158.68 63.04 Favored 'Cis proline' 0 N--CA 1.46 -0.498 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.123 -3.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -81.58 -35.64 29.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.984 0.421 . . . . 0.0 110.453 177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.54 ' CG1' ' HB3' ' A' ' 64' ' ' ASP . 71.3 t -130.54 130.61 65.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.445 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.7 m -116.92 141.2 36.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.098 0.475 . . . . 0.0 111.168 -179.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 10.1 m -80.44 117.51 21.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.229 176.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.2 mt -113.92 123.44 49.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.854 0.359 . . . . 0.0 110.681 -179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -88.79 104.37 16.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.078 176.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 95.9 mt -94.77 127.44 40.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.403 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.516 ' HB3' ' HB3' ' A' ' 25' ' ' MET . 10.4 tp10 -100.41 154.61 18.38 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.686 -179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -80.62 90.46 5.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.611 -178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.622 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 22.4 t60 -66.68 111.21 3.56 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -85.36 159.37 20.03 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.207 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -124.19 135.41 53.44 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.01 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -144.19 122.7 12.44 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.1 p-80 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.881 -0.58 . . . . 0.0 110.32 -178.166 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.5 p . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 120.985 0.421 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.0 m -84.07 163.98 19.53 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 176.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -81.55 4.16 22.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.422 0.63 . . . . 0.0 110.501 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.5 m -155.91 155.54 33.03 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -54.05 138.4 37.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.876 0.369 . . . . 0.0 110.621 176.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -75.11 -9.59 58.68 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.79 -171.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.415 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 84.0 mtt85 -97.48 -0.08 46.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.259 0.552 . . . . 0.0 110.191 177.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -118.15 87.44 29.16 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.57 -172.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 7' ' ' ARG . 16.8 Cg_exo -67.83 125.97 13.95 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.412 2.075 . . . . 0.0 111.983 -178.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 30.4 m -90.74 116.39 28.55 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.648 177.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.585 HD11 HD21 ' A' ' 41' ' ' ASN . 88.8 mt -108.85 131.84 54.6 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.18 0.514 . . . . 0.0 111.316 -173.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 m -103.86 99.14 8.91 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.823 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 69.5 mt -106.25 134.35 49.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.043 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.6 m -73.45 142.49 46.87 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.787 0.327 . . . . 0.0 110.75 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.751 HD11 HG13 ' A' ' 53' ' ' VAL . 55.4 tp -87.02 122.25 30.6 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.028 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 48.4 pt -108.93 153.78 10.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.141 0.496 . . . . 0.0 111.398 -179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -82.03 111.22 17.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.968 175.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -109.37 134.76 51.43 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.981 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.1 t30 62.28 18.15 9.94 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.707 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.502 HG23 HD12 ' A' ' 55' ' ' LEU . 31.0 m -72.09 118.95 71.61 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.922 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 20' ' ' THR . 7.0 Cg_exo -72.89 -179.95 4.74 Favored 'Trans proline' 0 C--O 1.237 0.442 0 C-N-CA 122.905 2.403 . . . . 0.0 112.365 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 23' ' ' ASN . . . -80.82 161.43 24.47 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.276 175.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 22' ' ' ALA . 95.3 m-20 75.28 -34.47 0.26 Allowed 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.532 0.733 . . . . 0.0 111.639 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.4 p -76.91 98.49 4.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.369 0.604 . . . . 0.0 109.695 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . 0.692 ' HB2' ' HB2' ' A' ' 92' ' ' HIS . 51.1 ttp -103.0 124.56 48.74 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.639 -174.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.422 HG12 ' CD2' ' A' ' 89' ' ' LEU . 17.4 mt -84.65 97.62 5.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 44.1 ttp -79.05 -20.23 49.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.027 0.441 . . . . 0.0 109.953 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.0 m -75.75 105.97 7.07 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 172.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -54.61 132.25 44.83 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.012 -176.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.51 114.64 29.88 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.438 -176.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -89.2 -161.24 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.936 2.424 . . . . 0.0 112.222 -178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.3 p -120.81 141.95 50.06 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.793 176.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.608 HG11 HG11 ' A' ' 67' ' ' VAL . 25.1 m -93.9 142.86 12.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.923 0.392 . . . . 0.0 109.964 179.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -112.05 93.25 4.36 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 121.456 0.646 . . . . 0.0 109.444 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 80' ' ' ILE . 30.2 m -99.22 162.55 2.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.676 -175.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 36.0 tttm -123.17 122.99 39.8 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.457 HG22 ' HA ' ' A' ' 77' ' ' ILE . 30.5 p -112.77 175.04 5.61 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.78 -175.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 76' ' ' LYS . 28.2 tt0 -123.84 117.51 25.02 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.74 -137.35 9.33 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.196 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.531 ' O ' ' HD3' ' A' ' 42' ' ' PRO . 79.2 m-85 -145.02 157.66 44.05 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.585 HD21 HD11 ' A' ' 11' ' ' LEU . 8.2 m120 -114.44 82.03 7.29 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 40' ' ' TYR . 1.2 Cg_endo -84.84 -68.53 0.01 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.781 2.321 . . . . 0.0 112.766 -176.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.6 p -93.72 -14.69 26.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.116 -178.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.4 mt -86.58 117.63 31.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.619 -176.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.0 t30 -84.79 128.16 34.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.931 -176.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.6 m -71.7 -17.11 19.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.198 -178.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -91.2 -0.04 57.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.143 0.497 . . . . 0.0 110.158 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -102.88 -28.22 12.18 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.2 mt -81.99 135.8 35.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.791 174.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -128.05 156.88 42.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.522 0.677 . . . . 0.0 111.755 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -108.21 138.45 44.47 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 170.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -136.42 151.68 49.77 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 121.472 0.653 . . . . 0.0 112.294 -171.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.751 HG13 HD11 ' A' ' 15' ' ' LEU . 4.9 m -112.54 118.11 56.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.433 169.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -88.68 98.5 11.72 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.79 -174.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.502 HD12 HG23 ' A' ' 20' ' ' THR . 60.1 mt -84.97 67.62 10.26 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.35 0.595 . . . . 0.0 110.248 -177.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.44 -20.73 59.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.18 176.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -99.36 142.51 16.05 Favored Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.248 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 m -92.94 38.12 1.03 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.646 ' HB2' ' OH ' ' A' ' 65' ' ' TYR . 11.1 mm-40 -66.16 110.22 4.38 Favored Pre-proline 0 C--O 1.232 0.174 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.765 -177.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -87.58 141.64 5.67 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.996 2.464 . . . . 0.0 111.994 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 108.21 -168.77 13.9 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.06 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 88' ' ' GLN . 36.3 mt-10 -82.51 97.73 8.58 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -122.77 143.13 50.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.956 -175.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 86' ' ' THR . 28.5 m-20 -81.29 119.91 24.25 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.759 0.314 . . . . 0.0 110.297 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.646 ' OH ' ' HB2' ' A' ' 59' ' ' GLU . 53.6 m-85 -111.03 167.17 10.46 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.15 0.5 . . . . 0.0 111.04 -179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -106.77 122.63 46.75 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.626 -173.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.608 HG11 HG11 ' A' ' 33' ' ' VAL . 67.8 t -79.74 113.82 19.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.293 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -100.83 151.4 21.75 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.708 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 50.5 t -118.44 141.38 38.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -64.26 123.21 81.75 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.65 113.67 1.34 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 123.002 2.468 . . . . 0.0 112.382 -177.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.409 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 48.7 mt -90.94 119.59 68.85 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.757 -176.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 72' ' ' ILE . 11.3 Cg_exo -71.94 149.57 53.52 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.733 2.289 . . . . 0.0 111.647 175.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 72.27 -51.22 0.7 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.589 0.756 . . . . 0.0 111.936 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 62.7 mt -83.89 134.25 27.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.348 0.594 . . . . 0.0 110.811 -177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 38' ' ' GLU . 76.8 tttt -88.87 124.35 34.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.891 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.457 ' HA ' HG22 ' A' ' 37' ' ' THR . 18.0 tt -87.98 133.49 30.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 177.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.701 HG12 ' HG3' ' A' ' 79' ' ' GLU . 43.5 t -112.26 -59.89 3.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-O 121.106 0.479 . . . . 0.0 111.849 -171.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.701 ' HG3' HG12 ' A' ' 78' ' ' VAL . 46.2 mt-10 -125.23 102.79 7.62 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.084 -172.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.563 ' HA ' HG12 ' A' ' 35' ' ' VAL . 53.0 mt -80.18 118.79 28.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 171.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 82' ' ' PRO . 36.5 m -141.58 116.48 7.0 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-O 120.548 0.213 . . . . 0.0 110.915 -177.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.479 ' HD2' HG12 ' A' ' 33' ' ' VAL . 94.6 Cg_endo -87.68 -177.24 12.92 Favored 'Cis proline' 0 C--N 1.343 0.252 0 C-N-CA 123.701 -1.374 . . . . 0.0 112.358 -2.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 83' ' ' ARG . 52.0 mtm180 -122.7 -35.94 2.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.837 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.13 117.74 55.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.042 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 18.1 m -128.39 135.38 62.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.031 0.443 . . . . 0.0 110.846 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 3.9 m -80.09 99.53 7.76 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.097 177.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.554 ' HB2' ' HD2' ' A' ' 65' ' ' TYR . 80.2 mt -96.0 120.98 37.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.035 0.445 . . . . 0.0 109.892 -179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 59.3 tt0 -86.75 97.7 10.75 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.093 178.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 89' ' ' LEU . 28.0 mt -82.04 109.57 16.49 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-O 121.626 0.727 . . . . 0.0 109.698 175.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -101.28 175.29 5.63 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.674 -175.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -91.55 110.44 21.75 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.603 -176.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.692 ' HB2' ' HB2' ' A' ' 25' ' ' MET . 36.7 t-80 -74.37 -15.59 60.93 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 175.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -110.29 100.63 9.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.243 171.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 18.4 m-70 70.61 88.97 0.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 O-C-N 124.129 0.893 . . . . 0.0 111.797 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 70.0 t60 -79.1 -12.37 60.0 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 171.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.4 m80 . . . . . 0 C--O 1.252 1.218 0 CA-C-N 114.664 -1.153 . . . . 0.0 108.851 172.92 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 25.2 t . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.949 ' HA ' ' HB3' ' A' ' 42' ' ' PRO . 15.1 m -56.4 -54.89 40.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.163 0.506 . . . . 0.0 110.107 177.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -126.04 100.83 6.52 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 170.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.534 HG22 ' H ' ' A' ' 6' ' ' ASP . 4.1 m -95.57 154.62 17.12 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.836 -172.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 41.2 tp -65.6 -33.91 77.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 172.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.534 ' H ' HG22 ' A' ' 4' ' ' THR . 28.3 t70 -76.01 93.57 3.29 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 171.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.46 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 22.4 mtm180 -68.16 -56.07 10.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.603 -172.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -103.74 97.22 10.36 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.846 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 7' ' ' ARG . 89.8 Cg_endo -89.21 144.76 5.01 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.884 2.39 . . . . 0.0 113.85 -175.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 21.2 m -88.11 109.19 19.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.291 171.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 42.3 tp -86.64 136.2 33.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.981 -174.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.1 m -101.15 119.26 38.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.432 178.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 76.2 mt -129.45 152.92 48.46 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.218 -176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 p -88.55 151.5 22.46 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.98 0.419 . . . . 0.0 111.091 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.651 HD11 HG13 ' A' ' 53' ' ' VAL . 38.6 tp -92.63 139.31 30.7 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.293 178.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 20.0 pt -127.78 160.33 37.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.441 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.417 ' HB1' HD12 ' A' ' 55' ' ' LEU . . . -109.11 129.12 55.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.365 -179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -120.29 131.87 55.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.092 0.472 . . . . 0.0 111.248 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.6 t30 61.72 46.27 7.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.53 179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.524 ' HB ' HD12 ' A' ' 55' ' ' LEU . 12.1 t -79.36 138.18 55.73 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 173.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_exo -52.51 146.82 32.08 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.811 2.341 . . . . 0.0 112.74 179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.54 -35.56 79.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.825 -176.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -100.74 20.31 15.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.796 0.331 . . . . 0.0 111.861 -176.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 82.4 p -110.61 127.39 55.22 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 174.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' MET . . . . . . . . . . . . . 43.1 ttp -112.6 126.5 55.42 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.228 -175.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.1 mt -84.95 111.7 20.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.396 -175.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 95.5 mmm -83.57 -42.52 16.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.993 0.425 . . . . 0.0 110.439 178.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.2 m -74.26 127.25 32.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.734 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttm -71.96 139.91 48.88 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.697 173.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 64.2 mt -71.78 115.73 40.83 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.79 -173.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 30' ' ' LEU . 22.5 Cg_exo -65.32 172.56 7.49 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.312 2.675 . . . . 0.0 113.627 -174.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 8.8 t -102.9 125.21 49.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.218 178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.581 HG11 HG11 ' A' ' 67' ' ' VAL . 13.2 m -90.59 153.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.976 0.417 . . . . 0.0 110.615 -176.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -130.04 101.62 5.91 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.705 HG11 HG21 ' A' ' 69' ' ' VAL . 34.9 m -104.41 135.05 44.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.859 -175.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 10' ' ' THR . 62.9 tttp -83.62 121.35 27.13 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.501 HG22 ' HA ' ' A' ' 77' ' ' ILE . 20.9 p -121.95 155.35 35.7 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.497 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.51 ' HG3' ' HB3' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -121.1 119.44 32.44 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.978 0.418 . . . . 0.0 110.13 176.033 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.9 169.24 12.75 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.032 178.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -96.0 136.92 35.81 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.481 ' HB3' ' CD1' ' A' ' 75' ' ' ILE . 19.6 p30 -128.96 55.35 17.71 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.949 ' HB3' ' HA ' ' A' ' 2' ' ' SER . 34.3 Cg_endo -67.18 -56.71 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 121.689 1.593 . . . . 0.0 111.987 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.8 m -114.64 38.39 3.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.088 0.471 . . . . 0.0 111.06 -176.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.3 mt -114.66 142.71 26.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.798 177.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -80.63 41.28 0.55 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.991 0.424 . . . . 0.0 111.008 -176.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.442 HG23 ' OD1' ' A' ' 47' ' ' ASN . 11.9 m -61.27 -36.19 71.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.126 -176.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.442 ' OD1' HG23 ' A' ' 46' ' ' VAL . 2.9 m-20 -79.4 -5.43 54.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.099 0.475 . . . . 0.0 110.604 -178.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -106.9 -10.84 15.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.736 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.2 mt -82.25 125.22 30.7 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 171.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -109.5 170.76 7.85 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.66 0.743 . . . . 0.0 112.353 -171.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.478 ' HB2' HG22 ' A' ' 69' ' ' VAL . . . -106.73 137.96 43.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.891 174.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.558 ' CZ ' ' HD3' ' A' ' 68' ' ' LYS . 27.2 p90 -135.29 158.08 45.28 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.615 -178.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.651 HG13 HD11 ' A' ' 15' ' ' LEU . 23.1 m -112.47 141.96 26.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.583 174.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -89.48 118.04 28.83 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.524 HD12 ' HB ' ' A' ' 20' ' ' THR . 85.6 mt -109.16 25.76 11.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.591 -177.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.2 m -73.49 95.32 2.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.309 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.82 23.03 14.25 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.601 179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 59.6 p -88.57 122.96 32.6 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.782 -0.246 . . . . 0.0 110.566 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -75.32 155.08 86.08 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.085 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.54 90.99 0.34 Allowed 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.59 2.193 . . . . 0.0 112.029 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.05 172.87 42.86 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 88' ' ' GLN . 40.0 tt0 -82.24 105.47 13.35 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 66.2 m-70 -130.61 167.9 17.99 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.347 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.431 ' HB3' HG11 ' A' ' 84' ' ' VAL . 13.6 m-20 -98.59 121.84 41.04 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.351 -178.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -116.89 128.09 54.9 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.104 -178.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.425 ' HG2' HG22 ' A' ' 84' ' ' VAL . 46.8 mt-10 -69.95 134.61 48.55 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.204 -175.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.581 HG11 HG11 ' A' ' 33' ' ' VAL . 59.4 t -78.92 112.18 16.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.546 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.558 ' HD3' ' CZ ' ' A' ' 52' ' ' TYR . 53.6 tttm -102.88 102.63 12.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.388 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.705 HG21 HG11 ' A' ' 35' ' ' VAL . 39.4 t -86.86 125.5 40.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 176.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -63.86 127.67 91.93 Favored Pre-proline 0 C--N 1.323 -0.58 0 O-C-N 123.198 0.311 . . . . 0.0 110.958 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.35 137.52 47.28 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.617 2.878 . . . . 0.0 112.92 -175.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.471 ' CG2' ' HB ' ' A' ' 75' ' ' ILE . 30.5 mm -89.17 126.89 57.37 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.262 -177.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -64.1 131.04 29.1 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.286 1.991 . . . . 0.0 111.725 176.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 10.3 t30 73.79 -44.42 0.57 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.538 0.735 . . . . 0.0 111.998 178.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.481 ' CD1' ' HB3' ' A' ' 41' ' ' ASN . 71.5 mt -83.94 140.84 15.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 120.946 0.403 . . . . 0.0 110.682 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.51 ' HB3' ' HG3' ' A' ' 38' ' ' GLU . 57.3 tttp -94.84 125.71 39.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.387 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.501 ' HA ' HG22 ' A' ' 37' ' ' THR . 14.0 tt -88.36 122.21 39.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.498 0.666 . . . . 0.0 109.94 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.3 t -85.31 -64.57 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.069 -175.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -130.51 136.8 49.31 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.113 -170.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.635 ' HA ' HG12 ' A' ' 35' ' ' VAL . 67.5 mt -104.41 108.26 24.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.203 175.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.455 ' HA ' ' C ' ' A' ' 82' ' ' PRO . 11.6 p -136.13 126.93 16.74 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.735 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.455 ' C ' ' HA ' ' A' ' 81' ' ' SER . 15.3 Cg_exo -68.51 156.85 88.81 Favored 'Cis proline' 0 C--N 1.344 0.32 0 C-N-CA 123.55 -1.438 . . . . 0.0 112.508 0.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -85.23 -38.1 19.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.746 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.431 HG11 ' HB3' ' A' ' 64' ' ' ASP . 59.3 t -137.86 143.58 33.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.375 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.8 m -118.26 140.03 43.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.957 0.408 . . . . 0.0 111.011 178.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 7.3 m -92.36 105.2 17.45 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.04 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.9 mt -105.37 124.91 50.34 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.761 -176.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 62' ' ' GLU . 47.0 tt0 -85.8 99.88 11.66 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.012 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.2 mt -88.22 139.52 30.41 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.14 174.0 7.22 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.74 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -83.89 137.57 33.6 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.36 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -74.36 -1.01 19.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.686 0.755 . . . . 0.0 109.296 173.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -104.51 134.85 47.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.307 -0.86 . . . . 0.0 108.839 175.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -87.54 19.21 3.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.303 0.573 . . . . 0.0 110.738 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -117.97 22.97 11.94 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 176.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 . . . . . 0 C--O 1.245 0.832 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.487 -171.238 . . . . . . . . 0 0 . 1 stop_ save_